PHYTOCHEMICALS
June 1, 2022SEX HORMONE BINDING GLOBULIN
August 3, 2022- Stem cell therapy in perspective
- Adult Stem cell therapy in perspective
- Stem cell therapy for human neurodegenerative disorders–how to make it work
- Stable benefit of embryonic Stem cell therapy in myocardial infarction
- Stem–cell therapy for diabetes mellitus
- New prospects for human Stem–cell therapy in the nervous syStem
- Neural Stem cell therapy for neurological diseases: dreams and reality
- Stem cell therapy in a caprine model of osteoarthritis
- Stem cell therapy and gene transfer for regeneration
- Adult Stem cell therapy for the heart
- Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
- Nonmyeloablative Stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of …
- Mesenchymal Stem cell therapy in joint disease
- The effect of neural embryonic Stem cell therapy in a rat model of cavernosal nerve injury
- Stem–cell therapy for amyotrophic lateral sclerosis
- Potential of hematopoietic Stem cell therapy in hepatology: a critical review
- Becoming immortal: Combining cloning and Stem–cell therapy
- 28. Embryonic and adult Stem cell therapy
- Dentin regeneration by dental pulp Stem cell therapy with recombinant human bone morphogenetic protein 2
- Stem cell and precursor cell therapy
- Stem cell therapy for ischemic heart disease
- Intervertebral disc cell therapy for regeneration: mesenchymal Stem cell implantation in rat intervertebral discs
- Stem cell therapy for ocular disorders
- Potential Stem cell therapy and application in neurotrauma
- Stem cell therapy of the liver—fusion or fiction?
- Stem cell therapy for diabetes: do we need to make beta cells?
- Stem cell therapy for myocardial repair: is it arrhythmogenic?
- Neural Stem cell therapy in the aging brain: pitfalls and possibilities
- Stem cell therapy for urinary incontinence
- Stem–cell therapy for renal diseases
- Stem cell therapy forcerebral palsy
- Genetically engineered Stem cell therapy for tissue regeneration
- Emerging neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and Stem cell therapy
- Hematopoietic Stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis
- In utero Stem cell therapy.
- Stem cell therapy for Parkinson’s disease: where do we stand?
- Stem cell therapy for the infarcted heart (“cellular cardiomyoplasty”)
- Monitoring Stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents
- Stem cell therapy for muscular dystrophy
- Stem cell therapy in ischemic heart disease
- Adult Stem cell therapy for heart failure
- Stem–cell therapy for myocardial diseases
- Stem cell therapy for the heart
- Stem cell therapy of cardiac disease: an update
- Applications of magnetic resonance imaging for cardiac Stem cell therapy
- The origin and development of the immune syStem with a view to Stem cell therapy
- Stem cell origin of cancer and differentiation therapy
- Novel approaches to allogeneic Stem cell therapy
- Autologous bone marrow-derived Stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases.
- Immune ablation and Stem–cell therapy in autoimmune disease-Clinical experience
- Stem–cell therapy for amyotrophic lateral sclerosis
- Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation
- Hematopoietic Stem cell therapy of autoimmune diseases.
- Three-dimensional approach to Stem cell therapy
- Editorial Stem cell therapy in human ALS
- Stem cell therapy in utero
- Human embryonic Stem cell therapy
- Stem cell plasticity: the growing potential of cellular therapy
- Pancreatic islet and Stem cell transplantation: new strategies in cell therapy of diabetes mellitus.
- Cardiovascular disease: potential impact of Stem cell therapy
- From Stem cells to beta cells: new strategies in cell therapy of diabetes mellitus
- Additional Stem cell therapy for graft failure after allogeneic bone marrow transplantation
- Stem cell therapy for ALS: Hope and Reality A discussion paper from the Executive of the European ALS Consortium
- Allogeneic cell therapy for patients who relapse after autologous Stem cell transplantation
- Stem cell plasticity or fusion: two approaches to targeted cell therapy
- Augmentation of virus-specific immunity after hematopoietic Stem cell transplantation by adoptive T-cell therapy
- Stem cell therapy for myocardial infarction
- Stem cell therapy in acute myocardial infarction
- Stem cell therapy for neurological disease and injury.
- Correction of ADA-SCID by Stem cell gene therapy combined with nonmyeloablative conditioning
- Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach
- Bone-marrow Stem cells as a source for cell therapy
- Stem–cell therapy: what dose should we use?
- Stem‐cell plasticity and therapy for injuries of the peripheral nervous syStem
- Public Stem cell banks: considerations of justice in Stem cell research and therapy
- Hematopoietic Stem cell compartment: acute and late effects of radiation therapy and chemotherapy
- Immune ablation and Stem–cell therapy in autoimmune disease: experimental basis for autologous Stem–cell transplantation
- Stem cells for cell therapy in Parkinson’s disease
- Dendritic-cell therapy after non-myeloablative Stem–cell transplantation for renal-cell carcinoma
- Nuclear transplantation, embryonic Stem cells and the potential for cell therapy
- Mylotarg™(gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received Stem cell transplantation
- cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy
- Comparison of high-dose therapy and autologous Stem–cell transplantation with conventional therapy for Hodgkin’s disease induction failure: a case-control study
- Autologous Stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy
- Current status and perspectives of Stem cell therapy for the treatment of diabetes mellitus
- Neural Stem cells in the developing central nervous syStem: implications for cell therapy through transplantation
- Nuclear transplantation, embryonic Stem cells, and the potential for cell therapy
- Exogenously regulated Stem cell-mediated gene therapy for bone regeneration
- The potential for Stem cell therapy in cystic fibrosis.
- High-dose therapy with autologous Stem cell transplantation in patients with peripheral T cell lymphomas
- Neuroreplacement therapy and Stem cell biology under disease conditions
- Stem cell gene therapy for chronic renal failure
- In utero hematopoietic Stem cell therapy
- Embryonic Stem cell therapy in experimental stroke: host-dependent malignant transformation
- Adoptive cellular therapy for early cytomegalovirus infection after allogeneic Stem–cell transplantation with virus-specific T-cell lines
- Prostate Stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate
- Influenza infections after hematopoietic Stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy
- Music therapy for mood disturbance during hospitalization for autologous Stem cell transplantation: a randomized controlled trial
- The potential of marrow stromal cells in Stem cell therapy
- cell therapy using human embryonic Stem cells
- Impact on survival of high-dose therapy with autologous Stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population …
- High-dose therapy and autologous peripheral blood Stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential …
- High‐dose therapy with autologous haemopoietic Stem cell support for Waldenström’s macroglobulinaemia
- A new concept of Stem cell disorders and their new therapy
- … response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic Stem cell transplantation. Myeloma Subcommittee of the …
- Autologous peripheral hematopoietic Stem cell transplantation restores hematopoietic function following marrow ablative therapy
- Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous Stem cell transplantation for relapsed B cell lymphomas
- A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic Stem cell transplantation
- Paradigms of adult Stem cell therapy for type 1 diabetes in mice
- CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic Stem–cell transplantation
- … ablation and Stem–cell therapy in autoimmune disease Immunological reconstitution after high-dose immunosuppression and haematopoietic Stem–cell …
- Rituximab and ICE as second-line therapy before autologous Stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
- Heal thyself: Potential applicability of Stem cell therapy in the management of heart disease
- Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting
- The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic Stem cell transplantation
- High-dose immunosuppressive therapy and autologous peripheral blood Stem cell transplantation for severe multiple sclerosis
- … impact of cytomegalovirus serostatus of donor and recipient before hematopoietic Stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic Stem cell transplantation
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic Stem cell transplantation: risk factors, correlation with DNA …
- Prognostic factors for survival and response after high‐dose therapy and autologous Stem cell transplantation in syStemic AL amyloidosis: a report on 21 patients
- Parainfluenza virus infections after hematopoietic Stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
- High-dose therapy and autologous peripheral blood Stem cell transplantation for patients with lymphoma
- Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy
- 486: Stem cell therapy in Treatment of Urinary Incontinence: First Clinical Results
- Mesenchymal Stem–cell therapy in a regulated environment
- therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous Stem cell transplantation
- Stem cell therapy in scleroderma
- High-dose therapy and autologous blood Stem cell transplantation in POEMS syndrome
- First-line therapy with thalidomide and dexamethasone in preparation for autologous Stem cell transplantation for multiple myeloma
- Intensive therapy with peripheral Stem cell transplantation in 16 patients with mantle cell lymphoma
- Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic Stem cell transplantation: Presented in …
- Infectious complications after allogeneic Stem cell transplantation: epidemiology and interventional therapy strategies
- Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and Stem–cell rescue: results of the Chicago Pilot II Study
- Viral interleukin-10–engineered autologous hematopoietic Stem cell therapy: a novel gene therapy approach to prevent graft rejection
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of multiple myeloma: an evidence-based review
- Thoracic transplantation and Stem cell therapy
- High-dose therapy with Stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience
- P75. Feasibility of Stem cell therapy for intervertebral disc degeneration
- Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic Stem cell transplantation: a phase …
- Imatinib mesylate therapy for relapse after allogeneic Stem cell transplantation for chronic myelogenous leukemia
- High-dose therapy and autologous Stem cell transplantation for multiple myeloma poorly responsive to initial therapy
- Prognostic factors for survival after high-dose therapy and autologous Stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients …
- Should immunoglobulin therapy be used in allogeneic Stem–cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
- Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood Stem cell support
- Relationship between spermatogonial Stem cell survival and testis function after cytotoxic therapy.
- High-dose melphalan, etoposide, total-body irradiation, and autologous Stem–cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not …
- High-dose therapy and autologous Stem–cell transplantation for adult patients with Hodgkin’s disease who do not enter remission after induction chemotherapy: results …
- The role of high-dose therapy and autologous hematopoietic Stem cell transplantation for mantle cell lymphoma
- Stem cell strategies for neuroreplacement therapy in Alzheimer’s disease
- Immune reconstitution to cytomegalovirus after allogeneic hematopoietic Stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
- High-dose intravenous melphalan and autologous Stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of …
- Blood Stem cell transplantation as therapy for primary syStemic amyloidosis (AL)
- … dose therapy and autologous Stem–cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients …
- Endocrine complications of high‐dose therapy with Stem cell transplantation
- A human umbilical cord Stem cell rescue therapy in a murine model of toxic liver injury
- High-dose therapy and autologous haematopoietic Stem–cell transplantation for HIV-1-associated lymphoma
- Hematopoietic Stem cell transplantation: a new therapy for autoimmune disease
- Implications of long-term survival in acute Stem cell leukemia of childhood treated with composite cyclic therapy
- … and autologous peripheral-blood Stem–cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy
- Pluripotent Stem cells–model of embryonic development, tool for gene targeting, and basis of cell therapy
- Sequential chemotherapy regimens followed by high-dose therapy with Stem cell transplantation in mantle cell lymphoma: an update of a prospective study
- Adult Burkitt’s and Burkitt-like non-Hodgkin’s lymphoma–outcome for patients treated with high-dose therapy and autologous Stem–cell transplantation in first remission …
- Hematopoietic Stem cell gene therapy: selecting only the best
- … reconstitution after autologous hematopoietic Stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications
- … followed by high-dose therapy with Stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell …
- High-dose therapy and autologous Stem–cell support for chemosensitive transformed low-grade follicular non-Hodgkin’s lymphoma: a case-matched study from the …
- Hormonal replacement therapy after Stem cell transplantation
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic Stem cell transplantation for relapsed follicular non-Hodgkin …
- Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and Stem cell rescue
- Myeloablative therapy with blood Stem cell transplantation is effective in mantle cell lymphoma.
- Temporary corneal Stem cell dysfunction after radiation therapy.
- Early autologous Stem–cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin’s lymphoma: an Italian …
- Therapeutic Effects of Massage therapy and Healing Touch on Caregivers of Patients Undergoing Autologous Hematopoietic Stem cell Transplant.
- Progress toward vector design for hematopoietic Stem cell gene therapy
- Embryonic and adult Stem cells as a source for cell therapy in Parkinson’s disease
- High-dose therapy followed by autologous hematopoietic Stem–cell infusion for patients with multiple myeloma.
- … relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and Stem cell rescue at the time of maximal response to conventional salvage therapy …
- cell-replacement therapy with Stem cells in neurodegenerative diseases
- Retroviral Stem cell gene therapy
- Mesenchymal Stem cells: cell biology and potential use in therapy
- High-dose therapy followed by autologous peripheral-blood Stem–cell transplantation for patients with Hodgkin’s disease and non-Hodgkin’s lymphoma using …
- Human pancreatic Stem cell and diabetes cell therapy
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence …
- Current antiviral strategies for controlling cytomegalovirus in hematopoietic Stem cell transplant recipients: prevention and therapy
- Risk to the coronary arteries of intracoronary Stem cell infusion and G-CSF cytokine therapy.
- High-dose therapy and autologous Stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT
- Therapeutic cloning and Stem cell therapy
- Stem cells in cardiovascular disease: from cell biology to clinical therapy
- … emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with Stem cell …
- … photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic Stem cell …
- Haematopoietic Stem cell transplantation and gene therapy in the fetus: ready for clinical use?
- High-dose therapy plus autologous hematopoietic Stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV …
- … -emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic Stem cell transplantation: a single …
- Stem cell transplantation therapy: controversy over ethical issues and clinical relevance.
- Adult Stem cell technology-prospects for cell based therapy in regenerative medicine
- High-dose chemotherapy followed by autologous Stem cell transplantation as first-line therapy in aggressive non-Hodgkin’s lymphoma: a meta-analysis
- Second malignancy following high-dose therapy and autologous Stem cell transplantation: incidence and risk factor analysis
- Epstein-Barr virus (EBV) reactivation in allogeneic Stem–cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
- Myeloablative radiochemotherapy followed by autologous peripheral blood Stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of …
- High-dose therapy with autologous Stem–cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …
- High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow Stem cell transplant recipients
- Hematopoietic Stem cell gene therapy: progress toward therapeutic targets
- Stem cell biology and gene therapy
- High-dose therapy with autologous Stem cell rescue for pediatric sarcomas
- … lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic Stem cell transplantation for severe …
- Parainfluenza virus type 3 infections in hematopoetic Stem cell transplant recipients: response to ribavirin therapy
- 10 Current status of Stem cell therapy and prospects for gene therapy for the disorders of globin synthesis
- Hematopoietic Stem cell gene therapy
- Stem cell Gene therapy for the β‐Chain Hemoglobinopathies: Problems and Progressa
- Hematopoietic Stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy [see comments]
- High-dose consolidation therapy with autologous Stem cell rescue in stage IV breast cancer.
- High-dose therapy/autologous Stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission
- Stem cell therapy and research
- High-dose immunoablative therapy with hematopoietic Stem cell support in the treatment of severe autoimmune disease: current status and future direction
- High-dose chemotherapy (HDC) and autologous hematopoietic Stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
- High-dose consolidation therapy with autologous Stem–cell rescue in stage IV breast cancer: follow-up report.
- Toward Epidermal Stem cell-Mediated ex Vivo Gene therapy of Junctional Epidermolysis Bullosa
- Mesenchymal Stem cells from the bone marrow stroma: basic biology and potential for cell therapy
- High-dose multimodality therapy with autologous Stem–cell support for stage IIIB breast carcinoma.
- … load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic Stem cell …
- Single agent dexamethasone for pre-Stem cell transplant induction therapy for multiple myeloma
- Efficacy of high-dose therapy and autologous hematopoietic Stem cell transplantation for non-Hodgkin’s lymphoma in adults 60 years of age and older
- Arsenic Trioxide (Trisenox®) therapy for Acute Promyelocytic Leukemia in the Setting of Hematopoietic Stem cell Transplantation
- Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic Stem cell transplantation: a pilot study
- Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and Stem cell …
- … high-dose cyclophosphamide without Stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease
- High dose therapy and autologous Stem cell transplantation for human immunodeficiency virus‐associated non‐Hodgkin lymphoma in the era of highly active …
- Autologous peripheral blood Stem cell transplantation after high dose therapy in patients with advanced lymphomas.
- Hematopoietic Stem cell gene therapy: a current overview.
- Muscle-derived Stem cells: characterization and potential for cell-mediated therapy
- Immunotherapy with rituximab following high-dose therapy and autologous Stem–cell transplantation for mantle cell lymphoma
- Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA‐identical hematopoietic Stem cell …
- … with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood Stem cell transplantation in elderly …
- therapy with imatinib mesylate (Glivec) preceding allogeneic Stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute …
- High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood Stem cell support in unresectable osteosarcoma
- Benefit of aggressive multimodality therapy with autologous Stem cell support for intra-abdominal desmoplastic small round cell tumor
- Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic Stem cell transplantation
- Stem–cell therapy for myocardial diseases
- Cytokine production during myeloablative and reduced intensity therapy before allogeneic Stem cell transplantation
- High risk of therapy-related leukemia after BEAM chemotherapy and autologous Stem cell transplantation for previously treated lymphomas is mainly related to primary …
- Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic Stem cell transplantation
- Results of high-dose therapy and autologous bone marrow/Stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma …
- Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic Stem cell …
- High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous Stem cell transplantation in Hodgkin’s disease and non-Hodgkin’s …
- Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic Stem cell transplantation
- Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous Stem cell transplant
- Stem cell gene therapy, position effects and chromatin insulators
- Role for high-dose therapy with autologous hematopoietic Stem cell support in Waldenstrom’s macroglobulinemia
- The hematopoietic Stem cell therapy for exploration of deep space
- … mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic Stem cell transplantation: a prospective …
- … determinant (CD) 34+ cell dose on the cost and consequences of peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma patients in front-line therapy
- Sequential high-dose therapy and autologous Stem cell transplantation for treatment of mantle cell lymphoma
- High-dose therapy and autologous Stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive …
- Adult mesenchymal Stem cells: characterization, differentiation, and application in cell and gene therapy
- Evaluation of the risk of therapy-related MDS/AML after autologous Stem cell transplantation
- Intensification of therapy using hematopoietic Stem‐cell support for high‐risk neuroblastoma
- Strategies for hematopoietic Stem cell gene therapy: insights from computer simulation studies
- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic Stem cell transplantation
- Stem cell defects after cytoreductive therapy in man.
- … with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or Stem cell rescue therapy
- Myeloma cell contamination of peripheral blood Stem cell grafts in patients with multiple myeloma treated by high-dose therapy.
- Embryonic Stem cell grafting: the therapy of the future?
- Transabdominal first trimester embryofetoscopy as a potential approach to early in utero Stem cell transplantation and gene therapy
- Single center experience of a new intensive induction therapy for Ewing’s family of tumors: feasibility, toxicity, and Stem cell mobilization properties
- Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic Stem cell transplantation
- High-dose therapy and autologous Stem cell transplantation in relapsing cutaneous lymphoma
- Peripheral blood Stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study
- … (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem cell …
- Where next with Stem–cell-supported high-dose therapy for breast cancer?
- Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high‐dose therapy and peripheral blood Stem cell transplantation
- Lymphoid development and function in X-linked severe combined immunodeficiency mice after Stem cell gene therapy
- Consolidation therapy with autologous Stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three …
- Analysis of feasibility of myeloablative therapy and autologous peripheral Stem cell (PBSC) transplantation in the elderly: an interim report
- Embryonic Stem cells in vitro-prospects for cell and developmental biology, embryotoxicology and cell therapy
- Peripheral blood Stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood …
- An update on the role of high-dose therapy with autologous or allogeneic Stem cell transplantation in mantle cell lymphoma
- Hematopoietic Stem cell transplantation for cancer therapy
- Hematopoietic Stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid …
- Hematopoietic Stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
- Superiority of double over single autologous Stem cell transplantation as first-line therapy for multiple myeloma.
- … (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic Stem cell …
- Twelve years experience with high-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s disease patients in first remission after MOPP/ABVD …
- Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood Stem cell transplantation
- The role of autologous Stem cell reconstitution in intensive therapy for resistant neoplasms
- Nonmyeloablative therapy and allogeneic hematopoietic Stem cell transplantation
- Decitabine with allogeneic peripheral blood Stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study
- Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous Stem cell transplantation for salvage therapy in B-NHL
- The place of high-dose therapy with haemopoietic Stem cell transplantation in relapsed and refractory Hodgkin’s disease
- siRNAs, ribozymes and RNA decoys in modeling Stem cell-based gene therapy for HIV/AIDS.
- Clinically‐based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic Stem cell …
- Embryonic Stem cell research and therapy: the need for a common European legal framework
- … high-dose chemotherapy with granulocyte colony-stimulating factor and autologous Stem–cell transplantation support as first-line therapy in high-risk diffuse large-cell …
- Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood Stem cell transplantation …
- Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in children: results of a prospective …
- Nutritional support of the patient receiving high-dose therapy with hematopoietic Stem cell support
- … Stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with α/β hepatosplenic T-cell …
- … boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high‐risk allogeneic hematopoietic Stem cell transplantation. Scedosporiasis and …
- Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic Stem cell transplantation
- … long‐term hematologic recovery despite a marked quantitative defect in the Stem cell compartment of patients with aplastic anemia after immunosuppressive therapy
- Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic Stem cell transplant …
- Potential use of human Stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias
- Effectiveness of high‐dose MCNU therapy and hematopoietic Stem cell autografts treatment of childhood acute leukemia/lymphoma with high‐risk features
- Interleukin-2 therapy after bone marrow or Stem cell transplantation for hematologic malignancies.
- Cytokines: value-added products in hematopoietic Stem cell gene therapy
- … of Multiple Myeloma and Breast Cancer cells by TH9402‐mediated Photodynamic therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem cell …
- Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic Stem cell transplantation
- Autologous Stem cell transplantation for AL amyloidosis: a standard therapy?
- A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in adults
- Hematopoietic Stem cell gene therapy: towards clinically significant gene transfer efficiency.
- Minimal residual disease–based role of imatinib as a first-line interim therapy prior to allogeneic Stem cell transplantation in Philadelphia chromosome–positive acute …
- Search for a cure for idiopathic pulmonary fibrosis: is Stem cell therapy a light at the end of a long tunnel?
- Stem cell Transplantationfor Leukemias Following Myelodysplastic Syndromesor Secondaryto Cytotoxic therapy
- Hematopoietic Stem cell–based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and …
- Stem cell therapy (Aastrom Biosciences Inc).
- High-dose chemotherapy with Stem cell rescue as initial therapy for anaplastic oligodendroglioma
- Directed mobilization of endogenous neural progenitor cells: the intersection of Stem cell biology and gene therapy.
- High‐dose intravenous methotrexate followed by autologous Stem cell transplantation as a potentially effective therapy for neurolymphomatosis
- 6The role of haematopoietic Stem cell-supported myeloablative therapy for the management of multiple myeloma
- Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood Stem cell transplantation
- Early intensive therapy with autologous Stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry
- Ultrasound-guided Stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy
- Hematopoietic Stem cell therapy for multiple sclerosis
- The remission status before and the PCR status after high-dose therapy with peripheral blood Stem cell support are prognostic factors for relapse-free survival in …
- Hematopoietic Stem cell gene replacement therapy
- … by non-myeloablative allogeneic Stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
- Peripheral blood Stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow …
- Stem cell therapy for intervertebral disc diseases in vitro and in vivo feasibility study
- The leukemogenic risk of integrating retroviral vectors in hematopoietic Stem cell gene therapy applications.
- Functional organization of the hematopoietic Stem cell compartment: implications for cancer and its therapy.
- The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood Stem cell rescue
- … suppression and autologous hematopoietic Stem cell transplantation in severe Crohn’s disease refractory to immunosuppressive and immunomodulator therapy
- Micro-injection-mediated hematopoietic Stem cell gene therapy.
- Early allogeneic blood Stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid …
- Fetal immune suppression as adjunctive therapy for in utero hematopoietic Stem cell transplantation in nonhuman primates
- Development of a modified selective amplifier gene for hematopoietic Stem cell gene therapy
- Embryonic Stem cells: a promising tool for cell replacement therapy
- Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic Stem cell transplant in children: results of a prospective randomized trial
- Value of autologous Stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS …
- Late infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- Stem cell gene therapy: a breakthrough combination magnified by therapeutic Stem cell homing
- Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous Stem cell transplantation
- Peripheral blood Stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin’s lymphoma
- Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after Stem cell transplantation: effective monitoring of CMV infection by quantitative …
- Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood Stem cell-based gene therapy
- Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood Stem cell transplantation for lymphoma
- Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic Stem cell transplantation
- Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood Stem cell transplant when started soon after engraftment
- Bone marrow Stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type …
- Front-line high-dose therapy with autologous Stem cell transplantation for high risk Hodgkin’s disease: comparison with combined-modality therapy
- Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical Stem cell transplantation
- Plasticity of skeletal muscle differentiation generating Stem cell-like phenotype: Possible application to cell therapy for muscular diseases
- The Hematopoietic Stem cell therapy for Exploration of Space
- Selective expansion of transduced cells for hematopoietic Stem cell gene therapy
- Progress towards hematopoietic Stem cell gene therapy.
- Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic Stem cell …
- When to harvest peripheral-blood Stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in …
- Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for Stem cell‐based gene therapy
- Autologous blood Stem cell transplantation as therapy for autoimmune diseases
- High‐dose therapy/Stem cell support: Comparison of mice and humans
- High‐dose therapy with Stem cell rescue for pediatric solid tumors: Rationale and results
- Transfusion therapy in the patient undergoing hematopoietic Stem cell transplantation
- Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood Stem cell transplantation
- Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic Stem cell transplantation
- Multivalent anti-CCR5 ribozymes for Stem cell-based HIV type 1 gene therapy
- Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic Stem cell transplantation: effect of aminoglycoside therapy
- High-dose therapy with Stem–cell transplantation in the malignant lymphomas.
- … Stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved Stem cell …
- Treatment of mantle-cell lymphomas with the VAD+/− chiorambucil regimen with or without subsequent high-dose therapy and peripheral blood Stem–cell …
- … Stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized Stem cell grafts …
- High-dose therapy and autologous peripheral Stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone …
- … of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood Stem cell …
- Technology evaluation: Stem–cell therapy, Aastrom Biosciences Inc.
- … colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic Stem cell transplantation for lymphoid …
- The present role of bone marrow and Stem cell transplantation in the therapy of children with acute leukemia.
- Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H. 82 with autologous Stem cell support and cyclosporin A
- Stem cell transplantation and gene therapy for HIV-related lymphomas
- High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood Stem cell support in the adjuvant therapy of high-risk breast cancer: a practical …
- High-dose therapy and Stem cell transplantation in follicular lymphoma
- Allogeneic hematopoietic Stem–cell transplantation: the next generation of therapy for metastatic renal cell cancer
- … for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic Stem cell transplantation depends on …
- Autologous peripheral blood Stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome
- Retroviral vector design studies toward hematopoietic Stem cell gene therapy for mucopolysaccharidosis type I
- Adult Stem cells and their importance in cell therapy.
- A novel sub-population of bone marrow–derived myocardial Stem cells: potential autologous cell therapy in myocardial infarction
- Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and Stem cell transplant
- Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic Stem cell transplantation
- High dose therapy and autologous Stem cell transplantation in follicular non-Hodgkin’s lymphoma
- Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood Stem cell transplantation for invasive thymoma
- High dose therapy and autologous hematopoietic Stem cell transplantation in poor risk solid tumors of childhood.
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin’s lymphoma
- Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and Stem cell rescue. A feasibility study
- … carboplatin and interleukin-2 (IL-2) activated autologous Stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma–a …
- Filgrastim‐induced Stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging
- The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and Stem cell gene therapy for AIDS
- Intensive therapy and autologous Stem cell transplantation for Hodgkin’s disease in first relapse after combination chemotherapy
- Stem cell-based gene therapy
- Stem–cell depletion and grid therapy
- Adult Stem cell therapy: Imagining Futures in cell Biology
- Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood Stem cell transplantation and interferon-alpha
- … of autologous Stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy
- Consolidation therapy with autologous blood Stem cell transplantation in a patient with primary plasma cell leukaemia
- … therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral Stem cell rescue.
- Intermediate‐dose melphalan (IDM) combined with G‐CSF (filgrastim) is an effective and safe induction therapy for autologous Stem cell transplantation in multiple …
- … therapy for Hodgkin’s disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous Stem …
- Stem cell therapy: medical advance or moral challenge?
- Experience with liposomal Amphotericin‐B in 60 patients undergoing high‐dose therapy and bone marrow or peripheral blood Stem cell transplantation
- In utero hematopoietic Stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases
- … non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem–cell transplantation: changing the natural history with monoclonal antibody therapy
- Future cure of hearing disorders? Gene therapy and Stem cell implantation are possible new therapeutic alternatives
- Thiotepa and cyclophosphamide with Stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and …
- High‐dose therapy and autologous blood Stem cell transplantation in multiple myeloma: Preliminary results of a randomized trial involving 167 patients
- Interferon-α therapy following autologous peripheral blood Stem cell transplantation for adult T cell leukemia/lymphoma
- Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood Stem–cell support as front-line therapy
- Hematopoietic Stem cell gene therapy for Niemann–Pick disease and other lysosomal storage diseases
- Neural Stem cells are uniquely suited for cell replacement and gene therapy in the CNS
- Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood Stem cells
- Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood Stem cell support is an effective adjuvant treatment for high-risk primary breast …
- Donor chimerism and Stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: effects of a retroviral-mediated gene transfer …
- Stem cell therapy for severe autoimmune diseases
- … use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic Stem cell transplantation as consolidation therapy for high-risk …
- Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic Stem cell transplantation
- … survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with Stem cell transplantation: a retrospective …
- therapy-related myelodysplastic syndrome after autologous Stem cell transplantation for breast cancer
- … significance of the detection of tumour cells in peripheral blood Stem cell collections in stage II and III breast cancer patients treated with high-dose therapy
- Male germ line Stem cells: from cell biology to cell therapy?
- High dose therapy with autologous Stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence
- Cytomegalovirus following Stem cell transplantation: from pharmacologic to immunologic therapy
- High-dose therapy followed by Stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin’s lymphoma
- High-dose therapy and autologous Stem cell rescue for poor risk and refractory lymphoma: a single centre experience of 123 patients.
- The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic Stem cell transplantation for patients with chronic myelogenous …
- Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood Stem cell transplantation
- … of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood Stem cell …
- High-dose therapy with Stem cell support in solid tumors
- cell sources and support programs for Stem cell research and cell-based therapy in the USA
- Immune ablation and Stem–cell therapy in autoimmune disease Introduction
- Current status in intrauterine fetal Stem cell therapy
- … exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic Stem cell …
- Allogeneic Stem cell–Derived “Repair Unit” therapy and the Barriers to Clinical Deployment
- Autologous Stem cell therapy for syStemic vasculitis
- Diabetes therapy boosts Stem–cell campaign
- Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood Stem cell transplantation when started soon after …
- A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood Stem cell transplantation as initial therapy for patients with high-risk non …
- Stem–cell gene therapy moves toward approval: an NIH advisory committee gives the nod to a new strategy for genetic therapy based on a rare type of blood cell
- Dog leukocyte antigen-haploidentical Stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model
- The case for and against high-dose therapy with Stem cell rescue for early poor prognosis Hodgkin’s disease in first remission
- Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous Stem cell …
- Neural Stem cells–a versatile tool for cell replacement and gene therapy in the central nervous syStem: Section Editor: Roderick R McInnes e‐mail: mcinnes@ sickkids …
- Cidofovir for cytomegalovirus-preemptive therapy in Stem cell transplant recipients
- Autologous Stem cell Transplantation as First Line therapy in Peripheral T cell Lymphomas. Update of a Prospective Multicenter Study.
- 1432: The Effect of Neural Embryonic Stem cell therapy in a Rat Model of Cavernous Nerve Injury
- In vitro T lymphopoiesis: a model syStem for Stem cell gene therapy for AIDS
- Immune therapy for EBV infections after hemopoietic Stem–cell transplant
- Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous Stem cell support
- High‐dose therapy with peripheral blood Stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment
- … ‐dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood Stem cell …
- Autologous Stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin’s disease in first complete remission after MOPP/ABVD
- Autologous blood Stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong …
- High-dose therapy with peripheral blood Stem cell transplantation for patients with relapsed or refractory Hodgkin’s disease: long-term outcome and prognostic factors
- … antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through Stem cell factor/granulocyte-macrophage …
- A human pluripotent Stem cell in the blood of adults: towards a new cellular therapy for tissue repair
- PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous Stem cell transplantation is a prognostic factor for event-free survival …
- … /nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential Stem cell.
- High dose therapy followed by autologous peripheral blood Stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study
- Neural Stem cell therapy
- Circulating hematopoietic Stem cell populations in human fetuses: implications for fetal gene therapy and alterations with in utero red cell transfusion
- … -associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by Stem cell gene therapy but require different …
- … of interferon tolerance after autologous bone marrow or peripheral blood Stem cell transplants for myeloma patients who have responded to induction therapy
- … suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous Stem cell …
- Tandem high-dose therapy followed by autologous Stem–cell transplantation for refractory or relapsed high grade non-Hodgkin’s lymphoma with poor prognosis …
- Efficacy and toxicity of sequential high-dose therapy with peripheral blood Stem cell support in patients with high-risk breast cancer.
- Hematopoietic Stem cell gene therapy: progress and prospects
- Purging of contaminating breast cancer cells from hematopoietic Stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation
- … cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood Stem cell harvests and bone marrow after therapy
- Embryonic Stem cell therapy: Progress and Perspectives
- High-dose combined alkylating agent therapy with autologous Stem cell support and chest radiotherapy for limited small-cell lung cancer
- Allogenic Stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution
- Development of gene therapy for hematopoietic Stem cell using viral vectors
- Stem cell therapy: prospects and
- Toxic megacolon: a life-threatening complication of high-dose therapy and autologous Stem cell transplantation among patients with AL amyloidosis
- Blood Stem cell transplantation and gene therapy of cancer
- MESENCHYMAL Stem cell therapy IN GROWTH PLATE CARTILAGE INJURY
- Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic Stem cell transplantation
- Repetitive low-dose radiation therapy for acute Stem–cell leukemia
- Modeling human hematopoietic Stem cell gene therapy in nonhuman primates.
- The role of high-dose therapy with hematopoietic Stem cell rescue in low-grade non-Hodgkin’s lymphoma
- Intensified daunorubicin in induction therapy and autologous peripheral blood Stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute …
- Mobilization of peripheral blood Stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in …
- High-dose chemotherapy and autologous Stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer …
- Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous Stem cell support in patients …
- Survival after high-dose therapy with autologous Stem cell support
- Stem–cell researchers offer possible therapy for diabetes
- Hematopoietic Stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges
- ESHAP+/− Rituximab as Salvage therapy for Relapsed Lymphoma Prior to Stem cell Transplant: Single Institution Experience.
- Stem cell (CFU-S) inhibitory peptides: Biological properties and application of pEEDCK as hemoprotector in cytostatic tumor therapy
- High-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s lymphoma: a single center experience
- Outcome after Second Autologous Stem cell Transplantation as Salvage therapy in Patients with Relapsed Multiple Myeloma.
- Complications after high dose therapy and autologous Stem cell transplantation. Retrospective study of an unselected patient sample
- Feasibility of using autologous transplantation to evaluate hematopoietic Stem cell-based gene therapy strategies in transgenic mouse models of human …
- … in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood Stem cell …
- Pulmonary infiltrates after cytokine therapy for Stem cell transplantation: massive deposition of eosinophil major basic protein detected by immunohistochemistry
- Hematopoietic Stem cell therapy.
- THE ETHICS OF Stem cell therapy
- High-dose therapy with autologous bone marrow Stem cell support in primary and metastatic human breast cancer
- Hematopoietic Stem cell autografts in support of myeloablative therapy for multiple myeloma
- The third conference on hematopoietic Stem cell gene therapy: biology and technology
- Survival Following Etanercept therapy for the Treatment of Idiopathic Pneumonia Syndrome Post Allogeneic Stem cell Transplantation.
- Excellent disease eradication by myeloablative therapy and Stem–cell transplantation in patients with acute myelogenous leukemia
- Phase I/II trials of autologous peripheral blood Stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the …
- NOVEL CLINICAL CONCEPTS ON Stem cell therapy: 336
- Monoclonal antibody therapy with autologous peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma
- Lamivudine therapy for acute hepatitis B infection following peripheral blood Stem cell transplantation
- The addition of topotecan to carboplatin and paclitaxel as first-line therapy for advanced ovarian cancer; is it possible only with peripheral blood Stem cell support?
- … high dose therapy and autologous Stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s disease responding to first line therapy
- Results of a Multi-Center Randomized Phase II Trial of Thalidomide and Prednisone Maintenance therapy for Multiple Myeloma Following Autologous Stem cell …
- Mesenchymal and nonhematopoietic Stem–cell therapy
- Neurosurgical Stem cell therapy
- A Stem cell therapy for stroke
- Embryonic Stem cell lines for regenerative therapy and pharmaceutical research
- Effect of prior therapy and bone marrow metastases on progenitor cell content of blood Stem cell harvests in breast cancer patients
- … by campath mab t cell depleted Stem cell allograftP14. Stem cell treatment in inflammatory myopathies: proposals for patient selectionP15. Autologous Stem cell …
- ALLOGENEIC Stem cell therapy FOR JOINT DISEASE
- … Foundations. Note: A. Hultquist is presently at the Department of Stem cell Biology, Strategic Center for Stem cell Research and Gene therapy, Lund University, S …
- High-dose chemotherapy and autologous Stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
- Early infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- High dose therapy and autologous hemopoietic Stem cell transplantation in rheumatoid arthritis–the feasibility of phase III trials.
- Adjuvant high-dose therapy with peripheral blood Stem cell support for patients with high-risk breast cancer
- High-dose therapy and autologous Stem cell transplantation in relapsed and refractory Hodgkin’s disease: outcome based on a prognostic model
- Rituximab given after high dose therapy and autologous Stem cell transplantation induces durable clearance of minimal residual disease in about half of the …
- Becoming Immortal: Combining Cloning and Stem‐cell therapy
- A Setback for Stem cell therapy?
- Safety and efficacy of Stem cell mobilization under imatinib therapy
- Stem cell therapy for Ischemic Heart Disease: A Status Report
- Repetitive cycles of cytoreductive therapy followed by Stem cell autografting for nonlymphoblastic transformation of chronic granulocytic leukaemia
- Intrauterine Stem cell therapy
- Embryonic and Adult Stem cell therapy.(Abstracts)
- Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous Stem cell transplantation to improve outcome in …
- Stem cell therapy in the Mouse Heart
- Good manufacturing practice production of human Stem cells for somatic cell and gene therapy
- Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous Stem cell support
- Stem cell therapy for Alzheimer’s Disease
- Mobilized versus non-mobilized peripheral Stem cell transplantation after high dose therapy for low grade nonhodgkin lymphoma: Effect on failure-free survival
- Cytapheresis—The Next 25 Years: Stem cell therapy
- COMBINATION GENE AND Stem cell therapy FOR MS: PROMISE OR FANTASY?
- Stem cell therapy for Ischemic Heart Disease: A Status Report
- Costs of high-dose salvage therapy and blood Stem cell transplantation for resistant-relapsed malignant lymphomas in a southern Italian hospital
- Stem cell therapy for ACS: The Possibility of Myocardial Regeneration
- Stem cell biology and gene therapy
- One strategy for cell and gene therapy: harnessing the power of adult Stem cells to repair tissues
- Stem cell therapy in diabetes mellitus: Dream or reality
- Intensified myeloablative therapy and autologous Stem–cell transplantation for patients with AML: single center experience
- Adoptive cellular therapy for Cytomegalovirus Following Allogeneic Stem cell Transplantation: Toxicity and Efficacy.
- Future treatment options for Parkinsonism: Stem cell therapy
- How far away is the Stem cell therapy from the glaucoma management. A ten-year review
- High-Dose therapy and Stem cell Transplantation
- Potential Use of Stem cell therapy for Traumatic Brain Injury
- Reduced Intensity Conditioning therapy Using Campath-1H Is Successful for Stem cell Transplantation in Non-Malignant Disorders.
- Adult Mesenchymal Stem cell therapy in Joint Injury and Disease
- Autologous Stem cell Transplantation and cell therapy for Acute Leukemia
- Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia
- Single cell DNA analysis: possibilities, methods, implications in relation to Stem cell therapy
- Stem cell transplantation and gene therapy in utero
- Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with Stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial
- Twelve cases of malignant hematopathy treated by combined therapy of hematopoietic Stem cell transplantation and Chinese herbal medicine
- Ethics of Stem cell therapy and genetic engineering on human tissue
- Observation on Stem cell therapy of far advanded skin trauma of guinea pig
- Stem cell therapy for diseases in the nervous syStem-A potential for regeneration of inner ear
- Understanding endocrine development of the human beta cell: guiding Stem cell therapy for Type 1 Diabetes
- Radiation therapy after high-dose chemotherapy with peripheral blood Stem cell support for high-risk breast cancer
- Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic Stem cell transplantation
- RELAPSE AFTER AUTOLOGOUS Stem cell therapy (ASCT) IN A PATIENT WITH SYStemIC LUPUS ERYTHEMATOSUS (SLE)
- High dose therapy with Stem cell support for breast cancer: the jury is still out
- cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy: Edited by George Mortsyn and Wiliam Sheridan (New York: Cambridge University …
- Allogeneic cell therapy (act) after relapse from autologous Stem cell transplantation (autosct)
- Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic Stem cell transplantation
- Muscle derived Stem cell-based cell therapy in urology
- … Stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4–9 positive nodes treated with adjuvant high-dose therapy and Stem …
- Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood Stem cells with a low CD34+ cell content
- Research for corresponding dental therapy for patients undergoing bone marrow and peripheral blood Stem–cell transplantation.
- Autologous Stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and …
- … with seven-drug induction therapy and intensive consolidation with or without autologous Stem cell transplantation followed by maintenance therapy. Experience of a …
- Disease‐or therapy‐related bone marrow damage cannot be overcome by changes in Stem cell source or dose in allogeneic transplantation
- The effects of Stem cell factor and granulocyte colony stimulating factor therapy on the activity of the neutrophil NADPH oxidase enzyme syStem.
- Idarubicin or Mitoxantrone, VP-16, and Cytarabine for Induction/Consolidation therapy Followed by Autologous Stem cell Transplantation in Elderly Patients with …
- Mending a broken heart: animal studies helped lay the groundwork for Stem cell therapy.(Hot Papers)
- Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow Stem cell support for advanced endometrial cancer
- Current Trends and Prospect of cell therapy using Hematopoietic Stem cells
- Willenbacher W, et al.: Somatic Risk Factors for Intermediate and Long-Term Sequelae after Hematological Stem cell therapy Predictive for Feasibility of a …
- therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and Stem cell transplantation
- Establishment of juvenile and tolerant immune syStems in patients with autoimmune diseases treated with immunoablation and autologous Stem cell therapy
- Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal Stem cells for cell and gene therapy
- Stem cell therapy for treatment of central nervous syStem pathology in α-mannosidosis guinea pigs.
- Early and late toxicity of involved-field radiation therapy in conjunction with high-dose chemotherapy and Stem cell rescue
- Sequential High‐Dose Alkylating therapy and Stem cell Support for High‐Risk Stage III Breast Cancer
- Adoptive therapy with monocyte‐derived macrophages in the setting of high‐dose chemotherapy and peripheral blood Stem cell transplantation
- Catheter Interventions in Congenital Heart Disease—Part I Guest Editor, Horst Sievert Applications of Magnetic Resonance Imaging for Cardiac Stem cell therapy.
- Sequential high-dose therapy of adult acute lymphoblastic leukemia: role of maintenance chemotherapy after peripheral blood Stem cell transplantation in first …
- Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood Stem cell transplantation for recurrent or refractory Hodgkin disease
- … therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem cell …
- High-dose therapy of cancer with CD34 positive cells as Stem cell support
- Hematopoietic chimerism following immunoablative therapy for non-malignant disorders-out-patient Stem cell transplantation
- Prospective Multicenter Trial Comparing Repeated Immunosuppressive therapy (IST) with Stem cell Transplantation (SCT) from an Alternative Donor as a Second …
- Autologus Stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome
- Myeloablative Chemotherapy and Peripheral Blood Stem cell Transplantation vs. Consolidation therapy of Acute Myelogenous Leukemia in First Remission
- … Heart Function after the Combined Treatment of Patients Undergoing Coronary Artery Bypass Grafting through Stem cell therapy and Transmyocardial Laser …
- Treatment of non-Hodgkin’s lymphoma with high-dose therapy and hematopoietic Stem cell support.
- KINETIC MODELING OF THE MOLECULAR PROBE 18F-FHBG FOR IMPROVED PET REPORTER GENE IMAGING OF Stem cell therapy
- Feasibility of a Stem cell Gene therapy Approach with Nonmyeloablative Conditioning in Patients with HIV-1 Infection.
- High-dose therapy with peripheral blood Stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive …
- Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose therapy with Autologous Stem cell Rescue Leads to High Molecular Remission Rate …
- High dosage therapy with Stem cell transplantation in neuroendocrine carcinoma
- High dose chemotherapy and Stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy
- Hepatocyte growth factor modified human umbilical cord mesenchymal Stem cell therapy promotes remyelination after intracerebral hemorrhage in rats
- Wednesday, September 22, 2004: Plenary Session PL1: Stem cell therapy
- High-dose melphalan with Stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective
- High dosage therapy and autologous peripheral Stem cell transplantation in breast carcinoma
- 710. Stem cell Gene therapy: Synergizing Improved Gene Repair/Modification & Targeted Integration of Transgenes to Transient In Vivo Topical Minigene …
- The effect of preemptive therapy with intravenous ganciclovir followed by oral ganciclovir against cytomegalovirus infection after allogeneic peripheral blood Stem cell …
- Current trends in Stem cell biology and cell replacement therapy
- Dose-intensive therapy with autologous Stem cell transplantation for patients with multiple myeloma
- Current trends of Stem cell-mediated gene therapy
- Stem cell Biology and Gene therapy.: Quesenberry PJ, Stein GS, eds.(£ 65.00.) Wiley, 1998. ISBN 0 47114 656 0.
- Expansion Of Muscle-Derived Stem cells: Implications of cell therapy For Muscle Regeneration
- HEMATOPOIETIC Stem cell GENE therapy
- High-dose therapy and autologous Stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK …
- Transplantation of hepatic Stem cells and potential applications for cell therapy
- 160 Importance of radiation therapy for high-risk breast cancer patients treated with high-dose chemotherapy and Stem cell transplant
- Scientific, logistical, and ethical issues related to creation of a Stem cell repository for use in experimental trials of gene therapy for AIDS
- Basic Studies Toward Hematopoietic Stem cell Gene therapy
- Integrating vector and Stem cell-based strategies for gene therapy of Duchenne muscular dystrophy
- … ANBL0032: a phase III randomized trial of chimeric anti-GD2 and GM-CSF/IL2 in high risk neuroblastoma following myeloablative therapy and autologous Stem cell …
- Human Stem cell Gene therapy
- … onset invasive pulmonary zygomycosis following allogeneic peripheral blood Stem cell transplantation in a patient with therapy-related myelodysplastic syndrome
- High-dose busulfan, VP-16 and ACNU therapy with Stem cell transplantation for the treatment of children with acute leukemia
- Delivery of a vector with vascular endothelial growth factor gene to the pluripotent Stem cell for gene therapy
- Diabetes therapy boosts Stem–cell campaign
- … -dose therapy and autologous Stem–cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy …
- cellular therapy by Non-Myeloablative Stem cell Transplantation and Immunotherapy of Minimal Residual Disease
- Pioneering Stem cell/Gene therapy Trials
- Hematopoietic Stem cell Transplantation. An Established therapy
- High Dose therapy (HDCT) with Autologous Stem cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment …
- Human embryonic Stem cells: possibilities for future cell transplantation therapy
- Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood Stem cell transplantation for breast cancer
- Advances in Hematopoietic Stem cell Transplantation and Molecular therapy
- The Biology of the Stem cell and Its Environment in the Role of Effective Gene therapy
- Evaluation of leukemic contamination in peripheral blood Stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a …
- Hematopoietic Stem cell Gene therapy
- Hematopoietic Stem cell gene therapy
- Cord blood Stem and progenitor cell therapy for immunodeficiency and other disorders
- High dose therapy with autologous Stem cell support–finally a progress in myelomatosis
- High-dose therapy and peripheral blood Stem cell transplantation for patients with aggressive non-Hodgkin’s lymphoma remaining in initial remission: results of a …
- High-dose chemotherapy and autologous Stem cell transplantation for refractory and relapsing Hodgkin’s disease as first-line therapy–studies at Sheba Medical …
- Autologous hematopoietic Stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission
- Prognostic factors for survival and response after high-dose therapy and autologous Stem cell transplantation in syStemic AL amyloidosis: a report on 21 patients
- Stem–cell gene therapy: problems and solutions
- Stem cell GENE therapy OR GENETIC DISEASES
- High dose therapy and autologous Stem cell transplantation (ASCT) for lymphoblastic lymphoma in adults: Results from the European Group for Bone Marrow …
- Aggressive neoplastic plasma cell growth with MLL gene rearrangement after high-dose therapy with autologous Stem cell support for multiple myeloma
- Stem cell GENE therapy OR GENETIC DISEASES
- A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with Stem cell transplantation
- Stem cell GENE therapy OR GENETIC DISEASES
- Stem cell and gene therapy approaches for skeletal disorders
- High-dose therapy and autologous hematopoietic Stem–cell transplantation for recurrent or refractory pediatric hodgkin’s disease: analysis of the stanford university …
- … Trial of Short-Course Preemptive Ganciclovir Compared with Conventional Ganciclovir therapy To Prevent Cytomegalovirus Infection after Allogeneic Stem cell …
- therapy-related acute myeloid leukemia following double autologous peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma
- Human hematopoietic Stem cell gene therapy
- Excessive Weight Gain during Mobilization Increases First Year Mortality Following High Dose therapy and Stem cell Transplantation in Patients with Primary …
- Contamination with minimal residual disease in autologous peripheral Stem cell collected from Non-Hodgkin’s lymphoma patients treated with high-dose therapy
- Leukocyte Depleted Blood Transfusion in Hematopoietic Stem cell Reconstitution therapy
- … therapy with Autologous Blood Stem cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-cell (dnDLBL) vs. Transformed …
- Evaluation of human hemopoietic Stem cell assays for transplantation and gene therapy
- Stem cell gene therapy–second conference. Biology and technology. 31 May-3 June 1998, Orcas Island, WA, USA.
- High-dose therapy with peripheral Stem cell support in patients with lymphomas and breast cancer
- Supportive therapy in patients with autologous hemopoietic Stem cell transplantation
- … Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose therapy and Autologous Peripheral Blood Stem cell …
- The biologic character of cancer Stem cell and targeted therapy
- CD34-positive cells as Stem cell support after high dose therapy
- … infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic Stem cell …
- … (Gemcitabine, Dexamethasone, Cisplatin) Salvage therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem cell …
- Application of mesenchymal Stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy
- Modulation of the Hematopoietic Stem cell Phenotype: Implications For Regenerative Medicine and Gene therapy
- Studies Add to Debate on High-Dose therapy & Stem cell Transplantation for NHL
- Surgical therapy for corneal epithelial Stem cell deficiency
- High dose therapy with autologous Stem cell support in malignant disorders; Hoeydosebehandling med autolog stamcellestoette ved maligne lidelser
- Studies of hematopoietic-human-Stem–cell viability in-vitro and of celocentesis in non-human primates for in-utero Stem cell gene therapy
- Mesenchymanl Stem cell Based Intradiscal Gene therapy: Therapeutic Implication in Degenerative Disc Disease
- Correction of mouse models of sickle cell disease and β-thalassemia using Stem cell and genetic-based therapy
- An investigation of murine trachea cellular kinetics: implications for Stem cell gene therapy
- … ARTHRITIS (JIA) ON LONG-TERM therapy WITH METHOTREXATEP172. THE POSITION OF AUTOLOGOUS Stem cell TRANSPLANTATION (ASTA) IN …
- Electronic data processing-assisted high dosage therapy with Stem cell transplantation at the Donauspital
- Twelve Cases of Malignant Hematopathy Treated by Combined therapy of Hematopoietic Stem cell Transplantation andChinese Herbal Medicine
- A Novel Stem cell Derived Gene therapy for HIV/AIDS
- Development of selective amplifier genes for hematopoietic Stem cell gene therapy
- Application of Risk-Adapted therapy for Acute Myeloid Leukemia to a Population. Effects of Stem cell Transplantation on Outcome.
- Correction of ADA-SCID by Stem cell gene therapy combined with nonmyeloablative conditioning
- Nonmyeloablative Allogeneic Peripheral Blood Hematopoietic Stem cell Transplantation for therapy of Hematologic Diseases
- Stem cells and cell therapy. Contribution to the ethical debate
- Stem cell Transplantation: Successful therapy for the Substitution of Unfunctional Hemato-Lymphoid SyStem
- Optimizing recovery from aplasia after high-dose therapy and hematopoietic Stem cell transplantation
- High-dose therapy with autologous Stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic Stem cells isolate from blood
- ABCG2: A new target for cancer therapy and new marker for Stem cell screening
- Renal transplantation and immunosuppressive therapy do not contraindicate Stem–cell donation for bone-marrow transplantation
- 15-year follow-up of myeloma patients receiving 140 MG/M2 melphalan without hematopoietic Stem cell or growth factor support as initial therapy
- Twelve cases of malignant hematopathy treated by combined therapy of hematopoietic Stem cell transplantation and Chinese herbal medicine
- High-dose therapy followed by autologous haematopoietic Stem cell transplantation in multiple myeloma.
- Thirteenth Annual Meeting of Society for Biological therapy, 454 interleukin-2 expression, CTL against renal cell carcinoma, 170 CD8 T cell activity, 307 Stem cell …
- Use of Cord Blood Stem cells in cell therapy
- … phase II study of maintenance chemotherapy versus high-dose chemotherapy with autologous peripheral blood Stem cell transplantation as postremission therapy of …
- High-dose immunosuppressive therapy with Stem cell transplantation for the treatment of autoimmune disease
- High dose therapy with autologous Stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services
- Application of real-time quantitative PCR for guidance therapy of cytomegalovirus infection after allohematopoietic Stem cell transplantation
- Myeloablative therapy, Stem cell rescue and gene transfer in advanced ewing tumors (AET)
- Gene therapy for Human Immunodeficiency Virus Infection Using Stem cell Transplantation
- … -non-identical peripheral blood Stem cell transplantation (total body irradiation, etoposide, thiotepa) and interleukin 2-based experimental therapy for poor prognosis …
- cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood Stem–cell products
- High-dose chemotherapy with peripheral blood Stem cell transplantation as adjuvant therapy for primary breast cancer
- 225. Phenotypic Correction of ALD Mouse after Hematopoietic cell Transplantation and Evaluation of Hematopoietic Stem cell Gene therapy with a Lentivirus Vector
- Autologous blood Stem cell transplantation as intensive consolidation therapy in hematological malignancies.
- Bone Stem cell mediated gene therapy and tissue engineering
- Dose-Intensive therapy with Autologous Blood Stem cell or Bone Marrow Transplantation for Treatment of Breast Cancer
- Etarnercept therapy for Idiopathic Pneumonia Sydrome After Allogeneic Hematopoietic Stem cell Transplantation in an Adul
- # 649 The feasibility of outpatient high dose multiagent cytoreductive rpeparative therapy (CPT) in patients undergoin autologous Stem cell transplantation (SCT) for …
- Autologous Stem cell harvesting after high dosage chemo-and/or growth factor therapy
- 1004. Integration Analyses in ADA-Deficient SCID Patients Successfully Treated with Stem cell Gene therapy
- Isolation of human mesenchymal Stem cell-like fibroblast from adipose tissue for reconstructive therapy
- … Targeted Integration of Minigenes: T Integration of Minigenes: Toward Improved Ex V oward Improved Ex V oward Improved Ex Vivo/In Vivo Stem–cell Gene-therapy
- High dose chemotherapy and autologous Stem cell transplantation as adjuvant therapy for primary breast cancer pa…
- 51. A Novel Approach to Stem cell Gene therapy: Controlling Stem cell ifferentiation with Engineered Zinc-Finger Protein Transcription Factors
- Dose intensive therapy and myeloablative chemotherapy with haematopoietic Stem cell rescue in childhood poor prognosis Ewing’s sarcoma
- Stem–cell engraftment as delayed therapy to repair organophosphate-induced brain damage
- predicts relapse of malignant lymphoma after high-dose therapy with Stem cell transplantation
- Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic Stem cell transplantation
- High-dose chemotherapy with peripheral blood Stem cell transplantation as adjuvant therapy for primary breast cancer with extensive lymph node involvement
- High-dose therapy and autologous peripheral blood Stem cell transplantation in patients with relapsed lymphoma
- 1125 High-dose therapy with hemopoietic Stem cell support for high risk breast cancer. A pilot study in 31 patients
- Role of Chemokine Receptor, CXCR4, Expression in Directing Neural Stem cell Vectors in Brain Tumor therapy
- Imatinib therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem cell Transplantation: A Molecular Analysis.
- Role of music therapy-based relaxation vs. expressive reading interventions in blood marrow Stem cell transplantation
- The Impact of Immunosuppressive therapy on an Early Quantitative Reconstitution of NK cells after Allogeneic Hematopoietic Stem cell Transplantation.
- Allogenic Peripheral Blood Stem cell Transplant Utilizing Rabbit Anti-Thymocyte Globulin as a Part of Non-Myeloablative Conditioning therapy.
- Engineered human mesenchymal Stem cells: a novel platform for skeletal cell mediated gene therapy
- 1162. Correction of the Immune and Metabolic Defect of ADA-SCID by Stem cell Gene therapy Combined with Nonmyeloablative Conditioning
- The HGFIN Gene Mediates cell Cycle Quiescence of CD34+/CD38-: Implications for Hematopoietic Stem cell Expansion and Gene therapy.
- Adenovirus-Mediated Targeted Gene therapy for Breast Cancer and for Purging Hematopoietic Stem–cell Sources
- … RESTORES THYMIC FUNCTION AND ENHANCES HEMOPOIESIS AND LYMPHOPOIESIS FOLLOWING ALLOGE-NEIC AND AUTOLOGOUS Stem cell …
- High Dose therapy with Autologous Blood Stem cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.
- Intracerebral Mesenchymal Stem cell Gene therapy in the Niemann-Pick Disease Mouse
- First Line therapy with Reduced Intensity Conditioning Allogeneic Stem cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete …
- … Intensity Induction therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem cell Transplantation (AHSCT) for Mantle cell …
- GMP Compliant Expansion of Hematopoietic Stem cells (CD34+) Selected from Cord Blood for a Phase I cell therapy Trial
- Sex streoid ablation therapy restores thymic function and enhances hemopoiesis and lymphopoiesis following allogeneic and autologous Stem cell transplantation
- … RESISTANT TO CONVENTIONAL THERAPEUTIC REGIMENSV4. 2. 18 CHILDREN AFTER AUTOLOGOUS Stem cell TRANSPLANTATION FOR REFRACTORY …
- Autologous Stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin’s …
- Development of hemopoietic Stem cell gene therapy for Niemann-Pick disease using the acid sphingomyelinase knock-out mouse model
- BCCA Protocol Summary for Myeloablative Conditioning therapy Prior to Autologous and Allogeneic Hematopoietic Stem cell Transplantation for Myeloid …
- # 703 High dose mobilization chemotherapy followed by myeloblative therapy with Stem cell support for the treatment of small, round, blue cell tumors
- … blood Stem cell transplantation (allo-pbsct): changing patterns and low dose short course (ldsc) gancyclovir (gcv) as an effective nontoxic presumtive therapy (pt) …
- Intensified induction followed by high-dose therapy with autologous peripheral blood Stem cell support in poor-prognosis aggressive non-Hodgkin’s lymphoma …
- 12 Multiple courses of high-dose alkylating therapy with autologous Stem cell support
- … Followed by High-Dose therapy with Autologous Peripheral Blood Stem cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line therapy …
- Improving dosing precision in busulfan (bu)-based preparative regimens for hematopoietic Stem cell transplantation (HSCT) using parmacokinetics directed therapy …
- Gene therapy: Bone Regeneration Using Adenovirus Mediated Bone Morphogenic Protein Engineered Mesenchymal Stem cell
- … Stem cell transplantation (PBSCT) for patients with malignant lymphoma–its role in the treatment strategy for non-Hodgkin’s lymphoma, and ESHAP+ PBSCT therapy
- The Useful Individualized Assessment of Immunosuppressive therapy with Cyclosporine A (CsA) after Allogeneic Stem cell Transplantation by Simultaneous …
- … Patients Undergoing Allogeneic Hematopoietic Stem cell Transplantation: Increased Incidence in Patients Receiving Alemtuzumab (ALEM) as Conditioning therapy …
- AUTOLOGOUS Stem cell TRANSPLANTATION (ASCT) FOR THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN’S LYMPHOMA (NHL) IN THE ERA OF …
- Intensified full-dose induction therapy (HD-MACHOP+ radiotherapy) follwed dy consolidation with BAVC regimen and autologous Stem cell transplantation as fron-line …
- Symposium 7: Stem cell Research; Application of Endothelial Progenitor cells (EPC) to Vascular Medicine: Mobilized EPC by GM-CSF accelerate …
- Intensive antileukemic therapy including Stem cell transplantation (SCT) for high risk MDS and AML following MDS (SAML) in patients< 60 years. a joint study of the …
- … Versus Gene Modified Autologous Stem cell Transplantation for Severe Combined Immunodeficiencies (SCID). The Risk/Benefit Balance Is in Favor of Gene therapy …
- Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic Stem cell transplantation …
- Repetitive High-Dose therapy with Dose Escalated CHOP+ Etoposide Followed by Autologous Stem cell Transplantation (Mega-CHOEP) in Younger Patients with …
- … POST TRANSPLANT-Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic Stem cell …
- Fludarabine and cytosine arabinoside as salvage therapy in patients with relapsed acute and chronic leukaemia after BMT or allogenic Stem cell transplantation
- Post-remission therapy with 4 cycles of intermediate (I) or high-dose (HD) cytarabine (AC) or autologous hematopoietic Stem cell transplantation (ASCT) for acute …
- … /Disease Consisting of a Higher Cutoff Point and a Lower Initial Dose of Ganciclovir after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) with an HLA …
- cell therapy Using Embryonic Stem cells
- … EXPRESSION IN SYStemIC JUVENILE IDIOPATHIC ARTHRITIS IS RESTORED BY AUTOLOGOUS Stem cell TRANSPLANTATION. AUTONOMIC NERVOUS …
- … purging of autologous hematopoietic Stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with …
- A novel sub-population of bone marrow derived myocardial Stem cells: potential autologus cell therapy in myocardial infarction
- Human neural Stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS
- Autologous mesenchymal Stem cells for articular and bone cell therapy
- Potential use of T cell receptor genes to modify hematopoietic Stem cells for the gene therapy of cancer
- … of Human Neural Stem cells in a New Primate Model of Motor Neuron Degeneration: An Experimental Study of Potential cell therapy for Amyotrophic Lateral …
- Engineering mesenchymal Stem cells with hypoxia-regulated gene syStem: A promising approach for effective cell therapy
- Recovery of stromal Stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction
- … of the rate of reduction in platelet counts in recipients of hematopoietic Stem and progenitor cell transplant: clinical implications for platelet transfusion therapy
- Mesenchymal Stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis
- Use of Embryonic Stem cells to Produce Islets in cell Replacement therapy as a Treatment for Type 1 Diabetes
- 1417: Mesenchymal Stem cells Alone or Modified with ENOS Restore Erectile Function in the Aged Rat: cell-Based Gene therapy for Erectile Dysfunction
- Adult Stem cell therapy in stroke
- Potential of mesenchymal Stem cell therapy
- Stem cell therapy and the retina
- Does mesenchymal Stem cell therapy help multiple sclerosis patients? Report of a pilot study
- Role of imaging in cardiac Stem cell therapy
- Stem cell therapy enhances electrical viability in myocardial infarction
- The potential for Stem cell therapy in diabetes
- Stem cell-based cell therapy for spinal cord injury
- Comparison of imaging techniques for tracking cardiac Stem cell therapy
- cell therapy and the safety of embryonic Stem cell-derived grafts
- Adult Stem cell therapy: dream or reality?
- Stem cell therapy for autism
- Stem cell therapy for vascular disease
- The dying Stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle
- Mesenchymal Stem cell therapy to rebuild cartilage
- Stem cell therapy for ischemic heart failure
- Stem cell therapy—Present status
- Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived Stem cells
- Injectable mesenchymal Stem cell therapy for large cartilage defects—a porcine model
- Autologous in vitro expanded mesenchymal Stem cell therapy for human old myocardial infarction
- Concise review: prospects of Stem cell therapy for temporal lobe epilepsy
- Enhancing Stem cell therapy through genetic modification
- Differentiation of mesenchymal Stem cells transplanted to a rabbit degenerative disc model: potential and limitations for Stem cell therapy in disc regeneration
- Successful Stem cell therapy using umbilical cord blood‐derived multipotent Stem cells for Buerger’s disease and ischemic limb disease animal model
- Stem cell therapy: hope or hype?
- Embryonic Stem cell therapy for diabetes mellitus
- Stem cell therapy for osteonecrosis of the femoral head
- Concise review: scientific and ethical roadblocks to human embryonic Stem cell therapy
- Stem cell therapy for human brain disorders
- New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal Stem cell therapy
- Mesenchymal Stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction?
- Lost and found: cardiac Stem cell therapy revisited
- Stem cell therapy for cardiovascular disease
- Cardiac Stem cell therapy: need for optimization of efficacy and safety monitoring
- Stem cell therapy for cardiac diseases
- Stem cell therapy in bone repair and regeneration
- The potential role of mesenchymal Stem cell therapy for intervertebral disc degeneration: a critical overview
- Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal Stem cell therapy
- Nonmyeloablative Stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease
- Practical issues in Stem cell therapy for Alzheimer’s disease
- Towards Stem–cell therapy in the endocrine pancreas
- Stem cell therapy for cardiac repair: ready for the next step
- Increase in vascular permeability and vasodilation are critical for proangiogenic effects of Stem cell therapy
- Stem cell plasticity and issues of Stem cell therapy
- Intravenous mesenchymal Stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic …
- Current concepts in adult Stem cell therapy for stroke
- Stem cell therapy for joint problems using the horse as a clinically relevant animal model
- Stem cell therapy for Parkinson’s disease
- Stem cell therapy for urinary stress incontinence
- Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with Stem cell therapy
- Preimplantation genetics: improving access to Stem cell therapy
- Stem cell therapy after myocardial infarction: ready for clinical application?
- Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances Stem cell therapy
- Stem cell therapy for human liver cirrhosis: a cautious analysis of the results
- Adult neural Stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation
- Stem cell therapy in postinfarction chronic coronary heart disease
- Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction syStem for keratinocyte Stem cell therapy
- Stem cell therapy delivery: treading the regulatory tightrope
- In situ Stem cell therapy: novel targets, familiar challenges
- Nonmyeloablative Stem cell transplantation and cell therapy for malignant and non-malignant diseases
- Paracrine and differentiation mechanisms underlying Stem cell therapy for the damaged kidney
- Gene and Stem cell therapy
- Heparin/poly (L-lysine) nanoparticle-coated polymeric microspheres for Stem–cell therapy
- Diabetes mellitus: a potential target for Stem cell therapy
- Multipotential mesoangioblast Stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy
- Stem cell therapy for sickle cell disease: transplantation and gene therapy
- Stem cell therapy for ischemic heart disease: beginning or end of the road?
- Neural Stem cell therapy and gastrointestinal biology
- Therapeutic angiogenesis for peripheral artery disease: Stem cell therapy
- Stem cell therapy for myelin diseases
- The allure of Stem cell therapy for muscular dystrophy
- Bone marrow Stem cell therapy for myocardial angiogenesis
- Gene and Stem cell therapy for erectile dysfunction
- The use of Stem cell therapy for cardiovascular disease
- Limbal epithelial Stem cell therapy
- Which place for Stem cell therapy in the treatment of acute radiation syndrome?
- cellular multiparametric MRI of neural Stem cell therapy in a rat glioma model
- Pharmacologic management of ischemic stroke: relevance to Stem cell therapy
- Stem cell therapy for myocardial repair
- Advances in the understanding of sress urinary incontinence and the promise of Stem–cell therapy
- Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, and cell/Stem cell therapy
- Stem cells and their applications in skin-cell therapy
- The potential of cardiac Stem cell therapy for heart failure
- Contemplating the bright future of Stem cell therapy for cardiovascular disease
- Stem cell therapy: a hope for dying hearts
- Neural Stem cell therapy for neuropsychiatric disorders
- Stem cell therapy or snake oil?
- Novel therapies for the treatment of cystic fibrosis: new developments in gene and Stem cell therapy
- G‐CSF‐based Stem cell therapy for the heart—unresolved issues part A: Paracrine actions, mobilization, and delivery
- Stem cell therapy for the treatment of heart failure
- … -colony-stimulating factor mobilization of Stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical Stem cell therapy?
- Mesenchymal Stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage
- Stem–cell therapy: hope and hype
- Gene and Stem cell therapy of the hair follicle
- Cardiac Stem cell therapy for myocardial regeneration. A clinical perspective.
- Embryonic Stem cell therapy.
- Isolation of amniotic Stem cell lines with potential for therapy
- … donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and cell therapy
- Stem cell therapy in the aging hearts of Fisher 344 rats: synergistic effects on myogenesis and angiogenesis
- Sources of cardiomyocytes for Stem cell therapy: an update
- The Netherlands bans private Stem cell therapy
- Adult Stem cell therapy beyond haemopoietic Stem cell transplantation? An update
- Gene therapy and Stem cell therapy for cardiovascular diseases today: a model for translational research
- The origin of deoxynucleosides in brain: implications for the study of neurogenesis and Stem cell therapy
- Stem cell therapy for central nervous syStem demyelinating disease
- Stem cell therapy for cardiac arrhythmias
- Cardiac Stem cell therapy: present and future
- Cancer Stem cell: target for anti‐cancer therapy
- T-cell therapy after hematopoietic Stem cell transplantation
- A method for quantitative cell tracking using SPECT for the evaluation of myocardial Stem cell therapy
- Umbilical cord Stem cell therapy for cerebral palsy
- Stem cell therapy for Parkinson’s disease
- Tubular regeneration and the role of bone marrow cells:’Stem cell therapy‘–a panacea?
- The promise of Stem cell therapy to restore urethral sphincter function
- The role of high-dose therapy and Stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
- Bone-marrow-derived cells for cardiac Stem cell therapy: safe or still under scrutiny?
- Cancer Stem cell and cancer Stemloids: from biology to therapy
- Clinical applications of Stem cell therapy–the pros and cons of Stem cell sources
- … and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: is autologous Stem cell therapy in nuclear accident …
- Safety of intramyocardial Stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up
- Functional considerations of Stem cell transplantation therapy for spinal cord repair
- Insertional mutagenesis in gene therapy and Stem cell biology
- Bone marrow Stem cell therapy for cardiac repair: challenges and perspectives.
- Stem–cell therapy for diabetes cure: how close are we?
- Platelet lysates promote mesenchymal Stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications
- Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources
- How does human Stem cell therapy influence gene expression after liver injury?: Microarray evaluation on a rat model
- … leukocyte antigen matching estimations in a hypothetical bank of human embryonic Stem cell lines in the Japanese population for use in cell transplantation therapy
- Stem cell‐based therapy for Parkinson’s disease
- Stem cell therapy for neuropathic pain treatment
- Stem cell therapy-Hope and scope in pediatric surgery
- Phenotypic characterization and preclinical production of human lineage‐negative cells for regenerative Stem cell therapy
- Stem cell therapy for acute myocardial infarction
- Stem cell therapy improves myocardial perfusion and cardiac synchronicity: new application for echocardiography
- 50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/Stem cell therapy …
- Stem cell strategies for Alzheimer’s disease therapy.
- Stem cell therapy and tissue engineering for cardiovascular repair: from basic research to clinical applications.
- Stem cell transplantation: a promising therapy for Parkinson’s disease
- The role of noninvasive imaging techniques in the assessment of Stem cell therapy after acute myocardial infarction
- From bench to bedside? Biomedical scientists’ expectations of Stem cell science as a future therapy for diabetes
- In vivo tracking in cardiac Stem cell-based therapy
- Hematopoietic Stem cell therapy for malignant diseases
- Gene therapy progress and prospects: Stem cell plasticity
- Preemptive therapy of EBV‐related lymphoproliferative disease after pediatric haploidentical Stem cell transplantation
- Stem cell therapy-A panacea for all ills?
- Bone marrow-derived Stem cell therapy in ischemic heart disease
- Survival of the fittest: in vivo selection and Stem cell gene therapy
- Cardiovascular MRI for Stem cell therapy
- Stem cell therapy for hearing loss: Math1 overexpression in VOT-E36 cells
- Impact of lenalidomide therapy on Stem cell mobilization and engraftment post-peripheral blood Stem cell transplantation in patients with newly diagnosed …
- REVIEW ARTILCE: cell therapy and Stem cells in animal models of motor neuron disorders
- Stem cell therapy for glomerular disease
- Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic Stem–cell transplantation: an international case-control study
- A look to the future: prediction, prevention, and cure including islet transplantation and Stem cell therapy
- Remaking the body? Scientists’ genetic discourses and practices as examples of changing expectations on embryonic Stem cell therapy for diabetes
- The impact of Stem cell therapy in hematology and oncology
- Youthful prospects for human Stem‐cell therapy: In another few decades, revised attitudes towards Stem cells could lead to disease prevention and life extension
- A natural Stem cell therapy? How novel findings and biotechnology clarify the ethics of Stem cell research
- Dutch clinic is ordered to stop giving Stem cell therapy
- Stem cell therapy in stroke: strategies in basic study and clinical application
- Hematopoietic Stem cell mobilization therapy accelerates recovery of renal function independent of Stem cell contribution
- Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic Stem cell transplant patients
- Development of human umbilical cord matrix Stem cell-based gene therapy for experimental lung tumors
- Celocentesis for in utero Stem cell therapy: where we now stand and future directions
- Clinical trials in Stem cell therapy: pitfalls and lessons for the future
- Stem cell therapy of acute spinal cord injury in dogs
- G‐CSF‐Based Stem cell therapy for the Heart—Unresolved Issues Part B: Stem cells, Engraftment, Transdifferentiation, and Bioengineering
- The challenge for Stem cell therapy
- … Renal Failure by Stem cell therapy—Paracrine Secretion Versus Transdifferentiation into Resident cells: Administered Mesenchymal Stem cells Protect against …
- Nonmyeloablative Stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative …
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review
- High-dose therapy and autologous blood Stem–cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term …
- Stem cell therapy in patients with multiple sclerosis
- Embryonic Stem cells: prospects for developmental biology and cell therapy
- Cardiac Stem cell therapy from bench to bedside
- Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with Stem cell gene therapy
- Stem cell and gene-based therapy
- A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic Stem cell transplantation
- Stem cell therapy for diabetes mellitus: progress, prospects and challenges
- Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic Stem cell transplantation: risk factors analysis and outcome
- Promises and pitfalls of Stem cell therapy for promotion of bone healing
- Quantitative assessment of molecular remission after high-dose therapy with autologous Stem cell transplantation predicts long-term remission in mantle cell …
- Launching a clinical program of Stem cell therapy for cardiovascular repair
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review
- Potential of Stem cell based therapy and tissue engineering in the regeneration of the central nervous syStem
- Allogeneic hematopoietic Stem cell transplantation as part of postremission therapy improves survival for adult patients with high‐risk acute lymphoblastic leukemia: a …
- … of the left ventricular myocardial contraction with Stem cell therapy: new insights into the therapeutic implication of Stem cell therapy in myocardial infarction
- Allogeneic Stem–cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma
- Embryonic Stem cells: meeting the needs for cell therapy
- Successful reconstitution of immunity in ADA-SCID by Stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
- High-dose therapy followed by autologous purged Stem–cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
- Stem–cell therapy for hepatobiliary pancreatic disease
- Safety and efficacy of enzyme replacement therapy in combination with hematopoietic Stem cell transplantation in Hurler syndrome
- Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic Stem–cell transplantation results in favorable outcomes
- Stem cell therapy in cardiovascular diseases
- Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous Stem cell transplantation in untreated patients with …
- Mesenchymal Stem cell therapy for multiple sclerosis
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based …
- … With Myeloablative Chemotherapy and Autologous Stem–cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma therapy …
- High-dose chemotherapy with autologous Stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a …
- Autologous Stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis
- Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic Stem cell transplantation
- Stem cell transplantation and gene therapy for hemoglobinopathies.
- The effect of first-line imatinib interim therapy on the outcome of allogeneic Stem cell transplantation in adults with newly diagnosed Philadelphia chromosome …
- Stem cell therapy in the heart and vasculature
- Perspectives of gene therapy in Stem cell tissue engineering
- Correction of murine hemophilia A by hematopoietic Stem cell gene therapy
- Stem cell therapy
- Stem cell migration: a quintessential stepping stone to successful therapy
- Dendritic cell therapy for tolerance induction to Stem cell transplants
- Integration of genomics, proteomics, and imaging for cardiac Stem cell therapy
- … in the peripheral blood after allogeneic Stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy
- Induction of neurotrophin expression via human adult mesenchymal Stem cells: implication for cell therapy in neurodegenerative diseases
- … syStem-based comparison between human dental pulp Stem cells (hDPSCs) and human mesenchymal Stem cells (hMSCs) for tissue engineering cell therapy
- Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic Stem cell transplant recipients
- Low‐energy laser therapy for prevention of oral mucositis in hematopoietic Stem cell transplantation
- New era of cardiac Stem cell therapy in heart failure
- Cripto as a Target for Improving Embryonic Stem cell–Based therapy in Parkinson’s Disease
- Gene and Stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial …
- Stem cell therapy in Iran
- Current practice and future perspectives of myocardial Stem cell therapy
- Current status and concepts of Stem cell therapy
- Rituximab and DHAP followed by intensive therapy with autologous Stem–cell transplantation as first-line therapy for mantle cell lymphoma
- Stem cell therapy in acute myocardial infarction
- Stem cell therapy for myocardial regeneration: creating hype ignoring reality
- The safety of interferon‐γ‐1b therapy for invasive fungal infections after hematopoietic Stem cell transplantation
- Targeting, imaging, and therapy using a humanized antiprostate Stem cell antigen (PSCA) antibody
- Mesenchymal Stem cell therapy of brain ischemic stroke in rats
- Stem cell-based therapy for the treatment of Type 1 diabetes mellitus
- Novel tyrosine kinase inhibitor therapy before allogeneic Stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant …
- Cardiovascular therapeutic aspects of cell therapy and Stem cells
- Neuropsychological function in high-risk breast cancer survivors after Stem–cell supported high-dose therapy versus standard-dose chemotherapy: evaluation …
- Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic Stem–cell transplant
- Effectiveness of prophylactic anti‐HBV therapy in allogeneic hematopoietic Stem cell transplantation with HBsAg positive donors
- … , dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous Stem cell …
- Stem cell therapy in chronic heart failure
- Tumorigenesis and embryonic Stem cell-derived therapy
- Imatinib therapy prior to myeloablative allogeneic Stem cell transplantation
- Stem cell therapy in heart failure: where do we stand and where are we heading?
- Development of hematopoietic Stem cell gene therapy for Wiskott-Aldrich syndrome.
- Neural Stem cells as biological minipumps: a faster route to cell therapy for the CNS?
- High-dose therapy with autologous Stem cell transplantation in first response in mantle cell lymphoma
- Stem cell pharmacogenomics: a reality check on Stem cell therapy.
- cell therapy using allogeneic bone marrow mesenchymal Stem cells prevents tissue damage in collagen‐induced arthritis
- Stem cell research: cloning, therapy and scientific fraud
- Stem cell therapy. Biology of hematopoietic Stem cells
- Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic Stem cell …
- Hematopoietic Stem–cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
- Myogenic Stem cells: regeneration and cell therapy in human skeletal muscle
- Lessons for the Stem cell discourse from the gene therapy experience
- Targeting the most critical cells: approaching leukemia therapy as a problem in Stem cell biology
- “Stealth immune tolerance” in Stem cell transplantation: potential for “universal donors” in myocardial regenerative therapy
- Ethical legal and social issues in Stem cell research and therapy
- Stem cell therapy for demyelinating disorders
- Hematopoietic Stem cell–targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice
- Stem cells engineering for cell-based therapy
- … veno-occlusive disease in pediatric Stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy
- … conditioning allogeneic Stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and cellular therapy …
- Value of Stem cell therapy for the treatment of stress incontinence. Current status and perspectives
- The role of high-dose therapy and autologous Stem cell transplantation for pediatric bone and soft tissue sarcomas
- … -occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood Stem cell transplantation in multiple …
- Application of liver Stem cells for cell therapy
- Stem cell therapy: a new perspective for the treatment of ischemic heart failure
- Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic Stem cell transplantation
- Estrogen-progestin therapy in women after Stem cell transplant: our experience and literature review
- Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic Stem cell recipients
- Extended lamivudine therapy against hepatitis B virus infection in hematopoietic Stem cell transplant recipients
- Mesenchymal Stem cell therapy for the injured heart
- Hematopoietic Stem cell gene therapy: dead or alive?
- The promise of Stem cell therapy for eye disorders
- Towards the generation of patient-specific pluripotent Stem cells for combined gene and cell therapy of hematologic disorders
- Use of bortezomib as induction therapy prior to Stem cell transplantation in frontline treatment of multiple myeloma: impact on Stem cell harvesting and engraftment
- Good manufacturing practice-compliant expansion of marrow-derived Stem and progenitor cells for cell therapy
- Salvage therapy for CLL and the role of Stem cell transplantation
- Chemotherapy with rituximab followed by high‐dose therapy and autologous Stem cell transplantation in patients with mantle cell lymphoma
- Short intensive sequential therapy followed by autologous Stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma
- Haematopoietic Stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
- Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood Stem cell transplantation
- Stem cell therapy for intervertebral disc degeneration: In vitro study
- Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load⩾ 10000 copies/ml: a safe and effective strategy for allogeneic Stem cell …
- High-dose therapy and autologous hematopoietic Stem cell transplantation for patients with primary syStemic amyloidosis: a Center for International Blood and Marrow …
- A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic Stem cell transplantation
- Stem cell controversy to stall European tissue and cell therapy rules
- cell therapy, Stem cells and brain repair
- Outcome of hematopoietic Stem cell transplantation for pediatric patients with therapy‐related acute myeloid leukemia or myelodysplastic syndrome
- New strategies of antifungal therapy in hematopoietic Stem cell transplant recipients and patients with hematological malignancies
- Stem cell Transplantation: Biology, Processes, therapy
- Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with Stem cell transplant: review and consensus statement
- therapy of Duchenne muscular dystrophy with umbilical cord blood Stem cell transplantation
- Human embryonic Stem cell therapy for Parkinson’s disease
- Autologous Stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
- Motor function recovery after adipose tissue derived mesenchymal Stem cell therapy in rats with cerebral infarction
- Efficacy of high‐dose therapy and hematopoietic Stem cell transplantation for mantle cell lymphoma
- Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic Stem cell gene therapy
- High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic Stem cell transplantation
- Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic Stem cell mobilization
- Cardiac effects within 3 months of BEAC high‐dose therapy in non‐Hodgkin’s lymphoma patients undergoing autologous Stem cell transplantation
- High dose chemotherapy and autologous Stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes …
- … intensity conditioning and allogeneic Stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non …
- High-dose chemotherapy with Stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up
- Thalidomide salvage therapy following allogeneic Stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du …
- Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human Stem cell and gene therapy
- Hematopoietic Stem cell gene therapy with drug resistance genes: an update
- Stem cell therapy in end-stage ischaemic heart failure: a catheter-based therapeutic strategy targeting myocardial viability
- … therapy with ICE Followed by High Dose therapy and Autologous Stem cell Transplantation for Relapsed/Refractory Peripheral T-cell Lymphomas: Minimal Benefit …
- Preclinical trials for Stem cell therapy
- Complexity of the human acute myeloid leukemia Stem cell compartment: implications for therapy
- Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic Stem cell …
- Catheter-based Stem cell and gene therapy for refractory myocardial ischemia
- Stem cell and Stem cell therapy in Thailand
- Reduced intensity conditioning allows for up-front allogeneic hematopoietic Stem cell transplantation after cytoreductive induction therapy in newly-diagnosed …
- Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic Stem cell transplantation
- Posaconazole salvage therapy allows successful allogeneic hematopoietic Stem cell transplantation in patients with refractory invasive mold infections
- Characterization of BioSafe SEPAX Manufactured Stem cell Intended for Cardiac cell therapy.
- Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic Stem cell transplantation
- The role of high-dose therapy and autologous Stem cell transplantation in patients with primary refractory Hodgkin’s lymphoma: a report from the Gruppo …
- Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic Stem cell recipients receiving immunosuppressive therapy or with acute graft …
- Medium-term survival without haematopoietic Stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy
- The effect of neural embryonic Stem cell therapy in a rat model of cavernosal nerve injury
- Review: Mesenchymal Stem cells: cell–Based Reconstructive therapy in Orthopedics
- Initial therapy of multiple myeloma patients who are not candidates for Stem cell transplantation
- Mantle cell lymphoma (MCL): induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (MC)(±rituximab) improves results of autologous Stem cell …
- High-dose chemotherapy and autologous hematopoietic Stem cell transplantation for metastatic breast cancer: a therapy whose time has passed
- Melphalan 200 mg/m2 with blood Stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related …
- Human embryonic Stem cell therapy, what is the attitude of the public?
- Progress and clashes in Stem cell therapy research
- The role of Stem–cell transplantation in chronic lympocytic leukemia risk-adapted therapy
- Haematopoietic Stem cell gene therapy to treat autoimmune disease
- Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic Stem cell transplantation: a single-center experience in Korea
- … Stem–cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy
- Effect of prior rituximab on high-dose therapy and autologous Stem cell transplantation in follicular lymphoma
- Stem cell therapy in ischemic heart disease
- High-dose therapy and autologous Stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma
- Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy
- Stem cell therapy for chronic cardiac insufficiency–therapy of the future?
- Outcome of Allogeneic Stem cell Transplantation after Hypomethylating therapy with 2′-Deoxy-5 Azacytidine for Patients with Myelodysplastic Syndrome.
- Rituximab long-term maintenance therapy after autologous Stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma
- First-line thalidomide–dexamethasone therapy in preparation for autologous Stem cell transplantation in young patients (< 61 years) with symptomatic multiple …
- Long-term event-free survivors after high-dose therapy and autologous Stem–cell transplantation for low-grade follicular lymphoma
- … staging syStems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood Stem cell transplantation as first-line therapy
- Human cordonal Stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats
- Stem cell therapy still not here
- … in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic Stem cell …
- Collection of fetal blood for Stem cell research and therapy
- Umbilical Cord Stem cell therapy: The Gift of Healing from Healthy Newborns
- Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic Stem cell transplantation during childhood
- … therapy for Treatment of Autoimmune Diseases, Basic Science and Clinical Studies, Including New Developments in Hematopoietic and Mesenchymal Stem cell …
- Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic Stem cell transplantation: a molecular analysis
- Current concepts of Stem cell therapy
- Diabetic cardiomyopathy: a “cardiac Stem cell disease” involving p66Shc, an attractive novel molecular target for heart failure therapy
- The yin and yang of Stem cell gene therapy: insights into hematopoiesis, leukemogenesis, and gene therapy safety
- Autologous Stem cell Transplantation as First-Line therapy in Peripheral T-cell Lymphomas. A Prospective Multicenter Study.
- Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous Stem cell support
- Recent View of Stem cell Plasticity and Stem cell therapy
- Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous Stem–cell transplantation as first-line treatment in …
- The therapeutic potential of mesenchymal Stem cells: cell-& tissue-based therapy
- Regulating Stem cell research & therapy
- Embryonic Stem cell-based diabetes therapy—a long road to travel
- Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic Stem cell transplantation
- Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous Stem cell …
- Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic Stem cell transplantation
- Stem and progenitor cell–based therapy of the human central nervous syStem
- Immobilization of mesenchymal Stem cells and monocytes in biocompatible microcapsules to cell therapy
- T cell suicide gene therapy to aid haematopoietic Stem cell transplantation
- … therapy between chemotherapeutic cycles and in vivo purging prior to autologous Stem cell transplantation, followed by maintenance therapy is a feasible …
- Suppressive anti-HCV therapy for prevention of donor to recipient transmission in Stem cell transplantation
- Frontline therapy with early intensification and autologous Stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non …
- Mechanistic insights into cardiac Stem cell therapy from a histopathologic perspective
- Modified total body irradiation as a planned second high-dose therapy with Stem cell infusion for patients with bone-based malignancies
- Early Stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide
- Successful therapy with whole‐lung lavage and autologous peripheral blood Stem cell transplantation for pulmonary alveolar proteinosis complicating acute …
- … during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent Stem cell …
- The shady side of embryonic Stem cell therapy
- … of In Vitro Irradiated CD34+ cells in the Presence of SCF, FLT3 Ligand, TPO and IL3: Potential Application to Autologous cell therapy in Accidentally Irradiated …
- The KIDStem European research training network: Developing a Stem cell based therapy to replace nephrons lost through reflux nephropathy
- Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic Stem cell transplantation outcome
- Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic Stem cell transplantation
- Successful interim therapy with imatinib prior to allogeneic Stem cell transplantation in Philadelphia chromosome‐positive acute myeloid leukemia
- rHuEpo before high-dose therapy allows autologous peripheral Stem–cell transplantation without red blood cell transfusion: a pilot study
- Stem cells, Stem cell therapy, and ethical problems of medicine
- The World of Stem cell therapy: Anonymity is not an Option
- The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic Stem cell transplant patients
- Mesenchymal Stem cells characteristics, niches, and applications for cell therapy
- Gene and cell therapy involving hematopoietic Stem cell
- Cardiovascular regeneration and Stem cell therapy
- Autologous Stem cell gene therapy: toward a universal platform for personalized therapy
- Embryonic Stem cell–derived astrocytes: a novel gene therapy vector for brain tumors
- The impact of histologic grade on the outcome of high-dose therapy and autologous Stem cell transplantation for follicular lymphoma
- A novel intensive induction therapy for high‐risk neuroblastoma utilizing sequential peripheral blood Stem cell collection and infusion as hematopoietic support
- Use of iron oxide MR contrast agents for monitoring Stem cell therapy
- Potentials and limitations of Stem cell therapy in myocardial disease
- Stem cell based cell therapy for muscular dystrophy
- Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic Stem cell …
- High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous Stem cell transplantation
- Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood Stem cell transplantation
- cell transplant and regenerative therapy with Stem cells
- Potential application of embryonic Stem cells in Parkinson’s disease: drug screening and cell therapy
- 328: Transurethral Ultrasound Guided Stem cell therapy of Urinary Incontinence
- … International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin’s lymphomas treated with high-dose BEAM therapy and autologous Stem cell …
- Effect of neurotrophic factor and Stem cell therapy on axonal regeneration after spinal cord injury: Overseas progress in basic and clinical researches
- A randomized, double-blinded, pilot trial of aprepitant added to standard antiemetics during conditioning therapy for hematopoietic Stem cell transplant (HSCT)
- Can Basic Fibroblast Growth Factor Pre-Treatment Enhance Mesenchymal Stem cell therapy in Undecorticated Posterior Spinal Fusion?
- Dog leukocyte antigen-haploidentical Stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model
- The Impact of Disease Status on the Outcome of High-Dose therapy (HDT) and Autologous Stem cell Transplantation (ASCT) for Peripheral T-cell …
- High‐dose therapy and autologous Stem‐cell transplantation can improve event‐free survival for indolent lymphoma: a study using patients as their own controls
- 230. In Vivo Fluorescence Tracking SyStem for Cardiac Stem cell therapy
- Autologous bone marrow Stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia
- Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases
- Initial therapy of multiple myeloma in patients who are candidates for Stem cell transplantation
- Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic Stem–cell transplant recipients?
- The future of allogeneic hematopoietic Stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy
- … therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous Stem cell …
- Lenalidomide as induction therapy before allogeneic Stem cell transplantation in a patient with proliferative CMML-2 and del (5q) not involving the EGR1 locus
- IMVP-16/Pd followed by high-dose chemotherapy and autologous Stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell …
- Embryo Stem cells from parthenotes and embryos produced by nuclear transfer: the distinction between them and their potential value in cell therapy
- Evaluation of the therapeutic responses of Stem cell therapy after myocardial infarction: Comparison of Thallium-201 gated-SPECT with 18F-FDG metabolism imaging
- cell therapy for heart failure—muscle, bone marrow, blood, and cardiac-derived Stem cells
- Mechanisms and applications of Stem cell gene therapy in autoimmunity
- CD34+ selected haematopoietic Stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure
- … circulation with localized transplantation in situ at the site of tissue/organ damage: a possible strategy to optimize the efficacy of Stem cell transplantation therapy
- Neural Stem cell therapy in lysosomal storage disorders
- Embryonic Stem cell-based therapy for the treatment of diabetes mellitus: a work in progress
- Pre‐Stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous …
- Triple antifungal therapy for severe syStemic candidiasis allowed performance of allogeneic Stem cell transplantation
- Gene and Stem cell therapy for autoimmune demyelination
- High‐dose therapy and autologous Stem cell transplantation for children with HIV‐associated non‐Hodgkin lymphoma
- Stability of colon Stem cell methylation after neo-adjuvant therapy in a patient with attenuated familial adenomatous polyposis
- Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous Stem cell transplant in multiple myeloma patients
- … recurred hemophagocytic syndrome in remission state of anaplastic large cell lymphoma following high‐dose therapy and autologous peripheral blood Stem cell …
- Successful therapy of patients in therapy-resistant cardiogenic shock with intracoronary, autologous bone marrow Stem cell transplantation
- Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic Stem cell …
- 568. Ex Vivo Mesenchymal Stem cell therapy with rAAV2 Encoding BMP-2 Enhances Bone Regeneration in Ovariectomized Mouse Model
- Peripheral blood Stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia
- Molecular imaging is indispensable for the development of Stem cell-based myocardial regenerative therapy
- Cancer Stem cells–new and potentially important targets for the therapy of oral squamous cell carcinoma
- Stem cell therapy of IBD
- The effect of induction therapy with novel agents on Stem cell mobilization in multiple myeloma
- Stem cell therapy: an emerging science
- Stem cell therapy: An Emerging Science
- … amphotericin B and combined syStemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic Stem cell transplant for a …
- Stem cell therapy ahead
- Autologous bone marrow Stem cell therapy for an ischemic ulcer of the lower limb in a diabetic patient
- Febrile neutropenia in paediatric peripheral blood Stem cell transplantation, in-vitro sensitivity data and clinical response to empirical antibiotic therapy
- … Complete Responses (CR/nCR) after Initial therapy with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Further Increased after Autologous Stem cell …
- Stem cell Biotechnology for cell therapy
- Maintenance therapy by Glivec® and Pegasys® in Patients with Philadelphia Positive Acute Lymphocytic Leukemia Not Eligible for Hematopoietic Stem cell …
- Planning time for peripheral blood Stem cell infusion after high-dose targeted radionuclide therapy using dosimetry
- An International Conversation on Stem cell Gene therapy: 4th Stem cell Conference on Stem cell Gene therapy Thessaloniki, Greece, 13–17 September …
- Hematopoietic Stem cell Gene therapy for Wiskott-Aldrich Syndrome.
- Investigation progress of imaging techniques monitoring Stem cell therapy
- KINETIC CONSIDERATIONS FOR. Stem cell therapy
- cellular therapy can be affected by the sex of the Stem cell used
- Biological modifiers as cytoreductive therapy before Stem cell transplant in previously untreated patientswith multiple myeloma
- Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic Stem cell transplantation in CML
- Stem cell therapy for Liver Disease
- Stem cell therapy for myocardial infarction
- 360. Transmitochondrial Stem cells: Toward Autologous Cybrid Stem cell therapy and Synergistic Transient Regenerative Gene therapy for Mitochondrial (mt) DNA …
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer …
- Autologous or allogeneic Stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
- Gene and Stem cell therapy
- Stem cell therapy in heart disease
- Hematopoietic Stem cell Transplantation, StemCells, and Gene therapy
- … Reduces the Cytotoxic Effects of In Vitro Expanded NK cells: Implications for Adoptive NK cell therapy in the Setting of Allogeneic Hematopoietic Stem cell …
- A PETHEMA study of high-dose therapy/Stem cell support (HDT), including tandem transplant, in primary refractory multiple myeloma (MM): Identification of two …
- Nuclear cloning, embryonic Stem cells and cell therapy: Promise, problems, reality
- Stem cell therapy of AD: Which way to go?
- Concerns Regarding Stem cell therapy from the Clinical Perspective
- therapy-related myelodysplastic syndrome following acute promyelocytic leukemia and biphenotypic acute leukemia following Stem cell transplantation in the …
- Durable remissions are rare following high dose therapy with autologous Stem cell transplantation for adults with” paediatric” bone and soft tissue sarcomas
- Neural Stem cells and cell replacement therapy: making the right cells
- Stem cell therapy in Liver Disease
- Stem cell therapy for myocardial infarction
- … Schedule Finding Study of Maintenance therapy with Low-Dose 5-Azacitidine (AZA) after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) for …
- Stem cell therapy: Moving towards reality
- … : ARTIFICIAL cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, and cell/Stem cell therapy. By Thomas Ming Swi …
- Stem–cell therapy for type 1 diabetes
- The Role of Pet Scan in Stem cell therapy
- Developmental aberrations of permanent teeth after high-dose anticancer therapy in childhood: A study on Stem cell transplant recipients
- Stem cell therapy in Acute Coronary Syndrome
- … PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic Stem cell transplantation–single-centre …
- Development of Adult Stem cell therapy Products
- Is Regulation of Stem cell therapy and Therapeutic Cloning Needed?
- New developments in Stem cell biology and therapy. meeting report from the working group of the German Society for Hematology and Oncology
- Hope to the cancer therapy: cancer Stem cell
- Stem cell therapy in endocrinology: reality and challenges
- New Approach in Ischemic Stroke Treatment: Stem cell therapy
- Adult Stem cell therapy–an option for the brain?
- Stem cell therapy for Erectile Dysfunction
- The Basics of Pathologic Assessment in Experimental Models of Stem cell therapy
- Understanding the Basics of Clinical Imaging for Assessing Stem cell therapy in the Heart
- Stem cell therapy for Patients with Myocardial Infarction
- Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic Stem cell transplantation in the treatment of adrenal cancer with …
- Clinical Utilization of Stem cell therapy in Acute Myocardial Infarction
- Stem cell therapy In Endocrinology-Scope And Limitations
- Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report
- Second autologous Stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free …
- Embryonic Stem cell therapy for diabetes mellitus
- Mechanisms of myocardium repairing by Stem cell therapy
- Stem cell therapy FOR MYOCARDIAL REGENERATION
- Stem cell therapy-role in corneal diseases: mini review
- 1088. Stem cell Gene therapy with No Pre-Conditioning for the ADA-Deficiency Patients Leads to Generalized Detoxification and Delayed, but Steady Hematological …
- Hearing loss treatment through Stem cell therapy
- Exploring Stem cell therapy Potentials: A Q&A with Anthony G. Payne, Ph.D.
- Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic Stem cell transplantation: a single-center experience in Korea
- Current Status of G-CSF Based Stem cell therapy for Patients with Myocardial Infarction
- Future of Stem–cell therapy for neuromuscular diseases
- Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood Stem cell transplantation
- Stem cell therapy for failing hearts: there is something else beyond the cells
- Cardiac Stem cell therapy research in China
- The Role of Non-invasive Imaging and cell Labelling Techniques in the Clinical Assessment of Stem cell therapy
- Bringing cardiac Stem cell therapy into the clinic
- A comparative review of legal and ethical issues arising from Stem cell therapy and therapeutic cloning
- Myocardium repair with Stem cell therapy
- Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic Stem cell transplantation
- Guided cardiogenesis for safe Stem cell‐based therapy
- Stem cell therapy of Intractable Human Diseases; Potentials and Pitfalls
- Efficacy of High-Dose therapy and Autologous Stem cell Transplantation for Chemoresistant Hodgkin’s Lymphoma.
- Stem cell therapy jumps another ethical hurdle
- Adult neural Stem cell therapy for the brain
- Stem cell therapy using Umbilical Cord Blood in Liver Disease
- Pre-Transplant Rituximab therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem cell …
- Stem cell therapy in animal models of inherited metabolic diseases
- Growth and differentiation of human embryonic Stem cells for cardiac cell replacement therapy
- Drug evaluation: ADA-transduced hematopoietic Stem cell therapy for ADA-SCID.
- In Vitro Model SyStem for Cardiac Stem cell therapy
- Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic Stem cell transplant (HSCT) recipients vs other patients with aspergillosis
- Does mesenchymal Stem cell therapy help multiple sclerosis patients? report of a pilot study
- Evaluation of Magnetic Nanoparticles for Stem cell therapy Using a Microfluidic SyStem
- The Role of High Dose therapy and Stem cell Rescue in the Management of T-cell Malignant Lymphomas (TCL): A BSBMT and ABMTRR Study.
- Hematopoietic AC133+ Stem cell therapy for patients with severe peripheral vascular disease
- Increasing importance of Stem cell gene therapy in adenosine deaminase deficiency?
- Dendritic cell therapy for Tolerance Induction to Stem cell Transplantation
- Regenerative medicine and cardiovascular diseases: Stem cell therapy
- Stem cell therapy FOR DEGENERATIVE DISC DISEASE: IN VITRO AND IN VIVO STUDY
- Complete remission upon bortezomib–dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic Stem cell …
- … -retinoic acid+ dexamethasone+ alpha interferon as maintenance therapy following high-dose chemotherapy and autologous Stem cell transplant for multiple …
- Stem cell therapy, smoking and obesity: getting the priorities right for reducing cardiovascular diseases
- The Application of Mesenchymal Stem cell therapy on Multiple SyStem Atrophy
- … High Dose Chemotherapy (HDC) Prior to Autologous Stem cell Transplantation (ASCT) as First Line therapy in Stage III-IV Diffuse Large B-cell Lymphoma (B-DLCL …
- Cancer Stem cell targeted therapy: Removing the sword of Damocles
- Does Stem cell therapy for ischemic cardiomyopathy result in the improvemnt of congestive heart failure: A prospective randomized study
- The effects of music therapy on anxiety, nausea and vomiting in patients receiving total body irradiation for hematopoietic Stem cell transplantation
- Stem cell therapy after irradiation of a malignant asecretory pheochromocytoma–a case report
- Indications for hematopoietic Stem cell therapy for patients with diagnosis of myelodysplastic syndromes
- Stem cell therapy FOR INTERVERTEBRAL DISC DEGENERATION IN-VITRO AND IN-VIVO FEASIBILITY STUDY
- Stem cell therapy in rat hind limb ischemic injury
- … Large B-cell Lymphoma (DLBCL) Does Not Affect Disease-Free (DFS) or Overall Survival (OS) Following High Dose therapy (HDT) and Autologous Stem cell …
- CD34+ Stem cell therapy in Chronic Stroke Patients
- Safety and Efficacy of Enzyme Replacement therapy (ERT) in Combination with Haematopoietic Stem cell Transplantation (HSCT) for Hurler’s Syndrome …
- Molecular imaging of cardiac Stem cell mediated angiogenic gene therapy
- Heart rate variability and cardiac rhythm alterations associated with Stem cell therapy in cardiovascular disease
- … Use of Palifermin and Pegfilgrastim Significantly Reduces Toxicity of High-Dose therapy and Autologous Blood Stem cell Transplantation in Patients with …
- … of Prevention of Severe Oral Mucositis Using Single Dose Velafermin in Patients Receiving Myeloablative therapy and Autologous Hematopoietic Stem cell …
- Restoration of the left ventricular synchronous contraction after acute myocardial infarction by Stem cell therapy
- Rostock Confocal Image Analysis of Patients Treated With Cultured Limbal Epithelial Stem cell therapy
- Bone marrow derived adult Stem cells: characterization and application in cell therapy
- Production, Transplantation and Outcome of Good Manufacturing Practice Compliant Limbal Epithelial Stem cell therapy
- Muscle Derived Stem cell/Alginate/Polycaprolactone/Injection therapy in Rats with Denervated Urethral Sphincter
- High-dose chemotherapy with autologous hematopoietic Stem cell transplantation for non-Hodgkin’s lymphoma in complete response as consolidation therapy …
- Engineering a New Insulin-Like Growth Factor-1 Protein for Embryonic Stem cell therapy
- The effect of cell therapy using a human mesenchymal Stem cell injection on left ventricular systolic function in rat myocardial infarction model
- 90Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose therapy (HDT) Followed by Autologous Stem cell Transplant (ASCT) May Improve …
- Human Mesenchymal Stem cell therapy: Platelet Lysate Supports Efficient Preclinical Expansion.
- … of a minimally invasive bone marrow harvest device and method for the rapid extraction of bone marrow for use in bone marrow transplantation and Stem cell therapy
- ENGINEERED MESENCHYMAL Stem cell therapy PROLONGED CARDIAC ALLOGRAFT SURVIVAL.
- Autologous Bone Marrow-Derived Stem cell therapy in Patients with Severe Peripheral Arterial Disorders: A Pilot Study.
- Mesenchymal Stem cell therapy Prevents Ischemia/Reperfusion Injury and Promotes Tissue Regeneration
- Update of melphalan 280 mg/m2 plus amifostine cytoprotection before autologous Stem cell transplantation as part of initial therapy in multiple myeloma patients
- … Correlates with Less Acute Graft-Versus-Host Disease and Better Survival in B-cell Lymphoma Patients Who Received Allogeneic Peripheral Blood Stem cell …
- Bone marrow Stem cell therapy for renal regeneration after acute tubular necrosis: A dream or a reality?
- Autologous Bone Marrow Stem cell Infusion (AMBI) therapy for Chronic Liver Diseases
- Patients with End-Stage Ischemic Heart Failure: a Growing Target Population for Cardiac Stem cell therapy
- … Stem cell therapy for Incurable and Intractable Disease: More than 700 Stem cell Panels are Stored and Umbilical Cord Blood Derived Stem cell Bank will be …
- … effects of hematopoietic Stem cells on cancer (gliosarcoma spheroids) and normal tissues: towards developing hematopoietic Stem cell therapy for astronauts’ cancer
- Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose therapy and Autologous Stem cell Transplantation Is a Prognostic …
- Prolonged Clinical and Molecular Remissions Following High-Dose therapy/Autologous Stem cell Transplantation (HDT/ASCT) and Rituximab and …
- Gene therapy and Stem cell therapy for cardiovascular diseases today: a model for translational research Cancer regression in patients after transfer of genetically …
- First trial in a case of Fibrocarcilaginous embolism by dorsolaminectomy and Stem cell therapy in a cocker spaniel dog
- 13N-NH3 PET: The assessment of myocardial perfusion in patients with AMI and Stem cell therapy
- … chemotherapy and autologous hematopoietic Stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast …
- Stem cell therapy with G-CSF Did Not Aggravate Neointimal Growth, but Induced Positive Remodeling in Patients with Myocardial Infarction who Underwent Drug …
- Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic Stem cell transplantation (ASCT) in patients (pts) with chronic myeloid leukemia (CML): No evidence …
- High-Dose therapy and Autologous Stem cell Transplantation for Chemoresistant Diffuse Large B cell Lymphoma: The Seattle Experience.
- Bringing cardiac cell therapy with bone marrow Stem cells to the clinic: where are we now?
- 1018. Stem cell Gene therapy: Toward a Universal Platform Relying on Custom Endonuclease-Boosted Gene Targeting, Cybridization, Transient Regenerative …
- Treosulfan-Based Tandem High-Dose Chemo-Immuno-therapy with Autologous Stem cell Transplantation for Relapsed and Refractory Aggressive B-cell …
- Idiotype (Id) immunotherapy (IT) following high dose therapy and autologous Stem cell transplant (HDT/ASCT) in mantle cell (MC) and indolent lymphoma (IL): cellular …
- Smoothened peptides inhibit prostate and gastric cancer cells by targeting the Hedgehog pathway: a potential cancer Stem cell therapy
- Treatment of AL amyloidosis with high dose therapy and autologous Stem cell transplantation
- Intervertebral disc cell therapy for regeneration: mesenchymal Stem cell cultivation in vitro and intervention in TGF-? 1 implantation in rabbit intervertebral discs
- Fetal Stem–cell and gene therapy
- Allogeneic Hematopoietic Stem cell Transplantation (Allo-SCT) Versus Conventional Postremission therapy (PRT) for AML in First Complete Remission …
- Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic Stem cell transplantation
- Treosulfan high dose therapy with autologous Stem cell rescue in high-risk Ewing tumors
- Tandem high-dose therapy with autologous Stem cell support for small-cell lung cancer (SCLC)
- … VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose therapy with Autologous Stem cell Transplantation and Maintenance …
- Air Leak Syndrome (ALS) Following Allogeneic Stem cell Transplantation (SCT): A Report of 22 Patients from Kanto Study Group for cell therapy (KSGCT) in Japan.
- High dose therapy with autologous Stem cell transplantation in patients with Hodgkin’s lymphoma: long-term follow-up in patients treated in one center
- Effects of injection therapy using muscle derived Stem cell/chitosan/hydroapatite composite gel in a rat model of urinary incontinence
- Stem cells as Targets for Gene and cell therapy
- … bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary Stem cell therapy in acute myocardial
- Immunomodulatory therapy for SSc: Will high-intensity immunosuppression with Stem cell rescue improve outcome?
- Stem–cell transplant for Hodgkin’s lymphoma: does choice of therapy prior to high-dose treatment matter?
- Bortezomib (BTZ) prior to and as maintenance therapy after autologous Stem cell transplant (ASCT) in multiple myeloma (MM): Long-term follow-up of a phase II study
- Potential of Stem cell based therapy and tissue engineering in the regeneration of the central nervous syStem
- Stem cells a Hope for cell therapy and Regenerative Medicine
- Maintenance therapy with 5-Azacytidine (5-AC) after Allogeneic Stem cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk …
- Dual-gene transfer and vector targeting for hematopoietic Stem cell gene therapy
- … therapy (ECP) with UVADEX® for the prevention of acute GVHD in patients (pts) undergoing standard myeloablative conditioning and allogeneic hematopoietic Stem …
- Gene therapy and Stem cell activation against stroke
- Directed differentiation of adult neural Stem cells for cell therapy in the nervous syStem
- Stem cell potential for type 1 diabetes therapy
- The Impact of Histologic Grade on the Outcome of High-Dose therapy and Autologous Stem cell Transplantation for Follicular Lymphoma.
- Reply to ‘Autologous Stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome’
- High Dose therapy and Autologous Peripheral Blood Stem cell Transplantation as Salvage therapy for HIV-Associated Lymphoma: Result of the GICAT Study.
- Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous Stem cell transplantation
- Clonal Analyses of Retroviral Vector Integrations in ADA-SCID Patients Treated with Stem cell Gene therapy.
- Prognostic Factors for CMV Reactivation/Infection after Stem cell Transplantation and Value of Oral Valganciclovir for Preemptive therapy.
- Haematopoietic Stem cell Based Gene therapy as a Strategy to Treat Autoimmune Disease
- Functional Comparison of Bone Marrow–Derived Liver Stem cells: Selection Strategy for cell-Based therapy
- Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem cell Transplantation (HSCT).
- … Preparative Regimens on the Incidence of therapy Related Myelodysplasia (t-MDS) or AML (t-AML) Following Autologous Stem cell Transplant (ASCT) for …
- High-dose cyclophosphamide as an effective therapy for a patient with refractory multiple myeloma relapsing after autologous Stem cell transplantation
- 1: Cytotoxic T lymphocyte therapy for the treatment and prevention of adenovirus infection after Stem cell transplant
- Preliminary Results of therapy with AM3 in Patients Undergoing Hematopoietic Stem cell Transplantation.
- The role of high-dose therapy and Stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and…
- Stem cell replacement therapy in type 1 diabetes
- 2520: Involved Field Radiation therapy Following Autologous Stem cell Rescue for Hodgkin and Non-Hodgkin Lymphoma-Is it Efficacious?
- … -Adapted therapy of Adult Acute Myeloid Leukemia (AML): Safety and Efficacy of Repetitive HD-ARA-C Courses with Low-Dose Autologous Blood Stem cell …
- The experimental study on bone marrow Stem cell transplantition combinated with bushen fang therapy for DMD
- Phase II trial of GM-CSF as maintenance therapy post–autologous peripheral blood Stem cell transplantation in multiple myeloma
- … after autologous peripheral blood Stem cell transplantation does not add any benefit regarding hematological engraftment and supportive therapy …
- … Incidence in Patients with Hematological Malignancies Receiving Myelotoxic therapy Requiring Hematopoietic Stem cell Support-Palifermin Experience.
- … of Interferon Versus Thalidomide Versus RIC Allotransplant for Maintenance/Consolidation therapy after Autologous Stem cell Transplantation in Patients …
- Stem cell transplantation therapy for diabetes mellitus
- Rituximab maintenance following high dose therapy and autologous Stem cell rescue after RICE cytoreduction improves event free and overall survival
- Posaconazole (POS) salvage therapy allows successful allogeneic hematopoietic Stem cell transplantation (HSCT) in patients with refractory invasive mold infections
- High dose therapy followed by autologous purged Stem cell
- High-Dose therapy/Stem cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group …
- Study Progress of Hematopioetic Stem cell Transplantation therapy on Acute Leukemia in Children
- … -CHOP, Based on CT and Gallium 67 Scan (G67S) with or without IFE Salvage therapy Followed by Peripheral Autologous Stem cell Transplant (PBSCT) in …
- … CsA, MTX, MMF and ATG and Triple therapy with CsA, MTX and ATG for Preventing Graft-Versus-Host Disease in Unrelated Donor Hematopoietic Stem cell …
- … Associated with Engraftment of Gene-Corrected Repopulating cells Achieved in ADA-SCID Patients by Stem cell Gene therapy without Myelopreparative Pre …
- Isolation of amniotic Stem cell lines with potential for therapy.
- … WITH LOW DOSE PARATHYROID HORMONE PULSE therapy INCREASES ALLOGENEIC HEMATOPOIETIC Stem cell ENGRAFTMENT IN NON-HUMAN …
- … Stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing Stem cells in hypoxic …
- … neurectodermal tumors (SPNET) treated with risk-adapted craniospinal (CSI) radiation (RT) therapy followed by 4 cycles of high-dose chemotherapy and Stem cell …
- Allogeneic Stem cell Transplantation for therapy-Related Myelodysplastic Syndrome (t-MDS) and Acute Myeloid Leukemia. A Report from the MDS …
- Reply to ‘Promotion of neurogenesis by human Stem cells in high-risk breast cancer survivals after Stem–cell supported high-dose therapy‘by K. Altundag et al.(Ann …
- Gene therapy and Stem cell transplantation in PAD
- Stem cell: From Bone Marrow Transplantation for the Treatment of Hematological Diseases to therapy for Other SyStemic Disorders
- EPIGENETIC INSTABILITY OF HUMAN EMBRYONIC Stem cell LINES: IMPLICATIONS FOR therapy
- Neural Stem cell can mediate immune therapy for brain tumor
- Osteosarcoma target therapy with Stem cell transplant: A case review
- Impact of intensive Stem cell mobilization therapy on outcomes following autologous Stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)
- Immunoablative therapy with Autologous Stem cell Transplantation in the Treatment of Poor Risk Multiple Sclerosis.
- Embryonic Stem cells and cardiac cell therapy
- Which Strategy of Immunoablative therapy with Autologous Stem cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.
- Combination therapy with mesenchymal Stem cell and erythropoietin in patients with ALS
- Experimental substantiation of embryonic Stem cell application in therapy of patients with extrapyramidal hyperkinesis
- therapy of Heart Failure Rats with Mesenchymal Stem cell Transplantation
- Long-term safety and efficacy of Stem cell gene therapy for ADA-SCID.
- Differentiation of Human Embryonic Stem cells; Prospects for Development Biology and cell therapy
- Autologous Stem cell Transplantation Provides Additional Cytoreduction Following Induction therapy in Multiple Myeloma.
- Correction of Murine Hemophilia A by Hematopoietic Stem cell Gene therapy.
- Experimental investigation on therapy of intravenous transplantation of neural Stem cell for spinal cord injury
- Are RIC allogeneic Stem cell transplants ready for prime time in CLL therapy?
- High-dose therapy with autologous Stem cell rescue in patients with breast cancer at high risk for relapse
- Regenerative cellular therapy: How To Enrich The Mesenchymal Stem cell Content In The Periinfarction Zone After Myocardial Infarction
- Bone marrow Stem cells: possible source for cell therapy in Parkinson’s disease
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy for Relapsed Multiple Myeloma.
- Tacrolimus therapy for Severe Recurrent Crohn’s Disease after Stem cell Transplant: 844
- Improved Survival in Patients with Peripheral T cell Lymphoma, Unspecified Following High-Dose therapy and Stem cell Transplantation: A Retrospective …
- Plasmid transfection of rat bone marrow mesenchymal Stem cells by cationic lipid for gene-modified cell transplantation therapy
- 1672: Early Phase I/II Clinical Trial Results for Human Cord Blood Stem cell Injection therapy for Stress Urinary Incontinence
- Thalidomide salvage therapy following allogeneic Stem cell transplantation for multiple myeloma: A…
- Conditioning therapy with intravenous busulfanum and cyclophosphamide for allogeneic hematopoietic Stem cell transplantation: A report of 19 cases☆
- 433 EVALUATION OF Stem cell POPULATIONS IN THE BLOOD OF PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION therapy.
- Estrogen-progestin therapy in women after Stem cell transplant: our experience and literature review.
- Gemtuzumab Ozogamicin as Maintenance therapy after Autologous Stem cell Transplantation (ASCT) in Patients with Acute Myeloid Leukemia (AML).
- Biological modifiers as cytoreductive therapy before Stem cell transplant in previously untreated patientswith m…
- Early Goal Directed therapy for Septic Shock Is Feasible and Safe in Hematopoietic Stem cell Transplant Patients.
- Sca-1+ Progenitors Derived from Stem cells Differentiate into Endothelial cells: Implications for Stem cell-Based therapy in the Injured Artery
- Limbal Stem cell autotansplantation in therapy of recurrent pterygium and ophthalmoherpes
- Characteristics of patients with false positive FDG-PET findings after high dose therapy and autologous Stem cell transplantation (HDT/ASCT)
- Comment on ‘CD34+ selected hematopoietic Stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment of graft failure’–G Milone et al
- Allogeneic hematopoietic Stem cell transplantation as consolidation therapy for adult T cell Leukemia/Lymphoma patients: A single-center experience in 35 patients.
- … therapy for Thymic Insufficiency after Hematopoietic Stem cell Transplantation: Generation of MTS24 Positive Definitive Endoderm from Murine Embryonic Stem …
- … results of risk adapted pre-emptive therapy of CMV infection with ganciclovir in 169 patients, after allogeneic hematopoietic Stem cell transplantation in Hematology …
- Voriconazole (VOR) is safe and effective as prophylactic antifungal therapy for allogeneic Stem cell transplantation (AT)
- Effects of Prior therapy on the in Vitro Proliferative Potential of Stem cell Factor Plus Filgrastim-mobilized CD34-positive Progenitor cells1
- Hematopoietc Stem cell Targeted Neonatal Gene therapy Cures oc/oc Mice from Osteopetrosis.
- Interferon-α therapy for patients with molecular relapse in leukemia after allogeneic Stem cell transplantation
- NOVEL METHODS IN THE DIAGNOSTICS AND therapy Intracoronary, autologous bone marrow Stem cell transplantation for treatment of postinfarction left …
- Involved Field Radiation therapy Following Autologous Stem cell Rescue for Hodgkin and Non-Hodgkin Lymphoma-Is It Efficacious?.
- Determining the Appropriate PCR Trigger for Pre-Emptive Anti-CMV therapy in Allogeneic Stem cell Transplant Recipients.
- FDG-PET for the prediction of therapy outcome in patients with high risk soft tissue sarcomas receiving high dose chemotherapy with Stem cell rescue
- … initial therapy may be associated with a poorer outcome in young patients subsequently treated with Stem cell transplantation for relapsed chemosensitive large B-cell …
- Clinical Prognostic Factors in Chemosensitive Multiple Myeloma (MM) Patients Intensified with High Dose therapy/Stem cell Support (HDT/SCS): Results of …
- High-dose therapy and autologous Stem cell transplantation for Hodgkin’s lymphoma in relapse or failure after initial chemotherapy: results of the Centre National de …
- … of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation therapy (HDT) with Stem cell …
- Gene therapy and neural Stem cell transplantation in rodent models of Huntington’s disease
- Poor Prognosis for Patients after Myelo-and Non-Myeloablative Conditioning therapy Followed by Allogeneic Peripheral Blood Stem cell Transplantation Admitted to …
- … Followed by Early High-Dose therapy and Hematopoietic Stem cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-cell …
- High dose chemotherapy with autologous Stem cell rescue as a part of combined modality therapy in stage IIIB inflammatory breast cancer
- … I/II-Study on PCR-Based Pre-Emptive therapy with Valganciclovir or Ganciclovir for Active CMV Infection Following Reduced Intensity Allogeneic Stem cell …
- 248: Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic Stem cell transplantation (ASCT) in patients with chronic myeloid leukemia (CML): No evidence …
- 442. LV Expressing MR Reporter Genes Allows In Vivo Monitoring of Stem cell Gene therapy
- High-Dose therapy (HDT) with Autologous Hematopoietic Stem cell Transplantation (HSCT) in Patients with Poor Prognosis Ewing Family Tumors (EFT).
- Busulfan and melphalan as preparative therapy for Stem cell transplantation in pediatric patients with acute myelogenous leukemia (AML) and myelodysplasia (MDS)
- … chemotherapy and autologous Stem cell transplantation in poor prognosis patients with advanced follicular lymphoma—effective therapy in first complete or partial …
- Administration of Virus-Specific Cytotoxic T-Lymphocytes for the Prophylaxis and therapy of Adenovirus Infection post Allogeneic Stem cell Transplant
- Modified Thalidomide, Cyclophosphamide and Dexamethasone (TCD) to Patients with Multiple Myeloma as Primary therapy Prior to Peripheral Blood Stem cell …
- Hematopoietic Stem cell Transplantation (HSCT) as Curative therapy for Fanconi Anemia (FA) Patients with Acute Leukemia or Advanced Myelodysplasia (MDS).
- Steroid therapy Increase Only Adenovirus Infection but Not Cytomegalovirus Infection in Dose Dependent Manner after Hematopoietic Stem cell Transplantation.
- Stem cell Transplantation (SCT) in Conjunction With Enzyme Replacement therapy (ERT) for a Child With Hurler Syndrome (MPS IH): 42
- Characterization of an Immunodeficient Mucopolysaccharidosis Type I (MPS-I) Mouse Model Suitable for Preclinical Testing of Human Stem cell and Gene therapy.
- … treatment for thrombocytopenia after salvage therapy with arsenic trioxide therapy followed by autologous hematopoietic Stem cell transplantation in acute …
- Comparison of HLA-Identical Sibling Hematopoietic Stem cell Transplant (HCT) Versus Chemotherapy as Postremission therapy in t (8; 21) Acute Myeloid Leukemia …
- Allogeneic Hematopoietic Stem cell Transplantation after Combination therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia …
- Zoledronic Acid Plus Thalidomide Is Safe and Well Tolerated When Used as Post-Autologous Stem cell Transplant Maintenance therapy in Patients with …
- 1055. High Levels of Human Factor IX Expression in Hemophilia B Mice after Adult Stem cell-Based Gene therapy Combined with Non-Myeloablative Conditioning
- Bortezomib therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem cell Transplantation (RICT).
- Maintenance therapy with Thalidomide/Prednisone Post Autologous Stem–cell Transplant for Patients with Multiple Myeloma Elevates D-Dimer and Possibly …
- Directed differentiation of pancreatic islets from human embryonic Stem cells and cell therapy of diabetes mellitus
- … a Phase II Study of Post-Transplant Maintenance therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem cell …
- … -Rituximab (DC-R) Plus GM-CSF as a Salvage therapy in B-Diffuse Large cell Lymphoma (B-DLCL) after Autologous Stem cell Transplantation (ASCT) Failure.
- Allogeneic Myelo-Ablative Stem cell Transplant (SCT) as Salvage therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome.
- Molecular mechanisms of immune deficiency in adenosine deaminase (ADA)-deficient SCID patients: implications for Stem cell gene therapy
- … Memory B cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant therapy after Autologous Stem cell …
- 347: Intentional induction of mixed hematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic Stem cell transplantation in childhood …
- Corticosteroid therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem cell Transplantation for Acute Myelogeneous Leukemia and …
- Tandem high-dose chemotherapy (HDC) with peripheral blood Stem cell rescue (PBSCR) as consolidation therapy for high-risk (primary unresectable pelvic tumors or …
- … -Based Maintenance therapy in Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) Ineligible for Allogeneic Stem cell …
- … Field Radiation Treatment (IFRT) in Patients With Bulky Non-Hodgkin Lymphoma (NHL) Undergoing High-Dose therapy and Autologous Bone Marrow/Stem cell …
- 131I-Metaiodobenzylguanidine (131I-MIBG) double infusion with autologous Stem cell transplant for neuroblastoma: A New Approaches to Neuroblastoma therapy …
- Allogeneic Stem cell Transplantation (AlloSCT) for the Treatment of therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results …
- … (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem cell (HSC) Recipients Receiving Long Term Caspofungin (C) therapy.
- Gleevec as therapy for CML Relapsed after Allogeneic Stem cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.
- Successful Engraftment Using Varied Stem cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in …
- Does Highly Active Anti-Retroviral therapy (HAART) Delay Myeloid Engraftment after Autologous Stem cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+ Ly …
- Low-Dose Methotrexate as Salvage therapy for Refractory Graft-Versus-Host Disease (GVHD) after Reduced-Intensity Conditioning (RIC) for Allogeneic Stem cell …
- 65. Long-Term Effects of Hematopoietic Stem cell Gene therapy in the Murine Model of Wiskott-Aldrich Syndrome: Persistence of Functional Correction of T cells and …
- 263: Non-myeloablative conditioning therapy with fludarabine, cyclophosphamide and ATG allogeneic hematopoietic Stem cell transplantation from HLA-identical …
- … , Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem cell Transplantation Followed by Randomization to therapy with Interleukin-2 Versus …
- Combined Stem cell Mobilization via CXCR4 Antagonist Augments Recruitment of EPCs Following Sonic Hedgehog Gene therapy via Increased Local Expression of …
- … Graft-Versus-Host Disease (GVHD) Following Bortezomib as Salvage therapy after Reduced Intensity Conditioning Allogeneic Stem cell Transplantation (RIC allo …
- DLA-Haploidentical Stem cell Allografts after Anti-CD44 therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI) …
- Sustained effect of first line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic Stem cell transplantation (ASCT) after reduced …
- 356: First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic Stem cell transplantation (ASCT) after reduced intensity …
- COMBINATION cell AND GENE therapy FOR PERIPHERAL ISCHEMIA USING MYOBLASTS AND Stem cells ENGINEERED WITH CONDITIONALLY …
- Stem cells and cell-based therapy in neurodegenerative disease
- Mobilis in Mobile–Human Embryonic Stem cells and Other Sources for cell therapy
- Stem cells and islet engineering for cell replacement therapy in diabetes
- Investigation into the application of adult human Mueller Stem cells in retinal ganglion cell replacement therapy
- Proliferation of bone marrow mesenchymal Stem cells, skeletal muscle cells and co-culture of both for cell myocardium therapy in Wistar rats
- Mesenchymal Stem cells: Differentiation, hematopoietic support and possible application in cell and gene therapy for osteoarthritis
- Neural Stem cells for cell replacement therapy in Huntington’s disease
- cell and gene therapy via human neural Stem cells (hNSCs) in transgenic SOD1 (G93A) ALS (amyotrophic lateral sclerosis) mice
- cell transplantation for periodontal diseases. A novel periodontal tissue regenerative therapy using bone marrow mesenchymal Stem cells
- Microencapsulation of Mesenchymal Stem cells (MSCs) for cell Based therapy
- Improvement of musculoskeletal function by cell-based therapy using mesenchymal Stem cells with a prolonged life span
- … Stem cells together with differentiated derivatives of human embryonic Stem cells. A novel strategy to enhance the efficacy of autologous cell-transplantation therapy …
- Discovery of a Novel Paracrine Angiogenic Factor from Akt-Transduced Mesenchymal Stem cells for cell/Protein-based therapy in angiogenesis
- Introduction to Stem cell therapy
- Stem–cell therapy for cardiac disease
- Stem cell‐based cell therapy in neurological diseases: a review
- Stem cell therapy in stroke
- Stem cell therapy–Hype or hope? A review
- Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal Stem cells
- Mesenchymal Stem cells: Stem cell therapy perspectives for type 1 diabetes
- Stem cell therapy is proarrhythmic
- The changing face of neural Stem cell therapy in neurologic diseases
- Feasibility of a Stem cell therapy for intervertebral disc degeneration
- A review of gene and Stem cell therapy in cutaneous wound healing
- Stem cell therapy for cardiac repair: benefits and barriers
- Stem cell therapy: MRI guidance and monitoring
- Intravenous mesenchymal Stem cell therapy for traumatic brain injury
- Stem cell therapy restores transparency to defective murine corneas
- Adult Stem cell therapy of female stress urinary incontinence
- Stem cell therapy for heart failure: are arrhythmias a real safety concern?
- Emerging hurdles in Stem cell therapy for peripheral vascular disease
- cellular MRI and its role in Stem cell therapy
- Mesenchymal Stem cell therapy for diabetes through paracrine mechanisms
- Critical issues of clinical human embryonic Stem cell therapy for brain repair
- Current status of Stem cell therapy for liver diseases
- Subacute neural Stem cell therapy for traumatic brain injury
- Mesenchymal Stem cell therapy for equine tendinopathy
- Prospects of Stem cell therapy for replacing dopamine neurons in Parkinson’s disease
- Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal Stem cell therapy
- Stem cell therapy and regenerative medicine
- Olfactory mucosa is a potential source for autologous Stem cell therapy for Parkinson’s disease
- Bone-marrow-derived mesenchymal Stem cell therapy for neurodegenerative diseases
- Stem–cell therapy in retinal disease
- Overview of Stem cell therapy for Crohn’s disease
- Combining growth factor and Stem cell therapy for amyotrophic lateral sclerosis
- Capillary regeneration in scleroderma: Stem cell therapy reverses phenotype?
- Current and future regenerative medicine—principles, concepts, and therapeutic use of Stem cell therapy and tissue engineering in equine medicine
- Cardiac regeneration and Stem cell therapy
- Proinflammatory cytokine effects on mesenchymal Stem cell therapy for the ischemic heart
- Embryonic Stem cell therapy of heart failure in genetic cardiomyopathy
- Mesenchymal Stem cell therapy for nonmusculoskeletal diseases: emerging applications
- Prospects for pluripotent Stem cell‐derived cardiomyocytes in cardiac cell therapy and as disease models
- Autologous mesenchymal Stem cell therapy delays the progression of neurological deficits in patients with multiple syStem atrophy
- Stem cell therapy for cartilage regeneration in osteoarthritis
- Bionetworking: experimental Stem cell therapy and patient recruitment in India
- Stem cell therapy: the great promise in lung disease
- Paracrine mechanisms in adult Stem cell signaling and therapy
- Muscle derived Stem cell therapy for stress urinary incontinence
- Stem cell therapy for cardiac repair
- Mesenchymal Stem cell therapy for protection and repair of injured vital organs
- Stem cell therapy for the kidney?
- Allogenic Stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension
- Potencial role of Stem cell therapy in type 1 diabetes mellitus
- Translational development of mesenchymal Stem cell therapy for cardiovascular diseases
- Stem cell‐based cell therapy for Huntington disease: a review
- Gene and Stem cell therapy in peripheral arterial occlusive disease
- Stem–cell therapy faces more scrutiny in China; but regulations remain unclear for companies that supply treatments
- Stem cell therapy to reduce radiation-induced normal tissue damage
- Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model
- Immunogenicity and allogenicity: a challenge of Stem cell therapy
- Differential destruction of Stem cells: implications for targeted cancer Stem cell therapy
- Comparison of different culture conditions for human mesenchymal stromal cells for clinical Stem cell therapy
- Cytokines as the major mechanism of mesenchymal Stem cell clinical activity: expanding the spectrum of cell therapy.
- Choosing between Stem cell therapy and drugs in myelofibrosis
- Stem cell therapy for ischemic heart disease: where are we?
- Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
- Tracking Stem cell therapy in the myocardium: applications of positron emission tomography
- Stem cell therapy for end-stage heart failure: indispensable role for the cell?
- Placental mesenchymal and cord blood Stem cell therapy for dilated cardiomyopathy
- Long-term outcome of Stem cell therapy for acute myocardial infarction: right results, wrong reasons
- A new dawn for Stem–cell therapy
- Stem cell therapy in myocardial repair and remodeling
- Stem cell therapy to treat diabetes mellitus
- Stem–cell-based therapy and lessons from the heart
- Stem cell therapy for Alport syndrome: the hope beyond the hype
- Gene and Stem cell therapy in ischemic stroke
- Stem cell therapy: a primer for interventionalists and imagers
- Drawbacks to Stem cell therapy in cardiovascular diseases
- Stem cell therapy for chronic liver disease—choosing the right tools for the job
- Bone marrow-derived mesenchymal Stem cell therapy as a candidate disease-modifying strategy in Parkinson’s disease and multiple syStem atrophy
- Stem cell therapy for heart failure
- Human amnion‐derived mesenchymal Stem cells are a potential source for uterine Stem cell therapy
- Prospects for Stem cell-based therapy
- Mesenchymal Stem cell therapy for degenerative inflammatory disorders
- Isolation of Stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease
- Mesenchymal Stem cell-based therapy for cartilage repair: a review
- Stem cell therapy for urethral sphincter regeneration.
- Adult Stem cell therapy for acute brain injury in children
- Histocompatibility testing of cultivated human bone marrow stromal cells–A promising step towards pre-clinical screening for allogeneic Stem cell therapy
- Stem cell therapy in multiple sclerosis: promise and controversy
- T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic Stem cell transplant
- … into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis—a novel approach in Stem cell therapy
- Inflammatory mediators: parallels between cancer biology and Stem cell therapy
- Strategies for future histocompatible Stem cell therapy
- Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of Stem cell therapy
- Cardiovascular regeneration and Stem cell therapy
- Stem cell therapy for cystic fibrosis: current status and future prospects
- What are the prospects of Stem cell therapy for neurology?
- Neuroimaging as a basis for rational Stem cell therapy
- Potential of Stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic
- Mesenchymal Stem cell‐based therapy: a new paradigm in regenerative medicine
- T cell therapy in allogeneic Stem cell transplantation
- Immunological considerations for cell therapy using human embryonic Stem cell derivatives
- Stem cell therapy for the broken heart: mini-organ transplantation
- Prostate cancer Stem cell therapy: hype or hope?
- Promise of blood-and bone marrow-derived Stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy
- … synchronous contraction after acute myocardial infarction by Stem cell therapy: new insights into the therapeutic implication of Stem cell therapy for acute myocardial …
- Stem cell therapy in orthopaedic surgery: Current status and ethical considerations
- Microenvironment at tissue injury, a key focus for efficient Stem cell therapy: A discussion of mesenchymal Stem cells
- cell therapy generates a favourable chemokine gradient for Stem cell recruitment into the infarcted heart in rabbits
- Implications of the cancer Stem–cell hypothesis for breast cancer prevention and therapy
- Stem cell therapy for heart failure: the science and current progress
- A review of current progress in gene and Stem cell therapy for erectile dysfunction
- Adipose Stem cells as a clinically available and effective source of adult Stem cell therapy
- Measurement of oxygenation at the site of Stem cell therapy in a murine model of myocardial infarction
- Autologous Stem–cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study
- cell therapy for the diseased liver: from Stem cell biology to novel models for hepatotropic human pathogens
- Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger’s disease
- Adult Stem cell therapy for autoimmune disease
- Physical exercise as adjuvant therapy for patients undergoing hematopoietic Stem cell transplantation
- cell therapy with autologous bone marrow mononuclear Stem cells is associated with superior cardiac recovery compared with use of nonmodified …
- Targeting the leukemic Stem cell: the Holy Grail of leukemia therapy
- Reduced-intensity allogeneic hematopoietic Stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European …
- Stem cell therapy for critical limb ischaemia—a review
- Immunostimulatory effects of mesenchymal Stem cell‐derived neurons: implications for Stem cell therapy in allogeneic transplantations
- Stem cell therapy for inherited metabolic disorders of the liver
- Placenta-derived Stem cells: new hope for cell therapy?
- Inflammatory bowel disease: moving toward a Stem cell-based therapy
- Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial Stem cell therapy
- Twisting immune responses for allogeneic Stem cell therapy
- Hematopoietic Stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
- Human parthenogenetic embryonic Stem cells: one potential resource for cell therapy
- Another new “super muscle Stem cell” leaves unaddressed the real problems of cell therapy for duchenne muscular dystrophy
- Stem cell research and therapy for liver disease
- Stem cell‐based therapy in gastroenterology and hepatology
- Effects of Stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction
- cell therapy for ischaemic heart disease: focus on the role of resident cardiac Stem cells
- Stem cell therapy: past, present, and future
- Neural commitment of embryonic Stem cells: molecules, pathways and potential for cell therapy
- Gene therapy and Stem cell transplantation: strategies for hearing restoration
- Genetic basis of inherited macular dystrophies and implications for Stem cell therapy
- A combined artificial chromosome-Stem cell therapy method in a model experiment aimed at the treatment of Krabbe’s disease in the Twitcher mouse
- Stem cell therapy and coordination dynamics therapy to improve spinal cord injury
- Rewiring the heart: Stem cell therapy to restore normal cardiac excitability and conduction
- Immunosuppressive therapy mitigates immunological rejection of human embryonic Stem cell xenografts
- Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf
- Stem cell therapy for hereditary breast cancer
- Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF‐CHF, HART, MASTER, POISE and Stem cell therapy
- Cancer Stem cell: implications in cancer biology and therapy with special reference to lung cancer
- Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic Stem cell transplantation in mouse and man
- cell therapy for diabetes mellitus: an opportunity for Stem cells?
- Combination of enzyme replacement and hematopoietic Stem cell transplantation as therapy for Hurler syndrome
- Unproven Stem–cell therapy ban
- … of invasive fungal infection in adult hematopoietic Stem cell transplant recipients: analysis of Multicenter Prospective Antifungal therapy (PATH) Alliance registry
- Stem cell therapy trials: a call for standardization
- Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications
- Functional outcome of bone marrow Stem cells (CD45+/CD34−) after cell therapy in acute spinal cord injury: In Exercise training and in sedentary rats
- Continuous renal replacement therapy (CRRT) after Stem cell transplantation. A report from the prospective pediatric CRRT Registry Group
- Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic Stem cell transplantation
- Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on Stem cell collection in multiple myeloma
- Compromised Stem cell mobilization following induction therapy with lenalidomide in myeloma
- Is Stem cell-based therapy going on or out for cardiac disease?
- Stem cell and cellular therapy developments
- How to approach Alzheimer’s disease therapy using Stem cell technologies
- High-dose immunosuppressive therapy with autologous hematopoietic Stem cell transplantation as a treatment option in multiple sclerosis
- … working group (IMWG) consensus statement and guidelines regarding the current status of Stem cell collection and high-dose therapy for multiple myeloma …
- Stem cell biology and cell transplantation therapy in the retina
- Cardiac Stem cell therapy: Advances from 2008
- Handbook of cardiac Stem cell therapy
- Stem cell therapy for tendon and ligament injuries in the horse-technique and outcome
- High incidence of leukemia in large animals after Stem cell gene therapy with a HOXB4-expressing retroviral vector
- Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic Stem cell transplant compared with enzyme replacement therapy
- Stem–cell therapy in China draws foreign patients
- The cancer Stem cell microenvironment and anti-cancer therapy
- The potential of biophotonic techniques in Stem cell tracking and monitoring of tissue regeneration applied to cardiac Stem cell therapy
- High-dose therapy and autologous peripheral blood Stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian …
- Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-Stem cell therapy
- Bone marrow mesenchymal Stem cell therapy on diabetic nephropathy in rats
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review
- A pilot study with autologous bone marrow-derived Stem cell therapy in patients with severe peripheral arterial disorder
- Mobilization in myeloma revisited: IMWG consensus perspectives on Stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib …
- Functional outcome of bone marrow Stem cells (CD45+/CD34−) after cell therapy in chronic spinal cord injury in wistar rats
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
- Translating Stem cell therapy to the clinic: déjà vu all over again
- Stem cell therapy in the treatment of stress urinary incontinence: a significant step in the right direction?
- Stem cell based therapy for skeletal muscle diseases
- Mesenchymal Stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
- Mesenchymal Stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice
- … T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated Stem cell …
- Stem cell therapy in acute myocardial infarction
- Gene therapy approaches for Stem cell protection
- Can radionuclide imaging predict future response to Stem cell therapy?
- Stem cell therapy: The eventual future
- Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic Stem cell transplantation
- Adoptive cellular therapy for cytomegalovirus infection following allogeneic Stem cell transplantation using virus-specific T cells
- Toward a Stem cell gene therapy for breast cancer
- A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic Stem cell transplantation
- cell therapy for Parkinson’s disease: III. Neonatal, fetal and embryonic Stem cell-based applications
- Use of enzyme replacement therapy (Laronidase) before hematopoietic Stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients
- Vascular endothelial growth factor in astroglioma Stem cell biology and response to therapy
- High-dose therapy followed by autologous purged Stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
- Prospective multicenter trial comparing repeated immunosuppressive therapy with Stem–cell transplantation from an alternative donor as second-line treatment for …
- Autologous bone marrow Stem cell therapy for the ischemic myocardium during coronary artery bypass grafting
- Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic Stem cell transplantation
- Issues and ethical problems of Stem cell therapy–where is hippocrates?
- Protection of Stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection
- Prenatal Stem cell transplantation and gene therapy
- Emerging Stem cell concepts for imatinib‐resistant chronic myeloid leukaemia: Implications for the biology, management, and therapy of the disease
- … —metaiodobenzylguanidine double infusion with autologous Stem–cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study
- Proof-of-concept trials for lung Stem cell therapy
- High‐dose therapy and autologous Stem cell transplantation for chemoresistant Hodgkin lymphoma: The Seattle experience
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, Stem cell transplantation and rituximab: a Cancer and Leukemia …
- Single autologous Stem–cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma …
- … PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic Stem cell …
- … factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous Stem cell transplantation (ASCT) as postremission therapy for acute myeloid …
- Casting doubt on the safety of “off-the-shelf” mesenchymal Stem cells for cell therapy
- The biological and ethical basis of the use of human embryonic Stem cells for in vitro test syStems or cell therapy
- cell and gene therapy using mesenchymal Stem cells (MSCs)
- Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic Stem cell transplant recipients
- Parthenogenetic embryonic Stem cells derived from cryopreserved newborn mouse ovaries: a new approach to autologous Stem cell therapy
- Pfizer acquires a Stem cell therapy
- Bevacizumab therapy before autologous Stem–cell transplantation for POEMS syndrome
- Endothelium‐specific gene and Stem cell‐based therapy for erectile dysfunction
- Perinatal Stem–cell and gene therapy for hemoglobinopathies
- Adipose‐derived Stem cells are a source for cell therapy of the corneal stroma
- Embryonic Stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications
- Regeneration of irradiated salivary glands by Stem cell therapy
- The new challenge of Stem cell: brain tumour therapy
- Stem cell therapy: how should nurses respond?
- … therapy and autologous Stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy …
- Involved-field radiotherapy before high-dose therapy and autologous Stem–cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity
- The extent of minimal residual disease reduction after the first 4‐week imatinib therapy determines outcome of allogeneic Stem cell transplantation in adults with …
- Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic Stem cell …
- … Stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy
- Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic Stem cell transplantation: a prospective evaluation
- Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic Stem cell transplantation
- Mesenchymal Stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia
- High prevalence of early-onset osteopenia/osteoporosis after allogeneic Stem cell transplantation and improvement after bisphosphonate therapy
- Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic Stem cell transplantation: single‐center …
- Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic Stem–cell transplant recipients
- Treating autoimmune diseases: is Stem cell therapy the future?
- Dental regenerative therapy: Stem cell transplantation and bioengineered tooth replacement
- Manufacturing neurons from human embryonic Stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy
- Stem cell niches as clinical targets: the future of anti-ischemic therapy?
- Multilevel targeting of hematopoietic Stem cell self-renewal, differentiation and apoptosis for leukemia therapy
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic Stem cell transplantation: implications for the emergence of drug-resistant …
- Myeloablative therapy with autologous Stem cell rescue for patients with Ewing sarcoma
- Nausea and vomiting with high-dose chemotherapy and Stem cell rescue therapy: a review of antiemetic regimens
- Porcine embryonic Stem cells: a possible source for cell replacement therapy
- Hematopoietic Stem cell gene therapy for adenosine deaminase deficient-SCID
- Stem cells to pancreatic β-cells: new sources for diabetes cell therapy
- … graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic Stem cell transplantation for multiple …
- Mesenchymal Stem cells—Stem cell therapy perspectives for type 1 diabetes
- Combination treatment of human umbilical cord matrix Stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic …
- Gene-Stem cell therapy for ischemic stroke
- Hematopoietic Stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
- The role of high-dose therapy with autologous Stem cell support in the era of novel agents
- Stem cell-based therapy in central nervous syStem diseases
- Vaccinations in children treated with standard-dose cancer therapy or hematopoietic Stem cell transplantation
- Human cord blood Stem cell applications in cell therapy.
- Antifungal therapy for invasive fungal diseases in allogeneic Stem cell transplant recipients: an update
- High‐dose therapy and autologous Stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B‐cell lymphoma
- Progress in researches on Stem cell therapy for erectile dysfunction
- Establishment of medakafish as a model for Stem cell-based gene therapy: Efficient gene delivery and potential chromosomal integration by baculoviral vectors
- Mathematical modelling of the impact of haematopoietic Stem cell‐delivered gene therapy for HIV
- Embryonic Stem cells and Parkinson’s disease: cell transplantation to cell therapy
- Gene therapy and bone marrow Stem–cell transfer to treat autoimmune disease
- cell therapy for Parkinson’s disease: II. Somatic Stem cell-based applications
- … parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic Stem cell transplant recipients receiving long-term caspofungin therapy
- Differentiation-chronology specific function of DNMT1 and selective anti-leukemia Stem–cell therapy
- Stem cell therapy: an update
- High-dose therapy with hematopoietic Stem cell rescue in patients with poor prognosis Ewing family tumors
- Can patient-specific Stem cell therapy enhance renal repair?
- Stem cell therapy: A “magic bullet” for cardiomyopathies?
- Stem cell therapy for spinal cord injury: A plea for rationality
- therapy for older AML patients: the role of novel agents and allogeneic Stem cell transplant
- The effect of human umbilical cord blood derived mesenchymal Stem cell therapy in rat model of cavernosal nerve injury
- High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic Stem cell transplantation as consolidation or salvage therapy
- Cord blood Stem cell therapy for acquired immune deficiency syndrome
- cell transplant and regenerative Stem cell therapy
- Primed for lethal battle: a step forward to enhance the efficacy and efficiency of Stem cell transplantation therapy
- Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous Stem cell …
- Childhood spinal muscular atrophy and Stem cell research: Is cellular replacement therapy the answer?
- Neural Stem cell-mediated therapy of primary and metastatic solid tumors
- … varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic Stem cell transplantation: utility of PCR for early recognition and therapy
- Does High-Dose therapy and Autologous Hematopoietic Stem cell Transplantation Have a Role in the Primary Treatment of Peripheral T-cell Lymphomas?
- Ethical issues in Stem cell research, therapy, and public policy
- Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Comparison of ex vivo expansion culture conditions of mesenchymal Stem cells for human cell therapy
- Radiation therapy Oncology Group translational research program Stem cell symposium: incorporating Stem cell hypotheses into clinical trials
- Stem–cell biology and cancer therapy: the more things change.
- Stem cell therapy in chronic spinal cord injuries
- Stem cell therapy in acute respiratory distress syndrome
- Human cytomegalovirus load measurement and its applications for pre‐emptive therapy in patients undergoing hematopoietic Stem cell transplantation
- Patients with mature T-cell lymphoma show high relapse rates after high dose therapy and autologous Stem cell transplantation
- Reduced-toxicity conditioning therapy with allogeneic Stem cell transplantation for acute leukemia
- Genetic engineering and Stem cells: combinatorial approaches for cardiac cell therapy [cellular/Tissue Engineering]
- Autologous hematopoietic Stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia
- Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic Stem cell gene transfer of α‐glucosidase in Pompe …
- … node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous Stem cell …
- Therapeutic window of Stem cell potential for targeting pediatric malignant brain tumors: an opportunity for Stem cell therapy
- Stem cell therapy in Neurodegenerative
- Stem cell therapy FOR BRAIN TUMORS
- Stem cell–Based therapy for Glomerular Diseases: An Evolving Concept
- Cardiac Stem cells: at the heart of cell therapy
- Viral diagnostics and antiviral therapy in hematopoietic Stem cell transplantation
- Is allogeneic Stem cell transplantation for transformed follicular lymphoma anti-lymphoma Stem cell therapy?
- Treatment options for impaired spermatogenesis: germ cell transplantation and Stem–cell based therapy.
- The moral status of human embryos with special regard to Stem cell research and therapy
- Outcome assessment measures for evaluating clinical effectiveness of canine adipose derived Stem cell therapy of osteoarthritis
- Novel cancer Stem cell therapy on the horizon
- Surgical Stem cell therapy for the Treatment of Heart Failure
- Macrophage subpopulations are essential for infarct repair with and without Stem cell therapy
- Hypervitaminosis A in pediatric hematopoietic Stem cell patients requiring renal replacement therapy
- Principles of Stem cell therapy in the horse-the science behind the technology
- Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered Stem cells in a murine model of airway injury
- Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic Stem cell transplantation as preemptive therapy for severe graft-versus …
- Sex of muscle Stem cells does not influence potency for cardiac cell therapy
- Properties of mesenchymal Stem cells to consider for cancer cell therapy
- … body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood Stem–cell transplantation followed by randomization to therapy with interleukin-2 …
- Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic Stem cell transplantation: a real‐world review
- Future of Stem cell therapy for neuronal regeneration
- Novel and immortalization-based protocols for the generation of neural CNS Stem cell lines for gene therapy approaches
- Translational perspectives—transient epigenetic gene therapy: hazard-free cell reprogramming approach and rising arm of a universal Stem cell gene therapy platform
- Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic Stem cell transplant recipients
- Stem cell therapy for Acute Myocardial Infarction and Heart Failure-Past, Present and Future
- Stem cell therapy: Numerical simulation of In Vivo Nutrient Transport and cells Growth
- Newly diagnosed multiple myeloma in Taiwan: the evolution of therapy, Stem cell transplantation and new treatment agents
- Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral Stem cell transplantation
- Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA‐matched allogeneic Stem cell transplantation in childhood …
- Post‐translational modifications of orphan nuclear receptor TR2–new insights into drug targets for Stem cell therapy and the effect of retinoic acid
- Autologous Stem cell transplantation is superior to myeloablative allogeneic SCT as a salvage therapy for patients with refractory/relapsed transformed …
- Mesenchymal Stem cells and their use as cell replacement therapy and disease modelling tool
- The role of cardiac ultrasound in Stem cell therapy
- Stem cells for cardiac regeneration by cell therapy and myocardial tissue engineering
- … on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic Stem cell …
- Structural and functional improvement of injured brain after severe acute carbon monoxide poisoning by Stem cell-based therapy in rats.
- Generation of insulin-producing beta cells from Stem cells-perspectives for cell therapy in type 1 diabetes
- Adult Stem cell therapy for acute renal failure: the hope beyond the hype
- The prospect of pluripotent Stem cell-based therapy
- Mesenchymal Stem cell therapy in a Rat Model for GvHD
- Iodine‐131‐metaiodobenzylguanidine therapy with reduced‐intensity allogeneic Stem cell transplantation in recurrent neuroblastoma
- Stem cell therapy
- … , epirubicin and etoposide) is a more effective Stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for …
- Human cardiac Stem cell therapy for heart failure
- Adult human Stem cell therapy for ischaemic stroke
- Antifungal therapy strategies in hematopoietic Stem–cell transplant recipients: early treatment options for improving outcomes
- Preemptive therapy for cytomegalovirus disease in allogeneic Stem cell transplant recipients
- Haploidentical allogeneic bone marrow Stem cell transplantation combined with peripheral blood Stem cells for therapy of leukemia
- Review of Stem cell-based therapy for the treatment of cardiovascular disease
- A long-term durable remission with high-dose therapy and autologous Stem cell transplant for stage IVB HIV-associated Hodgkins disease
- Adult Mesenchymal Stem cells for cell therapy in Clinical Application.
- Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous Stem cell transplantation: results of a Spanish …
- Comparison of adult versus embryonic Stem cell therapy for cardiovascular disease: insights from molecular imaging studies
- Counterpoint: cord blood Stem cell therapy for acquired immune deficiency syndrome
- Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance therapy Following Single Autologous Stem cell Transplant for Multiple …
- Specific Detection of Aberrant and Normal Stem cells in Acute Myeloid Leukemia Patients Opens the Way for Defining Highly Specific Targets for Stem cell therapy.
- Counterpoint: cord blood Stem cell therapy for acquired immune deficiency syndrome
- Cardiac Stem cell therapy and arrhythmogenicity: Prometheus and the arrows of Apollo and Artemis
- Embryonic Stem cells: overcoming the immunological barriers to cell replacement therapy
- Comparison of mesenchymal tissues-derived Stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit
- A microfabricated 3-D Stem cell delivery scaffold for retinal regenerative therapy
- Bispecific antibody targeted Stem cell therapy for myocardial repair
- Tissue Engineering for the Respiratory Epithelium: Is There a Future for Stem cell therapy in the Lung?
- Novel Tyrosine Kinase Inhibitor therapy Before Allogeneic Stem cell Transplantation in Patients with Chronic Myeloid Leukemia.
- Role of biomechanical force in Stem cell-based therapy for cartilage repair
- Autologous Stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of …
- R-CHOP, Followed by High Dose therapy and Autologous Stem cell Rescue (HDT/ASCR), and R-Hypercvad Have Equivalent Progression-Free Survival and Are …
- Stem cell therapy-An update
- Tweaking the immune syStem: gene therapy-assisted autologous haematopoietic Stem cell transplantation as a treatment for autoimmune disease
- Characterization and genetic manipulation of human umbilical cord vein mesenchymal Stem cells: potential application in cell-based gene therapy
- High-dose therapy and autologous Stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
- … Stem cell transplantation after myeloablative therapy in first remission may be beneficial in patients with advanced stage follicular lymphoma after front-line therapy …
- Stem cell transplantation and MBL replacement therapy
- Autologous Stem cell transplantation (autoSCT) as first-line therapy in peripheral T cell lymphomas (PTCL): results of a prospective multicenter study
- Adult and Embryonic Stem cell therapy
- New strategy of treatment for POEMS syndrome–autologous peripheral blood Stem cell transplantation and thalidomide therapy
- cell therapy using induced pluripotent Stem (iPS) cells meets next-next generation DNA sequencing technology
- Impact of lenalidomide therapy on Stem cell mobilization in myeloma
- Wnt5a-treated midbrain neural Stem cells improve dopamine cell replacement therapy in parkinsonian mice
- Plasma cell leukemia maintaining complete remission by syngeneic Stem cell transplantation combined with low-dose thalidomide maintenance therapy
- … Ibritumumab Tiuxetan (Zevalin®)-BEAM/C with Autologous Stem cell Support as Frontline therapy for Advanced Mantle cell Lymphoma.–Preliminary Results …
- Stem and progenitor cell-mediated tumor selective gene therapy
- Stem cell therapy in cardiovascular diseases
- Parkinson’s disease: Role of molecular imaging in monitoring the effectiveness of Stem cell therapy
- Effects of Embryonic Neural Stem cell therapy on Oxidative and Nitrosative Stress Biomarkers in Acute and Chronic Spinal Cord Injured Rats
- Ethical Issues in Stem cell therapy
- Induced pluripotent Stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases
- Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic Stem cell transplantation
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy in Patients with Relapsed Multiple Myeloma.
- Stem cell therapy× ETHICS AND RELIGION
- Islet cell therapy and pancreatic Stem cells
- … molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood Stem cell transplantation in a …
- Minimally invasive Stem cell therapy
- Stem cell therapy-emerging new field of medicine.
- Hematopoietic Stem cell gene therapy trial with lentiviral vector in X-linked adrenoleukodystrophy
- … does not adversely affect the Stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell …
- Fetal Stem cell therapy
- In vivo MRI of mouse heart at 11.7 t: monitoring of Stem–cell therapy for myocardial infarction and evaluation of cardiac hypertrophy
- INTERLEUKIN-10 ENGINEERED MESENCHYMAL Stem cell therapy TO PREVENT ISCHEMIA-REPERFUSION INJURY IN LUNG TRANSPLANTS: 167
- Stem cell therapy: Hype or Hope?
- Effects of Mesenchymal Stem cell therapy in BPD
- Exposing gaps in our knowledge of Stem cell therapy
- Brazilian experience using high-dose sequential therapy (HDS) followed by autologous hematopoietic Stem cell transplantation (ASCT) for malignant lymphomas
- Stem cell Transplant (SCT) and Pralatrexate therapy: Outcome of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma Who Received SCT …
- … Monoclonal Gammopathy: pulmonary hemorrhage during Stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy
- Fibrin microthreads promote Stem cell growth for localized delivery in regenerative therapy
- Stem cell Gene therapy for ADA-Deficiency without Myelopreparative Conditioning
- Progress in Stem cell therapy for Alzheimer’s disease
- cell therapy in Hematopoietic Stem cell Transplantation
- Stem cell therapy for Alzheimer’s
- Ethical aspects of Stem cell therapy and gene therapy
- A possible approach for Stem cell gene therapy of Fanconi anemia
- Outcomes with High Dose therapy and Peripheral Blood Stem cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.
- Cardiovascular Regeneration and Stem cell therapy
- Stem–cell therapy is the last option for cardiac disease?
- Second Autologous Stem cell Transplantation Is Effective Salvage therapy for Relapsed Multiple Myeloma.
- Stem cell therapy for corneal defects
- Potential applications of combined Stem cell and gene therapy for the treatment of infarcted heart
- Handbook Of Cardiac Stem cell therapy
- Cardiac regenerative therapy integrated via human autologous cardiac Stem cell and biodegradable bFGF-incorporating gelatin hydrogel
- 237. Stem cell therapy: Neuroplasticity as a novel cellular mechanism for regeneration
- Future Implementation of Adult Stem cell therapy in the Current Standards of Care for Myocardial Infarction
- Experience of Hanyang ALS Clinic for Autologous BM Stem cell therapy in the Patients with ALS
- Stem cell-targeted therapy–a new strategy for cancer treatment
- Red Fluorescent Protein as a Marker for Stem cell therapy
- … , pegylated-lyposomal-doxorubicin and dexamethasone (PAD) as induction therapy prior to reduced intensity autologous Stem cell transplant (ASCT) followed by …
- Microencapsulated Stem cells for tissue repairing: implications in cell-based myocardial therapy
- Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic Stem cell …
- Liver Stem cell therapy: current and near future
- Maintenance therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) for Relapsed or Refractory AML or …
- Selection of Optimal M esenchymal Stem cells for Stem cell therapy in Amyotrophic Lateral Sclerosis Patients
- Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic Stem cell transplantation in acute myeloid leukemia: influence of karyotype
- Autologous and Cancer Stem cell Gene therapy
- MO‐FF‐A2‐01: Neural Stem cell Sparing Radiation therapy—A Feasibility Study
- Stem cell mobilization following initial therapy with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
- Experimental Stem cell therapy in acquired neurological illnesses: Current status
- Gene and Stem cell therapy in pulmonary arterial hypertension
- Research progress of traditional Chinese medicine for Stem cell therapy of ischemic heart disease
- The evaluation of acute renal failure models for the study of Stem cell therapy
- Clinical Trials in Cardiac Stem cell therapy: An Update
- Low level laser therapy and phototherapy assisted hydrogel dressing in burn wound healing: light guided epithelial Stem cell biomodulation
- Stem cell therapy following acute myocardial infarction: Comparative studies with adipose tissue-derived Stem cells and bone marrow-derived Stem cells
- Cardiac Stem cell therapy, from bench to bedside
- Stem cell therapy to Promotor Functional Recovery Following Injury to the Nervous SyStem
- Mesenchymal Stem cell therapy Prevents Ischemia/Reperfusion Injury
- Impact of Allogeneic Stem cell Transplantation as Salvage therapy After T315I Mutation Detection in Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic …
- Chondroitin sulfate, a major niche substance of neural Stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification
- Characterization and optimization of in vitro culture conditions of adult Stem cells for clinical cell therapy
- Noninvasive methods for monitoring cardiac Stem cell therapy
- Effectiveness of Mesenchymal Stem cell therapy in Patients With Amyotrophic Lateral Sclerosis
- Stem cell therapy for age-related retinal disease
- Analysis of Umbilical Cord Blood Stem cell therapy for Regenerative Medicine Applications
- Cardiac resynchronization and Stem cell therapy: do associative benefits exist?
- Difficulty of peripheral blood Stem cell collection after multiple consolidation therapy in acute myeloid leukemia
- Cytoprotective Actions of Mesenchymal Stem cell therapy After Acute Myocardial Infarction
- Muscle‐derived Stem cell therapy for Stress Urinary Incontinence
- Autologous in vitro expanded mesenchymal Stem cell therapy for human old myocardial infarction
- 2 Overview of Adult Stem cell therapy in Cardiac Disease
- Autologous Stem cell therapy with surgical myocardial revascularization/Otolog kok hucre tedavisi ve cerrahi miyokardiyal revaskularizasyon
- Panoramic View of The Fifth International Symposium on Stem cell therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain)
- Engineering Cardiac Tissue Using Stem cell therapy to Mend the Broken Heart
- Adult Stem cell therapy for acute and subacute spinal cord injury: Early clinical results and combined therapy strategy
- ADIPOSE-TISSUE DERIVED MESENCHYMAL Stem cell (ASC) AS ALTERNATIVE SOURCE FOR AUTOLOGOUS cell therapy
- Allay the ailing hearts-promising Stem cell therapy through apheresis: An experience of a tertiary care hospital in South India, ie SVIMS, Tirupati, Andhra Pradesh.
- Long term follow-up after intramyocardial Stem cell therapy with AC133+ bone marrow cells
- cell therapy for Diabetes Mellitus: An Opportunity for Stem cells?
- Baylor’s contribution to thoracic surgery and cardiac Stem cell therapy for heart failure
- SyStemic and Gene Modified Mesenchymal Stem cell therapy for Metastatic Prostate Cancer
- G-CSF Based Peripheral Blood Stem cell therapy in Myocardial Infarction: Results of MAGIC cell Clinical Trial
- UMBILICAL CORD BLOOD DERIVED MESENCHYMAL Stem cell therapy IN NOVEL CORONA VIRUS INFECTION–A REVIEW
- Aspects of Embryonic Stem cell Derived Somatic cell therapy of Degenerative Diseases
- (90) y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem cell Support as Frontline therapy for Advanced Mantle cell Lymphoma.-Preliminary Results …
- Cardiac regeneration by intramyocardial Stem cell therapy: clinical development
- … and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose therapy with Autologous Stem cell Transplantation and Maintenance …
- Mesenchymal Stem cell therapy for traumatic brain injury: Implications for intracranial inflammation
- Value of MRI and iron oxide particle labeling in Stem cell therapy of brain ischemic rats
- R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous Stem–cell transplantation on outcome
- Results from functional and cellular studies using an ovine model to assess response to mesenchymal Stem cell therapy after induction of myocardial infarction
- Human Embryonic Stem cell‐Derived Cardiomyocytes for cell therapy and Drug Discovery
- Stem cell therapy for myocardial infarction: Overcoming the hypoxic impediment to enhance cell-survival and engraftment
- Two Patients with Sporadic Late-Onset Nemaline Myopathy Respond to Stem cell therapy
- Single Versus Tandem High Dose therapy (HDT) Supported with Autologous Blood Stem cell (ABSC) Transplantation Using Unselected or CD34-Enriched ABSC …
- Adoptive Immune cell therapy for the Control of Fungal Infections in Hematopoietic Stem cell Transplant Patients
- … Expression on Human CD34+ cells During Murine Leukemia Virus-Derived Retroviral Transduction with Recombinant Fibronectin for Stem cell Gene therapy
- Hedgehog Signaling Pathway Is a New Target of Cancer Stem cell therapy for Breast Cancer Patients.
- Placental mesenchymal and cord blood Stem cell therapy for dilated cardiomyopathy
- Autologous bone marrow-derived Stem cell therapy in patients with Buerger’s disease
- Intracoronary autologous bone marrow Stem cell therapy in diastolic heart failure
- Serendipity—Methotrexate and 6-mercaptopurine for Continuation therapy for Patients With Acute Lymphoblastic Leukemia: The Leukemic Stem cell and Beyond?
- … ®), Doxil®, and dexamethasone (VDD) is superior to thalidomide and dexamethasone (TD) as initial therapy prior to autologous Stem cell transplantation (ASCT) for …
- RESCUE OF LUMICAN NULL CORNEAL PHENOTYPE USING Stem cell therapy
- Autologous Bone Marrow-Derived Stem cell therapy: A Promising and Prospective Approach in the Treatment of Patients with Severe Buerger’s Disease.
- 100. Subacute Neural Stem cell therapy for Traumatic Brain Injury
- Lenalidomide as Salvage therapy after Allogeneic Stem′ cell Transplantation in Multiple Myeloma
- Sci—Thurs AM: YIS—11: A Hybrid SPECT and Contrast Enhanced CT Platform: Application in Stem cell therapy
- Rituximab based therapy followed by autologous Stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell …
- The role of allogeneic Stem cell transplantation in the therapy of adult acute lymphoblastic leukemia (ALL)
- Laboratory of Neurogenesis and cell therapy, Wallenberg Neuroscience Center, and Lund Stem cell Center, University Hospital, SE-221 84 Lund, Sweden. 2 …
- Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic Stem cell transplantation
- … by granulocyte colony-stimulating factor on myocardial perfusion and viability: Improvement of myocardial perfusion as a plausible mechanism of Stem cell therapy
- Advance of researches on thyroid tissues autotransplantation and embryonic Stem cell transplantation in therapy of hypothyroidism
- Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. An open gate towards endogenous Stem cell therapy in diabetes.
- Multipotent Progenitor cells: A New Era In Stem cell-Mediated Gene therapy?
- Mesenchymal Stem cell therapy increases proinflammatory cytokine production via NFkB activation independent of the PI3 kinase pathway
- Early evaluation of genetically engineered mesenchymal stromal Stem cell therapy for prevention of left ventricular dysfunction in pigs
- Stem cell Transplantation: Biology, Processes, therapy
- … Mononuclear cell Transfer Is Associated with Superior Cardiac Recovery and Neovascularization as Compared to Nonmodified Mesenchymal Stem cell therapy in …
- 2.5 Mesenchymal Stem cell therapy has significant clinical effect in proteoglycan induced arthritis
- Effects of Bone Marrow-Derived Stem cell therapy on Airway and Lung Parenchyma Remodeling in a Murine Model of Chronic Allergic Asthma.
- Allogeneic Stem cell transplantation (SCT) in advanced chronic myeloid leukemia (CML) patients after tyrosine kinase inhibitor (TKI) therapy
- 78. Genetically Modified Mesenchymal Stem cell therapy for Prostate Cancer Bone Metastasis
- Locally induced neural Stem cells/pluripotent Stem cells for in vivo cell replacement therapy
- Treatment failure due to intracerebral Stem cell-like behavior of glioblastoma (GBM) cells: A reason for targeted maintenance therapy with imatinib (I) and hydroxyurea …
- Corneal epithelial Stem cell deficiency and its therapy with transplantation of in vitro cultivated limbal Stem cells
- Allogeneic Hematopoietic Stem cell Transplantation (HSCT) as a Curative therapy in Primary and Secondary Myelofibrosis (MF): A 14-Year Period …
- … II Study of Sequential Velcade/Thalidomide/Dexamethasone (VTD) as Maintenance therapy Post Single Autologous Peripheral Stem cell (PSCT) in Patients …
- Salvage therapy with Allogeneic Stem cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared …
- Endonuclease-Boosted Gene Targeting and Cybridization for Long-Term Stem cell Gene therapy
- Stem cell based therapy for the treatment of prion diseases
- Stem cell-based therapy in Parkinson disease
- Stem–cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!
- … Phase II Study Using Dexamethasone Induction therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem cell Transplantation in 30 …
- Novel Stem/Progenitor Populations: Implications for cell therapy
- … Reduces the Cytotoxic Effects of in vitro Expanded NK cells: Implications for Adoptive NK cell therapy in the Setting of Allogeneic Hematopoietic Stem cell (HCT) …
- Application potential of human fetal Stem/progenitor cells in cell therapy
- Feasibility and Monitorization of Stem–cell Replacement therapy
- Sequential Chemotherapy Followed by High Dose therapy and Autologous Stem cell Rescue for Mantle cell Lymphoma: Impact of MIB-1 on Outcome
- Is the era of the therapy by tailor-made Stem cell coming?
- Stem cell based therapy to restore nearly normal hearing
- Mesenchymal Stem cell Based therapy in Liver Disease
- Stem cell research and therapy: A preliminary theological-ethical evaluation
- Bortezomib therapy followed by autologous Stem cell transplantation in POEMS syndrome
- Stem cell research and therapy: An overview of its feasibility with accompanying ethical implications
- Yasuo Takeuchi, Makoto Otsu, Akihiro Kume, 2 Masafumi Onodera, 3 Tadatoshi Kuratsuji, 4 Hiromitsu Nakauchi. 1Lab of Stem cell therapy, Center for Experimental …
- Prospective Study of Oral Valganciclovir for Pre-Emptive therapy of Cytomegalovirus After Allogeneic Stem cell Transplantation.
- High-Dose therapy with Peripheral Blood Stem cell Transplantation for Patients with Multiple Myeloma: Prognostic Impact of Chromosomal Aberrations and …
- Cancer Stem cell theory and cancer therapy
- Autologous haematopoietic Stem cell transplantation followed by thalidomide therapy in poems syndrome
- Outcomes of Allogeneic Stem cell Transplant in Patients with Myeloid Leukemias Over 65 Years of Age. Rationale for Aggressive therapy with Curative Intent.
- Hodgkin-lymphoma with relapsed or progressive disease after autologous Stem cell transplantation: efficacy of salvage radiation therapy
- Adipose derived Stem cells for regenerative cell therapy in peripheral vascular disease
- Rituximab combined with autologous hematopoietic Stem cell transplantation for therapy of CD_ (20), positive B-cell lymphoma
- DEVELOPING THE TOOLS FOR A Stem cell-BASED therapy FOR DEAFNESS: ISOLATION AND ANALYSIS OF HUMAN AUDITORY Stem cells
- 236: Busulfan and Single-Dose Melphalan as Preparative therapy for Infants and Young Children Undergoing Stem cell Transplantation for Leukemia: A Single …
- Caspofungin as secondary prophylaxis or therapy in patients undergoing allogeneic Stem cell transplantation with a prior or ongoing history of syStemic or …
- Bortezomib-based induction therapy induces better responses and outcomes of autologous Stem cell transplantation in newly diagnosed patients with multiple …
- Engineering embryonic Stem cells for myelin cell therapy
- Newly diagnosed multiple myeloma in Taiwan: the evolution of therapy, Stem cell transplantation and new treatment agents
- High Dose Chemotherapy and Autologous Stem cell Transplantation in the Primary therapy of Advanced Follicular Lymphoma in Adults: A SyStematic …
- Role of autologous Stem cell transplant after induction therapy with bortezomib-lenolidomide or bortezomib-thalidomide in newly diagnosed multiple myeloma patients
- Characterisation of neural Stem cells for oestrogen in vitro: potential for improving Stem cell based therapy for stroke
- Stem cell based therapy of malignant brain tumors
- … Interferon-Alpha Maintenance therapy for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Ineligible for Allogeneic Stem cell …
- Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived Stem cell…
- Stem cell therapy for Vascular Disease
- Regenerative therapy and mesenchymal Stem cell for veterinary medicine.
- … Stem cell Transplantation in the therapy of Acute Myeloid Leukemia in Adults Evidence-Based Review 137 The Role of Cytotoxic therapy with Hematopoietic Stem …
- … , Melphalan (RBEAM) and Autologous Stem cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-cell Lymphoma (DLBCL). ClinicalTrials. Gov …
- Allogeneic Stem cell Transplantation (Allo-SCT) For Relapsed, Refractory Myeloid Leukemia and Mds Using Clofarabine (Clo)±Fludarabine (Flu) with IV Busulfan (Bu …
- Evaluation of Selected Human Embryonic Stem cell Lines for Differentiation to Retinal cells and for cell-Based therapy
- Muscular dystrophy cell therapy: an in utero approach using human fetal mesenchymal Stem cells
- Role of high-dose therapy and autologous Stem cell transplantation in treatment of chemotherapy-efractory Hodgkin lymphoma
- Development of new human Stem cell-derived cellular vehicles for glioma gene therapy
- Generation of cells for cell Replacement therapy: Specification of Neural Precursors in Vivo and in Neural Stem cell Cultures
- Stem cell-based therapy of ocular surface diseases: novel approaches to expansion of adult epithelial Stem cells in culture
- Optimization of suicide gene therapy in Stem cell transplantation with special reference to the selection marker OuaSelect
- Feasibility and Efficacy of Autologous Stem cell Transplantation as First-Line therapy for Peripheral T-cell Lymphoma: a Single Center Experience
- High dose immunosuppressive therapy with autologous hematopoietic Stem cell transplantation in secondary progressive multiple sclerosis: Case report
- Adult Stem cell-based gene therapy for alpha 1-antitrypsin deficiency
- Long-Term Follow-up of HCV Infected Stem cell Transplant Patients and Effects of Antiviral therapy.
- The Effect of SyStemic Steroid therapy on Dry Eye in Hematopoietic Stem cell Transplantated Patients
- … of DNA Methylation Changes in a Phase I Clinical Trial of Low-dose 5-azacitidine (AZA) given as Maintenance therapy after Allogeneic Hematopoietic Stem cell …
- Protection of Stem cell-Derived Lymphocytes in a Primate AIDS Gene therapy Model
- A comparative study of the curative effects of cytomegalovirus preemptive therapy in various kinds of hematopoietic Stem–cell transplantation
- … outcome in transformed follicular lymphoma compared to de novo aggressive B-cell lymphoma treated with high-dose therapy and autologous Stem–cell …
- Hematopoietic Stem cell based gene therapy for the treatment of metachromatic leukodystrophy: towards clinical testing
- Preemptive therapy of HHV-6 Encephalitis with Foscarnet Sodium for High Risk Patients After Hematopoietic Stem cell Transplantation.
- Gemtuzumab-ozogamicin as maintenance therapy after autologous Stem cell transplantation in elderly patients with acute myeloid leukaemia
- Successful autologous Stem cell transplantation in a woman with Severe SyStemic Sclerosis, refractory to immunosuppressive therapy
- CML: Is Allogeneic Stem cell Transplantation the Second-Line therapy of Choice following Resistance to Imatinib?
- Bortezomib-Based therapy, without Stem cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t (4; 14).
- Gemtuzumab Ozogamicin as Induction therapy Followed by Post-Remission Hematopoietic Stem cell Transplantation in Elderly Patients with Acute Myeloid …
- Prognostic Value of Bone Marrow Angiogenesis in Patients with Multiple Myeloma Undergoing High-Dose therapy and Autologous Stem cell Transplantation …
- The rate of cytomegalovirus infection and disease in correlation with the type of haematopoietic Stem cell transplantation in the era of pre-emptive antiviral therapy
- … of Prior Radiation therapy Predicts Poor Progression Free Survival and Overall Survival in African Americans with Multiple Myeloma after Autologous Stem cell …
- Biological quantification of murine osteoarticular joints following treatment using Stem cell-based gene therapy
- High-Dose therapy with Peripheral Blood Stem cell Transplantation for Patients with Relapsed or Refractory Hodgkin’s Disease: A Single-Institution 20-Year …
- Treatment of diabetes by cell therapy: new insights on Stem cells and precursors
- “Hiper CVAD Followed by Rituximab Purging Previous to Autologous Stem–cell Transplantation as therapy of Mantle cell Lymphoma. Results of Manto 2000 …
- Epithelial to mesenchymal transition in breast cancer is associated with resistance to therapy and a cancer Stem cell-like phenotype
- Autologous Stem cell Transplant in Recurrent Diffuse Large B-cell Lymphoma: Prior Rituximab therapy Has No Impact On Early Lymphocyte Recovery and …
- Adoptive therapy with T-cell Precursors for Immune Reconstitution After Allogeneic Hematopoietic Stem cell Transplantation.
- Case Closed (If There Was Still Any Doubt): High-Dose Chemotherapy & Autologous Stem–cell Transplant As Adjuvant therapy for Breast Cancer
- 267. Targeted therapy of Metastatic Melanoma Using Neural Stem cell-Based Drug Delivery
- Mechanism of Action of Prostate Stem cell Antigen Targeted Antibody therapy and Its Relevance to Clinical Application in Prostate Cancer
- 90y-Ibritumumab Tiuxetan (Zevalin®-BEAM/C with Autologous Stem cell Support as therapy for Advanced Mantle cell Lymphoma.-Preliminary Results From …
- … of Cytomegalovirus Infection and Disease in Correlation with the Type of Hematopoietic Stem cell Transplantation in the Era of Preemptive Antiviral therapy
- Hyperbaric oxygen therapy for post-Stem cell transplant haemorrhagic cystitis in children and adolescents
- Stem cell Mobilization In Patients With Newly Diagnosed Multiple Myeloma Following therapy With Lenalidomide and Dexamethasone
- Comparative study of allogeneic peripheral blood Stem cell transplantation and immunosuppressive therapy for severe aplastic anemia
- … Seropositivity Does Not Affect the Outcome of Allogeneic Hematopoietic Stem cell Transplantation with Intensive Monitoring and Modern Anti-Viral therapy
- Adding Fludarabine to Cyclophophamide-dexamethason induction therapy impair Stem cell harvest in MM: Report from an interim analysis of the NMSG 13/03 …
- The effect of rituximab in first line therapy to results of autologus haematopoietic Stem cell transplantation in relapsed non-Hodgkin’s lymphoma patients
- Allogeneic haematopoietic Stem cell transplantation as a curative therapy in primary and secondary myelofibrosis
- Allogeneic Stem cell transplantation after sequential therapy using high-dose melphalan and myeloablative conditioning in patients with refractory acute myeloid …
- cell death of colorectal cancer Stem-like cell was induced by photodynamic therapy with protoporphyrin IX
- In the article entitled ”The Role of Cytotoxic therapy with Hematopoietic Stem cell Transplantation in the therapy of Myelodysplastic Syndromes: An Evidence-Based …
- Allogeneic haematopoietic Stem cell transplantation as front line therapy for patients with” de novo” or secondary myelodysplastic syndrome: a single-centre …
- Frequency of Allogeneic Stem cell Transplant (SCT) in Patients Presenting with Newly-Diagnosed AML or AML at Time of First Salvage therapy.
- The Combination of Cyclophosphamide and Thalidomide During Induction therapy for Multiple Myeloma Results in a High Rate of Stem cell Mobilization Failure.
- Future advances in glaucoma therapy: today’s research–gene therapy, Stem cell transplants, neuroprotective drugs and’real-time’pressure monitoring–will help …
- Gauging the response of circulating epithelial tumor cells (CETC) and tumor Stem cell subpopulations to therapy of early-stage cancer in the individual patient
- Immunosuppressive therapy and Future Response to Androgens or Survival After Hematopoietic Stem cell Transplantation in Fanconi Anemia.
- Peripheral Blood Stem cell (PBSC) Harvest Is More Expensive Following Bortezomib-Based therapy in Multiple Myeloma (MM), Related to Increase Number …
- Up-front allogeneic Stem cell transplantation as part of induction or salvage therapy in primary high-risk and relapsed acute myeloid leukaemia
- Resolution of pure red cell aplasia after reduced-intensity allogenic Stem cell transplantation with major ABO mismatch during therapy with lenalidomide
- Achievement of CR and nCR Before and After First High-Dose therapy Followed by Autologous Stem cell Transplantation Is a Major Marker for Long-Term …
- Combination Of Ifn-α/GM-CSF as Maintenance therapy for Multiple Myeloma Patients After Autologous Stem cell Transplantation (ASCT): Results of a Prospective …
- 902. Mucopolysaccharidosis Type I Ex Vivo Gene therapy Based on MLV-Mesenchymal Stem cell Transduction: Is There a Way To Be Attenuated When Older?
- Double Reduced-Intensity Allogeneic Hematopoietic Stem cell Transplantation: French Society of Bone Marrow Graft Transplantation and cellular therapy …
- Hypogammaglobulinemia Following Rituximab and High-Dose therapy and Autologous Stem–cell Transplant: Incidence and Predictors of Prolonged …
- Early allogeneic Stem cell transplantation for peripheral T-cell lymphoma results in a lower relapse rate and a higher non-relapse mortality than high-dose therapy …
- No benefit of autologous Stem cell transplantation as consolidation for high and high-intermediate risk diffuse large B-cell lymphoma in 1. CR after R-CHOP therapy–a …
- PAD Induction therapy Followed by Autologous Peripheral Blood Stem cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.
- … (Ph+) Leukemia cells in the Primitive (CD34posCD38neg) Stem cell Fraction in Chronic Myeloid Leukemia (CML) Patients during Tyrosine Kinase Inhibitor therapy.
- … of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human Stem cell and gene therapy“[Brain. Res. Bull 74 (2007) …
- Translation and validation of the Functional Assessment of Cancer therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into Arabic …
- Neural Stem cell-mediated enhanced gene therapy of malignant gliomas using a novel plant thymidine kinase
- … of Second-Line therapy in Multiple Myeloma Patients Relapsing After Uniform Front-Line Treatment with High-Dose Melphalan and Autologous Stem cell …
- … targeted therapy into conditioning regimen for patients undergoing autologous Stem cell transplant (ASCT) for aggressive CD20 positive B-cell lymphoma has altered …
- Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic Stem cell transplantation in aggressive forms of multiple sclerosis …
- Post Tandem Autologous Stem cell Transplant Maintenance therapy with Bortezomib Improves Remission Duration and Quality of Response in Multiple …
- BCCA Protocol Summary for Myeloablative Conditioning therapy Prior to Autologous and Allogeneic Hematopoietic Stem cell Transplantation for Myeloid …
- Effect of prior therapy with Nilotinib or Dasatinib on the outcome after allogeneic Stem cell transplantation for patients with chronic myeloid leukaemia
- Evaluating the Safety and Efficacy of Anti-HIV Transgenic cells in a Humanized Mouse Model (NOD/SCIDγc−/−) for HIV Stem cell Gene therapy.
- Abstract# 1071: Tumor Stem cell targeted therapy with mTOR inhibitor RAD001 and hedgehog signalling inhibitor Cyclopamine reverts chemoresistance towards 5 …
- … proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous Stem cell rescue (HDT/ASCR)
- Thalidomide-Dexamethasone as Induction therapy Prior to Autologous Stem–cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma and …
- Steroid Refractoriness, but Not Rapidity of Response, to Induction therapy Predicts for Outcome Post-Autologous Stem cell Transplant (ASCT) in Patients …
- Ganciclovir and Leflunomide Combination therapy for a Patient with Cytomegalovirus Pneumonia after Unrelated Allogenic Stem cell Transplantation
- … factors in relapsed acute myeloid leukaemia patients receiving an allogeneic haematopoetic Stem cell transplantation as salvage therapy: a retrospective analysis on …
- TI 4 Potential of muscle Stem cells and cell therapy for Duchenne muscular dystrophy
- … (MFAC) regimen as induction therapy in relapsed or refractory CD33+ acute myeloid leukaemia prior to allogeneic haematopoetic Stem cell transplantation: a single …
- … Haematopoietic Stem cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive Chemotherapy Followed by cellular therapy …
- Sequential therapy With Nonablative Allogeneic Stem cell Transplantation, Post Transplant Imatinib and Donor Lymphocyte Infusion for Chronic Myeloid Leukemia
- … Is No Longer An Adverse Prognostic Factor for Patients with Relapsed HL Undergoing High Dose therapy and Autologous Stem cell Transplant: Results of a …
- … with Multiple Myeloma Who Have Undergone High-Dose Melphalan therapy Followed by Autologous Peripheral Blood Stem cell Transplantation and Failed …
- 1007. Factor VIII Transgene Tolerance Is Induced by Nonmyeloablative Hematopoietic Stem cell Gene therapy for Hemophilia A
- … Trial of Pre-Emptive therapy with Oral Valganciclovir Compared with IV Ganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem cell …
- 340: Response to Steroids as Primary therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem cell Transplant (HSCT) Recipients …
- Antitumor Effects of Canine Adipose Tissue-Derived Mesenchymal Stem cell Based IFN- Gene therapy and Cisplatin in a Mouse Melanoma Model
- … (VD) or Bortezomib, Adriamycine and Dexamethasone (PAD) Followed by High Dose therapy and Peripheral Blood Stem cell Transplantation in First-Line Treatment …
- 13: The Outcome of Allogeneic Stem cell Transplantation (alloSCT) for the Treatment of therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid …
- … A, on behalf of the Tunisian Multiple Myeloma Study Group. Single autologous Stem–cell transplantation followed by maintenance therapy with thalidomide is superior …
- Mesenchymal Stem cells: Applications in cell and gene therapy
- … without Preceding Remission Induction therapy Induces Durable Remission in Patients with Relapsed Acute Leukemia After the First Allogeneic Stem cell …
- … with hematological malignancy and hematopoietic Stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of …
- Clofarabine [+ or-] fludarabine with IV busulfan as reduced-toxicity conditioning therapy for allogeneic Stem cell transplantation (Allo-SCT) in advanced myeloid …
- Islet neogenesis potential of human adult Stem cells and its applications in cell replacement therapy for diabetes
- High-dose therapy/autologous Stem cell transplantation increases complete remission rate in multiple myeloma irrespective of the induction regimen used: TD …
- The Effect of Mesenchymal Stem cells as a cell therapy in Renal Ischemia
- Stem cells and cell replacement therapy for Parkinson’s disease
- Developing cell therapy techniques for respiratory disease: Intratracheal delivery of genetically engineered Stem cells in a murine model of airway injury
- Bioluminescence Imaging of X-Ray Visible Microencapsulated Mesenchymal Stem cells for cell Based therapy of Peripheral Arterial Disease
- … Transduction of the Human Purine Nucleoside Phosphorylase (PNP) Gene in Murine Hematopoietic Stem cells: An In Vivo Model of Gene therapy for PNP-T-cell …
- … AND GENETIC MANIPULATION OF HUMAN UMBILICAL CORD VEIN MESENCHYMAL Stem cells: POTENTIAL APPLICATION IN cell-BASED GENE therapy
- Development of real-time MR cell tracking for human neural Stem/progenitor cell-mediated brain tumor therapy
- Lymphatic Reprogramming of Adult Endothelial Stem cells for a cell-Based therapy for Lymphedema in Breast Cancer Patients
- WITHDRAWN: Treatment of combining antiangiogenic therapy and cytotoxic chemotherapy reduce the cancer Stem-like cell fraction in hepatocarcinoma xenografts
- Evaluation of human fetal neural Stem/progenitor cells as a source for cell replacement therapy for neurological disorders: Properties and tumorigenicity after long …
- 323: Immunosuppressive therapy Mitigates Murine T-cell Mediated Rejection of Human Embryonic Stem cells Following Transplantation
- Hematopoietic Stem and progenitor cells and potentials for application in fetal cell replacement therapy
- Stem cells and Genetic therapy for Hair cell–Related Hearing Loss
- Molecular Characterization, Safety and Feasibility of Induced Pluripotent Stem (iPS) cell Derived Cardiomyocytes for Heart Regenerative therapy
- The effect of angiotensin (1-7) on bone marrow Stem cells: adjunctive pharmacological therapy for cell transplantation in heart failure
- Risk factors in the development of Stem cell therapy
- Embryonic and adult Stem cell therapy
- Mesenchymal Stem cell therapy: Two steps forward, one step back
- Angiomyeloproliferative lesions following autologous Stem cell therapy
- Stem cell therapy as an emerging paradigm for stroke (STEPS) II
- Stem cell therapy for type 1 diabetes mellitus
- Mesenchymal Stem cell therapy for knee osteoarthritis. Preliminary report of four patients
- Limbal Stem–cell therapy and long-term corneal regeneration
- Stem cell and progenitor cell therapy in peripheral artery disease
- Translation of Stem cell therapy for neurological diseases
- Stem cell therapy for heart diseases
- Autologous Stem cell therapy for peripheral arterial disease: meta-analysis and syStematic review of the literature
- Stem cell therapy for neonatal brain injury: perspectives and challenges
- Mesenchymal Stem cell therapy for nonhealing cutaneous wounds
- Stem cell therapy: A challenge to periodontist
- Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent Stem cells
- Mesenchymal Stem cell therapy for cardiac repair
- Combination Stem cell therapy for heart failure
- Feasibility of combination allogeneic Stem cell therapy for spinal cord injury: a case report
- Stem cell therapy: a new treatment for burns?
- Challenges of Stem cell therapy for spinal cord injury: human embryonic Stem cells, endogenous neural Stem cells, or induced pluripotent Stem cells?
- Stem cell therapy in acute myocardial infarction: a review of clinical trials
- Experimental Stem cell therapy: Biohierarchies and bionetworking in Japan and India
- Intestinal myofibroblasts: targets for Stem cell therapy
- Stem cell therapy in PAD
- Stem cell therapy for Alzheimer’s disease
- Prospects of Stem cell therapy in osteoarthritis
- Human Stem cell therapy in ischaemic stroke: a review
- cellular antioxidant levels influence muscle Stem cell therapy
- Update on Stem cell therapy for cerebral palsy
- Combination Stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis
- Congenic mesenchymal Stem cell therapy reverses hyperglycemia in experimental type 1 diabetes
- Recent advances in liver Stem cell therapy
- Stem cell therapy: pieces of the puzzle
- Stem cell separation: a bottleneck in Stem cell therapy
- What Have I Got to Lose?: An Analysis of Stem cell therapy Patients’ Blogs
- Mesenchymal Stem cell therapy modulates the inflammatory response in experimental traumatic brain injury
- Allogeneic periodontal ligament Stem cell therapy for periodontitis in swine
- The Stem cell niche should be a key issue for cell therapy in regenerative medicine
- Results of intracoronary Stem cell therapy after acute myocardial infarction
- Chemokines in mesenchymal Stem cell therapy for bone repair: a novel concept of recruiting mesenchymal Stem cells and the possible cell sources
- Mesenchymal Stem cell therapy for the treatment of chronic obstructive pulmonary disease
- Combined gene and Stem cell therapy for cutaneous wound healing
- Non-invasive Stem cell therapy in a rat model for retinal degeneration and vascular pathology
- Successful clinical implementation of corneal epithelial Stem cell therapy for treatment of unilateral limbal Stem cell deficiency
- Concise review: limbal epithelial Stem cell therapy: controversies and challenges
- Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications
- Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
- Stem cell therapy for retinal diseases: update
- Imaging: guiding the clinical translation of cardiac Stem cell therapy
- Stem cell therapy in pulmonary fibrosis
- Stem cell therapy for cardiac disease
- The regenerative medicine laboratory: facilitating Stem cell therapy for equine disease
- Stem cell therapy improves the outcome of liver resection in cirrhotics
- Human cord blood Stem cell therapy for treatment of stress urinary incontinence
- Mesenchymal Stem cell therapy for chronic renal failure
- Mesenchymal Stem cell therapy for treatment of cardiovascular disease: helping people sooner or later
- Human relevance of pre-clinical studies in Stem cell therapy: syStematic review and meta-analysis of large animal models of ischaemic heart disease
- Advancement of mesenchymal Stem cell therapy in solid organ transplantation (MISOT)
- Selection of optimal passage of bone marrow-derived mesenchymal Stem cells for Stem cell therapy in patients with amyotrophic lateral sclerosis
- Human placenta-derived mesenchymal Stem cells and islet-like cell clusters generated from these cells as a novel source for Stem cell therapy in diabetes
- Dental Stem cell therapy with calcium hydroxide in dental pulp capping
- Stem cell therapy in cardiovascular disorders
- Advances in Stem cell therapy for the lower urinary tract
- Case control series of intrathecal autologous bone marrow mesenchymal Stem cell therapy for chronic spinal cord injury
- Mesenchymal Stem cell therapy for cutaneous radiation syndrome
- Promises of Stem cell therapy for retinal degenerative diseases
- Stem cell therapy for spinal cord injury
- Animal models of cardiac disease and Stem cell therapy
- Mesenchymal Stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model
- G-CSF for Stem cell therapy in acute myocardial infarction: friend or foe?
- Dual Stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
- Effects of adipose tissue-derived Stem cell therapy after myocardial infarction: impact of the route of administration
- Terminal differentiation is not a major determinant for the success of Stem cell therapy-cross-talk between muscle-derived Stem cells and host cells
- Can HIV be cured with Stem cell therapy?
- Mesenchymal Stem cell therapy in necrotizing enterocolitis: a rat study
- Intracoronary autologous CD34+ Stem cell therapy for intractable angina
- Extinction models for cancer Stem cell therapy
- Potential and pitfalls of Stem cell therapy in old age
- Stem cell therapy for glaucoma: possibilities and practicalities
- Stem cell therapy for digestive tract diseases: current state and future perspectives
- Stem cell therapy for the kidney: a cautionary tale
- 10 years of intracoronary and intramyocardial bone marrow Stem cell therapy of the heart: from the methodological origin to clinical practice
- Regenerative medicine in the field of pain medicine: Prolotherapy, platelet-rich plasma therapy, and Stem cell therapy—Theory and evidence
- Mesenchymal Stem cell therapy and delivery syStems in nonhealing wounds
- Safety and efficacy of bone marrow-derived autologous CD133+ Stem cell therapy
- cell delivery and tracking in post-myocardial infarction cardiac Stem cell therapy: an introduction for clinical researchers
- In vivo imaging of embryonic Stem cell therapy
- Cervical multilevel intraspinal Stem cell therapy: assessment of surgical risks in Gottingen minipigs
- Gene and Stem cell therapy: alone or in combination?
- Stem cell therapy for myocardial infarction: are we missing time?
- Imaging cardiac Stem cell therapy: translations to human clinical studies
- Stem–cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process
- Stem cell therapy: a future treatment of stress urinary incontinence
- Oxygen and oxygenation in Stem–cell therapy for myocardial infarction
- Dermal substitute-assisted healing: enhancing Stem cell therapy with novel biomaterial design
- Stem cell therapy for incontinence: where are we now? What is the realistic potential?
- Stem cell therapy in stroke: designing clinical trials
- Combination Stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study
- FOXP3 gene expression in multiple sclerosis patients pre-and post mesenchymal Stem cell therapy
- Recruiter-patients as ambiguous symbols of health: bionetworking and Stem cell therapy in India
- Stem cell therapy for dermal wound healing
- Stem cell therapy for ischemic heart disease
- Stem cell therapy in acute myocardial infarction: a pot of gold or Pandora’s box
- Autologous Stem cell therapy maintains vertebral blood flow and contrast diffusion through the endplate in experimental intervertebral disc degeneration
- Allogeneic haematopoietic Stem cell transplantation: individualized Stem cell and immune therapy of cancer
- Current perspectives on imaging cardiac Stem cell therapy
- A new paradigm for Stem cell therapy: substance-P as a Stem cell-stimulating agent
- Advances in cardiovascular molecular imaging for tracking Stem cell therapy
- Cardiac Stem cell therapy: progress from the bench to bedside
- Stem cell therapy for chronic heart failure. Lessons from a 15-year experience
- Human umbilical cord blood as an emerging Stem cell therapy for diabetes mellitus
- Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized Stem cell therapy in corneal endothelial diseases and …
- Effects of Stem cell therapy on Left Ventricular Remodeling After Acute Myocardial Infarction: A Meta‐Analysis
- Neural crest regionalisation for enteric nervous syStem formation: implications for Hirschsprung’s disease and Stem cell therapy
- Surgical approaches to gene and Stem cell therapy for retinal disease
- Current status of Stem cell therapy in heart failure
- Synergistic effect of adipose-derived Stem cell therapy and bone marrow progenitor recruitment in ischemic heart
- Stem cell therapy for neuromuscular diseases
- Stem cell therapy for the heart: a perspective
- Effect of oxygenation on Stem–cell therapy for myocardial infarction
- Evidence-based medicine and Stem cell therapy: how do we know such technologies are safe and efficacious?
- Host tissue response in Stem cell therapy
- Stem cell therapy for stress urinary incontinence
- Mesenchymal Stem cell therapy of intestinal disease: are their effects syStemic or localized?
- Stem cell therapy for chronic lung diseases: hope and reality
- Stem cell therapy for the treatment of myocardial infarction
- Regenerative stromal cell therapy in allogeneic hematopoietic Stem cell transplantation: current impact and future directions
- GRNOPC1: the world’s first embryonic Stem cell-derived therapy
- Stem–cell therapy for peripheral arterial occlusive disease
- Bone marrow Stem cell therapy for recessive dystrophic epidermolysis bullosa
- The bioethics of Stem cell research and therapy
- Neural tube defects: review of experimental evidence on Stem cell therapy and newer treatment options
- Stem cell therapy in cardiology
- Evaluation of 28 human embryonic Stem cell lines for use as unrelated donors in Stem cell therapy: implications of HLA and ABO genotypes
- Clinical applications of Stem cell therapy for regenerating the heart
- Human pluripotent Stem cell therapy for Huntington’s disease: technical, immunological, and safety challenges
- Mesenchymal Stem cell exosome: a novel Stem cell-based therapy for cardiovascular disease
- From bone to brain: human skeletal Stem cell therapy for stroke
- Current and future status of Stem cell therapy in heart failure
- In vivo imaging for Stem cell therapy: new developments and future challenges
- Potential clinical applications of adult human mesenchymal Stem cell (Prochymal®) therapy
- Allogeneic human mesenchymal Stem cell therapy (Prochymal®) as a rescue agent for severe treatment resistant GVHD in pediatric patients
- Stem cell therapy for Parkinson’s disease: a road map for a successful future
- Stem cell therapy and research status in Iran: at A glance
- In sickness and in health: corneal epithelial Stem cell biology, pathology and therapy
- Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors
- Mesenchymal Stem cell therapy in the Treatment of Acute and Chronic Graft Versus Host Disease
- Stem cell therapy for the bladder: where do we stand?
- ABCG2: a potential marker of Stem cells and novel target in Stem cell and cancer therapy
- … of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear Stem cell administration on left …
- Bionetworking: between guidelines and practice in Stem cell therapy enterprise in India
- Emerging therapy for improving wound repair of severe radiation burns using local bone marrow‐derived Stem cell administrations
- Stem cell therapy extends incubation and survival time in prion-infected mice in a time window–dependant manner
- Stem cell based cancer gene therapy
- Stem cell therapy for chronic myocardial infarction
- Stem–cell gene therapy for the Wiskott–Aldrich syndrome
- Cultured and freshly isolated adipose tissue-derived cells: fat years for cardiac Stem cell therapy
- Adult Stem cell therapy for periodontal disease
- Hematopoietic Stem cell transplantation and implications for cell therapy reimbursement
- … of Mesenchymal and hematopoietic Stem cells derived from Peripheral blood of Acute Lymphocytic Leukemia patients for regenerative Stem cell therapy
- Cardiac Stem cell therapy
- PET molecular imaging in Stem cell therapy for neurological diseases
- Stem cell therapy for diabetes mellitus
- cell therapy for spinal cord injury by neural Stem/progenitor cells derived from iPS/ES cells
- A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic Stem cell transplantation
- Early increase in myocardial perfusion after Stem cell therapy in patients undergoing incomplete coronary artery bypass surgery
- Practical barriers to delivering autologous bone marrow Stem cell therapy as an adjunct to liver resection
- Stem cell therapy for the treatment of acute myocardial infarction
- The role of cardiac electrophysiology in myocardial regenerative Stem cell therapy
- Mesenchymal Stem cells for cardiac cell therapy
- Hematopoietic Stem cell transplantation and hematopoietic Stem cell gene therapy in X‐linked adrenoleukodystrophy
- Neural Stem cell-based gene therapy for brain tumors
- Identification of hematopoietic Stem cell–specific miRNAs enables gene therapy of globoid cell leukodystrophy
- The cardiomyocyte lineage is critical for optimization of Stem cell therapy in a mouse model of myocardial infarction
- New concepts in cardiac Stem cell therapy
- Treatment of peripheral arterial disease using Stem and progenitor cell therapy
- Advances in mesenchymal Stem cell-mediated gene therapy for cancer
- Stem cell therapy for cardiac disease: what can be learned from oncology
- Effect of Stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat
- Current developments in the use of Stem cell for therapeutic neovascularisation: is the future therapy” cell-free”?
- cell therapy of congenital corneal diseases with umbilical mesenchymal Stem cells: lumican null mice
- ATP‐Sensitive K+ Channel‐Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem cell therapy
- Stem cell therapy for diabetes
- … combined granulocyte colony stimulating factor and erythropoetin based-Stem cell therapy using intracoronary infusion of peripheral blood Stem cells in patients …
- Allogeneic Stem–cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin’s lymphoma relapsing after an autologous Stem–cell …
- An increase in cancer Stem cell population after primary syStemic therapy is a poor prognostic factor in breast cancer
- A case study of experimental Stem cell therapy and the risks of over-regulation
- Stem cell therapy for articular cartilage defects
- Targeting Stem cell niches and trafficking for cardiovascular therapy
- Toward an ideal animal model to trace donor cell fates after Stem cell therapy: production of stably labeled multipotent mesenchymal Stem cells from bone marrow of …
- Mesenchymal Stem cell therapy of Crohn’s disease: are the far-away hills getting closer?
- Stem cell-based anti-HIV gene therapy
- Stem cells and cell therapy approaches in lung biology and diseases
- Interview: Affordability at the cutting edge: Stem cell therapy for ocular surface reconstruction
- … to requests of families for unproven interventions in neurodevelopmental disorders: Hyperbaric oxygen “treatment” and Stem cell “therapy” in Cerebral Palsy
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based …
- Stem cells from human exfoliated deciduous teeth (SHED) enhance wound healing and the possibility of novel cell therapy
- Nodal/Activin signaling: a novel target for pancreatic cancer Stem cell therapy
- Stem cell therapy for peripheral arterial disease: a review of clinical trials
- Human gingiva-derived mesenchymal Stem cells are superior to bone marrow-derived mesenchymal Stem cells for cell therapy in regenerative medicine
- Which is the most suitable and effective route of administration for mesenchymal Stem cell-based immunomodulation therapy in experimental kidney transplantation …
- Clinical impact of suicide gene therapy in allogeneic hematopoietic Stem cell transplantation
- Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic Stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic …
- … compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous Stem–cell transplantation in newly …
- Eyes open to Stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients
- Enzyme replacement therapy and/or hematopoietic Stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European …
- Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
- Combination of Stem cell mobilized by granulocyte-colony stimulating factor and human umbilical cord matrix Stem cell: therapy of traumatic brain injury in rats
- Neural Stem cell therapy
- A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of Stem cell‐based therapy
- Getting to the heart of myocardial Stem cells and cell therapy
- Hematopoietic Stem cell gene therapy for adenosine deaminase–deficient severe combined immunodeficiency leads to long-term immunological recovery and …
- Stroke patients take part in “milestone” UK trial of Stem cell therapy
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after Stem cell transplantation
- Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial Stem cell therapy in myocardial infarction
- High-dose chemotherapy with autologous Stem–cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials
- Pluripotent Stem cell-derived natural killer cells for cancer therapy
- Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived Stem cell therapy on regional remodeling measured by cardiac MRI
- Concerns and hopes for Stem cell therapy in cardiology: focus on endothelial progenitor cells
- Glioma gene therapy using induced pluripotent Stem cell derived neural Stem cells
- Republished review: cardiac Stem cell therapy: progress from the bench to bedside
- Mesenchymal Stem cell infusion therapy in a carbon tetrachloride‐induced liver fibrosis model affects matrix metalloproteinase expression
- Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy
- Neural Stem cell-based therapy for ischemic stroke
- How to measure the effects of the intracoronary Stem cell therapy?
- Stem cells and cell therapy
- Human embryonic Stem cell-derived mesenchymal Stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma
- High-dose therapy and autologous Stem–cell transplantation in Waldenström macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and …
- … trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic Stem–cell …
- Advances in Stem cell therapy: application to veterinary medicine.
- Shedding new light on the mechanism underlying Stem cell therapy for the heart
- Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic Stem cell transplantation for BCR–ABL-positive acute lymphoblastic …
- Intracoronary administration of cardiac Stem cells in mice: a new, improved technique for cell therapy in murine models
- Amniotic fluid Stem cell migration after intraperitoneal injection in pup rats: implication for therapy
- Large animal models of hematopoietic Stem cell gene therapy
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic Stem cell transplant patients: an European Organisation for Research and …
- … connexin channel-dependent intercellular communication in human adult hematopoietic progenitor/Stem cells: probing mechanisms of autologous Stem cell therapy
- Neural Stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy
- B-cell function in severe combined immunodeficiency after Stem cell or gene therapy: a review
- Mesenchymal Stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats
- Stem cell therapy for cardiovascular regeneration: the beginning or the end of all hearts’ hopes
- Hematopoietic Stem cell expansion and gene therapy
- Stem cell therapy for islet regeneration
- Nanoscaffold based Stem cell regeneration therapy: recent advancement and future potential
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review
- … remains the most important determinant of CMV reactivation after allogeneic hematopoietic Stem cell transplantation in the era of surveillance and preemptive therapy
- Clinical application of adult Stem cell therapy in neurological disorders
- Development of novel efficient SIN vectors with improved safety features for Wiskott–Aldrich syndrome Stem cell based gene therapy
- Predifferentiated adult Stem cells and matrices for cardiac cell therapy
- Mesenchymal Stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
- Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting
- Stem cell-based therapy and regenerative approaches to diseases of the respiratory syStem.
- Stem cell transplantation for hematological malignancies: prospects for personalized medicine and co-therapy with mesenchymal Stem cells
- Use of encapsulated Stem cells to overcome the bottleneck of cell availability for cell therapy approaches
- Genetic basis for skeletal disease. Stem cell therapy for genetic bone disorders
- The continued promise of Stem cell therapy in regenerative medicine.
- Real-time 3D ultrasound guided interventional syStem for cardiac Stem cell therapy with motion compensation
- Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic Stem cell recipients
- Taking Stem cells beyond discovery: a milestone in the reporting of regulatory requirements for cell therapy
- Personalizing Stem cell research and therapy: the arduous road ahead or missed opportunity?
- Research for cell therapy by induced pluripotent Stem cell
- Genotoxicity of retroviral hematopoietic Stem cell gene therapy
- Vasculogenic Stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with …
- Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after syStemic mesenchymal Stem cell-mediated NIS gene delivery
- … but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous Stem–cell …
- Stem cell based therapy in the inner ear: appropriate donor cell types and routes for transplantation
- Alterations of epithelial Stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy
- Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived Stem cells
- Therapeutic angiogenesis using gene transfer and Stem cell therapy in peripheral artery disease
- … III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous hematopoietic Stem cell transplantation (AHSCT) for …
- Limbal Stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia
- … of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances Stem cell mobilization and angiogenesis after …
- Vessel-associated Stem cells from skeletal muscle: From biology to future uses in cell therapy
- Cyclosporine A-loaded and Stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression
- Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
- Cytoprotection and preconditioning for Stem cell therapy
- Welcome to Stem cell Research & therapy
- Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood Stem cell transplantation
- Induced pluripotent Stem cell technology and Stem cell therapy for diabetes
- Outcome of hematopoietic Stem cell transplant as salvage therapy for Hodgkin’s lymphoma in adolescents and young adults at a single institution
- Progress in hematopoietic Stem cell transplantation as allogeneic cellular gene therapy in thalassemia
- Mesenchymal Stem cells derived from canine umbilical cord vein—a novel source for cell therapy studies
- Surgical intramyocardial Stem cell therapy for chronic ischemic heart failure
- Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
- Cancer Stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancers
- Study and analysis of Stem cell therapy and its ethical consideration
- Stem cell therapy for intractable skin diseases
- Hierarchical scaffold design for mesenchymal Stem cell-based gene therapy of hemophilia B
- Generation of dendritic cells and macrophages from human induced pluripotent Stem cells aiming at cell therapy
- Establishment of a Brazilian line of human embryonic Stem cells in defined medium: implications for cell therapy in an ethnically diverse population
- Evolving role of high dose Stem cell therapy in multiple myeloma
- General overview of the seventh international symposium on Stem cell therapy and cardiovascular innovations
- Stem cell therapy feasible, safe and beneficial for fistulizing Crohn’s disease
- Lp3: endogenous Stem cell therapy improves diabetic wound healing
- Stem cell therapy for neurodegenerative disorders
- Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic Stem–cell transplantation
- Mesenchymal Stem cell therapy for Apoptosis After Spinal Cord Injury
- Stem–cell therapy for retinal diseases
- Neural Stem cell therapy for temporal lobe epilepsy
- Stem cell therapy in chronic ischemic heart dysfunction with and without viability
- Molecular imaging of the pro-angiogenic paracrine effects of Stem cell therapy
- Stem cell-based therapy for erectile dysfunction
- Hematopoietic Stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease
- Role of molecular imaging in Stem cell therapy for myocardial restoration
- Allogeneic Stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG …
- Outcomes of hematopoietic Stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit
- Stem cell therapy in the inner ear: recent achievements and prospects
- Stem cells and cell therapy: on the eve of scientific discovery
- Sparing of the neural Stem cell compartment during whole-brain radiation therapy: a dosimetric study using helical tomotherapy
- … CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic Stem cell …
- High-dose therapy followed by autologous Stem–cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma
- Tumor Stem cell research-basis and challenge for diagnosis and therapy
- Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous Stem cell transplant (ASCT) for multiple myeloma (MM) …
- Association of polymorphisms of zinc metalloproteinases with clinical response to Stem cell therapy
- Modulation of the major histocompatibility complex by neural Stem cell-derived neurotrophic factors used for regenerative therapy in a rat model of stroke
- … derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population Stem cell-like cancer cells to photodynamic therapy
- Bone marrow Stem cell therapy for stroke
- Some notes on Stem cell therapy in cardiovascular diseases
- Definition of an enhanced immune cell therapy in mice that can target Stem-like lymphoma cells
- First-line matched related donor hematopoietic Stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia
- Stem cell therapy & Other Recent Advances in Muscular Dystrophy
- Preclinical studies on mesenchymal Stem cell-based therapy for growth plate cartilage injury repair
- Stem cell therapy for stroke
- FDA approves first Stem–cell therapy
- Recent progress and challenges for the use of Stem cell derivatives in neuron replacement therapy for Parkinson’s disease
- High-dose therapy and Stem cell transplantation
- … initial and recurrent episodes of active CMV infection in the allogeneic Stem cell transplantation setting: implications for designing preemptive antiviral therapy …
- Stem cell therapy: A role for CXCR4 in homing bone marrow side population cells to areas of myocardial damage
- Allogeneic hematopoietic Stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia—a single-center analysis of 100 …
- Phage display technology for Stem cell delivery and syStemic therapy
- Mesenchymal Stem cell transplantation: a potential therapy for oral lichen planus
- Thalidomide, dexamethasone and lovastatin with autologous Stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and …
- A randomized phase III trial of thalidomide and prednisone as maintenance therapy following autologous Stem cell transplantation (ASCT) in patients with …
- Dual transfer of GFP gene and MGd into Stem-progenitor cells: toward in vivo MRI of Stem cell-mediated gene therapy of atherosclerosis
- Combined enzyme replacement therapy and hematopoietic Stem cell transplantation in mucopolysacharidosis type VI
- Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic Stem cell transplantation
- … kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic Stem cell …
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic Stem cell transplant recipients
- Stem cell therapy doctor struck off by the GMC
- High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic Stem cell transplant cytomegalovirus infection
- Hematopoietic Stem cell gene therapy as a treatment for autoimmune diseases
- Allogeneic haematopoietic Stem cell transplantation as therapy for chronic granulomatous disease—single centre experience
- Embryonic Stem cell therapy for osteo-degenerative diseases: methods and protocols
- Autologous mesenchymal Stem cell therapy for spinal cord injury: long term safety and clinical efficacy
- Immune modulation for Stem cell therapy
- Thalidomide-dexamethasone as induction therapy before autologous Stem cell transplantation in patients with newly diagnosed multiple myeloma and renal …
- Cardiac Stem cell therapy for the treatment of chronic stable angina refractory to conventional therapy. State of the art and current clinical experience of the San …
- Randomized clinical trials in Stem cell therapy for the heart-old and new types of cells for cardiovascular repair
- Human cytomegalovirus (HCMV) replication kinetics in Stem cell transplant recipients following anti-HCMV therapy
- listening to the messages of patients and stakeholders: where Stem cell therapy, spinal cord injury and neuroethics meet
- Nonviral gene delivery to mesenchymal Stem cells using cationic liposomes for gene and cell therapy
- Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic Stem–cell transplant recipients: a pilot …
- From cell therapy to organ regeneration therapy: generation of functional organs from pluripotent Stem cells
- Effect of immunoglobulin therapy on the rate of infections in multiple myeloma patients undergoing autologous Stem cell transplantation or treated with …
- Role of substrates in diabetes therapy: Stem cell differentiation and islet transplantation
- R-CHOP/R-DHAP compared to R-CHOP induction followed by high dose therapy with autologous Stem cell transplantation induces higher rates of molecular …
- SyStemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic Stem cell transplantation or enzyme replacement therapy–a review
- Human pluripotent Stem cells: from biology to cell therapy
- Embryonic Stem cell therapy for intractable epilepsy
- Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with Stem cell …
- High-dose therapy/autologous hematopoietic Stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma
- Stem cell therapy for myocardial regeneration: the Chinese experience
- Prospects of Stem cell therapy for Autism Spectrum Disorders
- Topical Stem and progenitor cell therapy for diabetic foot ulcers
- Repeated application of autologous bone marrow derived Stem cell therapy in patients with severe Buerger’s disease
- High rate of Stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma
- Primary CNS lymphoma—radiation-free salvage therapy by second autologous Stem cell transplantation
- Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine Stem cell virus and human phosphoglycerate kinase promoters
- A phase III PETHEMA/GEM study of induction therapy prior autologous Stem cell transplantation (ASCT) in multiple myeloma: superiority of VTD (bortezomib …
- … pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic Stem cell …
- cell therapy for the treatment of metabolic liver disease: an update on the umbilical cord derived Stem cells candidates
- Two cases of Stem cell therapy for pulmonary hypertension: A clinical report
- New cell therapy using bone marrow-derived Stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis
- Structure of neuromuscular junctions and differentiation of striated muscle fibers in mdx mice after bone-marrow Stem cell therapy
- Prospects for neural Stem cell therapy of alzheimer disease
- Role of maintenance therapy after autologous Stem cell transplant for multiple myeloma: lessons for cancer therapy
- Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic Stem‐cell transplantation: Report from the working …
- Artificial cell microencapsulated Stem cells in regenerative medicine, tissue engineering and cell therapy
- Stromal Stem cell therapy for Prophylaxis of Acute GVHD: Preliminary Results From a Phase 1 Trial
- Adult Stem cell therapy in the twitcher mouse model of Krabbe’s disease utilizing mesenchymal lineage Stem cells
- Adipobiology of Stem cell-based therapy: secretome insight
- Muscle-derived Stem cells: a model for Stem cell therapy in regenerative medicine
- Emerging candidates in breast cancer Stem cell maintenance, therapy resistance and relapse
- The ongoing challenge of hematopoietic Stem cell-based gene therapy for β-thalassemia
- Adipose-derived Stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials.
- Stem cell therapy in orthopaedics
- A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic Stem cell transplantation
- Prospects for Induced Pluripotent Stem cell-Derived Hepatocytes in cell therapy
- Perinatal Stem cell therapy
- Frontline therapy with bortezomib, lenalidomide, and dexamethasone (VRD) induction followed by autologous Stem cell transplantation, VRD consolidation …
- Stem cell therapy in Myocardial Infarction Clinical Point of View and the Results of the REANIMA Study (REgenerAtion of Myocardium with boNe Marrow …
- The National Stem cell therapy Patient Registry of Malaysia—Measuring Clinical Outcomes of Stem cell therapy
- Stem cell therapy doctor exploited desperate patients, GMC finds
- Functional improvement of injured retina following the adjuvant Stem cell-based therapy. Preliminary report
- Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic Stem cell transplant
- Perspectives of clinical Stem cell therapy in the treatment of musculoskeletal diseases in Germany
- ThaDD plus high dose therapy and autologous Stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo …
- Back to the bench: The rejuvenation of Stem cell therapy—the therapeutic potential of CD133+ progenitor cells
- Stem cell therapy: the expectations, considerations, and clinical research issues
- Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic Stem cell transplant recipients: incidence, risk factors, and …
- In vivo differentiation of magnetically labeled mesenchymal Stem cells into hepatocytes for cell therapy to repair damaged liver
- S1-5: Modulation of Cancer and Stem cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine therapy for Early Stage ER+ Breast Cancer.
- Tandem versus single autologous peripheral blood Stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in …
- Stem cell therapy for blindness: new developments and implications for the future
- Surveillance investigations after high-dose therapy with Stem cell rescue for recurrent follicular lymphoma have no impact on management
- Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic Stem cell transplant recipients
- Microstructural signatures of ischemia and Stem cell therapy in the myocardium revealed with serial diffusion tensor MRI and tractography of the mouse heart in vivo
- Stem cell therapy for congestive heart failure
- First-in-man cell therapy clinical trial for heart failure-AutoLogous human cardic-derived Stem cell to treat ischemic cardiomyopathy (ALCADIA)
- Non-myeloablative autologous haematopoietic Stem cell transplantation with consolidation therapy using mitoxantrone as a treatment option in multiple …
- cell therapy for diabetes: Stem cells, progenitors or beta-cell replication?
- Perspectives of Stem cell therapy in type 2 diabetes mellitus
- Homologous recombination in human embryonic Stem cells: a tool for advancing cell therapy and understanding and treating human disease
- Interventional, intramyocardial Stem cell therapy in ischemic cardiomyopathy: update 2010
- Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated …
- Stem cell transplant: an effective salvage therapy for multiple myeloma
- cellular therapy following allogeneic Stem–cell transplantation
- Promising cell-based therapy for bone regeneration using Stem cells from deciduous teeth, dental pulp, and bone marrow
- Molecular diagnostics, targeted therapy, and the indication for allogeneic Stem cell transplantation in acute lymphoblastic leukemia
- H1N1 infection in a cohort of hematopoietic Stem cell transplant recipients: prompt antiviral therapy might be life saving
- Efficacy of hormone therapy for osteoporosis in adolescent girls after hematopoietic Stem cell transplantation: a longitudinal study
- Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas
- Contrast echocardiography: finding its place in Stem cell therapy.
- Pilot assessment of HIV gene therapy-hematopoietic Stem cell clinical trial acceptability among minority patients and their advisors
- In vivo T-cell dynamics during immune reconstitution after hematopoietic Stem cell gene therapy in adenosine deaminase severe combined immune deficiency
- Long-Term Follow-Up of Stem cell therapy after Acute Myocardial Infarction
- Bortezomib-based induction therapy followed by autologous Stem cell transplantation and maintenance therapy with bortezomib improves outcome in …
- Second transplantation for graft failure after allogeneic hematopoietic Stem cell transplantation–a retrospective survey by Kanto Study Group for cell therapy
- Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous Stem cell transplant in the upfront setting?
- Stem cell-based hepatic differentiation for cell therapy of liver diseases
- Tandem autologous hematopoietic Stem cell transplants (AuHCT) with or without maintenance therapy (auto-auto) versus single AuHCT followed by HLA …
- Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic Stem cell transplant recipients
- A syStematic review of autologous Stem cell therapy in female stress urinary incontinence
- Adipose tissue-derived Stem cells for cell therapy of airway allergic diseases in mouse
- Stem cells and cell therapy: Popular Belief?
- Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic Stem cell …
- First stroke patient is recruited to take part in “milestone” UK trial of Stem cell therapy
- … Rhizopus microsporus infection cured by salvage allogeneic hematopoietic Stem cell transplantation, antifungal combination therapy, and surgical resection
- Stem cell therapy in no-option critical limb ischemia patients
- The cancer Stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
- Acceleration of Wound Healing Using Adipose-derived Stem cell therapy with Platelet Concentrates: Plateletrich Plasma (PRP) vs. Platelet-rich Fibrin (PRF)
- Ethical and scientific issues in gene therapy and Stem cell research
- Autologous Stem cell transplantation (ASCT) as upfront or salvage therapy for noncutaneous T-cell lymphoma (TCL): The University of Texas MD Anderson Cancer …
- Total ischemic time is an independent predictor of response to Stem cell therapy in patients with StemI
- Peripheral blood Stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage …
- MRI strain analysis as a novel modality for the assessment of myocardial function following Stem cell therapy-results from Amorcyte trial
- Keynote address—Working Toward Mesenchymal Stem cell therapy for HD
- 90Y-ibritumomab tiuxetan as consolidation therapy after autologous Stem cell transplantation in aggressive non-Hodgkin lymphoma
- Stem cells and cell therapy: on the eve of scientific approach
- … (auto-auto) with or without maintenance therapy versus single autologous transplant followed by HLA-matched sibling non-myeloablative allogeneic Stem cell …
- Cardiac Magnetic Resonance for evaluating early outcomes of Stem cell therapy in non-ischemic dilated cardiomyopathy
- Characteristics and outcomes after autologous Stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab …
- Dual CT and MRI in vivo tracking of Stem cell therapy in peripheral artery disease
- Cardiac Stem cell therapy for infarcted rat hearts
- Combination of IFN-α/Gm-CSF as a maintenance therapy for multiple myeloma patients after autologous Stem cell transplantation (ASCT): a prospective phase II study
- Long-term follow-up of tandem high-dose therapy with autologous Stem cell support for adults with high-risk age-adjusted international prognostic index …
- Rituximab purging and maintenance therapy combined with autologous Stem cell transplantation in patients with diffuse large B-cell lymphoma
- High-dose therapy and autologous peripheral blood Stem cell transplantation in patients with multiple myeloma
- Case of relapsed AIDS-related plasmablastic lymphoma treated with autologous Stem cell transplantation and highly active antiretroviral therapy
- Pre-Stem cell transplant induction therapy does not affect post-transplant survival in light chain (AL) amyloidosis
- Effects of Dual Stem cell therapy (g-csf+ sitagliptin) On Cardiac Levels of Micrornas After Myocardial Infarction
- Regenerative medicine for severe congenital skin disorders: restoration of deficient skin component proteins by Stem cell therapy
- Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic Stem cell transplantation: a prospective multi-center trial
- … at two years following Stem cell transplant in syStemic light-chain amyloidosis (AL) using short-course bortezomib and dexamethasone consolidation therapy
- A dose‐intensive approach (NB96) for induction therapy utilizing sequential high‐dose chemotherapy and Stem cell rescue in high‐risk neuroblastoma in children …
- … /ZK 222584 in a phase II study of post-transplant maintenance therapy in patients with multiple myeloma following high-dose chemotherapy and autologous Stem cell …
- Haploidentical allogeneic haematopoietic Stem cell transplantation as salvage therapy for engraftment failure after unrelated and autologous Stem cell transplantation …
- Potential application of induced pluripotent Stem cells in cell replacement therapy for Parkinson’s disease
- The Science and Politics of Umbelical Stem cell therapy
- Promising therapy of neural Stem cell transplantation for FASD model–neural network reconstruction and behavior recovery
- Stem cell therapy does not improve visual function or structure in children with optic nerve hypoplasia (septo-optic dysplasia)
- Stem cell therapy. Evaluation of risk factors
- Successful treatment of high-risk and refractory acute myeloid leukemia with haploidentical Stem cell transplantation plus NK cell therapy
- Impact on relapse of corticosteroid therapy after allogeneic hematopoietic Stem cell transplantation for acute myeloid leukemia
- Hematopoietic Stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients
- Stem cell transplantation and renal replacement therapy: new predictors of outcome
- Standard chemotherapy is superior to high-dose chemotherapy with autologous Stem cell transplantation on overall survival as the first-line therapy for patients with …
- Combining gene and Stem cell therapy in the treatment of disferlinopaties
- Ethical Considerations in Stem cell therapy Studies.
- Regenerative Stem cell therapy
- Fiber-modified adenovirus can mediate human adipose tissue-derived mesenchymal Stem cell-based anti-angiogenic gene therapy
- Nurses’ Attitudes toward Stem cell therapy
- Haploidentical Stem cell transplantation as a salvage therapy for cord blood engraftment failure in a patient with Fanconi anemia
- Stem cell therapy FOR E RAIN TU MORS
- Stem cells and cell therapy: on the eve of scientific approach
- Autologous Stem cell Transplantation as First-Line therapy in Peripheral T-cell Lymphomas.
- Clinical applications of a Stem cell-based therapy for oral bone reconstruction
- A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth Stem cells, dental pulp Stem cells, or bone-marrow-derived mesenchymal Stem …
- Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic Stem cell transplantation from HLA-matched or …
- Opportunities and Challenges of Stem cell therapy: Is there a Role in AMI?
- Status of Stem cell therapy in type-1 diabetics
- … vitro trans-differentiation of human umbilical cord derived hematopoietic Stem cells into hepatocyte like cells using combination of growth factors for cell based therapy
- Stem cell therapy for neurological disorders
- Special aspects of Stem cell therapy in patients with MLD
- Stem cell therapy: Promising and Controversial!
- ETHICAL ISSUES IN Stem cell RESEARCH AND cell therapy
- Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges
- Cardiovascular Regeneration and Stem cell therapy
- Stem cell therapy for Cardiovascular Disease
- Stem cell therapy in Orthopaedic Surgery.
- Mesenchymal Stem cells at the intersection of cell and gene therapy
- The mechanism of mesenchymal Stem cell therapy for diabets
- … reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous Stem cell …
- Correction of Wiskott-Aldrich syndrome by hematopoietic Stem cell gene therapy
- Challenges in Stem cell therapy: Bench-To-Bedside
- Embryonic Stem cell therapy; A novel cell delivery method
- Inotuzumab ozogamicin (IO) is an effective salvage therapy that allows for allogeneic hematopoietic Stem cell transplantation (HSCT) in remission in patients with …
- Stem cell therapy for cardiovascular disorders-our clinical experience.
- Inner ear cell therapy for hereditary deafness with multipotent Stem cells
- Mesenchymal Stem–cell-based therapy for the older patient
- Successful allogeneic Stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy
- General Overview of the Sixth International Symposium on Stem cell therapy and Cardiovascular Innovations
- … bortezomib-thalidomide-dexamethasone (VTD) versus thalidomide-dexamethasone (TD) as consolidation therapy after autologous Stem–cell transplantation (ASCT) in …
- Meeting Report: The First Midwest Conference on Stem cell Biology and therapy (SCBT)
- … of front-line therapy with either high-dose therapy and autologous Stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell …
- Stem cell therapy for the treatment of diabetes
- Vascular and Cardiac Adult Stem cell therapy Center
- Keynote address—FDA Regulation of Stem cell therapy
- AGING AND Stem cell therapy: A REVIEW AND HIGHLIGHTS OF CURRENT CONTROVERSIES
- Application of Stem cell therapy and magnetic resonance imaging in experimental models of cardiovascular diseases
- Pulmonary Hypertension and Stem cell therapy
- Adult Stem cell-Based therapy for the Heart
- Repetitive busulfan administration after hematopoietic Stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate
- Experimental myocardial regeneration with Stem cell therapy
- Update cardiac Stem cell therapy
- Mesenchymal Stem cells for cell therapy and Tissue Regeneration in Urology
- Stem cell Research & therapy marks its first anniversary
- 15 Opportunities and Challenges of Stem cell therapy: Is there
- Prospects of Stem cell therapy in Diabetes-Introduction to the RDS Special Issue
- Long-term IL-2 therapy after transplantation of T cell depleted Stem cells from alternative donors in children
- Stem cell therapy IN DIABETES MELLITUS: CURRENT TRENDS
- Stem cell AND REGENERATIVE MEDICINE: P-130: ETHICAL CONSIDERATIONS IN Stem cell therapy
- Development of human Stem cell culture conditions for clinical cell therapy
- Advances of reporter gene monitoring Stem cell therapy
- Stem cell therapy in Cardiology: Current Concepts and The Road Ahead
- The immune barriers of cell therapy with allogenic Stem cells of embryonic origin
- Advances in induced Pluripotent Stem cell therapy for neurological diseases
- Stem cell therapy for brain disorders: Why results are discordant
- Potential Confounds in Stem cell therapy: A Case Study of Mesenchymal Stem cells and Cancer Stem cells
- Stem cell therapy IN SPINE SURGERY, CURRENT STATUS AND ETHICAL CONSIDERATION
- Preclinical experience in Stem cell therapy for digestive tract diseases
- Cancer Stem cell: a big hurdle in cancer therapy
- Feasibility of combination allogeneic Stem cell therapy for spinal cord injury: a case report
- Peripheral arterial disease and Stem cell therapy: Critical appraisal
- A General Review of the Current Knowledge of Stem cell therapy for Lung Disorders
- One decade of Stem cell therapy for bone marrow: what is missing?
- Advances of reporter gene imaging monitoring Stem cell therapy
- Stem cell therapy for Patients with Chronic Liver Disease
- Prospects for Induced Pluripotent Stem cell therapy for Diabetes
- Stem cell therapy restores athlete to former glory
- Cardiac Stem cell therapy: An Overview
- Stem cell therapy for critical limb ischemia
- Gene-modified Stem cell therapy for ischemic heart disease
- Experimental Stem cell-Based therapy in Pediatrics: A Fictional Case Study
- Stem cell therapy in diabetic foot patients: where are we now?
- Stem cell therapy Works (in Mice Models of Emphysema)!
- Stem cell therapy Against Oxidative Stress and Hypoxia
- Stem cell therapy for cardiovascular disease: answering basic questions regarding cell behavior
- Re: Stem cell therapy for Stress Urinary Incontinence
- Stem cell therapy for refractory angina
- Stem cell therapy in Ocular Surface Disease
- From immunological tolerance to Stem cell therapy and back: an interview with Irving Weissman
- Human induced pluripotent Stem cells for Stem cell therapy in stroke
- Induced Pluripotent Stem cell therapy for Human Diseases: Are We There Yet?
- Nanobiodevice based single cell imaging for cancer diagnosis and in vivo imaging for Stem cell therapy
- Embryonic Stem cell therapy for Osteo-Degenerative Diseases
- Echo and Stem cell therapy: more than just an ejection fraction
- Stem cell therapy for acute myocardial infarction and subsequent heart failure
- Induction therapy followed by allogeneic Stem cell transplant for MPN blast phase: outcomes from Mayo Clinic in Arizona
- Vascular and Cardiac Adult Stem cell therapy Center (VC-CAST)
- Heart Failure: Will There be Any Light at the End of the Tunnel with Stem cell therapy?
- A New Paradigm for Stem cell therapy: Stem cell Mobilization for Tissue Repair
- Stem cell therapy applications in amyotrophic lateral sclerosis
- Quantitative cardiac imaging to evaluate Stem cell therapy of myocardial infarction
- Consolidative proton therapy following high-dose chemotherapy and autologous Stem cell transplant in an adolescent with relapsed Hodgkin lymphoma
- Relapsed pulmonary lymphomatoid granulomatosis grade III: curative treatment with radioimmune therapy and autologous Stem cell transplantation
- Mesenchymal Stem cell (MSC) therapy To Prevent Ischemia-Reperfusion Injury in Lung Transplantation (145.24)
- Stem/precursor cell-based CNS therapy: the importance of circumventing immune suppression by transplanting autologous cells
- EVALUATION OF CLINICAL TRIALS OF Stem cell therapy FOR LIVER DISEASES IN IRAN
- Flavopiridol is an effective therapy to bridge patients with chronic lymphocytic leukemia (CLL) to reduced-intensity conditioning allogeneic Stem cell transplant
- IMMUNOLOGICAL BASIS FOR ALLOGENEIC MESENCHYMAL Stem cell therapy
- Recent advance in Stem cell therapy for ischemic stroke and clinical concerns
- Stem cell therapy for type 1 diabetes: Can it be an effective clinical scheme?
- Commercialization of Stem cell therapy for the Treatment of Diabetic Retinopathy
- Design of a Large-Scale Clinical Trial for the Treatment of Spinal Cord Pain Using Stem cell therapy
- BONE MARROW-DERIVED Stem cell therapy IN ACUTE MYOCARDIAL INFARCTION
- Embryonic Stem cell therapy for osteo-degenerative diseases-Methods and protocols
- Stem cell therapy for Heart Failure Using Cord Blood
- Chemical Delay of Flaps through Endogenous Stem cell therapy
- CLINICAL RELEVANCE OF ISCHEMIC LARGE ANIMAL MODELS IN Stem cell therapy; AN OVERVIEW AND META-ANALYSIS.
- P4. 52 Combining gene and Stem cell therapy in the treatment of dysferlinophaties
- 81: Stem cell therapy IMPROVES BONY HEALING
- Review of” Research Warning: Non-Host Origin Tumors Resulting From Stem cell therapy“
- INVITED SPEAKERS: I-1: MESENCHYMAL Stem cell therapy
- Molecular Imaging of a Preclinical Model of Stroke: Functional Evaluation and Stem cell therapy
- Editorial [Hot Topic: Stem cell therapy for Cardiovascular Diseases: Are We Still at the Beginning of A Long Road?(Guest Editor: Lino M Goncalves)
- Editorial [Hot Topic: Advances and Perspectives on Stem cell therapy for Human Neurodegenerative Diseases (Guest Editor: Liang-Wei Chen)]
- Stem cell therapy for Vertebral Bone Tissue Engineering
- Neuroprotection and gene-Stem cell therapy for ischemic stroke
- Limbal Stem–cell therapy and long-term corneal regeneration.[5YIF: 54.39; Citations: 301]
- Nanobiodevice based single molecule and cell sensing for cancer diagnosis and in vivo imaging for Stem cell therapy
- Muscle-derived Stem cells: isolation, characterization, differentiation, and application in cell and gene therapy
- New Stem cell therapy may someday cure AMD: non-embryonic human Stem cells appear promising for retinal regeneration
- Improved survival for multiple myeloma in Denmark based on autologous Stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual …
- Stem cell therapy: resetting autoimmunity or postponing the inevitable?
- Bone Marrow Stem–cell therapy for Idiopathic Dilated Cardiomyopathy
- Arsenic trioxide and Stem cell transplantation is an effective salvage therapy in patients with relapsed APL
- Embryonic Stem cell-derived neurons for inner ear therapy
- Acoustic radiation force for vascular Stem cell therapy: An in vitro validation
- A severe haematologic adverse reaction after high dosage radioiodine therapy following blood Stem cell mobilization with growth factors
- Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous Stem cell transplantation
- … Salvage therapy in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem cell …
- Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic Stem cell transplantation
- … Safety And Pharmacokinetics Of Palifermin In Pediatric Subjects With Acute Leukemias Undergoing Myeloablative therapy And Allogeneic Hematopoietic Stem cell …
- Reduced mitochondrial respiration and improved coupling in infarcted heart following Stem cell therapy
- Dual Stem cell therapy After Myocardial Infarction Acts Specifically by the Cxcr4-sdf1 Axis
- P04 Lentivirus-mediated Stem cell therapy for Duchenne muscular dystrophy
- A novel X-ray-visible microencapsuled mesenchymal Stem cell therapy for peripheral arterial disease
- On the evolution of high-dose immunosuppressive therapy with autologous Stem cell transplantation in multiple sclerosis
- Neuroprotection and neuroregeneration: what to expect from a Stem cell-based therapy of acute brain injury
- LP39: Endogenous Stem cell therapy Improves Calvarial Bone Healing
- The influence of fear appeal messages on creating awareness of Stem cell therapy in Malaysian market.
- Telomere Binding Protein Antagonists for Stem cell therapy
- Legal imperialism in the regulation of Stem cell research and therapy: the problem of extraterritorial jurisdiction
- Restoration of fatty acid but not glucose utilization in the infarcted heart following Stem cell therapy
- Dose finding study of lenalidomide as maintenance therapy in multiple myeloma after allogeneic Stem cell transplantation
- (Stem) cell Based therapy for Neurological Disorders
- Regenerative Stem cell therapy for multiple myeloma osteolytic bone damage
- … KLINICZNE I DOŚWIADCZALNE W CHOROBACH SERCA, PŁUC I NACZYŃ A novel method for isolation of endothelial progenitor cells for cardiac Stem cell therapy
- Placental Umbilical Cord Blood Transfusion for Stem cell therapy in Neurological Diseases
- Development of peptide-modified hyaluronic acid hydrogels for neural Stem cell therapy
- Successful nonmyeloablative allogeneic Stem cell transplantation for therapy-related acute myelogenous leukemia in a patient with preexisting visceral fungal …
- Optimising Adoptive T cell therapy Following Allogeneic Hematopoietic Stem cell Transplantation
- Allogeneic NK cell therapy After Autologous Stem cell Transplant: Results of a Phase I Study
- Hematopoietic Stem cell therapy In Eight Patients with Metachromatic Leukodystrophy–Relevance of Post-Transplant Medication.
- Adult Stem cell therapy for Injured Solid-Organ Tissue (with Emphasis on Cardiac Tissue Repair)
- Mesenchymal Stem cell therapy for peripheral arterial disease: In vivo monitoring and tracking with noninvasive imaging
- Intracoronary autologous Stem cell therapy for acute myocardial infarction: a syStematic review and meta-analysis of randomised controlled trials
- Morphometric analysis of murine ischemic hindlimb revascularization after Stem cell therapy
- Factors limiting spontaneous repair and their relevance for the efficiency of Stem cell therapy of infarcted hearts
- Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic Stem cell transplantation
- Why not” do simple things in a simple way”: Use of the Pap test as the first step in screening genetic stability for human cultured Stem cell therapy?
- 761. Gene-and-Stem cell therapy for Vertebral Bone Fracture
- … plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous Stem–cell transplantation in newly …
- Embryonic Stem cell-Derived Multipotent Mesenchymal Stromal cell therapy Following Focal Ischemia in the Rat
- A pilot study to assess perfusion recovery from mesenchymal Stem cell therapy after induction of acute myocardial infarct (AMI)
- Hematopoietic Stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
- … Diffuse Large B cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem cell …
- Stem–cell therapy Mitigates Radiation-Induced Non-Union in Murine Mandibular Distraction Osteogenesis
- Human neural Stem cell therapy in a primate model for Parkinson’s disease
- What is the benefit of maintenance therapy with lenalidomide or bortezomib after autologous Stem cell transplantation in multiple myeloma and what is the risk of …
- Combination therapy with BCNU/Etoposide/Melphalan (BEM) as Conditioning Regimen for Autologous Stem cell Transplant In Multiple Myeloma.
- Assessment of the Microvascular Response to Stem cell therapy with Contrast Ultrasound Perfusion Imaging and Maximum Intensity Projection Angiography
- Autologous peripheral blood Stem–cell (PBSC) collection is not impaired by bortezomib-thalidomide-dexamethasone (VTD) induction therapy in newly …
- P3-398 DOES THE MESENCHYMAL Stem cell therapy IMPROVE THE STREPTOZOTOCIN-INDUCED NEURODEGENERATION IN RATS?
- INTRACORONARY Stem cell therapy AFTER MYOCARDIAL INFARCTION-TWELVE MONTHS FOLLOW-UP OF A RANDOMIZED, RIGOROUS DOUBLE-BLIND …
- Phosphodiesterase-5 Inhibition: A Novel Strategy to Improve Stem cell therapy in the Heart
- Targeting the 5-Lipoxygenase as a Novel Principle of Stem cell therapy In Acute Myeloid Leukemia
- … Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose therapy and Autologus Stem cell Transplant for Mantle cell …
- 912. Embryonic Stem cell therapy Enhances Tendon Regeneration in a Large Animal Flexor Tendonitis Model
- High-dose therapy (HDT) with hematopoietic Stem cell transplantation (HSCT) is effective therapy for patients with non-Hodgkin lymphoma (NHL) and central nervous …
- Cardiac regenerative therapy: which type of cell will breast the tape?/Autologous Stem cell therapy with surgical myocardial revascularization-the Rostock University …
- SELECTING OPTIMAL CULTIVATION OF HUMAN BONE MARROW MESENCHYMAL Stem cells FOR CLINICAL cell therapy
- Current issues and innovations in Stem cell based therapy
- Advances in Stem cell Reseach and therapy
- Stem and progenitor cell-based therapy approaches: Current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy
- Editorial [Hot Topic: Stem cell Based therapy for Autoimmunity (Guest Editor: Frank Alderuccio)]
- 175 HUMAN AMNIOTIC FLUID Stem cell therapy FOR URETHRAL SPHINCTER REGENERATION
- 69 Intracoronary Autologous Peripheral Stem cell therapy: A Promising Treatment for Heart Failure in Pediatric Dilated Cardiomyopathy
- Influence of Permeability on the Compressive Property of Articular Cartilage: A Scaffold-Free, Stem cell-Based therapy for Cartilage Repair
- … , And Montelukast (Fam) therapy In Reducing Steroid Exposure In Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoetic Stem cell Transplant (Hct)–A …
- 3.09 Hollow Fiber Membrane Bioreactor Technology for Tissue Engineering and Stem cell therapy
- In Situ Stem cell therapy Using Human Adipose Tissue-Derived Multi-lineage Progenitor cells Combined with HMG-CoA Reductase Inhibitor Synergistically Reduce …
- T cell therapy after allogeneic Stem cell transplantation: titration of IL-2 concentration when expanding cord blood t lymphocytes with and without IL-7, in order to …
- Stem cell AND REGENERATIVE MEDICINE: P-140: COMBINATION cell therapy USING OLIGODENDROCYTE PROGENITOR cells (OPC) AND BONE …
- 53 Effects Of GLP-1 eluting Stem cell therapy on collagen remodelling in a porcine model of myocardial infarction
- O. 9 Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs
- … : an investigation of genomic, molecular and cellular factors in graft-versus-host disease and mesenchymal stromal cell therapy in a rat model of allogeneic Stem cell …
- The Role of Time-Lapse Microscopy in Stem cell Research and therapy
- Neural Stem cells for diabetes cell‐based therapy
- 685 Anti-arrhythmic cell therapy for the failing heart: Mesenchymal Stem cell transplantation mitigates electrophysiological remodelling in a rat model of myocardial …
- … for Developing Human Herpes Virus-6 Encephalitis and Clinical Significance of Antiviral therapy In Early Phase After Allogeneic Hematopoietic Stem cell …
- … Interferon-α in Combination with Donor Lymphocyte Infusion for High Risk Acute Leukemia Patients Who Relapsed After Allogeneic Hematopoietic Stem cell …
- YIA6 Effects of GLP-1 eluting Stem cell therapy on collagen remodelling, infarct size and apoptosis in a porcine model of myocardial infarction
- Double knockdown of Prolyyl hydroxylase and factor inhibiting HIF with non-Viral minicircle gene therapy enhances Stem cell mobilization and angiogenesis …
- The Optimal Timing for Stem cell Collection After Induction therapy for Patients with Multiple Myeloma
- Embryonic Stem cell Derivatives for Cardiac therapy: Advantages, Limitations, and Long-Term Prospects
- Hematopoietic Stem cell Gene therapy with Lentiviral Vector in X-Linked Adrenoleukodystrophy
- Imatinib mesylate is superior to allogeneic hematopoietic Stem cell transplantation as the first-line therapy for patients with chronic myeloid leukemia in the …
- Breast cancer Stem cell extinction models: implications for HER2 targeted therapy
- High-dose therapy with Stem cell rescue
- Favorable Outcomes of Neutropenic Enterocolitis Following Hematopoietic Stem cell Transplantation (HSCT) Using a Conservative Medical therapy …
- Thiotepa (TT), Busulfan (Bu), And Clofarabine (Clo) As A Conditioning therapy For Allogeneic Hematopoetic Stem cell Transplant For Patients With High Risk …
- Effects of physical therapy factors on mechanism of Stem cell regulation
- Bortezomib combined with autologous peripheral blood hematopoietic Stem cell transplantation for therapy of patients with multiple myeloma
- Regenerative Medicine in the Central Nervous SyStem: Stem cell-Based Gene-therapy
- Embryonic Stem cell in the therapy of Neurodegenerative Diseases
- Association of Cardiac Resynchronization therapy with Stem cell Transplantation for Ischemic Heart Disease
- Stem cell Transplantation therapy for Heart Disease
- … abnormality during lenalidomide therapy depends on the capacity of the neoplastic Stem cell to differentiate into maturing erythroid committed Stem cells
- Large-Scale Expansion of Human Embryonic and Induced Pluripotent Stem cells for cell therapy Applications
- cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells …
- Induction therapy and the role of Stem cell transplantation in the treatment of myeloma multiplex in patients aged below 65 years
- Large-scale expansion of human embryonic and induced pluripotent Stem cells for cell therapy applications
- Prevention of Cytomegalovirus Infection after Hematopoietic Stem cell Transplantation: Preemptive therapy Vs Universal Prophylaxis
- New Advances in Gene therapy: The Use of MGMTP140K-Mediated Stem cell Selection in Nonhuman Primates
- 678. Update of Stem cell Gene therapy Clinical Trial for ADA-Deficiency in Japan
- A Phase II Trial of Sequential Treatment with Cytoreductive therapy and Reduced Intensity Conditioning Allogeneic Stem cell Transplantation for Relapsed …
- Response to Tyrosine Kinase Inhibitor therapy In Patients Undergoing Allogeneic Hematopoietic Stem cell Transplantation for Advanced Phase Chronic …
- Current Strategies in Antifungal therapy for Invasive Aspergillosis in Immunocompromised Patients Following Hematopoietic Stem cell Transplantation.
- Bortezomib-Based therapy without Autologous Stem cell Transplantation for Newly Diagnosed Multiple Myeloma Patients with t (4; 14): A Canadian National …
- Reapplication of high-dose chemotherapy with melphalan followed by autologous hematopoietic Stem cell transplantation as salvage therapy for patients with …
- Potent graft-versus-leukemia effect after reduced intensity (RIC) allogeneic Stem–cell transplantation (asct) as post-remission therapy for intermediate-risk de …
- cellULAR therapy AND HEMATOPOIETIC Stem cell TRANSPLANTATION FOR CANCER
- Using Stem cell and Gene therapy Technologies to Treat Parkinson’s Disease
- Allogeneic hematopoietic Stem cell transplantation versus immunosuppressive therapy as frontline treatment for severe aplastic anaemia
- Combination cellular therapy for Regenerative Medicine: The Stem cell Niche
- Outcomes of a late second autologous hematopoietic Stem cell transplant compared to nontransplantation salvage therapy in relapsed multiple myeloma after upfront …
- How to Overcome Myeloma Stem cell Resistance to therapy-Targeting the Stem cell Niche
- … empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic Stem cell …
- Stem cell Replacement therapy in the Retina
- Hormonal therapy After Stem cell Transplantation and the Risk of
- … Stem cell Transplantation Significantly Improves Overall Survival After Rituximab Containing Induction therapy in Patients with High-Risk Aggressive B cell …
- T cell Suicide Gene therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem cell Transplantation in the Absence of Post-Transplant …
- Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal Stem cell deficiency with recurrent epithelial defect
- Stem cell AND REGENERATIVE MEDICINE: O-36: COMBINATION therapy OF TRAUMATIC BRAIN INJURY IN RATS WITH A Stem cell …
- Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic Stem cell transplantation in CR1 as the front-line therapy for adult Ph (+) acute …
- Anti-Inflammatory Gene therapy for the Promotion of Implanted Stem cell Survival in Infarcted Myocardium
- Engineering bioactive scaffolds for Stem cell vascular therapy
- From High-Tech to Biotech Using Stem cell and Gene therapy to Treat Hearing Loss
- … /CT-guided high dose sequential induction therapy with autologous Stem cell transplantation (ASCT) does not improve outcome for poor prognosis diffuse large B-cell …
- … complete response (CR) to bortezomib-thalidomide-dexamethasone (VTD) as induction therapy prior to autologous Stem–cell transplantation (ASCT) in …
- Gene therapy Used for Adipose Stem cell Engineering
- Transfusion support therapy for patients undergoing hematopoietic Stem cell transplantation
- An eco theological reflection on Christian-ethical implications of Stem cell research and therapy
- Abstract LB-155: Molecular targeted therapy of Stem cell leukemia-lymphoma induced by ZNF198-FGFR1
- Muse cells: a novel type of adult human pluripotent Stem cells and their possible application to cell therapy
- … Antigen Receptor Modified CD8+ T cells Derived From Virus-Specific Central Memory cells for Adoptive therapy After Allogeneic Hematopoietic Stem cell …
- Diabetic treatment by Stem cell based therapy in vivo in combination with gynura procumbens extract
- A 34-Year-Old Woman with 2-Year History of therapy-Resistant, Rapidly Progressive SSc Successfully Treated by Autologous Hematopoietic Stem cell …
- Application of neural Stem cell transplantation to brain injury therapy
- Haematopoietic Stem cell gene therapy for metachromatic leukodystrophy
- Neural Stem cell gene therapy for exercise-induced spinal cord injury
- Stem–cell Gene therapy for the Wiskott-Aldrich Syndrome
- Stem cell Transplant Patients, Glucocorticoids and Physical therapy-How Well Do They Mix?
- Human Embryonic Stem cell-derived Tissue Transplantation therapy: Clinical Hurdles
- T-cell Depletion Is An Alternative Approach for Patients>/= 55 Years Undergoing Allogeneic Stem cell Transplantation as Curative therapy for Hematologic Diseases
- Stem cell Replacement therapy for the Mammalian Inner Ear: A SyStematic Literature Review
- Treating GM1 Gangliosidosis With Ex Vivo Hematopoietic Stem cell Gene therapy Without Using Total Body Irradiation: A Masters Thesis
- Development of an embryonic Stem cell-based therapy for replacement of spiral ganglion neurons
- Tissue repairing cells that exist among mesenchymal Stem cells; their potential for cell-based therapy
- Clinical impact of suicide gene therapy in allogeneic hematopoietic Stem cell transplantation
- Electrical competence of the infarcted heart following Stem cell based regenerative therapy, in a rat model.
- Application of protein and small-molecule microarrays to study Stem cell differentiation, cancer growth, and personalized therapy
- HUMAN UMBILICAL CORD BLOOD‐DERIVED MESENCHYMAL Stem cells IN THE CULTURED RABBIT INTERVERTEBRAL DISC‐A cell therapy …
- Autologous Stem cell Transplantation in Multiple Myeloma in the Era of Novel Agents: Impact of Depth of Response to Induction therapy. A Single Institution …
- therapy-Senescent Lymphoma cells Bear Potentially Detrimental Stem–cell Characteristics.
- … Assessment of Rat Heart Force Generation: A Quantitative Approach for Predicting Outcomes From Pluripotent Stem cell-Derived therapy for Myocardial Infarction
- Autologous Hematopoetic Stem cell Transplantation as An Intensive Consolidation therapy for Adult Patients in Remission from Acute Myeloid Leukemia.
- Mesenchymal Stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression
- 315. Therapeutic Efficacy of Hematopoietic Stem cell Gene therapy for Hurler Type 1 Mucopolysaccharidosis
- PATU8 Analysis of outcomes of high-dose immunosuppressive therapy with autologous Stem cell transplantation in 156 patients with multiple sclerosis
- Towards Defining An Optimal Conditioning Regimen for Stem cell Gene therapy In Fanconi Anemia.
- Key mechanisms underlying cancer Stem cell overpopulation in colon carcinomas: Implications for anticancer therapy.
- Autologous Stem cell Transplantation (ASCT) for Multiple Myeloma (MM) in HIV Positive Patients (PTS) in the Highly Active Antiretroviral therapy (HAART) Era
- Impact of Rituximab-Based therapy After Histological Transformation on High-Dose therapy and Autologous Stem cell Transplantation in Follicular …
- Use Of Mechanical Ventilation And Renal Replacement therapy In The Critically Ill Hematopoietic Stem cell Transplant Patient
- High Dose therapy with Autologous Stem cell Transplantation Vs Standard Dose Chemotherapy In Multiple Myeloma: A Meta-Analysis
- Hematopoietic Stem cell Transplantation and Gene therapy for Primary Immune Deficiency Diseases
- Autologous Stem cell Transplantation as Front Line therapy Does Not Improve the Outcome of High Risk Aggressive Non-Hodgkin’S Lymphoma: A Single Center …
- Induction therapy with Novel Agents Improves Relapse-Free Survival After Autologous Stem–cell Transplantation in Multiple Myeloma
- 864. Foamy Virus Vectors with MGMT-P140K Mediate Efficient Selection in a Canine Pyruvate Kinase Deficiency Model for Hematopoietic Stem cell Gene therapy
- … Stem cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem cell Transplantation Following a Lenalidomide-Based Initial therapy
- Ethical aspects of human embryonic Stem cell use and commercial umbilical cord blood Stem cell banking. Ethical reflections on the occasion of the regulation of the …
- … Stem cell Transplantation and Chemotherapy As a Salvage therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem cell …
- Applications for human neural Stem cell-derived motor neurons in amyotrophic lateral sclerosis: cell replacement therapy and disease modeling
- … therapy with high-dose chemotherapy (HDCT) and peripheral blood Stem cell transplant (PBSCT) in patients with primary mediastinal nonseminomatous germ cell …
- Decitabine as a Bridging therapy Before Allogeneic Stem cell Transplantation for Myelodysplastic Syndrome
- … cells in Blood of Metastatic Breast Cancer Patients Indicates therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem cell …
- Carbon Monoxide therapy Modulates Hematopoietic Stem cell Development in Heme-Oxygenase-1 Knockout Mice
- A Comparative Study of the Outcome of High-Dose therapy and Autologous Hematopoietic Stem cell Transplantation in Patients with High-Risk or Standard …
- Outcome after high-dose therapy with autologous Stem cell rescue with BEAM for relapsed follicular lymphoma.
- Tandem Stem cell transplantation as consolidation therapy for high-risk neuroblastoma: The Children’s Healthcare of Atlanta experience.
- Outcome In Follicular Lymphoma (FL) Patients (pts) Relapsing After Autologous Stem cell Transplantation (ASCT): Allografting Vs. Conventional therapy
- Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic Stem cell transplant recipients
- Autologous peripheral blood Stem cell transplantation with high-dose therapy for anaplastic large cell lymphoma with progressive myelofibrosis
- Collapsed-Dose Versus Standard-Dose Palifermin therapy in Hematopoietic Stem cell Transplantation
- The Role of High Dose Chemotherapy and Autologous Stem cell Transplantation In Patients with Multiple Myeloma Refractory to Initial Induction therapy
- Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose therapy with Autologous Stem cell Rescue for Lymphoma.
- Peripheral Blood Stem cell Collection In Patients Undergoing Induction therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches
- Idiotype Immunization Following High-Dose therapy and Autologous Stem cell Transplantation for Non-Hodgkin Lymphoma
- Comparison of hematopoietic Stem cell transplantation from HLA identical siblings vs intensive immunosuppression therapy for severe aplastic anemia
- … profound hematopoietic and mesenchymal Stem cell abnormalities involving palmar fat and skin in addition to fascia: Novel implications for pathogenesis and therapy
- Allogeneic Stem cell Transplantation in Patients with therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Effect of Patient Characteristics and …
- Frequency Of Allogeneic Stem cell Transplant (SCT) In Patients Presenting With Newly-Diagnosed AML Or AML At Time Of First Salvage therapy
- The negative Impact of Imatinib Mesylate therapy prior to Allogeneic Hematopoietic Stem cell Transplantation in patients with chronic Myeloid Leukemia
- Hepatitis C Virus-Induced Hepatocellular Carcinoma: cancer Stem cell and gene therapy
- Carbon Monoxide therapy Reduces Reactive Oxygen Species Production and the Short-Term Hematopoietic Stem cell Population In Heme-Oxygenase-1 Knockout …
- therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic Stem cell transplant
- The Novel Use of Hyperbaric Oxygen therapy to Improve Umbilical Cord Blood Stem cell Engraftment in Irradiated NOD/SCID Mice: What Did We Learn?
- P4. 37 Towards hematopoietic Stem cell gene therapy for the treatment of Pompe disease
- … cell Transplantation From HBsAg-Positive Donors Into HBsAg-Negative Recipients: A Safety and Practicable Regimen Under Active Prophylactic Anti-HBV therapy
- Tandem versus single autologous peripheral blood Stem cell transplantation as post-remission therapy in adult acute myeloid…
- Mesenchymal Stem cells therapy in Acute Renal Failure: Possible Role of Hepatocyte Growth Factor. J Stem cell Res Ther 1: 109. doi: 10.4172/2157 …
- Autologous (Auto) Peripheral Blood Stem cell (SCT) As a Consolidation therapy for Patients with Acute Myeloid Leukemia (AML) in 1st Complete Remission (CR): A …
- High resolution analysis of clonal pluripotent Stem cell lentiviral gene therapy in a mouse model of beta-thalassemia
- High-Dose Immunosuppressive therapy (Cyclophosphamide and Campath-1H) Followed by Autologous Hematopoietic Stem cell Transplantation In the Treatment of …
- Chemoresistance Can Be Reliably Overcome with High-Dose therapy and Autologous Stem cell Transplantation (HDT/ASCT) for Relapsed and Refractory …
- … Rituximab As a Pre-Emptive therapy for Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorders in 86 Adult Patients Having Allogeneic Stem cell …
- Allogeneic Stem cell Transplantation for Secondary or therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome with Poor-Risk Cytogenetics.
- … of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line therapy with Autologous Stem cell Transplantation: Implications for …
- … Ranimustine (MCNU), Carboplatin, Etoposide, and Cyclophosphamide (MCVC) therapy Followed by Autologous Stem cell Transplantation for Malignant …
- … of glioma Stem cells: Effect of antibody-conjugated magnetic nanoparticles and proteasomal inhibitor bortezomib on GBM-derived neurospheres and glioma Stem cell …
- 181 cell therapy with autologous urine-derived Stem cells for vesicoureteral reflux
- … of Myocardial and Hepatic T2∗ MRI Changes in β-Thalassemia Major Hematopoietic Stem cell Transplantation Recipients and the Effect of Iron Overload therapy
- Embryonic Stem cell-derived Macrophage-based Gene Replacement therapy In SOD3-deficient Mice Ameliorates LPS-induced Lung Inflammation
- High Dose Oral Busulfan and Intravenous Melphalan as Conditioning therapy for Autologous Hematopoietic Stem cell Transplant (HSCT) for the Treatment of …
- Does the magnitude of response to initial induction therapy impact plans for immediate autologous Stem cell transplant (ASCT) consolidation in the transplant-eligible …
- … Kinase Inhibitors therapy and Donor Lymphocyte Infusion In Patients with Chronic Myelogenous Leukemia Relapsing After Allogenic Hematopoietic Stem cell …
- … -Free Survival of Patients with AML Relapse After T-cell-Depleted Allogeneic Stem cell Transplantation by Re-Induction therapy and Subsequent Interferon …
- … modulation by dendritic cells as a mechanism of action of extracorporeal photopheresis therapy for graft-versus-host disease after allogeneic haematopoietic Stem cell …
- Maintenance therapy with Nilotinib (Tasigna) Post Allogeneic Stem cell Transplantation (AlloSCT) for Advanced (> CP1) Chronic Myeloid Leukemia (CML) and Ph+ …
- … Cytomegalovirus (CMV) Serologic Status on Outcome and Survival in Patients Undergoing Allogenic Stem cell Transplantation in the Era of CMV-Preemptive therapy
- … MCL-PET prognostic index and survival in patients treated with rituximab-hypercvad (R-HyCVAD) or high-dose therapy with autologous Stem cell rescue (HDT/ASCT).
- … therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem cell Transplantation Using Low Dose Alemtuzumab In Vivo T cell …
- … -Based Salvage therapy in Adult Patients with T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (T-ALL/LL) Relapsing After Allogeneic Stem cell …
- … versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous Stem cell transplant for previously untreated mantle cell …
- A new humanized mouse model for studying HIV infection and antiretroviral therapeutics and human hematopoietic Stem cell-delivered gene therapy to generate anti …
- … with Community-Based Parenteral Anti-Infective therapy with Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem cell …
- … Lymphocyte Infusion Could Reduce Relapse and Improve Survival in Standard-Risk Acute Leukemia Patients After Allogeneic Hematopoietic Stem cell …
- … of Response to therapy in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma Undergoing Salvage Chemotherapy and Autologous Stem cell …
- … Present with Plasma cells Lacking Phosphorylated Retinoblastoma and/or Cyclin A Expression Benefit From High Dose therapy and Autologous Stem cell …
- … Study Evaluating Busulfan and Fludarabine as Preparative therapy In Adults with Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem cell …
- Dual roles of mesenchymal Stem cells in spinal cord injury: cell replacement therapy and as a model syStem to understand axonal repair
- Emprirical Antifungal therapy of Persistent Neutropenic Fever After Allogeneic Hematopoietic Stem cell Transplantation With Caspofungin or Liposomal Amphotericin …
- Risk-adapted high-dose therapy including autologous and allogeneic Stem cell transplantation for relapsed or aggressive non-Hodgkin’s lymphoma-a phase II trial by …
- … Stem cell Transplantation in HBsAg-negative and Anti-HBs-positive Patients: High Risk in Lymphoid Malignancies and Indication for Pre-emptive Antiviral therapy
- CANCER AND CANCER Stem cell: O-8: COMBINING GENE therapy WITH ADENOVIRAL VECTOR ENCODING 4-1BB L, B7-1 AND P53 IN SKOV3 cell …
- High-Dose therapy and Autologous Hematopoietic Stem cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the …
- … -Defined and PET/CT-Defined Complete Response (CR) to Novel Agent-Based Induction therapy and Autologous Stem–cell Transplantation (ASCT) In …
- … therapy With Dose-Intensified Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Re-Induction Followed by High-Dose Melphalan (HDM) and Autologous Stem …
- … Blood Stem cell Collections in Multiple Myeloma Based on a Retrospective Analysis of 1,039 Patients Receiving Novel Agents As Induction therapy and …
- … Leukemia (AML), Including therapy-Related AML, Associates with Worse Treatment Outcomes, Than De Novo AML Even After Hematopoietic Stem cell …
- … , DEXAMETHASONE) INDUCTION FOLLOWED BY HIGH-DOSE therapy WITH AUTOLOGOUS Stem cell TRANSPLANTATION AND MAINTENANCE …
- Elimination of cancer Stem cells in pancreatic cancer cell lines by a combinatorial therapy
- Analytical investigation of Embryonic Stem cells propagation for cell therapy
- Neural crest Stem cells from adult bone marrow: a new source for cell replacement therapy?
- Vascular wall Stem cells. Selection and conditioning of progenitors useful for cell therapy. A pathological case study
- cell therapy WITH HUMAN UMBILICAL CORD BLOOD‐DERIVED MESENCHYMAL Stem cells FOR INTERVERTEBRAL DISC REPAIR IN CULTURED …
- An Animal Model for Assessing Cardiovascular cell therapy with Human Bone Marrow Stem cells
- Application in cell therapy for Stroke: Characterization of Apoptotic Expression in Mesenchymal Stem cells
- Mesenchymal Stem cells: cell-Based Reconstructive therapy in Orthopedics
- cell therapy with adipose tissue-derived Stem cells for insulin-dependent diabetes mellitus in mice
- cell-based therapy In Glaucoma: Co-cultures Of Neural Stem cells With Glaucomatous Retinal Explants
- cell therapy Of Alkali Burned Cornea With Human Umbilical Mesenchymal Stem cells In The Mouse Model
- … Purine Nucleoside Phosphorylase (PNP) Gene in Bone Marrow Derived Hematopoietic Stem cells: An In Vivo Model of Gene therapy for PNP Deficient T-cell …
- Mesenchymal Stem cells for the cell-based therapy of type 1 diabetes: An experimental approach
- 1-5 cell therapy OPTIONS FOR OSTEOARTHRITIS: Stem/PROGENITOR cell
- … DIFFERENTIATION OF HUMAN MESENCHYMATOUS Stem cells CULTIVATED ON COLLAGEN SPONGE: PERSPECTIVES FOR GUIDED cell therapy FOR …
- … umbilical blood mononuclear cell–derived mesenchymal Stem cells serve as interleukin‐21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice
- Progress of research on leukemia Stem/progenitor cell targeting therapy
- In Situ Expression of Gsk-3β in Mesenchymal Stem cells Phase-Dependently Affects the Efficiency of cell Based therapy for Chronic Myocardial Infarction
- Proton therapy targets cancer Stem cells in treatment-resistant non-small cell lung cancer
- Driving murine embryonic Stem cells toward endothelial phenotype for cell-based therapy
- Use of IPs cell-derived neural Stem cells as a cellular vehicle for glioma and breast cancer therapy
- Targeting the CML Stem/progenitor cell with JAK2 (BMS-911543)/ABL inhibitor combination therapy
- Abstract S5-7: Estrogen Receptor Alpha Negative (ER-) Breast Cancer Stem cells in ER+ cell Lines and Primary Cancers Are Enriched by Tamoxifen therapy
- … INFLUENCE OF IMMUNOSUPPRESSIVE therapy ON INFECTION RISK IN RHEUMATOID ARTHRITIS35 THE INFLUENCE OF IMMUNOSUPPRESSIVE therapy …
- Stem cell therapy in treatment of different diseases
- Stem cell therapy for cardiac disease
- Advances in Stem cell therapy for spinal cord injury
- Clinical application of Stem cell therapy in Parkinson’s disease
- Challenges for heart disease Stem cell therapy
- New horizons for Stem cell therapy in liver disease
- Journey of mesenchymal Stem cells for homing: strategies to enhance efficacy and safety of Stem cell therapy
- Stem cell therapy for cerebral ischemia: from basic science to clinical applications
- Stem cell therapy for retinal disease
- Key developments in Stem cell therapy in cardiology
- Stem cell therapy for the spinal cord
- Stem cell therapy for erectile dysfunction: a critical review
- Intraoperative Stem cell therapy
- Role of mesenchymal Stem cell therapy in Crohn’s disease
- Stem cell therapy for stress urinary incontinence: a critical review
- Stem cell therapy in chronic liver disease
- Kidney protection and regeneration following acute injury: progress through Stem cell therapy
- cell delivery routes for Stem cell therapy to the heart: current and future approaches
- Mesenchymal Stem cell therapy for attenuation of scar formation during wound healing
- Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy
- Infrapatellar fat pad-derived mesenchymal Stem cell therapy for knee osteoarthritis
- Autologous mesenchymal Stem cell therapy in progressive multiple sclerosis: an open label study
- Stem cell therapy in oral and maxillofacial region: An overview
- The potential benefit of Stem cell therapy after stroke: an update
- Translational Stem cell therapy for amyotrophic lateral sclerosis
- Stem cell therapy for the inner ear: recent advances and future directions
- The potential of Stem cell therapy for stroke: is PISCES the sign?
- Fat grafting versus adipose-derived Stem cell therapy: distinguishing indications, techniques, and outcomes
- Mesenchymal Stem cell therapy for cutaneous wounds
- Intervertebral disc regeneration or repair with biomaterials and Stem cell therapy-feasible or fiction?
- A review and update on the current status of Stem cell therapy and the retina
- Autologous Stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients
- … -like Stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous Stem cell therapy
- Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized Stem cell therapy
- Mesenchymal Stem cell therapy and lung diseases
- Mesenchymal Stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model
- Induced pluripotent Stem cell consensus genes: implication for the risk of tumorigenesis and cancers in induced pluripotent Stem cell therapy
- Nano Technology and Stem cell therapy for CV Diseases: Potential Applications
- Autologous intravenous mononuclear Stem cell therapy in chronic ischemic stroke
- Stem cell therapy for degenerative disc disease
- Stem cell therapy of tendinopathies: suggestions from veterinary medicine
- Advances in Stem cell therapy
- Case reports of adipose-derived Stem cell therapy for nasal skin necrosis after filler injection
- Toward personalized cell therapies by using Stem cells: seven relevant topics for safety and success in Stem cell therapy
- Endogenous Stem cell therapy enhances fat graft survival
- Allogeneic versus autologous Stem–cell therapy
- Concise review: Stem cell therapy for muscular dystrophies
- Adult mesenchymal Stem cell therapy for myelin repair in multiple sclerosis
- Stem cell therapy for voiding and erectile dysfunction
- Stem cell therapy for diabetes
- Progress in Stem cell therapy for the diabetic foot
- Novel insights in basic and applied Stem cell therapy
- Stem cell therapy: a novel & futuristic treatment modality for disaster injuries
- … cord blood-derived mesenchymal Stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell …
- Perspectives on Stem cell therapy for Cardiac Regeneration–Advances and Challenges–
- Stem cell therapy independent of Stemness
- Stem cell therapy: from bench to bedside
- The impact of mesenchymal Stem cell therapy in transplant rejection and tolerance
- Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?
- Mesenchymal Stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy
- Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease
- The convergence of cochlear implantation with induced pluripotent Stem cell therapy
- Toward personalized cell therapies by using Stem cells: seven relevant topics for safety and success in Stem cell therapy
- Plasmonic photothermic and Stem cell therapy of atherosclerotic plaque as a novel nanotool for angioplasty and artery remodeling
- Stem cell therapy in spinal cord injury: in vivo and postmortem tracking of bone marrow mononuclear or mesenchymal Stem cells
- Development of Stem cell therapy for stress urinary incontinence
- Allogeneic mesenchymal Stem cell therapy for refractory cytopenias after hematopoietic Stem cell transplantation
- Allogeneic cellular and autologous Stem cell therapy for sickle cell disease:’whom, when and how’
- Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future Stem cell therapy
- Human umbilical cord mesenchymal Stem cell therapy on neuromyelitis optica
- Adipose-derived Stem cell therapy for severe muscle tears in working German shepherds: two case reports
- Validating intramyocardial bone marrow Stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter …
- Functional heterogeneity of mesenchymal Stem cells: implications for cell therapy
- Current status of mesenchymal Stem cell therapy and bone marrow transplantation in IBD
- Issues in medicine Regulatory crackdown on Stem cell therapy: what would the position be in South Africa?
- Preconditioning approach in Stem cell therapy for the treatment of infarcted heart
- News Commentary: human embryonic Stem cell therapy in the post-Geron era
- Update on cardiac Stem cell therapy in heart failure
- Autologous Bone Marrow Stem cell therapy Shows Functional Improvement in Hemorrhagic Stroke.
- Acceptability of Stem cell therapy by pregnant women
- Imaging Stem cell therapy for the treatment of peripheral arterial disease
- Stem cell-based therapy for experimental stroke: a syStematic review and meta-analysis
- Stem–cell therapy takes off in Texas: a boom in unproven procedures is worrying scientists
- Carvedilol enhances mesenchymal Stem cell therapy for myocardial infarction via inhibition of caspase-3 expression
- Human amniotic fluid Stem cell-derived muscle progenitor cell therapy for stress urinary incontinence
- Mesenchymal Stem cell therapy following muscle trauma leads to improved muscular regeneration in both male and female rats
- Mesenchymal Stem cell secreted vesicles provide novel opportunities in (Stem) cell-free therapy
- Assessment of health-related quality of life in patients receiving Stem cell therapy for end-stage liver disease: an Egyptian study
- Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt?
- Neural Stem cell therapy for temporal lobe epilepsy
- Anti-HLA antibodies in regenerative medicine Stem cell therapy
- Stem cell therapy for arterial restenosis: potential parameters contributing to the success of bone marrow-derived mesenchymal stromal cells
- Neurotrophic factor‐secreting autologous muscle Stem cell therapy for the treatment of laryngeal denervation injury
- Stem cell therapy: social recognition recovery in a FASD model
- Mesenchymal Stem cell therapy in acute lung injury: is it time for a clinical trial?
- NK cell therapy: targeting disease relapse after hematopoietic Stem cell transplantation
- Effect of Stem cell therapy on induced diabetic keratopathy in albino rat
- State-of-the-Art on Basic and Applied Stem cell therapy; Stem cell Research Italy–International Society for cellular therapy Europe, Joint Meeting, Montesilvano (PE …
- Stem cell therapy in kidney transplantation
- Autism spectrum disorders: is mesenchymal Stem cell personalized therapy the future?
- The challenges of Stem cell therapy
- Liposome-mediated cancer gene therapy: clinical trials and their lessons to Stem cell therapy
- Mesenchymal Stem cell therapy in the sports knee: where are we in 2011?
- Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic Stem cell transplantation
- SPECT and PET to optimize cardiac Stem cell therapy
- Societal value of Stem cell therapy in stroke–a modeling study
- Prospects for Stem cell-derived therapy in stroke
- Mesenchymal Stem cell 1 (MSC1)-Based therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis
- The safety of embryonic Stem cell therapy relies on teratoma removal
- Hematopoietic-Stem–cell-based gene therapy for HIV disease
- Effect of Stem cell therapy on adriamycin induced tubulointerstitial injury
- Stem cell therapy in animal sciences-A review
- Advances in Stem cell transplantation and gene therapy in the β-hemoglobinopathies
- Stem cell educator therapy and induction of immune balance
- Update on gene and Stem cell therapy approaches for spinal muscular atrophy
- Stem cell therapy in retinal diseases?
- cell therapy using induced pluripotent Stem cells or somatic Stem cells: this is the question
- Moving successful virus-specific T-cell therapy for hematopoietic Stem cell recipients to late phase clinical trials
- Stem cell therapy–An Overview
- Evaluating the first-in-human clinical trial of a human embryonic Stem cell-based therapy
- … after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem cell Transplantation in Ischaemic …
- The cancer Stem–cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy
- Pluripotent Stem cell–based cancer therapy: Promise and challenges
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, Stem cell accumulation, and a mesenchymal phenotype
- Stem cell therapy for bone regeneration: present and future strategies.
- Human amniotic fluid Stem cell injection therapy for urethral sphincter regeneration in an animal model
- Human bone marrow-derived mesenchymal Stem cell: a source for cell-based therapy
- Position Statement of the Chinese Diabetes Society regarding Stem cell therapy for diabetes
- Stem cell based therapy-where are we going?
- Mesenchymal Stem cell-based therapy for the treatment of type 1 diabetes mellitus
- MicroRNA and cardiac Stem cell therapy
- Effect of mesenchymal Stem cell therapy on recovery of streptozotocin-induced diabetes mellitus in adult male albino rats: a histological and immunohistochemical …
- Mending the broken heart-Towards clinical application of human embryonic Stem cell therapy derivatives
- Second autologous Stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival
- A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived Stem cells
- Cardiac function, perfusion, metabolism, and innervation following autologous Stem cell therapy for acute ST-elevation myocardial infarction. A FINcell …
- Rituximab maintenance therapy after autologous Stem–cell transplantation in patients with relapsed CD20+ diffuse large B-cell lymphoma: final analysis of the …
- … of autologous Stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin’s lymphoma responding to prior salvage therapy
- Mesenchymal Stem cell therapy in a rat model of osteoarthritis
- Stem cell therapy for male infertility takes a step forward
- Retinal regeneration and Stem cell therapy in retinitis pigmentosa
- RETRACTED ARTICLE: Targeted suicide gene therapy for glioma using human embryonic Stem cell-derived neural Stem cells genetically modified by …
- Understanding the application of Stem cell therapy in cardiovascular diseases
- Hematopoietic Stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice
- Role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence …
- Combined strategy of mesenchymal Stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes‐associated erectile …
- Isolation and characterization of mesenchymal Stem cell-like cells from healthy and inflamed gingival tissue: potential use for clinical therapy
- Human neural Stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation
- High-dose therapy and autologous Stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data …
- Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal Stem cells target cancer cells in situ
- Stem cell based glioblastoma gene therapy
- HLA-mismatched Stem–cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up
- … -thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic Stem cell transplantation in patients …
- Exploring the enkephalinergic differentiation potential in adult Stem cells for cell therapy and drug screening implications
- Mesenchymal Stem cell-based tumor-targeted gene therapy in gastrointestinal cancer
- Clinical response of 277 patients with spinal cord injury to Stem cell therapy in iraq
- Corticotomy and Stem cell therapy for orthodontists and periodontists: rationale, hypotheses, and protocol
- Retracted: Tumor Tropism of Intravenously Injected Human‐Induced Pluripotent Stem cell‐Derived Neural Stem cells and Their Gene therapy Application in a …
- … , and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous Stem–cell transplantation: MRC Myeloma …
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence …
- Stem cell therapy: facts and fiction
- Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer Stem cell self-renewal
- Influence of Stem cell therapy on Statin-induced Myopathy of Skeletal Muscle in Female Rats.
- Alginate scaffolds for mesenchymal Stem cell cardiac therapy: influence of alginate composition
- Groups propose plan to accredit controversial Stem cell therapy clinics
- Utility of mesenchymal Stem cell therapy in type 1 diabetes
- Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic Stem cell transplantation
- When inner ear Stem cell therapy becomes a reality
- Mesenchymal Stem cell therapy on murine model of nonalcoholic steatohepatitis
- p53-Independent, normal Stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies
- The Promise of Hematopoietic Stem cell therapy for Stroke: Are We There Yet?
- Valproic acid enhances anti-tumor effect of mesenchymal Stem cell mediated HSV-TK gene therapy in intracranial glioma
- The Editor’s Roundtable: Advances in Stem cell therapy for treatment of cardiovascular disease
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic Stem cell transplantation improves progression‐free survival in multiple …
- Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic Stem cell gene therapy
- Hematopoietic Stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in …
- High‐dose therapy with autologous Stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
- Cancer Stem cell targeting: the next generation of cancer therapy and molecular imaging
- T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic Stem cell transplantation
- New directions in cardiac Stem cell therapy: An update for clinicians
- Recent trends and strategies in Stem cell therapy for Alzheimer’s disease
- Residual dormant cancer Stem–cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts
- Embryonic Stem cell therapy for intractable epilepsy
- Stem cell-based photodynamic therapy
- High-dose therapy and autologous Stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
- Stem cell therapy, regenerative medicine and hematopoietic Stem cell transplantation: Recent achievements
- Therapeutic alliance in telephone-administered cognitive–behavioral therapy for hematopoietic Stem cell transplant survivors.
- Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic Stem cell transplantation
- Molecular imaging of Stem cell therapy in brain tumors: a step towards personalized medicine
- Fighting HIV with Stem cell therapy: one step closer to human trials?
- PAMAM Dendrimer-Baculovirus Nanocomplex for Microencapsulated Adipose Stem cell-Gene therapy: In Vitro and in Vivo Functional Assessment
- Cardiac biointerventions whatever happened to Stem cell and gene therapy?
- … minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood Stem cell transplantation is an …
- Stem cell therapy in orthopaedics
- Stem cell therapy in kidney transplantation—reply
- Mesenchymal Stem cell therapy: immunomodulation and homing mechanisms
- Medical nutrition therapy provided to adult hematopoietic Stem cell transplantation patients
- Safety evaluation of Stem cells used for clinical cell therapy in chronic liver diseases; with emphasize on biochemical markers
- Prophylactic and preemptive therapy with dasatinib after hematopoietic Stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
- … Prognostic Scoring SyStem scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic Stem cell …
- Would cancer Stem cells affect the future investment in Stem cell therapy
- Role of salvage radiation therapy for patients with relapsed or refractory Hodgkin lymphoma who failed autologous Stem cell transplant
- Using the BLT humanized mouse as a Stem cell based gene therapy tumor model
- Hematopoietic Stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler’s syndrome after pharmacological …
- Quality of life in patients with coronary artery disease after Stem cell therapy
- cell therapy in Hematology: Hematopoietic Stem cell Transplantations in 2012
- Why CCR5 is chosen as the target for Stem cell gene therapy for HIV infection?
- Evaluation of the cell viability of human Wharton’s jelly Stem cells for use in cell therapy
- Mesenchymal Stem cells in drug/gene delivery: implications for cell therapy
- Stem cell therapy: Dental Aspects
- Stem cell therapy in amyotrophic lateral sclerosis
- Novel therapy for type 1 diabetes: Autologous hematopoietic Stem cell transplantation
- cellular therapy promotes endogenous Stem cell repair
- Autologous Stem cell therapy to treat chronic ulcer in heifer-A case study.
- T-cell therapy: a powerful tool for the management of viral infections and relapse post hematopoietic Stem cell transplantation
- Consolidation of first-line therapy with busulphan and melphalan, and autologous Stem cell rescue in children with Ewing’s sarcoma
- Autologous Stem cell therapy: an analysis of the South African regulatory regime
- Implications of different fluid overload definitions in pediatric Stem cell transplant patients requiring continuous renal replacement therapy
- Adipose tissue-derived multi-lineage progenitor cells as a promising tool for in situ Stem cell therapy
- Stem cell therapy in neurodegenerative diseases: From principles to practice
- Induction of antigen-specific tolerance through hematopoietic Stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
- … -induced cavernous hemangioma in long-term survivors who underwent hematopoietic Stem cell transplantation with radiation therapy during childhood or …
- Supportive care with art therapy, for patients in isolation during Stem cell transplant
- Prognostic factors influencing clinical outcome of allogeneic hematopoietic Stem cell transplantation following imatinib-based therapy in BCR–ABL-positive …
- Multiple myeloma: myeloablative therapy with autologous Stem cell support versus chemotherapy: a meta-analysis
- Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic Stem cell transplantation—guidelines of the Infectious …
- Oral valganciclovir versus ganciclovir as delayed pre‐emptive therapy for patients after allogeneic hematopoietic Stem cell transplant: a pilot trial (04‐0274) and …
- Stem cell therapy for small animal clinical use
- Involved field radiation therapy following high dose chemotherapy and autologous Stem cell transplant benefits local control and survival in refractory or recurrent …
- Induced pluripotent Stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects
- Tandem Stem cell rescue as consolidation therapy for high‐risk neuroblastoma
- Improving safety of preemptive therapy with oral valganciclovir for cytomegalovirus infection after allogeneic hematopoietic Stem cell transplantation
- Induced transgene expression for the treatment of solid tumors by hematopoietic Stem cell-based gene therapy
- Erythroid promoter confines FGF2 expression to the marrow after hematopoietic Stem cell gene therapy and leads to enhanced endosteal bone formation
- Maintenance therapy after Stem–cell transplantation for multiple myeloma with bortezomib/thalidomide vs. thalidomide vs. Alfa2b-interferon: Final results of a phase III …
- Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic Stem cell transplant recipients compared with conventional-dose …
- The role of allogeneic hematopoietic Stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia
- Therapeutic strategies against ischemia–reperfusion injury: Stem cell therapy and beyond
- INTRACORONARY Stem cell therapy IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION–36 MONTHS RESULTS OF A RANDOMIZED, DOUBLE-BLIND …
- Cardiopoietic Stem cell therapy in heart failure: The multicenter randomized c-cure trial
- Allogeneic Stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of …
- Stem–cell therapy in medicine–how far we came and what we can expect?
- Enhancement of cancer Stem cell susceptibility to conventional treatments through complementary yoga therapy: possible cellular and molecular mechanisms
- Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous Stem cell transplantation for high risk neuroblastoma
- Stem cell-based therapy for α1-antitrypsin deficiency
- Intracoronary autologous CD34+ Stem cell therapy for intractable angina
- Stem cell therapy in spinal cord injuries: current concepts.
- Researches on application of Stem cell therapy in exercise-induced spinal cord injury recovery
- Recognition of glioma Stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic Stem cell transplantation: macrophage-targeted steroid therapy
- Stem cells: Source for diabetes cell therapy
- Stem cell therapy for Hemorrhagic Stroke: A Single Case Study Report
- Stem cell therapy in Myocardial Infarction: Latest Trends
- Granulocyte transfusion therapy in pediatric patients after hematopoietic Stem cell transplantation: a 5-year single tertiary care center experience
- … in combination with cyclosporin a as pre-and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic Stem cell …
- High-dose chemotherapy followed by autologous Stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis
- Adherence of Stem cell transplant recipients receiving glucocorticoid therapy to an exercise-based rehabilitation program
- Stem cell therapy in the Eye: Current status and future prospects for retinal neurodegenerative disease
- Stem cell application for amyotrophic lateral sclerosis: Growth factor delivery and cell therapy
- Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Pseudoprogression after high-dose busulfan-thiotepa with autologous Stem cell transplantation and radiation therapy in children with brain tumors: impact on survival
- Research progress of Stem cell therapy for type 1 diabetes mellitus
- Stem cell therapy and amyotrophic lateral sclerosis
- … Stem cell transplant in patients with newly diagnosed multiple myeloma who exhibited at least very good partial response to bortezomib-based induction therapy
- Induction therapy and Stem cell mobilization in patients with newly diagnosed multiple myeloma
- 532 Priming of Stem cells With Celastrol to Enhance Survival for cell therapy
- The perspectives of Stem cell-based therapy in neurological diseases
- Late onset of hepatitis B virus reactivation following hematopoietic Stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy
- … , thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous Stem cell transplant and consolidation therapy with bortezomib for …
- Continuous renal replacement therapy in children post-hematopoietic Stem cell transplantation: The present and the future
- Consolidative therapy with Stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen
- The beneficial effects of cardiac Stem cell therapy on left ventricular function and structure persists for at least one year in rats with acute myocardial infarction
- MRI Stem cell tracking for therapy in experimental cerebral ischemia
- … of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous Stem cell transplantation for malignant …
- Non-myeloablative bone marrow Stem cell transplantation for mdx mice myodystrophy therapy
- … trial of Len/Dex induction followed by tandem mel140 with autologous blood Stem cell transplantation and Len maintenance versus continued therapy with Len/Dex in …
- Gene and Stem cell therapy in erectile dysfunction
- Stem cell therapy
- Stem cell therapy in Articular Cartilage Injury
- … in multiple myeloma: update on therapeutic benefit as an upfront single agent, induction regimen for Stem–cell transplantation and as maintenance therapy
- New directions in cardiac Stem cell therapy: An update for clinicians
- Radiation burns and mesenchymal Stem cell therapy
- Food allergy after cord blood Stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease
- … matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal Stem cells enhances cell therapy after myocardial infarction
- Adipose derived Stem cell therapy rescues delayed wound healing in chronic radiation injury
- Stem cell therapy
- Delivery strategies for Stem cell-based therapy
- Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous Stem cell transplant salvage therapy for relapsed/refractory aggressive non …
- Comment on ‘Stem–cell therapy for Peripheral Arterial Occlusive Disease’
- Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral Stem cell transplantation in patients with …
- New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous Stem cell transplantation after induction therapy with …
- Allogeneic Stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy
- cell therapy for pulmonary arterial hypertension: potential efficacy of endothelial progenitor cells and mesenchymal Stem cells
- Targeted delivery of vascular endothelial growth factor to enhance the Stem cell therapy in treating myocardial infarction in rats
- Peripheral nerve regeneration after traumatic injury and Stem–cell therapy
- Human induced pluripotent Stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy
- Stem cell Research & therapy in 2012
- Stem cell-derived microvesicles: a cell free therapy approach to the regenerative medicine
- Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous Stem cell …
- Long-term improvement of left ventricular function and infarct size after cardiac Stem cell therapy: 5-years follow-up of the MYSTAR study
- POEMS syndrome treated with melphalan high-dose therapy and autologous blood Stem cell transplantation: a single-institution experience
- 54: Early intracranial mesenchymal Stem cell therapy after a perinatal rat brain damage
- Human Stem cell therapy
- Safeguarding pluripotent Stem cells for cell therapy with a non-viral, non-integrating episomal suicide construct
- Durable Infarct Size Reduction Due to Allogeneic Mesenchymal Stem cell therapy Regulates Whole-Chamber Left Ventricular Remodeling
- 110 RAT BONE MARROW DERIVED MESENCHYMAL Stem cell therapy IN A PARKINSONIAN ANIMAL MODEL OF DETRUSOR OVERACTIVITY
- Idiotype immunization following high-dose therapy and autologous Stem cell transplantation for non-Hodgkin lymphoma
- Mesenchymal Stem cell therapy Comparing Bone Marrow And Adipose Tissue-Originated cells In A Murine Model Of Elastase-Induced Emphysema
- I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood Stem cell transplantation for recurrent neuroblastoma
- Issue of transparency in Stem cell therapy
- Stem cell therapy for Heart Failure
- A REVIEW AND UPDATE ON THE CURRENT STATUS OF Stem cell therapy IN ROYAN INSTITUTE; INVITED SPEAKERS
- Stem cell therapy for Type I Diabetes: 1811
- … immune reconstitution following post-transplant cyclophosphamide and regulatory MHC cell therapy in recipients of mhc matched allogeneic hematopoietic Stem cell …
- Bioethics and freedom of scientific research in gene therapy and Stem cell biology
- Stem cell therapy and the Governance of Uncertainty
- Stem cell therapy for nervous syStem diseases
- … with R-CHOP or high dose sequential therapy with autologous Stem cell transplantation (R-HDS) for high risk diffuse large B-cell lymphomas patients: results of the …
- cell therapy with adipose tissue-derived Stem/stromal cells for elastase-induced pulmonary emphysema in rats
- … with Two Cycles of Induction therapy with Bortezomib and Dexamethasone Followed by Bortezomib-High Dose Melphalan Conditioning and Autologous Stem cell …
- Regulatory questions in the development of blood Stem cell products for regenerative therapy
- Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic Stem cell transplantation
- Autologous Stem cell therapy for Diabetes: an exciting new frontier opens
- Gap junctions, Stem cells, and cell therapy: Rhythmic/arrhythmic implications
- The Use of Stem cell therapy in Treating Diabetes Mellitus
- T cell and B cell immunity can be reconstituted with mismatched hematopoietic Stem cell transplantation without alkylator therapy in artemis-deficient mice …
- Stem cell therapy in Parkinson’s disease.
- Stem cell therapy for inflammatory bowel disease
- Stem cell therapy in experimental type I diabetes in rats
- Autologous hematopoietic Stem cell transplantation versus intravenous pulse therapy cyclophosphamide for severe or rapidly progressive syStemic sclerosis, the …
- Omics in Stem cell therapy: The Road Ahead
- Stem cell therapy: Way to new era of regenerative dentistry
- Stem cell therapy in stroke: Where are we now?
- Developmental Strategy for Stem cell therapy Products in Regulatory Considerations
- Stem cell therapy for erectile dysfunction
- 5. Stem cell therapy
- Clinically relevant issues in cardiac Stem cell therapy
- MRI-Guided Stem cell therapy
- Umbilical cord blood Stem cell transplantation combined with mouse neural growth factor application and physical rehabilitation therapy for infantile cerebral palsy
- Autologous Stem cell therapy combined with exon skipping
- Do elderly myeloma patients benefit from high dose therapy (HDT) and autologous Stem cell transplant (ASCT)?: A comparative survival analysis using SEER Registry
- Apelin 13: a novel approach to enhance efficacy of hypoxic preconditioned mesenchymal Stem cells for cell therapy of diabetes
- Stem cell therapy and Tooth Regeneration-A Review.
- Stem cell therapy in the context of chronic liver disease: Promise and pitfalls
- Determining duration of HER2-targeted therapy using Stem cell extinction models
- Stem cell based therapy for muscular dystrophies: cell types and environmental factors influencing their efficacy
- Gene therapy and Stem cell therapy in chronic wound healing
- Bone Marrow-Derived Stem cell therapy for Myocardial Infarction
- Stem cell therapy Improves Critical Limb Ischemia
- Stem cell therapy for Spinal Cord Repair: A Current Status Report
- Is There a Role for Stem cell therapy for Overactive Bladder?
- First line therapy for patients with newly diagnosed multiple myeloma ineligible for autologous Stem cell transplantation: a syStematic review and meta-analysis …
- Parkinson’s disease and mesenchymal Stem cells: potential for cell-based therapy
- The Medical Nutrition therapy Provided to Adult Patients Undergoing Hematopoietic Stem cell therapy
- Cardiac Stem cell therapy for heart failure
- Design guidelines for an umbilical cord blood Stem cell therapy quality assessment model
- Stem cell therapy and Stress Response in Pancreas and Intestine
- Stem cell-based cellular therapy in rheumatoid arthritis
- Autologous Stem cell therapy to treat chronic ulcer in heifer-A case study
- Cardiac Stem and progenitor cell biology and therapy
- Development of Multi-functional Stem cell Delivery SyStems for Cardiac therapy
- … in Recipients of T cell Depleted (TCD) Allogeneic Hematopoietic Stem cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral therapy.
- Stem-like cells and therapy resistance in squamous cell carcinomas
- Stem cell therapy IN CHRONIC ISCHEMIC CARDIOMYOPATHY: A META-ANALYSIS
- A Journey into the World of Targeted therapy: A Review of Gene therapy, Stem cell therapy, and cell Reprogramming in Cardiovascular Medicine
- 137 Stem cell therapy for HIV Disease
- Dynamics of Myocardial Perfusion in Patients with Coronary Heart Disease and Post-infarction Cardiosclerosis After Stem cell therapy
- Scepticism in medicine, organ transplantation, gene and Stem cell therapy
- Clinical correlate: Stem cell therapy for craniofacial bone regeneration
- Neural Stem cells derived from iPSCs represent a safe and effective source for Stem cell therapy in experimental autoimmune encephalomyelitis
- … index for overall survival in patients treated with novel agents-based induction therapy and front-line autologous Stem cell transplantation, and allow the …
- Response to Comment on ‘Stem–cell therapy for Peripheral Arterial Occlusive Disease’
- Current Status of Stem cell therapy for Cochlear Hair Regeneration
- Effects of Stem cell therapy on amiodarone-induced liver injury in albino rats
- cell therapy for opportunistic infection and recurrent disease following allogeneic Stem cell transplantation
- Human amniotic epithelial cells as a reliable source for diabetes Stem–cell therapy
- Salvage T cell therapy for therapy Resistant Viral Diseases After Stem cell Transplantation
- Effect of Stem cell therapy on amiodarone-induced liver injury in albino rats
- Optimal Administration Routes for Adipose-Derived Stem cell therapy in Ischemic Flaps
- Stem cells in Normal and Malignant Breast Tissue: Is P-Cadherin a Stem cell Marker and a Possible Target for Cancer Stem cell therapy?
- Chemoprotection in brain tumor patients: another success for Stem cell gene therapy
- Long-term outcome of second allogeneic hematopoietic Stem cell transplantation as salvage therapy for young patients after relapse or graft failure: experience …
- Bone marrow mesenchymal progenitor and Stem cell biology and therapy
- Stem cell therapy in Alzheimer’s Disease Models: Neurogenesis Versus Trophic Support
- Dual Stem cell therapy Using Fetal Cardiac Progenitor cells with EPCs Enhances Benefit in an Acute Myocardial Infarction Model
- Safety, Feasibility and Signal of Activity of Intra-carotid Allogenic Mesenchymal Stem cell therapy in a Large Animal Stoke Model
- 565. Mechanisms of Stem cell therapy in Cystinosis Treatment
- Diffusion Tensor Imaging Biomarkers of Stem cell therapy Efficacy in Pediatric Cerebral Palsy
- Radioisotope-antibody conjugates selectively target bone marrow prior to Stem cell therapy
- … infusions induce sustained clinical remissions and tumor specific immunity in a series of patients with relapsed Hodgkin lymphoma after allogeneic Stem cell …
- Immune Mechanisms of Mesenchymal Stem cell therapy for Acute Graft versus Host Disease
- Stem cell therapy FOR MYOCARDIAL REGENERATION OF HUMAN cells USING SPECIAL RECEPTOR MARKERS CD45, CD34
- Derivation of Human Fetal Induced Pluripotent Stem (iPS) cells Using a Non-Integrating Sendai Virus Vector: Implications for Fetal Stem cell therapy
- Mesenchymal Stem cell therapy Prolongs Corneal Allograft Survival in Rats
- Effects of Embryonic Neural Stem cell therapy on DNA Damage Products in Urine and Tissue After Spinal Cord Injury in Rats
- Survival Advantage of cell therapy Over Cytotoxic therapy Alone in Adult Patients with Relapsed AML After Allogeneic Hematopoietic Stem cell …
- Lenalidomide Is Effective therapy for Relapse After Allogeneic Stem cell Transplant for Multiple Myeloma.
- Mesenchymal Stem cell therapy for Nerve Regeneration and Immunomodulation after Composite Tissue Allotransplantation
- MRI Monitored USPIO-Labelled Intracardial Stem cell therapy in Acute Myocardial Infarct, Imaging Features with Pathologic Correlation in Porcine Model
- Immediate Mesenchymal Stem cell therapy Provides Greater Attenuation of Myocardial Injury Than Deferred Treatment in Rats After Acute Myocardial Infarction
- Intra-Carotid Mesenchymal Stem cell therapy is Superior to Intravenous delivery in Rat Model of Cerebral Ischemia
- … hematopoietic Stem cell transplantation for primary and secondary myelofibrosis a retrospective, multicenter study of the Kanto Study Group for cell therapy (KSGCT)
- Intravenous Autologous Bone Marrow Derived Stem cell therapy for Patients with Subacute Ischemic Stroke (InVeST): A Multi-Centric Randomized Controlled Trial
- Adipose Stem cell therapy in Mice on Repetitive Intratracheal Bleomycin Induced Pulmonary Fibrosis
- LOP40: Allogeneic Mesenchymal Stem cell therapy Improves Burn Wound Healing via a Predominantly Paracrine Mechanism and Is Associated with Increased …
- Temporal Profiling of Immune-Related Cytokines after Intravenous Administration of Mesenchymal Stem cell therapy in Cerebral Ischemia in Mice
- Adipose Stem cell therapy in mice on repetitive intratracheal bleomycin induced pulmonary fibrosis
- Allogeneic Stem cell transplantation for FLT3/ITD positive acute myeloid leukemia in CR1: implication for personalized therapy to prevent early relapses
- Mesenchymal Stem cell therapy with Co-Stimulation Blockers Prolonged Marginal Mass of Islet Graft Survival in Allogeneic Murine Model: 2122
- High-Dose therapy and Autologous Stem cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for …
- … related mortality after brentuximab vedotin salvage therapy followed by reduced intensity conditioning regimen allogeneic Stem cell transplantation (RIC-ALLO …
- Bottlenecks of the clinical development of pluripotent Stem cell based therapy
- … (allo-CST) for poor risk cytogenetic IPSS myelodysplastic syndrome (PRC-MDS): A report from the French Society of Stem cell Transplantation and cell therapy …
- … therapy with interferon-α in combination with donor lymphocyte infusion for high risk acute leukemia patients who relapsed after allogeneic hematopoietic Stem cell …
- Impact of pitavastatin pretreatment on survival and functional activities of mesenchymal Stem cell: possible implication for cell transplantation therapy
- Lung progenitor and Stem cell biology and therapy
- Intensive induction, autologous Stem cell transplantation and rituximab maintenance has changed event free survival and overall survival in mantle cell …
- … , Stem cell therapy has been one of the most promising treatments for Alzheimer’s disease patients. This article aims to summarize the current progress in the Stem cell …
- Biomarkers Related with Tumor Formation of Stem cell-based therapy Products using hESC
- 736 Urine derived Stem cells with high telomerase activity for cell based therapy in urology
- Renal progenitor and Stem cell biology and therapy
- 026 Stem cell Based-therapy Using the Chitosan-Phosphorycholine Biopolymer
- Allogeneic Stem cell transplantation versus conventional postremission therapy for acute myeloid leukemia in first complete remission: a matched pairs …
- Stem cell replacement therapy as a potential treatment for SCA1 disease
- Lentiviral Vector Mediated Haematopoietic Stem cell Gene therapy For Mucopolysaccharidosis Type IIIA
- From Empirical Toward Preemptive Antifungal therapy for Patients With Hematological Malignancies and Hematopoietic Stem cell Transplant Recipients.
- Adipose tissue-derived Stem cell biology and therapy
- Stem cell-based gene therapy in HIV treatment
- Successful autologous Stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma
- Genitourinary progenitor and Stem cell biology and therapy
- Auditory progenitor Stem cell biology and therapy
- cell therapy Using Adipose-Derived Stem cells for Chronic Liver Injury in Mice
- Prolonged hypogammaglobulinemia after rituximab therapy for post-transplant EBV-lymphoproliferative disorder following hematopoietic Stem cell …
- cell-free derivatives from mesenchymal Stem cells are effective in wound therapy
- Amniotic fluid Stem cells: a promising therapeutic resource for cell-based regenerative therapy
- Oral cavity progenitor and Stem cell biology and therapy
- Advances in Stem cell transplantation and gene therapy in the ß-hemoglobinopathies
- Assessment of the Effect of Nilotinib (Tasigna) Maintenance therapy After Allogeneic Stem cell Transplantation in Patients with Advanced CML and Ph+ ALL On …
- Early Consolidation with High Dose therapy and Autologous Stem cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3) …
- Stem cell-Based therapy for Lysosomal Storage Diseases
- Human bone marrow-derived mesenchymal Stem cell: a source for cell-based therapy
- Combination antifungal therapy in hematopoietic Stem cell transplantation patients
- High-dose therapy with autologous Stem cell support for lymphoma–from experimental to standard treatment 1735–9
- Salvage therapy with azacitidine increases regulatory T cells in patients with AML or MDS and early relapse after allogeneic blood Stem cell transplantation
- High-dose therapy with autologous Stem cell support for lymphoma in Norway 1987–2008 1704–9
- Umbilical cord blood (UCB) progenitor and Stem cell biology and therapy
- Adult Stem cell-based therapy for degenerative joint diseases
- Cancer Research, Molecular and cell Biology: Look at the Nanotechnology, Based Nanoparticles for Diagnostics, and therapy. Stem cell for Treatment of Cancer …
- Role of Front-Line High Dose therapy with Stem cell Transplant in Peripheral T-cell Lymphomas. A Single Center Experience.
- Advanced therapy: New Treatment Development Based on Cancer Stem cell Theory
- Parthenogenetic embryonic Stem cells with H19 siRNA-mediated knockdown as a potential resource for cell therapy
- Photodynamic therapy Triggers Expression Of Haemopoietic Stem cell Marker Cd34 Of Keratocytes
- Induced Pluripotential Stem cells and the Prospects for Cardiac cell therapy
- Novel method for delivery of Stem cell-derived growth factors for heart therapy applications:«In vitro» and «In vivo» analysis
- A way out or a new prospect: The future development of autologons hematopoietic Stem cell transplantation in type 1 diabetes therapy
- 301 THE VOMERONASAL ORGAN AS A NEW SOURCE OF Stem cells FOR cell therapy
- Multicenter Study Evaluating the Impact of Hypomethylating Agents As Bridging therapy to Hematopoietic Stem cell Transplantation in Myelodysplastic Syndromes
- Improved lentiviral vectors for haematopoietic Stem cell gene therapy of Mucopolysaccaridosis type IIIA
- Reprogramming and Characterization of Cord Blood Derived Stem cells by Synthetic mRNAs: Potential for Cord Blood Stem cell Regenerative therapy
- Neural Stem cell Proliferation Surrounding the Area of Traumatic Brain Injury: Role of Exercise therapy
- Bone marrow mesenchymal Stem cell transplantation combined with gene therapy for treatment of ischemic cerebrovascular disease
- Risk of Nausea and Vomiting in Patients with Lymphoma Undergoing High Dose therapy with Autologous Stem cell Rescue
- … Combining Yttrium-90 Ibritumomab Tiuxetan and High Dose therapy with Stem–cell Transplantation in Poor Risk Patients with Diffuse Large B-cell …
- … Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem cell Source for Gene therapy of Beta-Thalassemia.
- Long-term follow-up of HCV infected hematopoietic Stem cell transplant patients and effects of antiviral therapy
- … Stem cell-LIKE cells DETERMINE A THERAPEUTIC MODEL IN BREAST CANCER PATIENTS WHEN ANY OTHER RECOMMENDED therapy FAILED …
- A Qualitative Study Utilizing Grounded Theory: themes Expressed Throughout Art therapy Interventions with Siblings of Pediatric Hematopoietic Stem cell …
- … ) for Stem cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem cell Transplantation Following a Lenalidomide Based Initial therapy
- Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer Stem …
- Long term impact of prior rituximab therapy, early lymphocyte recovery on autologous Stem cell transplant outcome for diffuse large B cell lymphoma
- In Vivo Confocal Microscopy Analysis and Image-Guided therapy of Limbal Stem cell Insufficiency
- Retrospective Review of Dpace therapy as a Salvage Regimen in Patients with Relapsed Multiple Myeloma Prior to Autologous Stem cell Transplant
- Successful Scale-Up and Quality Assessments of Human Embryonic Stem cells for cell therapy: Challenges and Overview
- Correction: High-Dose Chemotherapy Followed by Autologous Stem cell Transplantation as a First-Line therapy for High-Risk Primary Breast Cancer: A Meta …
- Autologous haematopoietic Stem–cell transplantation in refractory coeliac disease type II patients unresponsive to cladribine therapy
- Feasibility and Outcome of High Dose therapy Followed by Autologous Stem cell Transplantation in Relapsed/Refractory Lymphoma in the Geriatric …
- Replacement of Degraded Articular Cartilage Using Stem cell-based therapy in Rabbit Model of Osteoarthritis
- Human embryonic Stem cell-derived endothelial cells as cellular delivery vehicles for targeting therapy of metastatic breast cancer
- Molecular Monitoring and Stepwise Preemptive therapy to Prevent Epstein-Barr Virus-Associated Diseases After Allogeneic Hematopoietic Stem cell …
- Pilot study of MAGE-A3 protein vaccination and autologous Stem cell transplantation (autoSCT) as consolidation therapy for multiple myeloma (MM).
- Adjuvant Stem cell‐based therapy in acute retinal injury after sodium iodate administration in mice
- High-Dose therapy and Autologous Stem cell Transplantation for Multiple Myeloma: Analysis from Registry of Monoclonal Gammopathy of Czech Myeloma …
- Characterization of BDNF blended chitosan scaffolds for human umbilical cord mesenchymal Stem cell transplants in TBI therapy
- Enzyme replacement therapy and/or hematopoietic Stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European …
- … Treatment of Low-Dose Lenalidomide Maintenance therapy Followed by Second Autologous Peripheral Blood Stem cell Transplantation in Heavily Treated …
- The role of uPAR in inducing a cancer Stem cell-like phenotype in breast cancer and allowing cells to develop endocrine therapy resistance
- Cidofovir Is a Highly Effective and Safe Salvage therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem cell …
- Decitabine in Combination with Donor Lymphocyte Infusion as Salvage therapy for Relapsed AML Post-Allogeneic Stem cell Transplantation
- Nilotinib (Tasigna) therapy Post Allogeneic Stem cell Transplantation (AlloSCT) for Advanced (> CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute …
- Bortezomib-Based Induction therapy Followed by High-Dose Chemotherapy and Autologous Stem cell transplantation in Newly-Diagnosed Myeloma: Initial Report …
- THE CARDIOELECTRICAL ACTIVITY STUDY FOR therapy OF SARCOPLASMIC RETICULUM CA2+-ATPASE GENE MODIFIED BONE MARROW Stem cell …
- … Clofarabine Pre-Conditioning Prior to Full Intensity or Reduced Toxicity Allogeneic Stem cell Transplantation: A Promising New therapy for the Treatment of …
- Cost analysis comparing intensified chemotherapy alone to myelo-ablative therapy followed by autologous Stem cell rescue in newly diagnosed patients with …
- Maintenance Hypomethylating therapy Post Allogeneic Stem cell Transplantation Provides Favorable Progression Free Survival in High Risk Acute Myelogenous …
- Low Dose Azacitidine Maintenance therapy Following Allogeneic Stem cell Transplantation for MDS/AML Does Not Interact with Tacrolimus Dosing or …
- … Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem cell Transplantation At the Era of Preemptive therapy.
- … Myeloablative Allogeneic Hematopoietic Stem cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose therapy in the Era of …
- RESIDUAL DORMANT CANCER Stem cell FOCI ARE RESPONSIBLE FOR TUMOR RELAPSE AFTER ANGIOGENIC METRONOMIC therapy IN …
- … ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose therapy and Autologous Stem cell …
- … Following Risk Adapted Stem cell Transplant (SCT) in SyStemic Light-Chain Amyloidosis (AL) Using Bortezomib and Dexamethasone as Consolidation therapy
- Thiotepa (Tt), Busulfan (Bu), and Clofarabine (Clo) as a Conditioning therapy for Allogeneic Hematopoetic Stem cell Transplant for Patients with High Risk …
- … ) Chronic Myeloid Leukemia (CML) Patients (pts) After Surviving 5 Years of Initial therapy with Interferon Alpha (IFN), Imatinib (IMA) or Allogeneic Stem cell …
- … IMRT During Partial Brain Radiation therapy for High-Grade Gliomas With and Without Selective Sparing of the Hippocampus, Limbic Circuit, and Neural Stem cell …
- LC, Acute: O-056; The evaluation of effectiveness and safety for new therapy with bone marrow derived autologous mesenchymal Stem cell for hepatic failure caused …
- Expression of heme oxygenase-1 in cardiac Stem cells enhances the efficacy of cell therapy for attenuating left ventricular dysfunction and remodeling after myocardial …
- Sarcomas as a mise en abyme of mesenchymal Stem cells: exploiting interrelationships for cell mediated anticancer therapy
- Induced pluripotent Stem cells and the prospects for cardiac cell therapy.
- CANINE MESENCHYMAL Stem cells FROM VISCERAL AND SUBCUTANEOUS ADIPOSE TISSUE FOR cell-BASED therapy
- Hematopoietic progenitor and Stem cells circulate by surfing on intracellular Ca2+ waves: A novel target for cell-based therapy and anti-cancer treatment?
- Generation of Tumor Free Induced Pluripotent Stem cells for Safe cell Based therapy
- Pluripotent Stem cells for cell replacement therapy of diabetes
- Human embryonic Stem cells as a source for cell replacement therapy in diabetes
- cell-based therapy options for osteochondral defects. Autologous mesenchymal Stem cells compared to autologous chondrocytes
- LCA Gene therapy In Somatic-cell-Derived Induced Pluripotent Stem cells
- cell based gene therapy using mesenchymal Stem cells and vascular endothelial growth factor in ischemic heart disease rat model
- Targeted gene correction of spinal muscular atrophy induced pluripotent Stem cells and motoneurons as cell source for therapy
- Stem cell therapy market
- Mesenchymal Stem cell therapy for heart disease
- Progress in Stem cell therapy for major human neurological disorders
- Stem cell therapy without the cells
- Stem cell therapy: a clinical trial of stroke
- Cardiopoietic Stem cell therapy in heart failure: the C-CURE (Cardiopoietic Stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified …
- Large animal models for Stem cell therapy
- Progress and prospects in Stem cell therapy
- Stem cell therapy to cure type 1 diabetes: from hype to hope
- Cardiac Stem cell therapy and the promise of heart regeneration
- Mesenchymal Stem cell therapy in skin: why and what for?
- Stem cell therapy for heart failure
- Advances in Stem cell therapy against gliomas
- Hematopoietic Stem cell therapy for multiple sclerosis: top 10 lessons learned
- Meta-analysis of Stem cell therapy in chronic ischemic cardiomyopathy
- Stem cell therapy: an exercise in patience and prudence
- Cardiac Stem cell therapy to modulate inflammation upon myocardial infarction
- Macrophage subpopulations are essential for infarct repair with and without Stem cell therapy
- The rabbit as a model for studying lung disease and Stem cell therapy
- Adverse effect of high glucose concentration on Stem cell therapy
- Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial
- Mesenchymal Stem cell therapy in diabetes mellitus: progress and challenges
- Stem cell therapy for human cartilage defects: a syStematic review
- Stem cell therapy in bladder dysfunction: where are we? And where do we have to go?
- Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?
- Human umbilical cord mesenchymal Stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy
- Stem cell therapy for lower extremity diabetic ulcers: where do we stand?
- Priming mesenchymal Stem cells boosts Stem cell therapy to treat myocardial infarction
- Stem–cell therapy for erectile dysfunction
- Mesenchymal Stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal Stem cell
- Mesenchymal Stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors
- Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived Stem cell therapy
- Perspectives of Stem cell therapy in D uchenne muscular dystrophy
- Stem cell therapy for pediatric dilated cardiomyopathy
- Rationale of mesenchymal Stem cell therapy in kidney injury
- Stem cell therapy in stroke: a review literature
- Mesenchymal Stem cell therapy in horses: useful beyond orthopedic injuries?
- Safety and immunological responses to human mesenchymal Stem cell therapy in difficult-to-treat HIV-1-infected patients
- SyStemic delivery of microRNA‐34a for cancer Stem cell therapy
- Stem cell therapy for heart disease
- Stem cell therapy in inflammatory bowel disease: which, when and how?
- Stem cell therapy in amyotrophic lateral sclerosis
- An update on translating Stem cell therapy for stroke from bench to bedside
- Long-term reparative effects of mesenchymal Stem cell therapy following neonatal hyperoxia-induced lung injury
- Nanoparticle-based monitoring of Stem cell therapy
- Multifunctional upconversion nanoparticles for dual‐modal imaging‐guided Stem cell therapy under remote magnetic control
- Safety and efficacy of umbilical cord mesenchymal Stem cell therapy in hereditary spinocerebellar ataxia
- Mesenchymal stromal (Stem) cell therapy fails to improve outcomes in experimental severe influenza
- Autologous bone marrow mesenchymal Stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture
- Effects of mesenchymal Stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice
- Melatonin treatment improves adipose‐derived mesenchymal Stem cell therapy for acute lung ischemia–reperfusion injury
- Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease
- Autologous bone marrow-derived Stem cell therapy in heart disease: discrepancies and contradictions
- Mesenchymal Stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration
- Functional consequences of human induced pluripotent Stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling
- Doxorubicin cardiotoxicity and cardiac function improvement after Stem cell therapy diagnosed by strain echocardiography
- Durable scar size reduction due to allogeneic mesenchymal Stem cell therapy regulates whole‐chamber remodeling
- Clinical trials of adult Stem cell therapy for peripheral artery disease
- Peripheral blood-derived autologous Stem cell therapy for the treatment of patients with late-stage peripheral artery disease—results of the short-and long-term follow …
- Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells
- Mesenchymal Stem cell-based therapy
- Growth and development symposium: Stem cell therapy in equine tendon injury
- New nerve regeneration strategy combining laminin-coated chitosan conduits and Stem cell therapy
- Stem cell therapy for tendon injury
- Stem cell therapy in patients with heart failure
- Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology
- Stem cell therapy: promising treatment in heart failure?
- Stem cell therapy for neonatal diseases associated with preterm birth
- Safety of intra-articular cell–therapy with culture-expanded Stem cells in humans: a syStematic literature review
- Adipose tissue derived stromal Stem cell therapy in murine ConA‐derived hepatitis is dependent on myeloid‐lineage and CD4+ T‐cell suppression
- Stem cell therapy for stress urinary incontinence: a syStematic review in human subjects
- … in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem cell therapy in patients with …
- Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and Stem cell therapy
- Allogeneic mesenchymal Stem cell therapy for bisphosphonate-related jaw osteonecrosis in swine
- Concise review: genetically engineered Stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy
- Stem cell therapy in veterinary dermatology
- Histological study on effect of mesenchymal Stem cell therapy on experimental renal injury induced by ischemia/reperfusion in male albino rat
- Stem cell therapy remediates reconstruction of the craniofacial skeleton after radiation therapy
- Stem cell therapy for erectile dysfunction: progress and future directions
- Potential mesenchymal Stem cell therapy for skin diseases
- A phase I study of human cord blood-derived mesenchymal Stem cell therapy in patients with peripheral arterial occlusive disease
- Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials
- Current outlook of cardiac Stem cell therapy towards a clinical application
- Apoptotic adipose-derived mesenchymal Stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in …
- Stem cell therapy: a novel approach for vision restoration in retinitis pigmentosa
- Fantasies about Stem cell therapy in chronic ischemic stroke patients
- Stem cell therapy in chronic obstructive pulmonary disease. Seeking the prometheus effect
- Allogenicity & immunogenicity in regenerative Stem cell therapy
- Cyclosporine-assisted adipose-derived mesenchymal Stem cell therapy to mitigate acute kidney ischemia–reperfusion injury
- Mesenchymal Stem cell therapy in osteoarthritis: advanced tissue repair or intervention with smouldering synovial activation?
- Development of fully defined xeno-free culture syStem for the preparation and propagation of cell therapy-compliant human adipose Stem cells
- Cardiac cell therapy: boosting mesenchymal Stem cells effects
- Preconditioning strategy in Stem cell transplantation therapy
- Biomaterials for Stem cell therapy: state of art and vision for the future
- Harnessing the Stem cell potential: a case for neural Stem cell therapy
- Mesenchymal Stem cell therapy in heart disease
- Stem‐cell therapy for dilated cardiomyopathy: a pilot study evaluating retrograde coronary venous delivery
- The multiple aspects of stroke and Stem cell therapy
- Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation
- CD34+ Stem cell therapy in Nonischemic Dilated Cardiomyopathy Patients
- Steps toward safe cell therapy using induced pluripotent Stem cells
- Reply: The C-CURE randomized clinical trial (Cardiopoietic Stem cell therapy in heart failURE)
- Stem cell therapy for Alzheimer’s disease: hype or hope?
- Stem–cell therapy for erectile dysfunction
- The potential of Stem cell therapy for osteoarthritis and rheumatoid arthritis.
- Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for Stem cell therapy
- Atorvastatin: an efficient step forward in mesenchymal Stem cell therapy of diabetic retinopathy
- Stem cell therapy for chronic heart failure: an updated appraisal
- The C-CURE randomized clinical trial (Cardiopoietic Stem cell therapy in heart failURE)
- Enhancement of Fat Graft Survival by Bone Marrow–Derived Mesenchymal Stem cell therapy
- Adipose Stem cell therapy for soft tissue reconstruction
- Stem cell transplantation as a therapy for cardiac fibrosis
- Constitutive expression and activation of stress response genes in cancer Stem-like cells/tumour initiating cells: potent targets for cancer Stem cell therapy
- Stem cell-based therapy in neural repair
- Current concepts in Stem cell therapy for articular cartilage repair
- Promise of neurorestoration and mitochondrial biogenesis in Parkinson’s disease with multi target drugs: an alternative to Stem cell therapy
- The political economy of the global Stem cell therapy market
- Mesenchymal Stem cell exosomes: the future MSC-based therapy?
- The contribution of Stem cell therapy to skeletal muscle remodeling in heart failure
- Molecular imaging: the key to advancing cardiac Stem cell therapy
- Mesenchymal Stem cell therapy improves diabetic cardiac autonomic neuropathy and decreases the inducibility of ventricular arrhythmias
- Stem cell therapy for knee ligament, articular cartilage and meniscal injuries.
- Current perspectives on molecular imaging for tracking Stem cell therapy
- Autologous bone marrow concentrate (Mononuclear Stem cell) therapy in the treatment of oral submucous fibrosis
- Suppressing NF-κB and NKRF pathways by induced pluripotent Stem cell therapy in mice with ventilator-induced lung injury
- Stem cell therapy for ischaemic stroke: translation from preclinical studies to clinical treatment
- Stem cell-based therapy for malignant glioma
- Mesenchymal Stem cells: a new trend for cell therapy
- Critical path in cardiac Stem cell therapy: an update on cell delivery
- Application of human mesenchymal and pluripotent Stem cell microcarrier cultures in cellular therapy: achievements and future direction
- Hypoxic culture conditions as a solution for mesenchymal Stem cell based regenerative therapy
- Stem cell therapy for male urinary incontinence
- Stem cell–based therapy for corneal epithelial reconstruction: Present and future
- Role of mesenchymal Stem cell therapy in restoring ovarian function in a rat model of chemotherapy-induced ovarian failure: a histological and immunohistochemical …
- Role of neuregulin‐1/ErbB signaling in Stem cell therapy for spinal cord injury‐induced chronic neuropathic pain
- Mesenchymal Stem cell therapy for lung diseases: oasis or mirage?
- Stem cell therapy in osteoarthritis: a step too far?
- Stem cell-based therapy for spinal cord injury
- The hitchhikers guide to cancer Stem cell theory: markers, pathways and therapy
- Lentiviral hematopoietic Stem cell gene therapy in patients with Wiskott-Aldrich syndrome
- Stem cell therapy in stroke treatment: is it a viable option?
- Lentiviral hematopoietic Stem cell gene therapy benefits metachromatic leukodystrophy
- Advancing critical care medicine with Stem cell therapy and hypothermia for cerebral palsy
- Histological experimental study on the effect of Stem cell therapy on adriamycin induced chemobrain
- Multi-virus-specific T-cell therapy for patients after hematopoietic Stem cell and cord blood transplantation
- Stem cell–based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study
- Stem cell-based therapy for ischemic heart disease
- MicroRNAs in Stem cell function and regenerative therapy of the heart
- High-throughput screening of Stem cell therapy for globoid cell leukodystrophy using automated neurophenotyping of twitcher mice
- Stem cell‐based therapy for Huntington’s disease
- Mesenchymal Stem cell secretome and regenerative therapy after cancer
- Mesenchymal Stem cell therapy unable to rescue the vision from advanced B ehcet’s disease retinal vasculitis: report of three patients
- APOBEC3G-augmented Stem cell therapy to modulate HIV replication: a computational study
- Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal Stem cell therapy
- Stem cell research and therapy in the Islamic republic of Iran: pioneering in the Islamic world
- Neural Stem cell–mediated enzyme/prodrug therapy for glioma: Preclinical studies
- CD133-positive cells for cardiac Stem cell therapy: Current status and outlook
- Effects of intravenous human umbilical cord blood CD34+ Stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice
- Nonlinear growth kinetics of breast cancer Stem cells: implications for cancer Stem cell targeted therapy
- Cardiac Stem cell therapy: Stemness or commitment?
- Umbilical cord Stem cell therapy for bronchopulmonary dysplasia: ready for prime time?
- Autologous Stem cell transplantation: an effective salvage therapy in multiple myeloma
- Lentivirus-mediated CD/TK fusion gene transfection neural Stem cell therapy for C6 glioblastoma
- Intestinal Stem cell injury and protection during cancer therapy
- Stemming the degeneration: IVD Stem cells and Stem cell regenerative therapy for degenerative disc disease
- Endogenous cardiac Stem cell therapy for ischemic heart failure
- … insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent Stem cells (CB-SCs) in Stem cell educator therapy: phase I/II …
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer Stem cell model
- Impact of malignant Stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
- Preclinical Stem cell therapy in Chagas Disease: Perspectives for future research
- Human embryonic Stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident Stem cell proliferation in acute kidney injury
- Mesenchymal Stem cell therapy in HIV-infected HAART-treated nonimmune responders restores immune competence
- Development of hematopoietic Stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical …
- Dual differentiation-exogenous mesenchymal Stem cell therapy for traumatic spinal cord injury repair in a murine hemisection model
- Failure of Stem cell therapy to improve visual acuity in children with optic nerve hypoplasia
- Stem cell therapy for Parkinson’s disease: Are double-blind randomized control trials the best design for quantifying therapy outcomes
- Cardiac-derived Stem cell-based therapy for heart failure: progress and clinical applications
- Hematopoietic Stem cell senescence and cancer therapy-induced long-term bone marrow injury
- SyStematic review of induced pluripotent Stem cell technology as a potential clinical therapy for spinal cord injury
- Myeloid/Microglial driven autologous hematopoietic Stem cell gene therapy corrects a neuronopathic lysosomal disease
- Quantifying mesenchymal Stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy
- Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic Stem cell transplant recipients: guidelines of the 4th European Conference on …
- Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic Stem cell transplantation
- Stem cell therapy for bone disorders
- Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic Stem cell transplantation
- Exploiting Stem cell therapy: The 3rd meeting of Stem cell Research Italy
- A novel alternative to cryopreservation for the short-term storage of Stem cells for use in cell therapy using alginate encapsulation
- The potential of Stem cell therapy for Peyronie disease
- Stem cell therapy for Diabetes: A Call for Efficient Differentiation of Pancreatic Progenitors. J Regen Med 2: 1
- Applications of Stem cell therapy for physeal injuries.
- From single nucleotide polymorphisms to constant immunosuppression: mesenchymal Stem cell therapy for autoimmune diseases
- Humoral activity of cord blood-derived Stem/progenitor cells: implications for Stem cell-based adjuvant therapy of neurodegenerative disorders
- Chemical genetics and its potential in cardiac Stem cell therapy
- … to rituximab-based therapy and risk factor analysis in Epstein Barr Virus–related lymphoproliferative disorder after hematopoietic Stem cell transplant in children and …
- Cytometry in Stem cell research and therapy
- … by early high-dose therapy and hematopoietic Stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single …
- Fat grafting versus adipose-derived Stem cell therapy: distinguishing indications, techniques, and outcomes
- Comparative analysis of human mesenchymal Stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy
- Stem–cell-based gene therapy for HIV infection
- Hematopoietic Stem cell gene therapy for the multisyStemic lysosomal storage disorder cystinosis
- Pre-conditioned mesenchymal Stem cells: a better way for cell-based therapy
- Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic Stem cell transplant recipients
- Recent achievements in Stem cell therapy for pediatric gastrointestinal tract disease
- Experimental therapy for lung cancer: umbilical cord-derived mesenchymal Stem cell-mediated interleukin-24 delivery
- Hematopoietic Stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte–colony stimulating factor plus plerixafor in patients with …
- Stem cell therapy for electrophysiological disorders
- The potential role of microvesicles in mesenchymal Stem cell-based therapy
- Gene and Stem cell therapy for diabetes.
- The Present and Future of Stem cell therapy in Japan1
- … with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer Stem cell therapy …
- … therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood Stem cell …
- Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside?
- Progress and prospects in Stem cell therapy and drug discovery
- cell therapy with autologous mesenchymal Stem cells—how the disease process impacts clinical considerations
- Hematopoietic Stem cell gene therapy: assessing the relevance of preclinical models
- Molecular monitoring and stepwise preemptive therapy for Epstein–Barr virus viremia after allogeneic Stem cell transplantation
- Stem cell therapy for retinopathy of prematurity
- Allogeneic Stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
- Autophagy in chronic myeloid leukaemia: Stem cell survival and implication in therapy
- Perspectives on assessment of Stem cell therapy in stroke by 18F-FDG PET
- Induction of tumor Stem cell differentiation—novel strategy to overcome therapy resistance in gastric cancer
- Experimental study on the effect of intravenous Stem cell therapy on intestinal ischemia reperfusion induced myocardial injury
- Medical nutritional therapy in hematopoietic Stem cell transplantation (HSCT)
- Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic Stem cell transplantation
- The eye as a target organ for Stem cell therapy
- Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic Stem cell transplantation with Clostridium difficile-associated …
- Current status of Stem cell therapy in China
- Going 3D–cell culture approaches for Stem cell research and therapy
- cell transplantation and “Stem cell therapy” in the treatment of myopathies: many promises in mice, few realities in humans
- Gene delivery techniques for adult Stem cell-based regenerative therapy
- A possible usage of a CDK4 inhibitor for breast cancer Stem cell-targeted therapy
- Neural Stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma
- Mesenchymal Stem/stromal cells: a new”cells as drugs”paradigm. Efficacy and critical aspects in cell therapy
- The effect of Stem cell therapy versus melatonin on the changes induced by busulfan in the testes of adult rat: histological and immunohistochemical studies
- Stability of human mesenchymal Stem cells during in vitro culture: considerations for cell therapy
- cell adhesion molecules in neural Stem cell and Stem cell-based therapy for neural disorders
- … for multiple myeloma relapsing after allogeneic hematopoietic Stem cell transplantation: a report from the French Society of Bone Marrow and cellular therapy
- Mesenchymal Stem cell therapy for equine tendinitis
- Human immature dental pulp Stem cells (hIDPSCs), their application to cell therapy and bioengineering: an analysis by syStematic revision of the last decade of …
- Impact of disease status and Stem cell source on the results of reduced intensity conditioning transplant for Hodgkin’s lymphoma: a retrospective study from …
- Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous Stem cell transplantation
- Maintenance therapy with immunomodulatory drugs after autologous Stem cell transplantation in patients with multiple myeloma: a meta-analysis of …
- Evaluating the effects of lenalidomide induction therapy on peripheral Stem cells collection in patients undergoing autologous Stem cell transplant for multiple …
- Risk‐stratified adoptive cellular therapy following allogeneic hematopoietic Stem cell transplantation for advanced chronic lymphocytic leukaemia
- Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic Stem cell transplantation
- Human pluripotent Stem cells for modelling human liver diseases and cell therapy
- … indications of clinical practice guideline for Stem cell–therapy in cardiovascular diseases: A stepwise appropriate use criteria for regeneration therapy
- Safeguarding Stem cell-based regenerative therapy against iatrogenic cancerogenesis: Transgenic expression of DNASE1, DNASE1L3, DNASE2, DFFB …
- Removing the cells from adult bone marrow derived Stem cell therapy does not eliminate cardioprotection
- Adipose derived Stem cell therapy in the treatment of canine degenerative joint disease secondary to conformational abnormalities
- Identification of hematopoietic Stem cell engraftment genes in gene therapy studies
- Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic Stem cell therapy
- Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
- Lenalidomide consolidation and maintenance therapy after autologous Stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis
- High-dose therapy followed by Stem cell transplantation in Hodgkin’s lymphoma: past and future
- < The> effect of Stem cell therapy versus melatonin on the changes induced by busulfan in the testes of adult rat: histological and immunohistochemicaI studies
- Discarded leukoreduction filters: a new source of Stem cells for research, cell engineering and therapy?
- Stem cell Bioprocessing: For cellular therapy, Diagnostics and Drug Development
- High-dose therapy with autologous Stem cell support for lymphoma in Norway 1987–2008
- therapy-related myeloid neoplasms after autologous hematopoietic Stem cell transplantation in lymphoma patients
- High-dose therapy with autologous Stem cell support for lymphoma–from experimental to standard treatment
- Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of …
- … ‐reported quality of life in long‐term survivors of childhood lymphoblastic malignancy treated with hematopoietic Stem cell transplantation versus conventional therapy
- Recombinant human brain natriuretic peptide therapy combined with bone mesenchymal Stem cell transplantation for treating heart failure in rats
- … effectiveness of early treatment with hyperbaric oxygen therapy for severe late‐onset hemorrhagic cystitis after hematopoietic Stem cell transplantation in pediatric …
- Epigenetic therapy in allogeneic hematopoietic Stem cell transplantation
- Prospects for Stem cell therapy in neuronal ceroid lipofuscinosis
- Peripheral blood Stem cell mobilization in multiple myeloma patients treat in the novel therapy‐era with plerixafor and G‐CSF has superior efficacy but significantly …
- The effect of imatinib therapy on the outcome of allogeneic Stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
- Neuroimaging for optimization of Stem cell therapy in Parkinson’s disease
- Stem cell therapy in Lysosomal Storage Diseases
- FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous Stem cell transplant for relapsed and refractory Hodgkin …
- Are we there yet? Navigating roadblocks to induced pluripotent Stem cell therapy translation
- Amniotic Stem cell transplantation therapy for type 1 diabetes: a case report
- 421: Isolation and expansion of rabbit amniotic fluid Stem cells (AFS) for in-vivo Stem cell therapy
- Oxymatrine could promote mesenchymal Stem cell therapy in hepatic fibrosis rats: An experimental research
- Hypoxic preconditioning of Stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction
- Stem cell therapy for Multiple Sclerosise.
- Stem cells and cell therapy: From basic sciences to clinical perspectives
- The hope and hype of Stem cell therapy
- Part I: the role of maintenance therapy in patients with multiple myeloma undergoing autologous hematopoietic Stem cell transplantation
- Stimuli-responsive HA-PEI nanoparticles encapsulating endostatin plasmid for Stem cell gene therapy
- Stem cell research and therapy: the position of the National Society of Genetic Counselors
- An Update on Retinal Stem cell therapy
- Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic Stem cell toxicity
- Maintenance therapy with dasatinib after allogeneic hematopoietic Stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
- Dasatinib maintenance therapy after allogeneic hematopoietic Stem cell transplantation for an isolated central nervous syStem blast crisis in chronic myelogenous …
- Stem cell therapy for tendinopathy: Lessons from a large animal model
- The role of large animal studies in cardiac regenerative therapy concise review of translational Stem cell research
- Stem cell therapy for severe heart failure
- Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic Stem cell transplantation: will it be possible to …
- Mesenchymal Stem cell therapy for Peripheral Vascular Diseases
- Salvage therapy with high-dose chemotherapy and peripheral blood Stem cell transplant in patients with primary mediastinal nonseminomatous germ cell …
- Autologous Stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk …
- New treatment for sepsis: Stem cell therapy
- The effect of mesenchymal Stem cell therapy on ischemia–reperfusion-induced injury of the rat pancreas: a histological and immunohistochemical study
- VEGF overexpression improves mesenchymal Stem cell sheet transplantation therapy for acute myocardial infarction
- The use of hypoxic cultured mesenchymal Stem cell for oncolytic virus therapy
- Efficacy of acute myeloid leukemia therapy without Stem–cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm
- The influence of cerebrospinal fluid on epidermal neural crest Stem cells may pave the path for cell-based therapy
- High-dose cyclophosphamide therapy associated with diffuse alveolar hemorrhage after allogeneic hematopoietic Stem cell transplantation
- High-dose chemotherapy with autologous Stem cell support as salvage therapy in recurrent gestational trophoblastic disease
- Recent patents on mesenchymal Stem cell mediated therapy in inflammatory diseases
- Stem cell therapy for Female Urinary Incontinence
- Stem cell therapy for ischemic heart disease
- therapy‐related P h+ leukemia after both bone marrow and mesenchymal Stem cell transplantation for hypophosphatasia
- Phase II study of the combination of MLN 9708 with lenalidomide as maintenance therapy post autologous Stem cell transplant in patients with multiple …
- Intensified therapy followed by autologous Stem‐cell transplantation (ASCT) versus conventional therapy as first‐line treatment of follicular lymphoma: A meta …
- … in advancing Stem–cell therapies. a white paper sponsored by: california institute for regenerative medicinealliance for regenerative medicine cell therapy …
- Evaluation of myeloablative therapy followed by autologous Stem cell transplantation in first remission in patients with advanced stage follicular lymphoma …
- Stem cell therapy OF MALIGNANT BRAIN TUMORS: REALITY AND PROSPECTS
- Rehabilitation medicine implications of Stem cell therapy in spinal cord injury-a review
- … the Pluripotent Fate of Human Embryonic Stem cells for Tissue Engineering and cell therapy–The Turning Point of cell-Based Regenerative Medicine
- … Stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy …
- cell therapy for diabetic neuropathy using adult Stem or progenitor cells
- Stem cell therapy for ischemic stroke using iPS cells
- Bone marrow derived mesenchymal Stem cell therapy to improve nerve regeneration and function in a rat limb transplant model (P2170)
- Bone marrow-derived clonal mesenchymal Stem cells as a source of cell therapy for promoting vocal fold wound healing
- Autologous peripheral blood Stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute …
- Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic Stem cell transplantation in acute myeloid …
- Stem cell‐Mediated Prodrug Gene therapy of High‐Grade Brain Tumors
- New insight of ischemic postconditioning on Stem cell therapy
- … over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic Stem cell transplantation as consolidation or salvage therapy
- … of adipose tissue derived mesenchymal Stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 …
- … , Placebo Controlled Trial of Intracoronary Stem cell Delivery Two to Three Weeks Following Acute Myocardial Infarction from the Cardiovascular cell therapy …
- Current Status of Stem cell therapy in Royan Institute.
- A novel nanotechnology based Stem cell therapy for diabetic wound healing
- Sickle cell Disease (SCD) and Stem cell therapy (SCT): Implications for Psychotherapy and Genetic Counselling in Africa
- Erratum: Cardiopoietic Stem cell therapy in heart failure: The C-CURE (Cardiopoietic Stem cell therapy in heart failURE) Multicenter randomized trial with lineage …
- Stem cell derived therapy for cutaneous radiation exposure
- Gene therapy and Stem cell therapy to Improve the Outcome of Human Islet Transplantation
- Cultured Limbal Epithelial Stem cell therapy for Ocular Surface Diseases
- Abstract P39: Adipose-derived Stem cell therapy to improve musculofascial healing in the irradiated abdominal wall
- A Randomized Study of Interferon α‐2b Versus No Treatment as Consolidation After High Dose therapy and Autologous Stem cell Transplantation for Patients With …
- E-015 Differential expression of cytokines in Mesenchymal Stem cells as a potential target for Endovascular Stem cell therapy
- Experimental research effects of intravenous human umbilical cord blood CD34+ Stem cell therapy versus levodopa
- Investigation of mesenchymal Stem cells and the development of experimental strategies for rescuing glaucomatous eyes using a Stem cell-based therapy
- Hematopoietic Stem cell gene therapy for Wiskott-Aldrich syndrome
- Ex vivo mesenchymal Stem cell therapy protects vascular networks from ischemia reperfusion injury
- Contrast ultrasound molecular imaging of the pro-angiogenic paracrine effects of Stem cell therapy in Limb Ischemia
- Stem cells and Stem cell therapy
- Hematopoietic Stem cell gene therapy for lysosomal storage disorders: expected benefits and limitations
- cell therapy AND Stem cell BIOLOGY
- … AND EFFICACY OF CARDIAC cell therapy: FIRST RESULTS OF THE MESS (META–ANALYSIS OF CARDIAC Stem cell STUDIES) DATABASE INCLUDING …
- Simulated microgravity based Stem cell cultures enhance their utility for cell-based therapy
- Mesenchymal Stem cells: new aspect in cell-based regenerative therapy
- Neural fate of mesenchymal Stem cells and neural crest Stem cells: which ways to get neurons for cell therapy purpose
- Music therapy for the hematopoietic Stem cell transplant patients
- … Stem cell collection and storage: impact of Joint Accreditation Committee International Society for cellular therapy Europe standards implementation on Stem …
- Characterization of microbubble-loaded Stem cells for targeted cell therapy
- Melatonin Treatment Improves Adipose-derived Mesenchymal Stem cell therapy for Acute Lung Ischemia-reperfusion Injury
- Adult mesenchymal Stem cells and their potency in the cell-based therapy
- Kaposi sarcoma after non-myeloablative hematopoietic Stem cell transplant: response to withdrawal of immunosuppressant therapy correlated with whole blood …
- Scopes and limitations in Stem cell therapy: IVRI experience
- The Summary of Stroke and Its Stem cell therapy
- Isolation and characterization of novel, highly proliferative human CD34/CD73-double-positive testis-derived Stem cells for cell therapy
- Mesenchymal Stem cell transplantation may provide a new therapy for ultrafiltration failure in chronic peritoneal dialysis
- Hypoxic preconditioning with cobalt of bone marrow mesenchymal Stem cells improves cell migration and enhances therapy for treatment of ischemic acute …
- A possible turning point in the hematopoietic Stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral …
- Perspectives of Stem cell therapy in Orthopaedics
- Stem cell therapy for Blood Cancer
- 259 INTRACAVERNOSAL Stem cell therapy COMBINED WITH ORAL TADALAFIL ADMINISTRATION PRESERVES ERECTILE FUNCTION AFTER …
- Stem cell therapy for Athletes
- Stem cell therapy: A dawn or dusk of hope
- Progress and Prospects in Stem cell therapy and Drug Discovery
- Molecular imaging in Stem cell therapy
- Stem cell therapy: From the Heart to the Periphery
- Neurological Diseases and Stem cell therapy
- Italy blocks controversial Stem cell therapy
- Embryonic Stem cell therapy–From Bench to Bed
- Human umbilical Stem cell: Its important and application in cell therapy
- Role of high-dose melphalan with autologous Stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
- Getting at the heart of the issue: advanced imaging and Stem cell-based therapy offer a novel approach to cardiac resynchronization
- Stem cell therapy for ischemic stroke
- Stem cells from Cord Blood, in Utero Stem cell Development and Transplantation-Inclusive Gene therapy
- EMERGING HURDLES IN Stem cell therapy FOR PERIPHERAL VASCULAR
- Stem cell therapy in Pediatric Endocrine Disorders
- Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic Stem cell transplantation
- … therapy in patients with HER2-positive metastatic breast cancer who underwent high-dose chemotherapy and autologous hematopoietic Stem cell …
- Pluripotent Stem cells for Cardiac cell therapy: The Application of cell Sheet Technology
- Multidisciplinary research of human pluripotent Stem cells for application to cell therapy and drug discovery
- Nitazoxanide is effective therapy for norovirus gastroenteritis after chemotherapy and hematopoietic Stem cell transplantation (HSCT)
- Stem cell therapy for Acute Kidney Injury
- VI. Autologous Stem cell transplantation and maintenance therapy.
- Efficacy of cyclosporine A-nanoparticles emulsion combined with Stem cell transplantation therapy for acute myocardial infarction
- Cardiomyopathy and cell therapy: ejection fraction improvement and cardiac muscle mass increasing, after a year of bone marrow Stem cells transplantation, by …
- Autologous hematopoietic Stem cell transplantation and maintenance therapy for multiple myeloma
- Development of mesenchymal Stem cell-based cell therapy
- High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample Stem cell harvest yields after multiple chemotherapy …
- The right to care and the expectations of society—controversial Stem cell therapy in Italy
- Chronic Liver Disease: Stem cell therapy
- Beyond islet transplantation in diabetes cell therapy: from embryonic Stem cells to transdifferentiation of adult cells
- Neural Stem cell therapy in the Ischemic Brain (P02. 022)
- Early cardiac retention of administered Stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy
- Effect of bortezomib-based induction therapy on the peripheral blood Stem cell harvest in multiple myeloma
- Progress in non-renal derived adult Stem cell therapy for kidney disease
- Optimizing Stem cell therapy for Cardiac Repair Following a Myocardial Infarction
- Isolation and purification of self-renewable human neural Stem cells for cell therapy in experimental model of ischemic stroke
- … response in myelofibrosis patients receiving undergoing treatment with conventional therapy, The Measures Trial and Allogeneic Stem cell Transplant, The Symptoms …
- Stem cell therapy Aided Liver Regeneration
- GW24-e2985 Stem cell therapy: a meta-analysis of randomised Controlled trials in chronic heart failure
- Recent advances in hematopoietic Stem cell gene therapy
- Mechanisms of bone mesenchymal Stem cell therapy for ischemic stroke
- Multipotent mesechymal Stem cell therapy for the treatment of chronic nonhealing wound in a dog
- Application of molecular imaging in Stem cell therapy for ischemic heart diseases
- Stem cell therapy for the treatment of radiation-induced normal tissue damage
- Muscle Stem cell therapy for the Treatment of DMD Associated Cardiomyopathy
- Blood-derived biomaterials: What role can they play in regenerative medicine and Stem cell therapy?
- Development and Clinical Application of Equine Stem cell therapy Products
- Alternative Future Therapies for Lysosomal Storage Diseases: Embryonic Stem cell-and Induced Pluripotent Stem cell therapy
- Maintenance therapy with decitabine after allogeneic hematopoietic Stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic …
- Stem cell therapy for chronic ulcerative wound in a dog
- Abstract TP401: Inflated Expectations about Stem cell therapy in Patients With Chronic Stroke
- Mesenchymal Stem cell therapy. A new direction in the canine osteoarthritis therapy.
- Evidence-Based Review of Adipose Stem cell therapy in Cancer Reconstruction
- Maintenance hypomethylating therapy post allogeneic Stem cell transplantation provides favorable progression free survival in high risk acute myelogenous leukemia …
- GW24-e2228 The role of CXCR4 on Stem cell therapy for atherosclerosis
- Satellite cell Subpopulations and Environmental Mediators of Their Function: Implications for Stem cell therapy in Skeletal Muscle
- Abstract WP104: Chemical Preconditioning Enhances the Effectiveness of Stem cell therapy in Ischemic Stroke
- Suppression of involved immunoglobulin free light chain post therapy and survival outcomes following autologous Stem cell transplantation for myeloma
- Early versus delayed autologous Stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for …
- Stem cell ENGINEERING AND therapy
- The application of super paramagnetic iron oxide-labeled mesenchymal Stem cells in cell-based therapy
- Stem cell therapy in the Philippines-how makati medical center is responding to the demands and challenges of global standards (on the road to the fact evaluation)
- Use of Novel Biomaterial Design and Stem cell therapy in Cutaneous Wound Healing
- Stem cell therapy: Boon or bane? A comprehensive study on the inadequacy of the DOH administrative order 2013-012 and FDA circular 2013-017, regulatory …
- Glial differentiation of human adipose-derived Stem cells: implications for cell-based transplantation therapy
- Adipose-derived Stem cell therapy for Lipopolysaccharideinduced Acute Lung Injury in Mice
- Stem cell therapy of osteoarthritis using stromal vascular fraction cells
- Stem cell therapy for equine tendon regenerative medicine.
- Stiffness Gradient Scaffolds as an In Vitro Model for Stem cell Based Cardiac cell therapy
- High-dose immunosuppressive therapy combined with cord blood infusion and non-myeloablative peripheral blood Stem cell transplantation for patients with …
- Informed target discovery for gene and Stem cell therapy in acute lung injury
- Stem cell as a Novel therapy for Diabetic Cardiomyopathy
- Assessment of cell delivery in cardiac Stem cell therapy using PET-MR imaging
- Allogeneic and autogolous Stem cell therapy combined with physical rehabilitation: A case report on a chronically injured man with quadriplegia
- Combination of Final Blood Products Improves The Efficacy of Autologous Bone Marrow Stem cell therapy.
- Stem cell therapy REMEDIATES MANDIBULAR VASCULOGENESIS FOLLOWING RADIATION AND DISTRACTION OSTEOGENESIS
- Improving the Contractile Performance of Human Pluripotent Stem cell-Derived Cardiomyocytes for Cardiac cell therapy
- In Situ Forming Smart Supramolecular Hydrogels for Long-term Bioengineered Stem cell therapy
- Successful treatment of inter digital chronic ulcerative wound by mesenchymal Stem cell therapy in a cow
- Adoptive Autologous Vascular Stem cell therapy for Diabetic Foot Patients
- Monitoring CMV-specific CD8+ T-cell responses after allogeneic Stem cell transplantation: a new way of guiding anti-viral therapy
- … of Myocardial Function is Associated With Improvement in Ejection Fraction in Patients Treated With Autologous Stem cell therapy for Ischemic Cardiomyopathy
- Isolation, characterization, and differentiaton of baboon adipose-derived Stem cells: A nonhuman primate model for human Stem cell therapy and regeneration
- Embryonic Stem cell-derived macrophages: a novel approach to developing anti-inflammatory macrophages for cell therapy
- 432: Mesenchymal Stem cell therapy of hypoxi/ischaemic brain damage
- Oxymatrine could promote mesenchymal Stem cell therapy in hepatic fibrosis rats: an experimental research
- Autologous cell-sheet Transplantation therapy for Treating Cardiomyopathy: A Phase I Clinical Trial of Novel Stem cell therapy
- < The> effect of mesenchymal Stem cell therapy on ischemia-reperfusion-induced injury of the rat pancreas: a histological and immunohistochemical study
- Cancer vaccine therapy using genetically modified induced pluripotent Stem cell-derived dendritic cells expressing the TAA gene
- … (NOGA) IS ASSOCIATED WITH EXERCISE IMPROVEMENT IN PATIENTS TREATED WITH AUTOLOGOUS Stem cell therapy FOR REFRACTORY ANGINA
- Primary Neural Stem cell Cultures from Adult Pig Brain and Their Nerve-Regenerating Properties: Novel Strategies for cell therapy
- 13 Pluripotent Stem cell therapy for Cardiac Regeneration
- Characterizing the Relationship Between Energy Metabolism and Mesenchymal Stem cell therapy in the Infarcted Heart
- 494 MESENCHYMAL Stem cell MEDIATED CANCER therapy INHIBITS TUMOR GROWTH IN THE TRANSGENIC ADENOCARCINOMA OF THE MOUSE …
- Huntington’s disease modeling and Stem cell therapy in spinal cord disorders and injury
- … in combination with intensive chemotherapy including allogeneic hematopoietic Stem cell transplantation followed by maintenance therapy in FLT3-ITD …
- Regenerative Stem cell therapy with Umbilical Cord Mesenchymal Stromal cells In Deaf Animal Model
- cell therapy and muscle regeneration: skeletal myogenic differentiation of urine-derived Stem cells for potential use in treatment of urinary incontinence
- Autologous Intracoronary Stem cell therapy is Safe and Feasible for Children With Dilated Cardiomyopathy: A Randomised Controlled Cross-Over Pilot Study
- APOBEC3G-Augmented Stem cell therapy to Modulate HIV Replication: A Computational Study
- Impact of induced therapy before allogeneic hematopoietic Stem–cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre
- Topical adipose-derived Stem cell therapy ameliorates radiation-induced delayed wound healing
- Sequential therapy combining clofarabine and HLA-haploidentical hematopoietic Stem cell transplantation in the treatment of refractory and advanced …
- High fat feeding enhances the ability of mesenchymal Stem cell therapy to modulate mitochondria in the infarcted heart
- Differential effect of mesenchymal Stem cell therapy on cardiac glucose utilization in the infarcted heart following chow and high fat feeding
- Regenerative Stem cell therapy with Umbilical Cord Mesenchymal Stromal cells in Deaf Animal Model
- Additional Benefit of Cyclosporine-Assisted Adipose-Derived Mesenchymal Stem cell therapy for Against Acute Kidney Ischemia-Reperfusion Injury
- Stem cell Engineering and therapy
- 470. Human Parthenogenetic Stem cell-Derived Hepatocytes for Liver Repopulation: cell therapy Demonstrated in a Pilot Study with Gunn Rats
- Stem cell‐Mediated TRAIL therapy for Highly Aggressive Brain Tumors
- Mesenchymal Stem cell therapy to promote peripheral tissue insulin sensitivity in the high‐fat fed, myocardial infarcted mouse
- Fibroblast feeder cells in human pluripotent Stem cell culture and retinal differentiation-progress toward clinical cell therapy
- Cardiac Stem cell therapy in Conjugation with Anti-inflammatory Small molecule enhances function of infarcted rat hearts.
- Safety of intra-articular cell–therapy with culture-expanded Stem cells in humans: a syStematic
- Immunoregulation and allogenicity in cardiac Stem cell regenerative therapy.
- Efficacy of Stem cell therapy in a Hind Limb Ischemia-Reperfusion Injury in a Murine Model: The Critical Role of Indoleamine 2, 3 Dioxygenase (IDO)
- Advanced Aesthetic Facial Rejuvenation: Sculptural Fat Restoration by Autologous Fat Transfer with Adipose-Derived Stem cell therapy
- Corrigendum to ‘Use of Octreotide for relief of gastro-intestinal (GI) symptoms in syStemic mastocytosis'[Hematology/Oncology and Stem cell therapy 6/2 (2013) 72 …
- Acquired Stem cell properties in therapy-induced senescence of lymphomas and acute leukemias in vitro and in vivo
- Aldehyde Dehydrogenase-2 Deficiency Attenuates Bone Marrow Mesenchymal Stem cell therapy for ischemia
- A second autologous Stem cell transplant (ASCT2) induces superior durability of response (DuR) following bortezomib-containing re-induction therapy for …
- … of an HIV-positive multiple myeloma patient with high-dose chemotherapy followed by autologous peripheral blood Stem cell transplantation and maintenance therapy …
- HMMR-redirected adoptive T cell therapy for treatment of refractory acute myeloid leukemia in context of mismatched Stem cell transplantation
- Engineered cell therapy With Embryonic Stem cell-Derived Cardiomyocytes Encapsulated in Injectable Nanomatrix Gel Enhanced Engraftment and Promoted …
- Three years of Stem cell Research & therapy
- Bone-marrow stroma: A source of mesenchymal Stem cells for cell therapy
- Stem cell and T-cell Gene therapy Using SIN-Lentiviral Vector In Type 3 Familial Hemophagocytic Lymphohistiocytosis
- cell therapy using Stem cells: trophic factor, differentiation, and cell transplantation
- Stem cell–based gene therapy
- Gene therapy and cell reprogramming in mouse models of monogenic hematopoietic Stem cell diseases
- Let-7 and CDK4-targeting siRNA in Herceptin-conjugated Liposome for Breast Cancer Stem cell therapy
- The Efficacy of Clinically Approved Agents with Stem cell‐Delivered Therapeutics for Cancer therapy
- Regeneration of the retina by Stem cell transplantation therapy
- Decitabine as induction therapy for median-to-high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) before allogeneic Stem cell …
- Medical management of limbal Stem cell deficiency with anti-inflammatory therapy and tear film optimization
- Advances in Lentiviral Vector-based cell therapy with Mesenchymal Stem cells
- Stem‐cell‐Based cell‐Replacement therapy in Parkinson’s Disease
- Stem cell Alchemy for cell-Based therapy
- Impact Of Response Duration and Maintenance therapy After Autologous Stem cell Transplantation On Long-Term Survival In Multiple Myeloma Patients
- Experimental evaluation of targeted alpha therapy for treatment of metastatic prostate cancer using A11. 1 anti-prostate Stem cell antigen minibody labeled with …
- A novel three-dimensional cell culture platform for proliferating Stem cells for cell therapy
- The potential of fetal cell therapy for osteogenesis imperfecta using placenta derived Stem cells
- Stem cell Models & therapy in Neurodegeneration
- Regenerative Medicine in the Central Nervous SyStem: Stem cell-Based cell-and Gene-therapy
- IN HEMATOPOIETIC Stem cell RECONSTITUTION therapy
- Research Highlights: Loaded cargo for Stem cell-directed therapy
- therapy Resistance in Prostate Cancer: A Stem cell Perspective
- High dose therapy and autologous Stem cell transplantation results in good outcomes and acceptable toxicities in elderly patients with non-Hodgkin’s lymphoma
- … -Rituximab Followed By Autologous Stem cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary therapy …
- Abstract WMP80: Enhancement Of Antioxidative Activity Facilitates Neural Stem cell Transplantation therapy For Hemorrhagic Stroke
- A Randomized Study Of Music therapy In Patients Undergoing Autologous Stem cell Transplant: Decrease In Narcotic Medication Use For Pain Control
- Isolation and characterization of a novel strain of mesenchymal Stem cells from mouse umbilical cord: potential application in cell-based therapy
- Prospect of Cancer Stem cell-targeting therapy
- MODULATION OF ER STRESS RESPONSES THROUGH AN IDO (INDOLEAMINE 2, 3 DIOXYGENASE) DEPENDENT Stem cell therapy IN A MURINE HIND …
- … extramedullary plasmacytomas (EMPs) included in a phase III pethema/GEM study of induction therapy prior autologous Stem cell transplantation (ASCT) in …
- … in neural Stem cells with oxygen–glucose deprivation–reoxygenation injury: A potential approach to enhance effectiveness of cell transplantation therapy
- Menstrual blood Stem cells as a potential source for cell therapy
- Cardiac Stem and progenitor cell therapy: ready for the future?
- Surveillance cultures in pediatric hematopoietic Stem cell transplantation: the possibility of early directed antimicrobial therapy for bloodstream infections with …
- Stem cell based Gene therapy for Pompe’s Disease
- Abstract C225: IL1RAP as functionally relevant target for Stem–cell directed therapy in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
- … -Deletion Accelerates FLT3-ITD Malignancies In Mice By Hypomethylation Of Enhancer Sites and Activating Stem cell Programs; Implications For therapy
- Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic Stem cell transplantation
- … , Bortezomib and Dexamethasone (CyBorD) In Patients With AL Amyloidosis and Potentially Reversible Contraindications To Autologous Stem cell …
- Sustained remission with allogeneic peripheral blood Stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic …
- Applications of induced pluripotent Stem cell in cancer therapy
- PTCL: Should Initial Management Include High-Dose therapy with Autologous Stem cell Rescue?
- Gene therapy and haematopoietic Stem cell transfer as a strategy to treat autoimmunity
- … lymphocyte infusion followed by pentostatin, cyclophosphamide and rituximab therapy is effective for relapsed chronic lymphocytic leukemia after allogeneic Stem cell …
- Isolation and Characterization of Placental Mesenchymal Stem cells for Autologous in Utero cell therapy
- Fungal infections in Stem cell transplantation: epidemiology and therapy
- … in Pediatric Haematopoietic Stem cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance therapy
- Improving Hematopoietic Stem cell Based Gene therapy By Targeting CD133+ cells
- Advances of Stem cell and PRP therapy in cartilage regeneration
- Current status and future prospects of Stem cell gene therapy for primary immunodeficiency
- … therapy, and new agents and Stem cell transplant in the older patient with recurrent diffuse large b-cell lymphoma/Salvage therapy, New Agents and Stem cell …
- MicroRNA Adjuvants in Stem cell‐Based Cancer therapy
- 662. Stem cell and T-cell Gene therapy Using SIN-Lentiviral Vector in Type 3 Familial Hematophagocytic Lymphohistocytosis: A Comparative Approach
- Stem cell-TGFb Combination therapy for Treatment of the Degenerative Intervertebral Disc: Can Stem cells Initiate a Healing Response on Their Own?
- X-Ray-Visible Transmyocardial Catheter-Based Microencapsulated Mesenchymal Stem cell Delivery for Cardiac Regenerative therapy
- Hematopoietic Stem and progenitor cell migration after hypofractionated radiation therapy in a murine model
- … tissue derived mesenchymal Stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 …
- Second Autologous Stem cell Transplant As Salvage therapy For Multiple Myeloma
- Effects of Stem cell transplantation and intravenous prostaglandin therapy in peripheral arterial disease of the elderly
- Smart Supramolecular Hydrogels for Long-term Bioengineered Stem cell Cancer therapy
- … . Evaluation of Engraftment and Tolerance Induction after Reduced Intensity Conditioning for Hematopoietic Stem cell Transplantation in the Rhesus Gene therapy …
- The potential of amniotic fluid Stem cells in prenatal gene and cell therapy
- Stem cell Gene therapy Blocks HIV Infection and Boosts Antiviral Immunity
- Comparison of magnetic intensities for mesenchymal Stem cell-targeting therapy on ischemic myocardial repair
- Novel Pathological Detection SyStem of Induced Pluripotent Stem cell-Derived Cardiomyocytes Using T-cell Receptor Gene Locus for cell Transplantation therapy
- Feasibility of Exercise therapy in Neutropenic Patients Undergoing Hematopoietic Stem cell Transplantation
- … Mice Provides High Yields Of Long-Term Repopulating cells With Enhanced Engrafting Capacity: Implications For Human Stem cell Gene therapy
- Abstract WMP41: Induced Pluripotent Stem cell Derived Neural Progenitor therapy for Treatment in a MCAO Ischemic Brain Injury Pig Model
- Sequential cytokine induced killer cells therapy for acute myeloid leukemia after autologous peripheral blood Stem cell transplantation
- Stem cell collection and transplant in myeloma patients following lenalidomide or bortezomib based induction therapy
- Immune Responses in Patients with Lysosomal Storage Disorders Treated with Enzyme Replacement therapy and Haemopoietic Stem cell Transplantation
- Development and characterization of CD133 positive cancer Stem cell targeted toxins for use in carcinoma therapy
- Adjuvant Stem cell-based therapy in acute retinal injury after sodium iodate administration in mice: Morphological and functional study
- … Globulin and Role Of Stem cell Source On Outcome In Myeloablative Conditioning Of Allogeneic Hematopoietic Stem cell Transplantation With Identical Sibling and …
- Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood Stem cell-derived dendritic cell (CB-DC) vaccination
- Regenerating an Immune SyStem: Gene therapy and Stem cell Transplantation for Severe Combined Immune Deficiency
- Immortalized human fetal bone marrow-derived mesenchymal Stem cell expressing anti-tumor suicide gene for anti-tumor therapy in vitro and in vivo
- Characterization and targeted therapy of Stem cell-like side population cells in pancreatic cancer and esophageal cancer
- Menstrual blood Stem cells as a potential substrate of cell therapy
- Use of Stem cell transplantation (SCT) as initial therapy in multiple myeloma (MM) and impact of sociodemographic factors in the era of novel agents: Analysis of …
- Risk Factors For Relapse In Children Undergoing Preemptive Immunomodulatory therapy After Allogeneic Hematopoietic Stem cell (HSCT) For Acute …
- 309. Integration Site Analysis in a Clinical Trial of Lentiviral Vector Based Hematopoietic Stem cell Gene therapy for Metachromatic Leukodystrophy. An 18 Months …
- Mesenchymal Stem cell based ex vivo gene therapy provides enhanced neuroprotection in X-linked retinoschisis mouse model
- Clinical observation of feasibility and efficacy of decitabine bridge therapy followed by allogeneic hematopoietic Stem cell transplantation in patients with …
- … of SL-401, a targeted therapy directed to the interleukin-3 receptor on cancer Stem cells and tumor bulk, in patients with blastic plasmacytoid dendritic cell …
- Delayed Hematopoietic Recovery After Autologous Stem cell Transplantation In Patients Receiving Arsenic Trioxide-Based therapy For Acute Promyelocytic …
- Hematopoietic Stem cell gene therapy for the multisyStemic lysosomal storage disorder cystinosis
- Effective Steroid Pulse therapy for mitigate the acute phase symptoms of Human herpesvirus 6 encephalitis after allogenic hematopoietic Stem cell transplantation …
- cell therapy Using Adult Stem cells in Osteonecrosis and Nonunion Fractures
- Enrichment Of Embryonal Stem cell Signature and Persistent Genomic Complexity In Residual Disease Following Pomalidomide therapy In Myeloma
- Alemtuzumab As therapy for Mixed Chimerism After Hematopoietic Stem cell Transplantation for Fanconi Anemia (FA)
- HLA Allele Matched Unrelated Donor Stem cell Transplant As First Line therapy for Children with Acquired Severe Aplastic Anemia
- … predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous Stem–cell transplantation (ASCT) in …
- … differentiation of human bone marrow mesenchymal Stem cell with adenovirus mediated glucose transporter-1 and hypoxia inducible factor-1α gene therapy
- Clofarabine Salvage therapy Prior To Allogeneic Hematopoietic Stem cell Transplantation In Patients With Relapsed Or Refractory AML–Results Of The …
- … dysphagia with autologous peripheral blood hematopoietic Stem cell transplantation in a patient with long standing dermatomyositis refractory to standard therapy
- Assessment of the Effect of Nilotinib (Tasigna) Maintenance therapy After Allogeneic Stem cell Transplantation in Patients with Advanced CML and Ph+ ALL On …
- Intranasal delivery of neural Stem cells: a CNS-specific, non-invasive cell-based therapy for experimental autoimmune encephalomyelitis
- Allogeneic and autologous Stem cell transplantation with busulfan, cyclophosphamide, and etoposide conditioning therapy for relapsed/refractory non …
- … Duration≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose therapy and Autologous Stem cell …
- Bam Regimen Followed By High-Dose therapy and Autologous Stem cell Transplantation As First-Line Treatment Of Primary Central Nervous SyStem …
- Clofarabine Salvage therapy Prior To Allogeneic Hematopoietic Stem cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia
- … therapy for cerebral multiple hemorrhagic infarctions due to septic embolism by Bacillus cereus after allogeneic hematopoietic Stem cell transplantation for acute …
- The potential of human adipose tissue derived mesenchymal Stem cells in cell therapy for retinal degenerative diseases
- New, pathogenesis‐based pharmacologic approaches to gastrointestinal ulcers: Gene therapy with egr‐1 & cell therapy with bone marrow‐derived Stem cells
- Second Generation Cardiac cell therapy: Combining Cardiac Stem cells and Circulating Angiogenic cells for the Treatment of Ischemic Heart Disease
- Autologous hematopoietic Stem/progenitor cell (HSPC) therapy for monogenic blood disorders: scalable, cGMP-compliant process for generating highly …
- Hair Follicle: A Novel Source of Stem cells for cell and Gene therapy
- cell transplantation therapy using pluripotent Stem cells
- Limbal Biopsy As a Source of Stem cells for Autologous Stromal cell-based therapy
- The potential of human adipose tissue derived mesenchymal Stem cells in cell therapy for retinal degenerative diseases
- Bioengineering and Stem cells for corneal endothelial cell therapy
- … glioblastoma, neural Stem and multipotent mesenchymal stromal cells of a human: from cataloguing of cell proteins to novel paradigm of proteome-based cell therapy …
- An investigation of initial retention of Stem/progenitor cells following intracoronary injection: implications to cell therapy for the treatment of heart failure
- … of Novel Ferromagnetic, Nanoprobes Coupled to Bone Marrow Derived Multipotential Mesenchymal Stromal/Stem cells for cell Tracking in Cardiac cell therapy
- Mesenchymal Stem cells from aspirated adipose tissue can assist in ex vivo expansion of melanocytes for cell therapy
- Myeloma Patient-Derived Mesenchymal Stem cells Grown In 3-D Culture Induce Primary Myeloma cell Proliferation and Resistance To therapy
- P6-06 Mesenchymal Stem cells as an ideal cell therapy tool for rheumatoid arthritis in combination with nano-fiber scaffold
- Mesenchymal Stem cells as targeted cell vehicles to deliver drug-loaded nanoparticles for cancer therapy
- … Activity of SL-401, a Targeted therapy Directed to the Interleukin-3 Receptor on Cancer Stem cells and Tumor Bulk, Against Blastic Plasmacytoid Dendritic cell …
- Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma Stem/progenitor cells in vitro
- Keeping an eye on Stem cells for studying disease modelling and cell-based therapy
- Minimal residual disease (MRD) status pre-and post-high-dose therapy/autologous Stem (HDC/ASCT) cell transplantation for multiple myeloma (MM) in the era of …
- … therapy of Contused Rat Spinal Cord with Glial cell Line-Derived Neurotrophic Factor (GDNF) and Motoneurons Transdifferentiated from Adipose-Derived Stem …
- Triple therapy using radiation therapy (RT), Temozolomide (TMZ), and TRAIL agonist (TRA-8) enhances cell killing in primary glioma cancer Stem cells associated with …
- xCT inhibition suppresses CD44v-positive Stem-like tumor cells, which are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.
- Stem cell therapy for osteoporosis
- Enhancing the efficacy of mesenchymal Stem cell therapy
- Alzheimer’s disease and Stem cell therapy
- Progress of mesenchymal Stem cell therapy for neural and retinal diseases
- SyStematic review: the effects of autologous Stem cell therapy for patients with liver disease
- Stem cell therapy for cardiac dysfunction
- … novel and effective strategy for the isolation of adipose-derived Stem cells: minimally manipulated adipose-derived Stem cells for more rapid and safe Stem cell therapy
- Advancing Stem cell therapy from bench to bedside: lessons from drug therapies
- A preliminary report on Stem cell therapy for neuropathic pain in humans
- Mesenchymal Stem cell therapy and acute graft-versus-host disease: a review
- Mesenchymal Stem cell therapy for cardiac repair
- Ovarian cancer Stem cells express ROR1, which can be targeted for anti–cancer-Stem–cell therapy
- Adult Stem cell therapy in chronic wound healing
- Stem cell therapy for heart failure
- Stem cell therapy: a look at current research, regulations, and remaining hurdles
- Interferon-gamma modification of mesenchymal Stem cells: implications of autologous and allogeneic mesenchymal Stem cell therapy in allotransplantation
- Stem cell therapy for neonatal brain injury
- The current state of Stem cell therapy for peripheral artery disease
- Cardiac Stem cell therapy for cardiac repair
- Recent advances of Stem cell therapy for retinitis pigmentosa
- Rationale of mesenchymal Stem cell therapy in kidney injury
- Stem cell therapy for neonatal hypoxic-ischemic encephalopathy
- Intravenous autologous bone marrow mononuclear Stem cell therapy for ischemic stroke: a multicentric, randomized trial
- From isolation to implantation: a concise review of mesenchymal Stem cell therapy in bone fracture repair
- Allogeneic adipose Stem cell therapy in acute myocardial infarction
- Immunopharmacological intervention for successful neural Stem cell therapy: New perspectives in CNS neurogenesis and repair
- Stem cell therapy for treatment of epilepsy
- Stem cell therapy and curcumin synergistically enhance recovery from spinal cord injury
- Allogeneic human mesenchymal Stem cell therapy (remeStemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in …
- Cancer Stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
- Stem cell therapy for intervertebral disk regeneration
- … administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem cell therapy in Patients Undergoing …
- Regenerative medicine for the heart: perspectives on Stem–cell therapy
- Regenerative medicine for the kidney: renotropic factors, renal Stem/progenitor cells, and Stem cell therapy
- Impact of enzyme replacement therapy and hematopoietic Stem cell therapy on growth in patients with Hunter syndrome
- Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a syStematic review
- Long‐term evaluation of mesenchymal Stem cell therapy in a feline model of chronic allergic asthma
- Stem cell therapy for central nerve syStem injuries: glial cells hold the key
- Targeted delivery of vascular endothelial growth factor improves Stem cell therapy in a rat myocardial infarction model
- Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal Stem cell therapy in cardiac ischemia treatment
- Governing Stem cell therapy in India: regulatory vacuum or jurisdictional ambiguity?
- A review of novel optical imaging strategies of the stroke pathology and Stem cell therapy in stroke
- Amide‐type local anesthetics and human mesenchymal Stem cells: clinical implications for Stem cell therapy
- Health consumers and Stem cell therapy innovation: markets, models and regulation
- Adipose tissue–derived Stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie’s disease
- ACL injuries and Stem cell therapy
- Optimized cell survival and seeding efficiency for craniofacial tissue engineering using clinical Stem cell therapy
- Application of Stem cell/growth factor syStem, as a multimodal therapy approach in regenerative medicine to improve cell therapy yields
- Rationale and prospects of mesenchymal Stem cell therapy for liver transplantation
- Stem cell therapy for bone repair: a syStematic review and meta‐analysis of preclinical studies with large animal models
- cell therapy with embryonic Stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair
- The promise and challenges of cardiac Stem cell therapy
- Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal Stem cell therapy
- Molecular mechanisms of Stem cell therapy in alcoholic liver disease
- Ethical issues in Stem cell research and therapy
- Immunological barriers to Stem cell therapy in the central nervous syStem
- Bone marrow-derived mesenchymal Stem cell therapy for decompensated liver cirrhosis: a meta-analysis
- Efficacy of topical mesenchymal Stem cell therapy in the treatment of experimental dry eye syndrome model
- Mesenchymal Stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources?
- Doubts over heart Stem–cell therapy: study queries early-phase trials of heart-disease treatment
- Potential for cell therapy in Parkinson’s disease using genetically programmed human embryonic Stem cell–derived neural progenitor cells
- Melatonin treatment further improves adipose‐derived mesenchymal Stem cell therapy for acute interstitial cystitis in rat
- Mesenchymal Stem cell therapy in type 1 diabetes mellitus and its main complications: from experimental findings to clinical practice
- Immunological basis of Stem cell therapy in liver diseases
- Mesenchymal Stem cell therapy for salivary gland dysfunction and xerostomia: a syStematic review of preclinical studies
- Inducible metabolic adaptation promotes mesenchymal Stem cell therapy for ischemia: a hypoxia-induced and glycogen-based energy prestorage strategy
- The effect of adipose Stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice
- Mesenchymal Stem cell-based therapy for type 1 diabetes
- Combining enriched environment and induced pluripotent Stem cell therapy results in improved cognitive and motor function following traumatic brain injury
- Mesenchymal Stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow–derived cells
- Mesenchymal Stem cell therapy promotes corneal allograft survival in rats by local and syStemic immunomodulation
- Mesenchymal Stem cell therapy in patients with small bowel transplantation: single center experience
- Comparison of the effect of Stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia
- The promises of Stem cells: Stem cell therapy for movement disorders
- The mesenchymal Stem cell–derived microvesicles enhance sciatic nerve regeneration in rat: A novel approach in peripheral nerve cell therapy
- Mesenchymal Stem cell therapy induces glucocorticoid synthesis in colonic mucosa and suppresses radiation-activated T cells: new insights into MSC …
- Histolgical and immunohistochemical study on the effect of Stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat
- Mesenchymal Stem cell therapy for immune‐modulation: the donor, the recipient, and the drugs in‐between
- Adipose Stem cell therapy in cancer reconstruction: a critical review
- Molecular imaging in Stem cell therapy for spinal cord injury
- Stem cell-based cell therapy for glomerulonephritis
- Stem cell therapy for ischemic stroke
- Stem cell therapy in cartilage repair—culture-free and cell culture–based methods
- Pluripotent Stem cells as a potential tool for disease modelling and cell therapy in diabetes
- Paracrine mechanisms of mesenchymal Stem cell-based therapy: current status and perspectives
- Novel chemically modified bacterial cellulose nanocomposite as potential biomaterial for Stem cell therapy applications
- Above all, do no harm’: safeguarding pluripotent Stem cell therapy against iatrogenic tumorigenesis
- Transplantation KCNMA 1 modified bone marrow‐mesenchymal Stem cell therapy for diabetes mellitus‐induced erectile dysfunction
- Novel approaches to lupus drug discovery using Stem cell therapy. Role of mesenchymal-Stem–cell-secreted factors
- Advances toward regenerative medicine in the central nervous syStem: challenges in making Stem cell therapy a viable clinical strategy
- The effect of bone marrow mononuclear Stem cell therapy on left ventricular function and myocardial perfusion
- Cardiac Stem cell therapy: review of the native cardiac progenitor cells and future direction
- Embryonic Stem cell therapy improves bone quality in a model of impaired fracture healing in the mouse; tracked temporally using in vivo micro-CT
- Autologous mesenchymal Stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study
- Stem cell therapy for the treatment of nonischemic cardiomyopathy: a syStematic review of the literature and meta-analysis of randomized controlled trials
- Stem cell therapy for the treatment of parasitic infections: is it far away?
- Mesenchymal Stem cell therapy for neurodegenerative diseases
- Intravenous mesenchymal Stem cell therapy after recurrent laryngeal nerve injury: a preliminary study
- Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review
- Mesenchymal Stem cell insights: prospects in cardiovascular therapy
- Testing Stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow Stem cells and Stem cell factor in mucosal regeneration
- Bone marrow Stem cell therapy for liver disease
- … cord derived mesenchymal Stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic Stem cell transplantation: a retrospective …
- Pluripotent Stem cell therapy in ischemic cardiovascular disease
- Autologous Stem cell transplantation in refractory Asherman’s syndrome: A novel cell based therapy
- Pathogenesis and Stem cell therapy for premature ovarian failure
- Concepts of Dhatu Siddhanta (theory of tissues formation and differentiation) and Rasayana; probable predecessor of Stem cell therapy
- Application of tissue engineering in Stem cell therapy
- Comparative study between intravenous and intraperitoneal Stem cell therapy in amiodarone induced lung injury in rat
- Stem cell therapy and breast cancer treatment: review of Stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer …
- Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications
- Fate of graft cells: what should be clarified for development of mesenchymal Stem cell therapy for ischemic stroke?
- Stem cell therapy: a new approach to the treatment of refractory depression
- Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington’s disease
- Making choices: health consumers, regulation and the global Stem cell therapy market
- Modification of radiation-induced oral mucositis (mouse) by adult Stem cell therapy: single-dose irradiation
- Current perspectives in Stem cell therapy for spinal cord repair in humans: a review of work from the past 10 years
- Current trends in Stem cell therapy for improvement of bone quality
- Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic cells: Implications in cell Reprogramming and Stem cell therapy
- Prompt Bone Marrow-Derived Mesenchymal Stem cell therapy Enables Early Porcine Heart Function Recovery From Acute Myocardial Infarction Evaluation Using …
- Echocardiographic evaluation of the effects of Stem cell therapy on perfusion and function in ischemic cardiomyopathy
- In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective Stem cell therapy for the failing heart
- Exploring a new therapy for diabetic polyneuropathy–the application of Stem cell transplantation
- cell therapy for kidney injury: different options and mechanisms-mesenchymal and amniotic fluid Stem cells
- Induced pluripotent Stem cell therapy ameliorates hyperoxia-augmented ventilator-induced lung injury through suppressing the Src pathway
- Stem cell–based biological pacemakers from proof of principle to therapy: a review
- Autologous hematopoietic Stem cell therapy in severe syStemic sclerosis: ready for clinical practice?
- Effects of Stem cell therapy on dilated cardiomyopathy
- Moving Stem cell therapy to patients with idiopathic pulmonary fibrosis.
- Stem cell–based therapy for neonatal lung disease: it is in the juice
- Experimental cell therapy: the search for the best Stem cell continues
- Regulation of heme oxygenase 1 expression by miR-27b with Stem cell therapy for liver regeneration in rats
- Mesenchymal Stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
- Role of mesenchymal Stem cell therapy in cisplatin induced nephrotoxicity in adult albino rats: ultrastructural & biochemical study
- Stem cell therapy for cerebral palsy–a novel option
- Role of serum levels of angiogenic cytokines in assessment of angiogenesis after Stem cell therapy of diabetic patients with critical limb ischemia
- Mesenchymal Stem cell based therapy for osteo‐diseases
- Stem cell therapy clears first hurdle in AMD
- Stem cells and cell therapy
- Lysosomal storage diseases: Stem cell-based cell-and gene-therapy.
- Current status and perspectives in Stem cell therapy for heart
- Introduction: Germline Stem cell therapy in humans: two are not enough
- Advances in Stem cell therapy for erectile dysfunction
- Advances in Stem–cell–generated transplantation therapy for Parkinson’s disease
- Quantification of corneal neovascularization after ex vivo limbal epithelial Stem cell therapy
- Leaked files slam Stem–cell therapy: disclosures and resignations reveal scientific concerns over methods of Italy’s stamina foundation
- Transforming the promise of pluripotent Stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials
- Stem cell-based therapy for treating limbal Stem cells deficiency: A review of different strategies
- Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal Stem cell therapy
- … -17Aneg regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal Stem cell–supported minimized immunosuppressive therapy
- Stem cell therapy as an option for pediatric surgical conditions
- Eculizumab therapy in children with severe hematopoietic Stem cell transplantation–associated thrombotic microangiopathy
- Kallikrein-kinin in Stem cell therapy
- Bone marrow Stem–cell therapy for genetic and chronic liver diseases
- The developing role of Neuregulin1 in cardiac regenerative Stem cell therapy
- Inactive GSK3β is disturbed in the spinal cord during experimental autoimmune encephalomyelitis, but rescued by Stem cell therapy
- Expanding the pool of Stem cell therapy for lung growth and repair
- In utero Stem cell and gene therapy: current status and future perspectives
- Allogeneic mesenchymal Stem cell transplantation for lupus nephritis patients refractory to conventional therapy
- Human adipose-derived Stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy
- Human embryonic Stem cell derived-mesenchymal Stem cells: an alternative mesenchymal Stem cell source for regenerative medicine therapy
- … dose chemotherapy plus autologous Stem–cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous Stem–cell …
- Stem cell based gene therapy in prostate cancer
- Additional benefit of combined therapy with melatonin and apoptotic adipose‐derived mesenchymal Stem cell against sepsis‐induced kidney injury
- Stem cell therapy for heart disease: truly beneficial?
- Cost‐effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic Stem cell transplantation
- Back to the future! The evolving role of maintenance therapy after hematopoietic Stem cell transplantation
- Neural Stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy
- … characteristics of amniotic membrane, endometrium and ovarian derived mesenchymal Stem cells: a role for amniotic membrane in Stem cell therapy
- The promising potential of menstrual Stem cells for antenatal diagnosis and cell therapy
- Adult Stem cell as new advanced therapy for experimental neuropathic pain treatment
- Induction therapy with bortezomib and dexamethasone followed by autologous Stem cell transplantation versus autologous Stem cell transplantation alone in …
- Critical appraisal of Stem cell therapy in peripheral arterial disease: Do current scientific breakthroughs offer true promise or false hope?
- The metabolically-modulated Stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy
- Gene therapy in patient-specific Stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects
- The colon cancer Stem cell microenvironment holds keys to future cancer therapy
- Effect of microenvironment modulation on Stem cell therapy for spinal cord injury pain
- Favorable outcomes in elderly patients undergoing high-dose therapy and autologous Stem cell transplantation for non-Hodgkin lymphoma
- Mesenchymal Stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)
- Skin engineering and keratinocyte Stem cell therapy
- Advances in Stem cell therapy: specific applications in the treatment of cutaneous radiation syndrome
- Novel approaches and mechanisms in hematopoietic Stem cell gene therapy
- Stem cell therapy for GI neuromuscular disorders
- Evaluation of mesenchymal Stem cell migration after equine tendonitis therapy
- Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal Stem cell therapy in the infarcted heart
- Mesenchymal Stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts
- Response of primary glioblastoma cells to therapy is patient specific and independent of cancer Stem cell phenotype
- Potential application of temozolomide in mesenchymal Stem cell‐based TRAIL gene therapy against malignant glioma
- Stem cell therapy for organ failure
- Application of nanoscaffolds in mesenchymal Stem cell-based therapy
- Stem cell-based therapy for newborn lung and brain injury: feasible, safe, and the next therapeutic breakthrough?
- Translational Opportunities in Stem cell–based Endodontic therapy: Where Are We and What Are We Missing?
- Amniotic fluid Stem cell therapy for lung disease
- Isolation and characterization of swine MIAMI cells: a valuable animal model for adult Stem cell therapy
- Ewing’s sarcoma cancer Stem cell targeted therapy
- From Flavr Savr tomatoes to Stem cell therapy: young people’s understandings of gene technology, 15 years on
- Potential and limitation of HLA-based banking of human pluripotent Stem cells for cell therapy
- Stem cell therapy: how to do it right
- “Footprint-free” human induced pluripotent Stem cell-derived astrocytes for in vivo cell-based therapy
- … and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent Stem cell-based gene therapy
- Improvement of cardiac Stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional …
- Phase 2 trial of intravenously administered plerixafor for Stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy
- Mesenchymal stromal (Stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis
- High-dose therapy and autologous Stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis
- Aging as an essential modifier for the efficacy in mesenchymal Stem cell therapy through an inositol phosphate 6 kinase-inositol pyrophosphate 7-dependent …
- Reply: mesenchymal stromal (Stem) cell therapy: an emerging immunomodulatory strategy for the adjunctive treatment of sepsis
- Hematopoietic Stem cell gene therapy: progress on the clinical front
- Mild hypothermia combined with neural Stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy
- Autologous Stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution
- Rituximab maintenance therapy after autologous Stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma
- Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic Stem cell transplantation
- Generation of osteoporosis in immune-compromised mice for Stem cell therapy
- Clinical utilization of cord blood over human health: experience of Stem cell transplantation and cell therapy using cord blood in Korea
- The role of N-acetyltransferase 8 in mesenchymal Stem cell-based therapy for liver ischemia/reperfusion injury in rats
- Effects of intravenous human umbilical cord blood mesenchymal Stem cell therapy versus gabapentin in pentylenetetrazole-induced chronic epilepsy in rats
- Granulocyte colony-stimulating factor therapy for Stem cell mobilization following anterior wall myocardial infarction: the CAPITAL Stem MI randomized trial
- Establishment of endogenous human tympanic membrane-derived somatic Stem cells for Stem cell therapy
- Lentiviral hematopoietic Stem cell gene therapy in inherited metabolic disorders
- Stem cell therapy for necrotizing enterocolitis: innovative techniques and procedures for pediatric translational research
- The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic Stem cell transplant in asymptomatic children with sickle cell …
- Integrin β3 links therapy resistance and cancer Stem cell properties
- Mesenchymal Stem cell therapy in multiple sclerosis: An updated review of the current clinical trials
- … of unmanipulated haploidentical hematopoietic Stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with …
- Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent Stem cell-based myocardial therapy
- Caudal superficial epigastric axial pattern flap and Stem cell therapy for the management of large wound on medial aspect of thigh in a dog
- Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal Stem cell deficiency in rabbits
- Induced pluripotent Stem cell-derived neural Stem cells transduced with baculovirus encoding CD40 ligand for immunogene therapy in mouse models of breast cancer
- Autologous hematopoietic Stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term …
- Stem cell therapy: future of pain medicine
- Music therapy for patients who have undergone hematopoietic Stem cell transplant
- Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic Stem cell transplant recipients with …
- Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic Stem cell transplantation
- … Stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and cellular therapy
- Willingness of a convenience sample of horse owners to use Stem cell therapy for the treatment of equine tendon injury and factors that influence this decision
- Normalization of wound healing and Stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells
- Post-autologous (ASCT) Stem cell transplant therapy in multiple myeloma
- Allogeneic Stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update
- Stem cell therapy: the ethical issues
- … consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with Stem cell transplantation in poor-risk patients with diffuse large B cell …
- cell delivery routes for cardiac Stem cell therapy
- … in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic Stem cell transplantation at early age
- Mesenchymal Stem cell therapy for acute radiation syndrome: Innovative medical approaches in military medicine
- Immunomodulatory nature and site specific affinity of mesenchymal Stem cells: a hope in cell therapy
- Reflection of Stem cell therapy: an epilogue to the’Stem cells and the lung’review series
- Stem cell and gene therapy for cardiac regeneration
- Preconditioned Stem cells: a promising strategy for cell-based ischemic stroke therapy
- Successful autologous haemopoietic Stem cell transplantation in severe, therapy-resistant childhood-onset Crohn’s disease. Report on the first case in Hungary
- Cardiac Stem cell therapy: Checkered past, promising future?
- Psychosocial changes associated with participation in art therapy interventions for siblings of pediatric hematopoietic Stem cell transplant patients
- Stem cell therapy for spinal cord injury: cellular options
- Stem cell therapy: differentiation potential of insulin producing cells from human adipose derived Stem cells and umbilical cord MSCs
- Incidence of ventricular arrhythmias after Stem cell therapy in patients with Chagas cardiomyopathy
- Stem cell therapy in Cardiovascular Diseases:: The Reparative Mechanisms of Mesenchymal Stem cells for Myocardial Infarction Treatment
- Addressing the heart failure epidemic: from mechanical circulatory support to Stem cell therapy
- Cancer Stem-like cell: a novel target for nasopharyngeal carcinoma therapy
- cell therapy for Liver Disease: From Hepatocytes to Stem cells
- Recent advances in cardiac Stem cell therapy to restore left ventricular function
- cell games: clinical use of Stem cell therapy is starting to outpace the evidence
- Mesenchymal Stem cell-based developmental endothelial locus-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice
- Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural Stem cell-based cancer therapy
- Azacitidine in the treatment of pediatric therapy-related myelodysplastic syndrome after allogeneic hematopoietic Stem cell transplantation
- Intravenous autologous bone marrow mononuclear Stem cell therapy for ischemic stroke
- The Sources of Microbial Contamination of Stem cells for Application in cell therapy
- Busulfan and melphalan as consolidation therapy with autologous peripheral blood Stem cell transplantation following Children’s Oncology Group (COG) induction …
- Stem cell transplantation as rescue therapy for refractory Crohn’s disease: a sytematic review.
- Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem cell Gene therapy by Studies in the Hbbth-3 Mouse Model
- Human Neural Stem cell-Based cell-and Gene-therapy for Neurological Diseases
- Interim safety analysis: a phase I trial of high dose therapy and autologous Stem cell transplantation followed by infusion of chimeric antigen receptor modified …
- The potential of Stem cell-based therapy for retinal repair
- Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic Stem cell gene therapy model
- Impurity of Stem cell graft by murine embryonic fibroblasts–implications for cell-based therapy of the central nervous syStem
- TRAIL based therapy: Overview of mesenchymal Stem cell based delivery and miRNA controlled expression of TRAIL
- Serial brain SPECT imaging in monitoring treatment response to Stem cell therapy in cerebral palsy patients
- In Pursuit of Porcine Pluripotent Stem cells for Autologous cell therapy
- T cell–depleted related HLA-mismatched peripheral blood Stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor …
- Human transgene-free amniotic-fluid-derived induced pluripotent Stem cells for autologous cell therapy
- The human desmin promoter drives robust gene expression for skeletal muscle Stem cell-mediated gene therapy
- Investigating mesenchymal Stem cell therapy for ischemic repair
- ATP-binding cassette (ABC) transporters as emerging targets in modulation of neural Stem cells behavior in neurodegenerative diseases and cell therapy benefits
- A Novel In Vitro Method for Detecting Undifferentiated Human Pluripotent Stem cells as Impurities in cell therapy Products Using a Highly Efficient Culture …
- Distribution of mesenchymal Stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy
- Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to Stem cell transplant in relapsed and refractory acute leukemia
- Marked and rapid regression of hepatic amyloid deposition in a patient with syStemic light chain (AL) amyloidosis after high-dose melphalan therapy with Stem cell …
- Using Defined Neural cell Populations as a Possible Solution for Challenges in Neural Stem cell therapy
- Cancer therapy targeting cancer Stem cell
- Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous Stem–cell transplantation in patients with newly diagnosed …
- Front-line high dose therapy with following autologous Stem cell transplantation (ASCT) for follicular lymphoma patients
- Age-associated alterations of pleiotropic Stem cell and the therapeutic implication of Stem cell therapy in aging
- Heparan sulfate: a Stem cell therapy target?
- … into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous Stem cell transplantation for multiple …
- Allogeneic mesenchymal Stem cell therapy for knee osteoarthritis: safety and efficacy results of a randomized, double blind, phase 2, placebo controlled, dose finding …
- Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous Stem cell transplantation …
- To the novel paradigm of proteome-based cell therapy of tumors: Through comparative proteome mapping of tumor Stem cells and tissue-specific Stem cells of humans
- Pluripotent Stem cells on cell therapy
- Gene therapy delivery of myelin oligodendrocyte glycoprotein (MOG) via hematopoietic Stem cell transfer induces MOG-specific B cell deletion
- Gene-modified cells for Stem cell transplantation and cancer therapy
- Urine-derived Stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine
- Perspective of Stem cell research & therapy in diabetes
- Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous Stem cell transplantation for symptomatic multiple …
- Stem cell therapy to promote sensory and motor nerve function recovery in a limb transplant model (TRAN3P. 863)
- … and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic Stem cell transplantation: a single-center …
- Stem cell therapy Perspectives
- Development of Stem cell therapy for Medical Uses
- High-dose idarubicin plus busulfan as conditioning regimen to autologous Stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in …
- Stem cells for cell replacement therapy: a therapeutic strategy for HD?
- Cognitive change and neuroimaging following immunoablative therapy and hematopoietic Stem cell transplantation in multiple sclerosis: a pilot study
- Stem cell therapy-A Review
- … -PACE utilization in multiple myeloma patients treated at MSKCC for relapsed disease or cytoreduction and Stem cell mobilization after initial induction therapy
- Regulatory T-cells Support Stem cell therapy in Safe Minimization of Immunosuppression in Living Donor Renal Transplantation-Initial Single Centre Experience …
- Loss of donor chimerism in remission after allogeneic Stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy
- Total ischemic time as an independent predictor of response to Stem cell therapy in patients with ST segment elevation myocardial infarction
- P77: cell therapy approaches to enhancing neuro-regeneration after spinal cord injury: generation neural Stem cells from neurosphere-derived adipose Stem cells …
- Gene and Stem cell therapy
- Presence of osteoclast precursor cells during ex vivo expansion of bone marrow-derived mesenchymal Stem cells for autologous use in cell therapy
- Erratum to: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal Stem cell therapy
- Individualized Stem cell therapy
- Stem cells So far! Stem cell therapy Facts and Principles
- Lentiviral hematopoietic Stem cell gene therapy in patients with wiskott-Aldrich syndrome
- Rituximab maintenance therapy after autologous Stem cell transplantation improves survival of patients with mantle cell lymphoma
- Assessing the effectiveness of Gelclair® in the prevention and therapy of stomatitis in patients undergoing hematopoietic Stem–cell transplantation: A randomized trial
- Fetal-cell revival for Parkinson’s: moratorium on controversial therapy lifted as Stem cells emerge as alternative source of treatment
- Intravitreal Autologous Bone Marrow CD34+ Stem cell therapy for Macular Degenerative Disease–A Pilot Clinical Trial
- Stem cell therapy and heart failure: hopes and disappointments
- Stem cell and Gene therapy in Cardiology.
- Thalidomide, cyclophosphamide and dexamethasone induction therapy: feasibility for myeloma patients destined for autologous Stem cell transplantation
- Vascular Stem cell therapy
- Stem cell therapy of the eye
- High-dose therapy and autologous hematopoietic Stem cell transplant in T-cell lymphoma: a single center experience
- The application of Stem cell therapy in cardiovascular diseases
- Stem cell-Based therapy (cell therapy) in Iran and other Countries
- New Advanced Technologies in Stem cell therapy
- AB08. Stem cell therapy in urology
- Hematopoietic Stem cell based therapy of immunosuppressive viral infection—Numerical simulations
- … -thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous Stem cell transplantation in multiple …
- Combination cell therapy using mesenchymal Stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation …
- Stem cell-Based therapy (cell therapy) in Iran and other Countries
- Stem cell-based therapy (cell therapy) in Iran and other countries
- Effects of Stem cell therapy on dilated cardiomyopathy
- H2S preconditioning of human adipose tissue-derived Stem cells increases their efficacy in an in vitro model of cell therapy for simulated ischemia
- Animal Models for Stem cell therapy
- Stem cell therapy for Diabetes Comes of Age
- Stem cell therapy-challenges from bench to bedside
- NHMRC Warning on unjustified claims relating to Stem cell therapy
- … affecting outcome of allogeneic Stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy
- Stem cell therapy and autism: A case study
- Strategies to Improve Homing of Stem cells to achieve better Efficacy in Stem cell therapy
- Immunnogenic aspects of Stem cell therapy in regenerative medicine
- Strategies to Improve Homing of Stem cells to achieve better Efficacy in Stem cell therapy
- Stem cell therapy for multiple sclerosis
- Can pluripotent Stem cells be used in cell-based therapy?
- Stem cell therapy: The Ultimate Cure
- Advances in Cancer Stem cell therapy: Targets and Treatments
- The role of Stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies
- Stem cell therapy for erectile dysfunction
- Stem cell therapy for preterm infants
- Stem cell therapy–A Root for Dentistry
- Stem cell therapy for Spinal Cord Injuries
- Manipulating PHD2 to Promote Efficacy of Stem cell therapy for Myocardial Infarction
- Bioprocessing of Human Pluripotent Stem cells for cell therapy Applications
- Clinical trials of Stem cell therapy for ischemic stroke: a mini-review
- Stem cell therapy for heart disease: too good to be true?
- Biological characteristics of human-urine-derived Stem cells: potential for cell-based therapy in neurology
- Stem cell therapy for neurodegenerative diseases: mind the gap
- Stem cell therapy for Neurological Disorders: From Bench to Bedside
- Stem cell therapy in Hypoxic Ischemic Encephalopathy
- Stem cell therapy for Veterinary Orthopedic Lesions
- Mesenchymal Stem cell therapy for the treatment of myocardial infarction
- Treatment of liver disease using placental Stem cells: feasibility of placental Stem cells in liver diseases: potential implication of new cell therapy-based strategies for …
- Myeloblative therapy with autologous haematopoietic Stem cell support as consolidation of first remission in acute myeloid leukaemia-very long follow-up.
- Effects of sex hormones on Stem cells and Stem cell therapy for liver fibrosis
- Features of transfusion therapy in patients undergoing hematopoietic Stem cell transplantation. Review of the literature
- Towards Mesenchymal Stem cell therapy in Kidney Transplant Recipients
- Italian doctors behind an unproved Stem cell therapy face prosecution
- Stem cell therapy as a treatment for Ischemic stroke
- Stem cell therapy as a treatment for ischemic stroke
- ENGINEERING THREE DIMENSIONAL CULTURE PLATFORMS FOR HUMAN ADIPOSE DERIVED Stem cell therapy
- Stem cell therapy in Premature Ovarian Failure
- Failure of intensified induction therapy and inability to undergo Stem cell transplantation predict dismal outcomes in relapsed/refractory MYC+ B-cell …
- Using Stem cell therapy to Enhance Diabetic Wound Healing
- Stem cell therapy for Acute and Chronic Liver Failure
- Craniofacial Stem cell therapy: New light at the end of the tunnel
- NEWS FROM THE JOINT MEETING OF ACTRIMS/ECTRIMS: Stem cell therapy in MS Looks Safe; Test of Efficacy Awaits Future Trials
- Early Consolidation with High Dose therapy and Autologous Stem cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3) …
- Impact of radiation therapy on Stem cell harvest in multiple myeloma
- Stem cell therapy for obstructive nephropathy: current situation and problems
- Long-Term Results of Stem cell therapy in Non-Reconstructable Critical Limb Ischemia
- Recent advances in Stem cell therapy for myelodysplastic syndromes
- Targeted mesenchymal Stem cell therapy for chronic obstructive pulmonary disease
- Supramolecular Hyaluronate Hydrogels for Bioengineered Stem cell therapy
- Molecular characterization of human mesenchymal Stem cell differentiation to identify biomarkers for quality assurance in Stem cell therapy
- Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic Stem cell transplantation in myeloma patients with solitary kidney: a case series
- High Dose therapy with Autologous Stem cell Transplantation (HDT/ASCT) Support in Follicular Lymphoma (FL) a Very Long Follow-up Analysis of 640 …
- Stem cell therapy and regenerative biology: Implication on success of ocular regeneration Virendra S Sangwan, Vivek Singh 2, Sachin Shukla 2, Dilip
- Stem cell therapy in animal models of central nervous syStem (CNS) diseases: therapeutic role, challenges and perspectives
- Adoptive lymphocyte (Stem cell) therapy in cancer
- From mesenchymal Stem cell therapy to discovery of drug therapy for syStemic sclerosis
- PNUH Experience of Stem cell therapy for Airway Allergic Diseases in Animal Model
- Repeated intranasal application of neural Stem cell-mediated enzym/prodrug therapy using a novel hsv-thymidine kinase variant improves therapeutic efficiency in an …
- Stem cell therapy for Cardiac Tissue Regeneration Post-myocardial Infarction
- … response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous Stem cell transplantation: phase II …
- Smart Supramolecular Hydrogels for Long-term Bioengineered Stem cell therapy
- Physical therapy during the hemopoietic Stem cell transplant process to improve quality of life
- Nanotechnology for improvement of Stem cell therapy of laser damaged retina in an animal model
- Stem cell therapy and Curcumin Synergistically Enhance Recovery from Spinal
- Hepatic cell proliferation and outcome in alcoholic hepatitis: histology, gene expression and effect of Stem cell therapy.
- Clinical Gene and Stem cell therapy in Patients with Acute and Chronic Myocardial Ischemia
- High dose therapy and autologous Stem cell transplantation in marginal zone lymphoma: an EBMT-FIL-gimeto retrospective study
- Application of Stem cell therapy for dilated cardiomyopathy: a syStematic review and meta-analysis of randomized controlled trials
- first generation Stem cell therapy for ischemic heart disease: a review, a meta-analysis and future prospectives
- The Stem cell therapy to Prevent Expansion of Abdominal Aortic Aneurysm (STOP-AAA) Trial: Rationale and Design
- Preclinical Validation of Multilevel Intraspinal Stem cell therapy for Amyotrophic Lateral Sclerosis (ALS)
- … -e0810 Intravenous ferumoxytol before mesenchymal Stem cell harvest: a new method for tracking Stem cell with MR imaging in cell therapy for myocardial infarction
- Stem cell therapy for Healing Wounded Skin and Soft Tissues
- Optimizing Performance of Endogenous Neural Stem cell therapy for Ischemic Stroke: A Neuroinformatics and Neuroimaging Approach to Translational Medicine
- Inducible Metabolic Adaptation Promotes Mesenchymal Stem cell therapy for Ischemia
- … , cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous Stem cell transplantation results in …
- Antibiotic Prophylaxis therapy for Pediatric Patients Undergoing Hematopoietic Stem cell Transplant (HSCT): A Tale of 2 Centers
- The use of Stem cell therapy in the treatment of bone marrow aplasia improves blood biochemical parameters in a dog
- T-cell therapy for viral infections after hematopoietic Stem cell transplantation in the 55th ASH annual meeting
- Engineering cardiomyocytes from diverse human pluripotent Stem cell lines for cardiac cell therapy with optimized cell yield and efficiency
- Autologous adipose-derived Stem cell therapy improves pain and improves function in patients with osteoarthritis
- Mesenchymal Stem cell therapy to Promote Sensory and Motor Nerve Function in a Limb Transplant Model.: Abstract# C1574
- Autologous bone marrow derived Stem cell therapy in traumatic spinal cord injury: A case report and review of literature
- Stem cell-based therapy in orthopaedics and trauma surgery-current concepts
- Optimising Stem cell therapy for liver disease through modulation of sphingosine 1-phosphate signalling
- Editorial (Thematic Issue: Unlocking the Potential of Stem cells in cell therapy, Drug Delivery and Drug Discovery)
- Neuro-regenerative effect of autologous mesenchymal Stem cell therapy in cerebral palsy patients: pilot clinical trial
- PP-348 Adipose Tissue Derived Stem cell therapy for Diabetic Foot
- Adipose tissue derived stromal Stem cell therapy in murine ConA-derived hepatitis is dependent on myeloidlineage and CD4+ T-cell suppression
- Role of bone marrow-derived Stem cell therapy in treatment of experimentally induced type 1 diabetes mellitus in canine model
- Glycan-based biomarkers for the quality assurance in Stem cell therapy: cell surface N-glycosylation of human Stem cells and its changes during the process of …
- Investigating reorganization of the motor cortices following Stem cell therapy in a non-human primate model of cortical ischemia
- Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and Stem cell therapy as a novel therapeutic …
- Human embryonic Stem cell-derived mesenchymal Stem cells as a therapy for spinal cord injury
- Designing a Fibrin Scaffold for Lung Resident Mesenchymal Stem cell therapy in Emphysema Patients
- Mesenchymal Stem cell-based cancer gene therapy: Application and unresolved problems
- Vascular Stem cell therapy of the diabetic retina with COMP-Ang1 and endothelial progenitor cells
- Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous Stem cell …
- A New Horizon in Facial Plastic Surgery: Skin Tissue-Engineering and Stem cell therapy—Reality or Dream?
- The Efficacy and Safety of Mesenchymal Stem cell therapy in Chronic Antibody-Mediated Rejection After Kidney Transplantation.: Abstract# C1578
- Reduced-intensity allogeneic Stem cell transplantation for co-emergence of chemotherapy-refractory follicular lymphoma and therapy-related myelodysplastic …
- Adipose-derived mesenchymal Stem cell therapy for radiation-induced vascular injury in small intestine of rat
- Stem cell transplantation as rescue therapy for refractory Crohn’s disease: a sytematic review
- Expression of concern: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal Stem cell therapy
- Ex Vivo Primed Mesenchymal Stem cell therapy Prevents Endothelial Failure and Enhances Allograft Perfusion
- Different artificial bones combined with bone marrow mesenchymal Stem cell therapy for early osteonecrosis of the femoral head: controversy and progress
- … : Diminishing impairments in glucose uptake, mitochondrial content, and ADP-stimulated oxygen flux by mesenchymal Stem cell therapy in the infarcted heart
- Improvement of dopamine transporter binding after bone marrow mesenchymal Stem cell therapy in a rat model of Parkinson’s disease: Small animal PET studies with …
- A Canadian cost impact analysis comparing maintenance therapy with bortezomib versus lenalidomide in multiple myeloma patients ineligible for Stem cell transplant
- … after Allogeneic Stem cell Transplantation for Myelodysplastic Syndromes: A Study from the French Society of Bone Marrow Transplantation and cell therapy (SFGM …
- The use of mesenchymal Stem cells in therapy of steroid-resistance chronic refractory graft-versus-host disease after hematopoietic Stem cell transplantation
- Effect of temperature sensitive umbilical cord mesenchymal Stem cell therapy combined with mild hypothermia on cognitive function in rats of severe traumatic brain …
- Microbubble spectroscopy of microbubble-loaded Stem cells for targeted cell therapy
- … with newly diagnosed myeloma: a phase 2 trial assessing the impact of Minimal Residual Disease (MRD) in patients with deferred autologous Stem cell …
- 1844707 Ultrasound for Evaluation of Adipose Stem cell therapy for End-Stage Unresectable Peripheral Arterial Disease: Case Studies Elizabeth Turner,* Arturo …
- Application of allogenic Stem cells in the treatment of tendon injuries: clinical case reports of cell therapy in horses
- Mesenchymal Stem cell based therapy for osteo-diseases
- IS-051 Neural Embryonic Stem/isps cell therapy
- Potential therapy of intravenous neural Stem cell transplantation for psychiatric disorder–a strategy for facilitation of neural network and behavioral recovery
- Efficacy and side effects of maintenance therapy with thalidomide following Stem cell transplantation in patients with multiple myeloma
- … : Long-Term Survival and Impact of Donor Availability–Clofarabine Salvage therapy Prior to Allogeneic Hematopoietic Stem cell Transplantation in Patients …
- Oral valganciclovir as preemptive therapy for cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing High Dose therapy Followed By Autologous Stem cell …
- … REGULATES TUMOR RESISTANCE TO ANTIANGIOGENIC therapy THROUGH EMT AND ANGIOGENESIS-RELATED MECHANISMS IN GLIOMA Stem cell …
- Immunologic outcomes of allogeneic Stem cell transplantation: graft-versus-host and graft-versus-leukemia responses and implications for future therapy
- Successful Stem cell mobilization with high-dose cytarabine plus G-CSF after lenalidomide therapy for multiple myeloma-a series of four cases
- Allogeneic Hematopoietic Stem cell Transplantation Is an Effective Salvage therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with …
- Stem cell AND GENE therapy FOR HEART FAILURE
- cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal Stem cells
- Mesenchymal Stem cells for regenerative therapy: optimization of cell preparation protocols
- Gene therapy of Limbal cells Alleviates Wound Healing and Stem cell Marker Abnormalities in Organ-Cultured Human Diabetic Corneas
- Hematopoefic-‐Stem-‐cell based therapy for HIV disease
- Stem cell Biomarkers in Early Diagnosis, Prognosis, and therapy of Cancer
- Donor lymphocyte infusion is an effective therapy for relapsed Hodgkin lymphoma after reduced-intensity allogeneic hematopoietic Stem cell transplantation
- Stem cell Biomarkers in Early Diagnosis, Prognosis, and therapy of Cancer
- Hereditary cerebellar degeneration and Stem–cell based therapy
- … as an advanced therapy medicinal product (ATMP), for the treatment of ADV infections following an allogeneic haematopoietic Stem cell transplantat (allo-HSCT)
- Mesenchymal Stem cell-Based therapy for Prostate Cancer
- Investigating the potential of Stem cell based therapy in murine models of Alzheimer’s disease
- The Role of Occupational therapy and Its Impact on Quality of Life for the Pediatric Stem cell Recipient
- … vzYro-cultivation of human oral mucosa epithelial cells and tissue explants as a modem method for applications in therapy of limbal Stem cell deficiency. A pilot …
- Cardiac cell Replacement therapy With Pluripotent Stem cell Derived Cardiomyocytes
- SC-07 cyclic intranasal application of neural Stem cell-mediated enzym/prodrug therapy using a novel HSV-thymidine kinase variant inhibits intracerebral glioma …
- … PLATELET SUPERNATANT CAN AUGMENT THE ANGIOGENIC POTENTIAL OF PERIPHERAL BLOOD Stem cells IN Stem cell-BASED therapy
- Effect of therapy” in vitro” with Stem cell of bone marrow in mammary tumors canine.
- … ‐10: Level of Breast Cancer Stem cell Correlated with Tumor Radioresistence: An Indication for Individualized Breast Cancer therapy Adapted to Cancer Stem cell …
- Laser Induced Mouse Glaucoma Model Suitable for Studying Stem cell-based therapy
- … cells from Mobilized Peripheral Blood Stem cell (PBSC) Collections As an Integral Part of Hematopoietic Stem cell Transplantation (HSCT) and cellular therapy (CT …
- Recovery of IgG Production Following Rituximab therapy after Allogeneic Stem cell Transplantation
- High-dose therapy combined with autologous peripheral blood Stem cell transplantation in patients with peripheral T-cell lymphoma: a retrospective study
- Stem cells as a Source for cell therapy in Parkinson’s Disease
- Bortezomib-based induction therapy followed by autologous hematopoietic Stem cell transplantation in multiple myeloma
- Allogeneic Hematopoietic Stem cell Transplantation for therapy-Related Acute Myeloid Leukemia
- Biological and synthetic membranes for human induced pluripotent Stem cell-based transplantation therapy
- 20. Development of Lentiviral Mediated Stem cell Gene therapy for Mucopolysaccharidosis Type IIIA
- High-Dose Chemotherapy and Autologous Stem cell Rescue therapy for High-Risk Neuroblastoma Patients
- Treatment-resistant depression requiring electroconvulsive therapy following Stem cell transplantation
- Gene therapy on patient-specific Stem cell lines with MFRP defect
- Preclinical studies of EpCAM-targeted therapy for human hepatocellular carcinoma with specific inhibition of Stem cell features
- Clinical effectiveness of high dose immunosuppressive therapy with autologous hematopoietic Stem cell transplantation in multiple sclerosis patients.
- Comparison the Clinical Efficacy of Autologous Hematopoietie Stem cell Transplantation and Traditional Insulin therapy in Newly Diagnosed Primary Childhood …
- Personalizing busulfan therapy for children undergoing hematopoietic Stem cell transplantation
- The Potential Use of Skin-derived Precursors (SKPs) in Stem–cell Based therapy for Hirschsprung’s Disease
- Adipose Derived Stem cell (ADSC) therapy Prevents The Progression Of Hypertension And Improves Cardiac Functions
- … Siriraj Hospital, Mahidol University, Bangkok, Thailand. 3Unit of Stem cell Research and Development for Medicine therapy, Department of Obstetrics and
- Induction therapy with bortezomib and dexamethasone followed by autologous Stem cell transplantation versus autologous Stem cell transplantation alone in …
- Bioprocess engineering of induced pluripotent Stem cells for application in cell therapy and pre-clinical research
- Functionalization of carbon nanotubes for mesenchymal Stem cell-assisted photothermal therapy
- Graft-versus-host disease, a major complication after Stem cell transplantation–home care for prevention and stromal cells for therapy
- Oxymetholone therapy of Fanconi Anemia Induces Hematopoietic Stem cell Cycling By Suppressing Osteopontin Transcription
- Canine Adipose Tissue Derived Stem cell Administration as Adjuvant therapy for Chronic Hepatitis in Dog
- Necessary Stem cell transplantation using myeloablative therapy for myelodysplastic syndrome with progression of genotypic abnormalities and TP 53 dysfunction in a …
- Dose intensity and autologous Stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
- … : AUTOLOGOUS Stem cell TRANSPLANT FOLLOWING AN ORTHOTOPIC HEART TRANSPLANT AND CYTOXAN/BORTEZOMIDE/DEXAMETHASONE therapy …
- … on FDG-PET and Multiple Lines of Prior therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem cell Transplantation for Lymphoma
- Development of a Unique Anti-AML Immune therapy Consisting of Cord Blood HSCT and Cord Blood Stem cell-Derived Dendritic cell (CB-DC) Vaccination
- Outcomes in Patients on Hemodialysis Who Undergo High Dose therapy Followed By Autologous Peripheral Blood Stem cell Transplant for Multiple …
- Cord blood Stem cell transplantation combined with traditional Chinese therapy for kidney nourishing and dampness elimination in treatment of patients with Child A or …
- … therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem …
- Most patients with germ cell tumors will be cured with local therapy and/or standard chemotherapy. When relapse occurs, two salvage treatment paradigms exist …
- Synergistic effect of human tubal mesenchymal Stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
- Rituximab, Age and High Dose therapy Followed By Autologus Stem cell Transplantation Are Independent Prognostic Factors for Survival in the First Line …
- Induction therapy with Bortezomib and Dexamethasone Followed By Autologous Stem cell Transplantation for SyStemic Light Chain Amyloidosis: Our …
- OB-30: A Novel cell therapy source for preterm premature rupture of membrane using amnionic epithelial Stem cells: Preliminary study
- Targeting Interleukin-2 to the Bone Marrow Stroma for therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem cell Transplantation
- … therapy Predicts a Favorable Outcome in Patients with Acute Myeloid Leukemia and an Intermediate Risk Karyotype Undergoing Allogeneic Stem cell …
- … Agents for Secondary Prophylaxis Based on Response to Initial Antifungal therapy in Allogeneic Hematopoietic Stem cell Transplant Recipients with Prior …
- A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous Stem cell transplantation (ASCT) in patients with multiple …
- … to Induction or High Dose therapy, Pre/Post Transplant PET Negativity and Absence of Minimal Residual Disease within Mobilized Stem cell Graft Predict Long Term …
- … therapy with Deferasirox Is a Favorable Prognostic Factor in Iron-Overloaded Patients with Severe Apastic Anemia Undergoing Allogeneic Stem cell …
- … 1 Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination with Etoposide As Preparative therapy for Autologous Stem cell Transplant in Acute …
- Dose-escalation study using novel continuous flow intracoronary delivery of allogeneic cardiosphere-derived Stem cells: is there a threshold for cell therapy?
- The assessment of immunomodulatory effects of cell therapy in multiple sclerosis patients after autologous mesenchymal/stromal Stem cells transplantation
- … of umbilical cord processing techniques and multiparametric immunophenotyping of umbilical cord Wharton’s jelly mesenchymal Stem cells for cell therapy …
- Are umbilical cord mesenchymal Stem cells advantageous over bone marrow mesenchymal Stem cells for cell therapy in orthopaedics?
- Pituitary cell differentiation from Stem cells and other cells: toward restorative therapy for hypopituitarism?
- PRECONDITIONING HUMAN Stem cells WITH OXYTOCIN TO OPTIMIZE cell therapy FOR THE TREATMENT OF CARDIOVASCULAR DISEASE
- Lentiviral mediating genetic engineered mesenchymal Stem cells for releasing IL-27 as a gene therapy approach for autoimmune diseases. cell J. 2014; 16 (3) …
- Effect of amniotic membrane-derived mesenchymal Stem cells on innate immune syStem and a their usefulness in ocular cell therapy
- Targeted therapy of leukemia Stem cells (LSCs) in PTEN-deficient T-cell acute lymphoblastic leukemia (T-ALL)
- … ACTIVITIES OF MESENCHYMAL Stem AND STROMAL cells: Optimal Dose And Mechanism Of Action Of Human Mesenchymal Stromal cell therapy In E. coli …
- … Stem cells Induced In Vitro Generation of Antigen Specific Regulatory T-cells Containing CD4+ CD8+ Population: A cell-Based therapy To Promote Transplantation …
- In vitro characterization of Stem/progenitor cells from semitendinosus and gracilis tendons as a possible new tool for cell-based therapy for tendon disorders
- … of immunity T-cell link state and content of cancer Stem cells as criterion to estimate efficiency of preventive breast cancer therapy with cryopreserved fetal liver cells
- … Institute, 2Vita-Salute University, 3San Raffaele Telethon Institute for Gene therapy (HSR-TIGET), Division of Regenerative Medicine, Gene therapy and Stem …
- Human umbilical cord mesenchymal Stem cells: a new era for Stem cell therapy
- Mesenchymal Stem cell therapy for liver fibrosis
- Stem cell therapy for intervertebral disc regeneration: obstacles and solutions
- Strategies to improve homing of mesenchymal Stem cells for greater efficacy in Stem cell therapy
- Mesenchymal Stem cell therapy for osteoarthritis: current perspectives
- Application of encapsulation technology in Stem cell therapy
- Stem cell therapy for inflammatory bowel disease
- Autologous Stem cell therapy: how aging and chronic diseases affect Stem and progenitor cells
- Stem cell therapy for Alzheimer’s disease and related disorders: current status and future perspectives
- Mesenchymal Stem cell therapy for autoimmune disease: risks and rewards
- Mesenchymal Stem cell therapy for inflammatory bowel disease: a syStematic review and meta-analysis
- Long-term results of adipose-derived Stem cell therapy for the treatment of Crohn’s fistula
- Stem cell therapy for retinal diseases
- Our fat future: translating adipose Stem cell therapy
- Effect of aging on human mesenchymal Stem cell therapy in ischemic cardiomyopathy patients
- A safeguard syStem for induced pluripotent Stem cell-derived rejuvenated T cell therapy
- Stem cell therapy in the management of shoulder rotator cuff disorders
- Mesenchymal Stem cell therapy for cirrhosis: present and future perspectives
- Stem cell therapy: challenges ahead
- Stem cell therapy for chronic heart failure
- Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?
- Sepsis induces long-term metabolic and mitochondrial muscle Stem cell dysfunction amenable by mesenchymal Stem cell therapy
- Bone engineering of maxillary sinus bone deficiencies using enriched CD90+ Stem cell therapy: a randomized clinical trial
- Stem cell therapy and tissue engineering for correction of congenital heart disease
- Autologous, allogeneic, induced pluripotent Stem cell or a combination Stem cell therapy? Where are we headed in cartilage repair and why: a concise review
- Supramolecular hydrogels for long‐term bioengineered Stem cell therapy
- Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study
- The emergence of Stem cell therapy for patients with congenital heart disease
- Stem cell therapy for glaucoma: science or snake oil?
- Stem cell therapy for heart failure
- Stem cell therapy in brain trauma: implications for repair and regeneration of injured brain in experimental TBI models
- Ambivalent journeys of hope: Embryonic Stem cell therapy in a clinic in India
- Caveats of mesenchymal Stem cell therapy in solid organ transplantation
- Stem cell therapy for corneal epithelium regeneration following good manufacturing and clinical procedures
- Patient-specific age: the other side of the coin in advanced mesenchymal Stem cell therapy
- cell therapy using human induced pluripotent Stem cell-derived renal progenitors ameliorates acute kidney injury in mice
- Exosomes as potential alternatives to Stem cell therapy in mediating cardiac regeneration
- Adoptive T-cell therapy of prostate cancer targeting the cancer Stem cell antigen EpCAM
- Mesenchymal Stem cell therapy for acute radiation syndrome: innovative medical approaches in military medicine
- Regeneration of the retina: toward Stem cell therapy for degenerative retinal diseases
- Efficacy of mesenchymal Stem cell therapy for steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic Stem cell transplantation: a …
- Allogenic benefit in Stem cell therapy: cardiac repair and regeneration
- Stem cell therapy: A novel treatment approach for oral mucosal lesions
- Stem cell therapy for kidney disease
- Conjugated polymer nanodots as ultrastable long‐term trackers to understand mesenchymal Stem cell therapy in skin regeneration
- Stem cell therapy for myocardial infarction 2001–2013 revisited
- Comparative analysis of human mesenchymal Stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy
- Trans-amniotic Stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida
- Effects of nitric oxide on Stem cell therapy
- Concise review: mesoangioblast and mesenchymal Stem cell therapy for muscular dystrophy: progress, challenges, and future directions
- Role of angiotensin II in Stem cell therapy of cardiac disease
- Translational applications of molecular imaging in cardiovascular disease and Stem cell therapy
- Mesenchymal Stem cell therapy alleviates interstitial cystitis by activating Wnt signaling pathway
- Mesenchymal Stem cell therapy in proteoglycan induced arthritis
- Stem cell therapy for amyotrophic lateral sclerosis
- High tibial osteotomy in combination with chondrogenesis after Stem cell therapy: a histologic report of 8 cases
- Stem cell therapy for sensorineural hearing loss, still alive?
- Effects of mesenchymal Stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat
- Stem cell therapy in intracerebral hemorrhage rat model
- The clinical status of Stem cell therapy for ischemic cardiomyopathy
- Stem cell therapy for erectile dysfunction of cavernous nerve injury rats: a syStematic review and meta-analysis
- Delayed administration of allogeneic cardiac Stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in …
- Research progress in animal models and Stem cell therapy for Alzheimer’s disease
- Engineered composite fascia for Stem cell therapy in tissue repair applications
- Stem cell therapy for myocardial infarction: challenges and prospects
- Biological effects and mechanisms of action of mesenchymal Stem cell therapy in chronic obstructive pulmonary disease
- Adipose derived mesenchymal Stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing …
- Could Stem cell therapy be the cure in liver cirrhosis?
- Novel treatment strategies for feline chronic kidney disease: A critical look at the potential of mesenchymal Stem cell therapy
- Sweat gland regeneration after burn injury: is Stem cell therapy a new hope?
- Comparative effects of mesenchymal Stem cell therapy in distinct stages of chronic renal failure
- Mesenchymal Stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
- Stem cell therapy in multiple sclerosis: a future perspective
- The future of Stem cell therapy for stroke rehabilitation
- Nicorandil enhances the efficacy of mesenchymal Stem cell therapy in isoproterenol-induced heart failure in rats
- Bone marrow mesenchymal Stem cell aggregate: an optimal cell therapy for full-layer cutaneous wound vascularization and regeneration
- The coming of age of adoptive T-cell therapy for viral infection after Stem cell transplantation
- Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation
- Stem cell therapy for cardiovascular diseases: a progressive journey
- Combining enriched environment, progesterone, and embryonic neural Stem cell therapy improves recovery after brain injury
- Allogeneic mesenchymal Stem cell therapy outcomes for three patients with spinal muscular atrophy type 1
- Importance of the Stem cell microenvironment for ophthalmological cell-based therapy
- Stem cell therapy in spinal trauma: Does it have scientific validity?
- Stem cells-biological update and cell therapy progress
- Stem cell therapy: a novel treatment option for cerebral malaria?
- Papilla regeneration by injectable Stem cell therapy with regenerative medicine: long‐term clinical prognosis
- Repair of ischemic injury by pluripotent Stem cell based cell therapy without teratoma through selective photosensitivity
- Stem cell therapy: current applications and potential for urology
- New immunosuppressive cell therapy to prolong survival of induced pluripotent Stem cell–derived allografts
- Effect of allogeneic limbal mesenchymal Stem cell therapy in corneal healing: role of administration route
- The future of Stem cell therapy in hernia and abdominal wall repair
- Dual protective and cytotoxic benefits of mesenchymal Stem cell therapy in combination with chemotherapy/radiotherapy for cancer patients
- Adipose Tissue-Derived Stem cell therapy for Post-Surgical Breast Reconstruction–More Light than Shadows.
- Devices for Stem cell isolation and delivery: current need for drug discovery and cell therapy
- Opportunities and challenges: Stem cell‐based therapy for the treatment of ischemic stroke
- Translational research of adult Stem cell therapy
- Stem cell therapy for CHD: Towards translation
- Next-generation Stem cell therapy poised to enter EU market
- Adipose tissue-derived Stem cell therapy in rat cryopreserved ovarian grafts
- Thioredoxin-1 (Trx1) engineered mesenchymal Stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat …
- Bladder recovery by Stem cell based cell therapy in the bladder dysfunction induced by spinal cord injury: syStematic review and meta-analysis
- Stem cell hype: media portrayal of therapy translation
- Inner ear cell therapy targeting hereditary deafness by activation of Stem cell homing factors
- Priming mesenchymal Stem cells with endothelial growth medium boosts Stem cell therapy for syStemic arterial hypertension
- Stem cell therapy for neurodegenerative diseases
- Mesenchymal Stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration
- … novel and effective strategy for the isolation of adipose-derived Stem cells: minimally manipulated adipose-derived Stem cells for more rapid and safe Stem cell therapy
- Development of gene and Stem cell therapy for ocular neurodegeneration
- Modern Stem cell therapy: approach to disease
- A proposed novel Stem cell therapy protocol for liver cirrhosis
- Cancer Stem cell targeted therapy: progress amid controversies
- Preventing Stem cell transplantation-associated viral infections using T-cell therapy
- Mesenchymal Stem cell therapy: clinical progress and opportunities for advancement
- Preclinical validation of multilevel intraparenchymal Stem cell therapy in the porcine spinal cord
- Bronchopulmonary dysplasia and chronic lung disease: Stem cell therapy
- … failure secondary to chronic overload in congenital heart diseases: Benefits of cell therapy using human embryonic Stem cell–derived cardiac progenitors
- Combination cell therapy with mesenchymal Stem cells and neural Stem cells for brain stroke in rats
- cell adhesion and long-term survival of transplanted mesenchymal Stem cells: a prerequisite for cell therapy
- … -short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved Stem cell therapy in a hepatic failure …
- Mesenchymal Stem cell therapy for acute respiratory distress syndrome: a light at the end of the tunnel?
- Stem cell transplantation therapy in Parkinson’s disease
- Stem cell therapy in injured vocal folds: a three-month xenograft analysis of human embryonic Stem cells
- Manganese‐Enhanced Magnetic Resonance Imaging Enables In Vivo Confirmation of Peri‐Infarct Restoration Following Stem cell therapy in a Porcine Ischemia …
- Update on mesenchymal Stem cell-based therapy in lupus and scleroderma
- Effect of low-level laser therapy on mesenchymal Stem cell proliferation: a syStematic review
- Development of Stem cell-based therapy for Parkinson’s disease
- Genetically engineered mesenchymal Stem cell therapy using self-assembling supramolecular hydrogels
- Bone marrow-derived Stem cell therapy for metastatic brain cancers
- An effective strategy of magnetic Stem cell delivery for spinal cord injury therapy
- Does adipose tissue-derived Stem cell therapy improve graft quality in freshly grafted ovaries?
- Methods of liver Stem cell therapy in rodents as models of human liver regeneration in hepatic failure
- Stem cell therapy for corneal regeneration medicine and contemporary nanomedicine for corneal disorders
- Immunologic network and response to intramyocardial CD34+ Stem cell therapy in patients with dilated cardiomyopathy
- Development of an encapsulated Stem cell-based therapy for diabetes
- Efficacy of autologous Stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study
- Mesenchymal Stem cell therapy in nonhematopoietic diseases
- Stem cell-paved biobridges facilitate Stem transplant and host brain cell interactions for stroke therapy
- Stem cell therapy for cardiac regeneration: hits and misses
- Mesenchymal Stem cell therapy for inflammatory bowel diseases: promise and challenge
- Stem cell therapy in Dentistry: An Overview.
- Impact of National and International Stem cell Banking Initiatives on progress in the field of cell therapy: IABS-JST Joint Workshop: Summary for Session 5
- Pre-clinical cell-based therapy for limbal Stem cell deficiency
- PDGFB-based Stem cell gene therapy increases bone strength in the mouse
- Mesenchymal Stem cell–based therapy for nonhealing wounds: today and tomorrow
- CTLA4 overexpressing adipose tissue-derived mesenchymal Stem cell therapy in a dog with steroid-refractory pemphigus foliaceus
- Stem cell therapy for dementia
- Therapeutic efficacy of Stem cell-based therapy in peripheral arterial disease: a meta-analysis
- Stem cell-based therapy in idiopathic pulmonary fibrosis
- cell therapy for macular degeneration—first phase I/II pluripotent Stem cell-based clinical trial shows promise
- Delivery of mitogen-activated protein kinase inhibitor for hepatocellular carcinoma Stem cell therapy
- Brentuximab vedotin as consolidation therapy after autologous Stem–cell transplantation in patients with Hodgkin’s lymphoma at risk of relapse or progression …
- Cardiac Stem cell therapy: Have we put too much hype in which cell type to use?
- Application of biomaterials to advance induced pluripotent Stem cell research and therapy
- The inflammatory milieu of the degenerate disc: is mesenchymal Stem cell-based therapy for intervertebral disc repair a feasible approach?
- Behind the scenes of the world’s first commercial Stem–cell therapy
- Current status of Stem cell therapy in urology
- The perspectives of mesenchymal Stem cell therapy in the treatment of multiple sclerosis
- Progressing a human embryonic Stem–cell-based regenerative medicine therapy towards the clinic
- Translating G-CSF as an adjunct therapy to Stem cell transplantation for stroke
- Stem cell therapy in drug discovery and development
- Stem cell therapy in neonatal diseases
- Regenerative medicine for central nervous syStem disorders: Role of therapeutic molecules in Stem cell therapy
- Advance and challenges in Stem cell therapy for Alzheimer’s disease
- Allogeneic Stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and cell therapy
- Exploiting AT2R to improve CD117 Stem cell function in vitro and in vivo-perspectives for cardiac Stem cell therapy
- Stem cell therapy for heart disease-Meta-analysis may be misleading.
- Hair regrowth in alopecia areata patients following Stem cell Educator therapy
- Modulation of autoimmune T-cell memory by Stem cell educator therapy: phase 1/2 clinical trial
- A single epidermal Stem cell strategy for safe ex vivo gene therapy
- Skin Stem cells in skin cell therapy
- Potential of neural Stem cell-based therapy for Parkinson’s disease
- Stem cell regenerative therapy in alveolar cleft reconstruction
- How to mend a broken heart: adult and induced pluripotent Stem cell therapy for heart repair and regeneration
- A method for preparation of hydrogel microcapsules for Stem cell bioprocessing and Stem cell therapy
- Adipose-derived Stem cell sheet transplantation therapy in a porcine model of chronic heart failure
- Portable and quantitative evaluation of Stem cell therapy towards damaged hepatocytes
- Haploidentical hematopoietic Stem cell transplantation as a platform for post-transplantation cellular therapy
- Impact of enzyme replacement therapy and hematopoietic Stem cell transplantation in patients with Morquio A syndrome
- Current progress in Stem cell-based gene therapy for articular cartilage repair
- Invited review: Stem cells and muscle diseases: advances in cell therapy strategies
- Umbilical cord-derived mesenchymal Stem cell therapy for neurological disorders via inhibition of mitogen-activated protein kinase pathway-mediated …
- The secret role of microRNAs in cancer Stem cell development and potential therapy: a Notch-pathway approach
- Stem cell therapy for retinal diseases
- Using the cost–effectiveness of allogeneic islet transplantation to inform induced pluripotent Stem cell-derived β-cell therapy reimbursement
- Maintenance therapy with decitabine after allogeneic Stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
- Stem cell therapy for heart failure: Out with the new and in with the old?
- Enrichment of human hematopoietic Stem/progenitor cells facilitates transduction for Stem cell gene therapy
- Radiosensitizing and hyperthermic properties of hyaluronan conjugated, dextran-coated ferric oxide nanoparticles: implications for cancer Stem cell therapy
- NANO scaffolds and Stem cell therapy in liver tissue engineering
- Induced pluripotent Stem cell technology for modelling and therapy of cerebellar ataxia
- Stem–cell-based therapy in the field of urology: a review of Stem cell basic science, clinical applications and future directions in the treatment of various sexual and …
- … Multi‐GNRs Crystal‐Seeded Magnetic Nanoseaurchin for Enhanced In Vivo Mesenchymal‐Stem‐cell Homing, Multimodal Imaging, and Stroke therapy
- Long-term culture of pluripotent Stem–cell-derived human neurons on diamond–A substrate for neurodegeneration research and therapy
- SRY and OCT4 are required for the acquisition of cancer Stem cell‐like properties and are potential differentiation therapy targets
- The challenges and promises of allogeneic mesenchymal Stem cells for use as a cell-based therapy
- Combination therapy of Stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury
- Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic Stem cell transplantation
- Stem–cell therapy for neurologic diseases
- Bone marrow mesenchymal Stem cell therapy for voiding dysfunction
- Stem cell state and the epithelial‐to‐mesenchymal transition: Implications for cancer therapy
- … with intensive induction and as single agent maintenance therapy after consolidation therapy with allogeneic hematopoietic Stem cell transplantation or high-dose …
- Human tissue legislation in South Africa: Focus on Stem cell research and therapy
- Evaluation of the proliferative effects induced by low-level laser therapy in bone marrow Stem cell culture
- Hematopoietic Stem cell gene therapy corrects neuropathic phenotype in murine model of mucopolysaccharidosis type II
- High-dose therapy and autologous Stem cell transplant in older adults with multiple myeloma
- Stem cell therapy of cataract
- Intestinal Stem cells and Stem cell-based therapy for intestinal diseases
- Perspectives on the evolution of Stem cell therapy for heart failure
- Mesenchymal Stem cell therapy in pulmonary disease
- Consensus statement from the first international conference for in utero Stem cell transplantation and gene therapy
- Mesenchymal Stem cell–mediated, tumor stroma–targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene
- Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic Stem cell transplantation
- Design of a regulated lentiviral vector for hematopoietic Stem cell gene therapy of globoid cell leukodystrophy
- Adeno-associated virus (AAV) gene delivery in Stem cell therapy
- … intensive chemotherapy and autologous Stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II …
- Induction therapy with bortezomib followed by bortezomib-high dose melphalan and Stem cell transplantation for light chain amyloidosis: results of a …
- Adipose-derived stromal cells protect intervertebral disc cells in compression: implications for Stem cell regenerative disc therapy
- … 19-28z CAR-T) post-high dose therapy and autologous Stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma …
- Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic Stem cell support: A study based on the nationwide …
- Prolonged antiretroviral therapy preserves HIV-1-specific CD8 T cells with Stem cell-like properties
- Clinical Implications of Basic Science Discoveries: Induced Pluripotent Stem cell therapy in Transplantation—A Potential Role for Immunologic Tolerance
- Stem cell therapy as a treatment modality for neurotrauma
- Synergistic effect of immunoliposomal gemcitabine and bevacizumab in glioblastoma Stem cell-targeted therapy
- Stem cell-based therapy of corneal epithelial and endothelial diseases
- Virus integration and genome influence in approaches to Stem cell based therapy for andro-urology
- Combination of hyperthermia and photodynamic therapy on mesenchymal Stem cell line treated with chloroaluminum phthalocyanine magnetic-nanoemulsion
- Influence of Stem cell source on outcomes of allogeneic reduced-intensity conditioning therapy transplants using haploidentical related donors
- Comparison of magnetic intensities for mesenchymal Stem cell targeting therapy on ischemic myocardial repair: high magnetic intensity improves cell retention but has …
- … (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous Stem cell transplantation in multiple myeloma
- Second autologous Stem cell transplant: an effective therapy for relapsed multiple myeloma
- Angiotensin II, oxidative stress and Stem cell therapy: a matter of delicacy
- A gene and neural Stem cell therapy platform based on neuronal cell type-inducible gene overexpression
- … mucositis in pediatric patients undergoing hematopoietic Stem cell transplantation: Clinical outcomes in a context of specialized oral care using low‐level laser therapy
- Attenuating hypoxia-induced apoptosis and autophagy of mesenchymal Stem cells: the potential of sitagliptin in Stem cell-based therapy
- … cryotherapy associated with laser therapy for decreasing severity of melphalan‐induced oral mucositis during hematological Stem‐cell transplantation: a prospective …
- … rituximab with high‐dose cytarabine mobilization therapy and high‐dose thiotepa, busulfan, and cyclophosphamide autologous Stem cell transplantation in patients …
- Advanced research on Stem cell therapy for hepatic diseases: potential implications of a placenta-derived mesenchymal Stem cell-based strategy
- Mesenchymal Stem cell-based FGF2 gene therapy for acute lung injury induced by lipopolysaccharide in mice
- Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic Stem cell transplantation
- Neural Stem cell replacement: a possible therapy for neurodevelopmental disorders?
- The influence of rituximab, high-dose therapy followed by autologous Stem cell transplantation, and age in patients with primary CNS lymphoma
- Stem cell therapy in cerebral palsy: current evidence
- Intra-arterial approaches to Stem cell therapy for ischemic stroke
- Orthopedic uses of Stem cell therapy
- Comparison of unrelated cord blood and peripheral blood Stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity …
- Stem cell therapy status in veterinary medicine
- … Stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin’s lymphoma: a French Society of Bone Marrow Transplantation and cellular therapy …
- Preparation of autologous bone marrow-derived mesenchymal Stem cells (MSCs) for mesenchymal Stem cell therapy for canadians with multiple sclerosis (MESCAMS …
- Allogeneic hematopoietic Stem cell transplantation is an effective salvage therapy for patients with chronic myeloid leukemia presenting with advanced …
- The impact of low-level laser therapy on oral mucositis and quality of life in patients undergoing hematopoietic Stem cell transplantation using the oral health impact …
- Tumoral Stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy
- Bronchopleural fistula treatment: From the archetype of surgery to the future of Stem cell therapy
- Freeze-dried rat bone marrow mesenchymal Stem cell paracrine factors: a simplified novel material for skin wound therapy
- Stem cell and gene therapy for cardiovascular disease
- Dental Stem cells: a future asset of ocular cell therapy
- High-dose therapy and autologous Stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European …
- Predicting poor peripheral blood Stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and …
- … and central nervous syStem non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous Stem cell transplantation. A 60 …
- Mesenchymal Stem cell expression of stromal cell‐derived factor‐1β augments bone formation in a model of local regenerative therapy
- Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic Stem cell cycling
- Molecular imaging for Stem cell therapy in the brain
- Stem cell gene therapy for HIV: strategies to inhibit viral entry and replication
- 660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem cell therapy
- Outcomes in two Japanese adenosine deaminase-deficiency patients treated by Stem cell gene therapy with no cytoreductive conditioning
- Cancer Stem cells, cancer cell plasticity and radiation therapy
- … on the efficacy of combined intraoral and extraoral low-level laser therapy for prevention of oral mucositis in pediatric patients undergoing hematopoietic Stem cell …
- The use of autologous mesenchymal Stem cells for cell therapy of patients with amyotrophic lateral sclerosis in belarus
- Stem cells and cell therapy: Autologous cell Manufacturing
- Stem cell therapy in spinal trauma: Does it have scientific validity?
- Human adipose-derived mesenchymal Stem cells in cell therapy: safety and feasibility in different” hospital exemption” clinical applications
- CD33 directed chimeric antigen receptor T cell therapy as a novel preparative regimen prior to allogeneic Stem cell transplantation in acute myeloid leukemia
- Current understanding of safety and efficacy of Stem cell therapy for discogenic pain—A syStematic review of human studies
- Immune-neuroendocrine interactions involving thymus and pineal gland in Stem cell therapy of age-related diseases
- Breast cancer Stem cell correlates as predicative factors for radiation therapy
- Stem cell therapy versus T lymphocytes: friend or foe?
- Upper airway Stem cells: understanding the nose and role for future cell therapy
- Stem cell therapy for spinal cord injury: The use of oligodendrocytes and motor neurons derived from human embryonic Stem cells
- Adult Stem cell therapy in chronic liver diseases
- Mesenchymal Stem cells as a Biological Drug for Heart Disease: Where Are We With Cardiac cell–Based therapy?
- Prophylactic antiviral therapy in allogeneic hematopoietic Stem cell transplantation in hepatitis B virus patients
- A global comparative overview of the legal regulation of Stem cell research and therapy: lessons for South Africa
- Human umbilical cord mesenchymal Stem cells: an overview of their potential in cell-based therapy
- A double-switch cell fusion-inducible transgene expression syStem for neural Stem cell-based antiglioma gene therapy
- Memory or amnesia: the dilemma of Stem cell therapy in muscular dystrophies
- Mesenchymal stromal Stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up
- … after allogeneic Stem cell transplantation for myelodysplastic syndromes: a study from the French Society of Bone Marrow Transplantation and cellular therapy
- The influence of BDNF on human umbilical cord blood Stem/progenitor cells: implications for Stem cell-based therapy of neurodegenerative disorders
- Human adipose Stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction
- Neuroprotective potential of mesenchymal Stem cell-based therapy in acute stages of TNBS-induced colitis in guinea-pigs
- Bortezomib maintenance therapy after induction with R-CHOP, ARA-C and autologous Stem cell transplantation in newly diagnosed MCL patients, results of a …
- Aquapuncture using Stem cell therapy to treat MdX mice
- The use of hyperbaric oxygen therapy in the treatment of hemorrhagic cystitis after allogeneic Stem cell transplantation from an unrelated donor
- Phase I/II study of the deacetylase inhibitor panobinostat as maintenance therapy after an allogeneic Stem cell transplantation in patients with high-risk MDS …
- The Future of Stem cell therapy in Retina
- Occurrence of adverse events caused by valganciclovir as pre‐emptive therapy for cytomegalovirus infection after allogeneic Stem cell transplantation is reduced by …
- 211Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem cell Gene therapy
- Thioredoxin-1 (Trx1) engineered mesenchymal Stem cell therapy is a promising feasible therapeutic approach for myocardial infarction.
- Genome editing and Stem cell therapy pave the path for new treatment of sickle-cell disease
- … -dose caspofungin as a component of combination antifungal therapy in 91 patients with neoplastic diseases and hematopoietic Stem cell transplantation: a critical …
- Stem cell therapy in pediatric neurological disorders
- … of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous Stem cell transplant (ASCT) for …
- Developing a Stem cell-based therapy for the treatment of hearing loss
- Imaging of fluid in cancer patients treated with syStemic therapy: chemotherapy, molecular targeted therapy, and hematopoietic Stem cell transplantation
- Stem cell therapy for type 1 diabetes mellitus
- Stem cell therapy: medico-legal perspectives in Italy
- The roles of consolidation and maintenance therapy with novel agents after autologous Stem cell transplantation in patients with multiple myeloma
- A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous Stem cell rescue
- cell therapy with G-CSF-mobilized Stem cells in a rat osteoarthritis model
- Human induced pluripotent Stem cells in Parkinson’s disease: A novel cell source of cell therapy and disease modeling
- Stem cell therapy in Brain Trauma
- Molecular imaging: the key to advancing Stem cell therapy
- Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after Stem cell transplantation
- Stem cell therapy in Traumatic Injuries
- Single Stem cell gene therapy for genetic skin disease
- An avian model for ascertaining the mechanisms of organophosphate neuroteratogenicity and its therapy with mesenchymal Stem cell transplantation.
- Current concepts in Stem cell therapy for cardiovascular diseases: what we know and don’t know
- Advancement in high dose therapy and autologous Stem cell rescue in lymphoma
- … use of brentuximab vedotin for refractory anaplastic large cell lymphoma as a bridging therapy to haploidentical Stem cell transplantation and maintenance therapy …
- Introducing dendrosomal nanocurcumin as a compound capable of in vitro eliminating undifferentiated Stem cells in cell therapy practices
- Role of consolidative radiation therapy following autologous Stem cell transplant for relapsed or refractory diffuse large B-cell lymphoma
- Neural Stem cell therapy for Spinal Cord Injury
- Stem cell therapy for cartilage defects
- Successful Autologous Stem cell therapy In Premature Ovarian Failure
- Stem cell therapy for Parkinson’s disease: researching for an effective cure
- Autologous Stem cell transplantation is an effective salvage therapy for primary refractory multiple myeloma
- Stem cell therapy for degenerative disc diseases: present status and prospects
- Mesenchymal Stem cell therapy for bladder dysfunction
- Autologous Mesenchymal Stem cell therapy in Patients with Stroke
- Management of cytokine release syndrome (CRS) in patients undergoing chimeric antigen receptor modified (CAR) T-cell therapy following autologous Stem cell …
- Bone marrow-and cord blood-derived Stem cell transplantation for diabetes therapy
- Era of Stem cell therapy for regenerative medicine and cancers: an introduction for the special issue of Pan Pacific Symposium on Stem cells and Cancer …
- Adoptive T-cell therapy to prevent and treat human metapneumovirus (hMPV) infections post hematopoietic Stem cell transplant (HSCT)
- A Stem–cell-Derived cell-Free therapy for Stroke: Moving Conditioned Medium into Clinical Trial
- Tissue Engineering and Stem cell therapy for Orthodontists
- Mesenchymal Stem cell therapy for breast cancer: Challenges remaining
- The need to review the existing guidelines and proposed regulations for Stem cell therapy in India based on published scientific facts, patient requirements …
- A comparison of Wharton’s jelly and cord blood as a source of mesenchymal Stem cells for diabetes cell therapy
- Application of reporter gene labeling in Stem cell therapy for acute myocardial infarction
- Developing Stem cell therapy for retinal dystrophies
- Legal implications of translational promises of unproven Stem cell therapy
- Impact of early remission by induction therapy on allogeneic Stem cell transplantation for acute myeloid leukemia with an intermediate‐risk karyotype in first complete …
- Mesenchymal Stem cell therapy, a new hope for eye disease
- Lentiviral hematopoietic Stem cell gene therapy for older patients with X-linked severe combined immunodeficiency
- SyStematic review and meta-analysis of efficacy and safety of Stem cell therapy in Amyotrophic lateral sclerosis
- Induced pluripotent Stem cell therapy in transplantation—A potential role for immunologic tolerance
- The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous Stem cell transplant for hematologic malignancies
- High-dose thiotepa as consolidation therapy with autologous hematopoietic Stem cell transplantation for high-risk Ewing family tumors: Single-institution experience
- Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous Stem cell transplantation (HDT/ASCT)-induced mucositis
- Intensive chemotherapy and consolidation with high dose therapy and autologous Stem cell transplant in patients with mantle cell lymphoma
- Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic Stem cell …
- Steroids reduce the efficacy of mesenchymal Stem cell therapy for liver cirrhosis
- Phase II study of the combination of ixazomib with lenalidomide as maintenance therapy following autologous Stem cell transplant in patients with multiple …
- A genetically immortalized human Stem cell line: a promising new tool for Alzheimer’s disease therapy
- Safety and clinical benefit of lentiviral hematopoietic Stem cell gene therapy for Wiskott-Aldrich syndrome
- Conditional survival and excess mortality after high-dose therapy with autologous Stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma …
- Abstract T MP5: Factors Determining Consent in a Randomized Trial of Intra-Arterial Stem cell therapy for Sub-Acute Ischemic Stroke
- The hope for iPSC in lung Stem cell therapy and disease modeling
- Pre-treating the myocardium with collagen matrix improves the efficacy of cardiac Stem cell therapy for myocardial infarction
- therapy of chronic cardiosclerosis in WAG rats using cultures of cardiovascular cells enriched with cardiac Stem cell
- Combination cell therapy: A New Approach for Stem cell therapy
- Nitazoxanide is effective therapy for norovirus gastroenteritis after chemotherapy and hematopoietic Stem cell transplantation (HSCT)
- Frontiers of plasmonic photothermal and Stem cell therapy of atherosclerosis: Nanotoxicity in NANOM-PCI trial
- MP19-06 MESENCHYMAL Stem–cell therapy ALLEVIATES INTERSTITIAL CYSTITIS BY ACTIVATING WNT SIGNALING PATHWAY
- A Phase I study of allogeneic Natural Killer cell therapy generated from cord blood hematopoietic Stem and progenitor cells in elderly acute myeloid …
- Oral valganciclovir as preemptive therapy for cytomegalovirus reactivation in pediatric hematopoietic Stem cell transplant patients
- Novel approach to treat fecal incontinence with muscle Stem cell-based therapy
- Multidifferentiation potential of human mesenchymal Stem cells from adipose tissue and hamstring tendons for musculoskeletal cell-based therapy
- … granulocyte colony stimulating factor (GCSF) Zarzio for progenitor cell mobilization and the treatment of therapy-induced neutropenia in adult hematopoietic Stem cell …
- Ethical issues in genetics (premarital counseling, genetic testing, genetic engineering, cloning and Stem cell therapy, DNA fingerprinting)
- Stem cell therapy-RECENT ADVANCES
- Potential role of induced pluripotent Stem cells (IPSCs) for cell-based therapy of the ocular surface
- The story behind the first Stem cell therapy
- P79-Stem cell therapy in Iran
- Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series)
- Lentiviral Stem cell gene therapy for Pompe disease
- Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic Stem cell transplantation in multiple …
- Adipose‐derived Stem cells protect against endoneurial cell death: cell therapy for nerve autografts
- Preclinical Study Design for Evaluation of Stem cell–derived cellular therapy Products: A Pathologist’s Perspective
- O11-REGULATORY CHALLENGES IN Stem cell therapy
- Perspectives on Stem cell gene therapy for genetic disorders
- Stem cell therapy: an emerging technology in the field of Medicine
- … for Blastic Plasmacytoid Dendritic cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and cell therapy (SFGM-TC)
- The Cerebrospinal Fluid–Stem cell Interactions as Target for Regenerative therapy in Neurological Diseases
- … cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapy
- An Animat as a Model of Stem cell therapy in Stroke
- Mantle cell lymphoma: first-line therapy in patients not eligible for Stem cell transplantation
- Targeted Cancer Stem cell therapy
- Mesenchymal Stem cell therapy for Acute Respiratory Distress Syndrome: A Light at the End of the Tunnel?: Optimizing Therapeutic Potential of Human …
- -Basic science: What will it deliver? Gene and Stem cell therapy
- Stem cell therapy for Neurodegenerative Diseases
- Gene therapy and Stem cell therapy: Overview
- Clinical Application and Molecular Mechanism of Multipotent Stem cell therapy for Liver Disease
- Mesenchymal Stem cell therapy in Nonhematopoietic Diseases
- Harnessing Stem cell-Like Memory T cells for Adoptive cell Transfer therapy of Cancer
- Significance of cell/Stem cell therapy in Wound Care Management
- … Yttrium-90 Ibritumomab Tiuxetan (90Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous Stem–cell …
- Deciphering Stem cell therapy for the interventional cardiologist
- P36-THE MAJOR ETHICAL QUESTIONS IN Stem cell therapy
- Stem cell Extracellular Vesicles: A Novel cell-Based therapy for Cardiovascular Diseases
- Stem cell therapy: science fact or science fiction?
- Novel application of 3-dimensional real-time cardiac imaging to guide Stem cell-based therapy
- P66-The Current Biosafety Considerations in Stem cell therapy
- Challenges towards Stem cell therapy for Parkinson’s disease
- High dose therapy and autologous hematopoietic Stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?
- Bio-inspired polymer surfaces for improving Stem cell therapy
- Amniotic fluid-derived Stem cells as an effective cell source for transplantation therapy in stroke
- O29-Stem cell therapy IN ATHEROSCLEROSIS
- Stem cell therapy for GVHD
- A phase Ib/II study of cancer Stem cell inhibitor BBI608 administered with panitumumab in KRAS wild-type (wt) patients (pts) with metastatic colorectal cancer (mCRC) …
- Application of Stem cell therapy in Cardiovascular Disease: Current Status
- Chinical Application of Adult Stem cell therapy in Neurological Disorders; Present and Future
- SyStematic review: improved function in patients with stroke following Stem cell therapy
- Stem cell therapy in Skin Rejuvenation
- Mesenchymal Stem cell therapy in endstage liver cell failure: comparison of cell types and routes of administration
- OP45–3024: Efficient lentiviral vector-mediated hematopoietic Stem cell gene therapy in MNGIE mice
- Animal models for preclinical efficacy evaluation of Stem cell therapy
- Novel Leukemia Stem cell-Targeted therapy for Acute Myeloid Leukemia Based on Dual Inhibition of Ezh1/Ezh2
- Stem cell therapy and the Heart: A Contemporary Review of the Literature. J Cardiobiol. 2015; 3 (1): 7. J Cardiobiol January 2015 Vol.: 3, Issue: 1 All rights are …
- Regulation and Approval Process of Stem cell therapy Products
- Redosing strategies for mesenchymal Stem cell therapy for chronic obstructive pulmonary disease
- Optimized Mesenchymal Stem cell therapy for Chronic Obstructive Pulmonary Disease
- Prolotherapy And Stem cell therapy
- P6: Perspective of Stem cell therapy for Treatment of Spinal Cord Injury
- Muscle Stem cell therapy for the Treatment of DMD Associated Cardiomyopathy
- Hodgkin’s lymphoma (relapsed or refractory): autologous Stem cell therapy
- Cost comparison of hematopoietic Stem cell transplantation and conventional therapy for patients with thalassemia major in China
- The Psychological and Compliance Factors can Modulate the Outcome of StemI Patients Treated by Stem cell therapy-A Pilot Study
- A salvage autologous Stem cell transplant (ASCT2) induces superior overall survival following bortezomib-containing re-induction therapy for relapsed …
- Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury
- Cancer Stem cell-Targeted therapy: Harapan Baru Terapi Kanker
- O8-Intracoronary Stem cell therapy in Patients Afflicted by Systolic Heart Failure
- Stem cells: Supramolecular Hydrogels for Long‐Term Bioengineered Stem cell therapy (Adv. Healthcare Mater. 2/2015)
- … I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous Stem cell transplantation in acute …
- Human Stromal Stem cell therapy Using Gene-Modified cells
- Effective SyStemic Mesenchymal Stem cell therapy for Vertebral Compression Fractures
- Mechanism of umbilical cord mesenchymal Stem cell therapy for metabolic syndrome
- Stem cells and Stem cell therapy for diabetes mellitus: Chinese clinical trial registration information analysis
- Development of a Haematopoietic Stem cell-based cell therapy to Treat Brain Metastases
- Fortuitous benefits of activity-based rehabilitation in Stem cell-based therapy for spinal cord repair: enhancing graft survival
- Induced pluripotent Stem cell therapy: transplant rejection and safety
- The business of cellular therapy and hematopoietic Stem cell transplantation
- Stem cell based cell therapy with incurable disease animal model
- P57-Stem cell therapy FOR CARDIAC REPAIR: A REVIEW
- … acute myeloid leukaemia which allows early identification of patients for whom allogeneic Stem cell transplantation represents the only curative therapy
- Just Over the Horizon: Catheter Delivery of Stem cell therapy
- Stem cell therapy for Neonatal Hypoxic–Ischemic Brain Injury
- Stem cell therapy for Optic Nerve Regeneration
- Advances and Challenges in SyStemic Stem cell therapy for Muscular Dystrophies
- Autologous Fat Grafting and Adipose-Derived Stem cell therapy
- Mesenchymal Stem cell-Conditioned Medium in Trans-Amniotic Stem cell therapy (TRASCET) for Experimental Spina Bifida
- THE IMPACT-CABG TRIAL: A CANADIAN RCT OF CD133+ Stem cell therapy FOR ISCHEMIC CARDIOMYOPATHY
- Development of an Injectable cell-laden Microniche for Mesenchymal Stem cell therapy
- Strategy of Stem cell therapy for healing racehorse s bone cartilage
- An in vitro Model of Cardiac Stem cell therapy to Study the Coupling of Primary and Stem cell-derived Cardiomyocytes
- Liver Stem cell therapy for cirrhosis: advances in cell classification and selection
- Curcumin has the potential to prevent tumor formation in Stem cell therapy of diabetes type I
- Interim analysis of a phase 2 study of bortezomib plus rituximab maintenance therapy in patients with mantle cell lymphoma status post autologous Stem cell …
- Stem cell therapy for the Treatment of Dry Age-Related Macular Degeneration
- Hypofibrinogenemia associated with steroid therapy for the patients who developed GVHD after allogeneic Stem cell transplantation
- Molecular mechanism underlying immune modulation during Stem cell therapy of overt type 1 diabetes (THER5P. 917)
- Molecular Imaging in Response Evaluation to Human Embryonic Stem cell therapy in Neurodegenerative Diseases
- TGF beta regulates tumor resistance to antiangiogenic therapy through POSTN in glioma Stem cell models
- Regenerative Stem cell therapy for Breast Cancer Bone Metastasis
- 1LF-5: Bio-inspired polymer scaffolds to potentiate Stem cell therapy
- Hope and Wish for Brain Resuscitation-hypothermia and Stem cell therapy
- Metabolic Status Determines the Efficacy of CD34+ Stem cell therapy in Patients With Non-Ischemic Dilated Cardiomyopathy
- Mesenchymal Stem cell therapy for traumatic and degenerative eye disease
- Mesenchymal Stem cell therapy Prevented Doxorubicin Induced Cardiac Dysfunction in Diabetics Rats
- P59-Stem cell therapy IN CARDIOVASCULAR ABNORMALITIES IN OSTEOGENESIS IMPERFECTA
- Quantification of micro-explant culture of myoblasts and optimization of autologous adult Stem cell therapy for female stress urinary incontinence
- Preclinical evaluation of immunogenicity and immunotoxicity of Stem cell therapy
- Rat Bone Marrow Mesenchymal Stem cell therapy in regenerating necrotic cytotrophoblast cell following exposed to carbon black.
- … Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem cell …
- CD33 directed chimeric antigen receptor T cell therapy as a novel regimen prior to allogeneic Stem cell transplantation in acute myeloid leukemia
- Adipose Tissue-Derived Stem cell therapy for Post-Surgical Breast Reconstruction–More Light than Shadows
- Histological Evaluation of Bone Marrow Derived Stem cell therapy on Experimentally Induced Osteoarthritis in Albino Rats’ Knee Joint
- Designing biomaterials for controlled cardiac Stem cell differentiation and enhanced cell therapy in the treatment of congestive heart failure
- 251. Intrauterine Haemopoietic Stem cell therapy Followed By Postnatal cell Re-Infusion To Enhance Engraftment in a Murine Thalassaemia Model
- EFFICACY OF CD34+ Stem cell therapy IN NON-ISCHEMIC DILATED CARDIOMYOPATHY IS ABSENT IN PATIENTS WITH DIABETES BUT PRESERVED IN …
- Improving rotator cuff tear repair: OREF grant recipient investigates promising perivascular Stem cell therapy
- Optimized antiretroviral therapy during allogeneic hematopoietic Stem cell transplantation in HIV-infected individuals
- P113-Autologous cell therapy for Liver Disease by Mesenchymal Stem cell-derived Hepatocyte Like cells
- Mechanical behavior of abdominal aorta aneurysm in rat model treated by cell therapy using mesenchymal Stem cells
- Combination of nano and microcarriers for Stem cell therapy of Huntington’s disease: new regenerative medicine strategy
- SCARs: endogenous human Stem cell-associated retroviruses and therapy-resistant malignant tumors
- Infarcted Hearts Respond Better to Cardiac Stem cell therapy After Pre-treatment With a Collagen Hydrogel
- Regenerative Medicine: Conjugated Polymer Nanodots as Ultrastable Long‐Term Trackers to Understand Mesenchymal Stem cell therapy in Skin Regeneration …
- … of cyclophosphamide plus G-CSF versus G-CSF alone for peripheral blood Stem cell (PBSC) mobilisation following first line therapy in patients with multiple …
- … combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood Stem cell …
- Relevance of Neutrophils and Neutrophil Extracellular Traps in Bronchiolitis Obliterans Syndrome of Patients Receiving Stem cell therapy
- … of Stem cell niche and Stem cell migration promotes functional angiogenesis by enhancing Stem cell homing in ischemic rat myocardium: a novel concept of cell-free …
- Mesenchymal Stem cells for cardiac regenerative therapy: optimization of cell differentiation strategy
- Role of miR-122 in bone marrow derived Stem cell therapy for acute liver injury in rats
- Unopposed TNF/TNFR1 Signaling Prevents Therapeutic Benefit From Cardiac Stem cell therapy After Reperfused Myocardial Infarction in Mice
- … profile of the novel Begev regimen (bendamustine, gemcitabine and vinorelbine) used as salvage therapy prior to autologous Stem cell transplant for relapsed …
- MP52-01 NANOTECHNOLOGY IMPROVED ADIPOSE DERIVED Stem cell therapy IN ERECTILE DYSFUNCTION IN POST RADICAL PROSTATECTOMY …
- Harnessing Stem cell potential for regenerative medicine and cell-based therapy
- … with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma cell therapy Consortium (LCTC) Trial
- Long-Term Follow up of Pediatric Patients with Hodgkin Lymphoma Treated with High Dose therapy and Autologous Stem cell Transplantation
- Mesenchymal Stem cell as delivery carrier for prodrug gene therapy against colorectal cancer cell
- Human mesenchymal Stem cell-educated macrophages: a potential therapy for GVHD and radiation injury (TRAN1P. 944)
- Receptor tyrosine kinase-like orphan receptor-1 (ROR1) expression in breast cancer Stem cells can be targeted for anti-cancer-Stem–cell therapy
- … for Efficient Engraftment of Gene-Modified cells and Prevention of Antibody Production Against Transgene Products in a Rhesus Stem cell Gene therapy …
- OP-015 Impact of CD (34) Pluripotent Mesenchymal Stem cell therapy in Patients with Choronic Critical Limb Ischemia
- Mesenchymal Stem cell: A New Vehicle for Cancer therapy
- SL-07 Competency of Diploid Parthenogenesis Embryonic Stem cell (pESC) for cell therapy
- A global comparative overview of the legal regulation of Stem cell research and therapy: lessons for South Africa: legislation
- A Study on the Regulatory Trends on Stem cell-Based therapy in the USA
- Case report: pomalidomide as consolidation therapy after salvage autologous Stem cell transplant
- ASSESSING THE USE OF MESENCHYMAL Stem cell WINN FELINE FOUNDATION therapy FOR FELINE CHRONIC KIDNEY DISEASE
- Combination Antiretroviral therapy during Autologous Stem cell Transplant for HIV Infected Patients with Haematological Malignancies
- Innovative Concepts of cell therapy: Pluripotent and Multipotent Stem cells and New Bio-Material Solution in Research and Clinical Application
- Fusion of mesenchymal Stem cells and islet cells for cell therapy
- First steps towards successful post-transplantation therapy for myeloid malignancies after allogeneic blood Stem cell transplantation
- Global Governance of Human Embryonic Stem cell Research and therapy-An Example from India: Report of the Rising Powers Policy Workshop
- Combined therapy of acupuncture and neural Stem cell transplantation in immature rats with cerebral palsy
- Targeted molecular therapy based on advanced cancer Stem cell model
- P177-The Role of Cancer Stem cell in Cancer therapy
- Research Progress of Genetic Modified Bone Marrow Mesenchymal Stem cell Transplantation for the therapy of Parkinson’s Disease
- … P2-06-04: Proteosome inhibitor bortezomib inhibits NFκB and effectively overcomes cancer Stem cell escape triggered by Wnt inhibitor therapy in FOXC1+ basal-Like …
- … auto-immune disease adult patients: analysis of outcomes from the French Society for Bone Marrow Transplantation and cellular therapy (SFGMT-TC) in …
- P154-Mesenchymal Stem cell: A New Vehicle for Cancer therapy
- Hematopoietic Stem cell mobilization for gene therapy: the combination of G-CSF+ plerixafor in patients with beta-thalassemia major provides high yields of …
- Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent Stem cells and cell sheet technology: A …
- Cryopreservative against noncryopreservative therapy in autologous hematopoietic Stem cell transplantation (the Egyptian experience)
- ATPS-32TUMOR-HOMING HUMAN INDUCED NEURAL Stem cells: TOWARDS PERSONALIZED cell therapy FOR GLIOBLASTOMA
- … mucositis in pediatric patients undergoing hematopoietic Stem cell transplantation: clinical outcomes in a context of specialized oral care using low-level laser therapy.
- Mesenchymal Stem cell Based therapy for Prostate Cancer
- … nucleotide polymorphisms, prognosis, and predicting benefit from imid® compound maintenance therapy following autologous Stem cell transplant for multiple …
- A new “age” for high dose therapy and autologous Stem cell transplant
- Neural Stem cell Based therapy For Parkinson’s Disease (S48. 007)
- MRD evaluation, targeted therapy and Stem cell transplantation: how to combine in adult ALL
- Abstract S4-03: Identification of a notch-driven breast cancer Stem cell gene signature for anti-notch therapy in an ER+ presurgical window model
- Insights into the use of adipose Stem cells for clinical cell therapy: Novel culturing conditions and characterization of multipotency and immunogenic properties
- Protein-Engineered Hydrogels for Improved Efficacy of Stem cell-Based Injection therapy in a Murine Model of Peripheral Arterial Disease
- Amniotic Fluid-Derived Stem cells (AFSC) and Their Application in cell therapy and Tissue Engineering
- By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer Stem cells to hormonal therapy
- cell Transplantation therapy for Diabetes Mellitus: From Embryonic Stem cells to Transdifferentiation of Adult cells
- 295. Hematopoietic Stem cell Gene therapy (2.0) Based on Purified CD34+ CD38-cells
- A Point-of-Care Platform for Hematopoietic Stem cell Gene therapy
- Salvage Radiation therapy Prior to Stem cell Transplantation for Chemorefractory B-cell Lymphoma
- Autologous cell therapy with CD133+ bone marrow Stem cells in refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study
- Hyperthyroidism As a Complication Following Myloablative therapy and Stem cell Transplantation for Childhood Diseases
- Epigenetic Modulation: A Promising Avenue to Advance Hematopoietic Stem cell-Based therapy for Severe Autoimmune Disorders
- Targeting Cancer Stem cell-Related miRNAs for Prostate Cancer therapy
- Consolidation and maintenance therapy after autologous hematopoietic Stem cell transplantation
- Surviving Cancer: A Personal Story of the Physical and Mental Effects of Chemotherapy, Radiation therapy, and a Stem cell Transplant
- Stem cell marker LGR5: a new target for cancer therapy
- Developing Xeno-Free Human Induced Pluripotent Stem cell-Derived Cardiac Construct for Regeneration therapy Using a Rat Myocardial Infarction Model
- Stem-01NEURAL Stem cell-MEDIATED ENZYME/PRODRUG therapy FOR NEUROBLASTOMA: TRANSLATION TO THE CLINIC
- 279. Efficient and Safe Lentiviral Vector-Mediated Hematopoietic Stem cell Gene therapy in MNGIE Mice
- Evaluating breast cancer Stem cell response to antiangiogenic therapy
- Human somatic Stem cell-based therapy for cartilage regeneration
- … : Improving the Angiogenic Abilities of Mobilized Peripheral Blood Stem cells Achieved by Priming with Activated Platelet Supernatant for Regenerative cell therapy
- Gene therapy and cell Fusion Enhances Stem cell Mediated Cardiac Repair
- AN AUDIT EVALUATING ADHERENCE TO ANTI-FUNGAL therapy IN PAEDIATRIC Stem cell TRANSPLANT (SCT) PATIENTS
- ATPS-31POLYMERIC BIO-SCAFFOLDS INCREASE THE EFFICACY OF Stem cell-MEDIATED therapy FOR GLIOBLASTOMA
- Modification of mesenchymal Stem cells as a way to improve the effectiveness of cell therapy of ischemic myocardial injury
- Stem cell-based ovarian cancer suicide gene therapy
- Stem cell-based ovarian cancer suicide gene therapy
- The immunogenicity and immune tolerance in pluripotent Stem cell based therapy
- Multiple myeloma patients at various cytogenetic risks benefit differently from autologous Stem cell transplantation as a consolidation therapy
- … therapy by transplantation of autologous CD34+ Stem cells transduced ex vivo with the lentiglobin BB305 lentiviral vector in subjects with severe sickle cell …
- Improvement of Quality of Response After Additional therapy Before Autologous Stem cell Transplant is not Translated in Improvement of Global Outcome of Multiple …
- P125-THE EFFECT OF Stem cell-BASED therapy IN SKIN TISSUE ENGINEERING AND WOUND HEALING
- Is there a role for short intensive therapy without Stem cell support in relapsed germ cell tumours? A single centre experience of GAMEC chemotherapy.
- Mesenchymal Stem cell based therapy for restoring corneal graft transparency
- Application of MR Stem cell markers in research of temozolomide intervention gliomas angiogenesis and therapy
- Transplantation of an iPSC-derived CD15+ CXCR4+ VLA4+ neural Stem cell subpopulation as a new therapy for ALS.(S50. 003)
- Graft-Versus-Host Disease Following Radiation therapy in Patients With a History of Allogeneic Stem cell Transplant
- cellular Immune therapy for Epstein-Barr Virus Infection after Hematopoietic Stem cell Transplantation
- 258. Universal Stem cell Gene therapy Platform: Broadening the Transient Epigenetic Gene therapy Arm by Using Nuclease-Null dCas9 as an Additional Drive for …
- Early high-dose therapy and autologous Stem–cell transplantation in angioimmunoblastic T-cell lymphoma: Outcome study using the National Cancer Data Base.
- … haematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas: long-term follow-up data of the German Registry for Stem cell …
- SC-03NEURAL Stem cell-MEDIATED ENZYME/PRODRUG therapy FOR MEDULLOBLASTOMA
- … with Extramedullary Plasmacytomas (EMPs) Included in a Phase III PETHEMA/GEM Study of Induction therapy Prior Autologous Stem cell Transplantation (ASCT) in …
- A Preclinical Non-Human Primate Model to Test Reversible Myeloablation Following IV Busulfan therapy without Stem cell Rescue
- 79. Development and Validation of a Globally Portable Platform for Lentivirus Mediated Hematopoietic Stem cell Gene therapy
- Stem cell implantation therapy improves myocardial oxygen consumption after myocardial infarction in pigs: 11C-acetate PET with dobutamine stress.
- Bone mineral density of the left femoral neck in lymphoma survivors treated with high dose therapy with autologous Stem cell support.
- B cell Reconstitution after Gene therapy in Patients with Wiskott Aldrich Syndrome and Comparison with Mismatched Allogeneic Hematopoietic Stem cell …
- Creation of miRNA-loaded, mesenchymal Stem cell derived microparticles as targeted cancer therapy
- Allogeneic Stem cell Transplantation Is Superior to Immunosuppressive therapy in Children with Aplastic Anaemia–a Single Centre Analysis from India
- Utility of Corticosteroids As Adjunct therapy for Respiratory Syncytial Virus Infection in Allogeneic Stem cell Transplant Recipients
- Lung cancer Stem cell targets sensitizing tumor cells to chemo therapy and radiation therapy by exploiting synthetic lethal relationships in an RNAi high-throughput …
- Budesonide/Formoterol therapy Increases FEV1 in Stem cell Transplant–associated Bronchiolitis Obliterans Syndrome
- Matched unrelated peripheral blood Stem cell transplantation as a salvage therapy for very severe aplastic anemia with uncontrolled infections: a case report
- Salvage therapy for Graft Rejection with Second Haploidentical Allogeneic Stem cell Transplantation (Haplo-HCT) from a Second Related Donor
- Innovative Hematopoietic Gene-therapy Concepts for Hereditary Pulmonary Alveolar Proteinosis Utilizing Hematopoietic Stem cell Derived Macrophages
- A national study on conditional survival and excess mortality after high dose therapy with autologous Stem cell transplantation for non-Hodgkin lymphoma.
- … with Extramedullary Plasmacytomas (EMPs) Included in a Phase III PETHEMA/GEM Study of Induction therapy Prior Autologous Stem cell Transplantation (ASCT) in …
- The first tumor relapse after allogeneic hematopoietic Stem cell transplantation in a therapy-related acute myeloid leukemia patient: a case report and literature review
- Clinical Impact of Cardiac Regenerative therapy With Autologous Skeletal Stem cell Sheet Implantation on Treating Severe Heart Failure
- cell therapy with pluripotent Stem cells differentiated to retinal pigment epithelium and photoreceptor cells in a rat model of Retinitis Pigmentosa
- … Vinorelbine and Prednisone (CGEV) As Salvage therapy for Relapsed or Refractory Hodgkin´ s Lymphoma before Hematopoietic Stem cell Transplantation: A Single …
- … High Dose Cytarabine as Salvage therapy for Relapsed or Refractory Acute Myeloid Leukemia in the Setting of Intensified Anthracycline Induction and Post Stem–cell …
- … Effectiveness of Tyrosine Kinase Inhibitor (TKIs) therapy in Chronic Myelogenous Leukemia (CML) in Comparison to Allogeneic Hematopoietic Stem cell …
- Study of cell therapy for ALS using neuronal Stem cells from iPSCs with ectopic SOX2 expression
- … of Spleen Directed therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem cell Transplantation for Patients …
- A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients who received autologuos Stem cell …
- DNA Methyltransferase-1 (DNMT1): A Flow Cytometric Pharmacodynamic Assay for Azacitidine Hypomethylating therapy after Allogeneic Hematopoietic Stem cell …
- … . Toward Genosafe Endonuclease-Boosted Gene Targeting Using Breakthrough CRISPR/Cas9 for Next Generation Stem cell Gene therapy Culminating in Efficient …
- MESENCHYMAL Stem cells AND ITS POTENTIAL USE IN cell therapy-AN OVERVIEW
- Haploidentical/Mismatched Hematopoietic Stem cell Transplantation for Nonresponders to Immunosuppressive therapy Compared with First-Line Rabbit …
- … and Outcome for Patients with CNS Lymphoma (CNSL) Consolidated with High-Dose therapy and Autologous Stem cell Transplantation (HDT-ASCT) Using …
- Outcomes Following Salvage Autologous Stem cell Transplant (ASCT2) Vs Low Dose Alkylating Consolidation therapy Following Bortezomib-Containing Re …
- Potential cell source for cell-based therapy and tissue engineering applications: urine-derived Stem cells
- … Stem cells EXPRESSING THE GPX1 AND NURR1 GENES BY USING LENTI VIRUS VECTORS; NEW cells SOURCES FOR cell therapy IN …
- … WE USE HUMAN ADIPOSE-DERIVED Stem cells (ADSCS) FROM UROLOGIC CANCER PATIENTS FOR AUTOLOGOUS cell therapy?: A PILOT STUDY
- Single cell Whole Transcriptome Analysis Reveals Distinct Molecular Signatures of therapy-Resistant Chronic Myeloid Leukemia Stem cells
- Pluripotent Stem cells as a cellular model for skin: relevance for physiopathology, cell/gene therapy and drug screening
- Culture of adipose-derived Stem cells in a closed bioreactor syStem for cell therapy
- Strategy for cell therapy using adipose derived mesenchymal Stem cells for canine spinal cord injury
- NurOwn™: mesenchymal Stem cells secreting neurotrophic factors. An autologous cell therapy in clinical trials for ALS
- Adoptive T cell therapy using rejuvenated antigen-specific T cells from induced pluripotent Stem cells (VAC7P. 1044)
- … OSTEOCLASTS FROM SITE SPECIFIC GENE-CORRECTED INDUCED PLURIPOTENT Stem cells: AN AUTOLOGOUS cell therapy APPROACH TO TREAT …
- P56-Stem cells in Treatment of Type 1 Diabetes: A Novel cell therapy Approach (Especially IPS cells)
- 0413: Cardiac differentiation of human pluripotent Stem cells: the first step toward cardiac tissue engineering and cell therapy
- cell and gene therapy via human neural Stem progenitor cells in the lithium-pilocarpine model of rat temporal lobe epilepsy
- Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and reality
- Neural Stem cells interaction with the brain environment and prospects for cell replacement therapy for Stroke
- Purinergic receptors in spinal cord-derived ependymal Stem/progenitor cells and their potential role in cell-based therapy for spinal cord injury
- Neural Stem cells-interaction with the brain and prospects for cell replacement therapy for Stroke
- Induced pluripotent Stem (iPS) cells for cell replacement therapy in Huntington’s disease (HD)
- The development of statin-based therapy for patients with hepatitis C virus (HCV) infection using human induced pluripotent Stem (iPS) cell technology
- Beyond cell-Based therapy: Paracrine Action of Human Adipose Derived Stem/Stromal cells
- Declined presentation single-cell analysis of myelodysplastic sydrome Stem cells during therapy and disease progression
- Analysis of Myelodysplastic Syndrome Stem cells at Single cell Resolution during DNA Methyltransferase Inhibitor therapy
- Functional Recovery and in Vivo cell Tracking after Human Adipose Tissue-Derived Stem cells therapy for Experimental Spinal Cord Injury
- cell-based therapy in ovarian cancer: Improved adenoviral transduction strategy of human mesenchymal Stem cells as tumor-homing drug factories
- Adult Stem cell therapy and heart failure, 2000 to 2016: a syStematic review
- Adult Stem cell therapy for stroke: challenges and progress
- Strategies to optimize adult Stem cell therapy for tissue regeneration
- Clinical efficacy of Stem cell therapy for diabetes mellitus: a meta-analysis
- Challenges and opportunities for Stem cell therapy in patients with chronic kidney disease
- Neural Stem cell therapy for cancer
- Clinical trials of adult Stem cell therapy in patients with ischemic stroke
- Nanomedicine-mediated cancer Stem cell therapy
- Mesenchymal Stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients
- Advances in Stem cell therapy for cardiovascular disease
- Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of Stem cell therapy for heart disease
- Stem cell therapy and administration routes after stroke
- Mesenchymal Stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy–a review
- Stem cell therapy for heart failure: ensuring regenerative proficiency
- Stem cell therapy for Alzheimer’s disease: a review of recent clinical trials
- Improving cell engraftment in cardiac Stem cell therapy
- Stem cell therapy: is there a future for reconstruction of large bone defects?
- The current perspectives of Stem cell therapy in orthopedic surgery
- Current concept of Stem cell therapy for spinal cord injury: a review
- Current biosafety considerations in Stem cell therapy
- Stem cell therapy for the treatment of hip osteonecrosis: a 30-year review of progress
- … adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous Stem cell therapy for orthopaedic conditions
- Stem cell therapy: a prospective treatment for Alzheimer’s disease
- New strategies for improving Stem cell therapy in ischemic heart disease
- Potential role of herbal remedies in Stem cell therapy: proliferation and differentiation of human mesenchymal stromal cells
- The role of Stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies
- Peripheral nerve injury: Stem cell therapy and peripheral nerve transfer
- Emerging targets for glioblastoma Stem cell therapy
- Stem cell therapy for treatment of stress urinary incontinence: the current status and challenges
- Mesenchymal Stem cell therapy for osteoarthritis
- Mitochondria in mesenchymal Stem cell biology and cell therapy: from cellular differentiation to mitochondrial transfer
- The current status of Stem–cell therapy in erectile dysfunction: a review
- Bone marrow mesenchymal Stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies
- Current status and future prospects of mesenchymal Stem cell therapy for liver fibrosis
- Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus
- A phase III clinical trial showing limited efficacy of autologous mesenchymal Stem cell therapy for spinal cord injury
- Stem cell therapy for acute respiratory distress syndrome: a promising future?
- Current perspectives on Stem cell therapy for erectile dysfunction
- The promise of mesenchymal Stem cell therapy for diabetic kidney disease
- Stem cell therapy and immunological rejection in animal models
- Neural Stem cell therapy and rehabilitation in the central nervous syStem: emerging partnerships
- Stem cell therapy for treatment of ocular disorders
- Management of inflammatory bowel disease using Stem cell therapy
- Assessment of the potential of a high frequency acoustomicrofluidic nebulisation platform for inhaled Stem cell therapy
- White paper on guidelines concerning enteric nervous syStem Stem cell therapy for enteric neuropathies
- Mesenchymal Stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
- Role of nanodiamonds in drug delivery and Stem cell therapy
- Promoting tumor penetration of nanoparticles for cancer Stem cell therapy by TGF-β signaling pathway inhibition
- Allogeneic mesenchymal Stem cell therapy promotes osteoblastogenesis and prevents glucocorticoid-induced osteoporosis
- Current progress of human trials using Stem cell therapy as a treatment for diabetes mellitus
- Developing an automated robotic factory for novel Stem cell therapy production
- Nanoparticle improved Stem cell therapy for erectile dysfunction in a rat model of cavernous nerve injury
- Nanoparticles-assisted Stem cell therapy for ischemic heart disease
- Biobridge concept in Stem cell therapy for ischemic stroke.
- Stem cell therapy in spinal cord injury: Hollow promise or promising science?
- Gene transfection for Stem cell therapy
- Mesenchymal Stem cell: considerations for manufacturing and clinical trials on cell therapy product
- Genome therapy of myotonic dystrophy type 1 iPS cells for development of autologous Stem cell therapy
- Optimal timing of mesenchymal Stem cell therapy for neonatal intraventricular hemorrhage
- … Open study Of dental pulp Stem cell therapy in Humans): study protocol for evaluating safety and feasibility of autologous human adult dental pulp Stem cell therapy …
- Coupling primary and Stem cell–derived cardiomyocytes in an in vitro model of cardiac cell therapy
- Stem cell therapy for diabetic erectile dysfunction in rats: a meta-analysis
- Bone marrow cells differentiation into organ cells using Stem cell therapy
- Assessment of pulp regeneration induced by Stem cell therapy by magnetic resonance imaging
- Mesenchymal Stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
- A rational strategy for the use of amniotic epithelial Stem cell therapy for liver diseases
- Stem cell therapy: a promising biological strategy for tendon–bone healing after anterior cruciate ligament reconstruction
- Evaluating mesenchymal Stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
- … Stem cells of mesenchymal nature within the process of vascular remodeling: cellular basis, clinical relevance, and implications for Stem cell therapy
- Human embryonic Stem cell therapy in chronic spinal cord injury: a retrospective study
- Stem cell therapy for Alzheimer’s disease: hope or hype?
- Recent insights: mesenchymal stromal/Stem cell therapy for acute respiratory distress syndrome
- Stem cell therapy for interstitial cystitis/bladder pain syndrome
- Intravenous adipose-derived mesenchymal Stem cell therapy for the treatment of feline asthma: a pilot study
- Recent progress in Stem cell therapy for diabetic nephropathy
- … CAR T cell therapy for B-ALL are superior in patients receiving a fludarabine/cyclophosphamide preparative regimen and post-CAR hematopoietic Stem cell …
- The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133+ Stem cell therapy during coronary artery bypass grafting for ischemic …
- Transamniotic Stem cell therapy (TRASCET) mitigates bowel damage in a model of gastroschisis
- Fibrin matrices enhance the transplant and efficacy of cytotoxic Stem cell therapy for post-surgical cancer
- Advances in Stem cell therapy for leukemia
- Utilizing pharmacotherapy and mesenchymal Stem cell therapy to reduce inflammation following traumatic brain injury
- Self-assembling peptides optimize the post-traumatic milieu and synergistically enhance the effects of neural Stem cell therapy after cervical spinal cord injury
- Mesenchymal Stem cell therapy for refractory scleroderma: a report of 2 cases
- Strategies to enhance the effectiveness of adult Stem cell therapy for ischemic heart diseases affecting the elderly patients
- Current state and perspectives of Stem cell therapy for stroke
- A comparison between placental and amniotic mesenchymal Stem cells for transamniotic Stem cell therapy (TRASCET) in experimental spina bifida
- Stem cell therapy for epidermolysis bullosa—does it work?
- Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism
- Nanovesicle-mediated syStemic delivery of microRNA-34a for CD44 overexpressing gastric cancer Stem cell therapy
- Effectiveness of autologous Stem cell therapy for the treatment of lower extremity ulcers: A syStematic review and meta-analysis
- Stem cell therapy‒Approach for multiple sclerosis treatment
- Stem cell therapy for the heart: blind alley or magic bullet?
- Effect of Stem cell therapy on bone mineral density: a meta-analysis of preclinical studies in animal models of osteoporosis
- Mesenchymal Stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution
- Safety of mesenchymal Stem cell therapy: A syStematic review and meta-analysis
- Efficacy of CD34+ Stem cell therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance
- Chimeric antigen receptor T cell therapy targeting CD19-positive leukemia and lymphoma in the context of Stem cell transplantation
- Stem cell therapy in nonneovascular age-related macular degeneration
- … to cell communication, autophagy and mitochondrial dysfunction in a model of hepatocellular carcinoma: Potential protective effects of curcumin and Stem cell therapy
- Transplantation and Stem cell therapy for cerebellar degenerations
- Mesenchymal Stem cell therapy for the treatment of vocal fold scarring: a syStematic review of preclinical studies
- Potential strategies to address the major clinical barriers facing Stem cell regenerative therapy for cardiovascular disease: a review
- Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted Stem cell therapy
- Clinical course and outcomes of patients with multiple myeloma who relapse after autologous Stem cell therapy
- Mesenchymal Stem cell: a new horizon in cancer gene therapy
- A role for the host in the roadmap to diabetes Stem cell therapy
- Stem cell therapy for the central nervous syStem in lysosomal storage diseases
- Stem cell therapy for perianal fistulas in Crohn’s disease
- Efficacy of Stem cell therapy in amyotrophic lateral sclerosis: a syStematic review and meta-analysis
- Senescence in human mesenchymal Stem cells: functional changes and implications in Stem cell-based therapy
- Mesenchymal Stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation
- Current state of Stem cell therapy for ischemic heart disease
- Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer Stem cell therapy
- Features specific to retinal pigment epithelium cells derived from three-dimensional human embryonic Stem cell cultures—a new donor for cell therapy
- Human platelet lysate as a replacement for fetal bovine serum in limbal Stem cell therapy
- Mesenchymal Stem cell therapy for acute radiation syndrome
- Designing 3D mesenchymal Stem cell sheets merging magnetic and fluorescent features: when cell sheet technology meets image-guided cell therapy
- Mesenchymal Stem/stromal cell‐derived extracellular vesicles as a new approach in Stem cell therapy
- Optimization of magnetic hyperthermia effect for breast cancer Stem cell therapy
- Consistently inconsistent—bone marrow mononuclear Stem cell therapy following acute myocardial infarction: a decade later
- Photodynamic approach for teratoma-free pluripotent Stem cell therapy using CDy1 and visible light
- Mesenchymal Stem cell therapy associated with endurance exercise training: effects on the structural and functional remodeling of infarcted rat hearts
- Stem cell therapy for white matter disorders: don’t forget the microenvironment!
- Challenges of Stem cell therapy in developing country
- Stem cell therapy for sequestering neuroinflammation in traumatic brain injury: an update on exosome-targeting to the spleen.
- Can chondral healing be improved following microfracture? The effect of adipocyte tissue derived Stem cell therapy
- Improving Stem cell therapy in cardiovascular diseases: the potential role of microRNA
- Mesenchymal Stem cell therapy for treatment of craniofacial bone defects: 10 years of experience
- Bone marrow derived Stem cell therapy for type 2 diabetes mellitus
- Stem cell therapy for neurodegenerative diseases: Strategies for regeneration against degeneration
- Stem cell therapy restores viscoelastic properties of myocardium in rat model of hypertension
- Stem cell-based therapy: Improving myocardial cell delivery
- Osteoporosis: the current status of mesenchymal Stem cell-based therapy
- … vector technology limits DNA size restrictions on ex vivo gene delivery using nanoparticle vectors: Overcoming a translational barrier in neural Stem cell therapy
- Mesenchymal Stem cell therapy promotes the improvement and recovery of renal function in a preclinical model
- Umbilical cord as prospective source for mesenchymal Stem cell-based therapy
- The cancer Stem–cell signaling network and resistance to therapy
- Preface: sight restoration through Stem cell therapy
- Stem cell therapy for knee pain—what exactly are we injecting, and why?
- Potential for Stem cell‐based periodontal therapy
- Mesenchymal Stem cell-based therapy in kidney transplantation
- cell therapy using bone marrow-derived Stem cell overexpressing BMP-7 for degenerative discs in a rat tail disc model
- Mesenchymal Stem cell-based therapy for kidney disease: a review of clinical evidence
- Fraudsters operate and officialdom turns a blind eye: a proposal for controlling Stem cell therapy in China
- The use of mathematical modelling for improving the tissue engineering of organs and Stem cell therapy
- Advances in Stem cell and cell-based gene therapy approaches for experimental acute lung injury: a review of preclinical studies
- Cancer Stem cell metabolism: a potential target for cancer therapy
- Advances in Stem cell therapy: bench to bedside
- Stem cell therapy and congenital heart disease
- Effect of Stem cell-based therapy for ischemic stroke treatment: a meta-analysis
- An update on human Stem cell-based therapy in Parkinson’s disease
- Hypoxic preconditioning enhances dental pulp Stem cell therapy for infection-caused bone destruction
- Hypoxia-specific, VEGF-expressing neural Stem cell therapy for safe and effective treatment of neuropathic pain
- Cancer Stem cell quiescence and plasticity as major challenges in cancer therapy
- The potential of nanofibers in tissue engineering and Stem cell therapy
- pH-sensitive and thermosensitive hydrogels as Stem–cell carriers for cardiac therapy
- Mesenchymal Stem cell-derived exosomes: new opportunity in cell-free therapy
- Therapeutic potential of mesenchymal Stem cell based therapy for osteoarthritis
- Gene therapy and Stem cell transplantation in retinal disease: the new frontier
- Stem cell therapy of ischemic heart disease
- Mesenchymal Stem cell therapy for the streptozotocin-induced neurodegeneration in rats
- Allogeneic clonal mesenchymal Stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study
- Personalized Stem cell therapy to correct corneal defects due to a unique homozygous-heterozygous mosaicism of ectrodactyly-ectodermal dysplasia-clefting …
- Human pluripotent Stem cells: myths and future realities for liver cell therapy
- Autologous Stem cell‐based therapy for sickle cell leg ulcer: a pilot study
- Meta-analysis of preclinical data reveals efficacy of cardiac Stem cell therapy for heart repair
- Cytomegalovirus viral load and mortality after haemopoietic Stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
- In utero Stem cell transplantation and gene therapy: Recent progress and the potential for clinical application
- Towards personalized regenerative cell therapy: mesenchymal Stem cells derived from human induced pluripotent Stem cells
- Lentiviral hematopoietic Stem cell gene therapy for X-linked severe combined immunodeficiency
- Mesenchymal Stem cell therapy
- Immunomodulatory role of mesenchymal Stem cell therapy in vascularized composite allotransplantation
- Harnessing mesenchymal Stem cell homing as an anticancer therapy
- Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and Stem cell therapy
- Lentiviral haemopoietic Stem–cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- Engineered biomaterials to enhance Stem cell‐based cardiac tissue engineering and therapy
- Concise review: pluripotent Stem cell-derived cardiac cells, a promising cell source for therapy of heart failure: where do we stand?
- Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer
- Autologous cell therapy with CD133+ bone marrow-derived Stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study
- Biomaterials control of pluripotent Stem cell fate for regenerative therapy
- Inhibition of Src and forkhead box O1 signaling by induced pluripotent Stem–cell therapy attenuates hyperoxia-augmented ventilator-induced diaphragm dysfunction
- Overview and perspectives of mesenchymal Stem cell therapy in intensive care medicine
- In utero Stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
- First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous Stem cell transplantation
- Optimizing autologous cell grafts to improve Stem cell gene therapy
- Efficacy of umbilical cord-derived mesenchymal Stem cell-based therapy for osteonecrosis of the femoral head: a three-year follow-up study
- The role of conditioning in hematopoietic Stem–cell gene therapy
- Cyclooxygenase-2: a role in cancer Stem cell survival and repopulation of cancer cells during therapy
- IL1RAP expression as a measure of leukemic Stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome
- Stem–cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy
- Cancer Stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance
- Hypoxic preconditioning enhances neural Stem cell transplantation therapy after intracerebral hemorrhage in mice
- On-chip clonal analysis of glioma-Stem–cell motility and therapy resistance
- Exercise as an adjuvant therapy for hematopoietic Stem cell mobilization
- Mesenchymal Stem cell-based gene therapy: A promising therapeutic strategy
- Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic Stem cell …
- Progress and prospect of mesenchymal Stem cell-based therapy in atherosclerosis
- Stem and progenitor cell-based therapy of the central nervous syStem: hopes, hype, and wishful thinking
- … Stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy …
- Enzyme replacement therapy prior to haematopoietic Stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres
- Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood Stem cell apheresis product …
- Effects of Stem cell therapy on protein profile of parkinsonian rats using an18O‐labeling quantitative proteomic approach
- Innervation of dystrophic muscle after muscle Stem cell therapy
- Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration
- Acute myeloid leukemia Stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
- Stem cell-based therapy for diseases of the retinal pigment epithelium: from bench to bedside
- Induction therapy pre‐autologous Stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
- … clinical trial (RCT) of tandem myeloablative autologous Stem cell transplant (ASCT) using peripheral blood Stem cell (PBSC) as consolidation therapy for high-risk …
- Mesenchymal Stem cell-based gene therapy for erectile dysfunction
- Electrospun nanofibrous scaffolds increase the efficacy of Stem cell-mediated therapy of surgically resected glioblastoma
- … -related mortality in children undergoing haematopoietic Stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide …
- The endocrine regulation of Stem cells: physiological importance and pharmacological potentials for cell-based therapy
- Thiotepa-based high-dose therapy for autologous Stem cell transplantation in lymphoma: a retrospective study from the EBMT
- Stem cell therapy for Breast Cancer: A Review
- Delivery modes for cardiac Stem cell therapy
- Bringing cardiac Stem cell therapy from bench to bedside: lessons from the past and future perspectives
- Role of Stem cell transplant and maintenance therapy in plasma cell disorders
- Pim1 Overexpressing ckit+ Cardiac Stem cells in Cardiac Regeneration: Preconditioning as Next-Generation Stem cell therapy?
- Low-level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic Stem cell transplantation: a randomized clinical trial
- … nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural Stem cell differentiation for Alzheimer’s disease therapy
- Wharton’s jelly-derived mesenchymal Stem cell therapy to improve β-cell function in patients with type 1 diabetes and ketoacidosis: a single-centre, single-group, open …
- Umbilical cord derived mesenchymal Stem cells useful in insulin production-another opportunity in cell therapy
- Arrhythmogenesis: a roadblock to cardiac Stem cell therapy
- Clinical observation of employment of umbilical cord derived mesenchymal Stem cell for juvenile idiopathic arthritis therapy
- Fail-safe therapy by gamma-ray irradiation against tumor formation by human-induced pluripotent Stem cell-derived neural progenitors
- Partial cranial cruciate ligament tears treated with Stem cell and platelet-rich plasma combination therapy in 36 dogs: a retrospective study
- Stem cell therapy and Orthopedics
- Prospects of Neural Stem cell therapy for Alzheimer’s Disease
- Role of Stem cell therapy in oral premalignant and malignant lesions
- Interventional Stem cell therapy
- Effects of FVIII immunity on hepatocyte and hematopoietic Stem cell–directed gene therapy of murine hemophilia A
- Hematopoietic Stem cell transplantation for scleroderma: effective immunomodulatory therapy for patients with pulmonary involvement
- Use of human cadaveric mesenchymal Stem cells for cell therapy of a chronic radiation-induced skin lesion: A case report
- Integrating gene correction in the reprogramming and transdifferentiation processes: a one-step strategy to overcome Stem cell-based gene therapy limitations
- Synergistic chemo–photothermal therapy of breast cancer by mesenchymal Stem cell-encapsulated yolk–shell GNR@ HPMO-PTX nanospheres
- … mucositis of patients undergoing haematopoietic Stem cell transplantation and receiving specialised oral care with low‐level laser therapy: a prospective observational …
- Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic Stem cell transplant recipients: Progress and challenges
- Human embryonic Stem cell therapy in Crohn’s disease: A case report
- Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal Stem cell-based therapy in experimental autoimmune encephalomyelitis
- Intensification therapy with bortezomib-melphalan-prednisone versus autologous Stem cell transplantation for newly diagnosed multiple myeloma: an …
- Preemptive antiviral therapy for CMV infection in allogeneic Stem cell transplant recipients guided by the viral doubling time in the blood
- Do increased doses to Stem–cell niches during radiation therapy improve glioblastoma survival?
- … may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer Stem cell hypothesis: a meta …
- Mesenchymal Stem cell-based therapy for ischemic stroke
- Hypoxia-targeted 131I therapy of hepatocellular cancer after syStemic mesenchymal Stem cell-mediated sodium iodide symporter gene delivery
- Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem cell therapy for Myocardial Infarction.
- Human mesenchymal Stem cell therapy for acute graft versus host disease
- Stem cell therapy in animal models of allergic airway diseases
- … of a preemptive antiviral therapy strategy based on combined virological and immunological monitoring for active cytomegalovirus infection in allogeneic Stem cell …
- Stem cell therapy seems safe in refractory RA
- Adult nephrotic syndrome after hematopoietic Stem cell transplantation: renal pathology is the best predictor of response to therapy
- Results of a first-in-man study of mesenchymal Stem cell therapy for bronchiolitis obliterans syndrome
- Pluripotent Stem cell based gene therapy for hematological diseases
- Comparative analysis of human mesenchymal Stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy
- Frontline therapy with carfilzomib, lenalidomide, and dexamethasone (KRd) induction followed by autologous Stem cell transplantation, Krd consolidation and …
- … of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic Stem cell therapy
- The effect of combined pulsed wave low-level laser therapy and human bone marrow mesenchymal Stem cell-conditioned medium on open skin wound healing in …
- Evaluation of simvastatin and bone marrow-derived mesenchymal Stem cell combination therapy on airway remodeling in a mouse asthma model
- Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic Stem cell transplantation
- Leukemic Stem cell quantification in newly diagnosed patients with chronic myeloid leukemia predicts response to nilotinib therapy
- Dynamics of Epstein‐Barr viral load after hematopoietic Stem cell transplantation and effect of preemptive rituximab therapy
- … of expression of CD44, a cancer Stem cell marker, on the treatment outcomes of intensity modulated radiation therapy in patients with oropharyngeal squamous cell …
- Adenoviral gene therapy for diabetic keratopathy: effects on wound healing and Stem cell marker expression in human organ-cultured corneas and limbal …
- Biomanufacturing of human mesenchymal Stem cells in cell therapy: influence of microenvironment on scalable expansion in bioreactors
- Nonhuman primate model in clinical modeling of diseases for Stem cell therapy
- Looking into the future: Using induced pluripotent Stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling
- Application of droplet digital PCR for estimating vector copy number states in Stem cell gene therapy
- Differences of cytomegalovirus diseases between kidney and hematopoietic Stem cell transplant recipients during preemptive therapy
- Stem cell therapy in wound healing and tissue regeneration
- Response to antiviral therapy in haematopoietic Stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV …
- Initiation of Antiretroviral therapy Restores CD4+ T Memory Stem cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques
- Activation of endogenous human Stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors
- Safety of ruxolitinib therapy prior to allogeneic hematopoietic Stem–cell transplantation for myeloproliferative neoplasms
- Can yoga therapy stimulate Stem cell trafficking from bone marrow?
- The development of a Stem cell therapy for deafness
- Initial embryology and pluripotent Stem cells in the pig—The quest for establishing the pig as a model for cell therapy
- Combined effects of low-level laser therapy and human bone marrow mesenchymal Stem cell conditioned medium on viability of human dermal fibroblasts cultured in …
- Stem cell therapy for cardiovascular diseases
- … reach allogeneic Stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy
- Mesenchymal Stem cell therapy for corneal diseases
- … in leukemia patients with allogeneic hematopoietic Stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft‐versus …
- Editorial commentary: Precise nomenclature is critical for evaluating progress in the field of lipoaspirate-derived Stem cell therapy
- … dehydrogenase is a prognostic marker for mesenchymal Stem cell-mediated cytosine deaminase gene and 5-fluorocytosine prodrug therapy for the treatment …
- Correlation between canine inflammatory bowel disease activity indices after Stem cell therapy
- Effects of healing touch and relaxation therapy on adult patients undergoing hematopoietic Stem cell transplant: a feasibility pilot study
- Antifungal therapy in hematopoietic Stem cell transplant recipients
- Comparative analysis of human mesenchymal Stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy
- Clofarabine salvage therapy before allogeneic hematopoietic Stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
- Endurable injectable mesenchymal Stem cell therapy for osteoarthritis by encapsulation in alginate constructs
- The role of high-dose melphalan and autologous Stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy
- Developing induced pluripotent Stem cell-based therapy for the masses
- Cytomegalovirus pre‐emptive therapy after hematopoietic Stem cell transplantation in the era of real‐time quantitative PCR: comparison with recipients of solid organ …
- Enhancing therapeutic efficacy and reducing cell dosage in Stem cell transplantation therapy for ischemic limb diseases by modifying the cell injection site
- … cell delivery with polymer hydrogel for treatment of intervertebral disc degeneration: from 3D culture to design of the delivery device for minimally invasive therapy
- Allogeneic hematopoietic Stem cell transplantions in blastic plasmacytoid dendritic cell neoplasm in first complete remission: an effective therapy for a rare disease
- Translational lab-to-clinic hurdles in Stem cell therapy
- Neural Stem cell therapy for Easing Status Epilepticus Induced Hippocampus Dysfunction and Chronic Temporal Lobe Epilepsy
- Studying mesodiencephalic dopaminergic neuron development in vivo to improve Stem cell therapy in Parkinson’s disease
- CAR T cells targeted with a high affinity scFv against the HCMV glycoprotein Gb as adoptive T cell therapy after hematopoietic Stem cell transplantation
- Stem cell therapy: Accepted Therapies, Managing the Hope of Society, and a Legal Perspective
- Amniotic Stem cell transplantation therapy for type 2 diabetes: 3 years’ follow-up report
- Stem cell therapy for brain tumors
- A study of human leukocyte antigen mismatched cellular therapy (Stem cell microtransplantation) in high-risk myelodysplastic syndrome or transformed acute …
- … incidence of afebrile bloodstream infection detected by surveillance blood culture in patients on corticosteroid therapy after allogeneic hematopoietic Stem cell …
- Stem cell therapy for ischemic heart disease
- Addendum: Stem cell therapy in postinfarction chronic coronary heart disease
- Behavior, PET and histology in novel regimen of MPTP marmoset model of Parkinson’s disease for long-term Stem cell therapy
- Distinct responses of Stem cells to telomere uncapping—a potential strategy to improve the safety of cell therapy
- Piperacillin‐tazobactam vs. imipenem‐cilastatin as empirical therapy in hematopoietic Stem cell transplantation recipients with febrile neutropenia
- Lab-to-clinic application of Stem cell therapy for stroke
- Stem cell therapy in liver cirrhosis
- Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic Stem cell transplant recipients
- Hematopoietic Stem cell transplantation and lentiviral vector‐based gene therapy for Krabbe’s disease: Present convictions and future prospects
- Quantitative assessment of rat corneal thickness and morphology during Stem cell therapy by high-speed optical coherence tomography
- Advances in research of Stem cell therapy for human parasitic diseases: a review
- … multifocal leukoencephalopathy after autologous peripheral blood Stem cell transplantation in a patient with multiple myeloma treated with combination therapy
- In support of upfront Stem cell transplantation as first-line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor.
- … in children and adolescents with acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic Stem cell transplantation: a pediatric blood …
- A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous Stem cell transplantation for non‐Hodgkin …
- Low pH preconditioned amniotic epithelial cells for Stem cell therapy of cancer
- Successful Curative therapy With Rituximab and Allogeneic Haematopoietic Stem cell Transplantation for MALT Lymphoma Associated With STK4‐Mutated CD4+ …
- cell-based therapy in TBI: magnetic retention of neural Stem cells in vivo
- Prostate Stem cell antigen expression in radical prostatectomy specimens predicts early biochemical recurrence in patients with high risk prostate cancer …
- Impact of outpatient non-myeloablative haematopoietic Stem cell transplantation in quality of life vs. conventional therapy
- Haploidentical hematopoietic Stem cell transplantation for nonresponders to immunosuppressive therapy against acquired severe aplastic anemia
- Haematopoietic Stem cell transplants should be a second-line therapy for highly active MS-YES.
- … outcome of elderly patients with multiple myeloma treated with tandem melphalan 100 high-dose therapy, autologous Stem cell transplantation and novel …
- Mesenchymal Stem cell therapy for recessive dystrophic epidermolysis bullosa: prospects and clinical progress
- Muscular Dystrophy: Stem cell therapy
- Neural Stem cell therapy for Parkinson’s Disease
- Shining light on the sprout of life: optogenetics applications in Stem cell research and therapy
- Haploidentical hematopoietic Stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)
- Haematopoietic Stem cell transplants should be a second-line therapy for highly active MS–NO
- Role of Stem cell therapy in Treatment of Muscular Dystrophy
- Stem cell therapy regenerates primate hearts
- Novel subventricular zone early progenitor cell-specific adenovirus for in vivo therapy of central nervous syStem disorders reinforces brain Stem cell heterogeneity
- Pioglitazone effect on glioma Stem cell lines: really a promising drug therapy for glioblastoma?
- Stem cell therapy against chronic myocarditis
- Multi-cycle chemotherapy with the glycolipid-like polymeric micelles evade cancer Stem cell enrichment in breast cancer therapy
- The effects of transplanted cells in Stem cell therapy for myocardial ischemia
- Stem cell genetic therapy for Fanconi Anemia-a New Hope
- Breaking dogma for future therapy using Stem cell-Where we have reached?
- A descriptive study on the safety and efficacy of mesenchymal Stem cell therapy for Parkinson’s disease: A case series
- Stem cell therapy in Multiple Sclerosis: Current Progress and Future Prospects.
- Stem cell-derived oligodendroglial cells for therapy in neurological diseases
- Degenerative Disc Disease: A Review of cell Technologies and Stem cell therapy
- Hypomethylating agents as bridging therapy before allogeneic hematopoietic Stem cell transplantation in patients with chronic myelomonocytic leukemia?
- Daratumumab is an effective and safe salvage therapy in relapsed/refractory patients with multiple myeloma after allogeneic Stem cell transplantation
- The potential application of biomaterials in cardiac Stem cell therapy
- Maintenance therapy after autologous haematopoietic Stem cell transplantation (auto-HSCT) in multiple myeloma patients with and without minimal residual …
- Research highlights on Stem cell therapy for the treatment of Peyronie’s disease
- Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic Stem cell transplant survivorship patients in Australia
- Experimental myocardial Stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence.
- Stem cell therapy for the Treatment of Cartilage Defects and Osteoarthritis
- Emerging regenerative approaches for periodontal regeneration: from cytokine therapy to Stem–cell therapy
- Stem cell therapy for early stage osteonecrosis: challenges and future research directions
- Pluripotent human embryonic Stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
- Canadian cost analysis comparing maintenance therapy with bortezomib versus lenalidomide for patients with multiple myeloma post autologous Stem cell …
- Effectiveness of human mesenchymal Stem cell therapy for left ventricular dysfunction in ischemic cardiomyopathy is influenced by cell injection site
- Preclinical study of cell therapy for osteonecrosis of the femoral head with allogenic peripheral blood-derived mesenchymal Stem cells
- Transfer of allogeneic Stem cell transplant recipients to the intensive care unit: guidelines from the Francophone society of marrow transplantation and cellular therapy …
- Bone marrow-derived mesenchymal Stem cell therapy for myocardial infarction: a syStematic review and meta-analysis
- Migratory cancer side population cells induces Stem cell altruism in bone marrow mesenchymal Stem cells to resist therapy, and enhance tumorigenic potential of non …
- Ex-vivo expansion of cardiac Stem cell therapy products for clinical use: the importance of moving towards the optimization of process development
- Magnetic labelling of mesenchymal Stem cells with iron-doped hydroxyapatite nanoparticles as tool for cell therapy
- Improved epilepsy and speech outcomes with human embryonic Stem cell therapy in children with cerebral palsy
- Impact of Telomere Shortening with Age in Stem cell therapy: New Strategies to Increase Telomere Length
- … followed by donor lymphocyte infusion (DLI): interim results of the HOVON-116 Phase I/II Feasibility Study in poor-risk AML recipients of allogeneic Stem cell …
- Non-directional conjugation of fluorescent antibodies to gold nanoparticles for Stem cell therapy
- Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus Stem cell gene therapy model
- Induced pluripotent Stem cells for modeling and cell therapy of Parkinson’s disease
- Improvements made with Stem cell therapy
- 90Y-ibritumomab-tiuxetan consolidation therapy for advanced-stage mantle cell lymphoma after first-line autologous Stem cell transplantation: is it time for a step …
- “Stem cell therapy”-A REVIEW
- … and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic Stem cell …
- Immunobiology of dental tissue-derived Stem cells; as a potentiated candidate for cell therapy
- Basics of Stem cell therapy.
- Tracking of iron-labeled human neural Stem cells by magnetic resonance imaging in cell replacement therapy for Parkinson’s disease
- Stem cell therapy in ST-Elevation Myocardial Infarction With Reduced Ejection Fraction: A Multicenter, Randomized, Double-Blind Trial. From MiHeart/AMI …
- Discussion on the management status of Stem cell therapy in clinical application in China
- SyStemic autologous mesenchymal Stem cell therapy for immunomodulation in resistant myasthenia gravis
- Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic Stem cell …
- The future of Stem cell and cell therapy in ophthalmology
- Mesenchymal Stem cells and cell therapy for bone repair
- Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage therapy with High Peripheral Blood Stem cell Mobilization Capacity for Poorly …
- Stem cell therapy: The Methods in the Madness
- Cancer Stem cell markers in nasopharyngeal carcinoma and its relevance for therapy
- Clinical features before hematopoietic Stem cell transplantation or enzyme replacement therapy of children with combined immunodeficiency
- Benefits Of Young Donor Adipose-Derived Mesenchymal Stem cell therapy In The Rescue Of Bleomycin-Induced Pulmonary Fibrosis In An Aged Mouse Model
- Signaling Networks of Retinal Ganglion cell Formation and the Potential Application of Stem cell–Based therapy in Retinal Degenerative Diseases
- Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic Stem cell transplantation: two case reports
- 242. Genetically Engineered Mesenchymal Stem cell Spheroids for Brain Tumor therapy
- Tocilizumab is effective therapy for cytokine release syndrome after haploidentical peripheral blood Stem cell transplantation with post-transplant cyclophosphamide
- Recent developments in Stem and progenitor cell therapy for cardiac repair
- Current biosafety considerations in Stem cell therapy
- … Stem cell transplantation versus medical therapy in patients with advanced myelofibrosis: matched survival analysis and the effect of JAK2 inhibitor therapy
- Advances in research of Stem cell therapy for human parasitic diseases: a review
- Transamniotic Stem cell therapy (TRASCET)
- Autologous Stem cell therapy & its Effects on COPD
- Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic Stem cell transplantation.
- Haematopoietic Stem cell transplants should be a second-line therapy for highly active MS–Commentary
- Recruiter-patients as ambiguous symbols of health: bionetworking and Stem cell therapy in India
- … and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: A study on behalf of the French society of bone marrow transplantation or cell therapy …
- MECHANISMS BEHIND Stem cell therapy IN ACUTE MYOCARDIAL INFARCTION
- Cancer Stem cell and gastrointestinal cancer: current status, targeted therapy and future implications
- Stem cell therapy for Ischemic Stroke
- … for patients hospitalized during allogeneic Stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- Stem cell therapy for Acute Myocardial Infarction: The European Experience
- Stem cell therapy in postinfarction chronic coronary heart disease
- Recruiter-patients as ambiguous symbols of health: bionetworking and Stem cell therapy in India
- Stem cell therapy for Autoimmune Disease
- Stem cell therapy for Abrogating Stroke-Induced
- An analysis of consent with specific regard to Stem cell therapy and research
- Risk-adjusted therapy of acute lymphoblastic leukemia can optimize the indication of Stem cell transplantation and cranial irradiation: results of Japan …
- Clinical application of pluripotent Stem cells: an alternative cell-based therapy for treating liver diseases?
- Current global trends in regulations for Stem cell therapy and the way ahead for India
- Stem cell therapy as a potential treatment for glaucoma
- … myeloma (MM) patients (Pts) after a cybord induction regimen and autologous Stem cell transplantation (ASCT): impact of maintenance therapy in the real …
- Regenerative Stem cell therapy in ophthalmology.
- Understanding the signaling pathway as a new strategy for bum management and treatment based on Stem cell therapy
- Efficacy and prognostic factors of induction therapy combined with autologous Stem cell transplantation in 201 patients with multiple myeloma
- Stem cell therapy and Macular Degeneration
- A role for the host in the roadmap to diabetes Stem cell therapy
- Hemostasis and Stem cell therapy in Myocardial Infarction
- The Role of Stem cell therapy in Alzheimer’s Disease
- … of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic Stem cell transplantation in the era of targeted therapy. A report from …
- A MESENCHYMAL Stem cell therapy CAN RESULT IN THE DIFFERENT OUTCOMES OF INFECTIOUS INFLAM-MATORY PROCESS
- Stem cell therapy for a debilitating retinal disorder
- Stem cell therapy AS A POTENTIAL TREATMENT FOR GLAUCOMA
- Autologous Stem cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral therapy (cART): A Retrospective …
- Stem cell therapy Against Cardiac Inflammation
- In Vitro Expansion and Functional Enhancement of Human Mesenchymal Stem cell in cell therapy
- Stem cell therapy for Neonatal Lung Diseases
- Analysis of the Expectation of Stem cell therapy in Patients with Alzheimer’s Disease
- MESENCHYMAL Stem cell therapy IN VETERINARY DERMATOLOGY
- Mesenchymal Stem cell therapy for rheumatic diseases
- Mesenchymal Stem cell therapy in Rheumatoid Arthritis
- Stem cell therapy for Male Enhancement & ED [Top Rated Treatment]
- Recent Innovations in Stem cell therapy for Retinal Disease
- Stem cell therapy ITS CHALLENGES, SUCCESSES, FAILURES AND POTENTIAL APPLICATIONS: ON-GOING TRANSLATIONAL RESEARCH
- Expression patterns of cancer Stem cell markers during specific celecoxib therapy in multistep rat colon carcinogenesis bioassays
- Anchored lentiviral vector episomes for Stem cell gene therapy in Fanconi anemia
- Stem cell therapy for osteonecrosis
- Essay: The current state of Stem cell–therapy in diabetic retinopathy
- Steroid pulse therapy for blood cell recovery in allogeneic hematopoietic Stem cell transplantation
- Novel agent induction therapy alone or followed by autologous Stem cell transplantation in younger patients with multiple myeloma: A single‑center …
- Best Non-Surgical Alternative to Spinal Fusion [Stem cell therapy]
- Research progress of preconditioned Stem cell therapy on ischemic heart disease
- Mesenchymal Stem cell therapy in Knee Osteoarthritis: The Way Forward
- Stem cell therapy for the treatment of erectile dysfunction: where do we stand?
- Characteristics of Mesenchymal Stem cells Derived from Amniotic Membrane: A Potential Candidate for Stem cell-Based therapy
- Stem cell therapy for No-Option Critical Limb Ischemia
- High-Dose therapy (HDT) with Melphalan and Autologous Stem cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma
- Affordable Clean Air Facility for (Stem) cell therapy in an Academic Setting
- … Stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- … Models of therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple cell Subpopulations with Leukemia Stem cell …
- External beam radiation therapy: a promising tool to enhance mesenchymal Stem cell migration towards tumors
- Degenerative disc disease: a review of cell technologies and Stem cell therapy
- The impact of Stem cell therapy on atherosclerosis progression in ST-elevation myocardial infarction patients
- Translational predictive model for heart failure recovery in LVAD patients receiving Stem cell therapy
- Long-term results of intramyocardial CD133+ bone marrow Stem cell therapy for myocardial ischemia: experience with Stem cell register
- GW27-e0429 Meta-analysis of Studies on Stem cell therapy for Patients Undergoing Coronary Artery Bypass Grafting
- Effect of Microenvironment Modulation on Stem cell therapy for Peripheral Nerve Injury
- Effect of Stem cell therapy on All-Cause Mortality in Patient with Heart Failure: A Comprehensive Updated Meta-Analysis of Randomized Controlled Trials
- Optimizing subretinal injection conditions for retinal gene and Stem cell therapy
- Adipose-derived perivascular Stem cell as a source for cell therapy
- 2015 Year in Review-Advancing the Fields of Stem cell Biology and therapy
- Glial Orchestrated Neurodegeneration: An Important Crossroad for Neural Stem cell therapy to the Intestine
- Abstract TMP28: Upper Extremity Motor Impairment After Ischemic Stroke-Implications for Stem cell therapy
- CARDIAC Stem cell therapy AND IMAGING: A RAY OF HOPE FOR POOR HEARTS.
- Role of nanodiamonds in drug delivery and Stem cell therapy
- The next generation of Stem cell therapy:“From cartilage explants to arthritic patients”
- … study of incidence and prognostic significance of eosinophilia after allogeneic hematopoietic Stem cell transplantation: influence of corticosteroid therapy
- Application of Stem cell therapy (Ad-MSC, EPC and NPC) in a Case of Canine Spinal Injury
- Effectiveness of structured teaching programme on knowledge and attitude regarding cord blood Stem cell therapy among antenatal mothers in selected private …
- Challenges in translating germinal Stem cell research and therapy
- The importance of cell therapy controls for a safe, EU-approved Advanced therapy Medicinal Product application to limbal Stem cell deficiency
- Clinical study of cytomegalovirus infection and preemptive therapy after allogenic hematopoietic Stem cell transplantation
- CRISPR/Cas9 technology: from cells to mice to Stem cell therapy
- Stem cell In-Vitro Strategies for the Induction of Sensory Neurons for Inner Ear cell therapy
- Advantages and limitations of the parthenogenetic embryonic Stem cells in cell therapy
- cell Injection Site Influences the Human Mesenchymal Stem cell therapy Effectiveness for Left Ventricular Dysfunction in Ischemic Cardiomyopathy
- Factors Determining Consent in a Randomized Trial of Intra-arterial Stem cell therapy for Sub-Acute Ischemic Stroke (P2. 386)
- Novel Stem cell therapy for Heart Failure Using 3D Printed Cardiac Tissue
- Mammary gland tumors in a female dog-the implications of Stem cell therapy.
- The efficacy of salvage autologous Stem cell transplant for patients with multiple myeloma who received maintenance therapy following initial transplant
- Transplantation routes and mechanism of mesenchymal Stem cell therapy in porcine models with acute liver failure
- EVALUATION OF MESENCHYMAL Stem cell therapy IN DOXORUBICINE-INDUCED CARDIOTOXICITY IN ADULT FEMALE ALBINO RATS
- The Impact Of Mesenchymal Stem cell therapy In Bronchopulmonary Dysplasia: The Interaction Between Inflammation And Oxidative Stress
- Commentary: Preclinical Validation of Multilevel Intraparenchymal Stem cell therapy in the Porcine Spinal Cord
- Stem cell therapy for Avascular Femoral Head Necrosis: From Preclinical to Clinical Study
- DTI Analysis of the Corticospinal Tracts in Clinical Trial of Intra-Arterial Stem cell therapy for Stroke (P3. 302)
- Stem–cell therapy, β-cell-and islet cell-neogenesis: possible treatments of type 1 diabetes in the future?
- Adoptive T-cell therapy to Prevent and Treat Parainfluenza Virus 3 (PIV-3) Infections Post Hematopoietic Stem cell Transplant (HSCT)
- Human Umbilical Cord Blood Mesenchymal Stem cell Delivered Intra-nasally: A Noninvasive Stem cell therapy to Target Niemann-Pick Type C1
- UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem cell Transplantation with a Novel Adoptive T cell therapy
- Intra-Arterial Stem cell therapy for a Persistent Vegetative State Patient: A DTI Analysis of Recovery (P6. 066)
- cell therapy composition for healing wounds comprising mesenchymal Stem cell or the culture medium treated with silver nano particle
- Stem cell therapy to Improve Nerve Regeneration and Functional Recovery in Vascular Composite Allotransplantation (VCA)
- Emerging role for USP1 in glioblastoma Stem cell maintenance and radioresistance: a potential target for glioblastoma therapy
- Photodynamic approach for teratoma-free pluripotent Stem cell therapy using CDy1 and visible light**.
- Abstract WP145: Intra-arterial Stem cell therapy for a Persistent Vegetative State Patient: A DTI Analysis of Recovery
- Functional Validation of GLP-grade Induced Pluripotent Stem cell Derived Retinal Pigment Epithelium: developing a cell therapy for AMD.
- … change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic Stem cell transplant in multiple …
- Transmyocardial Laser Revascularization and Stem cell therapy to Remodel an Infarcted Heart
- The Potential Role of Erythropoietin versus Human Umbilical Cord Blood Stem cell therapy Following Sciatic Nerve Injury In Rats
- Cerebral and retinal injuries in a rat model of bronchopulmonary dysplasia: May Stem cell therapy with ECFCs repair these injuries?
- The use of hyperbaric oxygen therapy for refractory hemorrhagic cystitis after allogeneic hematopoietic Stem cell transplantation
- EXTH-58. DEVELOPING POLYMERIC SCAFFOLDS TO ENHANCE NEURAL Stem cell therapy FOR POST-OPERATIVE GLIOBLASTOMA
- Identification of blood biomarkers and monitoring of degenerative disorders of the equine foot in response to autologous mesenchymal Stem cell therapy
- D25 NEONATAL AND CONGENITAL LUNG DISEASES: The Impact Of Mesenchymal Stem cell therapy In Bronchopulmonary Dysplasia: The Interaction Between …
- 129. A Myoblast Expansion SyStem for Improving the Efficiency of Autologous Stem cell therapy To Treat Muscular Dystrophy
- Developing Autologous cell therapy for Age-related Macular Degeneration using Patient-specific Induced Pluripotent Stem cell derived Retinal Pigment Epithelium
- … undergoing allogeneic hematopoietic Stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- ALLOGENEIC ADIPOSE Stem cell therapy REDUCES APOPTOSIS AND PROMOTES ANTI-INFLAMMATORY MACROPHAGES PHENOTYPE IN A PORCINE …
- Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic Stem cell transplantation
- Stem–cell-specific aptamers for targeted cancer therapy
- C39 IPF: MORE ON DIAGNOSIS AND therapy: Benefits Of Young Donor Adipose-Derived Mesenchymal Stem cell therapy In The Rescue Of Bleomycin-Induced …
- Bone marrow Stem cells in response to intervertebral disc-like matrix acidity and oxygen concentration: implications for cell-based regenerative therapy
- Induced pluripotent Stem cells in Huntington’s disease: Disease modeling and the potential for cell-based therapy
- Treatment with Bortezomib (Bor) Based therapy Followed By Autologous Stem cell Transplantation (SCT) Improves Outcomes in Light Chain Amyloidosis …
- Efficacy of marrow-derived mesenchymal Stem cell-based therapy compared with conservative treatment post ischemic stroke: a syStematic review
- Effects of iron chelation therapy on allogeneic hematopoietic Stem cell transplantation in myelodysplastic syndrome patients with iron overload
- Effect of minimally invasive puncture drainage combined with Stem cell transplantation therapy on recovery and nerve function in patients with hypertensive …
- Hypoxia-based Stem/Progenitor cell therapy: Focus on CXCR4/SDF-1 Axis
- Specificities of complex nutritive support of patients with cytostatic therapy and haemopoietic Stem cell transplantation
- Endometrial mesenchymal Stem cells as a cell based therapy for pelvic organ prolapse
- Optimal treatment strategies in myeloma: An argument against maintenance therapy after autologous Stem cell transplantation
- Allogeneic Stem cell Transplantation As Salvage therapy for First Relapse after Autografting in Multiple Myeloma Patients
- 166. Lentiviral hematopoietic Stem cell gene therapy for sjögren-larsson syndrome
- Mesenchymal Stem/stromal cell therapy: mechanism of action and host response
- 1035. Functional Characterization of Neural Stem cells from a Murine Model of Globoid cell Leukodystrophy: Relevance for the Development of Gene/cell therapy …
- Decitabine As Salvage therapy for Relapse of AML and MDS after Allogeneic Stem cell Transplantation-a Retrospective Multicenter Analysis on Behalf of the …
- Improving Stem cell-Based therapy and Developing a Novel Gene therapy Approach for Treating Duchenne Muscular Dystrophy (DMD)
- Long-term follow-up of children with chronic myeloid leukemia after hematopoietic Stem cell transplantation and tyrosine kinase inhibitor therapy
- Design and Development of miRNA and Stem cell based micro/nano syStems as lung disease therapy
- Bortezomib-based regimens as consolidation therapy after autologous hematopoietic Stem cell transplantation in multiple myeloma: A single center …
- … hematopoietic Stem cell transplantation: a multicenter retrospective study on behalf of the francophone society of Stem cell transplantation and cellular therapy …
- … multiple myeloma patients with severe renal impairment: a retrospective study of the Francophone Society of Stem cell Transplantation and cellular therapy …
- 1035. Functional Characterization of Neural Stem cells from a Murine Model of Globoid cell Leukodystrophy: Relevance for the Development of Gene/cell therapy …
- Stem cell-Based therapy for Duchenne Muscular Dystrophy
- CC-486 (Oral Azacitidine) maintenance therapy is well tolerated after allogeneic hematopoietic Stem cell transplantation (AlloHSCT) in patients with myelodysplastic …
- Practice Patterns of Re-Initiation of therapy at Time of Relapse or Progression Post-Autologous Stem cell Transplant (ASCT) Among Patients with AL …
- Outcomes of Allogeneic Stem cell Transplantation (alloSCT) for therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Evaluation of Wharton’s Jelly-derived Mesenchymal Stem cells under Conditions of Ischemia-a Step Towards cell therapy
- Rebuilding the damaged heart: mesenchymal Stem cells, cell-based therapy, and engineered heart tissue
- Results of salvage autologous Stem cell transplantation (asct) for relapsed multiple myeloma (mm) in the era of novel agents: outcome of patients (pts) …
- Phase II study of the combination of interleukin-2 with zoledronic acid as maintenance therapy following autologous Stem cell transplant in patients with …
- … for hematopoietic Stem cell transplantation donors and recipients: Guidelines from the Franchophone society of bone marrow transplantation and cellular therapy …
- … -derived Stem cells in miniature swine with coronary microembolization: Novel ischemic cardiomyopathy model to assess the efficacy of cell-based therapy
- Effect of human umbilical cord mesenchymal Stem cell adjuvant therapy on liver function and fibrosis indicators as well as the degree of inflammation in patients …
- 10th R. Gorbacheva Memorial Symposium “hematopoietic Stem cell transplantation. Gene and cellular therapy”: an overview
- Risk-Adapted Melphalan and Stem cell Transplantation after Suboptimal Responses to Bortezomib-Based Initial therapy in Patients with SyStemic Light …
- Investigation of human mesenchymal Stem cell genetic characteristics to ensure therapy safety
- Metabolic regulation of human mesenchymal Stem cells for cell therapy
- Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic Stem cell transplantation for multiple myeloma
- … in AML patients: prognostic impact and comparative analysis of mutations burden in diagnostic samples, after standard therapy, and after allogeneic Stem cell …
- Rapid identification of cytokine release syndrome after haploidentical peripheral blood Stem cell transplantation and successful therapy with tocilizumab
- Superior therapeutic index in lymphoma therapy: CD30+ CD34+ hematopoietic Stem cells resist a chimeric antigen receptor T-cell attack
- … Infection Due to Vancomycin-Resistant Enterococcus in Patients with Hematological Malignancy Undergoing Induction therapy or Hematopoietic Stem cell …
- … therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before Stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing …
- Features of transfusion therapy in hematopoietic Stem cell transplantation
- 209. Stem cell/Nanoparticle Constructs for Targeted Ovarian Cancer therapy
- WAR 38 HALAL Stem cell RESEARCH AND therapy: THE MALAYSIAN PERSPECTIVE
- … therapy with rituximab for epstein-barr virus reactivation in children after T-cell-replete haploidentical hematopoietic Stem cell transplantation with low-dose …
- … Patients with< CR Following Single High-Dose Chemotherapy (HDT) Conditioned Autologous Stem cell Transplantation (ASCT) As Part of First Line therapy
- Autologous Stem cell transplantation as a consolidation therapy in acute myeloid leukemia patients
- Leukemic Stem cell quantification in newly diagnosed chronic myeloid leukemia patients predicts response to nilotinib therapy
- … after Addition of Plerixafor during Stem cell Mobilization Have Similar Survival as Good Mobilizers When Given High Dose therapy with Autologous Stem cell …
- 442. Developing Polymeric Bio-Scaffolds That Increase the Efficacy of Stem cell-Mediated therapy for Brain Tumors
- Stem cell-based gene therapy for malignant gliomas
- Mesenchymal Stem cell directed baculoviral gene therapy of colon cancer.
- … Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem cell Transplantation: A Survey from the EBMT-cellular therapy & Immunobiology Working …
- Managing Relapse and Maintenance therapy after Allogeneic Stem cell Transplantation
- Early Intervention Stem cell-Based therapy (EISCBT) for Corneal Burns and Trauma
- … Rescued By Addition of Plerixafor during Stem cell Mobilization Have Equal Survival As Good Mobilizers When Given High Dose therapy with Autologous Stem cell …
- MHC Class I & II-Deficient Human Embryonic Stem cell Line as a Promising Tool to Abrogate Allogenic Immune Rejection in cell-Based therapy
- Incremental Innovation of Ex Vivo Hematopoietic Stem cell Engineering to Expand Clinical Gene therapy Applications
- Radiobiological effects of cancer Stem cell-targeting therapy in a head and neck cancer model
- … Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Who Undergo Intensive Consolidation therapy (ICT) and Autologous Stem cell …
- 685. Restoration of Antiviral Immunity Following Hematopoietic Stem cell Transplantation with Virus-Specific T-Lymphocyte therapy
- … B012: Preclinical study of Kiatomab, a novel monoclonal antibody to the cancer Stem cell surface marker KIAA1114, for anti-cancer therapy in colorectal carcinoma
- Autologous Stem cell Transplantation (ASCT) Is Effective therapy for Older Patients with Non-Hodgkin’s Lymphoma (NHL)
- The role of proto-oncogene PELP1 in breast cancer Stem cell maintenance and therapy resistance
- Outcome of Immune-Suppressive therapy (IST) and Hematopoietic Stem cell Transplantation (SCT) in Patients with Aplastic Anemia: A Retrospective Single Center …
- 443. Neural Stem cell-Mediated Enzyme/Prodrug therapy for Medulloblastoma
- Do disseminated tumor cells with Stem cell character after therapy predict prognosis in primary ovarian cancer
- 364. Neurological Correction of Mucopolysaccharidosis IIIB Mice by Haematopoietic Stem cell Gene therapy
- 678. Neural Stem cell-Based Gene therapy for Malignant Brain Tumor by Doubl-Stranded Adeno-Associated Viral Vectors
- Development of a clinically relevant insulated foamy viral vector for hematopoietic Stem cell gene therapy
- Biological Effects of Mesenchymal Stem cell (MSC) therapy in Patients with Chronic Lung Allograft Dysfunction (CLAD)
- Successful therapy with Ledipasvir/Sofosbuvir for hepatitis C reactivation in a hematopoietic Stem cell transplant recipient
- … Nanoparticles and Biphotonic Microscopy: Innovative Approach to Track In Vivo Muscle Stem cells, a Promising Candidate for cell therapy of Muscular Dystrophy
- 333. Intracellular Ankyrin Specific to p24 and zfp Specific to 2-LTR Are Alternatives to CCR5 Knockdown for Stem cell Gene therapy
- Personalizing therapy in Transplantation: Focus on Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Drugs Used in Hematopoeitic Stem cell and …
- Lentiviral hematopoietic Stem cell gene therapy in inherited immune and lysosomal enzyme deficiencies
- A pilot study using hyperbaric oxygen therapy to improve umbilical cord blood Stem cell engraftment: 6-months follow up results.
- 350. Hematopoietic Stem cell Based Gene therapy for the Treatment of Metachromatic Leukodystrophy: Towards Clinical Testing
- PiggyBac transposons for Stem cell-based gene therapy of Duchenne muscular dystrophy
- Acute Fibrinous and Organizing Pneumonia Following Hematopoietic Stem cell Transplantation Responsive to Corticosteroid therapy
- Human Olfactory Bulb Neural Stem cell Based therapy for CNS Traumatic and Neurodegenerative Diseases
- Comparable Outcomes of therapy-Related and De Novo Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem cell Transplantation
- … By Autologous Stem cell Transplantation in Patients with Hodgkin Lymphoma: A Francophone Society of Bone Marrow Transplantation and cellular therapy …
- … -Intensity and Myeloablative Conditioning: A Study on Behalf of the Francophone Society of Stem cell Transplantation and cellular therapy (SFGM-TC) Study
- … Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem cell Transplantation As Useful Biomarkers and the Target for Rituximab therapy
- … -DQB1 Mismatch Hematopoietic Stem cell Transplantation: A Study on Behalf of the Francophone Society of Stem cell Transplantation and cellular therapy …
- Effects of iron chelation therapy on allogeneic hematopoietic Stem cell transplantation in myelodysplastic syndrome patients with iron overload
- PM232 Major Histocompatibility Complex-I Deficient Embryonic Stem cell-Derived Cardiomyocytes as Potential Off-the-shelf therapy for Cardiac Regeneration
- Is allogeneic hematopoietic Stem cell transplantation still the first-line therapy after the first remission in adult patients with Philadelphia chromosome-negative acute …
- Validation of rapid sterility test with BacT/ALERT 3D on human mesenchymal Stem cells as cell therapy product inside an hospital cell factory
- … (len) for Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapse Following Allogeneic Stem cell Transplantation (allo-SCT)
- Clinical study of cytomegalovirus infection and preemptive therapy after haploidentical peripheral blood hematopoietic Stem cell transplantation
- Incidence and Prognostic Impact of Secondary Neoplasia after High Dose therapy Supported By Autologous Stem cell Transplantation in Follicular …
- Optimization of a Neural Stem cell-mediated Carboxylesterase/Irinotecan Gene therapy for Metastatic Neuroblastoma
- … determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood Stem‑cell …
- Re: Fibrin Glue therapy for Severe Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem cell Transplantation
- Outcome of Allogeneic Hematopoietic Stem cell Transplant in therapy Related Myeloid Neoplasms: Comparative Study with a De Novo Myeloid Neoplasms Group
- Synthesis of Fe3O4 nanoparticles and Fe3O4@GO nanocomposites with low effects on Stem cells for cancer cell therapy
- … characteristics of Cryptogenic organizing pneumonia (COP)/Bronchiolitis obliterans organizing pneumonia (BOOP) after steroid therapy in hematopoietic Stem cell …
- Extracorporeal photopheresis and anticytokine therapy in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic Stem cell …
- Reduced-Intensity and Non-Myeloablative Allogeneic Stem cell Transplantation from Alternative HLA-Mismatched Donors for Hodgkin’s Lymphoma: A Study By the …
- Postremission therapy with Repeated Courses of HD-Arac, Idarubicin and Limited Autologous Stem cell Support Achieves a Very Good Long-Term Outcome …
- … -DQB1 Identical Hematopoietic Stem cell Transplantation: A Study on Behalf of the Francophone Society of Stem cell Transplantation and cellular therapy …
- 1P-228: Graphene Oxide Sheets for Protection of Mesenchymal Stem cell in Cardiac therapy
- JAK1/2 Inhibition As a Salvage therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem cell …
- Erratum for the Research Article:“Lentiviral hematopoietic Stem cell gene therapy for X-linked severe combined immunodeficiency” by SS De Ravin, X. Wu, S. Moir, S …
- … induction followed by maintenance therapy with ixazomib citrate or placebo in newly diagnosed multiple myeloma patients not eligible for autologous Stem cell …
- Toxicities and Outcomes for Patients with CNS Lymphoma (CNSL) Consolidated with High-Dose therapy and Autologous Stem cell Transplantation (HDT-ASCT) …
- Microcarrier Culture of Adipose-Derived Stem cells in a Closed Bioreactor SyStem For cell therapy
- Abstract WP338: combined coiling and allogeneic mesenchymal Stem/stromal cell therapy could be a more cost-effective alternative to coiling alone
- Perspectives of the cell therapy in Ophthalmology1. The Application of Stem cells in the Regeneration of Damaged Surface of the Eye
- Comparative analysis of human mesenchymal Stem cells from fetal-bone marrow, adipose tissue, and Warton’s jelly as sources of cell immunomodulatory therapy
- Drug discovery toward successful cell transplantation therapy for Parkinson’s disease using human pluripotent Stem cells
- The characterization of adipose derived Stem cells from canine tissue for animal cell therapy
- Integration site-based clonality analyses of potency of Stem and progenitor cells and safety in human gene and cell therapy
- Gene therapy for blood cell diseases with autologous hematopoietic Stem cells
- cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal Stem cells?
- L29 Utilising the intrinsic epigenetic memory of induced pluripotent Stem cells to enhance cell replacement therapy for huntington’s disease
- Adeno-associated virus-VEGF-165 Mediated Modification of Adipose Derived Stem cells for cell therapy
- 528. Towards Personalized cell therapy for Cancer: Tumor-Homing Human Induced Neural Stem cells
- … REGIONAL AND TRANSLATIONAL MECHANISMS IN ARDS: cell therapy For The Treatment Of Acute Lung Injury: Alveolar Type Ii cells Or Mesenchymal Stem …
- Short Term Safety and Tolerance of Mesenchymal Stem cells (MSC) Infusion as cell therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung …
- effect of miR-184 in oligodendrocytic differentiation on human neural progenitor Stem cells for cell therapy of MS
- Outcomes of Gene therapy for Severe Sickle cell Disease (SCD) via Transplantation of Autologous Hematopoietic Stem cells Transduced Ex Vivo with a Lentiviral …
- An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem cells to therapy at Single cell Resolution
- Stem cell therapy for ischemic heart diseases
- Mesenchymal Stem cell therapy: A promising cell‐based therapy for treatment of myocardial infarction
- Mesenchymal Stem cell therapy in type 2 diabetes mellitus
- Advances in bone marrow Stem cell therapy for retinal dysfunction
- Neural Stem cell therapy for neurodegenerative disorders: the role of neurotrophic support
- Current and future perspectives of Stem cell therapy in dermatology
- Stem cell therapy for congenital heart disease: a syStematic review
- Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms
- Translational cardiac Stem cell therapy: advancing from first-generation to next-generation cell types
- Mesenchymal Stem cell therapy for ischemic stroke
- Gene delivery approaches for mesenchymal Stem cell therapy: strategies to increase efficiency and specificity
- Stem cell therapy for neonatal disorders: prospects and challenges
- No evidence for the use of Stem cell therapy for tendon disorders: a syStematic review
- Concise review: mesenchymal Stem cell therapy for pediatric disease: perspectives on success and potential improvements
- Advances, challenges and future directions for Stem cell therapy in amyotrophic lateral sclerosis
- Mesenchymal Stem cell therapy in the treatment of hip osteoarthritis
- Route of delivery modulates the efficacy of mesenchymal Stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials
- Induced pluripotent Stem cell-derived neural Stem cell therapy enhances recovery in an ischemic stroke pig model
- Neurotrophin signaling and Stem cells—implications for neurodegenerative diseases and Stem cell therapy
- A look into Stem cell therapy: exploring the options for treatment of ischemic stroke
- Mesenchymal Stem cell therapy for inflammatory skin diseases: clinical potential and mode of action
- A review of the emerging potential therapy for neurological disorders: human embryonic Stem cell therapy
- Recent advances in retinal Stem cell therapy
- Alzheimer’s disease, dementia, and Stem cell therapy
- A pilot study of mesenchymal Stem cell therapy for acute liver allograft rejection
- Human neural Stem cell therapy for chronic ischemic stroke: charting progress from laboratory to patients
- Stem cell therapy for chronic pain management: review of uses, advances, and adverse effects
- Current perspective of Stem cell therapy in neurodegenerative and metabolic diseases
- Mesenchymal Stem cell therapy in Parkinson’s disease animal models
- Benefit of cardiopoietic mesenchymal Stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative therapy …
- SyStematic review with meta-analysis: the efficacy and safety of Stem cell therapy for Crohn’s disease
- A molecular and clinical review of Stem cell therapy in critical limb ischemia
- A nano-in-micro syStem for enhanced Stem cell therapy of ischemic diseases
- Intrinsic mesenchymal Stem cell dysfunction in diabetes mellitus: implications for autologous cell therapy
- Exosomes generated from iPSC-derivatives: new direction for Stem cell therapy in human heart diseases
- Stem cell therapy for nerve injury
- Stem cell therapy for nerve injury.
- Exosomes as potential alternatives to Stem cell therapy for intervertebral disc degeneration: in-vitro study on exosomes in interaction of nucleus pulposus cells …
- Stem cell-derived exosomes, autophagy, extracellular matrix turnover, and miRNAs in cardiac regeneration during Stem cell therapy
- Stem cell therapy for reconstruction of alveolar cleft and trauma defects in adults: a randomized controlled, clinical trial
- Improved Stem cell therapy of spinal cord injury using GDNF-overexpressed bone marrow Stem cells in a rat model
- Cortical bone Stem cell therapy preserves cardiac structure and function after myocardial infarction
- … improves BMSC cell therapy: anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal Stem cell …
- Mesenchymal Stem cell therapy on tendon/ligament healing
- Mesenchymal Stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expression
- A comprehensive review of Stem–cell therapy
- Stem cell therapy: healing or hype? why Stem cell delivery doesn’t work
- Contemplating Stem cell therapy for epilepsy-induced neuropsychiatric symptoms
- Adipose Extracellular Matrix/Stromal Vascular Fraction Gel: A Novel Adipose Tissue–Derived Injectable for Stem cell therapy
- Stem cell therapy for enhancement of bone consolidation in distraction osteogenesis: A contemporary review of experimental studies
- Is Stem cell therapy ready for prime time in treatment of inflammatory bowel diseases?
- G-CSF and Stem cell therapy for the treatment of refractory thin lining in assisted reproductive technology
- Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal Stem cell therapy for chronic stroke
- The influence of timing and frequency of adipose-derived mesenchymal Stem cell therapy on immunomodulation outcomes after vascularized composite …
- Resituating overseas Stem cell therapy
- Safety analysis of autologous Stem cell therapy in a variety of degenerative diseases and injuries using the stromal vascular fraction
- Adult Stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical …
- Pre‐clinical validation of a selective anti‐cancer Stem cell therapy for Numb‐deficient human breast cancers
- Effect of autologous adipose-derived mesenchymal Stem cell therapy in the treatment of a post-traumatic chondral defect of the knee
- Hydrogel based 3D carriers in the application of Stem cell therapy by direct injection
- Priming of the cells: hypoxic preconditioning for Stem cell therapy
- Stem cell therapy for inflammatory bowel disease
- Stem–cell therapy for erectile dysfunction
- Combining gene and Stem cell therapy for peripheral nerve tissue engineering
- A review of Stem cell therapy for spinal cord injury: large animal models and the frontier in humans
- Progress in Stem cell‐based therapy for liver disease
- Mechanisms in endocrinology: towards the clinical translation of Stem cell therapy for type 1 diabetes
- cell therapy in Parkinson’s disease: host brain repair machinery gets a boost from Stem cell grafts
- Towards the standardization of Stem cell therapy studies for ischemic heart diseases: bridging the gap between animal models and the clinical setting
- The effect of autologous adipose derived mesenchymal Stem cell therapy in the treatment of a large osteochondral defect of the knee following unsuccessful …
- Multimodal assessment of mesenchymal Stem cell therapy for diabetic vascular complications
- Induction of spermatogenesis after Stem cell therapy of azoospermic guinea pigs
- Transamniotic Stem cell therapy (TRASCET) in a leporine model of gastroschisis
- Stem cell therapy for the treatment of Peyronie’s disease
- Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal Stem cell therapy
- Efficacy and safety of autologous hematopoietic Stem cell therapy for refractory Crohn’s disease: A syStematic review and meta-analysis
- Allogenic adipose-derived Stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: syStems biology study
- Stem cell therapy in wound healing
- Stem cell therapy for the syStemic right ventricle
- Hematopoietic Stem cell gene therapy: progress and lessons learned
- Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?
- Stem cell therapy clinical research: a regulatory conundrum for academia
- Donor mesenchymal Stem cells home to maternal wounds after transamniotic Stem cell therapy (TRASCET) in a rodent model
- cellular layer-by-layer coculture platform using biodegradable, nanoarchitectured membranes for Stem cell therapy
- Stem cell therapy: A Rising Tide: How Stem cells Are Disrupting Medicine and Transforming Livespdf
- Biogovernance beyond the state: The shaping of Stem cell therapy by patient organizations in India
- Bone marrow Stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1‐antitrypsin
- Adipose Stem cell therapy mitigates chronic pancreatitis via differentiation into acinar-like cells in mice
- Sources of hematopoietic Stem and progenitor cells and methods to optimize yields for clinical cell therapy
- Bone marrow very small embryonic-like Stem cells: new generation of autologous cell therapy soon ready for prime time?
- Exendin-4-assisted adipose derived mesenchymal Stem cell therapy protects renal function against co-existing acute kidney ischemia-reperfusion injury and …
- Stem cell therapy for Fanconi anemia
- Stem cell therapy for avascular necrosis of femoral head in sickle cell disease: report of 11 cases and review of literature
- Mesenchymal Stem cell therapy for laryngotracheal stenosis: a syStematic review of preclinical studies
- Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke
- Should we practice Stem cell therapy for type 1 diabetes mellitus as precision medicine?
- Stem cell therapy: An emerging modality in glomerular diseases
- Stem cell therapy in fecal incontinence: a narrative review
- Next-generation Stem cell therapy: genetically modified mesenchymal Stem cells for cardiac repair
- Autologous bone marrow derived Stem cell therapy in patients with type 2 diabetes mellitus-defining adequate administration methods
- Adipose Stem cell therapy for chronic pancreatitis
- Mesenchymal Stem cell-based therapy as a new horizon for kidney injuries
- Stem cell therapy: A promising therapeutic approach for multiple sclerosis
- Fetal Stem cell and gene therapy
- Stem cell manipulation, gene therapy and the risk of cancer Stem cell emergence
- Autologous pluripotent Stem cell–derived β-like cells for diabetes cellular therapy
- Characteristics, applications and prospects of mesenchymal Stem cells in cell therapy
- Hematopoietic Stem–cell gene therapy for cerebral adrenoleukodystrophy
- Tumor-homing Stem cell therapy for brain cancer
- Mesenchymal Stem cell therapy for advanced liver cirrhosis: a case report
- Enhancing plasticity of the central nervous syStem: drugs, Stem cell therapy, and neuro-implants
- Melatonin as a promising agent of regulating Stem cell biology and its application in disease therapy
- Mesenchymal Stem cell (MSC) as a potential cell therapy for immune related disease
- Adipose tissue-derived Stem cell therapy for erectile dysfunction in rats: a syStematic review and meta-analysis
- Attitudes to Stem cell therapy among ischemic stroke survivors in the Lund Stroke Recovery Study
- Autologous adipose Stem cell therapy for autonomic nervous syStem dysfunction in two young patients
- Nanoporous immunoprotective device for Stem–cell-derived β-cell replacement therapy
- Differences in Stem cell Processing Lead to Distinct Secretomes Secretion—Implications for Differential Results of Previous Clinical Trials of Stem cell therapy for …
- Phase I clinical trial of autologous Stem cell–sheet transplantation therapy for treating cardiomyopathy
- Focus on mesenchymal Stem cell-derived exosomes: opportunities and challenges in cell-free therapy
- Recent progress in nanotechnology for Stem cell differentiation, labeling, tracking and therapy
- Two complementary strategies to improve cell engraftment in mesenchymal Stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue …
- Hematopoietic Stem cell gene therapy for storage disease: current and new indications
- Angiopoietin-1 modified human umbilical cord mesenchymal Stem cell therapy for endotoxin-induced acute lung injury in rats
- SyStematic review of patient factors affecting adipose Stem cell viability and function: implications for regenerative therapy
- Repair of neonatal brain injury: Bringing Stem cell‐based therapy into clinical practice
- Emerging regenerative approaches for periodontal regeneration: the future perspective of cytokine therapy and Stem cell therapy
- Limbal stromal Stem cell therapy for acute and chronic superficial corneal pathologies: early clinical outcomes of the Funderburgh technique
- Hematopoietic Stem cell transplantation and cellular therapy
- Review on Stem cell therapy and their role in cancer treatment
- Does Stem cell therapy induce myocardial neoangiogenesis? Histological evaluation in an ischemia/reperfusion animal model
- Single-cell molecular analysis defines therapy response and immunophenotype of Stem cell subpopulations in CML
- Stem cell therapy in pediatric neurological disabilities
- Complications following Stem cell therapy in inflammatory bowel disease
- CRISPR/Cas9 gene-edited hematopoietic Stem cell therapy for sickle cell disease
- Catching moving targets: cancer Stem cell hierarchies, therapy-resistance & considerations for clinical intervention
- An update clinical application of amniotic fluid-derived Stem cells (AFSCs) in cancer cell therapy and tissue engineering
- Historical perspective on the current renaissance for hematopoietic Stem cell gene therapy
- Pursuing meaningful end-points for Stem cell therapy assessment in ischemic cardiac disease
- Mesenchymal Stem cell therapy for the treatment of heart failure caused by ischemic or non-ischemic cardiomyopathy: immunosuppression and its implications
- Cure for thalassemia major–from allogeneic hematopoietic Stem cell transplantation to gene therapy
- Novel murine xenograft model for the evaluation of Stem cell therapy for profound dysphagia
- Can the outcomes of mesenchymal Stem cell‐based therapy for myocardial infarction be improved? Providing weapons and armour to cells
- Human embryonic Stem cell therapy for aplastic anemia
- Neural Stem cell plasticity: advantages in therapy for the injured central nervous syStem
- Infrapatellar fat pad Stem cells: from developmental biology to cell therapy
- Evidence supporting intralesional Stem cell therapy to improve equine flexor tendon healing
- Multi-functional nanotracers for image-guided Stem cell gene therapy
- Overview of retinal differentiation potential of mesenchymal Stem cells: A promising approach for retinal cell therapy
- Neural Stem cell–based anticancer gene therapy: a first-in-human study in recurrent high-grade glioma patients
- Mesenchymal Stem cell therapy to promote limb transplant functional recovery
- Regenerative Stem cell therapy optimization via tissue engineering in heart failure with reduced ejection fraction
- The potential of microRNAs for Stem cell-based therapy for degenerative skeletal diseases
- Efficient and fast differentiation of human neural Stem cells from human embryonic Stem cells for cell therapy
- Mesenchymal Stem cell therapy of hepatocellular carcinoma in rats: Detection of cell homing and tumor mass by magnetic resonance imaging using iron oxide …
- Stem cell therapy and its potential role in pituitary disorders
- Generation of human induced pluripotent Stem cell-derived bona fide neural Stem cells for ex vivo gene therapy of metachromatic leukodystrophy
- … promotes survival of aged human mesenchymal Stem cells via FAIM: a pharmacological strategy to improve Stem cell-based therapy for rat myocardial …
- Hematopoietic Stem cell involvement in BCR-ABL1–positive ALL as a potential mechanism of resistance to blinatumomab therapy
- … characterization in an HIV-infected individual following allogeneic Stem cell transplant and analytic cessation of antiretroviral therapy: A case study
- A homologous Stem cell therapy for obesity and its related metabolic disorders
- The effects of music therapy in patients with high‐dose chemotherapy and Stem cell support: a randomized pilot study
- Induced pluripotent Stem cell-based therapy for age-related macular degeneration
- Thrombotic microangiopathy after allogeneic Stem cell transplantation: a comparison of eculizumab therapy and conventional therapy
- Controlling adult Stem cell behavior using nanodiamond-reinforced hydrogel: implication in bone regeneration therapy
- Emerging nanotechnology for Stem cell therapy
- The RANK/RANKL/OPG syStem in tumorigenesis and metastasis of cancer Stem cell: potential targets for anticancer therapy
- Tracheal replacement therapy with a Stem cell-seeded graft: lessons from compassionate use application of a GMP-compliant tissue-engineered medicine
- Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy
- … , prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic Stem cell …
- Stem cell therapy for brain injury in neonates
- Perspectives of Stem cell–Based therapy for Age-Related Retinal Degenerative Diseases
- Process parameters for the high-scale production of alginate-encapsulated Stem cells for storage and distribution throughout the cell therapy supply chain
- … variability in LQT3 human induced pluripotent Stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: an in silico …
- Unproven Stem cell therapy for macular degeneration
- Stem cell, biomaterials and growth factors therapy for hepatocellular carcinoma
- Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic Stem cell transplantation
- … of biotinylated IGF‑1 with biotinylated self‑assembling peptides combined with bone marrow Stem cell transplantation promotes cell therapy for myocardial infarction
- Nivolumab salvage therapy before or after allogeneic Stem cell transplantation in Hodgkin lymphoma
- Inhibition of p38MAPK potentiates mesenchymal Stem cell therapy against myocardial infarction injury in rats
- Endocrine therapy of estrogen receptor-positive breast cancer cells: early differential effects on Stem cell markers
- Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic Stem cell transplant patients
- Combination of low-energy shock-wave therapy and bone marrow mesenchymal Stem cell transplantation to improve the erectile function of diabetic rats
- cell therapy using embryonic Stem cell source in clinical trial studies: advantages and limitations
- Introduction to gene and Stem–cell therapy
- Bone marrow as a hematopoietic Stem cell source for gene therapy in sickle cell disease: evidence from rhesus and SCD patients
- Clinical studies of bone marrow-derived Stem cell therapy in stroke patients
- Outcomes of maintenance therapy with bortezomib after autologous Stem cell transplantation for patients with multiple myeloma
- Concise review: dental pulp Stem cells: a novel cell therapy for retinal and central nervous syStem repair
- cellular therapy for multiple pathogen infections after hematopoietic Stem cell transplant
- … -dose therapy and autologous Stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma cell Disorder sub-committee of …
- Music therapy for symptom management after autologous Stem cell transplantation: results from a randomized study
- Non-coding RNAs are promising targets for Stem cell-based cancer therapy
- Treatment by Stem cell therapy of erectile dysfunction of diabetic origin: State of the art
- … , prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic Stem cell …
- Correlation of micro vessel density and c-Myc expression in breast tumor of mice following mesenchymal Stem cell therapy
- Preclinical studies for a phase 1 clinical trial of autologous hematopoietic Stem cell gene therapy for sickle cell disease
- Targeting transferrin receptor delivery of temozolomide for a potential glioma Stem cell-mediated therapy
- Outcome after intensive reinduction therapy and allogeneic Stem cell transplant in paediatric relapsed acute myeloid leukaemia
- Imaging of hepatic toxicity of syStemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic Stem cell transplantation, molecular targeted therapies, and …
- Immunosuppressive therapy versus alternative donor hematopoietic Stem cell transplantation for children with severe aplastic anemia who lack an HLA …
- Long-term results of high-dose therapy and autologous Stem cell transplantation for mantle cell lymphoma: effectiveness of maintenance rituximab
- Stem cell therapy for neurodegenerative disorders
- Delineation of the timing of second-line therapy post–autologous Stem cell transplant in patients with AL amyloidosis
- The Met tyrosine kinase receptor as a therapeutic target and a potential cancer Stem cell factor responsible for therapy resistance
- CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem–cell Gene therapy Transplants
- Update on a phase II study of ixazomib with lenalidomide as maintenance therapy following autologous Stem cell transplant in patients with multiple myeloma
- Liver fibrosis and Stem cell therapy
- Favorable impact of allogeneic Stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status
- Stem cell therapy: The Phoenix in Clinical Medicine?
- Reduced-intensity and non-myeloablative allogeneic Stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the …
- General Overview of the 14th International Symposium on Stem cell therapy and Cardiovascular Innovations: Working Progress of a Global Initiative in 2017
- Efficient ex vivo engineering and expansion of highly purified human hematopoietic Stem and progenitor cell populations for gene therapy
- Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood Stem cell transplantation: a 10-year follow …
- Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic Stem cell transplantation therapy as an important risk factor
- … severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic Stem cell transplantation: a randomized …
- Gene-cell therapy of HIV and hematological malignances based on hematopoietic Stem cell transplantation and site-specific genome editing
- Impact of pretransplant induction therapy on autologous Stem cell transplantation for patients with newly diagnosed POEMS syndrome
- Reducing second gram-negative antibiotic therapy on pediatric oncology and hematopoietic Stem cell transplantation services
- T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic Stem cell transplantation as curative therapy for hematologic …
- Mesenchymal Stem cell in venous leg ulcer: an intoxicating therapy
- Reply: Mechanical Isolation of Stromal Vascular Fraction: A New Advance in Stem cell therapy?
- Enhancement of bone-marrow-derived mesenchymal Stem cell angiogenic capacity by NPWT for a combinatorial therapy to promote wound healing with large …
- Autonomous magnetic labelling of functional mesenchymal Stem cells for improved traceability and spatial control in cell therapy applications
- Mesenchymal Stem cell therapy for retro-corneal membrane–a clinical challenge in full-thickness transplantation of biosynthetic corneal equivalents
- … : a comparative analysis of patients treated with autologous nonmyeloablative hematopoietic Stem–cell transplantation and conventional medical therapy
- Embryonic Stem cell therapy applications for autoimmune, cardiovascular, and neurological diseases: a review
- Lenalidomide in combination or alone as maintenance therapy following autologous Stem cell transplant in patients with multiple myeloma: a review of options for and …
- Progress of the application of Stem cell therapy for end-stage liver disease
- Stem cell therapy to restore pancreatic function in dogs and cats
- Comparison of haploidentical hematopoietic Stem cell transplantation and immunosuppressive therapy for the treatment of acquired severe aplastic anemia in …
- Brief report: external beam radiation therapy for the treatment of human pluripotent Stem cell-derived teratomas
- An update on Stem cell therapy for neurological disorders: cell death pathways as therapeutic targets
- Stem cell therapy in Traumatic Brain Injury
- Stem cell therapy in diabetes
- Bortezomib, lenalidomide and dexamethasone (VRD-GEM) as induction therapy prior autologous Stem cell transplantation (ASCT) in multiple myeloma (MM) …
- Stem cell therapy in the treatment of rheumatic diseases and application in the treatment of syStemic lupus erythematosus
- (Mesenchymal) Stem cell-based therapy in cisplatin-induced acute kidney injury animal model: risk of immunogenicity and tumorigenicity
- Clinical applications of Stem cells from human exfoliated deciduous teeth in Stem cell therapy
- Mesenchymal Stem cells as a source of dopaminergic neurons: a potential cell based therapy for Parkinson’s disease
- India cracks down on clinics offering Stem cell therapy and blood cord banking
- Lenalidomide maintenance therapy post-autologous Stem cell transplant: a healthcare cost-impact analysis in Europe
- Biomaterial-assisted cell therapy in osteoarthritis: From mesenchymal Stem cells to cell encapsulation
- (Mesenchymal) Stem cell-based therapy in cisplatin-induced acute kidney injury animal model: risk of immunogenicity and tumorigenicity
- Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous Stem cell transplantation: a study based on the nationwide …
- Stem cell therapy in heart failure
- The frustration and futility of intracoronary Stem cell therapy
- Transplantation of airway epithelial Stem/progenitor cells: a future for cell-based therapy
- Stem cell therapy with skeletal myoblasts accelerates neointima formation in a mouse model of vein graft disease
- Preclinical safety evaluation of allogeneic induced pluripotent Stem cell-based therapy in a swine model of myocardial infarction
- Stem cell therapy for Autoimmune Disease
- Injection therapy: intra-articular platelet-rich plasma and Stem cell therapy
- Towards Stem cell therapy of polycystic ovary syndrome (PCOS): Human mesenchymal Stem cells engrafment in letrozole-induced PCOS murine model
- Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic Stem cell transplant
- … approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic Stem cell transplantation recipients with oral ribavirin therapy: a pilot study
- Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal Stem cell preserved renal function in a chronic kidney disease and sepsis …
- Single cell-based vector tracing in patients with ADA-SCID treated with Stem cell gene therapy
- Novel therapy for pancreatic fistula using adipose-derived Stem cell sheets treated with mannose
- Gene-modified Mesenchymal Stem cell–based therapy in Renal Ischemia-Reperfusion Injury
- Effect of Stem cell therapy on gentamicin induced testicular dysfunction in rats
- Enhanced chondrogenesis of bone marrow-derived Stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 …
- IL-11 promotes the treatment efficacy of hematopoietic Stem cell transplant therapy in aplastic anemia model mice through a NF-κB/microRNA-204 …
- Conditioning regimens for autologous haematopoietic Stem cell transplantation-can natural killer cell therapy help?
- Stem cell regulation by death ligands and their use in cell therapy
- Stem cell therapy for Ischemic Heart Disease
- Optimization of a neural Stem–cell-mediated carboxylesterase/irinotecan gene therapy for metastatic neuroblastoma
- Fetal therapy model of myelomeningocele with three-dimensional skin using amniotic fluid cell-derived induced pluripotent Stem cells
- Imaging cardiac Stem cell therapy
- Usage of human mesenchymal Stem cells in cell-based therapy: advantages and disadvantages
- Stem cell therapy in autism spectrum disorders
- Allogeneic mesenchymal Stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation …
- Biohybrid membrane syStems for testing molecules and Stem cell therapy in neuronal tissue engineering
- Promises and challenges in hematopoietic Stem cell gene therapy
- Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous Stem cell rescue
- Preliminary results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous Stem cell transplant in patients with multiple …
- Adult Stem cell therapy for salivary glands, with a special emphasis on mesenchymal Stem cells
- Stem cell therapy in Duchenne Muscular Dystrophy
- Stem cell therapy and tissue engineering in urogenital diseases
- Stem cell therapy for Amyotrophic Lateral Sclerosis
- Cardiac Stem cell-based regenerative therapy for the ischemic injured heart—a short update 2017
- Stem cell therapy
- Current Research of the Renin-Angiotensin SyStem Effect on Stem cell therapy
- Intrathecal autologous bone marrow derived mesenchymal Stem cell therapy for amyotrophic lateral sclerosis
- Advanced approaches in Stem cell therapy for stroke and traumatic brain injury
- Advances in umbilical cord blood therapy: Hematopoietic Stem cell transplantation and beyond
- Stem–cell therapy
- Gene and cell therapy for β-thalassemia and sickle cell disease with induced pluripotent Stem cells (iPSCs): the next frontier
- Stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives
- Stem cell therapy in Muscle Degeneration
- Opening marrow niches in patients undergoing autologous hematopoietic Stem cell gene therapy
- Multiple myeloma: Maintenance therapy after autologous hematopoietic Stem cell transplantation, depending on minimal residual disease
- Use of brentuximab vedotin as salvage therapy pre‐allogeneic Stem cell transplantation in relapsed/refractory CD30 positive lympho‐proliferative disorders: a single …
- Targeted drugs as maintenance therapy after autologous Stem cell transplantation in patients with mantle cell lymphoma
- Stem cell transplantation for myeloproliferative diseases in the era of molecular therapy
- Engineering A11 minibody-conjugated, polypeptide-based gold nanoshells for prostate Stem cell antigen (PSCA)–targeted photothermal therapy
- Salvage therapy for acute chemorefractory leukemia by allogeneic Stem cell transplantation: the Korean experience
- Development of cost efficient platforms for the industrial manufacture of pluripotent Stem cell-derived products for cell therapy: cell expansion is the starting point
- Computed tomographic assessment of coronary arteries in patients undergoing Stem cell therapy following an acute myocardial infarction
- Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous Stem cell transplantation
- The optimization of cell therapy by combinational application with apicidin-treated mesenchymal Stem cells after myocardial infarction
- Endogenous repair mechanisms enhanced in Parkinson’s disease following Stem cell therapy
- High-dose therapy and autologous Stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma
- CAR-T cell therapy in combination with allogeneic Stem cell transplantation
- … Stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal replacement therapy
- Stem cell therapy on the Internet: information quality and content analysis of English language web pages returned by Google
- Adipose-Derived Mesenchymal Stem cell therapy for Liver Cirrhosis in Mice
- Human mesenchymal stromal/Stem cell as a source of cell therapy and a pharmacological target for disease treatment.
- A dual therapy of off-pump temporary left ventricular extracorporeal device and amniotic Stem cell for cardiogenic shock
- Acute respiratory failure in a patient with idiopathic pulmonary fibrosis following nebulized and intravenous Stem cell therapy
- Complete cartilage regeneration Stem cell therapy for osteochondral lesions of the talus: early outcomes in a pilot study
- Intrinsic variability present in Wharton’s jelly mesenchymal Stem cells and T cell responses may impact cell therapy
- Mesenchymal Stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission
- Mesenchymal Stem cell therapy for ex vivo repair of ischemic injury in pig donor lungs
- Current strategy of fetal therapy I: Principles of in-utero treatment, pharmacologic intervention, Stem cell transplantation and gene therapy
- … adolescents with leukemia after hematopoietic Stem cell transplantation: prolonged steroid therapy for GvHD and endocrinopathy after hematopoietic Stem cell …
- … (d; dara-RVd) vs. RVd in patients (pts) with newly diagnosed multiple myeloma (mm) eligible for high‐dose therapy (HDT) and autologous Stem cell …
- Induced Pluripotent Stem cell-Derived Autologous cell therapy for Age-Related Macular Degeneration
- Histological study on the promising role of mesenchymal Stem cell therapy in paraquat induced lung injury in adult male albino rats
- Evaluation of lymphoma patients receiving high-dose therapy and autologous Stem cell transplantation: experience of a single center
- Genetic modulation therapy through Stem cell transplantation for human immunodeficiency virus 1 infection
- Effects of human umbilical cord mesenchymal Stem cell therapy on the immune function and prognosis in patients with decompensated liver cirrhosis due to hepatitis …
- Nestin and CD146 expression in metaplastic breast cancer: Stem–cell therapy in need? Lessons reported from a male patient
- Stem cell-based therapy in transplantation and immune-mediated diseases
- Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic Stem cell transplant …
- Stem cell therapy in Stroke
- therapy targeting Stem cell in patients with decompensated cirrhosis of liver in a tertiary treatment care center of Bangladesh
- Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous Stem cell transplantation
- Application of Bone Marrow Stem cell Based therapy in Bone Loss Diseases
- From Stem cell therapy to Cancer Treatment
- Stem cell therapy in Osteoarthritis
- Concept of Targeted Cancer Stem cell therapy and New Versions
- Stem cell therapy: from translational hurdles to new frontiers
- A randomized study comparing Stem cell transplantation versus conventional therapy for low-and intermediate-risk myelodysplastic Syndromes patients
- Stem cell therapy in Glaucoma
- Stem cell therapy As A Regenerative Approach In Veterinary Medicine
- Stem cell therapy in Diabetes Mellitus
- DESIGNING PROTEIN-ENGINEERED BIOMATERIALS FOR Stem cell therapy
- Stem cell therapy Applications: The Challenge of Regenerative Medicine
- New Advances in Stem cell therapy for Diabetes Mellitus
- Haploidentical hematopoietic Stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with …
- Stem cell therapy in glaucoma
- Evasion of targeted cancer therapy through Stem–cell-like reprogramming
- Cardiac Stem cell therapy: Current status
- Inflammation and Stem cell therapy for stroke
- A novel highly conserved hematopoietic Stem/progenitor cell population for Stem cell transplantation and gene therapy
- Stem cell therapy for Type-1 Diabetes Mellitus
- Stem cell therapy In Spinal Cord Injury
- Osteoarthritis and Mesenchymal Stem cell therapy: An Overview
- Rationale for Stem cell therapy for type 2 diabetes mellitus
- Single dose preemptive plerixafor for Stem cell mobilization for ASCT after lenalidomide based therapy in multiple myeloma: impact in resource limited setting
- Evaluation of low‐dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for Stem cell transplantation
- Stem cell therapy for Autism
- Stem cell therapy for Spinal Cord Injury
- Stem cell therapy for Autism
- Stem cell therapy: an Adjunct in the Treatment of MDR Tuberculosis
- Bone marrow Stem cell therapy for stroke
- Gene and Stem cell therapy for type 1 diabetes mellitus
- Update of Stem cell therapy for orthopedic diseases of animals
- therapy targeting Stem cell in patients with decompensated cirrhosis of liver in a tertiary treatment care center of Bangladesh
- High-dose chemotherapy and Stem–cell rescue for salvage therapy for relapsed malignant mixed ovarian germ cell tumor: A case report
- Impact of post-autologous Stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the …
- Progress of Stem cell therapy in Spinal Cord Injury
- Bone Marrow Hematopoietic Stem cell therapy in Stroke
- When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic Stem cell transplant recipients?
- Stem cell therapy for Retinal Disease Treatment: An Update
- Stem cell therapy in Neurological and Neurodegenerative Disease
- Safety of Neural Stem cell therapy for Traumatic Brain Injury
- Therapeutic and economic implications of regulating Stem cell therapy and blood components
- … (ITd) induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous Stem cell …
- Stem cell therapy for chronic bladder ischaemia
- Stem cell therapy for glaucoma—there is still a long way to go
- Stem cell therapy as an Effective Treatment Method for Traumatic Burn Injuries
- Future Medicine such as Gene or Stem cell therapy are Better than Nonbiological or Some Biological (Antibiotic) Medicine
- Anterior cruciate ligament injury and Stem cell therapy
- Stem cell therapy for Neurovascular and Traumatic Brain Diseases
- Development of Membrane-Based Coculture Platforms for Effective Stem cell therapy
- Research progress and challenge of the Stem cell therapy for intervertebral disc regeneration
- Future Medicine such as Gene or Stem cell therapy Are Better Than Non biological or Some Biological (Antibiotic) Medicine
- Embryonic Toxic Lesions and Stem cell therapy
- Novel Stem cell-targeted therapy for multiple myeloma based on dual inhibition of EZH1/2
- Feasibility of renal tissue Stem cell therapy for acute renal failure
- Mesenchymal Stem cell therapy for Chronic Wound Healing in Dogs
- Clinical Findings and Outcome after Stroke. Including a Translational Stem cell therapy Perspective.
- Into the hearts of babes: Stem cell therapy for pediatric heart failure
- TYPE 2 DIABETES MELLITUS AND Stem cell therapy: A REVIEW
- Stem cell therapy in patients with ischemic stroke: A syStematic review and meta-analysis of randomized controlled trials
- Human Umbilical Cord Mesenchymal Stem cell therapy for Patients
- … strategies after allogeneic hematopoietic Stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy …
- Nitazoxanide is effective therapy for norovirus gastroenteritis after hematopoietic Stem cell transplantation
- Mesenchymal Stem cell therapy for Liver Cirrhosis Treatment: Mechanisms and Bioeffects
- GENE AND Stem cell therapy IN β-THALASSEMIA
- Stem cell therapy for intervertebral disc regeneration
- Acute Respiratory Failure In A Patient With Ipf Following Nebulized And Intravenous Stem cell therapy
- Stem cell transplantation in patients with syStemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy
- Mesenchymal Stem cell therapy for Airway Restoration Following Surgery
- Potential Ciliary Neurotrophic Factor Application in Dental Stem cell therapy
- POTENTIAL OF Stem cell therapy DURING DENGUE INFECTION IN MICE
- Preclinical development of a neural Stem cell therapy for stroke and traumatic brain injury
- Immunomodulatory Effects of Stem cell therapy on Racehorses with Musculoskeletal Disorders
- Soldier with brain injury can have experimental Stem cell therapy, says judge
- Stem cell therapy for Articular Cartilage Repair
- A Compressed Collagen Gel Vehicle for Stem cell therapy of Wounded Corneas
- Stem cell therapy in End Stage Liver Disease and Liver Failure
- Induced Pluripotent Stem cell therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases
- Stem cell AND ITS therapy
- Manufacturing solutions for mesenchymal stromal/Stem cell therapy expansion
- Regenerating Life: Exploring the Potential for Stem cell therapy in Traumatic Brain Injury
- The effect of human mesenchymal Stem cell therapy on in vitro model of alopecia areata
- Shear susceptibility of human mesenchymal Stem cells increases with generation number: Implications for Stem cell therapy scale-up and manufacturing
- Cervical papanicolaou smears in hematopoietic Stem cell transplant recipients: high prevalence of therapy-related atypia during the acute phase
- Autologous mesenchymal Stem cell therapy in behcet disease
- Stem cell therapy: Optimization, Regeneration, Reprogramming, Expansion, Tissue Engineering
- Modulation of structural and functional networks in the ischemic mouse brain by Stem cell therapy
- CD34+ Stem cell therapy Does Not Increase the Risk of Arrhythmias in Patients With Chronic Heart Failure
- EFFECTS OF ADIPOSE TISSUE MESENCHYMAL Stem cell therapy ON DIABETIC RATS
- Mechanisms of action of mesenchymal Stem cell therapy in lung emphysema
- Does Stem cell therapy improve beta cell function in type 2 diabetic mellitus patients: A syStematic review and single arm meta-analysis
- The Impact of Sex on the Response to Mesenchymal Stem cell therapy in Patients With Non-Ischemic Dilated Cardiomyopathy
- Development of a cost efficient platform for the industrial manufacturing of pluripotent Stem cell derived products for cell therapy: cell expansion is the starting …
- ROS, pH and temperature responsive hydrogels for Stem cell therapy
- Mixed phenotype acute leukemia with t (9; 22): success with nonacute myeloid leukemia‐type intensive induction therapy and Stem cell transplantation
- Stem cell therapy Effect on the Inflammatory Response in a Porcine Model of Acute Lung Injury
- Dose adaptation of the drugs used for hematopoietic Stem–cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines …
- Imaging in Stem cell Transplant and cell-based therapy
- … UPDATED COMPREHENSIVE META-ANALYSIS OF RANDOMIZED TRIALS EVALUATING THE EFFICACY OF Stem cell therapy FOR REFRACTORY ANGINA
- P6319Novel swine models of single syStemic ventricle for Stem cell therapy in univentricular heart application
- Adipose Stem cell therapy for Early Retinal Complications of Diabetes in the Ins2Akita Mouse
- Phenotype of Super-Responders to Stem cell therapy for Non-Ischemic Dilated Cardiomyopathy
- GW28-e0652 Meta-analysis of Bone Marrow Stem cell therapy on Patients with Chronic Ischemic Heart Disease and Congestive Heart Failure
- … of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/Stem (regenerative) cell
- Stromal vascular fraction and adipose derived Stem cells from chronic disease and obese patients can affect Stem cell therapy
- Clinical trials of Stem cell therapy in dogs and cats with refractory diseases
- Olfactory Stem cell therapy in Canine Age-related Disorders Treatment: A Controlled Study
- 14 Stem cell therapy in Duchenne Muscular Dystrophy
- Clinical applications of a Stem cell-based therapy for oral bone reconstruction
- Stem cell Biology, Research & therapy
- ID: 1041 Effectiveness of human adipose-derived Stem cell therapy pretreated with hepatocyte growth factor in liver fibrosis mouse model
- Bilateral Osteonecrosis Associated with Corticosteroid Treatment: Stem cell therapy Versus Core Decompression in the Same Patient
- Stem cell therapy for end stage COPD: a cautionary tale of direct-to-consumer advertising
- Human Mesenchymal Stem cell therapy Reverses Sugen/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
- Mesenchymal Stem cell therapy on Tendon/Ligament Healing. J Cytokine Biol 2: 112
- P 53: Stem cell therapy for Treatment of Autoimmune Diseases (with Emphasis on Multiple Sclerosis)
- Use of Stem cell in Fetal therapy: Current Status and Future Perspectives
- Effect of mesenchymal Stem cell therapy on the proteinuria of dogs with chronic kidney disease.
- THE ROLE OF GENDER ON MESENCHYMAL Stem cell therapy IN NON-ISCHEMIC DILATED CARDIOMYOPATHY: A SUB-ANALYSIS OF THE POSEIDON …
- P 111: Use of Stem cell therapy for Treatment of Temporal Lobe Epilepsy (TLE)
- To evaluate the effect of autologous adipose derived mesenchymal Stem cell therapy in the treatment of osteoarthritis–A case series analysis
- Do Males and Females with Non-Ischemic Dilated Cardiomyopathy Respond Similarly to Stem cell therapy? an Analysis From the POSEIDON-DCM Trial
- Optimal delivery route of mesoangioblasts for Stem cell therapy in rat model for simulated vaginal birth injury
- 193 Does Stem cell therapy Hold Promise In The Management Of Traumatic Brain Injuries? A Literature Review of Animal Studies
- Human umbilical cord-mesenchymal Stem cell therapy protects against experimental ischemic stroke and neurotrauma
- Final analysis of the phase I/II study of CC-486 (oral azacitidine) maintenance therapy after allogeneic Stem cell transplantation (Allo-SCT) in patients with …
- Granulocyte colony-stimulating factor and autologous CD133-positive Stem–cell therapy in liver cirrhosis (REALISTIC)
- Novel strategies for generation and hypothermic storage of human pluripotent Stem cell-derived cardiomyocytes for cell therapy applications
- A syStemically-delivered Stem cell therapy for dry age related macular degeneration
- Evaluation of the effectiveness of Stem cell therapy with use of adult multipotent neural crest-derived Stem cells for modeled adrenal-induced glaucoma treatment
- Biological performance of novel phosphate-based glass microspheres for mesenchymal Stem cell therapy in osteoporotic patients
- Stem cell Pool: What Are the Best Patterns for cellular therapy?
- Exosomes isolated from human inducible pluripotent Stem cell-derived cardiomyocytes enhance angiogenesis in-vitro; a new potential therapy for the post-ischemic …
- … to: Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic Stem cell therapy
- Post-Autologous Stem cell Transplantation therapy for Multiple Myeloma Patients: Impact on Clinical Outcomes
- Recover of voluntary muscular contractile capacity in spinal cord injury patients who received combined autologous Stem cell therapy: In spinal cord and skeletal …
- T‐cell‐rich HLA‐haploidentical hematopoietic Stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome‐positive acute lymphoblastic …
- Impact of FDA approval of lenalidomide maintenance therapy in the first-line treatment of multiple myeloma after autologous Stem cell transplant on total healthcare …
- Generation of HIV-1 resistant, functional blood cells from human pluripotent Stem cells for the Stem cell-based therapy
- Stem cell-derived exosome transplantation as a new cell-free therapy for liver regeneration
- P11: Can delivery of mesenchymal Stem cell aggregates enhance retention of cells at the site of injury in cell therapy of equine tendon?
- Cutting Edge Advances in Stem cell Biology and therapy
- Towards an experimental Stem cell-based therapy for Age-related Macular Degeneration
- Maintenance rituximab after high-dose therapy and autologous Stem cell transplantation in mantle cell lymphoma
- PDTM-18. INVESTIGATING INTRA-CAVITY NEURAL Stem cell therapy FOR POST-SURGICAL DISEASE IN A NOVEL SURGICAL RESECTION/RECURRENCE …
- Progress of Stem/progenitor cell-based therapy for retinal degeneration
- Treatment of Myocardial Infarction by Stem cell Based therapy
- IGF-1 C domain-modified hydrogel facilitates Stem cell therapy in renal ischemia in diabetic mice
- Stem cell Biology, Research & therapy
- … of biotinylated IGF-1 with biotinylated self-assembling peptides combined with bone marrow Stem cell transplantation promotes cell therapy for myocardial infarction
- Stem cell Strategies for the Modeling and therapy of Alzheimer’s Disease
- Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic Stem cell transplantation in Hodgkin’s …
- … myeloid leukemia (SM-AML): a poor-risk multi-mutated disease that follows a distinct diagnostic algorithm and requires high-dose Stem cell-targeting therapy
- Development of Stem cell-based therapy for cornea-from tissue Stem cell to iPS cell
- Stem-40. THE ROLE OF SYMMETRIC cell DIVISION IN POST therapy GLIOMA Stem cell EXPANSION
- Development of a Stem cell gene therapy for Sanfilippo syndrome type B
- … Phase II Study of Clarithromycin or Placebo Combined with VCD Induction therapy Prior to High-Dose Melphalan with Stem cell Support in Patients with …
- Benefits afforded by combined temozolomide, radiation and Stem cell strategy for glioma therapy
- Lung Stem cell-based therapy: a possible way to repair the injuried lung
- Combining multiple therapeutic strategies for Friedreich’s ataxia (FRDA): antioxidant metallic nanoclusters as coadjuvants for gene and Stem cell therapy
- Clinical Safety and Applications of Stem cell Gene therapy
- Clinical study on foscarnet prophylaxis and pre-emptive therapy for cytomegalovirus infection in hematopoietic Stem cell transplantation
- … Azacitidine and High Dose Lenalidomide therapy Is Well Tolerated and Clinically Active in Patients Who Relapse after Allogeneic Stem cell Transplantation for Actue …
- Melphalan dose in myeloma patients over 65 years of age undergoing high-dose therapy and autologous Stem cell transplantation
- Predictive model for Stem cell transplantation with suicidal gene construct for the treatment of leukemia: Analytical model for gene therapy of leukemia
- Design of a quality control and safety program Stem cell-based therapy
- Hematopoietic Stem cell gene therapy corrects neuronopathic phenotype in
- Mesenchymal stromal/Stem cells: a new era in the cell-based targeted gene therapy of cancer
- IND-Enabling GLP study to support a clinical trial of dual adoptive cell therapy combining Stem cells and T cells engineered with an NY-ESO-1 TCR
- … -World Treatment Outcomes in Patients with Newly Diagnosed Multiple Myeloma Treated with Triplet therapy without Stem cell Transplant: An Enhanced …
- Acute Kidney Injury during Vancomycin therapy Associated with Combination Use of Piperacillin-Tazobactam after Allogeneic Stem cell Transplantation
- Optimized gene therapy normalizes wound healing and Stem cell marker expression in cultured diabetic limbal epithelial cells.
- Stem cells as potential candidates for psoriasis cell-replacement therapy
- Directly induced Neural Stem cells transplantation and prospects for Stem cell-based therapy
- Foam-cell Signified Blood Vessel Endhotel Repair and Histopatology of Abdominal Aorta through Stem cell Allogenous therapy to Rats (Rattus norvegicus) …
- … STUDIES OF NEURAL Stem cell MEDIATED CARBOXYLESTERASE/IRINOTECAN ENZYME/PRODRUG GENE therapy FOR RECURRENT GLIOMA LEADING …
- … radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous Stem cell transplantation (HDT-ASCT)
- A Single autologous Stem cell transplant (ASCT) followed by two years of post-transplant therapy is safe in older recently diagnosed multiple myeloma (MM) …
- Reduction of Gingival Black Triangles with Dental Pulp or Gingival Stem cell Injection therapy: Clinical and Outcomes Research Gaps
- The pathway regulation and targeted therapy of tumor Stem cells regulatory and targeting therapy of tumor Stem cell related signal pathway
- Engineering Stem cell fate for drug development and therapy
- Gene Modified Stem/Progenitor‐cell therapy for Ischemic Stroke
- Lenalidomide maintenance therapy after autologous peripheral blood Stem cell transplant (PBSCT) in multiple myeloma patients: factors that impact treatment
- Hematopoietic Stem cell transplantation in the era of molecular targeted therapy.
- Infectious complications associated with infliximab therapy for allogeneic Stem cell transplant patients with corticosteroid refractory acute graft versus host disease
- LACE high dose therapy with autologous Stem cell support
- Effective BiRd therapy after the Addition of Clarithromycin for Lenalidomide and Dexamethasone Resistant Multiple Myeloma Ineligible for Stem cell Transplantation
- A Mathematical Model of Cancer Stem cell Kinetics and Response to Radiation therapy
- A quest for the best retinal pigment epithelium (Stem) cell replacement therapy
- Establishing the optimal viral load threshold for initiation of therapy for cytomegalovirus infection in hematopoietic Stem cell transplant recipients: a prospective …
- Interleukin-6 blockade, a novel cancer Stem cell targeted therapy, attenuates lung cancer tissue construction
- Supportive (Maintenance) therapy in Hematopoietic Stem cell Transplantation: Main Principles and New Perspectives
- Inherent immunogenicity or lack thereof of pluripotent Stem cells: implications for cell replacement therapy
- … myeloma patients undergoing intensive preparative regimen with autologous Stem cell transplantation (ASCT) followed by maintenance therapy using novel agents
- Cancer Stem cell-selective photodynamic therapy
- Stem cell-Based therapy in Transplantation and Immune-Mediated Diseases
- … OF QUALITATIVE AND QUANTITATIVE INDICATORS OF SUBSTITUTIONARY TRANSFUSION therapy IN DIFFERENT TYPES OF HEMATOPOIETIC Stem cell …
- PP27. ESTABLISHMENT OF A HAEMATOPOIETIC Stem–cell BASED therapy FOR BRAIN TUMOURS IN PRE-CLINICAL MOUSE MODELS
- The role of high-dose therapy and autologous Stem cell transplantation in the treatment of patients with multiple myeloma
- … by CHASER as induction therapy for high-dose chemotherapy (HDT), LEED, and autologous Stem–cell transplantation (ASCT) in poor-risk diffuse large B-cell …
- Prospects for Stem cell-based mucosal regeneration therapy in inflammatory bowel disease.
- Research progress of Stem cell-derived RPE cell transplantation therapy for retinal degenerative diseases
- … of scientific reports and lectures at the XI Raisa Gorbacheva meeting hematopoietic Stem cell transplantation. Gene and cellular therapy (September 14-16 …
- Neuroanatomy of music therapy and hematopoietic Stem–cell transplantation
- Human Gingiva: A Promising Source of Mesenchymal Stem cells for cell therapy and Regenerative Medicine
- EXTH-20. ENHANCEMENT OF GAP JUNCTIONAL ACTIVITY BY iPS cell-DERIVED NEURAL Stem cells IN Stem cell-BASED SUICIDE GENE therapy
- PRELIMINARY RESULTS OF THE PHASE I CLINICAL STUDY EVALUATING NEURAL Stem cell BASED therapy FOR PARKINSON’S DISEASE (S4. 004)
- Development of iPS (induced pluripotent Stem cells) using natural product from extract of fish oocyte to provide Stem cell for regenerative therapy
- High-Dose therapy and Haemopoietic Stem cell Transplantation in Waldenström’s Macroglobulinaemia
- Mesenchymal Stem cell based-suicide gene therapy for the treatment of brain tumors
- Stem cell Replacement therapy for the Mammalian Inner Ear: A SyStematic Literature
- … to Any First Line therapy for Multiple Myeloma Should Proceed to Autologous Stem cell Transplantation Instead of Receiving Second Line therapy to …
- Mesenchymal Stem cell-based therapy for autoimmune disease: immunomodulatory potential and clinical applications
- Stem-11. A MAPK-DRIVEN miR-124-SOX9 AXIS IS CRITICAL FOR Stem cell MAINTENANCE, PROGRESSION, AND therapy-RESISTANCE IN …
- Stem cell-engineered invariant natural killer T cells for cancer therapy
- … /congelation of hematopoietic Stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- Lentiviral Hematopoietic Stem cell Gene therapy for MNGIE
- Analysis of cytokines from different disease modify therapy treated multiple sclerosis patients by mesenchymal Stem cell stimulation
- Multiple Myeloma and Renal Impairment: Analysis of Induction therapy Strategies and Outcome after Autologous Stem cell Transplantation
- Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose therapy (HDT) and Autologous Stem cell …
- 2325: Steroid therapy limits Stem cell activation required to enact mucosal healing in inflammatory bowel disease
- Development of Mesenchymal Stem cell Laden Patch-Type therapy using 3D cell-Printing Technology for Liver Cirrhosis Treatment
- … Establishment of Tumorigenicity Assay Promise the Safety in the Cardiomyogenesis therapy Using Human Induced Pluripotent Stem cell-Derived Cardiomyocytes for …
- … treated with autologous nonmyeloablative hematopoietic Stem–cell transplantation (AHST) compared with conventional medical therapy (CT). research design …
- Maintenance therapy with Azacitadine and Valproic Acid after Allogeneic Stem cell Transplant in Patients with High-Risk Acute Myelogenous Leukemia
- Outcomes of Salvage Second Autologous Stem cell Transplantation for Relapsed/Refractory Multiple Myeloma in the Era of Modern therapy
- Post Autologous Stem cell Transplant Light Chain Response Is a Prognostic Marker in Multiple Myeloma Patients in PR/VGPR after Induction therapy
- Factors Determining Utilization of Stem cell Transplant (SCT) for Initial therapy of Multiple Myeloma (MM) By Patient Race: Exploring Intra-Racial Healthcare …
- The efficacy of Salvage Autologous Stem cell Transplant for Patients With Multiple Myeloma Who Received Maintenance therapy Post an Initial Transplant
- … II study of intensive consolidation and Stem cell mobilization therapy with ofatumumab, etoposide, and high-dose ara-C (OVA), followed by autologous Stem cell …
- … of the angiogenic subset of human adipose-derived Stem cells by evaluation of capability to induce M2-dominant macrophage polarization in cell therapy
- Understanding cell signaling in cancer Stem cells for targeted therapy–can phosphoproteomics help to reveal the secrets?
- Result of Bortezomib Induction therapy Prior to Stem cell Transplantation in Newly Diagnosed Multiple Myeloma Cases in Mongolia
- therapy Related Myeloid Neoplasia in Hodgkin Lymphoma after Autologous Stem cell Transplantation (ASCT)–A Case Report
- Double Autologous Stem cell Transplantation Followed by Maintenance therapy Conquers the Adverse Cytogenetic Abnormalities in Newly Diagnosed Multiple …
- In situ immune expression signatures before and after ipilimumab therapy for relapsed acute myeloid leukemia after allogeneic Stem cell transplantation
- A novel process using human sera for the production of secretome and potentially clinical grade mesenchymal Stem cell for regenerative therapy/Nazmul Haque
- Improving Oral Assessments and Implementing Preventative Low Level Laser therapy in Hematopoietic Stem cell Transplant Patients to Prevent Oral Mucositis
- … of Duration of Induction therapy on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Undergoing Upfront Autologous Stem cell …
- 18f-FDG PET-CT Assessment of Responses to Salvage therapy and Autologous Stem cell Transplant (ASCT) in Relapsed/Refractory Classical Hodgkin …
- The Effect of Sorafenib therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem cell Transplantation
- TMOD-03. GENES PRESERVING Stem cell STATE IN GROUP 3 MB BTICS CONTRIBUTE TO therapy EVASION AND RELAPSE
- Hypoxia Promotes Stem cell Phenotypes, Resistance to therapy and Poor Prognosis through Epigenetic Regulation of DICER
- Update on safety and efficacy of lentiviral hematopoietic Stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD)
- Non eligibility criteria for hematopoietic Stem cell donors: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy (SFGM-TC)
- 2203: Engraftment and gene expression of an HIV resistant immune syStem in a Phase I trial of an HIV Stem cell gene therapy strategy
- MEDU-30. GENES PRESERVING Stem cell STATE IN GROUP 3 MB BTICS CONTRIBUTE TO therapy EVASION AND RELAPSE
- Brentuximab Vedotin Consolidation therapy after Autologous Stem–cell Transplantation in Patients with High-Risk Hodgkin’s Lymphoma: The Real World Experience …
- Improved Survival Outcomes By Iron Chelating therapy with Deferasirox after Allogeneic Hematopoietic Stem cell Transplantation in Patients with Acute …
- Clinical investigation of sequential therapy with micafungin and reduced-dose voriconazole in prevention of fungal in patients after allogeneic hematopoietic Stem cell …
- … in-Hospital Morbidity and Mortality in SyStemic Light Chain (AL) Amyloidosis after High Dose therapy and Autologous Stem cell Transplant (HDT/ASCT)
- … of Cytomegalovirus (CMV) Viral Load on Probability of Spontaneous Clearance and Efficacy of Pre-Emptive therapy Among CMV Seropositive Allogeneic Stem cell …
- Comprehensive assessment of cancer Stem cell like cells in prediction of pathologic complete response to preoperative dual anti–HER2 therapy for HER2–positive …
- Corrigendum to “Combination of low-energy shock-wave therapy and bone marrow mesenchymal Stem cell transplantation to improve the erectile function of diabetic …
- Intensification therapy with autologous Stem cell transplantation versus bortezomib-melphalan-prednisone for newly diagnosed multiple myeloma patients: A …
- … choroidal thickness and peripapillary retinal thickness after high‐dose melphalan therapy followed by autologous peripheral blood Stem cell transplantation in a …
- The Impact of Thalidomide, Zoledronate and High-dose therapy with Autologous Stem cell Support on Patient Reported Outcomes in Multiple Myeloma: Results of …
- … dexamethasone (d; Dara-RVd) vs. RVd in patients (pts) with newly diagnosed multiple myeloma (MM) eligible for high-dose therapy (HDT) and autologous Stem cell …
- … and Vorinostat Followed By CD19 CAR-T therapy in a Patient with MLL-Rearranged ALL after Early Relapse Post Allogeneic Hematopoietic Stem cell …
- … B-regulatory cells from donor adipose tissue derived mesenchymal Stem cells and recipient peripheral blood mononuclear cells for potential cell therapy
- Assay development and cell characterization challenges of human induced pluripotent Stem cells for cell therapy applications
- Bioprocessing of human Pluripotent Stem cells for cardiac cell therapy and pre-clinical research
- Damaging effects of cigarette smoke on organs and Stem/progenitor cells and the restorative potential of cell therapy
- cell therapy of combat related spinal cord injury with use of adult neural crest-derived multipotent Stem cells
- Human-cell microparticles for cell–therapy and cargo delivery to Stem cells
- Age of Donor of Human Mesenchymal Stem cells Drastically Affects Structural and Functional Recovery After cell therapy Following Ischemic Stroke
- 5T4-targeted therapy ablates cancer Stem cells and prevents recurrence of head and neck squamous cell carcinoma
- Is there a place for human fetal-derived Stem cells for cell replacement therapy in Huntington’s disease?
- Therapeutic value of immune cell therapy based on T memory Stem cells and central memory T cells for hematological malignancies
- … Resveratrol Treatment for the Reduction in the Induced Pluripotent Stem (iPS) cell Tumorigenicity to Confirm the Safety of iPS cell-Based Cardiomyogenesis therapy
- Induced pluripotent Stem cells (iPSC) from small volume peripheral blood samples for in vitro modeling and cell therapy of pediatric liver diseases
- Microencapsulated Umbilical Cord Wharton Jelly-Derived Human Mesenchymal Stem cells for the cell therapy of Type 1 Diabetes Mellitus (T1d): Applications …
- The use of mesenchymal Stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy–a perspective on cell biological mechanisms
- An analysis of the transcriptional response of myelodysplastic syndrome Stem cells to therapy at single-cell resolution
- Ex Vivo Expanded Murine Mesenchymal Stem cells as Targets for the Generation of a cell Replacement therapy for Type 1 Diabetes
- A Universal Approach to Correct Various HBB Gene Mutations in Human Stem cells for Gene therapy of Beta-Thalassemia and Sickle cell Disease
- A potential therapy using engineered neural Stem cells prevented malignant melanoma from cell proliferation, epithelial-mesenchymal transition and metastasis in …
- A Modified Approach to Induce Differentiation of Muscle-Derived Stem cells into Schwann cell-Like cells: Implications for Remyelination therapy
- … -23. PHASE I STUDY OF ADOPTIVE cellULAR therapy (X-ALT) PLUS TOTAL TUMOR RNA-DENDRITIC cell VACCINE (TTRNA-DC)+ HEMATOPOIETIC Stem …
- Abstract LB-149: ITGA1 marks pre-malignant pancreatic lesions and drives Stem-like cell survival and TGFβ/collagen-induced therapy resistance and metastasis in …
- … Stem/progenitor cell neurogenic behaviour0009: Detection and quantification of bacteria in degenerating intervertebral discs0120: SMaRT human Stem cells to modify …
- Neural Stem cell therapy—Brief review
- Stem cell therapy in heart diseases–cell types, mechanisms and improvement strategies
- Stem cell therapy: a new therapeutic option for cardiovascular diseases
- Preclinical studies of Stem cell therapy for heart disease
- Osteoarthritis and Stem cell therapy in humans: a syStematic review
- Mesenchymal Stem cell therapy for bone regeneration
- Stem cell therapy for multiple sclerosis
- Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research
- A biodegradable hybrid inorganic nanoscaffold for advanced Stem cell therapy
- Current approaches for the treatment of premature ovarian failure with Stem cell therapy
- Neural Stem cell therapy for subacute and chronic ischemic stroke
- Mesenchymal Stem cell therapy for ischemic tissues
- Novel approach to Stem cell therapy in Parkinson’s disease
- Intra-articular mesenchymal Stem cell therapy for the human joint: a syStematic review
- Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell-based therapy
- Induced pluripotent Stem cells: the most versatile source for Stem cell therapy
- Stem cell therapy: a promising therapeutic method for intracerebral hemorrhage
- The current status of Stem cell therapy in ischemic heart disease
- Mesenchymal Stem cell therapy in stroke: a syStematic review of literature in pre-clinical and clinical research
- Hematopoietic Stem cell therapy for autoimmune diseases–clinical experience and mechanisms
- Long-term efficacy and safety of Stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn’s disease
- Advances in Stem cell therapy for amyotrophic lateral sclerosis
- The application of nanomaterials in Stem cell therapy for some neurological diseases
- Stem cell therapy in autism: recent insights
- Optimal electrical stimulation boosts Stem cell therapy in nerve regeneration
- … and Stem cell therapy: AMPK as an applicable pharmacological target for rejuvenation of aged Stem cells and achieving higher efficacy in Stem cell therapy
- Limited evidence for adipose-derived Stem cell therapy on the treatment of osteoarthritis
- Neural Stem cell therapy aiming at better functional recovery after spinal cord injury
- Mesenchymal Stem cell therapy in cats: Current knowledge and future potential
- Advances in Stem cell therapy for erectile dysfunction
- Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
- Safety and efficacy of adult Stem cell therapy for acute myocardial infarction and ischemic heart failure (Safecell Heart): a syStematic review and meta-analysis
- Mesenchymal Stem cell therapy of pulmonary fibrosis: improvement with target combination
- Stem–cell therapy and platelet-rich plasma in regenerative medicines: A review on pros and cons of the technologies
- Stem cell therapy for treating osteonecrosis of the femoral head: from clinical applications to related basic research
- A review on Stem cell therapy for multiple sclerosis: special focus on human embryonic Stem cells
- First off-the-shelf mesenchymal Stem cell therapy nears European approval
- Autologous Stem cell therapy in critical limb ischemia: a meta-analysis of randomized controlled trials
- The promise of mesenchymal Stem cell therapy for acute respiratory distress syndrome
- Mesenchymal Stem cell therapy in Ischemic stroke: a meta‐analysis of preclinical studies
- Stem cell therapy on skin: mechanisms, recent advances and drug reviewing issues
- Tissue engineering in osteoarthritis: current status and prospect of mesenchymal Stem cell therapy
- Stem cell therapy for articular cartilage repair: review of the entity of cell populations used and the result of the clinical application of each entity
- Stem cell therapy for patients with diabetes: a syStematic review and meta-analysis of metabolomics-based risks and benefits
- Stem cell therapy and type 1 diabetes mellitus: treatment strategies and future perspectives
- Pluripotent Stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation
- The current state of Stem cell therapy for ocular disease
- Stem cell therapy in necrotizing enterocolitis: Current state and future directions
- Outcome of allogeneic adult Stem cell therapy in dogs suffering from osteoarthritis and other joint defects
- Promotion of cell-based therapy: special focus on the cooperation of mesenchymal Stem cell therapy and gene therapy for clinical trial studies
- A syStematic review and meta-analysis of clinical trials of mesenchymal Stem cell therapy for cartilage repair
- Mesenchymal Stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases
- Efficacy of Stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy–Phase I–II
- Stem cell therapy for hypoplastic left heart syndrome: mechanism, clinical application, and future directions
- Stem cell therapy: Repurposing cell-based regenerative medicine beyond cell replacement
- The role of Stem cell therapy in regeneration of dentine-pulp complex: a syStematic review
- Nanomedicine in cancer Stem cell therapy: from fringe to forefront
- Feasibility, safety, and tolerance of mesenchymal Stem cell therapy for obstructive chronic lung allograft dysfunction
- Mesenchymal Stem cell therapy for acute and chronic pancreatitis
- Stem cell therapy in refractory perineal Crohn’s disease: long‐term follow‐up
- Potentials of combining nanomaterials and Stem cell therapy in myocardial repair
- Mesenchymal Stem cell therapy for aging frailty
- Granulocyte colony-stimulating factor and autologous CD133-positive Stem–cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled …
- Improvement in left ventricular function with intracoronary mesenchymal Stem cell therapy in a patient with anterior wall ST-segment elevation myocardial …
- Human leukocyte antigen class I and II knockout human induced pluripotent Stem cell–derived cells: universal donor for cell therapy
- Current status of Stem cell therapy, scaffolds for the treatment of diabetes mellitus
- Donor mesenchymal Stem cell linetics after transamniotic Stem cell therapy (TRASCET) for experimental spina bifida
- Combinatorial screening of nanoclay-reinforced hydrogels: a glimpse of the “holy grail” in orthopedic Stem cell therapy?
- Maturation of pluripotent Stem cell-derived cardiomyocytes: a critical step for drug development and cell therapy
- Interaction between hypothermia and delayed mesenchymal Stem cell therapy in neonatal hypoxic-ischemic brain injury
- Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia
- The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of Stem–cell therapy
- Efficient promotion of autophagy and angiogenesis using mesenchymal Stem cell therapy enhanced by the low-energy shock waves in the treatment of …
- Inducible pluripotent Stem cell-derived mesenchymal Stem cell therapy effectively protected kidney from acute ischemia-reperfusion injury
- Role of autologous bone marrow-derived Stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of …
- Articular cartilage aging-potential regenerative capacities of cell manipulation and Stem cell therapy
- Stem cell therapy for faecal incontinence: current state and future perspectives
- Stem cell therapy in patients with chronic nonischemic heart failure
- Compressed collagen enhances Stem cell therapy for corneal scarring
- Stem cell therapy for treatment of thromboangiitis obliterans (Buerger’s disease)
- Autologous and allogeneic cardiac Stem cell therapy for cardiovascular diseases
- Towards standardized Stem cell therapy in type 2 diabetes mellitus: a syStematic review
- Specific cancer Stem cell–therapy by albumin nanoparticles functionalized with CD44-mediated targeting
- Stem cell therapy for COPD: where are we?
- Haemopoietic Stem cell therapy in cirrhosis: the end of the story?
- Subchondral Stem cell therapy versus contralateral total knee arthroplasty for osteoarthritis following secondary osteonecrosis of the knee
- Ethical and safety issues of Stem cell-based therapy
- Mesenchymal Stem cell therapy for paraquat poisoning: a syStematic review and meta-analysis of preclinical studies
- Immune inflammatory modulation as a potential therapeutic strategy of Stem cell therapy for ALS and neurodegenerative diseases
- Stem cell therapy for multiple sclerosis
- Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
- Regulation of Stem cell therapy travel
- Transamniotic Stem cell therapy: a novel strategy for the prenatal management of congenital anomalies
- Stem cell therapy of gliomas
- Gender-independent efficacy of mesenchymal Stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident Stem cell recovery
- Mesenchymal Stem cell therapy in intracerebral haemorrhagic stroke
- Mesenchymal Stem cell therapy for ischemic heart disease: Advances and challenges
- Allogeneic adipose‐derived mesenchymal Stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety
- Stem cell therapy for osteonecrosis of the femoral head: current trends and comprehensive review
- Composite hydrogel modified by IGF-1C domain improves Stem cell therapy for limb ischemia
- Cochrane Corner: Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
- Clinical performance of Stem cell therapy in patients with acute-on-chronic liver failure: a syStematic review and meta-analysis
- Mesenchymal Stem cell-based therapy for cardiovascular disease: progress and challenges
- Current approaches for the treatment of male infertility with Stem cell therapy
- Evaluation of the curative effect of umbilical cord mesenchymal Stem cell therapy for knee arthritis in dogs using imaging technology
- Advances in Stem cell therapy for cartilage regeneration in osteoarthritis
- A review of Stem cell therapy for acquired brain injuries and neurodegenerative central nervous syStem diseases
- Stem cell therapy for tendon regeneration: current status and future directions
- Postnatal periodontal ligament as a novel adult Stem cell source for regenerative corneal cell therapy
- Mesenchymal Stem cell therapy prevents abortion in CBA/J× DBA/2 mating
- Bladder regeneration through Stem cell therapy
- Stem–cell therapy Advances in China
- Potential of Stem cell-based therapy for ischemic stroke
- Is Stem cell therapy the future of orthopedics?
- Stem‐cell therapy in ST‐segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double‐blind randomized trial
- Stem cell therapy for lung diseases: From fundamental aspects to clinical applications
- Stem cell therapy in early post-traumatic talus osteonecrosis
- Fetal bone marrow homing of donor mesenchymal Stem cells after transamniotic Stem cell therapy (TRASCET)
- Stem cell therapy for retinal ganglion cell degeneration
- Stem cell therapy using bone marrow-derived mononuclear cells in treatment of lower limb lymphedema: a randomized controlled clinical trial
- A collagen based cryogel bioscaffold coated with nanostructured polydopamine as a platform for mesenchymal Stem cell therapy
- Intra-cavity Stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection
- High-grade purification of third-generation HIV-based lentiviral vectors by anion exchange chromatography for experimental gene and Stem cell therapy applications
- Pluripotent Stem cell-based therapy for Parkinson’s disease: Current status and future prospects
- Will nanotechnology bring new hope for Stem cell therapy?
- An oxygen plasma treated poly (dimethylsiloxane) bioscaffold coated with polydopamine for Stem cell therapy
- Stem cell therapy in cerebrovascular disease
- Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic Stem cell transplantation treated by CAR T-cell therapy: a case report
- Stem cell fate in cancer growth, progression and therapy resistance
- Hematopoietic Stem cell transplantation in the era of engineered cell therapy
- Amputation-site soft-tissue restoration using adipose Stem cell therapy
- Stem cell therapy for perianal Crohn’s disease
- Mesenchymal Stem cell/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure
- Human mesenchymal Stem cell therapy reverses Su5416/hypoxia-induced pulmonary arterial hypertension in mice
- Autologous Stem cell therapy for inherited and acquired retinal disease
- The challenges of Stem cell therapy in myocardial infarction and heart failure and the potential strategies to improve the outcomes
- Cancer Stem cell metabolism: target for cancer therapy
- Recent updates on treatment of ocular microbial infections by Stem cell therapy: a review
- Advancement in Stem cell therapy for ischemic myocardial cell: A syStematic review
- Clinical experience with regenerative therapy in heart failure: advancing care with cardiopoietic Stem cell interventions
- Human mesenchymal Stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease–review of pathomechanism and existing clinical data
- Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer
- Treating childhood traumatic brain injury with autologous Stem cell therapy
- Stem cell therapy in osteonecrosis of the femoral head
- A pooled analysis of mesenchymal Stem cell-based therapy for liver disease
- Concise review: optimized strategies for Stem cell-based therapy in myocardial repair: clinical translatability and potential limitation
- Mesenchymal Stem cell therapy in osteoarthritis and regenerative medicine
- Six years’ experience of tolerance induction in renal transplantation using Stem cell therapy
- Progress in mesenchymal Stem cell–based therapy for acute liver failure
- Mesenchymal Stem cell migration during bone formation and bone diseases therapy
- Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?
- NK cell therapy after hematopoietic Stem cell transplantation: can we improve anti-tumor effect?
- A review of clinical trials: mesenchymal Stem cell transplant therapy in type 1 and type 2 diabetes mellitus
- Stem cell therapy in erectile dysfunction: science fiction or realistic treatment option?
- Current status and potential challenges of mesenchymal Stem cell-based therapy for malignant gliomas
- Mesenchymal Stem cell-based therapy for radiation-induced lung injury
- Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side
- Current perspectives regarding Stem cell-based therapy for liver cirrhosis
- Efficiency of Stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis
- Combining Stem cell therapy for advanced heart failure and ventricular assist devices: a review
- cell-free therapy based on adipose tissue Stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway
- Cancer-testis antigens: Unique cancer Stem cell biomarkers and targets for cancer therapy
- Lipocalin 2 enhances mesenchymal Stem cell-based cell therapy in acute kidney injury rat model
- Mesenchymal Stem cell therapy in hematopoietic Stem cell transplantation
- Current perspectives regarding Stem cell-based therapy for Alzheimer’s disease
- Sports Injuries: Diagnosis, Prevention, Stem cell therapy, and Medical Sport Strategy
- … differentiation of mesenchymal Stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis
- Early relapse for multiple myeloma patients undergoing single autologous Stem cell therapy: a single-center experience
- The effect of age on Stem cell function and utility for therapy
- Modulation of autophagy as new approach in mesenchymal Stem cell-based therapy
- Local mesenchymal Stem cell therapy in experimentally induced colitis in the rat
- Advantages of graphene biosensors for human Stem cell therapy potency assays
- Intrathecal autologous bone marrow-derived hematopoietic Stem cell therapy in neurological diseases
- The use of Stem cell therapy to reverse opioid tolerance
- Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy
- Safety and efficacy of hematopoietic and mesanchymal Stem cell therapy for treatment of T1DM: a syStematic review and meta-analysis protocol
- An acute immune response underlies the benefit of cardiac adult Stem cell therapy
- Stem cell culture in microgravity and its application in cell-based therapy
- Molecular and cellular mechanisms involved in mesenchymal Stem cell-based therapy of inflammatory bowel diseases
- Stem cell therapy in severe pediatric motility disorders
- Current perspectives regarding Stem cell-based therapy for ischemic stroke
- Donor-derived second generation of CD19 CAR-T cell therapy for relapsed B-cell acute lymphoblastic leukemia after allogenic Stem cell transplantation
- Biomaterials for Stem cell therapy for cardiac disease
- A new approach for loading anticancer drugs into mesenchymal Stem cell-derived exosome mimetics for cancer therapy
- Psychological Issues for Patients Undergoing Stem cell therapy and Regenerative Medicine
- Music therapy supported the health‐related quality of life for children undergoing haematopoietic Stem cell transplants
- Intranasal Stem cell treatment as a novel therapy for subarachnoid hemorrhage
- Brain‐targeted Stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms
- Sorafenib as maintenance therapy post allogeneic Stem cell transplantation for FLT3-ITD positive AML: results from the randomized, double-blind, placebo …
- Critical role of tumor necrosis factor signaling in mesenchymal Stem cell-based therapy for autoimmune and inflammatory diseases
- Modulation of post-stroke plasticity and regeneration by Stem cell therapy and exogenic factors
- Stem cell-based RPE therapy for retinal diseases: engineering 3D tissues amenable for regenerative medicine
- Stem cell therapy for stroke: lessons learned from recent successful randomized trials of interventional therapy for stroke
- HDACis (class I), cancer Stem cell, and phytochemicals: Cancer therapy and prevention implications
- Long-term survival of older patients with MDS treated with HMA therapy without subsequent Stem cell transplantation
- Stem–cell therapy restores heart function after MI in macaques
- Twenty years of limbal epithelial therapy: an update on managing limbal Stem cell deficiency
- Cerebrospinal fluid-Stem cell interactions may pave the path for cell-based therapy in neurological diseases
- Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal Stem cell membrane for tumor-targeted therapy
- Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal Stem cell therapy for EAE
- cell therapy for ischemic stroke. Stem cell types and results of pre-clinical trials
- Mesenchymal Stem cell expressing TRAIL as targeted therapy against sensitised tumour
- Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic Stem cell …
- Upfront autologous Stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the …
- Hydrogel-Based Strategies for Stem cell therapy
- … approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic Stem cell therapy
- Stem cell therapy for cirrhosis of liver in Bangladesh: Specific design compatible for developing country
- Pharmacological approaches promoting Stem cell-based therapy following ischemic stroke insults
- Understanding the therapeutic potential of bone marrow Stem cell therapy in ischemic stroke
- Stem cell‐and gene‐based therapies as potential candidates in Alzheimer’s therapy
- FDA approval summary: lenalidomide as maintenance therapy after autologous Stem cell transplant in newly diagnosed multiple myeloma
- Improvement of common variable immunodeficiency using embryonic Stem cell therapy in a patient with lyme disease: A clinical case report
- Human mesenchymal Stem cell-derived extracellular vesicles/estrogen combined therapy safely ameliorates experimentally induced intrauterine adhesions in …
- Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by Stem cell gene therapy
- Unique Aspects of the Design of Phase I/II Clinical Trials of Stem cell therapy
- NAMPT is a potent oncogene in colon cancer progression that modulates cancer Stem cell properties and resistance to therapy through Sirt1 and PARP
- Stem cells treatment to combat Cancer and genetic disease: from Stem cell therapy to gene-editing correction
- siRNA delivery with Stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy
- Stem‐cell cardiospheres for myocardial regeneration: advancing cell therapy in myocardial infarction and heart failure
- Impact of the initial fitness level on the effects of a structured exercise therapy during pediatric Stem cell transplantation
- A Light‐Triggered Mesenchymal Stem cell Delivery SyStem for Photoacoustic Imaging and Chemo‐Photothermal therapy of Triple Negative Breast Cancer
- Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following Stem cell therapy
- Apparent diffusion coefficient is a useful biomarker for monitoring adipose-derived mesenchymal Stem cell therapy of renal ischemic-reperfusion injury
- The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent Stem cell-derived therapy of myocardial infarction
- Personalizing therapy for atrial fibrillation: the role of Stem cell and in silico disease models
- Impact of induction therapy on the outcome of immunoglobulin light chain amyloidosis after autologous hematopoietic Stem cell transplantation
- Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic Stem cell transplantation …
- A comprehensive meta‐analysis of Stem cell therapy for chronic angina
- DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic Stem cell transplantation in myelodysplastic syndromes and …
- Stem cell therapy role in neurodegenerative disorders
- Enhancement strategies for cardiac regenerative cell therapy: focus on adult Stem cells
- Limbal stromal Stem cell therapy for acute and chronic superficial corneal pathologies: one-year outcomes
- Graphene oxide cellular patches for mesenchymal Stem cell-based cancer therapy
- Regulating human Stem cell research and therapy in low-and middle-income countries: Malaysian perspectives
- Stem cell biology: a new hope in regenerations and replenishments therapy
- Nanotechnology-assisted adipose-derived Stem cell (ADSC) therapy for erectile dysfunction of cavernous nerve injury: In vivo cell tracking, optimized injection …
- … (D; Dara‐Vrd) vs. Vrd in patients (PTS) with newly diagnosed (nd) multiple myeloma (Mm) eligible for High‐Dose therapy (HDT) and autologous Stem cell …
- Stem cell therapy for Alzheimer’s Disease
- The promise of Stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma
- … ebmt autoimmune diseases working party and the autologous Stem cell transplantation in refractory cd—low intensity therapy evaluation study investigators
- Preclinical efficacy and safety evaluation of hematopoietic Stem cell gene therapy in a mouse model of MNGIE
- Mesenchymal Stem cell-derived exosomes: applications in cell-free therapy
- Impact of oral side effects from conditioning therapy before hematopoietic Stem cell transplantation: protocol for a multicenter study
- Nicotine augments the beneficial effects of mesenchymal Stem cell-based therapy in rat model of multiple sclerosis
- Serum Stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma
- External beam radiation therapy enhances mesenchymal Stem cell–mediated sodium–iodide symporter gene delivery
- Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous Stem cell transplantation
- Age of donor of human mesenchymal Stem cells affects structural and functional recovery after cell therapy following ischaemic stroke
- Successful nivolumab therapy in an allogeneic Stem cell transplant child with post‐transplant lymphoproliferative disorder
- One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy
- A phase 3, trial of gilteritinib, as maintenance therapy after allogeneic hematopoietic Stem cell transplantation in patients with FLT3-ITD+ AML.
- Sirtuin3 protects aged human mesenchymal Stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases
- Regenerative medicine/cardiac cell therapy: Pluripotent Stem cells
- Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic Stem cell …
- Trends in Stem cell therapy
- Stem cell therapy for Parkinson’s disease: a review
- PET/CT for lymphoma post-therapy response assessment in other lymphomas, response assessment for autologous Stem cell transplant, and lymphoma follow-up
- Stem cell therapy: recent success and continuing progress in treating diabetes
- Hematopoietic Stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections
- Concomitant use of mesenchymal Stem cells and neural Stem cells for treatment of spinal cord injury: A combo cell therapy approach
- Creation of dystrophin expressing chimeric cells of myoblast origin as a novel Stem cell based therapy for Duchenne muscular dystrophy
- A Study to evaluate the effectiveness of structured teaching program regarding collection of cord blood for Stem cell therapy in terms of knowledge among staff nurses …
- The effect of combined pulsed wave low‐level laser therapy and mesenchymal Stem cell‐conditioned medium on the healing of an infected wound with methicillin …
- Handling, processing and disposal of Stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for …
- Stem cell therapy for ischemic stroke: from bench to bedside
- cell therapy of a knee osteoarthritis rat model using precartilaginous Stem cells
- Optimal delivery strategy for Stem cell therapy in patients with ischemic heart disease
- Stem cell therapy in anal fistula: a mini review
- Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic Stem cell transplant recipients after withdrawal of immunosuppressive therapy
- Delivering hematopoietic Stem cell gene therapy treatments for neurological lysosomal diseases
- Diabetic patients on Rutherford’s stage 5 is the best indication of Stem cell therapy in peripheral artery disease: A retrospective study on 367 patients
- Problems in Stem cell therapy for cardiac repair and tissue engineering approaches based on graphene and its derivatives
- High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous Stem cell transplantation for non-Hodgkin lymphoma: no differences in …
- … and prospective factor analysis of high-dose therapy combined with autologous peripheral blood Stem cell transplantation in patients with peripheral T-cell …
- Tonsil-derived mesenchymal Stem cell-embedded in situ crosslinkable gelatin hydrogel therapy recovers postmenopausal osteoporosis through bone …
- Stem cell therapy for liver cirrhosis unREALISTIC?
- R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic Stem cell support in fit patients with mantle cell lymphoma: 20 years …
- High‐dose therapy and autologous Stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL …
- Autologous Stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue …
- Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous Stem cell transplantation
- General Approaches to the Stem cell therapy in Diabetes Mellitus as Innovative Researches
- Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the Stem cell graft in newly diagnosed patients …
- Stem cell therapy in Veterinary Medicine
- The efficacy of salvage autologous Stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant
- … phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous Stem cell …
- Bcl-2 overexpression improves survival and efficacy of neural Stem cell-mediated enzyme prodrug therapy
- Knowledge and attitude toward Stem cell therapy in health and disease.
- A Review on Stem cell therapy in Cerebral Palsy with a Focus on Motor Function Improvement
- Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous Stem cell transplantation: the Memorial Sloan …
- The Regulation of Mesenchymal Stem cell therapy through magnetic resonance imaging agents-based cellular condition and oxygen environment
- Mesenchymal Stem cell-based therapy improves lower limb movement after spinal cord ischemia in rats
- Predictors of mononuclear cell yield in patients undergoing autologous mononuclear Stem cell therapy in non-haemopoietic degenerative disorders
- The role of FLT3 inhibitors as maintenance therapy following hematopoietic Stem cell transplant
- Flame-Spheroidized Phosphate-based glass particles with improved characteristics for applications in mesenchymal Stem cell culture therapy and tissue engineering
- Updated results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous Stem cell transplant (AuSCT) in patients (Pts) with …
- Combination therapy of autologous adipose mesenchymal Stem cell‐enriched, high‐density lipoaspirate and topical timolol for healing chronic wounds
- Novel challenges of Stem cell therapy in neurodegenerative disorders
- Effect of Stem cell therapy on Patients’ Quality of Life in Heart Failure with Reduced Ejection Fraction
- A perspective on Stem cell therapy for ear disorders
- Influence of Stem cell therapy on thyroid function and reactive oxygen species production in diabetic rats
- The current status and future of cardiac Stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy
- Human urine-derived Stem cells: potential for cell-based therapy of cartilage defects
- Editing the genome ex vivo Stem cell therapy
- Low‐dose azacitidine maintenance therapy after allogeneic Stem cell transplantation for high‐risk pediatric acute myeloid leukemia
- Regenerative Medicine and Stem cell therapy for the Eye
- Regulatable lentiviral hematopoietic Stem cell gene therapy in a mouse model of Parkinson’s disease
- Maintenance therapy with the oral proteasome inhibitor (PI) ixazomib significantly prolongs progression-free survival (PFS) following autologous Stem cell …
- Methodological exploration of bone marrow Stem cell therapy in acute myocardial infarction-how to achieve greater benefit on cardiac outcomes: A syStematic review …
- Umbilical cord mesenchymal Stem cell and neural Stem cell therapy for cerebral palsy: study protocol for a randomized, parallel-controlled trial
- Gynura divaricata attenuates tumor growth and tumor relapse after cisplatin therapy in HCC xenograft model through suppression of cancer Stem cell growth and Wnt …
- Stem cells and beta cell replacement therapy: a prospective health technology assessment study
- Preliminary Report on the Effect of Mesenchymal Stem cell therapy in Patients with Chronic Lung Allograft Dysfunction
- … disease after allogeneic Stem cell transplantation have altered metabolic profiles due to the disease and immunosuppressive therapy: potential implication for …
- Abstract QS11: Stem cell therapy enriched fat graft reconstruction of craniofacial deficits
- Allogeneic hematopoietic Stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: monocentric observational study and review of …
- Time-dependent recovery of human synovial membrane mesenchymal Stem cell function after high-dose steroid therapy: case report and laboratory study
- Acute myeloid leukaemia relapsing after allogeneic haemopoietic Stem cell transplantation: prognostic factors and impact of initial therapy of relapse
- Administration of Cripto in GRP 78 overexpressed human MSC s enhances Stem cell viability and angiogenesis during human MSC transplantation therapy
- Stem cell therapy for male infertility: A review
- Analysis of fractional order mathematical model of hematopoietic Stem cell gene-based therapy
- Ecto-mesenchymal Stem cells: a new player for immune regulation and cell therapy
- Feasibility of busulfan melphalan and Stem cell rescue after 131I-MIBG and topotecan therapy for refractory or relapsed metastatic neuroblastoma: the French …
- Stem cell-based gene therapy in neurological disorders
- Safety analysis of intra-patient dose-study of crenolanib maintenance therapy in patients with FLT3 mutant AML following allogeneic hematopoietic Stem cell …
- … post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic Stem cell gene therapy
- Intervertebral Disc Degeneration and Low Back Pain: Molecular Mechanisms and Stem cell therapy
- Mesenchymal Stem cell therapy for osteoarthritis: how apoptotic cells modulate inflammation
- Current advances in combining Stem cell and gene therapy for neurodegenerative diseases
- P691 Cx601, a novel Stem cell therapy for complex perianal fistulas in Crohn’s disease has rapid onset of clinical remission and low relapse rate by week 52
- Prospective randomization of post-remission therapy comparing autologous peripheral blood Stem cell transplantation versus high-dose cytarabine consolidation for …
- CD19-CAR therapy using naive/memory or central memory T cells integrated into the autologous Stem cell transplant regimen for patients with B-NHL
- Stem cell therapy for erectile dysfunction: Preliminary results from a single-center pilot study in Greece
- Regenerative medicine in the retina: from Stem cells to cell replacement therapy
- Stem–cell therapy for non-nAMD: We’re Getting Closer
- Noncoding RNAs and Stem cell function and therapy
- Stem–cell therapy in Fistulizing Perianal Crohn’s Disease
- Estrogen Iontophoresis Versus Stem cell therapy in the Treatment of Chronic Wound in the Lower Limb
- Combining electrical stimulation with Stem cell therapy improves endogenous mechanisms of stroke recovery
- A single autologous Stem cell transplant (ASCT) followed by two years of post-transplant therapy in recently diagnosed elderly multiple myeloma (MM) …
- Stem cell transplantation unit: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)
- … receptor T cells therapy strategy that dual targeting CD19 and CD123 to treat relapsed acute lymphoblastic leukemia after allogeneic hematopoietic Stem cell …
- … of alternative antiviral therapy and poor outcomes of acyclovir‐resistant herpes simplex virus infections in recipients of allogeneic Stem cell transplant–a retrospective …
- Biocrossing Heterotopia: Revisiting Contemporary Stem cell Research and therapy in India
- … of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic Stem cell …
- Negative pressure wound therapy promotes muscle‐derived Stem cell osteogenic differentiation through MAPK pathway
- No evidence of disease activity after five years of autologous hematopoietic Stem cell therapy for multiple sclerosis: detailed report of five patients
- Neurodegeneration with brain iron accumulation for Stem–cell therapy: Anesthetic management
- Combined treatment with extracorporeal shock‑wave therapy and bone marrow mesenchymal Stem cell transplantation improves bone repair in a rabbit …
- Early consolidation with high-dose therapy and autologous Stem cell transplantation is a feasible and effective treatment option in HIV-associated non …
- … , dexamethasone (KCRD) vs an immunomodulatory agent containing triplet (CTD/CRD) induction therapy prior to autologous Stem cell transplant: results of …
- Stem cell therapy: Promises versus Challenges
- Stem cell therapy for the damaged heart
- … -controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with Stem cell support in patients …
- Stem cell therapy IN DIABETES
- MP81-20 NON-INVASIVE, DUAL-LABELING TECHNOLOGY FOR cell TRACKING IN Stem cell therapy FOR ERECTILE DYSFUNCTION
- A Review on Stem cell therapy a Beginning of New Revolution.
- Mesenchymal Stem/Stromal cell-Based therapy for Heart Failure―What Is the Best Source?―
- Interim Clinical Assessment of a Neural Stem cell Based therapy for Parkinson’s Disease (S26. 002)
- Stem cell therapy in liver disease
- Stem cell therapy for Management of Chronic Pancreatitis
- The effects of autologous mesenchymal Stem cell therapy on elbow osteoarthritis in dogs: A pilot study
- … (ITd) induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous Stem cell …
- Transforming the treatment landscape with Stem cell therapy
- Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous Stem cell transplantation
- Second autologous hematopoietic Stem cell transplant as salvage therapy for relapsed multiple myeloma: a global treatment option for eligible patients
- CD19-CAR-T therapy followed by allogeneic hematopoietic Stem cell transplantation in refractory/relapsed and High risk B-cell acute lymphoblastic leukemia
- Early changes in tumor perfusion from T1-weighted dynamic contrast-enhanced MRI following neural Stem cell-mediated therapy of recurrent high-grade …
- Neural Stem cell therapy: A case of identity
- Division of Stem cell therapy
- Stem cell therapy for thalassemia: present and future
- Imaging in Stem cell Transplant and cell-Based therapy
- Human mesenchymal Stem cell therapy of polycystic ovary syndrome (PCOS) enhances adiponectin expression in the fat and protect against brown fat whitening
- Banked cord blood is a potential source of cells for deriving induced pluripotent Stem cell lines suitable for cellular therapy
- … Stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy (SFGM-TC) in …
- Adipose Derived Mesenchymal Stem cell therapy Is Comparable or Superior to Bone-Marrow Derived on Hypoxia-Induced Lung Injury in Primary Rat Alveolar …
- Stem cell therapy and regenerative medicine in RPE degenerative disease: advances and challenges
- Mixed cell therapy of bone marrow-derived mesenchymal Stem cells and articular cartilage chondrocytes ameliorates osteoarthritis development
- Stem cell therapy in Reproductive Medicine
- Hematopoietic Stem cell gene therapy for the cure of blood diseases: primary immunodeficiencies
- The current application of Stem cell based therapy in pulmonary hypertension
- Advances in Stem cell therapy for amyotrophic lateral sclerosis
- … Medicine: Stem cell and Gene therapy Organized Jointly by the European Society of Gene & cell therapy (ESGCT), International Society for Stem cell …
- T1 Mapping in Stem cell therapy
- Stem cell therapy and Regenerative Medicine in the Cornea
- What can we do to optimize Stem and progenitor cell therapy for heart failure?
- Intrathecal Autologous Stem cell therapy in Neurological Diseases
- Stem cell therapy: in treatment of neurodegenerative diseases
- The role of BMP-2, low-level laser therapy and low x-ray doses in dental follicle Stem cell migration
- Consider using biological agents or Stem cell therapy when managing perianal Crohn’s disease
- Stem cell therapy in Neonates—the Time Has (Almost) Come
- High transplant-related mortality associated with haematopoietic Stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on …
- Identification of novel targets for lung cancer therapy using an induced pluripotent Stem cell model
- Engineering mesenchymal Stem cells to improve their exosome efficacy and yield for cell-free therapy
- Stem cell therapy: hype or hope?
- Data Science Research to Support Stem cell therapy for Muscular Dystrophy
- Abstract A071: PSMA-specific CARTyrin T-Stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model
- P137: Stem cell therapy in Alzheimer’s Disease
- Stem cell therapy and the Central nervous syStem diseases: findings, obstacles, and future
- High-dose therapy and hematopoietic Stem cell transplantation in Waldenström macroglobulinemia
- REVIEW ON Stem cell therapy AS A INITIATIVE TOWARDS DIABETES MELLITUS
- Mesenchymal Stem cell therapy for the Treatment of Osteoarthritis
- Stem cell therapy for traumatic spinal cord injury
- Stem cell therapy enhancement with gold nanoparticles functionalized with nerve growth factor in an animal model of laser damaged retina
- Magnesium-based supports for Stem cell therapy of vascular disease
- … DYSFUNCTION REVEALS PATHWAYS ASSOCIATED WITH THERAPEUTIC EFFECTIVENESS OF Stem cell therapy FOR ISCHEMIC CARDIOMYOPATHIES
- Stem cell therapy for Cirrhosis of Liver in Bangladesh: Specific Design Compatible for Developing Country
- The role of ixazomib as an augmented conditioning therapy in salvage autologous Stem cell transplant (ASCT) and as a post-ASCT consolidation and …
- Aging and Stem cell therapy: ampk as an applicable pharmacological target for rejuvenation of aged Stem cells and achieving higher efficacy in Stem cell therapy
- A Stem cell therapy of amyotrophic lateral sclerosis: From bench to bedside
- … prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic Stem cell …
- Mesenchymal Stem cell therapy for diabetic foot ulcer
- Adoptive therapy with EBV-Specific T cells for Treatment of CNS EBV Post-Transplant Lymphoproliferative Disease Arising after Hematopoietic Stem cell …
- … D–red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti‐D and panreactive autoantibodies arising after hematopoietic Stem cell …
- Induced pluripotent Stem cells: cell therapy and disease modeling
- Autologous Adipose Tissue-Derived Mesenchymal Stem cell therapy Improves Skin Photo-Ageing
- THE ROLE OF cell DEATH IN MESENCHYMAL Stem cell therapy FOR OSTEOARTHRITIS
- Treatment with bortezomib-based therapy, followed by autologous Stem cell transplantation, improves outcomes in light chain amyloidosis: a retrospective study
- Meta-analysis to evaluate high-dose therapy followed by Stem cell transplant in patients with multiple myeloma
- Low-Dose Laser Activated Stem cell therapy
- Stem cell therapy in Anterior Cruciate Ligament (ACL) Injury
- Magnesium-based supports for Stem cell therapy of vascular disease
- Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic Stem cell …
- Progress and opportunities of gene and Stem cell therapy on hereditary ocular fundus diseases
- … cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of the Francophone Society for Stem cell Transplantation and cell therapy
- Targeted Delivery of Insulin-Like Growth Factor-1 Improves Stem cell therapy in A Rat Myocardial Infarction Model
- A phase 1 clinical trial of personalized adoptive cellular therapy targeting myelodysplastic syndrome (MDS) Stem cell neoantigens (PACTN)
- Mesenchymal Stem cell therapy in Proteoglycan Induced Arthritis
- Utility of cell therapy to control relapsed acute myeloid leukemia following allogeneic Stem cell transplantation: Does cell source matter
- Hysteroscopy and Stem cell therapy to Approach Refractory Asherman’s Syndrome
- Re-educating immunity in respiratory allergies: the potential for hematopoietic Stem cell-mediated gene therapy
- Stem cell therapy For Stroke. Modulation of structural and functional adjustments after Stem cell implantation in a mouse model of cortical stroke
- Stem cell therapy for the treatment of severe tissue damage after radiation exposure
- Meta-analysis to Evaluate High-Dose therapy Followed by Stem cell Transplant in Patients With Multiple Myeloma—Reply
- … from the CALGB study of lenalidomide maintenance therapy in newly diagnosed multiple myeloma post-autologous Stem cell transplantation adjusted for …
- cell-free therapy with the secretome of adipose tissue-derived Stem cells in rats’ frozen-thawed ovarian grafts
- Arrhythmogenic consequences of Stem cell therapy for cardiac regeneration
- … Follow Up of Chronic Spinal Cord Injury Patients Receiving Autologous Bone Marrow-Derived Mesenchymal Stem cell therapy Combined with Physical therapy
- Hyperbaric Oxygen therapy (HBOT) of an Adolescent Stem cell Transplantation (SCT) Recipient with Hemorrhagic Cystitis, and BK Virus: A Rare Case Study in the …
- Stem cell therapy, COST AND TOP 10 HOSPITALS IN INDIA-A RAY OF HOPE FOR COMMONS AND MIDDLE CLASS PEOPLE
- Role of Notch signaling pathway in bone marrow mesenchymal Stem cell therapy for phosgene inhalationinduced lung injury in rats
- Stem cell-mediated Biobridge: Crossing the Great Divide Between Bench and Clinic in Translating cell therapy for Stroke
- Stem cell therapy for treatment of ischemic optic neuropathy
- How optimizing efficiency for autologous Stem cell collection can set the stage for novel cell therapy growth in multiple departments
- Effectiveness assessment of kidney Stem cell therapy, derived from cat metanephro, in the treatment of chronic kidney disease in felines.
- Double-Blind, Placebo-Controlled, Randomized Trial of Stem cell therapy Combined With Bypass Surgery-The MiHeart Trial
- Could mesenchymal Stem cell therapy help in the treatment of muscle damage caused by Bothrops alternatus venom?
- The Impact of Mesenchymal Stem cell therapy on Cognitive Performance in People Living with Multiple Sclerosis
- James B Richardson: persuaded NICE to recommend Stem cell therapy for cartilage repair
- Secretome from bone marrow mesenchymal Stem cells: A promising, cell-free therapy for allergic rhinitis
- … quality of life with 5mg versus 25mg lenalidomide maintenance after first-line high-dose therapy and autologous blood Stem cell transplantation for multiple …
- Human Mesenchymal Stem cell therapy Reverses SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
- A syStematic review of conventional therapy and role of Stem cell transplantation for primary plasma cell leukemia
- cell therapy Using Genetically Modified Mesenchymal Stem cell in a Murine Model of Sepsis
- Whole-body vibration training as a supportive therapy during allogeneic haematopoietic Stem cell transplantation—a randomised controlled trial
- Stem-02. DEVELOPING BRAIN METASTATIC TUMOR MODELS FOR TARGETED Stem cell therapy
- KCNN4 Ion Channel Gene-Transfer Enhances the Effectiveness of Stem–cell therapy for Cardiac Injury
- … of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous Stem cell therapy for orthopaedic conditions
- Noncoding RNA Regulatory Networks, Epigenetics, and Programming Stem cell Renewal and Differentiation: Implications for Stem cell therapy
- cost-effectiveness analysis of lenalidomide for maintenance therapy after autologous Stem cell transplant (ASCT) in newly diagnosed multiple myeloma …
- Mechanisms of Mesenchymal Stem cell therapy for Enteric Neuropathy Associated with Colitis
- Human Placental Stem cell therapy in Stroke: Endothelial/Smooth Muscle Mechanisms Underlying Protection
- TMOD-31. NOVEL HETEROGENEOUS GLIOBLASTOMA MODELS TO OPTIMIZE HUMAN TUMORICIDAL NEURAL Stem cell therapy
- The mesenchymal Stem cell therapy for canadians with multiple sclerosis (MESCAMS) clinical trial: cell manufacturing of autologous bone marrow-derived mscs in …
- … the quality of Stem cell-derived hepatocytes for cell therapy: Role of pluripotency state in determining lineage commitment of human induced pluripotent Stem cells
- An Evaluation of Procedural Sedation Techniques in Duchenne Muscular Dystrophy Patients Undergoing Stem cell therapy
- Expression profile of Stem cell pathway genes in patients with advanced breast cancer after neoadjuvant therapy
- 2P-211: Hierarchically multipatterned topographical cues for Stem cell therapy approaches
- Stem/cell/syStematics/and/potentials/for/modeling/and/therapy
- Stem cell therapy Suppresses Infiltration of Platelets into Healing Corneal Wounds
- therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic Stem cell transplantation, from a persistent R882H-DNMT3A mutated …
- … based Chinese herbal medicine extraction inhibits cancer Stem cell growth and sensitizes of drug-resistant human non-small cell lung cancer cells for targeted therapy
- Functional Activation of Autologous Human Diabetic Stem cells for cell therapy
- PGD to select HLA matched embryo for Stem cell therapy in epidermolysis bullosa dystrophica
- Preclinical development of a hematopoietic Stem and progenitor cell bioengineered factor VIII lentiviral vector gene therapy for hemophilia A
- Comparison of TVT-secur mini-sling & Stem cell therapy in the treatment of stress urinary incontinence in women
- Differential risk of viral infections in children undergoing complex anticancer therapy or hematopoietic Stem cell transplantation
- An evolution of Stem cell research and therapy in Viet Nam
- … study to assess the effectiveness of self-instructional module (Sim) on knowledge regarding cord blood banking & Stem cell therapy among antenatal women in …
- Successful steroid therapy for lipoid pneumonia developing after allogeneic hematopoietic Stem cell transplant: a case report
- Phase 1 safety outcomes of mesenchymal stromal Stem cell therapy in pateints with low and intermediate-1 ipss risk myelodysplastic syndrome
- P165: Therapeutic Potentials of Stem–cell-Based therapy for Parkinson’s Disease; Current Status of Human Endometrium-Derived Mesenchymal Stem cells
- … inhibition induces metabolic reprogramming in T-cells leading to induction of Stem cell memory CD8 cells that enhance potency of adoptive cell therapy and anti-OX40 …
- … /refractory patients with FLT3-ITD mutated AML are poor when treated with non-targeted therapy with a potential role for Stem cell transplantation: results from …
- A rotating cerium anode X-ray syStem allows visualization of intramural coronary vessels after cardiac Stem cell therapy for myocardial infarction
- Prospective evaluation of minimal residual disease in multiple myeloma following autologous Stem cell transplantation (ASCT) and consolidation therapy.
- Using Functional Assessment of Cancer therapy-Bone Marrow Transplant (FACT-BMT) Tool to Explore Quality of Life in Patients Undergoing Autologous Stem cell …
- Consolidative whole-brain radiation therapy versus autologous Stem cell transplant for primary central nervous syStem lymphoma: a large dose of perspective and …
- Using Stem cell-Derived Microvesicles in Regenerative Medicine: A New Paradigm for cell-Based-cell-Free therapy
- … multiforme treated with Stem cell sparing intensity-modulated radiation therapy and nonStem cell sparing three-dimensional conformal radiation therapy: a …
- A Novel therapy Protocol Improves Outcomes of Hematopoietic Stem cell Transplantation in Juvenile Myelomonocytic Leukemia Patients Using …
- Stem cells derived from amniotic fluid: a potential pluripotent-like cell source for cellular therapy?
- Effect of the preventative allopurinol therapy within the framework of the peripheral blood Stem cell donation
- Stem cell Transplantation in Scleroderma therapy
- Superiority of allogenic Stem cell transplantation after anti-pd1 therapy over anti-pd1 monotherapy alone in relapse/refractory Hodgkin lymphoma: real world evidence …
- Validation of a library of cGMP-compliant human pluripotent Stem cell lines for use in liver therapy
- … EFFICIENCY OF RITUXIMAB therapy IN CHILDREN WITH RENAL THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH HEMATOPOIETIC Stem cell …
- therapy for limbal Stem cell deficiency: cell fate after limbal Stem cell transplants
- XII R. Gorbacheva Memorial Symposium Hematopoietic Stem cell Transplantation. Gene and cellular therapy: an Overview
- A Universal Approach to Correct Various HBB Gene Mutations in Human Stem cells for Gene therapy of Beta-Thalassemia and Sickle cell Disease
- FVIII induced expression in adipose-derived Mesenchymal Stem cells for Haemophilia A cell therapy
- Hydrogels for Stem cell Encapsulation: Toward cellular therapy for Diabetes
- Public Opinion About Stem cell Research And Human Cloning-The Bioethics Of Stem cell Research And therapy
- … myeloma using molecular and clinical prognostic factors in 657 patients treated with bortezomib-based induction, high-dose therapy and autologous Stem cell …
- Abstract IA13: Imaging Stem cell signals in cancer heterogeneity and therapy resistance
- Adipose-derived Stem cell-Based Immunomodulatory therapy in a Translational Porcine Limb Transplant Model
- … relapsed/refractory large cell lymphoma who were also refractory to salvage chemotherapy: outcome with salvage radiation therapy followed by autologous Stem cell …
- Photobiomodulation therapy and vitamin C on longevity of cell sheets of human dental pulp Stem cells
- Multiple Myeloma: Front Line therapy and Autologous Stem cell Transplantation
- Lenalidomide maintenance therapy after autologous peripheral blood Stem cell transplant (PBSCT) in multiple myeloma patients: Factors that impact treatment
- Mesenchymal Stem cell-based therapy for infectious disease.
- Dual Effects of Mesenchymal Stem/Stromal cell in Tumor Animal Models: A SyStematic Review For Risk Management therapy of Stem cell in Cancer Patients
- The New Age of Stem cell Gene therapy for Regenerative Medicine
- The Efficacy of Mesenchymal Stem cell Injection Versus Physical therapy Intervention on Womac Scores in Patients with Knee Osteoarthritis: A Meta-Analysis
- Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose therapy and Autologous Hematopoietic Stem cell Transplantation
- Molecular basis of adipose-derived Stem cell (ASCs) therapy for management of radiation-induced fibrosis (RIF)
- Advances in biomarkers and Stem cell-targeted therapy for hepatocellular carcinoma
- A Global View on Regulatory Issues in Stem cell Transplantation and cellular therapy
- P100 Stem cell Factor Leads to Lung Cancer Escapes from Anti-Angiogenic therapy by Increasing the ALDH1+ Lung Cancer cell Number
- Use of iPS cell-Derived Neural Stem cell as a cellular Vehicle for Glioma and Breast Cancer therapy
- Stem cell-derived exosomes as a biomaterial source for immune modulating therapy
- … and donor lymphocyte infusion as salvage therapy in patients with FLT3-positive acute myeloid leukemia relapse after allogeneic hematopoietic Stem cell …
- Development of core technology for promotion of radiation therapy efficacy by targeting cancer Stem cell
- therapy-related Myelodysplastic Syndrome after Autologous Stem cell Transplantation Using Plerixafor for Mobilized Stem cells in a Patient with Multiple Myeloma
- Development of a Stem cell-based therapy for the recovery of skeletal muscle mass following immobilization
- A new insight on the Stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma
- A preliminary study to assess the impact of Stem cell sparing radiation therapy on the outcomes of the treatment of glioblastoma multiformae
- Salvage Autologous Stem cell Transplantation in Multiple Myeloma: Investigating the Impact of Pre-Transplant therapy
- Development of New Neural Stem cell-Based Tumor-Targeted Gene therapy Approaches
- Genes preserving Stem cell state in group 3 medulloblastoma brain tumor initiating cells contribute to therapy evasion and relapse
- [Retracted] Combined treatment with extracorporeal shock‑wave therapy and bone marrow mesenchymal Stem cell transplantation improves bone repair in a rabbit …
- The Effect of Maintenance therapy Following Salvage Autologous Stem cell Transplant in Multiple Myeloma Patients
- Trends in utilization and in-hospital outcomes of high dose therapy and autologous Stem cell transplantation among patients with AL amyloidosis in the United States.
- Evaluation of Antiemetic therapy for Breakthrough Nausea and Vomiting in Patients with Hematopoietic Stem cell Transplantation
- Efficacy of Maintenance therapy after Autologous Hematopoietic Stem cell Transplantation in High-Risk Aggressive Lymphoma: A Single-Center Prospective …
- Autologous Stem cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous therapy and Histological Subtype
- OPTIMIZATION OF A COMBINED ADIPOSE Stem cell-GDF6 therapy FOR INTERVERTEBRAL DISC REGENERATION
- therapy of relapse and progression of classical Hodgkin lymphoma after allogeneic hematopoetic Stem cell transplantation
- Second allogeneic hematopoietic Stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)
- … Induction therapy+ Autologous Stem cell Trasplantation, Comparing Velcade-Dexametasone to Alkylating Polichemotherapy As Induction therapy
- Immune modulation by a cellular network of mesenchymal Stem cells and breast cancer cell subsets: Implication for cancer therapy
- The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous Stem cell transplant.
- Role of Hypomethylating therapy in Patients with Myelodysplastic Syndrome Before Allogeneic Hematopoietic Stem cell Transplantation
- Abstract CT137: Biomarkers of response to leukemia Stem cell targeted therapy with low dose daunorubicin in relapsed/refractory acute leukemia
- First-Line therapy with Donor Derived HCMV-Specific T cells Reduce Persistent HCMV Infection after Allogenic Stem cell Transplantation
- Abstract B014: Simulating prostate cancer Stem cell dynamics to predict patient-specific sensitivity or resistance to intermittent androgen-deprivation therapy
- Anti-PD1 (muDX 400) therapy given after radiation has greatest impact on (CD8+ Tim3-CD73+) Stem cell like cells: Implications for improved clinical trial design …
- The Development of Angiogenesis cell therapy Using Syngeneic Adipose-Derived Stem cells for Lower Limb Ischemia in Mice
- A cellular therapy with Haploidentical Peripheral Hematopoietic Stem cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed …
- Establishment of insulin-producing cells from human embryonic Stem cells underhypoxic condition for cell based therapy
- therapy-Related Myeloid Neoplasms Following Autologous Stem cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation—a …
- Stem cell-derived extracellular vesicles as a cell-free therapy for tissue repair/regeneration: a syStematic review and meta-analysis of preclinical studies
- Stem cell-Specific Internalizing Immunotoxin as a therapy for Myelodysplastic Syndromes
- Successful treatment with brentuximab vedotin maintenance therapy after autologous Stem cell transplantation in high-risk Hodgkin lymphoma
- 1601. Effect of Preemptive Rituximab therapy on Epstein–Barr Reactivation in Allogenic Hematopoietic Stem cell Pediatric Transplants
- Mesenchymal Stem cells: applications in immuno-cell therapy
- Plastic Adaptation: A Neuronal Imperative Capable of Confounding the Goals of Stem cell Replacement therapy for either Huntington’s or Parkinson’s Disease
- Enabling efficient ex vivo expansion of long-term human hematopoietic Stem and progenitor cells for cell therapy
- Comparison of two automated cell counters for enumeration and viability of mesenchymal Stem cells for clinical cellular therapy trials
- Varied therapeutic effects of Human Amniotic Mesenchymal Stem cell Transplantation with Different Transplantation Methods for Spinal Cord Injury therapy in Rats
- Impact of Combined Adipose-Derived Mesenchymal Stem cell (ADMSC) and Low-Energy of Extracorporeal Shock Wave therapy on Protecting Brain Death-Induced …
- … 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) As Salvage therapy Prior to Autologous Stem cell Transplant for Relapsed …
- Lenti-D Hematopoietic Stem cell Gene therapy to Arrest Progression of Cerebral Adrenoleukodystrophy: Interim Results of an International Phase 2/3 Trial
- Treatment efficacy of ponatinib as salvage therapy in relapse chronic myeloid leukemia with T315I mutation after allogeneic Stem cell transplantation: report of 12 …
- Epigenetic therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem cell Transplantation in Non …
- 54 Genes preserving Stem cell state in Group 3 MB BTICs contribute to therapy evasion and relapse
- Hematopoietic Stem cell transplantation with alpha/beta T lymphocyte and CD19 cell depletion in adolescents and young adults with paroxysmal nocturnal …
- … -Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction therapy Prior to Autologous Stem cell Transplantation in Japanese …
- … therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem cell Transplantation for AL …
- Abstract A28: Donor lymphocyte infusion after allogeneic Stem cell transplantation is a feasible therapy option with acceptable toxicity rates in patients with refractory …
- … -CD (25) monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease in 80 patients receiving allogeneic hematopoietic Stem cell …
- Stem cell, low-energy shock wave and phosphodiesterase type 5 inhibitor therapy to promote erectile function recovery in a rat pelvic neurovascular trauma model
- … Study to Evaluate Ruxolitinib Compared to Best Available therapy in Patients with Corticosteroid-Refractory Acute Graft vs Host Disease after Allogeneic Stem cell …
- … clinical data collection: impact on clinicians’ time and administrative costs151. Isolation and characterization of an adult Stem cell population within human epidural …
- Polyinosinic-Polycytidylic Acid Primes Cardiac Progenitors From Human Induced Pluripotent Stem cells for Enhanced cell therapy and Cardiomyocyte Maturation
- Photoreceptor cell Replacement therapy from Stem cells
- Interferon-gamma/Hypoxia Primed Mesenchymal Stem cells for an Improved Immunosuppressive cell therapy
- Generation and selection of photoreceptor precursors from human-induced pluripotent Stem cells for cell therapy
- Abstract SY39-01: Stem cells in squamous cell carcinomas: Their biology, heterogeneity, and resistance to therapy
- Myogenic differentiation of human induced pluripotent Stem cells: a tool for cell therapy and disease modelling of myotonic dystrophy type 1= Diferenciación …
- IMMU-20. HEMATOPOIETIC Stem cells POTENTIATE EFFICACY OF ADOPTIVE cell therapy AGAINST BRAIN Stem GLIOMA
- Functional Polymeric Hydrogels in Stem/Progenitor cell therapy and Therapeutic Angiogenesis
- Preclinical efficacy of dendritic cells derived from bone marrow hematopoietic Stem cells for the treatment of syngeneic prostate cancer immune cell therapy.
- Metastatic cell responses to anticancer therapy: The possible role of cancer Stem cells
- … and Mitotic Activity in Peripheral Lymphocytes to Predict Life Expectancy of Patients with Metastatic Non-Small cell Lung Cancer after Conventional therapy
- Single-agent plerixafor mobilization to collect autologous Stem cells for use in gene therapy for severe sickle cell disease
- … cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-syStems approach to cancer therapy (US FDA …
- … -110 (G> A) mRNA restores β-globin levels in a novel cell model and acts as mono-and combination therapy for β-thalassemia in primary hematopoietic Stem …
- … [IVSI-110 (G> A)] mRNA restores-globin levels in a novel cell model and acts as mono-and combination therapy for-thalassemia in primary hematopoietic Stem …
- Exploiting Molecular Subtype cell Plasticity As Novel Strategy for Targeting Glioma Stem cells Through Alternating therapy
- Challenges and controversies in human mesenchymal Stem cell therapy
- Stem cell therapy for neurological disorders
- Mesenchymal Stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives
- Concise review: Stem cell therapy for stroke patients: are we there yet?
- Stem cell therapy: A novel approach for myocardial infarction
- The clinical trials of mesenchymal Stem cell therapy in skin diseases: an update and concise review
- Nanoparticle technology and Stem cell therapy team up against neurodegenerative disorders
- Stem cell therapy for neurological disorders: a focus on aging
- Stem cell therapy for erectile dysfunction
- Neural Stem cell therapy for stroke: A multimechanistic approach to restoring neurological function
- Stem cell therapy for heart failure: an unfulfilled promise?
- Adipose-derived mesenchymal Stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial
- Mesenchymal Stem cell therapy for the treatment of traumatic brain injury: progress and prospects
- Myths, reality and future of mesenchymal Stem cell therapy
- Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
- Thrombogenic risk induced by intravascular mesenchymal Stem cell therapy: current status and future perspectives
- Biomaterials used in Stem cell therapy for spinal cord injury
- Intravascular mesenchymal stromal/Stem cell therapy product diversification: time for new clinical guidelines
- Dual Stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction
- Mitochondrial dysfunction in stroke: implications of Stem cell therapy
- Efficacy of mesenchymal Stem cell therapy in systolic heart failure: a syStematic review and meta-analysis
- Transamniotic Stem cell therapy (TRASCET) in a rabbit model of spina bifida
- Safety and efficacy of Stem cell therapy for treatment of neural damage in patients with multiple sclerosis
- Development of hematopoietic Stem cell-engineered invariant natural killer T cell therapy for cancer
- Stem cell therapy in discogenic back pain
- Stem cell therapy for chronic skin wounds in the era of personalized medicine: from bench to bedside
- New advances in Stem cell therapy for osteonecrosis of the femoral head
- Bone marrow mesenchymal Stem cell therapy and related bone marrow-derived orthobiologic therapeutics
- Combined adipose tissue-derived mesenchymal Stem cell therapy and rehabilitation in experimental stroke
- Mesenchymal Stem cell therapy for doxorubicin-induced cardiomyopathy: potential mechanisms, governing factors, and implications of the heart Stem cell …
- Advances, challenges, and perspectives in translational Stem cell therapy for amyotrophic lateral sclerosis
- Mechanisms of endometrial fibrosis and the potential application of Stem cell therapy
- 3D Bioprinting of cardiac tissue and cardiac Stem cell therapy
- Rationale and design of the European multicentre study on Stem cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE)
- Ankylosing spondylitis and mesenchymal stromal/Stem cell therapy: a new therapeutic approach
- Mesenchymal Stem cell therapy for spinal cord contusion: a comparative study on small and large animal models
- Stem cell therapy for hepatocellular carcinoma: future perspectives
- Stem–cell therapy for hearing loss: are we there yet?
- Advances of hyaluronic acid in Stem cell therapy and tissue engineering, including current clinical trials
- Bone Marrow–Derived and Adipose‐Derived Mesenchymal Stem cell therapy in Primary Knee Osteoarthritis: A Narrative Review
- Transplantation of human-induced pluripotent Stem cell-derived cardiomyocytes is superior to somatic Stem cell therapy for restoring cardiac function and …
- Stem cell therapy in pain medicine
- Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic Stem cell transplantation
- Is Stem cell therapy an answer to heart failure: a literature search
- Advancing mesenchymal Stem cell therapy with CRISPR/Cas9 for clinical trial studies
- The clinical efficacy of Stem cell therapy for complex perianal fistulas: a meta-analysis
- Nomenclature inconsistency and selective outcome reporting hinder understanding of Stem cell therapy for the knee
- The potential of Stem cell therapy to repair white matter injury in preterm infants: lessons learned from experimental models
- Mesenchymal Stem cell therapy targeting mitochondrial dysfunction in acute kidney injury
- The role of electrospun fiber scaffolds in Stem cell therapy for skin tissue regeneration
- Application of injectable hydrogels for cardiac Stem cell therapy and tissue engineering
- Mesenchymal Stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration
- Human umbilical cord-derived mesenchymal Stem cell therapy ameliorates nonalcoholic fatty liver disease in obese type 2 diabetic mice
- Osteochondritis dissecans (OCD) in horses–Molecular background of its pathogenesis and perspectives for progenitor Stem cell therapy
- … antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic Stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia …
- Office-based mesenchymal Stem cell therapy for the treatment of musculoskeletal disease: a syStematic review of recent human studies
- Immunological considerations for retinal Stem cell therapy
- Neurodegeneration and neuro-regeneration—Alzheimer’s disease and Stem cell therapy
- Two‐step Stem cell therapy improves bone regeneration compared to concentrated bone marrow therapy
- Should platelet-rich plasma or Stem cell therapy be used to treat osteoarthritis?
- Recent biomedical applications on Stem cell therapy: a brief overview
- Allogeneic mesenchymal Stem cell therapy: A regenerative medicine approach to geroscience
- Mesenchymal Stem–cell therapy for perianal fistulas in Crohn’s disease: a syStematic review and meta-analysis
- Cortical bone-derived Stem cell therapy reduces apoptosis after myocardial infarction
- Human induced pluripotent Stem cell-derived mesenchymal Stem cell therapy effectively reduced brain infarct volume and preserved neurological function in …
- Effect of autologous bone marrow Stem cell therapy in patients with liver cirrhosis: a meta-analysis
- The role of autologous Stem cell transplantation in the treatment of diffuse large B-cell lymphoma in the era of CAR-T cell therapy
- Autologous Stem cell therapy for hypoplastic left heart syndrome: safety and feasibility of intraoperative intramyocardial injections
- Potentials of “Stem cell–therapy” in pancreatic cancer: An update
- Stem cell therapy for musculoskeletal diseases
- Bone marrow-derived mesenchymal Stem cell (BM-MSC): a tool of cell therapy in hydatid experimentally infected rats
- Targeting hyaluronan interactions for glioblastoma Stem cell therapy
- In utero amniotic fluid Stem cell therapy protects against myelomeningocele via spinal cord coverage and hepatocyte growth factor secretion
- Tumoricidal Stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma
- Hydrogen sulfide enhances the effectiveness of mesenchymal Stem cell therapy in rats with heart failure: In vitro preconditioning versus in vivo co-delivery
- Autologous haematopoietic Stem cell therapy for multiple sclerosis: a review for supportive care clinicians on behalf of the Autoimmune Diseases Working …
- Bone mesenchymal Stem cell therapy for ovariectomized osteoporotic rats: a syStematic review and meta-analysis
- Mesenchymal Stem cell and bone marrow mononuclear cell therapy for cardiomyopathy: from bench to bedside
- Subconjunctival bone marrow‐derived mesenchymal Stem cell therapy as a novel treatment alternative for equine immune‐mediated keratitis: A case series
- Stand alone or join forces? Stem cell therapy for stroke
- Efficacy and safety of Stem cell therapy in patients with dilated cardiomyopathy: a syStematic appraisal and meta-analysis
- Hyaluronan-based grafting strategies for liver Stem cell therapy and tracking methods
- Stand alone or join forces? Stem cell therapy for stroke
- Tissue engineering and Stem cell therapy in pediatric urology
- Back to square one: The future of Stem cell therapy and regenerative medicine after the recent events
- Development of functional dendrisomes based on a single molecule of polyesterbenzylether dendrimer and their application in cancer Stem cell therapy
- High-dose melphalan and Stem cell transplantation in syStemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
- Adipose-derived Stem cell therapy inhibits the deterioration of cerebral infarction by altering macrophage kinetics
- Stem cell therapy for Parkinson’s disease using non-human primate models
- Stem–cell therapy for ovariectomy-induced osteoporosis in rats: a comparison of three treatment modalities
- Non-invasive cell tracking with brighter and red-transferred luciferase for potential application in Stem cell therapy
- Reparative dentin formation using Stem cell therapy versus calcium hydroxide in direct pulp capping: an animal study
- Stem cell therapy for autoimmune disease
- Characterization of the chondrogenic and osteogenic potential of male and female human muscle‐derived Stem cells: Implication for Stem cell therapy
- Adipose-derived Stem cell therapy ameliorates ionizing irradiation fibrosis via hepatocyte growth factor-mediated transforming growth factor-β downregulation and …
- Stem–cell therapy for esophageal anastomotic leakage by autografting stromal cells in fibrin scaffold
- Intra-articular umbilical cord derived mesenchymal Stem cell therapy for chronic elbow osteoarthritis in dogs: a double-blinded, placebo-controlled clinical trial
- Neural Stem cell transplantation therapy for brain ischemic stroke: Review and perspectives
- Novel application method for mesenchymal Stem cell therapy utilizing its attractant-responsive accumulation property
- cell therapy for spinal cord injury using induced pluripotent Stem cells
- Mesenchymal Stem cell therapy inhibited inflammatory and profibrotic pathways induced by partial bladder outlet obstruction and prevented high-pressure urine …
- Mesenchymal Stem cell-based therapy of osteoarthritis: current knowledge and future perspectives
- Efficacy and safety of Stem cell therapy in advanced heart failure patients: a syStematic review with a meta-analysis of recent trials between 2017 and 2019
- Intra-arterial Stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke
- Stem cell therapy in diabetic men with erectile dysfunction: a step closer to safe and effective regenerative technology
- Mesenchymal Stem cells: cell therapy and regeneration potential
- Wnt signaling: the double-edged sword diminishing the potential of Stem cell therapy in congenital heart disease
- ARTIFICIAL cell evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/Stem cell therapy …
- Mesenchymal Stem cell therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia
- Cardiac regeneration by statin-polymer nanoparticle-loaded adipose-derived Stem cell therapy in myocardial infarction
- Animal‐and human‐based evidence for the protective effects of Stem cell therapy against cardiovascular disorders
- Stem cell therapy-An Overview
- Intravenous Stem cell therapy for high-grade aneurysmal subarachnoid hemorrhage: case report and literature review
- Lercanidipine boosts the efficacy of mesenchymal Stem cell therapy in 3-NP-induced Huntington’s disease model rats via modulation of the calcium/calcineurin …
- Mesenchymal Stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives
- Effect of autologous adipose-derived mesenchymal Stem cell therapy in the treatment of acromioclavicular joint osteoarthritis
- Human umbilical cord mesenchymal Stem–cell therapy to increase the density of osteoporotic mandibular bone
- A Mini Review: Stem cell therapy for osteonecrosis of the femoral head and pharmacological aspects
- Patient experience of chimeric antigen receptor (CAR)-T cell therapy vs. Stem cell transplant: longitudinal patient reported adverse events, cognition and …
- Mesenchymal Stem cell therapy overcomes steroid resistance in severe gastrointestinal acute graft-versus-host disease
- Collagen fibrillar structures in vocal fold scarring and repair using Stem cell therapy: a detailed histological, immunohistochemical and atomic force microscopy study
- Advances in Stem cell therapy for male stress urinary incontinence
- Exploring the most promising Stem cell therapy in liver failure: a syStematic review
- Coexpression profile of leukemic Stem cell markers for combinatorial targeted therapy in AML
- Stem cells from the apical papilla: a promising source for Stem cell-based therapy
- Stem cell therapy in critical limb ischemia: Current scenario and future trends
- Recent advances in the design of injectable hydrogels for Stem cell-based therapy
- Stem cell therapy for diabetes mellitus: Recent progress and hurdles
- “Stem cell therapy to promote limb function recovery in peripheral nerve damage in a rat model”–Experimental research
- Stem cell‐based therapy for Parkinson’s disease with a focus on human endometrium‐derived mesenchymal Stem cells
- Mesenchymal Stem cell-derived extracellular vesicle therapy for stroke: challenges and progress
- Effects of exercise training and Stem cell therapy on the left ventricle of infarcted rats
- cell therapy for Parkinson’s disease with induced pluripotent Stem cells
- Efficacy of Stem cell therapy for pulmonary arterial hypertension: a syStematic review and meta-analysis of preclinical studies
- Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal Stem cells-a clue to Stem cell-based therapy
- Mesenchymal Stem cell therapy in submandibular salivary gland Allotransplantation: experimental study
- Mesenchymal Stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases
- Phage-based artificial niche: the recent progress and future opportunities in Stem cell therapy
- Scleral ischemia in acute ocular chemical injury: long-term impact on rehabilitation with limbal Stem cell therapy
- Influence of lineage-negative Stem cell therapy on articulatory functions in ALS patients
- Cancer Stem cell (a) symmetry & plasticity: tumorigenesis and therapy relevance
- Human keratinocyte Stem cells: From cell biology to cell therapy
- The mesenchymal Stem cell secretome as an acellular regenerative therapy for liver disease
- Teeth‐derived Stem cells: a source for cell therapy
- Adipose tissue-derived Stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model: a syStematic review and meta-analysis using …
- Allogeneic Stem cell transplantation and chimeric antigen receptor (CAR) T-cell therapy for the treatment of non-Hodgkin lymphoma
- “Microgravity” as a unique and useful Stem cell culture environment for cell-based therapy
- Intrabone hematopoietic Stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- Regeneration of trabecular meshwork in primary open angle glaucoma by Stem cell therapy: A new treatment approach
- Stem cell plasticity and dormancy in the development of cancer therapy resistance
- Stem cell-based therapy for inflammatory bowel disease
- Japan responds: Stem–cell therapy justified
- Mesenchymal Stem cell exosomes: a two-edged sword in cancer therapy
- Recent updates on mesenchymal Stem cell based therapy for acute renal failure
- Effect of nonmyeloablative hematopoietic Stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting …
- Combination of Stem cell and gene therapy ameliorates symptoms in Huntington’s disease mice
- Miraculous’ Stem cell therapy has sickened people in five states
- Utilization of hematopoietic Stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted therapy …
- Mesenchymal Stem cell exosomes as a cell-free therapy for nerve injury–induced pain in rats
- In vivo hematopoietic Stem cell gene therapy ameliorates murine thalassemia intermedia
- Fetal Stem cell transplantation and gene therapy
- Dental pulp Stem cell-derived conditioned medium: an attractive alternative for regenerative therapy
- Delivery of anti-miRNA for triple-negative breast cancer therapy using RNA nanoparticles targeting Stem cell marker CD133
- Computational strategies for niche-dependent cell conversion to assist Stem cell therapy
- Autologous Stem–cell-based gene therapy for inherited disorders: state of the art and perspectives
- Targeting cancer Stem cell redox metabolism to enhance therapy responses
- A review on different methods to increase the efficiency of mesenchymal Stem cell‐based wound therapy
- Stem cell therapy for Alzheimer’s disease: research status and developmental trend
- … Commentary: Considering Clinical Application of Bone Marrow Aspirate Concentrate for Restoration of Cartilage Defects in the Knee? Is It a Kind of Stem cell therapy …
- … , multi-lineage differentiation and aging of zebrafish heart and liver tissue-derived mesenchymal Stem cells as a novel approach in Stem cell-based therapy
- Mesenchymal Stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles
- Single cell gene expression analysis reveals human Stem cell-derived graft composition in a cell therapy model of Parkinson’s disease
- Xenofree generation of limbal Stem cells for ocular surface advanced cell therapy
- Hematopoietic Stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
- Validation of current good manufacturing practice compliant human pluripotent Stem cell-derived hepatocytes for cell-based therapy
- Engineered mesenchymal Stem cell/nanomedicine spheroid as an active drug delivery platform for combinational glioblastoma therapy
- Mesenchymal Stem cell therapy improves spatial memory and hippocampal structure in aging rats
- Cancer Stem cell‐platelet hybrid membrane‐coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma
- Innovative curative treatment of beta thalassemia: cost-efficacy analysis of gene therapy versus allogenic hematopoietic Stem–cell transplantation
- Allogeneic Stem cell transplantation as part of front line therapy for Mantle cell lymphoma
- Haploidentical Stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a …
- Verification of mesenchymal Stem cell injection therapy for interstitial cystitis in a rat model
- New era of heart failure therapy in pediatrics: cardiac Stem cell therapy on the start line
- Scientific Basis for Stem cell therapy
- Mesenchymal Stem cells for spinal cord injury: current options, limitations, and future of cell therapy
- Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic Stem cell transplantation
- Stem cell derived exosomes: microRNA therapy for age-related musculoskeletal disorders
- Therapeutic abortion and ectopic pregnancy: alternative sources for fetal Stem cell research and therapy in Iran as an Islamic country
- Is the adipose-derived mesenchymal Stem cell therapy effective for treatment of knee osteoarthritis?
- Role of the microenvironment in regulating normal and cancer Stem cell activity: implications for breast cancer progression and therapy response
- Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal Stem cell exosomes
- The landscape of hematopoietic Stem cell transplant and gene therapy for X-linked adrenoleukodystrophy
- Local Stem cell therapy for Crohn’s Perianal Fistulae
- Psychophysical effects of an exercise therapy during pediatric Stem cell transplantation: a randomized controlled trial
- Novel Stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa
- Activity of p53 in human amniotic fluid Stem cells increases their potentiality as a candidate for Stem cell therapy
- Mesenchymal Stem cell therapy of male infertility
- Advances of Stem cell therapy to treat heart failure
- Brief review: Can modulating DNA methylation state help the clinical application of oligodendrocyte precursor cells as a source of Stem cell therapy?
- Adoptive T cell therapy following haploidentical hematopoietic Stem cell transplantation
- Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for Stem cell transplantation: a structured review
- Long-term follow-up of patients with Buerger’s disease after autologous Stem cell therapy
- Role of physical therapy before and after hematopoietic Stem cell transplantation: white paper report
- … -based strategy with autologous Stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for cell therapy and …
- 4. Bone Stem cell therapy in the clinical perspective: a focus on nonrandomized and randomized trials
- Assessing Stem cell DNA integrity for cardiac cell therapy
- Autoimmune enteropathy: an updated review with special focus on Stem cell transplant therapy
- Cancer therapy-induced cardiomyopathy: can human induced pluripotent Stem cell modelling help prevent it?
- Characteristics of intestinal microecology during mesenchymal Stem cell-based therapy for mouse acute liver injury
- Combination lenalidomide and azacitidine: a novel salvage therapy in patients who relapse after allogeneic Stem–cell transplantation for acute myeloid …
- Reprogramming of cancer Stem cells into non-tumorigenic cells using Stem cell exosomes for cancer therapy
- Pre-clinical safety and efficacy of lentiviral vector-mediated ex vivo Stem cell gene therapy for the treatment of mucopolysaccharidosis IIIA
- The effect of photobiomodulation therapy on the differentiation, proliferation, and migration of the mesenchymal Stem cell: a review
- Stem cell-derived models of neural crest are essential to understand melanoma progression and therapy resistance
- Concise review: reduction of adverse cardiac scarring facilitates pluripotent Stem cell-based therapy for myocardial infarction
- Human embryonic Stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models
- GDNF enhances the anti-inflammatory effect of human adipose-derived mesenchymal Stem cell-based therapy in renal interstitial fibrosis
- Hypoxia induced cancer Stem cell enrichment promotes resistance to androgen deprivation therapy in prostate cancer
- … cell-derived exosome promote endothelial cell angiogenesis in a dose dependent manner: a new perspective on regenerative medicine and cell-free therapy
- Mesenchymal Stem cell therapy modulates synovial macrophages in a murine model of osteoarthritis
- BMT CTN protocol 1506: a phase 3 trial of gilteritinib as maintenance therapy after allogeneic hematopoietic Stem cell transplantation in patients with FLT3 …
- Exploiting tumor-intrinsic signals to induce mesenchymal Stem cell-mediated suicide gene therapy to fight malignant glioma
- Current status of Stem cell therapy for sepsis and acute respiratory distress syndrome
- Quality of life (QOL) in patients undergoing CAR-T therapy versus Stem cell transplant (SCT).
- Genetic communication by extracellular vesicles is an important mechanism underlying Stem cell-based therapy-mediated protection against acute kidney …
- Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic Stem cell transplant?
- Low-dose anti-inflammatory combinatorial therapy reduced cancer Stem cell formation in patient-derived preclinical models for tumour relapse prevention
- Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic Stem cell transplantation
- Bone marrow–derived mesenchymal Stem cell–mediated dual-gene therapy for glioblastoma
- Physical therapy pathway and protocol for patients undergoing hematopoietic Stem cell transplantation: recommendations from the eastern Mediterranean …
- An explorative study of qualities in interactive processes with children and their parents in music therapy during and after pediatric hematopoietic Stem cell …
- A Hyaluronan hydrogel scaffold for culture of human oral mucosal epithelial cells in limbal Stem–cell therapy
- Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic Stem cell transplantation
- Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic Stem cell line
- Can Stem cell therapy increase the rate of myocardial recovery in left ventricular assist device-supported advanced heart failure patients?—current data and …
- Autologous bone marrow Stem cell therapy for patients undergoing coronary artery bypass grafting: A meta‑analysis of 14 randomized controlled trials
- Stem cell membrane vesicle–coated nanoparticles for efficient tumor‐targeted therapy of orthotopic breast cancer
- Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal Stem cell-based sTRAIL gene therapy against malignant glioma
- Dental pulp Stem cells: an attractive alternative for cell therapy in ischemic stroke
- Comparison of outcomes of frontline immunosuppressive therapy and frontline haploidentical hematopoietic Stem cell transplantation for children with severe …
- … reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre-or post-Stem cell …
- Stem cell-derived exosomes protect astrocyte cultures from in vitro ischemia and decrease injury as post-stroke intravenous therapy
- Cancer prevention and therapy of two types of gap junctional intercellular communication–deficient “cancer Stem cell”
- Outcome of hematopoietic Stem cell gene therapy for Wiskott-Aldrich syndrome
- Identification and targeting of Stem cell-activated pathways in cancer therapy
- Impact of consolidation therapy post autologous Stem cell transplant in patients with light chain amyloidosis
- SyStemic dental pulp Stem cell secretome therapy in a mouse model of amyotrophic lateral sclerosis
- Mesenchymal Stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies
- Latent Stem cell-stimulating therapy for regeneration of chronic tympanic membrane perforations using IGFBP2-releasing chitosan patch scaffolds
- Reversal of surfactant protein B deficiency in patient specific human induced pluripotent Stem cell derived lung organoids by gene therapy
- Paving the road for mesenchymal Stem cell-derived exosome therapy in bronchopulmonary dysplasia and pulmonary hypertension
- cellular and molecular assessment of rose bengal photodynamic antimicrobial therapy on keratocytes, corneal endothelium and limbal Stem cell niche
- Hematopoietic Stem cell-Targeted Neonatal Gene therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in oc/oc Mice
- Adipocyte-derived Stem cell-based gene therapy upon adipogenic differentiation on microcarriers attenuates type 1 diabetes in mice
- Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic Stem cell transplantation, assessed by patient-reported …
- In vivo selection for gene-corrected HSPCs advances gene therapy for a rare Stem cell disease
- … following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem cell Transplantation and cellular therapy (SFGM …
- High tibial osteotomy in combination with arthroscopic abrasion arthroplasty and autologous adipose-derived mesenchymal Stem cell therapy in the treatment …
- Insights into GBA Parkinson’s disease pathology and therapy with induced pluripotent Stem cell model syStems
- Productivity losses in patients with newly diagnosed multiple myeloma following Stem cell transplantation and the impact of maintenance therapy
- … induction therapy, autologous Stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell …
- Role of Stem cell therapy for Pain
- Treatment of the bone marrow stromal Stem cell supernatant by nasal administration—a new approach to EAE therapy
- Cardiac Stem cell therapy, Resident Progenitor cells and the role of cellular Signalling; a Review
- Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I therapy
- Interaction between mesenchymal Stem cells and intervertebral disc microenvironment: from cell therapy to tissue engineering
- A novel approach for image-guided 131I therapy of pancreatic ductal adenocarcinoma using mesenchymal Stem cell-mediated NIS gene delivery
- Melphalan dose in myeloma patients≥ 65 years of age undergoing high-dose therapy and autologous Stem cell transplantation: a multicentric observational registry …
- Stem cell-Based therapy for Lung Disease
- Stem cell therapy in the elderly with liver disease
- Autologous Stem cell transplantation in refractory Crohn’s disease–low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised …
- A single dose of CD117 antibody drug conjugate enables autologous gene-modified hematopoietic Stem cell transplant (gene therapy) in nonhuman primates
- … ) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and cellular therapy …
- Autologous Stem cell transplantation is a viable postremission therapy for intermediate-risk acute myeloid leukemia in first complete remission in the absence of a …
- Stem cell therapy for knee osteoarthritis: a narrative review of a rapidly evolving treatment with implications for physical therapy management
- Stem cell-based therapy for ischemic stroke
- … with improved outcomes for FMS-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia relapsing after allogeneic hematopoietic Stem cell …
- Stem cell therapy
- … 1–specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical Stem cell transplantation: a feasibility pre …
- Induced pluripotent Stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review
- Stem cell therapy in Motor Neuron Disease
- The impact of multiple myeloma induction therapy on hematopoietic Stem cell mobilization and collection: 25-year experience
- Stem cell therapy for Liver Diseases
- Review on: regenerative medicine, tissue engineering and Stem cell therapy in diabetes mellitus
- Induction therapy with bortezomib and dexamethasone and conditioning with high-dose melphalan and bortezomib followed by autologous Stem cell …
- … T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic Stem cell transplantation or after gene therapy
- Mesenchymal Stem cell exosome-mediated prodrug gene therapy for cancer
- Public Engagement for Regulatory Reform: A Case Study of Autologous Stem cell therapy Regulation in Australia
- Induced Pluripotent Stem cell-Based cell therapy of the Retina
- Comparison between autologous and allogeneic Stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous Stem cell …
- Evaulation of intra-articular adipose derived mesenchymal Stem cell therapy in the treatment of symptomatic knee osteoarthritis–a randomised controlled trial.
- Ultrasonic debridement with Stem cell therapy of suspensory branch desmitis in an equine patient
- Stem cell and Left Ventricular Assist Device Combination therapy: A Novel Approach Aiming to Achieve Myocardial Recovery in Patients With Advanced Chronic …
- Recent advances in cancer Stem cell targeted therapy
- … hematopoietic Stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- Diffuse iris melanoma: conservative treatment with proton beam therapy after limbal Stem cell preservation or enucleation?
- Extensive metabolic correction of hurler disease by hematopoietic Stem cell-based gene therapy: Preliminary results from a phase I/II trial
- Stem cell therapy for perianal Crohn’s
- Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated Stem cell release in a mouse model of type 1 diabetes …
- Ex-Vivo Expanded NK cell therapy Combined with Elotuzumab for MRD after Autologous Stem cell Transplantation: A Phase I/II Clinical Trial in Progress
- Negative pressure wound therapy with potential autologous Stem cell therapy: the challenge and future of complex defect healing
- GP248 Mesenchymal Stem cell therapy in microvillus inclusion disease
- Autologous Stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy
- Mesenchymal Stem cell therapy for neonatal intraventricular hemorrhage: a long way to go?
- Personal cell therapy for interstitial cystitis with autologous stromal vascular fraction Stem cells
- Stem cell therapy
- Bone marrow harvesting from paediatric patients undergoing haematopoietic Stem cell gene therapy
- cell-based therapy Using Induced Plutipotent Stem cell
- Comparative analysis of mesenchymal Stem cells from bone marrow, adipose tissue, and dental pulp as sources of cell therapy for zone of stasis burns
- The evolving role of maintenance therapy following autologous Stem cell transplantation in multiple myeloma
- Stem cell therapy
- Role of cancer Stem cell, apoptotic factor, dna repair, and telomerase toward radiation therapy response in stage IIIB cervical cancer
- Effect of sirolimus exposure on the need for preemptive antiviral therapy for cytomeglovirus infection after allogeneic hematopoietic Stem cell transplantation
- Stem cell therapy: A Great Leap Forward in Alzheimer’s Treatment
- A comparison of BMP2 delivery by coacervate and gene therapy for promoting human muscle-derived Stem cell-mediated articular cartilage repair
- Inflammasome Mediated reduction of myeloperoxidase in ischemic stroke by intra-arterial mesenchymal Stem cell therapy
- … chimeric antigen receptor T-cell therapy for recurrent chronic myeloid leukemia in lymphoid blast crisis after allogeneic hematopoietic Stem cell transplantation: a two …
- Safety and Feasibility of Chimeric Antigen Receptor T cell therapy after Allogeneic Stem cell therapy in Relapsed/Refractory B cell Lymphomas
- Stem cell therapy for Multiple Sclerosis: An Exciting Challenge or a Treatment Hope
- Mesenchymal Stem cell Based therapy for Parkinsonʼs Disease
- Revisiting CLEC 12A as leukaemic Stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy
- Personalized cell therapy for pulpitis using autologous dental pulp Stem cells and leukocyte platelet-rich fibrin: a case report
- … therapy with single‐dose rituximab for Epstein‐Barr virus infection to prevent post‐transplant lymphoproliferative disease after pediatric hematopoietic Stem cell …
- Stem cell therapy: An overview
- Treatment for Canine Corneal Ulcer using Adipose Tissue-derived Mesenchymal Stem cell therapy-Case Report
- Peripheral Stem cell apheresis is feasible post 131Iodine-metaiodobenzylguanidine-therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution
- A fatal case of Exophiala dermatitidis disseminated infection in an allogenic hematopoietic Stem cell transplant recipient during micafungin therapy
- Rapid regulation of human mesenchymal Stem cell proliferation using inducible caspase-9 suicide gene for safe cell-based therapy
- Human limbus-derived mesenchymal/stromal Stem cell therapy for superficial corneal pathologies: Two-year outcomes
- Case Report: Effect of autologous adipose-derived mesenchymal Stem cell therapy in the treatment of acromioclavicular joint osteoarthritis
- Stem cell therapy in Nepal: Challenges and Opportunities
- Effects of Mesenchymal Stem cell therapy in BPD
- Indication of autologous Stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: guidelines from the Francophone Society of Bone Marrow …
- Stem cell factor lifted as a promising clinical target for cancer therapy
- Adipose-derived mesenchymal Stem cell therapy in the treatment of knee osteoarthritis—reply
- Cost‐effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic Stem cell transplant
- Brincidofovir as a salvage therapy in controlling adenoviremia in pediatric recipients of hematopoietic Stem cell transplant
- cell therapy using extraocular mesenchymal Stem cells
- Challenges and Opportunities for the Future of Stem cell therapy for Lung Diseases
- Combination cell therapy: A New Approach for Stem cell therapy
- Current status of Stem cell therapy
- Possible Mechanisms and Prospects of Stem cell therapy for Keloids
- Call for Papers: Special Issue on Stem cell therapy for Traumatic Brain Injury: Submission Deadline: October 1, 2019
- Stem cell therapy and hair loss: Present evidence and future perspectives
- Maintenance therapy with the oral proteasome inhibitor (PI) ixazomib significantly prolongs progression-free survival (PFS) following autologous Stem cell …
- Accelerated bone regeneration via three-dimensional cell-printed constructs containing human nasal turbinate-derived Stem cells as a clinically applicable therapy
- Vasculogenic Stem and progenitor cells in human: future cell therapy product or liquid biopsy for vascular disease
- Cancer Stem cell resistance to targeted therapy
- Hematopoietic Stem cell Transplant and cellular therapy
- Novel mesenchymal Stem cell delivery syStem as targeted therapy against neuroblastoma using the TH-MYCN mouse model
- … of critically Ill pediatric cancer and hematopoietic Stem cell transplant patients requiring continuous renal replacement therapy: a retrospective nationwide …
- Stem–cell therapy in Human Osteoarthritis: A Debate
- Stem cell therapy for Enteric Neuropathies
- Mesenchymal Stem versus stromal cells: International Society for cell & Gene therapy (ISCT®) Mesenchymal Stromal cell committee position statement on …
- Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous Stem cell transplantation in a case of syStemic light-chain amyloidosis with …
- Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated with autologous haematopoietic Stem cell …
- Stem cell–Derived Islets: Next Steps for Histologic and Functional Assessment During Development as a cellular therapy for the Treatment of Diabetes
- Differential effects of neural Stem cell therapy in adult and middle-aged Parkinsonian mice
- Stem cell Based therapy for Lung Disease Preclinical evidence for the role of Stem/stromal cells Clinical application of Stem/stromal cells in lung fibrosis
- Therapeutic application of Stem cell and gene therapy in Parkinson’s disease
- Stem cell therapy for renal failure: present considerations
- Ethics of Stem cell therapy for heart failure
- Stem cell therapy for ischemic stroke injury: A current status
- Auditory Dysfunction in Aging: Prospects for Stem cell therapy
- Stem cell therapy in T2DM: Progress and Challenges
- Current Status of Stem cell therapy for Thromboangiitis Obliterans (Buerger’s Disease)
- AL amyloidosis: the effects of maintenance therapy on autologous Stem cell transplantation outcomes
- … in autologous and allogenic hematopoietic Stem cell transplant: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy …
- Dental pulp Stem cells: Novel cell-based and cell-free therapy for peripheral nerve repair
- A Phase II, multicenter study of high dose chemotherapy with autologous Stem cell transplant followed by maintenance therapy with romidepsin for T-cell …
- Circulatory support and Stem cell therapy in the management of advanced heart failure: a concise review of available evidence
- Efficacy and safety of a weekly cyclophosphamide-bortezomib-dexamethasone regimen as induction therapy prior to autologous Stem cell transplantation in Japanese …
- … as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous Stem cell transplantation: A report …
- Fight for Regulation and its Enforcement on Stem cell therapy in China
- Music therapy: an intervention effecting quality of life and health in children going through hematopoietic Stem cell transplantation
- Combination treatment of autologous bone marrow Stem cell transplantation and hyperbaric oxygen therapy for type 2 diabetes mellitus: A randomized controlled trial
- A Prospective, Multicenter Study of Involved-Field Radiation therapy With Autologous Stem cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive …
- Is Stem cell therapy an Answer to Heart Failure: A Literature Search
- Optoacoustic guidance for Stem cell therapy
- Immuno-suppressive hydrogels for Stem cell therapy after traumatic brain injury
- Stem cell Joint therapy: Promising, but Not Ready for Prime Time
- Hypomethylating agent maintenance therapy after allogeneic Stem cell transplant improves transplant outcome in high risk acute myelogenous leukemia
- Stem cell therapy in stroke: Mechanism and progress in clinical research
- STATE OF THE ART OF Stem cell therapy FOR ISCHAEMIC CARDIOMYOPATHY PART
- Stem cell therapy in regenerative medicine of reproductive diseases
- Commentary: Stem cell therapy for single-ventricle congenital heart disease: Exciting, but a long way to go
- Mechanisms and Clinical Applications of Stem cell therapy
- Efficacy of Mesenchymal Stem cell therapy for Steroid-Refractory Acute Graft-versus-Host Disease: A SyStematic Review and Meta-Analysis
- Mesenchymal Stem cell-Based therapy of Osteoarthritis: Current Clinical Developments and Future Therapeutic Strategies
- State of the art of Stem cell therapy for ischaemic cardiomyopathy. Part 2.
- Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic Stem cell transplantation
- towards Stem cell therapy of polycystic ovary syndrome (PCOS): therapeutic effect of human mesenchymal Stem cells transplantation in pcos mouse model by …
- Mesenchymal Stem cell therapy logistics: A paradigm between quantity and/or quality of the “reparative” cell product
- Differentiation of human adipose-derived Stem cells into neuron/motoneuron-like cells for cell replacement therapy of spinal cord injury
- Safety and efficacy of allogeneic Stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma
- Principles and advances in Stem cell therapy in neuropsychiatric disorders
- Stem cell therapy for Parkinson’s Disease: Past, Present and Future
- … for treatment of cytomegalovirus reactivations in allogeneic haematopoietic Stem cell transplant recipients who are intolerant/unsuitable for Ganciclovir therapy
- Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal Stem cells for cardiovascular disease
- Current Stem cell therapy for Osteoarthritis
- Stem cell therapy Acquiring a Medical Patent
- Adult Stem cell therapy: Social Risks
- BEAM-modified conditioning therapy with cisplatin+ dexamethasone instead of carmustine prior to autologous hematopoietic Stem cell transplantation (HSCT) …
- E-077 Stem cell therapy for spinal cord injury
- Outcome of autologous Stem cell transplantation following PD-(L) 1 based salvage therapy for multiply relapsed patients with classic Hodgkin lymphoma
- Role of Stem cells in Cardiac cell therapy and Tissue Engineering
- Tuberculosis: A Complication after Hematopoietic Stem cell therapy (HSCT) and Bone Marrow Transplant.
- … therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous Stem …
- Adipose Stem cell therapy for Amputation Site Soft Tissue Restoration: A Prospective, Randomized Controlled Clinical Trial
- Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic Stem cell transplant recipients
- P5746 Human induced pluripotent Stem cell-derived mesenchymal Stem cell therapy effectively reduced brain infarct volume and preserved neurological function in …
- Autologous Stem cell therapy in Acute Motor Sensory Axonal Neuropathy
- Stem cell therapy to Avoid Major Leg Amputation
- A Medical/Legal Perspective on Stem cell therapy: A Scientific Breakthrough or Snake Oil?
- Durable control of hepatitis C through interferon‐free antiviral combination therapy immediately prior to allogeneic haematopoietic Stem cell transplantation
- A meta-analysis of randomized controlled trials conducted using Stem cell therapy for patients with ischemic stroke
- Osteochondroreticular Stem cell therapy for osteoarthritis: the right cells for the job
- Cortical-bone Stem cell therapy Alters the Inflammatory Response After Myocardial Infarction
- The human amniotic fluid mesenchymal Stem cells therapy on, SKOV3, ovarian cancer cell line
- Bloodstream Infections in Children Undergoing Allogeneic, Autologous Hematopoietic Stem cell Transplantation or Chimeric Antigen Receptor T cell therapy
- Stem cell therapy for patient with osteoarthritis detected by Radiology imaging Case report and literature review
- Mesenchymal Stem cell therapy for Liver Cirrhosis-Basic Study and Clinical Application
- … -Thymocyte Globulin in Unrelated Donor Stem cell Transplant Recipients: Longer Follow-up of a Multicentre cell therapy Transplant Canada Randomized …
- Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy
- Stem cell therapy To Improve Burn Wound Healing
- Mesenchymal Stem cell therapy in Graft Versus Host Disease
- Induction therapy and Stem–cell mobilization in myeloma, look at the past to plan the future
- Islet Transplantation in Type 1 Diabetes: Stem cell Research and therapy
- Induction therapy with Novel Agents and Autologous Stem cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
- Human Induced Pluripotent Stem cell-and mRNA-based Gene therapy Strategies for Treatment of Arginase Deficiency
- ALLOGENIC Stem cell therapy FOR IMMUNE MEDIATED HEMOLYTIC ANEMIA
- … CHIMERIC ANTIGEN RECEPTOR (CAR)-T cell therapy VS. AUTOLOGOUS AND ALLOGENEIC Stem cell TRANSPLANT FOR HEMATOLOGIC …
- Enzyme Replacement therapy and Hematopoietic Stem cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
- Muscle Stem cell Biology and Implications in Gene therapy
- Mesenchymal Stem cell therapy and Chronic Non-Tuberculous Mycobacterium Infection
- SAT-102 AUTOLOGOUS Stem cell therapy USING LENTIVIRAL VECTOR FOR TREATMENT OF FABRY DISEASE
- A Rat Model of Radiation Vasculitis for the Study of Mesenchymal Stem cell-Based therapy
- Feasibility of brentuximab vedotin as consolidation therapy after autologous Stem–cell transplantation in children and adolescents (< 18 years) with early relapse …
- The Effects of Mesenchymal Stem cell therapy on Knee Pain and Function During Knee Osteoarthritis
- Potential and therapeutic efficacy of cell-based therapy using mesenchymal Stem cells for acute/chronic kidney disease
- Coreceptor-Based Hematopoietic Stem cell Gene therapy for HIV Disease
- 152. Stem cell therapy for pressure injury: a pilot study with autologous bone marrow derived Stem cell (BM-MNC)
- Autologous Hematopoietic Stem cell Infusion for Myelosuppression after Bcma-CART therapy in Relapsed Myeloma Patients
- THER-15. DEVELOPING TUMOR-HOMING CYTOTOXIC HUMAN INDUCED NEURAL Stem cell therapy FOR BRAIN METASTASES
- Treatment for Canine Corneal Ulcer using Adipose Tissue-derived Mesenchymal Stem cell therapy-Case Report
- Administration of Third-Party Virus-Specific T-cells (VST) at the Time of Initial therapy for Infection after Haemopoietic Stem cell Transplant Is Safe and …
- A New Step in Understanding of Fanconi Patients Peripheral Stem cell Harvesting, a Bridge to Gene therapy
- Inferior Survival with Use of Autologous Stem cell Transplant As Second-Line therapy in Multiple Myeloma
- … embryonic Stem (hES) cells and human induced pluripotent Stem (hiPS) cells as well as biomaterials used in clinical trials of Stem cell therapy. Human pluripotent Stem …
- Maintenance therapy after second autologous Stem cell transplant in multiple myeloma improves overall survival
- Assessing Myo‐mechanicals Characteristic of Rectus Abdominis Muscle after Stem cell therapy
- Efficacy and safety of autologous Stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone
- PBI3 A REVIEW ON PEARLS & PITFALLS OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STROMAL/Stem cell therapy IN END STAGE LUNG …
- Abstract TP140: Intra-Arterial Mesenchymal Stem cell therapy Modulates Expression of NLRP1 Inflammasome in Animal Model of Ischemic Stroke
- Human Placental Stem cell therapy in Stroke: Endothelial/Smooth Muscle Mechanisms Underlying Protection?
- Salvage therapy with azacitidine for pediatric acute myeloid leukemia with t(16;21)(p11;q22)/FUS‐ERG and early relapse after allogeneic blood Stem cell …
- Allogeneic Stem cell Transplantation in therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the …
- Towards cell therapy of polycystic ovary syndrome (PCOS): Human mesenchymal Stem cells secretome inhibits androgen production by pcos theca cells
- Development of Stem cell-Based therapy for Limbal Stem cell Deficiency—From Tissue Stem cell to iPS cell
- Anti tumor activity of cord blood Stem cell derived CD16 positive NK cells as an immune cell therapy for acute lymphoblastic leukemia (ALL)
- Updated safety and efficacy outcomes from an ongoing phase 2/3 trial of lenti-D autologous hematopoietic Stem cell gene therapy for the treatment of cerebral …
- Successful Treatment of Severe Aspergillosis with Isavuconazole therapy after Allogeneic Stem cell Transplantation
- Combination of Extracorporeal Life Support and Mesenchymal Stem cell therapy for Treatment of ARDS in Combat Casualties and Evacuation of Service Members …
- Results of an Open Label, Dose Escalating, Phase 1 Clinical Trial Evaluating the Safety of a Human Neural Stem cell Based therapy in Parkinson’s Disease (P1. 8 …
- Healthcare professionals’, students’, patients’ and donors’ perceptions of Stem cell research and therapy: a syStematic review protocol
- Antioxidant preconditioning enhances adipose tissue-derived Stem cell therapy by increasing intrahepatic engraftment for liver fibrosis
- Correction to: Hypoxic Preconditioning Enhances Dental Pulp Stem cell therapy for Infection-Caused Bone Destruction by Wu Y, Huang F, Zhou X, Yu S, Tang Q, Li S
- … -Specific CD8+ T cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral therapy in Allogeneic Hematopoietic Stem cell Transplant …
- Hematopoietic Stem cell gene therapy for inherited monogenic diseases and its implications for future gene therapy trials in Turkey
- Characteristics and Outcomes of therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem cell Transplantation
- Mapping Stem cell Dependencies in Cancer Heterogeneity and therapy Resistance
- … Stem cell GENE therapy FOR INHERITED MONOGENIC DISEASES AND ITS IMPLICATIONS FOR FUTURE GENE therapy TRIALS IN TURKEY
- Allogeneic Stem cell transplantation (AlloSCT) for patients (pts) with acute leukemia following venetoclax-based therapy.
- art therapy and quality of life among children undergoing Stem cell transplantation: a pilot study
- … and comparative analysis secreted from exfoliated deciduous teeth, dental pulp, and bone marrow derived mesenchymal Stem cells for functional cell-based therapy
- Myelosuppression After Radiation therapy in Patients With and Without Autologous Peripheral Blood Stem cell Transplantation: A Retrospective Observational Study
- … Markers of Dental Pulp Stem cell Isolated from Impacted Third Molar Based on International Society for cellular therapy Proposed Mesenchymal Stem cell …
- Design and Development of Small Molecules from Somatic, Stem cell Reprogramming, and therapy
- Maintenance therapy with Decitabine after Allogeneic Hematopoietic Stem cell Transplantation to Prevent Relapse of High Risk Acute Myeloid Leukemia
- MEDU-25. genes preserving Stem cell state in group 3 MB BTICs contribute to therapy evasion and relapse
- Sequential matrix-RICE therapy followed by autologous Stem cell transplant in patients with diffuse large B-cell lymphoma and secondary central nervous …
- Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic Stem cell transplantation
- Stem–cell based therapy for dry AMD
- cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal Stem cells
- Patterns of Relapse After Salvage Autologous Stem cell Transplant for Hodgkin’s Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to …
- A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after Stem cell …
- Stem cell Factor Antibody: Effective Manipulation of Antihormonal therapy in Resistant Human Breast Cancer In Vitro.
- Retraction of “Glioma Gene therapy Using Induced Pluripotent Stem cell Derived Neural Stem cells”
- The Effects of Pre-transplant Music therapy on Distress, Quality of Life, Pain, Anxiety, Mood, and Pain Medication for Patients Undergoing Hematopoietic Stem cell …
- cell therapy of liver disease: From hepatocytes to Stem cells
- Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline Stem cell transplant in …
- Mesenchymal Stem cell–Based therapy for Chronic Kidney Disease
- All‑trans retinoic acid therapy induces asymmetric division of glioma Stem cells from the U87MG cell line
- New Methods for Lentiviral-Based Hematopoietic Stem cell Gene therapy
- The Role of Radiation therapy in Hematopoietic Stem cell Transplantation
- Automation in Hemopoietic Stem cell Gene therapy: Results of a Head-to-Head Comparison of a Manual Vs an Automated Procedure
- Intraarticular xenogeneic mesenchymal Stem cell-based therapy increases CD4+ CD25+ cells in the synovial fluid but does not contribute to pathological change
- Fully Closed, Large-Scale, and Clinical Grade cell Sorting of Hematopoietic Stem cell (HSC)-Enriched CD90+ cells for Transplantation and Gene therapy
- Stem-01. CHARACTERIZATION OF ORTHOTOPIC GLIOBLASTOMA MODEL FOR THE GENE-AND cell therapy
- Polymer Composite Strategies in Cancer therapy, Augment Stem cell Osteogenesis, Diagnostics in the Central Nervous SyStem, and Drug Delivery
- Lentiviral haemopoietic Stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1 …
- … ) is associated with less complications in Individuals with Type 1 Diabetes treated with hematopoetic Stem–cell transplantation and conventional therapy
- Optimal therapy for Relapsed AL Amyloidosis Post Autologous Stem cell Transplant
- Use of Maintenance therapy Post Autologous Stem cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
- Hematopoietic Stem cell transplantation gene therapy for hemophilia a using non-genotoxic ANTI-CD117 immunotoxin conditioning
- Mesenchymal Stem/Stromal cell therapy for Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit
- Interferon‐regulated suprabasin is essential for stress‐induced Stem‐like cell conversion and therapy resistance of human malignancies
- Outcomes of chronic myeloid leukemia with T315I mutation in the absence of targeted therapy or hematopoietic Stem cell transplantation
- … HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem cell Transplantation: A Study from the cellular therapy and Immunobiology Working …
- Molecular and cellular mechanisms underlying the Stem cell Educator therapy for the clinical treatment of diabetes
- Multiple Myeloma in a Patient with ANKRD26-Related Thrombocytopenia Successfully Treated with Combination therapy and Autologous Stem cell …
- Long-Term Clinical and Molecular Remissions in Patients with Mantle cell Lymphoma (MCL) Following High-Dose therapy (HDT) and Autologous Stem cell …
- … Oligodendroglial Differentiation as Potential Therapeutic Mechanisms of Mesenchymal Stem cell-Derived Neural Progenitors (MSC-NPs) cellular therapy in MS (P2 …
- Depth of Response and Outcomes by Initial therapy Prior to Autologous Hematopoietic Stem cell Transplantation for Multiple Myeloma
- Is Stem cell injection therapy an effective treatment option for osteoarthritic knee pain?
- … Diffuse Large B cell Lymphoma Who Are Ineligible for Autologous Stem cell Transplantation and Receive Commercially-Available Salvage therapy
- Focus on Stem cell-based therapy for retinal degenerative diseases
- Outcomes of therapy Related Acute Lymphoblastic Leukemia in Adults after Allogeneic Stem cell Transplantation-Twenty-Year Experience from a Tertiary …
- Evaluation of human induced pluripotent Stem cell (IPSC)-derived mesenchymal stromal/Stem cells (MSC) for use in cell-based therapy
- Renal transplantationplus hematopoietic Stem cell transplantation as Induction therapy: a single-center 10-year experience
- Outpatient PT Management of Patient with Bilateral Knee Pain S/P Stem cell Cartilage Replacement therapy of Both Knees
- Production of insulin producing cells from cord blood mesenchymal Stem cells and their potential in cell therapy
- Mesenchymal Stem cell-based therapy for Treatment of Bone Metastases in Breast Cancer
- Stratification therapy for cytomegalovirus infection after allogeneic hematopoietic Stem cell transplantation
- Antimicrobial therapy in cancer patients and hematopoietic Stem cell transplantation receptors
- Total Skin Electron Beam therapy in Patients with Advanced Cutaneous T cell Lymphoma Undergoing Allogeneic Stem cell Transplantation: A Single Centre …
- … of Outcomes in Adult Patients with therapy Related Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem cell Transplantation-Twenty Year …
- … TERM FOLLOW-UP OF MAINTENANCE therapy WITH INTEREFRON ALPHA AFTER AUTOLOGOUS HEMATOPOIETIC Stem cell TRANSPLANT IN MULTIPLE …
- PS1220 EX-VIVO HEMATOPOIETIC Stem cell GENE therapy (GT) FOR MUCOPOLYSACCHARIDOSIS TYPE I HURLER (MPSIH): PRELIMINARY RESULTS …
- Outcomes Following Allogeneic Stem cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD …
- Mesenchymal Stem cell‐Based Delivery of Gene‐Silencing Products: Toward a Biological therapy
- SUN-339 External Beam Radiation therapy Improves TGFB1-Induced Mesenchymal Stem cell-Mediated NIS Gene 131I therapy
- Genes Preserving Stem cell State in Medulloblastoma Contribute to therapy Evasion and Relapse
- PS1389 IMPACT OF DIFFERENT MAINTENANCE therapy OPTIONS AFTER AUTOLOGOUS HEMATOPOIETIC Stem cell TRANSPLANTATION IN MULTIPLE …
- … HEMATOPOIETIC Stem cell TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH SUBOPTIMAL RESPONSE TO PRIMARY INDUCTION therapy
- Low scale production of advanced therapy medicinal products for limbal Stem cell deficiency.
- Abstract DP-003: TOWARD A HEMATOPOIETIC Stem cell-BASED PROPHYLACTIC IMMUNO-GENE therapy APPROACH FOR OVARIAN CANCER
- ROLE OF MESENCHYMAL Stem cell EXTRAcellULAR VESICLES IN CARTILAGE BIOLOGY AND therapy
- Antimicrobial therapy in cancer patients and hematopoietic Stem cell transplantation receptors Parte iv. Terapia antimicrobiana en pacientes con cáncer y receptores …
- Maintenance therapy after hematopoietic Stem cell transplantation for abdominal myeloid sarcoma: a case report and literature review
- Subcutaneous Bortezomib, Thalidomide and Dexamethasone As Induction therapy Prior to Autologous Peripheral Blood Stem cell Transplantation in Young …
- … Stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results …
- … failure after allogeneic hematopoietic Stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular therapy …
- The efficacy of empirical antibiotic therapy of febrile neutropenia in patients after allogeneic hematopoietic Stem cell transplantation
- Research advances in glioma Stem cell surface marker CD133 and related targeted therapy
- Reprogramming human gastrointestinal Stem cells into insulin-secreting cells: developing a cell therapy for diabetes
- A Single Autologous Stem cell Transplant (ASCT) Followed By Two Years of Post-Transplant therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients …
- Overcoming therapy resistance in Stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition
- Autologous Stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy
- PS1536 EMPIRICAL ANTIBIOTIC therapy FOR NEUTROPENIC FEVER AFTER ALLOGENEIC Stem cell TRANSPLANTATION INFLUENCES GRAFT-VERSUS …
- Salvage therapy of haploidentical hematopoietic Stem cell transplantation for one hepatosplenic αβ T-cell lymphoma: a case report
- … -RELATED QUALITY OF LIFE (HRQOL) OUTCOMES OF ORAL IXAZOMIB MAINTENANCE therapy POST AUTOLOGOUS Stem cell TRANSPLANT (ASCT) IN …
- Ibrutinib therapy for a blastoid variant mantle cell lymphoma patient with early extranodal relapse after autologous Stem cell transplantation
- … Line of therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma: Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem cell …
- High-CLDN4 ESCC cells harbor Stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
- … Effects of Pre-Transplant Music therapy on Distress, Quality of Life, Pain, Anxiety, Mood, and Pain Medication Use for Patients Undergoing Hematopoietic Stem cell …
- Can Peri-Transplant Radiation therapy Improve Outcomes of Autologous Stem cell Transplant in Hodgkin Lymphoma?
- Hyperbaric Oxygen therapy for Refractory Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem cell Transplantation
- … Stem cell transplantation for healthcare professionals: Recommendations of the Francophone Society of Bone Marrow Transplantation and cellular therapy (SFGM …
- Lentiviral hematopoietic Stem and progenitor cell gene therapy for Wiskott-Aldrich Syndrome (WAS): up to 8 years of follow up in 17 subjects treated since 2010
- Thrombopoietin receptor agonist romiplostim in refractory thrombocytopenia as a bridging therapy to the second allogeneic Stem cell transplantation
- … DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR Stem cell TRANSPLANT therapy
- PS1535 AUTOLOGOUS Stem cell TRANSPLANT FOLLOWED BY POST-TRANSPLANT IMMUNOtherapy WITH NIVOLUMAB AND UNSELECTED …
- Health-related quality of life (HRQOL) outcomes of oral ixazomib maintenance therapy post autologous Stem cell transplant (ASCT) in newly diagnosed multiple …
- Analysis of children who received anticancer agent therapy, underwent Stem cell transplantation, and were treated with metronidazole injection at our institute …
- Effects of different doses of cytarabine consolidation therapy followed by haploidentical hematopoietic Stem cell transplantation on low-risk and intermediate-risk acute …
- … therapy AND ALTERNATIVE TREATMENTS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA (MM) INELIGIBLE FOR Stem cell …
- Brentuximab Vedotin As Consolidation therapy Post Hematopoietic Stem cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma …
- Treatment with mesenchymal Stem cells for xerostomia: a new paradigm in cell therapy
- Intelligent photosensitive mesenchymal Stem cells and cell-derived microvesicles for photothermal therapy of prostate cancer
- … the EpiX™ Technology–A Unique Solution that Unleashes the Potential of Tissue-Resident Epithelial Stem and Progenitor cells for Regenerative cell therapy
- cell Biology and Translational Medicine, Volume 5: Stem cells: Translational Science to therapy
- Protective effect of photobiomodulation therapy and bone marrow stromal Stem cells conditioned media on pheochromocytoma cell line 12 against oxidative …
- Towards cell free therapy of premature ovarian insufficiency: human bone marrow mesenchymal Stem cells secretome enhances angiogenesis in human …
- RPE tissue engineering based on human pluripotent Stem cells for cell therapy
- Production of hepatocytes from human pluripotent Stem cells for cell-based therapy
- Mesenchymal Stem/Stromal cell therapy during Pediatric Cardiac Surgery on Neurogenesis in the Porcine Subventricular Zone (P5. 6-055)
- PANCREATIC β cell REGENERATION FROM HUMAN EMBRYONIC Stem cells AS A POSSIBLE therapy FOR TYPE 1 DIABETES
- … transplantation in non-human primates of human muscle-derived Stem cells (MuStem cells), a promising candidate for cell therapy of muscular dystrophies
- Induced pluripotent Stem cells: cell therapy in regenerative medicine and modeling of human disease
- Human CD271+ Adipose-Derived Stem cells Possess Angiogenic Capacity Through Mediating M2-Dominant Macrophage Polarization in cell therapy
- Comparison of CD44 expression in pancreatic cancer, pancreatic Stem and normal pancreatic cells: Development of CLENs for tumor targeting and therapy using cell …
- Inhibition of cancer Stem-like cells in esophageal squamous cell carcinoma with SOCS-1 gene therapy
- … )/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer Stem …
- … cell DISEASE TREATED UNDER A REVISED PROTOCOL WITH LENTIGLOBIN GENE therapy USING PLERIXAFOR-MOBILISED HAEMATOPOIETIC Stem …
- Genetically distinct glioma Stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy
- Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer Stem cells to hormonal therapy
- Mesenchymal Stem cells: the cell replacement therapy for liver cirrhosis
- Stem cells for the cell and Molecular therapy of Type 1 Diabetes Mellitus (T1D) between Lights and Shadows
- Pluripotent Stem cell-based cell therapy—promise and challenges
- Mesenchymal Stem cell therapy for COVID-19: present or future
- Stem cell therapy for COVID‐19: Possibilities and challenges
- Recent progress of Stem cell therapy in cancer treatment: molecular mechanisms and potential applications
- An acute immune response underlies the benefit of cardiac Stem cell therapy
- Mechanisms of cancer Stem cell therapy
- The emerging antioxidant paradigm of mesenchymal Stem cell therapy
- Stem cell therapy for Alzheimer’s disease
- The potential of mesenchymal Stem cell therapy for chronic lung disease
- Current progress in Stem cell therapy for type 1 diabetes mellitus
- Progress in Stem cell therapy for spinal cord injury
- Stem cell therapy for preventing neonatal diseases in the 21st century: current understanding and challenges
- Mesenchymal Stem cell therapy for liver disease: full of chances and challenges
- Combating COVID-19 with mesenchymal Stem cell therapy
- Mesenchymal Stem cell therapy for acute respiratory distress syndrome: from basic to clinics
- Stem cell therapy: old challenges and new solutions
- Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
- Stem cell therapy in heart failure: Where do we stand today?
- Mesenchymal Stem cell‐conditioned media: A novel alternative of Stem cell therapy for quality wound healing
- Sequential paracrine mechanisms are necessary for the therapeutic benefits of Stem cell therapy
- Human umbilical cord-derived mesenchymal Stem cell therapy in patients with COVID-19: a phase 1 clinical trial
- Stem cell therapy for Parkinson’s disease: safety and modeling
- Clinical trials of Stem cell therapy for cerebral ischemic stroke
- Stem cell therapy for muscular dystrophies
- Optimizing Stem cell therapy after ischemic brain injury
- Stroke treatment: Is exosome therapy superior to Stem cell therapy?
- The clinical efficacy and safety of Stem cell therapy for diabetes mellitus: a syStematic review and meta-analysis
- Prospect of Stem cell therapy and regenerative medicine in osteoporosis
- Recent advances in Stem cell therapy for limbal Stem cell deficiency: a narrative review
- Stem cell-based disease modeling and cell therapy
- Current and future directions of Stem cell therapy for bladder dysfunction
- Feasibility of mesenchymal Stem cell therapy for COVID-19: a mini review
- From the lab to patients: a syStematic review and meta-analysis of mesenchymal Stem cell therapy for stroke
- Mesenchymal Stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects
- Stem cell therapy as a treatment for osteogenesis imperfecta
- Current status and future prospects of Stem cell therapy in Alzheimer’s disease
- Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials
- Current status of mesenchymal Stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19
- A review on the Stem cell therapy and an introduction to exosomes as a new tool in reproductive medicine
- Efficacy of Stem cell therapy for tendon disorders: a syStematic review
- Recent trends in Stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review
- Cardiopoietic Stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
- Can mesenchymal Stem cell therapy be the interim management of COVID-19?
- Neural Stem cell therapy for neurovascular injury in Alzheimer’s disease
- Stem cell therapy for Alzheimer’s disease
- Stem cell therapy for diabetes: beta cells versus pancreatic progenitors
- Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering
- An update on Stem cell therapy for Asherman syndrome
- Efficacy of mesenchymal Stem cell therapy for sepsis: a meta-analysis of preclinical studies
- Mesenchymal Stem cell therapy alleviates the neuroinflammation associated with acquired brain injury
- Mesenchymal Stem cell therapy and Alzheimer’s disease: current status and future perspectives
- Mesenchymal Stem cell therapy in acute kidney injury (AKI): review and perspectives
- Inflammatory bowel disease: Therapeutic limitations and prospective of the Stem cell therapy
- Efficacy of Stem cell therapy for burn wounds: a syStematic review and meta-analysis of preclinical studies
- Cytoprotective effects of antioxidant supplementation on mesenchymal Stem cell therapy
- Human mesenchymal Stem cell therapy for cartilage repair: review on isolation, expansion, and constructs
- Ethical and practical considerations for integrating cellular (“Stem cell”) therapy into clinical practice
- Cardiopoietic Stem cell therapy restores infarction-altered cardiac proteome
- Replacing what’s lost: a new era of Stem cell therapy for Parkinson’s disease
- Mesenchymal Stem cell therapy for sports injuries-From research to clinical practice
- First-in-human high-cumulative-dose Stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline
- Multifaceted application of nanoparticle-based labeling strategies for Stem cell therapy
- Mesenchymal Stem cell therapy for liver fibrosis/cirrhosis
- Prospect of Different Types of Magnetic Nanoparticles in Stem cell therapy
- A safety consideration of mesenchymal Stem cell therapy on COVID-19
- A syStematic review of human trials using Stem cell therapy for erectile dysfunction
- Challenges in bone tissue regeneration: Stem cell therapy, biofunctionality and antimicrobial properties of novel materials and its evolution
- Overview of Stem cell therapy for acute respiratory distress syndrome with focus on COVID 19
- Stem cell therapy for osteonecrosis of femoral head: Opportunities and challenges
- Clinical efficacy and safety of Stem cell therapy for knee osteoarthritis: a meta-analysis
- Prenatal Stem cell therapy for inherited diseases: Past, present, and future treatment strategies
- Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury
- Ventricular remodeling in ischemic heart failure stratifies responders to Stem cell therapy
- Developing implantable scaffolds to enhance neural Stem cell therapy for post-operative glioblastoma
- Biomechanical modulation therapy—a Stem cell therapy without Stem cells for the treatment of severe ocular burns
- Targeting strategies for renal cancer Stem cell therapy
- Regenerative potential of Wharton’s jelly‐derived mesenchymal Stem cells: A new horizon of Stem cell therapy
- Stem cell therapy for neurodegenerative diseases: how do Stem cells bypass the blood-brain barrier and home to the brain?
- Fetal surgery and Stem cell therapy for meningomyelocele
- Therapeutic effect and safety of Stem cell therapy for chronic liver disease: a syStematic review and meta-analysis of randomized controlled trials
- A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal Stem cell therapy for hindlimb ischemia
- Adipose-derived Stem cell therapy shows promising results for secondary lymphedema
- Correlation between the efficacy of Stem cell therapy for osteonecrosis of the femoral head and cell viability
- Limbal epithelial and mesenchymal Stem cell therapy for corneal regeneration
- The application of Stem cell therapy and brown adipose tissue transplantation in metabolic disorders
- Engineering of SPECT/photoacoustic imaging/antioxidative stress triple-function nanoprobe for advanced mesenchymal Stem cell therapy of cerebral ischemia
- … of current position on cell therapy in transfusion science and medicine: from fictional promises to factual and perspectives from red cell substitution to Stem cell therapy
- Advancing a Stem cell therapy for age-related macular degeneration
- Chimeric antigen receptor T‐cell therapy as a bridge to haematopoietic Stem cell transplantation for refractory/relapsed B‐cell acute lymphoblastic leukemia
- The effect of Stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study
- Potential of Stem cell therapy in intracerebral hemorrhage
- Bioprocess Development for Human Mesenchymal Stem cell therapy Products
- Mesenchymal Stem cell therapy for diabetic kidney disease: a review of the studies using syngeneic, autologous, allogeneic, and xenogeneic cells
- Mesenchymal Stem cell therapy for osteoradionecrosis of the mandible: a syStematic review of preclinical and human studies
- Prussian blue nanocubes as a multimodal contrast agent for image-guided Stem cell therapy of the spinal cord
- Matrix-delivered autologous mesenchymal Stem cell therapy for refractory rectovaginal Crohn’s fistulas
- Neural Stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model
- Mesenchymal Stem cell therapy using human umbilical cord in a rat model of autoimmune-induced premature ovarian failure
- Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo: a review
- Efficacy and Safety of Stem cell therapy for T1DM: An Updated SyStematic Review and Meta-Analysis
- Advancing Stem cell therapy for repair of damaged lung microvasculature in amyotrophic lateral sclerosis
- Autologous bone marrow-derived Stem cell therapy for Asherman’s syndrome and endometrial atrophy: a 5-year follow-up study
- Autologous adipose Stem cell therapy for knee osteoarthritis: where are we now?
- Mesenchymal Stem cell therapy improves erectile dysfunction in experimental spinal cord injury
- Online direct-to-consumer advertising of Stem cell therapy for musculoskeletal injury and disease: misinformation and violation of ethical and legal advertising …
- Enhancing the efficacy of Stem cell therapy with glycosaminoglycans
- A review on Stem cell therapy for neuropathic pain
- Is Stem cell therapy the new savior for cerebral palsy patients? A Review
- Stem cell therapy in heart disease: limitations and future possibilities
- Mesenchymal Stem cell therapy in chondral defects of knee: current concept review
- Intraperitoneal injection of graphene oxide nanoparticle accelerates Stem cell therapy effects on acute kidney injury
- Application of mesenchymal Stem cell therapy and inner ear regeneration for hearing loss: a review
- A review of application of Stem cell therapy in the management of congenital heart disease
- … -activated protein-based injectable adhesive hydrogel incorporated with decellularized adipose extracellular matrix for tissue-specific regenerative Stem cell therapy
- A multicenter experience using adipose-derived mesenchymal Stem cell therapy for cats with chronic, non-responsive gingivostomatitis
- Effects of mesenchymal Stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Sorafenib and Mesenchymal Stem cell therapy: A Promising Approach for Treatment of HCC
- Blood-based biomarkers and Stem cell therapy in human stroke: a syStematic review
- Patients’ expectations and experiences of Stem cell therapy for the treatment of knee osteoarthritis
- Research Trends in the Efficacy of Stem cell therapy for Hepatic Diseases Based on MicroRNA Profiling
- Stem cell therapy in brain ischemia: the role of mitochondrial transfer
- Stem cell therapy improves heart function by triggering an acute immune response
- Evaluation of autologous adipose-derived mesenchymal Stem cell therapy in focal chondral defects of the knee: a pilot case series
- Healing the broken heart; the immunomodulatory effects of Stem cell therapy
- Mechanisms underlying the protective effects of mesenchymal Stem cell-based therapy
- Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic Stem cell …
- Current status of Regulatory perspectives on Stem cell therapy in India
- Efficacy and safety of Stem cell therapy for the early-stage osteonecrosis of femoral head: a syStematic review and meta-analysis of randomized controlled …
- Stem cell–based therapy for coronavirus disease 2019
- Consolidative allogeneic hematopoietic Stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute …
- Umbilical cord blood Stem cell therapy in premature brain injury: opportunities and challenges
- Stem–cell therapy as a Potential Strategy for Radiation-Induced Brain Injury
- Hematogenous donor cell routing pathway after transamniotic Stem cell therapy
- Human Umbilical Cord–Derived Mesenchymal Stem cell therapy Effectively Protected the Brain Architecture and Neurological Function in Rat After Acute Traumatic …
- Combining growth factor and Stem cell therapy for stroke rehabilitation, a review
- Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal Stem cell therapy improves pathology in mice with repeated traumatic brain injury
- A narrative review of research advances in mesenchymal Stem cell therapy for asthma
- Value of mesenchymal Stem cell therapy for patients with septic shock: an early health economic evaluation
- Mesenchymal Stem cell therapy can transcend perianal crohn’s disease: How colorectal surgeons can help in the coronavirus disease 2019 crisis
- Stem cell therapy for neurogenic bladder after spinal cord injury: clinically possible?
- Targeting cancer Stem cell pathways for cancer therapy
- An overview of Stem cell therapy for paediatric heart failure
- Nanomedicine in Cancer Stem cell therapy
- Transamniotic mesenchymal Stem cell therapy for neural tube defects preserves neural function through lesion-specific engraftment and regeneration
- Safety and efficacy of Stem cell therapy in patients with ischemic stroke
- Stem cell ‘therapy‘advertisements in China: Infodemic, regulations and recommendations
- Intra-amniotic delivery of CRMP4 siRNA improves mesenchymal Stem cell therapy in a rat spina bifida model
- Safety and efficacy of human adipose-derived stromal/Stem cell therapy in an immunocompetent murine pressure ulcer model
- Initial mechanistic screening of transamniotic Stem cell therapy in the rodent model of spina bifida: host bone marrow and paracrine activity
- Heat shock protein 27 as a neuroprotective biomarker and a suitable target for Stem cell therapy and pharmacotherapy in ischemic stroke
- Improving human kidney function in renovascular disease with mesenchymal Stem cell therapy
- Stem cell programs in cancer initiation, progression, and therapy resistance
- Autologous bone-marrow mononuclear Stem cell therapy in patients with stroke: a meta-analysis of comparative studies
- In vitro study of SDF-1α-loaded injectable and thermally responsive hydrogels for adipose Stem cell therapy by SDF-1/CXCR4 axis
- Evaluation of mesenchymal Stem cell therapy for sepsis: a randomized controlled porcine study
- Altered T-lymphocyte biology following high-dose melphalan and autologous Stem cell transplantation with implications for adoptive T-cell therapy
- A biomarker for predicting responsiveness to Stem cell therapy based on mechanism-of-action: evidence from cerebral injury
- Transcriptomic analysis of human mesenchymal Stem cell therapy in incontinent rat injured urethra
- Historical aspects of gene therapy and Stem cell therapy in the treatment of hearing and balance disorder
- Stem cell therapy and FUS [1‐359]‐transgenic mice: A recent study highlighting a promising ALS model and a promising therapy
- Hydrogel‐Based Multifunctional Dressing Combining Magnetothermally Responsive Drug Delivery and Stem cell therapy for Enhanced Wound Healing
- Congenital diaphragmatic hernia as a potential target for transamniotic Stem cell therapy
- Effects of nicotine on the translation of Stem cell therapy
- Mesenchymal Stem cell therapy for heart failure: A meta-analysis
- A comparison between placental and amniotic mesenchymal Stem cells in transamniotic Stem cell therapy for experimental gastroschisis
- Mircrining the injured heart with Stem cell-derived exosomes: an emerging strategy of cell-free therapy
- Cytokine storm in COVID-19: An overview, mechanism, treatment strategies, and Stem cell therapy perspective
- Donor mesenchymal Stem cell kinetics after transamniotic Stem cell therapy (TRASCET) in a rodent model of gastroschisis
- … membrane vesicles of human umbilical cord mesenchymal Stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel Stem cell therapy
- Immunogenicity in Stem cell therapy for cardiac regeneration
- Possible roles of epigenetics in Stem cell therapy for Parkinson’s disease
- Application of nanotechnology in Stem–cell-based therapy of neurodegenerative diseases
- Liver damage in schistosomiasis is reduced by adipose tissue-derived Stem cell therapy after praziquantel treatment
- Influence of bone marrow-derived mesenchymal Stem cell therapy on oxidative stress intensity in minimally conscious state patients
- Stem cell therapy for neurogenic bladder dysfunction in rodent models: a syStematic review
- … receptor T-cell therapy followed by radiotherapy for a recurrence of blastic plasmacytoid dendritic cell neoplasm after allogeneic hematopoietic Stem cell …
- Stem cell therapy for thromboangiitis obliterans (Buerger’s disease)
- Peripheral Blood Stem cell therapy Does Not Improve Outcomes of Femoral Head Osteonecrosis With Cap‐Shaped Separated Cartilage Defect
- Stem cell based therapy option in COVID-19: is it really promising?
- Stem cell transplantation: a promising therapy for spinal cord injury
- Status, challenges, and future prospects of Stem cell therapy in pelvic floor disorders
- The efficacy of mesenchymal Stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model
- Advances in Stem cell therapy for the treatment of Peyronie’s disease
- … (PET) for Assessment of Post Myocardial Infarction Angiogenesis as a Predictor for Left Ventricular Remodeling in Mice after Cardiac Stem cell therapy
- Stem cell therapy: a potential for the perils of pancreatitis
- Stem–cell therapy for bronchopulmonary dysplasia
- Challenges for mesenchymal Stem cell-based therapy for COVID-19
- Some aspects of Stem cell therapy
- Advances in Stem cell-based therapy for hair loss
- RPE and Stem cell therapy
- Multifunctional nanoparticles in Stem cell therapy for cellular treating of kidney and liver diseases
- Stem cell therapy as a Treatment Method for Rheumatoid Arthritis
- Mesenchymal Stem cell therapy combined with arthroscopic abrasion arthroplasty regenerates cartilage in patients with severe knee osteoarthritis: A case series
- Polymeric biomaterial scaffolds for tumoricidal Stem cell glioblastoma therapy
- Effect of autologous adipose-derived mesenchymal Stem cell therapy in the treatment of an osteochondral lesion of the ankle
- Genetically modified mesenchymal Stem cells: The next generation of Stem cell-based therapy for TBI
- What is the role of Stem cell therapy in the treatment of anal incontinence?
- Mapping global research trends in Stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019
- Role of liposomes-based Stem cell for multimodal cancer therapy
- Arrhythmogenic risks of Stem cell replacement therapy for cardiovascular diseases
- Mesenchymal Stem cell-derived extracellular vesicles: a novel cell-free therapy
- The achievements and challenges of mesenchymal Stem cell-based therapy in inflammatory bowel disease and its associated colorectal cancer
- Plasticity of cancer Stem cell: origin and role in disease progression and therapy resistance
- Effect of SyStemic adipose-derived Stem cell therapy on functional nerve regeneration in a rodent model
- Stem cell therapy and Hydrogen Sulfide: Conventional or Nonconventional Mechanisms of Action?
- Adiponectin stimulates exosome release to enhance mesenchymal Stem–cell-driven therapy of heart failure in mice
- SOX2 for Stem cell therapy and Medical Use: Pros or Cons?
- Stem cell therapy for Acute Myocardial Infarctions: A SyStematic Review
- Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of Stem cell therapy
- Autologous haematopoietic Stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated …
- Epithelial–mesenchymal transition programs and cancer Stem cell phenotypes: mediators of breast cancer therapy resistance
- Stem cell research and therapy in India: General awareness for the public and Stem cell therapy providers
- Clinical Efficacy and Safety of Stem cell-Based therapy in Treating Asherman Syndrome: A SyStem Review and Meta-Analysis
- Preconditioning strategies to enhance neural Stem cell-based therapy for ischemic stroke
- Hypoxia-mediated cancer Stem cell resistance and targeted therapy
- Effectiveness of Stem cell therapy in the treatment of ovarian disorders and female infertility: a syStematic review
- Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous Stem cell transplantation and receive active therapy. A retrospective analysis of …
- Pluripotent-Stem–cell-derived hepatic cells: hepatocytes and organoids for liver therapy and regeneration
- Promising impacts of mesenchymal Stem cell therapy in treatment of SARS-CoV-2 (COVID-19)
- Mesenchymal Stem cell-derived exosome: A promising alternative in the therapy of Alzheimer’s disease
- Stem cell therapy for Chronic and Advanced Heart Failure
- … in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (Stem) cell (MSC) therapy—Achieving global consensus and …
- Adoptive natural killer cell therapy: a human pluripotent Stem cell perspective
- Introduction for Stem cell–Based therapy for Neurodegenerative Diseases
- Stem cell therapy and Cats: What Do We Know at This Time
- Curative options for sickle cell disease: haploidentical Stem cell transplantation or gene therapy?
- Inflammatory mediators in glioma microenvironment play a dual role in gliomagenesis and mesenchymal Stem cell homing: implication for cellular therapy
- … Working Party of the European Society for blood and marrow transplantation (EBMT) and the Spanish hematopoietic Stem cell transplantation and cell therapy …
- Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic Stem cell transplant relapse
- Nanoparticles for Stem cell therapy bioengineering in glioma
- SyStematic review of platelet-rich plasma use in androgenetic alopecia compared with Minoxidil®, Finasteride®, and adult Stem cell-based therapy
- SyStematic Review of Stem–cell-Based therapy of Burn Wounds: Lessons Learned from Animal and Clinical Studies
- … haematopoietic Stem–cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy …
- Stem cell therapy for pediatric traumatic brain injury
- Pathogenesis of inflammatory bowel disease and mesenchymal Stem cell therapy: therapeutic application and existing problems
- Mesenchymal Stem cell-derived extracellular vesicles: a novel cell-free therapy for sepsis
- Current Status of Stem cell therapy for Sepsis and Acute Respiratory Distress Syndrome
- A Comparative Study of Novel Stem cell therapy-Based Treatments for Diabetic Foot Ulcers
- Importance of Stem cell migration and angiogenesis study for regenerative cell-based therapy: a review
- Hematopoietic Stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
- cellular therapy of corneal epithelial defect by adipose mesenchymal Stem cell-derived epithelial progenitors
- Autologous fractionated adipose tissue as a natural biomaterial and novel one-step Stem cell therapy for repairing articular cartilage defects
- Impact of ultrasound therapy on Stem cell differentiation-a syStematic review
- Establishment of a Rapid Lesion-Controllable Retinal Degeneration Monkey Model for Preclinical Stem cell therapy
- Human artificial chromosomes for pluripotent Stem cell-based tissue replacement therapy
- … of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent Stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid …
- The effect of Stem cell transplantation therapy for post viral chronic liver cell failure on associated type II diabetes mellitus: a pilot study
- A nano-based thermotherapy for cancer Stem cell-targeted therapy
- Melatonin preconditioning is an effective strategy for mesenchymal Stem cell‐based therapy for kidney disease
- Research and development strategy for future embryonic Stem cell-based therapy in Japan
- Safety and efficacy of a mesenchymal Stem cell intramammary therapy in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis
- Acute graft-versus-host disease after humanized anti-CD19-CAR T therapy in relapsed B-ALL patients after allogeneic hematopoietic Stem cell transplant
- Trends and targets of various types of Stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity
- Stem cell‐Derived Liver cells: From Model SyStem to therapy
- … artery transplantation of bone marrow-derived NCS-01 cells for ischemic stroke: Behavioral and histological readouts and mechanistic insights into Stem cell therapy
- Stromal cell-derived factor-1 (SDF-1) expression in very preterm human lungs: Potential relevance for Stem cell therapy for bronchopulmonary dysplasia
- Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac Stem cell-based therapy
- Haematopoietic Stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
- Intravitreal Stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases
- A combined approach to intracerebral hemorrhage: intravenous mesenchymal Stem cell therapy with minimally invasive hematoma evacuation
- Comparison of Different Culture Conditions for Mesenchymal Stem cells from Human Umbilical Cord Wharton’s Jelly for Stem cell therapy
- Ubiquitination in cancer Stem cell: roles and targeted cancer therapy
- Stem cell-based delivery of gold/chlorin e6 nanocomplexes for combined photothermal and photodynamic therapy
- Challenges and translational considerations of mesenchymal Stem/stromal cell therapy for Parkinson’s disease
- Sequential scalp assessment in hair regeneration therapy using an adipose-derived Stem cell–conditioned medium
- The roles of nanoparticles in Stem cell-based therapy for cardiovascular disease
- Lentiviral hematopoietic Stem cell gene therapy corrects murine Pompe disease
- Amniotic fluid and breast milk: a rationale for breast milk Stem cell therapy in neonatal diseases
- Physical training prior to myocardial infarction potentializes Stem cell therapy, SDF-1/CXCR4 axis activation and inhibits the vasoconstrictor response in hypertensive …
- … the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and Stem cell …
- Sequential response-driven bortezomib-based therapy followed by autologous Stem cell transplant in AL amyloidosis
- Stem cell therapy, ophthalmic applications, and the current controversies with direct-to-consumer marketing
- De novo modeling and structural characterization of IL9-IL9 receptor complex: A potential drug target for hematopoietic Stem cell therapy
- Curative in vivo hematopoietic Stem cell gene therapy of murine thalassemia using large regulatory elements
- Mesenchymal Stem cell-Based therapy for Allergic Rhinitis
- Improving mesenchymal Stem/stromal cell potency and survival: Proceedings from the International Society of cell therapy (ISCT) MSC preconference held in May …
- … epithelial-to-mesenchymal transition and cancer Stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary syStemic therapy
- Hematopoietic Stem cell Gene therapy for Brain Metastases Using Myeloid cell–Specific Gene Promoters
- The Future of Brain Repair: A Realist’s Guide to Stem cell therapy
- Cxcr6-based mesenchymal Stem cell gene therapy potentiates skin regeneration in murine diabetic wounds
- Nelarabine as salvage therapy and bridge to allogeneic Stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia …
- Stem cell therapy for stress urinary incontinence
- CXCR4 antagonists as Stem cell mobilizers and therapy sensitizers for acute myeloid leukemia and glioblastoma?
- The anti-scarring effect of corneal stromal Stem cell therapy is mediated by transforming growth factor β3
- Still’dwelling in the possibility’-critical update on Stem cell therapy for acute on chronic liver failure
- Unexpected toxicities when nivolumab was given as maintenance therapy following allogeneic Stem cell transplantation
- AL amyloidosis: the effect of maintenance therapy on autologous Stem cell transplantation outcomes
- Clinical-grade human pluripotent Stem cells for cell therapy: characterization strategy
- Future challenges and perspectives for Stem cell therapy of neurodegenerative diseases
- A current update in COVID-19 associated acute respiratory distress syndrome: Focus on mesenchymal Stem cell therapy
- Autoimmune cytopenias following allogeneic hematopoietic Stem cell transplant in pediatric patients: Response to therapy and late effects
- Novel Players and a Target of Stem cell therapy for the Heart
- CD38-directed CAR-T cell therapy: A novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic Stem cell transplantation
- CORR synthesis: what is the evidence for the clinical use of Stem cell-based therapy in the treatment of osteoarthritis of the knee?
- Autologous hematopoietic Stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
- Stem cell therapy in Wound Care
- Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome: a novel therapeutic strategy
- Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous Stem cell transplantation
- Comparison between the Effect of Hyaluronic Acid and Mesenchymal Stem cell therapy on Cornea of Adult Albino Rats after Exposure to Alkali Burn (Light and …
- Prospect of Stem cell therapy to avoid cytokine storm in severe covid-19
- Postnatal fate of donor mesenchymal Stem cells after transamniotic Stem cell therapy in a healthy model
- cellular therapy in Follicular Lymphoma: Autologous Stem cell Transplantation, Allogeneic Stem cell Transplantation, and Chimeric Antigen Receptor T-cell therapy
- Stem cell-based therapy for Neurodegenerative Diseases
- Stem cell membrane–camouflaged bioinspired nanoparticles for targeted photodynamic therapy of lung cancer
- Stem cell transplantation therapy: a potential method for treating cytokine storm syndromes induced by COVID-19
- Editorial Commentary: Are We Ready to Apply Stem cell therapy in Rotator Cuff Tear Surgery?
- Cardiac Stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): under-regulated, under-observed, incompletely understood
- Stem cell membrane-coated Au-Ag-PDA nanoparticle-guided photothermal acne therapy
- Use of letermovir for salvage therapy for resistant cytomegalovirus in a pediatric hematopoietic Stem cell transplant recipient
- … induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous Stem cell …
- Identification of AAV serotypes for lung gene therapy in human embryonic Stem cell-derived lung organoids
- Stem cell therapy in Orthopedics
- … life of first-line haploidentical hematopoietic Stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe …
- Stem cell therapy for Parkinson’s disease
- … antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic Stem cell transplantation: a retrospective …
- Prophylactic in vivo hematopoietic Stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models
- Mesenchymal Stem cell-based Smad7 gene therapy for experimental liver cirrhosis
- Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic Stem cell transplantation for refractory hemophagocytic lymphohistiocytosis
- … effectiveness of treatment strategy of tandem high‐dose chemotherapy and autologous Stem cell transplantation in combination with 131I‐MIBG therapy for high‐risk …
- Epigenetic Research in Stem cell Bioengineering—Anti-Cancer therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials
- Polydopamine nanoparticles camouflaged by Stem cell membranes for synergistic chemo-photothermal therapy of malignant bone tumors
- Transplantation site affects the outcomes of adipose-derived Stem cell-based therapy for retinal degeneration
- Human CD34+ hematopoietic Stem cells culture in humanized culture medium for cell therapy
- Promise of autologous CD34+ Stem/progenitor cell therapy for treatment of cardiovascular disease
- … therapy with donor-derived Human Cytomegalovirus (HCMV)–specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic Stem …
- Role of natural cellulose and hydrogel matrices in Stem cell therapy of diabetic foot ulcer
- … landmark treatment methods—allogeneic hematopoietic Stem cell transplantation and chimeric antigen receptor T cell therapy together to cure high-risk B cell …
- On Our Doorstep, A Precious Cargo From MSCs: The Role of Extracellular Vesicles in Stem cell therapy
- Bone marrow stromal cells induce an ALDH+ Stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway
- A combinational therapy of articular cartilage defects: rapid and effective regeneration by using Low-Intensity focused ultrasound after adipose tissue-derived Stem cell …
- The role of the Stem cell epigenome in normal aging and rejuvenative therapy
- … donors in hematopoietic Stem cell transplantation. A real world experience from the Argentine Group For Bone Marrow Transplantation And cell therapy (GATMO-TC …
- Personalized therapy and Stem cell transplantation for pro-inflammatory modulation of cancer Stem cells microenvironment in glioblastoma
- Potential survival benefit for patients receiving allogeneic hematopoietic Stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin …
- Author Correction: Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal Stem cell therapy for EAE
- Maintenance therapy with decitabine after allogeneic hematopoietic Stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
- Photobiomodulation and Stem cell therapy for Temporomandibular Joint Disc Disorders
- Upfront autologous hematopoietic Stem–cell transplantation improves overall survival in comparison with bortezomib-based intensification therapy in newly …
- LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem cell Population during Temozolomide therapy in Glioblastoma
- CDK5 Inhibition Abrogates TNBC Stem‐cell Property and Enhances Anti‐PD‐1 therapy
- Tolerability and efficacy of treatment with azacytidine as prophylactic or preemptive therapy for myeloid neoplasms after allogeneic Stem cell transplantation
- RETRACTED ARTICLE: High-dose therapy and autologous Stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey
- Photobiomodulation therapy improves human dental pulp Stem cell viability and migration in vitro associated to upregulation of histone acetylation
- Stem cell transplantation therapy for retinal degenerative diseases
- Mesenchymal Stem cell therapy improves pulmonary function and exercise tolerance in patients with chronic obstructive pulmonary disease (copd) and high baseline …
- Autologous Mesenchimal Stem cell therapy in Patients with Unexplainable Low Ovarian Response
- Preclinical development of autologous hematopoietic Stem cell-based gene therapy for immune deficiencies: a journey from mouse cage to bed side
- 89Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem cell Targeted therapy
- Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic Stem cell …
- In vitro generation of red blood cells from Stem cell and targeted therapy
- Clinical profiles and outcomes of patients with neurological diseases treated with Stem cell therapy: a single-center experience in the Philippines
- Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic Stem cell transplantation for young patients with …
- Convalescent plasma and mesenchymal Stem cell therapy
- … Outcomes Following Donor-Derived Anti-CD19 CAR-T cell therapy for B-cell Acute Lymphoblastic Leukemia Patients Relapsed after Allogenic Stem cell …
- Mechanistic underpinnings of Stem cell therapy for neurological disorders
- Hepatic focal nodular hyperplasia after pediatric hematopoietic Stem cell transplantation: The impact of hormonal replacement therapy and iron overload
- Functional and histological evaluation of bone marrow Stem cell-derived exosomes therapy on the submandibular salivary gland of diabetic Albino rats …
- Establishment of a novel fetal growth restriction model and development of a Stem–cell therapy using umbilical cord-derived mesenchymal stromal cells
- … and pathways in macrophages responsible for the Th1/Th17 inflammatory condition of Periodontal infection that can be candidates in Stem cell therapy of the disease.
- Allogeneic donor-derived anti-CD19 CAR T cell is a promising therapy for relapsed/refractory B-ALL after allogeneic hematopoietic Stem–cell transplantation
- Stem cell therapy for Acute Respiratory Distress Syndrome: There Are Certain Things That Should Be Done and Should Not Be Done
- Encapsulation of Mesenchymal Stem cells: Dissecting the Underlying Mechanism of Mesenchymal Stem cell Transplantation therapy
- … refractory classical hodgkin lymphoma who relapsed after salvage autologous Stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup …
- Nephroprotective effect of mesenchymal Stem cell-based therapy of kidney disease induced by toxicants
- Evaluating the clinical effectiveness of autologous haematopoietic Stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching …
- Clinical applicability of adult human mesenchymal Stem cell therapy in the treatment of knee osteoarthritis
- Allogeneic Stem cell transplantation for high-risk acute leukemia and maintenance therapy: no time to waste
- Influence of Organismal Aging in Mesenchymal Stem cell therapy
- Cancer Stem cell as Target of CAR-T cell therapy
- A neural crest Stem cell-like state drives nongenetic resistance to targeted therapy in melanoma
- Modeling and Analyzing Stem–cell therapy toward Cancer: Evolutionary Game Theory Perspective
- Development of Effective Stem cell therapy by cell Surface Modification
- … is necessary to ameliorate central nervous syStem involvement of murine model of mucopolysaccharidosis type II by hematopoietic Stem cell targeted gene therapy
- … Megatherapy with Autologous Stem cell Transplantation in Children with Relapsing or therapy-Resistant Extracranial Germ-cell Tumors—A Retrospective Analysis
- Treating primary immunodeficiencies with defects in NK cells: from Stem cell therapy to gene editing
- … therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood Stem cell …
- Effects of hormone replacement therapy on bone mass after allogeneic hematopoietic Stem cell transplantation
- Lentiviral hematopoietic Stem cell gene therapy rescues clinical phenotypes in a murine model of Pompe disease
- Mesenchymal Stem cell therapy maximizes lung preservation by preventing ischemic organ injury
- Analyzing the Effectiveness of Adipose Tissue Stem cell and Microvesicle therapy in Premature Skin Aging Caused by Chronic Exposure to Ultraviolet Radiation
- Improvement in viability and mineralization of osteoporotic bone marrow mesenchymal Stem cell through combined application of photobiomodulation therapy and …
- Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic Stem cell transplantation in patients with hematological malignancy
- Outcome and risk factors for therapy-related myeloid neoplasms treated with allogeneic Stem cell transplantation in Japan
- Infection prophylaxis patterns following pediatric autologous hematopoietic Stem cell transplantation: A survey of Pediatric Transplant and cell therapy Consortium …
- Impact of preemptive therapy for cytomegalovirus on hospitalizations and cost after hematopoietic Stem cell transplantation
- Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer Stem cell markers SOX2, OCT4 …
- Pluripotent Stem cell Modeling of Anticancer therapy–Induced Cardiotoxicity
- Mouse models in hematopoietic Stem cell gene therapy and genome editing
- Exploring the potential of mesenchymal Stem cell-based therapy in mouse models of vascular cognitive impairment
- Mesenchymal Stem cell therapy—Is the Vessel Half Full or Half Empty?
- … experience and quality of life of children and adolescents undergoing hematopoietic Stem cell transplantation compared to chimeric antigen receptor T-cell therapy
- Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous Stem–cell transplantation
- Immortalized Stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapy
- Intra-articular xenogeneic mesenchymal Stem cell-based therapy increases CD4+ CD25+ cells in synovial fluid
- Update of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous Stem cell transplant (AuSCT) in patients (pts) with multiple …
- Anti-inflammatory exosomes mediate the beneficial effect of mesenchymal Stem cell therapy on lung preservation
- … of autologous hematopoietic Stem cell transplantation with gene addition therapy for transfusion-dependent β-thalassemia, sickle cell disease, and cerebral …
- Immune dysregulation in HFpEF: a target for mesenchymal Stem/stromal cell therapy
- Lines of therapy before Autologous Stem cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL)
- Effect of autologous adipose-derived mesenchymal Stem cell therapy in combination with autologous platelet-rich plasma in the treatment of elbow tendinopathy
- … and quality of life experienced by children undergoing Hematopoietic Stem cell Transplantation or Chimeric Antigen Receptor T-cell therapy: an argument for …
- CD34 cells in somatic, regenerative and cancer Stem cells: developmental biology, cell therapy, and omics big data perspective
- Phospholipase Cγ signaling in bone marrow Stem cell and relevant natural compounds therapy
- (NNN03) Preliminary Cognitive Outcomes Following Mesenchymal Stem cell therapy in Multiple Sclerosis.
- Personalized Stem cell-based therapy for degenerative retinal diseases
- Lines of therapy in patients with relapsed or refractory large B-cell lymphoma and Stem cell transplant-intended treatment
- A novel Stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure
- Xenogeneic and Stem cell-based therapy for cardiovascular diseases: genetic engineering of porcine cells and their applications in heart regeneration
- Umbilical Cord Derived Mesenchymal Stem cell therapy for Osteoarthritis: A Consolidated Review
- cell therapy with mesenchymal Stem cells induces an innate immune memory response that attenuates experimental colitis in the long term
- Stem cell therapy in improving the motor function of patients with cerebral palsy: SyStematic review with meta-analysis.
- Towards Biology-Driven Strategies for Stem cell therapy Applications
- EXTH-52. GLIOBLASTOMA-TARGETING AUTOLOGOUS INDUCED NEURAL Stem cell therapy: EVALUATING SAFETY, TOXICITY, PERSISTENCE, AND …
- Cerebrospinal fluid (CSF) exchange therapy with artificial CSF enriched with mesenchymal Stem cell secretions ameliorates cognitive deficits and brain pathology in …
- The effect of autologous adipose derived mesenchymal Stem cell therapy on juvenile osteochondritis dissecans of the patella: a case study
- … as post-autologous Stem cell transplant maintenance therapyin patients with multiple myeloma (MM) using minimal residual disease todirect therapy duration …
- Willingness of volunteers from Canadian Blood Service’s Stem cell Registry to donate blood, marrow, and other tissues for regenerative therapy
- Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous Stem cell support achieves a very good long‐term outcome …
- Hematological Findings in COVID-19 and Insights to Stem cell therapy: From Bench to Practice
- Calcium sensing receptor involving in therapy of embryonic Stem cell transplantation alleviates acute myocardial infarction by inhibiting apoptosis and …
- The genetically-engineered Stem cell therapy of huntington disease: spt4 knockout hd patient ipsc-npcs transplantation rescue abnormal neuronal dysfunction in the …
- Corneal Stem cells as a source of regenerative cell-based therapy
- Stem cell therapy for Vascular Diseases: State of the Evidence and Clinical Applications
- INSPIRE Neuro-Spinal Scaffold™: An Implantable Alternative to Stem–cell therapy for Endogenous Repair in Spinal Cord Injury
- Effective hematopoietic Stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis
- Stem cell therapy for Brain Injury
- Sticky bone-specific artificial extracellular matrix for Stem cell-mediated rapid craniofacial bone therapy
- … acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic Stem cell transplantation can improve …
- … Phase I Study of Allogeneic Mesenchymal Stem cell therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem cell …
- Optimising process quality and cost for closed, automated and commercial scale manufacture of allogeneic Stem cell therapy products
- A long-term response to allogeneic hemopoietic Stem cell transplantation from haploidentical donor and post-transplant therapy in an adolescent with primary …
- POTENTIAL OF Stem cell therapy IN TREATMENT OF PARKINSON’S DISEASE
- Introduction and Basic Concepts in Stem cell Research and therapy: The Facts and the Hype
- Effectiveness of the Structures Teaching Programme on Stem cell therapy
- Faculty ofPostgraduate Childhood Studies, Faculty ofMedicine-Ain Shams University, Cairo, Egypt Stem cell therapy Group Vienna Medical University of …
- New-onset post-transplant diabetes and therapy in long-term survivors after allogeneic hematopoietic Stem cell transplantation
- Human Umbilical Cord-Derived Mesenchymal Stem cell therapy in COVID-19 Patients: A Phase 1 Clinical Trial
- SIRT3 Transfection of Aged Human Bone Marrow-Derived Mesenchymal Stem cells Improves cell therapy-Mediated Myocardial Repair
- Stem cell therapy in knee osteoarthritis
- Mesenchymal Stem cell-Mediated therapy of Peripheral Artery Disease Is Stimulated by a Lamin A-Progerin Binding Inhibitor
- Autologous Stem cell therapy for Cerebral Palsy
- … of cytomegalovirus DNAemia blips in allogeneic hematopoietic Stem cell transplant recipients: Implications for optimization of preemptive antiviral therapy …
- … Myeloablative Conditioning before Allogeneic Hematopoietic Stem cell Transplantation: A Multicenter Analysis from the Kanto Study Group for cell therapy …
- Elotuzumab-based maintenance therapy following autologous Stem cell transplant in multiple myeloma deepens post-transplant responses
- Hyperbaric oxygen therapy of an adolescent Stem cell transplantation recipient with hemorrhagic cystitis and BK virus
- Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic Stem cell-derived cardiomyocytes
- Stem cell therapy in Treating Type 1 Diabetes Mellitus–Potential and Ethical Issues.
- Feasibility of Stem cell therapy for renal ischemia/reperfusion injury: a syStematic review based on animal experiments
- Implications of Stem cell therapy in Cancer Treatment
- Is Stem cell therapy the New Savior for Cerebral Palsy Patients? A Review
- Therapeutic effect of autologous bone marrow Stem cell mobilization combined with anti-infective therapy on moyamoya disease
- Transcriptional Analysis Reveals Alteration of Lung Macrophages Following Mesenchymal Stem cell therapy in Neonatal Mice With Hyperoxia-Induced Injury
- Concerns About Mesenchymal Stem cell therapy
- CHAPTER Stem cell therapy for Psychiatric Disorders
- Stem cell therapy for dilated cardiomyopathy: syStematic review of the existing data and ongoing trials
- Best available therapy versus autologous hematopoietic Stem cell transplantation for multiple sclerosis
- Important considerations for cell therapy manufacturing of mesenchymal Stem cell
- Case report: Effect of autologous adipose-derived mesenchymal Stem cell therapy in combination with autologous platelet-rich plasma in the treatment of …
- Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent Stem cells‐derived hepatic Stem cells
- DOP85 The role of fibroblasts in the pathogenesis of Crohn’s disease-associated fistulas and in mesenchymal Stem cell therapy
- Imaging of Stem cell therapy in Acute Respiratory Distress Syndrome in sheep and its relationship with histopathology
- Antitumor effect of cell therapy with mesenchymal Stem cells on murine melanoma B16-F10
- Present and future challenge for the use of Stem cell in hematopoietic transplantation and cell therapy
- Human placental-derived Stem cell therapy ameliorates experimental necrotizing enterocolitis and supports restoration of the intestinal Stem cell niche
- Combining cell therapy with Autologous Schwann cell and Bone Marrow-derived Mesenchymal Stem cell in Patients with Subacute Complete Spinal Cord …
- Stem cell therapy for Your Brain
- Stem cell therapy for non-obstructive azoospermia
- Autologous hematopoietic Stem cell transplantation for syStemic sclerosis: Position statement of the Stem cell therapy working party of the German Society of …
- 213. Study comparing NTG-101, a growth factor-based therapy with mesenchymal Stem cell (MSC) based treatment of degenerative disc disease (DDD) in pre-clinical …
- Stem cell therapy: cell‐Based therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs (Adv. Sci. 23/2020)
- Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic Stem cell transplantation
- Stem cell therapy as an Alternative for Osteoarthritis of the Knee
- Mesenchymal Stem cells could be considered as a candidate for further studies in cell-based therapy of Alzheimer’s disease via targeting the signaling pathways
- Maintenance therapy following salvage autologous Stem cell transplant in patients with multiple myeloma
- In horses with osteoarthritis, is mesenchymal Stem cell therapy more effective at managing lameness than intra-articular corticosteroids?
- An In Vitro study to investigate the effects of Stem cell therapy for treating Osteoarthritis
- Healing a Broken Heart: Can Stem cell and Gene therapy Regenerate and Repair the Myocardium?
- Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem cell Transplantation With Biomodulatory therapy
- Mesenchymal Stem cell therapy for Traumatic Brain Injury
- Postnatal Fate of Donor Mesenchymal Stem cells after Transamniotic Stem cell therapy
- Mesenchymal Stem cell therapy for Severe Sepsis and Septic Sock.
- Should Mesenchymal Stem cell therapy be used in the treatment of COVID-19?
- Stem cell therapy IN COMMUNICATION DISORDERS
- Comparison of breakthrough Gram‐positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic Stem cell transplantation
- Novel Application Method for Mesenchymal Stem cell therapy Utilizing Its Attractant-Responsive Accumulation Property
- Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic Stem cell transplantation: a prospective …
- Stem cell therapy as a potential therapy for Duchenne muscular dystrophy.
- In Reply to the Letter to the Editor Regarding” Bibliometric and Visualized Analysis of Stem cell therapy for Spinal Cord Injury Based on Web of Science and …
- AUTOLOGOUS Stem cell therapy FOR SINGLE RIGHT VENTRICULAR DYSFUNCTION AFTER FONTAN OPERATION: PHASE I SAFETY AND FEASIBILITY …
- Stem cell therapy in Diabetes-Techniques and its therapeutic potential
- Retraction Note to: high-dose therapy and autologous Stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey
- Stem cell therapy: Differences between expanded cells, adipose tissue preparations, bone marrow aspirates
- Platelet-rich plasma therapy enhances the beneficial effect of bone marrow Stem cell transplant on endometrial regeneration
- Stem cell therapy: A Breakthrough in Diabetes Mellitus
- The impact of Stem cell therapy in chronic ischaemic heart disease and congestive heart failure: an updated cochrane syStematic review and meta-analysis of …
- Relapse Management and Role for Consolidative Hematopoietic Stem cell Transplantation Following CAR T-cell therapy
- Stem cell therapy modulates inflammasome signaling in stroke: Possible involvement of Mitochondria?(1588)
- Stem cell therapy for Ischemic Heart Disease: Clinical Use
- Owner of a Broken Heart: Stem cell therapy, Inflammation, and Wound Healing in the Infarcted Heart
- Stem cell therapy for osteogenesis imperfecta: a syStematic review and meta-analysis of preclinical studies using mouse models
- An acute immune response underlies the benefit of cardiac Stem cell therapy
- Successful salvage treosulfan-based megachemotherapy with allogeneic Stem cell transplantation in nonsyndromic, therapy-resistant disseminated juvenile …
- MiRNA Mediated Stem cell therapy for Cardiac Arrhythmia
- Unique anabolic action of Stem cell gene therapy overexpressing PDGFB-DSS6 fusion protein in OVX osteoporosis mouse model
- Recent Advances in Stem cell therapy for Limbal Stem cell Deficiency: A Narrative Review
- Mesenchymal Stem cell‐conditioned media: A novel alternative of Stem cell therapy for quality wound healing
- Concept formation of non-expansion technology in Stem cell therapy and its application prospect
- Enhancing the therapeutic potential of mesenchymal Stem cell-based therapy via CRISPR/Cas9-based genome editing
- Stem–cell therapy for musculoskeletal conditions
- Regression of renal amyloid deposits by VAD therapy plus autologous Stem cell transplantation in a patient with primary AL amyloidosis
- Nicotine does not affect Stem cell properties requisite for suicide gene therapy against glioma
- A Review of Mesenchymal Stem cell therapy for Severe SARS-CoV-2 Infection
- TURNITIN Stem cell therapy: ITS LEGALITY IN THE PERSPECTIVES OF INDONESIAN LAW AND PROGRESSIVE ISLAMIC JURISPRUDENCE
- Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and Stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas
- … t (9; 11) translocation presenting as blueberry muffin baby: successful treatment by ALL-BFM induction therapy, allogeneic Stem cell transplantation from an …
- Successful Anti-TNF-Alpha therapy for Crohn’s Disease After Allogeneic Stem cell Transplantation: A Case Report
- Pluripotent Stem cell–Derived Islet Replacement therapy for Diabetes
- Wound Healing: Hydrogel‐Based Multifunctional Dressing Combining Magnetothermally Responsive Drug Delivery and Stem cell therapy for Enhanced Wound …
- Athersys Stem cell therapy Targets Top Cause of COVID-19 Deaths: Chairman and CEO Gil Van Bokkelen, PhD, Discusses BARDA’s “Highly Relevant” Designation …
- Stem cell based therapy option in COVID-19: is it really promising?
- Mesenchymal Stem cell therapy for hip osteoarthritis: a syStematic review
- Safety and Ethical Issues in Mesenchymal Stem cell therapy
- Stem cell therapy for Muscular Dystrophy 2020
- Stem cell therapy for Burn Victims–As a Fast Growing Modality of Treatment
- PICU Admission Rates in Pediatric Cancer and Hematopoietic Stem cell Transplant Patients Receiving High-flow Nasal Cannula Oxygen therapy on the General …
- Allogeneic Stem cell therapy for cardiac repair and host immune response
- Pilot study of Stem cell therapy in Heart Failure Patients
- Analysis of the suicide gene based-safeguard syStem for induced pluripotent Stem cell-based therapy of Parkinson’s disease
- Stem cell therapy to cure syStemic lupus erythematosus; a revolutionary therapy or a temporarily hype?
- Pseudo-Allogeneic CAR-T therapy after Allogeneic Stem cell Transplantation in Relapsed/Refractory B-cell NHL
- Getting to the Root of It All: The Anatomical Record Explores Advances in Gene and Stem cell therapy in the Treatment of Hearing, Balance and Other Head and …
- The Effect of Mesenchymal Secretome Stem cell therapy toward Caspase-3 Expression in Pregnant Mice with Pristan-Induced Lupus Model
- … (HDC) with Autologous Stem–cell Transplant (ASCT) with Consolidative Radiation therapy (RT) for Relapsed or Refractory (R/R) Primary Mediastinal B-cell …
- SAFEty and efficacy of autologous bone marrow–derived mononuclear Stem cell therapy in patients with severe chronic ischemic Heart Failure–rationale and …
- Intranasal Stem cell Secretome therapy to prevent COVID-19 complications
- First-line therapy, autologous Stem–cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma
- … TREATMENT STRATEGY AGAINST ISCHEMIC BRAIN DAMAGE BASED ON COMBINED APPLICATION OF Stem cell therapy AND PLANT POLYPHENOLS
- Combination between Stem cell therapy and Cocoa Consumption for Treatment of Parkinson’s Disease in Indonesia
- Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic Stem cell …
- 310 Does Improvement in Endothelial Function affect Erectile Function following Stem cell therapy in Men with Cardiomyopathy?
- Functional Neurorehabilitation and Stem cell therapy in Canine Degenerative Myelopathy
- Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic Stem cell transplantation
- Hematopoietic Stem cell gene therapy for the treatment of β-hemoglobinopathies
- Angiogenesis following peripheral blood Stem cell therapy: evidence from perfusion MRI of patients with ischemic stroke
- False Promises: The Danger of Unproven Stem cell therapy Clinics
- Attitudes of Batswana towards Stem cell technology as an alternative therapy in Botswana
- Autologous Mesenchymal Stem cell therapy in Patients with Unexplainable Low Ovarian Response: First Case in Mexico
- Updates on Stem cell therapy in Transfusion Medicine, New Approaches to RBC Substitution therapy, the Use of IFC for the Assessment of Extracellular-Derived …
- Innovation in induced mesenchymal Stem cell uses in therapy
- … globulin for patients with early-onset hemophagocytic lymphohistiocytosis refractory to steroid and etoposide therapy following allogeneic hematopoietic Stem cell …
- Stability study of autologous mesoangioblasts intermediate and drug product for myogenic Stem cell therapy for m. 3243A> G mutation carriers
- Study on Optimized Stem cell therapy Methods for Promoting Bone Consolidation in Distraction Osteogenesis
- Mesenchymal Stem cell therapy in Cartilage Injuries of Knee–Review
- A Study to Assess the Awareness Regarding Umbilical Cord Stem cell therapy among Health Team Members in Tertiary Care Hospital, Karad
- Stem cell therapy as an Alternative to Reconstruction of Complete ACL Tears and Associated Physical therapy Considerations–A Case Report
- ALLOGENIC MESENCHYMAL Stem cell therapy FOR IMMUNE MEDIATED CYTOPENIAS–A 22 CASE SERIES
- cell biobank as a necessary infrastructure for the development and implementation of mesenchymal Stem cell-based therapy in the treatment of anthracycline-induced …
- … Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem cell …
- Bidirectional enhancement of cell proliferation between iron oxide nanoparticle-labeled mesenchymal Stem cells and choroid plexus in a cell-based therapy …
- Dual Stem cell therapy Improves the Cardiac Function After Experimental Myocardial Infarction
- EXTH-02. TUMOR-HOMING INDUCED NEURAL Stem cell therapy INHIBITS THE PROGRESSION OF BREAST CANCER BRAIN METASTASIS AND …
- … life after allogeneic hematopoietic Stem cell transplant: Guidelines and patient booklet from the Francophone Society of Bone marrow Transplant and cellular therapy …
- Stem cell therapy combined with CRISPR to engineer anti-inflammatory chondrocytes to improve neuroinflammation in rheumatoid arthritis
- Immunosuppressive therapy and Immunomodulation in Stem cell Transplantation
- Mesenchymal stromal/Stem cell therapy for acute graft versus host disease: the next step
- 56. TUMOR-HOMING Stem cell therapy INHIBITS THE PROGRESSION OF BREAST CANCER LEPTOMENINGEAL CARCINOMATOSIS
- Clathrin-mediated Endocytosis Plays a Key Role in Stem cell therapy for Ischemic Heart Disease
- Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic Stem cell transplant recipients
- … Wound Healing in Rat (Wistar) by Using the Combination of Peripheral Blood Mononuclear cells (PBMCs) and Bone Marroe BM-Derived Mesenchymal Stem cell
- 032 Stem cell therapy for the Treatment of Erectile Dysfunction and Peyronie’s Disease: A Survey of Stem cell Clinics Across the USA
- A Single Dose of CD117 Antibody Drug Conjugate Enables Hematopoietic Stem cell Based Gene therapy in Nonhuman Primates
- Music therapy for children going through haematopoietic Stem cell transplantation
- Induced pluripotent Stem cells: Reprogramming platforms and applications in cell replacement therapy
- Salvage therapy versus upfront autologous Stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy
- Downregulation of Inflammation and a Cascade of Proangiogenic Signals Mediate the Beneficial Effects of Gene-Modified Stem cell therapy in Hindlimb Ischemia
- Updates on safety and efficacy of maintenance therapy after autologous Stem cell transplantation in newly diagnosed multiple myeloma: A syStematic review.
- Ex-vivo autologous Stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: trial in progress-NCT04201405
- … for validation and improvement of a highly efficient culture (HEC) assay for detection of undifferentiated human pluripotent Stem cells intermingled in cell therapy …
- Patient Specific Models of Nutrient Availability in Degenerated Intervertebral Discs: Which Patients are Candidates for Stem cell therapy?
- Evaluating Tumor-Homing Neural Stem cell therapy Using Bio-Inspired 3D Models of Brain Cancer
- 199 Enhanced immune responses in human breast and colon cancer following checkpoint therapy in a CD34+ Stem cell humanized NCG (HuCD34NCG) mouse …
- Hematopoietic Stem cell Gene therapy for the Treatment of Beta-hemoglobinopathies
- P095: Safety and efficacy of intravenous allogeneic umbilical cord blood-derived mesenchymal Stem cell therapy in patients with recessive dystrophic epidermolysis …
- Effects of Stem cell therapy on 6-Minute Walk Test Distance and Left Ventricular Ejection Fraction in Patients with Nonischemic Cardiomyopathy
- Efficacy of Amniotic Membrane-Mesenchymal Stem cell therapy for Burn wounds: Metaanalysis study
- COVID-19 SARS-CoV-2 zoonotic risk from domestic and exotic animals and possible mitigation by mesenchymal Stem cell therapy
- Evaluation of CD34+ hematopoietic Stem cell-associated extracellular vesicles as a potential personalized therapy for osteoarthritis
- Stem cell transplantation therapy in glaucoma
- … of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for cellular therapy (4540)
- Role of Adoptive T-cell therapy in Post Hematopoietic Stem cells Transplant Viral Infections-: A SyStemic Review
- Early Intervention Stem cell Based therapy (EISCBT) for Corneal Burns and Trauma
- Predictors of Outcomes in Adult Patients with therapy Related Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem cell Transplant-Twenty Year …
- Cortical Bone Stem cell therapy Alters Macrophage Phenotype and Reduces Cardiac cell Death After Myocardial Infarction
- Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic Stem cell transplantation
- 23 Increasing capacity for autologous Stem cell transplants by outpatient conditioning therapy: a quality improvement study
- Introduction to Hematopoietic Stem cell Transplantation and cellular therapy
- Novel therapies for heart failure treatment: Stem cell and protein therapy
- Brain-Derived Neurotrophic Factor and Stem cell-Based Technologies in Huntington’s Disease therapy
- Relevance of antibodies in hematopoietic Stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines …
- Combination of Lodenafil and Human Mesenchymal Stem cell therapy Reduces Cardiac Remodeling and Vascular Dysfunction in Su5416/hypoxia-induced …
- The Risk Factors of Ventriculo-peritoneal Shunt Tube Blockage in Infantile Hydrocephalus and the Effect of Mesenchymal Stem cell therapy Prior to Surgery
- Stem cell cure for kidney injury: therapy to solve most complex issues in renal syStem
- Handbook of Stem cell Transplantation and cellular therapy Management
- Allogeneic Hematopoietic Stem cell Transplant Versus Gene therapy in Sickle cell Disease: Updated Results from a SyStematic Review
- Effectiveness and Clinical Perspectives of Adipose Derived Stem cell Based therapy in Vascularized Composite Allotransplantation
- 2P-260: Novel Stem cell therapy using blue light based photobiomodulation for improving angiogenesis in mouse hindlimb ischemia
- Second Autologous Stem cell Transplant As Salvage therapy in Multiple Myeloma-the Oregon Health and Science University Experience
- … Cytomegalovirus Infection and Graft-Versus-Host Disease in an Allogeneic Hematopoietic Stem cell Transplant Recipient: Review of Antiviral therapy and Use of …
- Angiogenic Effect of Amniotic Mesenchymal Stem cell Spheroid-Derived Secretome as a cell-Free therapy in Cardiac Repair
- Efficacy and tolerability of high-versus low-dose lenalidomide maintenance therapy of multiple myeloma after autologous blood Stem cell transplantation
- OR29-03 The Effects of Hormone therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem cell Transplantation: A Single-Center …
- cell therapy for Parkinson’s disease with induced pluripotent Stem cells
- Lenti-D Hematopoietic Stem cell Gene therapy Stabilizes Neurologic Function in Boys with Cerebral Adrenoleukodystrophy
- A Single Dose of Short Half-Life CD117 Antibody Drug Conjugate Enables Hematopoietic Stem cell Based Gene therapy in Nonhuman Primates
- Real-World Use of Maintenance therapy and Associated Outcomes Following Autologous Stem cell Transplant in US Patients with Newly Diagnosed …
- Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous Stem–cell transplant and its effect on health-related quality of life
- 156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic Stem cell transplant therapy
- Combined Human Umbilical Cord-Derived Stem cell and Hyperbaric Oxygen therapy Effectively Preserved the Neurological Function and Brain Architecture in …
- … . The Real-World Use of Isavuconazole as Primary or salvage therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem cell …
- Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem cell Transplant By Venetoclax Combination therapy
- Consolidative Radiation therapy Following Autologous Stem cell Transplant in Relapsed or Refractory Hodgkin Lymphoma
- A doxycycline-inducible C17.2 neural Stem cell-based combination of differentiation and suicide gene therapy for an in vitro tumorigenic C6 glioma model
- … mold agents in preventing early invasive fungal disease after allogeneic Stem cell transplantation: assessment of antifungal therapy in haematological disease …
- Differentiation and Maturation Effect of All-trans Retinoic Acid on Cultured Fetal RPE and Stem cell-Derived RPE cells for cell-Based therapy
- Mesenchymal Stem cell-derived exosomes and regenerative medicine: outlook for future cell-free therapy in clinical practice
- Autologous Stem cell-Derived β cells for Diabetes cell Replacement therapy
- Ex vivo Stem cell gene therapy of the skin: Ready for clinical use?
- cellULAR therapy AND Stem cell USAGE DURING HAIR LOSS: FUTURE PERSPECTIVES
- … of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem cell Transplantation (alloSCT) with Venetoclax-Based therapy
- Hematopoietic Stem cell transplantation ocular complications: Guidelines from the Francophone Society of Bone Marrow Transplantation and cellular therapy (SFGM …
- … of Hypomethylating Agents in Combination with Donor Lymphocyte Infusions As Initial Salvage therapy Post Allogeneic Stem cell Transplant in Relapsed …
- Retraction Note: Targeted suicide gene therapy for glioma using human embryonic Stem cell-derived neural Stem cells genetically modified by baculoviral vectors
- Hyperbaric Oxygen therapy for Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem cell Transplantation and Effective Factors Prediction
- C-Stem, a new technology fro scale up of cell therapy production
- Clonal Hematopoiesis Drives therapy-Related Myeloid Neoplasms Following Autologous Stem cell Transplantation and Propagates during Disease …
- … Myelofibrosis Undergoing a Two-Step Approach to Hematopoietic Stem cell Transplantation (HSCT): Effects of Donor Source and Pre-HSCT Splenic therapy …
- Applications of Stem cell-derived extracellular vesicles in bone regenerative therapy
- Plasticity of cancer Stem cell: origin and role in disease progression and therapy resistance
- Relapsed/refractory ETP-all successfully treated with novel combination therapy venetoclax with nelarabine prior to allogeneic Stem cell transplant
- Vyxeos in high-risk MDS as induction therapy prior to Stem cell transplantation
- Desensitization therapy for Patients with DSA Receiving Haploidentical (Haplo) Stem cell Transplantation
- Elevated cellular PpIX potentiates sonodynamic therapy in a mouse glioma Stem cell-bearing glioma model by downregulating the Akt/NFkB/MDR1 pathway
- Low-Dose Decitabine Plus Venetoclax Maintenance therapy Can Decrease the Relapse after Allogeneic Stem cell Transplantation for MRD Positive High …
- … acute carbon monoxide poisoning from oak burning gas cured by therapy combined with transplantation of human umbilical cord blood Stem cell, injection of nicholine …
- Hematopoietic Stem cell Transplantation versus Immunosuppressive therapy in Patients with Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis
- … cell Transplant (HSCT) Patients with Graft Versus Host Disease (GvHD) On High Dose≥ 0.5 mg/kg/day (HD) and Low Dose< 0.5 mg/kg/day (LD) Steroid therapy
- Clinical observation of cidofovir in salvage therapy for cytomegalovirus infection in patients with haploid hematopoietic Stem cell transplantation
- … Grade Human Induced Pluripotent Stem cell-derived Cardiac Tissues for a Rat Myocardial Infarction Model: A Pre-clinical Study for a cell Transplantation therapy
- Nutritional status and nutritional therapy in pediatric and adolescent patients submitted to autologous hematopoietic Stem cell transplantation
- Research advances on umbilical cord blood derived mesenchymal Stem cell in therapy of sensorineural hearing loss
- Disparities in utilization of autologous Stem cell transplantation as consolidative therapy for multiple myeloma: A single-institution retrospective review.
- Alzheimer Disease (AD) cell therapy Using Human Neural Stem cells: Validity of the Approach
- … Post Autologous Stem cell Transplant (ASCT) in Patients with Multiple Myeloma (MM) Based on Dosage of Melphalan (mel) As Part of Conditioning therapy: Single …
- … Anti-CD117 Antibody Drug Conjugate (ADC) Designed for Patient Conditioning Prior to Stem cell Transplant and HSC-Based Gene therapy Has a Broad …
- … Burden of Cytomegalovirus infection in CMV-Seropositive Hematopoietic Stem cell Transplant Recipients Managed with Pre-Emptive therapy: A Single Center …
- … Stem cell Transplantation Outcomes: A Study from the cellular therapy and Immunobiology Working Party (CTIWP) of the EBMT A Study from the cellular therapy …
- … analysis of antithrombin III replacement therapy for the treatment of hepatic sinusoidal obstruction syndrome in children following hematopoietic Stem cell …
- Tumor mhicroenvironment effects on hematopoietic Stem cell induced tumor growth following radiation therapy
- Measles, Mumps & Rubella Titers Post Autologous Stem cell Transplant in Multiple Myeloma Patients Induced with Modern therapy
- Building New Arteriogenic therapy for Ischemic Cardiomyopathyusing Notch-induced Mesenchymal Stem cell Patch
- Can Peri-Transplant Radiation therapy Improve Outcomes of Autologous Stem cell Transplant in Hodgkin Lymphoma?
- … Patients with Severe Aplastic Anemia Treated with Combined Immunosuppressive therapy, Eltrombopag and Eculizumab and Their Clinical Course to Stem cell …
- Mesenchymal Stem cell-Derived Extracellular Vesicle therapy Delivered in a Hydrogel Preserves Hemodynamic Function Following Myocardial Infarction
- 205. Rectal Stool Surveillance Cultures to Guide Empiric Antibiotic therapy in Patients with Hematologic Malignancies with or without Hematopoietic Stem cell …
- Re: Verification of Mesenchymal Stem cell Injection therapy for Interstitial Cystitis in a Rat Model
- Transplantation site affects the outcome of adipose-derived Stem cell-based therapy for retinal degeneration
- … TREATMENT WITH COMBINATION OF MESENCHYMAL Stem cell DERIVED EXOSOMES AND FOCUSED LOW-INTENSIVE SHOCK WAVE therapy
- Nanoparticle enhanced combination therapy for Stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma
- … paraspinal muscles in a rat modelPresentation J61. Abstract 157: A self-assembling peptide biomaterial to enhance human neural Stem cell-based regeneration of …
- Allogeneic Hematopoietic Stem cell Transplantation Overcomes the Poor Prognosis in MLL-Rearranged Solid Tumor therapy Related-Acute Myeloid Leukemia
- INVESTIGATING THE POTENTIAL OF COMBINED therapy USING MESENCHYMAL Stem cell EXOSOMES WITH HYALURONIC ACID FOR FUNCTIONAL …
- Mesenchymal Stem cell Spheroids as an Active Nanomedicine Delivery Platform for Cancer therapy
- Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic Stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic …
- Abstract PO-112: miR-149-3p inhibits the glioma Stem cell phenotype and re-sensitizes therapy-resistant GBM cells
- Clinical observation of haploid hematopoietic Stem cell transplantation and intensive immunosuppressive therapy for the treatment of severe aplastic anemia in …
- Biomimetic nanovesicles made from iPS cell-derived mesenchymal Stem cells for targeted therapy of triple-negative breast cancer
- Effect of IA10 regimen induction therapy on newly diagnosed adult acute myeloid leukemia patients without allogeneic hematopoietic Stem cell transplantation and the …
- … therapy and Maintenance therapy with Immunomodulatory Drugs (Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem cell Transplantation in the …
- … HUCPVC) and Bone Marrow-Derived Mesencymal Stem cells (BMSC) using the chemstress® fingerprinting assay, reveals hidden differences between cell therapy …
- Peripheral nerve-derived adult pluripotent Stem (NEDAPS) cells for induction to osteoblast as a cell therapy in segmental bone defect fractures
- Genetic Modification of Mesenchymal Stem cells for Neurological Disease therapy: What Effects Does it Have on Phenotype/cell Behavior, Determining Their …
- 773 Adoptive cell therapy Response in Melanoma is Mediated by Stem-like CD8 T cells
- Mesenchymal Stem cells cultured on innovate composites and their derivatives as a novel cell therapy approaches in the treatment of osteoarthritis In Vivo
- The secretome of Mesenchymal Stem cells as a cell-free based therapy for Spinal Cord Injury
- Wound healing and cell dynamics including mesenchymal and dental pulp Stem cells induced by photobiomodulation therapy: an example of socket-preserving …
- Mgta-456, a cell therapy Utilizing Expansion of CD34+ Hematopoietic Stem cells (HSC), Improves HLA Matching for Adult Recipients, Promotes Faster …
- EFFECTS OF EXOSOMES FROM MESENCHYMAL Stem cells ON NUCLEUS PULPOSUS-DERIVED cells: A POTENTIAL cell-FREE therapy
- Optimization of Nanoparticle Gene therapy for Stem cells using cell Penetrating Peptides
- RONC-13. RADIATION INDUCED BRAIN Stem GLIOMA AFTER RADIATION therapy FOR MIXED GERM cell TUMOR
- Inhibition of PAK6-Mediated Survival and cell Cycle Controls Selectively Targets therapy-Resistant CML Stem/Progenitor cells
- Stem cell therapy for spinal cord injury
- Progress in mesenchymal Stem cell therapy for ischemic stroke
- The development of mesenchymal Stem cell therapy in the present, and the perspective of cell-free therapy in the future
- Application of Stem cell therapy for infertility
- Stem cell therapy in the heart: Biomaterials as a key route
- Nanotechnology shaping Stem cell therapy: Recent advances, application, challenges, and future outlook
- The quest of cell surface markers for Stem cell therapy
- Emerging understanding of apoptosis in mediating mesenchymal Stem cell therapy
- Engrafted Stem cell therapy for Alzheimer’s disease: A promising treatment strategy with clinical outcome
- Mesenchymal Stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential
- Fostering mesenchymal Stem cell therapy to halt cytokine storm in COVID-19
- Autologous Stem cell therapy in knee osteoarthritis: a syStematic review of randomised controlled trials
- Nanoconjugates-based Stem cell therapy for the management of COVID-19
- Mesenchymal Stem cell therapy for severe COVID-19
- Stem cell therapy for burns: story so far
- Stem cell therapy potency in personalizing severe COVID-19 treatment
- … in mesenchymal Stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent Stem cell‐derived mesenchymal Stem cells
- Mesenchymal Stem cell therapy for severe COVID-19 ARDS
- The syStematic effect of mesenchymal Stem cell therapy in critical COVID-19 patients: a prospective double controlled trial
- An update on the potential of mesenchymal Stem cell therapy for cutaneous diseases
- Mesenchymal Stem cell therapy for Alzheimer’s disease
- Mechanisms of Stem cell therapy in Spinal Cord Injuries
- Characteristics and developments in mesenchymal Stem cell therapy for COVID-19: An update
- Stem cell therapy for heart failure: Medical breakthrough, or dead end?
- Surfing the clinical trials of mesenchymal Stem cell therapy in ischemic cardiomyopathy
- A Nanoformulation‐Mediated Multifunctional Stem cell therapy with Improved Beta‐Amyloid Clearance and Neural Regeneration for Alzheimer’s Disease
- Regenerative Stem cell therapy for neurodegenerative diseases: An overview
- An update for mesenchymal Stem cell therapy in lupus nephritis
- Current progress of rehabilitative strategies in Stem cell therapy for spinal cord injury: a review
- Looking backward to move forward: a meta-analysis of Stem cell therapy in amyotrophic lateral sclerosis
- Neuronal Replacement in Stem cell therapy for Stroke: Filling the Gap
- An update on Alzheimer’s disease: Immunotherapeutic agents, Stem cell therapy and gene editing
- Advantages and challenges of Stem cell therapy for osteoarthritis
- Application of Stem cell therapy in myelofibrosis
- Application of Stem cell therapy for ACL graft regeneration
- Pluripotent Stem cell therapy for retinal diseases
- The Current Dilemma and Breakthrough of Stem cell therapy in Ischemic Heart Disease
- Stem cell therapy in coronavirus disease 2019: current evidence and future potential
- Targeting mesenchymal Stem cell therapy for severe pneumonia patients
- Application of mesenchymal Stem cell therapy for aging frailty: From mechanisms to therapeutics
- Mesenchymal Stem cell therapy for liver disease: current status and future perspectives
- Stem cell therapy for microvascular injury associated with ischemic nephropathy
- Stem cell therapy: A paradigm shift in breast cancer treatment
- Convergence of 3D printed biomimetic wound dressings and adult Stem cell therapy
- Stem cell therapy for chronic obstructive pulmonary disease
- Hematopoietic Stem cell therapy for Wiskott–Aldrich syndrome: improved outcome and quality of life
- Stem cell therapy for neonatal hypoxic-ischemic encephalopathy: a syStematic review of preclinical studies
- Control of microbial opsin expression in Stem cell derived cones for improved outcomes in cell therapy
- The Feasibility and Applicability of Stem cell therapy for the Cure of Type 1 Diabetes
- Progress in clinical trials of Stem cell therapy for cerebral palsy
- Insights into Stem cell therapy for diabetic retinopathy: a bibliometric and visual analysis
- Mesenchymal Stem cell therapy for osteogenesis imperfecta
- Stem cell therapy in ocular pathologies in the past 20 years
- Umbilical cord mesenchymal Stem cell therapy for regenerative treatment of rheumatoid arthritis: opportunities and challenges
- Neuroregeneration and functional recovery after stroke: Advancing neural Stem cell therapy toward clinical application
- Personalized‐induced neural Stem cell therapy: Generation, transplant, and safety in a large animal model
- Angiogenic CD34 Stem cell therapy in Coronary Microvascular Repair—A SyStematic Review
- Stem–cell therapy for erectile dysfunction: a review of clinical outcomes
- Mesenchymal Stem cell therapy for patients with ischemic heart failure-past, present, and future
- Stem cell therapy for copd: Hope and exploitation
- Application prospects of mesenchymal Stem cell therapy for bronchopulmonary dysplasia and the challenges encountered
- COVID-19 and hematopoietic Stem cell transplantation and immune effector cell therapy: a US cancer center experience
- Safety and feasibility of mesenchymal Stem cell therapy in patients with aqueous deficient dry eye disease
- Preclinical efficacy of Stem cell therapy for skin flap: a syStematic review and meta-analysis
- Allogeneic Stem cell transplantation in mantle cell lymphoma in the era of new drugs and CAR-T cell therapy
- Stem cell therapy for retinal degeneration: the evidence to date
- On the road from phenotypic plasticity to Stem cell therapy
- Effectiveness and mechanisms of adipose-derived Stem cell therapy in animal models of Parkinson’s disease: a syStematic review and meta-analysis
- Human mesenchymal Stem cell therapy and other novel treatment approaches for premature ovarian insufficiency
- Stem cell therapy for modulating neuroinflammation in neuropathic pain
- Safety and efficacy of Stem cell therapy: an overview protocol on published meta-analyses and evidence mapping
- Nanotechnology in cardiac Stem cell therapy: cell modulation, imaging and gene delivery
- Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem cell therapy
- Comparative analysis on the anti-inflammatory/immune effect of mesenchymal Stem cell therapy for the treatment of pulmonary arterial hypertension
- Hybrid SMART spheroids to enhance Stem cell therapy for CNS injuries
- Lung multipotent Stem cells of mesenchymal nature: cellular basis, clinical relevance, and implications for Stem cell therapy
- Combined hydrogel and mesenchymal Stem cell therapy for moderate-severity disc degeneration in goats
- Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A syStematic review
- Developing bioinspired three-dimensional models of brain cancer to evaluate tumor-homing neural Stem cell therapy
- Human pluripotent Stem cell-derived cardiac cells: application in disease modeling, cell therapy, and drug discovery
- Impact of SARS-CoV-2 in hematopoietic Stem cell transplantation and chimeric antigen receptor T cell therapy recipients
- Mesenchymal Stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
- Human Stem cell models of polyglutamine diseases: sources for disease models and cell therapy
- Understanding neural Stem cell regulation in vivo and applying the insights to cell therapy for strokes
- Human mesenchymal Stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats
- In vivo study for clinical application of dental Stem cell therapy incorporated with dental titanium implants
- Stem cell therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury
- Intravenous allogeneic umbilical cord blood–derived mesenchymal Stem cell therapy in recessive dystrophic epidermolysis bullosa patients
- Human-induced neural and mesenchymal Stem cell therapy combined with a curcumin nanoconjugate as a spinal cord injury treatment
- Constructing a cell microenvironment with biomaterial scaffolds for Stem cell therapy
- Mesenchymal Stem cell therapy of acute thermal burns: a syStematic review of the effect on inflammation and wound healing
- … an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy
- Intranasal mesenchymal Stem cell therapy to boost myelination after encephalopathy of prematurity
- Cancer Stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
- Mesenchymal Stem cell therapy for intractable neonatal disorders
- A single-blinded randomized controlled trial of mesenchymal Stem cell therapy for the treatment of osteoarthritis of the knee with active control
- Advances in Stem cell therapy for Brain Diseases via the Intranasal Route
- Stem cell therapy and tissue engineering strategies using cell aggregates and decellularized scaffolds for the rescue of liver failure
- Current concepts of Stem cell therapy for chronic spinal cord injury
- Wnt signaling activation: Targets and therapeutic opportunities for Stem cell therapy and regenerative medicine
- Mesenchymal Stem cell therapy in Canine Osteoarthritis Research:“Experientia Docet”(Experience Will Teach Us)
- Progress and prospect of Stem cell therapy for diabetic erectile dysfunction
- Autophagy controls mesenchymal Stem cell therapy in psychological stress colitis mice
- Neural Stem cell therapy for brain disease
- Stem cell therapy in patients with epilepsy: A syStematic review
- Enhancing the surface properties of a bioengineered anterior cruciate ligament matrix for use with point-of-care Stem cell therapy
- Stem cell therapy as a treatment for autoimmune disease—updates in lupus, scleroderma, and multiple sclerosis
- Stem cell therapy for Crohn’s disease: syStematic review and meta-analysis of preclinical and clinical studies
- Human umbilical cord-derived mesenchymal Stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis
- Review of operative considerations in spinal cord Stem cell therapy
- The promise (s) of mesenchymal Stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model syStems
- Highly interconnected inverse opal extracellular matrix scaffolds enhance Stem cell therapy in limb ischemia
- Gain of CXCR7 function with mesenchymal Stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation
- Preclinical Stem cell therapy in fetuses with myelomeningocele: A syStematic review and meta‐analysis
- Mesenchymal Stem cell therapy in hypertrophic and keloid scars
- Functional assessment of cryopreserved clinical grade hESC-RPE cells as a qualified cell source for Stem cell therapy of retinal degenerative diseases
- … CAR T-cell therapy and transplantation: comparisons of safety and long-term efficacy of allogeneic hematopoietic Stem cell transplantation after CAR T-cell or …
- Efficacy of mesenchymal Stem cell therapy on glucose levels in type 2 diabetes mellitus: A syStematic review and meta‐analysis
- Perspective on Stem cell therapy in Organ Fibrosis: Animal Models and Human Studies
- Stem cell therapy in liver regeneration: Focus on mesenchymal Stem cells and induced pluripotent Stem cells
- Therapeutic Aspects of Mesenchymal Stem cell-Based cell therapy with a Focus on Human Amniotic Epithelial cells in Multiple Sclerosis: A Mechanistic …
- Novel Balance Mechanism Participates in Stem cell therapy to Alleviate Neuropathology and Cognitive Impairment in Animal Models with Alzheimer’s Disease
- Can nanotechnology overcome challenges facing Stem cell therapy? A review
- Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal Stem cell in patients with subacute complete spinal …
- Brain morphological and connectivity changes on MRI after Stem cell therapy in a rat stroke model
- Autologous Stem cell therapy for Chronic Lower Extremity Wounds: A Meta-Analysis of Randomized Controlled Trials
- … DNAemia and risk of mortality in allogeneic hematopoietic Stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and cell therapy …
- Mesenchymal Stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
- Recent advances in Stem cell therapy for neurodegenerative disease: Three dimensional tracing and its emerging use
- Fractional numerical simulation of mathematical model of HIV-1 infection with Stem cell therapy.
- Neuroblastoma and Stem cell therapy: An updated review
- Research Progress of Mesenchymal Stem cell therapy for Severe COVID-19
- Cardiomyocyte death and genome-edited Stem cell therapy for ischemic heart disease
- Stem cell therapy and diabetic erectile dysfunction: A critical review
- CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic Stem cell …
- Molecular investigation of adequate sources of mesenchymal Stem cells for cell therapy of COVID-19-associated organ failure
- An Overview of the Safety, Efficiency, and Signal Pathways of Stem cell therapy for SyStemic Lupus Erythematosus
- Hyaluronic acid supplement as a chondrogenic adjuvant in promoting the therapeutic efficacy of Stem cell therapy in cartilage healing
- Human Stem cell-derived oligodendrocytes: From humanized animal models to cell therapy in myelin diseases
- Treatment of COVID-19 by stage: any space left for mesenchymal Stem cell therapy?
- Current evidence on mesenchymal Stem cell therapy for traumatic spinal cord injury: SyStematic review and meta-analysis
- Neuromodulation-based Stem cell therapy in brain repair: recent advances and future perspectives
- Stem cells and Cancer Stem cells: The Jekyll and Hyde Scenario and Their Implications in Stem cell therapy
- Current status of hepatocyte-like cell therapy from Stem cells
- Where Do We Stand in Stem cell therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020
- Multipronged Attack of Stem cell therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy
- Quantitative Analysis of Factors Regulating Angiogenesis for Stem cell therapy
- Comparison of Fat harvested from flank and falciform regions for Stem cell therapy in dogs
- Age-related changes in the inflammatory status of human mesenchymal Stem cells: implications for cell therapy
- Endovascular Stem cell therapy post stroke rescues neurons from endoplasmic reticulum stress-induced apoptosis by modulating brain-derived neurotrophic factor …
- Narrative review of Stem cell therapy for ischemic brain injury
- Stem cell therapy and Exercise for Treatment of Intervertebral Disc Degeneration
- Mesenchymal Stem cell therapy improved outcome of early post-traumatic shoulder osteonecrosis: A prospective randomized clinical study of fifty patients with over …
- A New Predictive Technology for Perinatal Stem cell Isolation Suited for cell therapy Approaches
- … Extramedullary Multiple Myeloma With Anti-BCMA CAR-T cell therapy Followed by Haploidentical Hematopoietic Stem cell Transplantation: A Case Report …
- Additional benefit of induced pluripotent Stem cell-derived mesenchymal Stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated …
- Intra-arterial Stem cell therapy diminishes inflammasome activation after ischemic stroke: a possible role of acid sensing ion channel 1a
- Clinical Trial of Allogeneic Mesenchymal Stem cell therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to …
- Allogeneic mesenchymal Stem cell sheet therapy: A new frontier in drug delivery syStems
- Stem cell-based therapy for COVID-19 and ARDS: a syStematic review
- Stem cell therapy for Post-Traumatic Stress Disorder: A Novel Therapeutic Approach
- Stem cell therapy as a recent advanced approach in male infertility
- Clinical mesenchymal Stem cell therapy in ischemic cardiomyopathy
- Dual Stem cell therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of cell Functions
- Stem cell therapy in the Management of Fracture Non-Union–Evaluating cellular Mechanisms and Clinical Progress
- Stem cell therapy: A promising treatment for COVID-19
- Integrative analysis of microRNAs and mRNAs in LPS-induced macrophage inflammation based on adipose tissue Stem cell therapy
- Stem cell therapy prior to full-mouth tooth extraction lacks substantial clinical efficacy in cats affected by chronic gingivostomatitis
- Adipose-derived Stem cells secretome and its potential application in “Stem cell-free therapy”
- Human placental-derived Stem cell therapy ameliorates experimental necrotizing enterocolitis
- Induced pluripotent Stem cell technology for spinal cord injury: a promising alternative therapy
- Clinical application of Stem cell therapy in neurogenic bladder: a syStematic review and meta-analysis
- Fetal hematogenous routing of a donor hematopoietic Stem cell line in a healthy syngeneic model of transamniotic Stem cell therapy
- Comparative evaluation of pulpal repair after direct pulp capping using Stem cell therapy and biodentine: an animal study
- Mesenchymal Stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials
- Stem cell therapy: A Promising Approach in Treatment of COVID-19
- The potential of platelet-rich plasma injections and Stem cell therapy for penile rejuvenation
- Mesenchymal Stem cell‐derived small extracellular vesicles as cell‐free therapy: Perspectives in periodontal regeneration
- Current advances of Stem cell-based therapy for kidney diseases
- Human allogeneic bone marrow-derived mesenchymal Stem cell therapy for cerebellar ataxia: A case report
- Intrapericardial Delivery of APA-Microcapsules as Promising Stem cell therapy Carriers in an Experimental Acute Myocardial Infarction Model
- Stem cell therapy in dermatology
- Stem cell therapy in the Treatment of Patients With Autism Spectrum Disorder: a SyStematic Review and Meta-analysis
- Stem cell therapy for acute myocardial infarction-focusing on the comparison between Muse cells and mesenchymal Stem cells
- Programmed cell death in Stem cell-based therapy: Mechanisms and clinical applications
- Stem cell-based therapy for experimental ischemic stroke: A preclinical syStematic review
- Bone marrow mesenchymal Stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats
- Mesenchymal Stem cell spheroids: potential cell materials for cell therapy
- Mesenchymal Stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
- Chimeric antigen receptor T-cell therapy after allogeneic Stem cell transplant for relapsed/refractory large B-cell lymphoma
- Exercise Training in Boosting Post-Mi Mesenchymal Stem cell therapy
- The future of regenerative medicine: cell therapy using pluripotent Stem cells and acellular therapies based on extracellular vesicles
- Transamniotic Stem cell therapy for experimental congenital diaphragmatic hernia: structural, transcriptional, and cell kinetics analyses in the nitrofen model
- Mesenchymal Stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises
- A syStematic review and meta-analysis on the efficacy of Stem cell therapy on bone brittleness in mouse models of osteogenesis imperfecta
- The critical role of mesenchymal stromal/Stem cell therapy in COVID‐19 patients: An updated review
- Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy
- The promise of Stem cell-derived islet replacement therapy
- Cross-Culture Online Knowledge Validation and the Exclusive Practice of Stem cell therapy
- An Alternative cell therapy for Cancers: Induced Pluripotent Stem cell (iPSC)-Derived Natural Killer cells
- Stem cell therapy for fracture non-union: The current evidence from human studies
- Development of pH-Responsive Polymer Coating as an Alternative to Enzyme-Based Stem cell Dissociation for cell therapy
- Results and prospects of using activator of hematopoietic Stem cell differentiation in complex therapy for patients with COVID-19
- Stem cell-based therapy for COVID-19 and ARDS: a syStematic review
- Mesenchymal Stem cell-based therapy for COVID-19: possibility and potential
- … results of a phase I trial of FT516, an off-the-shelf natural killer (NK) cell therapy derived from a clonal master induced pluripotent Stem cell (iPSC) line expressing high …
- cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal Stem cells: a phase 1 clinical trial
- Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic Stem cell transplantation
- Enhancing Stem cell therapy for Cartilage Repair in Osteoarthritis—A Hydrogel Focused Approach
- Correction to: Treating primary immunodeficiencies with defects in NK cells: from Stem cell therapy to gene editing
- Clinical Efficacy and Safety of Human Mesenchymal Stem cell therapy for Degenerative Disc Disease: A SyStematic Review and Meta-Analysis of …
- Probable Factors Associated with Response to Mesenchymal Stem cell therapy in Stroke Patients: A Post Hoc Analysis of the STARTING-2 Trial
- Mesenchymal Stem cell-based therapy for stroke: current understanding and challenges
- Efficacy of mesenchymal Stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis
- Mesenchymal Stem cell-based therapy for diabetes mellitus: enhancement strategies and future perspectives
- Hematopoietic Stem cell‐and induced pluripotent Stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
- Enhancement of transamniotic Stem cell therapy for spina bifida by genetic engineering of donor mesenchymal Stem cells with an Fgf2 transgene
- Mesenchymal Stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
- Stem cell therapy for dilated cardiomyopathy
- Consolidative Hematopoietic Stem cell Transplantation After CD19 CAR-T cell therapy for Acute Lymphoblastic Leukemia: A SyStematic Review and Meta …
- Stem cell-based therapy as a promising approach in Alzheimer’s disease: current perspectives on novel treatment
- Autologous bone marrow derived mesenchymal Stem cell therapy for osteonecrosis of femoral head: A syStematic overview of overlapping meta-analyses
- Role of prostaglandin E2 in allogeneic mesenchymal Stem cell therapy for cardiac repair
- Translational Stem cell therapy: vascularized skin grafts in skin repair and regeneration
- Clinical benefits of single vs repeated courses of mesenchymal Stem cell therapy in epilepsy patients
- Efficacy and safety of neural Stem cell therapy for spinal cord injury: A syStematic literature review
- Label-Free Quantitative Proteome Profiling of Cerebrospinal Fluid from a Rat Stroke Model with Stem cell therapy
- Stem cell-derived exosomes as a cell free therapy against spinal cord injury
- Making More Womb: Clinical Perspectives Supporting the Development and Utilization of Mesenchymal Stem cell therapy for Endometrial Regeneration and …
- Stem cell sheet therapy: another option for acute kidney injury?
- Mesenchymal Stem cell-based therapy and exosomes in COVID-19: current trends and prospects
- Prospect of Stem cell therapy and Nanotechnology
- Stem cell therapy and Its Significance in Pain Management
- Stem cell therapy in stroke
- Cross-Sectional Survey of Clinical Trials of Stem cell therapy for Heart Disease Registered at ClinicalTrials. gov
- Mesenchymal Stem cell and microRNA therapy of musculoskeletal diseases
- Experiences of Pain in Hospitalized Children During Hematopoietic Stem cell Transplantation therapy
- Current status and challenges of Stem cell-based therapy for the treating of glioblastoma multiforme
- The comparative effects of mesenchymal Stem cell transplantation therapy for spinal cord injury in humans and animal models: A syStematic review and meta-analysis
- Mesenchymal Stem cell-derived exosome microRNA as therapy for cardiac ischemic injury
- Stem cell therapy for the management of lateral elbow tendinopathy: A syStematic literature review
- From Hematopoietic Stem cell Transplantation to Chimeric Antigen Receptor therapy: Advances, Limitations and Future Perspectives
- Evaluation of the Efficacy of Stem cell therapy in Ovariectomized Osteoporotic Rats Based on Micro-CT and Dual-Energy X-Ray Absorptiometry: A …
- Efficacy and safety of allogenic canine adipose tissue-derived mesenchymal Stem cell therapy for insulin-dependent diabetes mellitus in four dogs: A pilot study
- ROS-scavenging hybrid hydrogel for genetically engineered Stem cell delivery and limb ischemia therapy
- Surgical options for perianal fistula in patients with Crohn’s disease: A comparison of seton placement, fistulotomy, and Stem cell therapy
- Exploring the Current Trends of Artificial Intelligence in Stem cell therapy: A SyStematic Review
- Update on clinical ex vivo hematopoietic Stem cell gene therapy for inherited monogenic diseases
- Molecular Basis of the Effect of Atorvastatin Pre-treatment on Stem cell therapy in Chronic Ischemic Diseases–Critical Limb Ischemia
- … Stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and cell therapy …
- Establishment of a novel mesenchymal Stem cell-based regimen for chronic myeloid leukemia differentiation therapy
- A comparative study of mesenchymal Stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease
- … of human-induced pluripotent Stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of …
- A syStematic review of quality of life in sickle cell disease and thalassemia after Stem cell transplant or gene therapy
- … and Glyco (proteo) mic tools in the profiling of cardiac progenitors and pluripotent Stem cell derived cardiomyocytes: Accelerating translation into therapy
- Cone Reconstruction for Ebstein Anomaly: Ventricular Remodeling and Preliminary Impact of Stem cell therapy
- Therapeutic potential of mesenchymal Stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders
- Human amniotic fluid Stem cell-derived exosomes as a novel cell-free therapy for cutaneous regeneration
- The safety and efficacy of mesenchymal Stem cell therapy in diabetic lower extremity vascular disease: a meta-analysis and syStematic review
- Allogeneic expanded adipose‐derived mesenchymal Stem cell therapy for perianal fistulas in Crohn’s disease: A case series
- Stem cell therapy and Its Significance in HIV Infection
- Comparative analysis of mouse bone marrow and adipose tissue mesenchymal Stem cells for critical limb ischemia cell therapy
- Efficacy of Stem cell application in diabetes mellitus: promising future therapy for diabetes and its complications
- Current Status of Stem cell therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering
- Insights into Stem cell therapy for premature ovarian insufficiency
- Stem cell therapy targets the neointimal smooth muscle cells in experimentally induced atherosclerosis: involvement of intracellular adhesion molecule (ICAM …
- Ex vivo mesenchymal Stem cell therapy to regenerate machine perfused organs
- Long-term effects of muscle-derived Stem cell therapy on the regeneration of the urethra of female rats
- Process development and safety evaluation of ABCB5+ limbal Stem cells as advanced-therapy medicinal product to treat limbal Stem cell deficiency
- Stem cell therapy in Single-Ventricle Physiology: Recent Progress and Future Directions
- Mesenchymal Stem cell-derived extracellular vesicles carrying miRNA as a potential multi target therapy to COVID-19: an in silico analysis
- Mesenchymal Stem cell-based therapy for burn wound healing
- Enzyme replacement therapy and hematopoietic Stem cell transplant: a new paradigm of treatment in Wolman disease
- Mesenchymal Stem cell therapy for COVID-19
- Case Report: Stem cell therapy in amyotrophic lateral sclerosis
- Stem cell therapy in Children With Sensorineural Hearing Loss: A Narrative Review
- Regional hyperthermia enhances mesenchymal Stem cell recruitment to tumor stroma: implications for mesenchymal Stem cell-based tumor therapy
- Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem cell therapy
- Addressing the importance of Stem cell-based therapy: a perspective in the treatment of COVID-19
- A Review on the Role of Artificial Intelligence in Stem cell therapy: An Initiative for Modern Medicines
- Application Effect Analysis of Nursing Intervention in Stem cell therapy for Stroke Patients
- Towards Tissue-Specific Stem cell therapy for the Intervertebral Disc: PPARδ Agonist Increases the Yield of Human Nucleus Pulposus Progenitor cells in Expansion
- … International Regenerative Medicine & Surgery Societies: recommendations in the use of platelet-rich plasma (PRP), autologous Stem cell-based therapy (ASC-BT) in …
- Nicotinamide N-Methyltransferase in Acquisition of Stem cell Properties and therapy Resistance in Cancer
- Identification of key genes in type 2 diabetes‐induced erectile dysfunction rats with Stem cell therapy through high‐throughput sequencing and bioinformatic analysis
- Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury
- Long-term follow-up of hematopoietic Stem–cell gene therapy for cerebral adrenoleukodystrophy
- Glioblastoma therapy: Rationale for a Mesenchymal Stem cell-based Vehicle to Carry Recombinant Viruses
- Roles of mesenchymal Stem cell-derived exosomes in cancer development and targeted therapy
- Autologous Stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
- Pluripotent Stem cell-based gene therapy approach: human de novo synthesized chromosomes
- Immune reprogramming precision photodynamic therapy of peritoneal metastasis by scalable Stem–cell-derived extracellular vesicles
- MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-cell therapy Bridging to Allogeneic Stem cell …
- Mesenchymal Stem cell therapy for Oral Inflammatory Diseases: Research Progress and Future Perspectives
- Gene therapy of dominant CRX-Leber congenital amaurosis using patient Stem cell-derived retinal organoids
- Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer Stem cell properties
- Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic Stem cell transplantation for myelofibrosis: a study of the CMWP …
- MATRix–RICE therapy and autologous haematopoietic Stem–cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement …
- Case Report: Successful Chimeric Antigen Receptor T cell therapy in Haploidentical-Allogeneic Stem cell Transplant Patients With Post-Transplant …
- … Peripheral Blood Hematopoietic Stem cell Transplant Combined With Adoptive T-cell therapy for the Treatment of High-Grade B-cell Lymphoma in Ten …
- Efficacy and safety of autologous adipose tissue-derived Stem cell therapy for children with refractory Crohn’s complex fistula: a Phase IV clinical study
- Method Categorization of Stem cell therapy for Degenerative Osteoarthritis of the Knee: A Review
- Nanofat cell-Mediated Anti-Aging therapy: Evidence-Based Analysis of Efficacy and an Update of Stem cell Facelift
- … Crest Stem cells to Combat Ischemic Stroke. Comment on Othman, FA; Tan, SC Preconditioning Strategies to Enhance Neural Stem cell-Based therapy for …
- Regeneration of Trabecular Meshwork in Primary Open Angle Glaucoma by Stem cell therapy
- Research progress of Stem cell therapy for ischemic stroke
- Dysregulation of mitophagy and mitochondrial homeostasis in cancer Stem cells: Novel mechanism for anti‐cancer Stem cell‐targeted cancer therapy
- Mesenchymal Stem cell therapy efficacy in COVID-19 patients: A syStematic review and meta-analysis
- Goals and challenges of Stem cell-based therapy for corneal blindness due to limbal deficiency
- Diagnosis and Treatment Guidelines for Mesenchymal Stem cell therapy for Coronavirus Disease 2019 (Beijing, 2021)
- Mesenchymal Stem cell-derived extracellular vesicle-based therapy for Alzheimer’s disease: progress and opportunity
- Will Mesenchymal Stem cell therapy Be Effective In COVID-19?
- Concentrated autologous bone marrow aspirate is not “Stem cell” therapy in the repair of nonunions and bone defects
- Mesenchymal Stem cell-derived extracellular vesicles in therapy against fibrotic diseases
- Continuous renal replacement therapy: a review of use and application in pediatric hematopoietic Stem cell transplant recipients
- ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic Stem cell transplantation
- Stem cell therapy for Anal Fistula Treatment-Video Vignette.
- Identification of Key microRNAs in Diabetes Mellitus Erectile Dysfunction Rats with Stem cell therapy by Bioinformatic Analysis of Deep Sequencing Data
- … antigen receptor (CAR) T cell therapy, versus standard of care (SOC) with salvage chemotherapy (CT) followed by autologous Stem cell transplantation (ASCT) as …
- Stem cell therapy against COVID-19
- Autologous haematopoietic Stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’multiple sclerosis
- MESENCHYMAL Stem cell therapy FOR ACUTE KIDNEY DISEASE IN A CAT–CASE REPORT
- SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic Stem cell transplantation
- Hematopoietic Dyscrasias and Stem cell Transplantation/CAR-T cell therapy
- Stem cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem cell-Based therapy for Huntington’s Disease
- Stem cell-Based therapy for Asherman Syndrome: Promises and Challenges
- … graft‐versus‐host disease in allogeneic peripheral blood Stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy …
- Single-cell RNA Sequencing of Human Pluripotent Stem cell-Derived Macrophages for Quality Control of The cell therapy Product
- Predicting genotoxicity of viral vectors for Stem cell gene therapy using gene expression-based machine learning
- Cancer Stem cell for Tumor therapy
- New Prospects for Stem cell therapy in Alzheimer’s Disease
- Stem cell therapy in ischemic stroke: A syStematic review and meta-analysis of randomized controlled trials
- Combating COVID-19 with mesenchymal Stem/stromal cell therapy: Promise and challenges
- Intrathecal autologous bone marrow Stem cell therapy in children with autism: A randomized controlled trial
- Neuroprotective therapy for retinal neurodegenerative diseases by Stem cell secretome
- Stem cell-based islet replacement therapy in diabetes: A road trip that reached the clinic
- Efficacy and Safety of Stem cell Combination therapy for Osteonecrosis of the Femoral Head: A SyStematic Review and Meta-Analysis
- … -based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic Stem cell …
- … in a Rat Hemisection Spinal Cord Injury Model With Combined Neural Stem cell, Endothelial Progenitor cell, and Biomimetic Hydrogel Matrix therapy
- Deep tumor‐penetrated nanosyStem eliminates cancer Stem cell for highly efficient liver cancer therapy
- … Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer Stem cell dynamics
- Stem cell therapy and Regenerative Medicine in Autoimmune Diseases
- Randomized controlled study for the anti‐aging effect of human adipocyte‐derived mesenchymal Stem cell media combined with niacinamide after laser therapy
- Critical roles of TLRs on the polarization of mesenchymal Stem cells for cell therapy of viral infections: a notice for COVID-19 treatment
- Mesenchymal Stem cell-Based Heart cell therapy: The Effect of Route of cell Delivery in the Clinical Perspective
- Clinical Application of Stem cell therapy for Liver Cirrhosis: Progress, Pitfalls, and Prospects.
- A syStematic review of Stem cell therapy treatment for women suffering from stress urinary incontinence
- Azacitidine maintenance therapy post-allogeneic Stem cell transplantation in poor-risk acute myeloid leukemia
- Establishment of a cell processing laboratory to support hematopoietic Stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy
- The role of mesenchymal Stem cell therapy in traumatic brain injury: a review from basic research to clinical challenges.
- Mesenchymal Stem cells: The Potential Therapeutic cell therapy to Reduce Brain Stroke Side Effects
- cell therapy and Methods of Stem cell Delivery for Regeneration of Heart Tissue Following Myocardial Infarction
- Stem cell-Derived Nanovesicles: A Novel cell-Free therapy for Wound Healing
- Potential for Stem cell-Based therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19
- Predictors of outcomes of therapy-related acute myeloid leukemia after allogeneic hematopoietic Stem cell transplantation
- Exploring the potential of Stem cell-based therapy for aesthetic and plastic surgery
- Human Stem cell-based retina on chip as new translational model for validation of AAV retinal gene therapy vectors
- Success Stories and Challenges Ahead in Hematopoietic Stem cell Gene therapy: Hemoglobinopathies as Disease Models
- Is Stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy …
- Physical therapy exerts sub-additive and suppressive effects on intracerebral neural Stem cell implantation in a rat model of stroke
- Adult Stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a syStematic review and meta-analysis
- Stem cell-based therapy for hirschsprung disease, do we have the guts to treat?
- Mesenchymal Stem cell therapy in a Preterm Infant with Bronchopulmonary Dysplasia
- Stem cell as Vehicles of Antibody in Treatment of Lymphoma: A Novel and Potential Targeted therapy
- The Antiviral Drug Efavirenz in Breast Cancer Stem cell therapy
- Diabetic Retinopathy and Stem cell therapy
- Quality Management and Accreditation in Hematopoietic Stem cell Transplantation and cellular therapy: The JACIE Guide
- Advancements in transplantation therapy for diabetes: Pancreas, islet and Stem cell
- Stem–cell therapy Following High-Dose Chemotherapy in Advanced Retinoblastoma: A SyStematic Review
- … as an effective salvage therapy and bridge to allogeneic hematopoietic Stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia
- Investigating the barrier activity of novel, human enhancer-blocking chromatin insulators for hematopoietic Stem cell gene therapy
- HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO Stem cell therapy
- Improving outcomes for children requiring extracorporeal membrane oxygenation therapy following hematopoietic Stem cell transplantation
- Stem cell therapy for Stroke
- Autologous Stem–cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience
- O6 Analysis of angiogenic gene profiling after E-selectin+ Stem cell therapy in murine ischemic limb
- Mesenchymal Stem cell-Based therapy for Advanced Colorectal Cancer: Potential Mechanisms of therapy and Associated Risks
- Stem cell therapy for degenerative disc disease: A review
- Hematopoietic Stem cell Gene therapy for Cystinosis: From Bench-to-Bedside
- Efficacy and safety of mesenchymal Stem/stromal cell therapy for inflammatory bowel diseases: an up-to-date syStematic review
- Stem cell therapy as a Treatment for Autoimmune Disease—Updates in Lupus, Scleroderma, and Multiple Sclerosis
- Immunosuppressive therapy after autologous hematopoietic Stem cell transplantation in syStemic sclerosis patients—high efficacy of Rituximab
- Stem cell therapy for the Treatment of Myocardial Infarction: How Far Are We Now?
- … and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous Stem cell transplantation lenalidomide maintenance therapy
- Lines of therapy before autologous Stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin’s lymphoma
- The Potential Safe Antifibrotic Effect of Stem cell Conditioned Medium and Nilotinib Combined therapy by Selective Elimination of Rat Activated HSCs
- Hematopoietic Stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model
- 196-LB: Stem cell–derived islet replacement therapy (VC-02) demonstrates production of C-peptide in patients with type 1 diabetes (T1D) and hypoglycemia …
- Introduction to Stem cell therapy and Its Application in Vascular Diseases
- Post-Resuscitation Neuroinflammation in a Porcine Model of Cardiac Arrest: Effect of SyStemic Allogeneic Mesenchymal Stem cell therapy
- Mesenchymal Stem cell therapy For COVID-19; Is A New Challenge Review
- Perspectives on Stem cell-Based Regenerative Medicine with a Particular Emphasis on Mesenchymal Stem cell therapy
- Stem cell-based therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic cells
- Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic Stem cell transplantation …
- Relationship between left ventricular global longitudinal strain, infarct size and left ventricular function in patients with acute myocardial infarction in a Stem cell therapy …
- Iron toxicity and chelation therapy in hematopoietic Stem cell transplant
- Stem cell therapy Delivery in Liver Disease
- … analysis of allogeneic versus autologous Stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy
- Stem cell therapy Enhances Motor Activity of Triceps Surae Muscle in Mice with Hereditary Peripheral Neuropathy
- Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem cell Containing Advanced therapy Medicinal Product (ATMP)—An In Vivo Animal Trial
- Stem cell therapy for COVID-19
- Sepsis and Septic Shock; Current Treatment Dilemma and Role of Stem cell therapy in Pediatrics
- Stem cell therapy to Improve Acute Myocardial Infarction Remodeling
- Stem cell therapy in Alzheimer’s disease
- Stem cell and Gene-Based therapy for Erectile Dysfunction: Current Status and Future Needs
- … gene imaging “visualized” the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent Stem cell therapy
- Stem cell therapy in Children With Sensorineural Hearing Loss: A Narrative Review
- Stem–cell therapy for the Treatment of Knee Osteoarthritis
- Stem cell therapy for Diabetic Foot Ulcers
- Neural Crest-Like Stem cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and therapy Resistance
- cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and …
- Mesenchymal Stem cell-Derived Extracellular Vesicle: A Promising Alternative therapy for Osteoporosis
- … therapy and a Combination of Eltrombopag Plus Immunosuppression therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem cell …
- Editorial Commentary: Stem cell therapy for the Knee: Heterogeneity in cell Sources, Delivery Methods, and Concomitant Surgery Needs to Be Considered
- Molecular Imaging of Stem cell therapy in Ischemic Cardiomyopathy
- Autologous hematopoietic Stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases
- Safety and efficacy of consolidation therapy with ipilimumab plus nivolumab after autologous Stem cell transplantation
- Induced pluripotent Stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019
- Mesenchymal Stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
- Stem cell therapy for Ophthalmic Vascular Disease
- Mesenchymal Stem cell-Derived Exosomes for COVID-19 therapy, Preclinical and Clinical Evidence
- The Clinical Outcomes of Stem cell therapy for Decompensated Liver Disease: A SyStematic Review and Meta-Analysis
- Off-label use of letermovir as preemptive anti-cytomegalovirus therapy in a pediatric allogeneic peripheral blood Stem cell transplant
- Sphingosine kinase 1 could enhance Stem cell therapy efficiency for neurodegenerative diseases through induction of HIF-1
- Challenges in Stem cell-derived islet replacement therapy can be overcome
- Clinical Manufacture of FT819: Use of a Clonal Multiplexed-Engineered Master Induced Pluripotent Stem cell Line to Mass Produce Off-the-Shelf CAR T-cell therapy
- Targeting Programmed cell Death to Improve Stem cell therapy: Implications for Treating Diabetes and Diabetes-Related Diseases
- Allogeneic umbilical cord mesenchymal Stem cell therapy for autism
- … for validation and improvement of a highly efficient culture assay for detection of undifferentiated human pluripotent Stem cells intermingled in cell therapy …
- … in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous Stem cell transplantation therapy
- cell therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem cells Cross the Blood–Brain Barrier?
- Hematopoietic Stem-and progenitor-cell gene therapy for Hurler syndrome
- Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal Stem cells by transglutaminase 2
- … Stem cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and cellular therapy
- An Overview of Mesenchymal Stem cell-based therapy Mediated by Noncoding RNAs in the Treatment of Neurodegenerative Diseases
- The Ethical Challenges of Stem cell therapy in Vascular Disorders
- Pluripotent Stem cells for cell therapy
- Stem cell therapy in the treatment of organic and dysfunctional endometrial pathology.
- Immune Protection of Stem cell-Derived Islet cell therapy for Treating Diabetes
- The role of induction therapy before autologous Stem cell transplantation in low disease burden AL amyloidosis patients
- Functional maturation of immature β cells: A roadblock for Stem cell therapy for type 1 diabetes
- The preconditioning of lithium promotes mesenchymal Stem cell-based therapy for the degenerated intervertebral disc via upregulating cellular ROS
- Stem–cell therapy with bone marrow (hematopoietic) Stem cells for intestinal diseases
- Stem cell therapy for Lymphedema
- Alzheimer’s Disease: Neural Stem cell therapy using 3x-Tg Mice
- Author Correction: The promise (s) of mesenchymal Stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model syStems
- Intra-arterial Stem cell therapy Diminishes Inflammasome Activation After Ischemic Stroke: a Possible Role of Acid Sensing Ion Channel 1a
- Review on Stem cell therapy: An Approach to Combat Cancer Proliferation
- Recent Research and Development in Stem cell therapy for Cancer Treatment: Promising Future and Challenges
- Cytokine and Chemokine Responses in Invasive Aspergillosis Following Hematopoietic Stem cell Transplantation: Past Evidence for Future therapy of Aspergillosis
- Stem cell therapy for periodontal disease: new progress of microenvironment cognition
- Elevated cellular PpIX potentiates sonodynamic therapy in a mouse glioma Stem cell-bearing glioma model by downregulating the Akt/NF-κB/MDR1 pathway
- Immune cell therapy against disseminated melanoma by utilizing induced pluripotent Stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15 …
- Characteristics and outcomes of therapy-related myeloid neoplasms following autologous Stem cell transplantation for multiple myeloma
- T-control: T-cell therapy in the context of allogeneic Stem cell transplantation
- Outcomes with autologous Stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma
- Bone marrow mesenchymal Stem cell co-adjuvant therapy with albendazole for managing Toxocara vitulorum-rat model
- Brentuximab vedotin consolidation therapy after autologous Stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study
- Hematopoietic Stem–cell transplantation versus immunosuppressive therapy in patients with adult acquired severe aplastic anemia: a cost-effectiveness …
- RAPID cell PHENOTYPING USING ARRAY-BASED SENSORS: APPLICATIONS IN CANCER Stem cell therapy AND HIGH-CONTENT SCREENING
- Biomaterials and Scaffolds in Stem cell therapy
- … trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic Stem cell …
- In vitro follicular activation and Stem cell therapy as a novel treatment strategies in Dismished ovarian reserve and primary ovarian insufficiency
- Multicenter Trial of Stem cell therapy for Osteoarthritis (MILES)
- Therapeutic effect of mesenchymal Stem cell therapy in the LVEF, LVEDV, and LVESV after myocardial infarction.
- Using Big Data Analytics on Health Industry Development: The Empirical Intellectual Property Analysis from Stem cell therapy
- Stem cell therapy for the Treatment of Chronic Ischemic Heart Disease
- Correction to: Intra-arterial Stem cell therapy Diminishes Inflammasome Activation After Ischemic Stroke: a Possible Role of Acid Sensing Ion Channel 1a
- Non-genotoxic conditioning facilitates hematopoietic Stem cell gene therapy for hemophilia A using bioengineered factor VIII
- Stem cell-free therapy for glaucoma to preserve vision
- Possibility of in utero Stem cell therapy for multiple fetal genetic diseases
- Role of mesenchymal and other Stem cell therapy in intestinal diseases
- Positive aspects, negative aspects and challenges associated with Stem cell therapy for COVID-19: A Mini-Review.
- A Novel CMV-Specific TCR-T cell therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem cell Transplantation
- Impact of time to relapse and response to salvage therapy on post autologous Stem cell transplant outcomes in relapsed or refractory diffuse large B-cell lymphoma.
- … of Allogeneic Hematopoietic Stem cell Transplantation after Chimeric Antigen Receptor T-cell therapy in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- The effect of music therapy on the physical and mental parameters of cancer patients during hematopoietic Stem cell transplantation
- Autologous Stem–cell transplantation in syStemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all
- Autologous Mesenchymal Stem cell therapy for Idiopathic Pulmonary Fibrosis and Comprehensive Assessment of Circulating Immune Populations cells
- Commentary: Evidence based human Stem cell therapy for myocardial healing:’Miles to go’
- Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous Stem cell transplantation
- Microphysiological stroke model for syStematic evaluation of neurorestorative potential of Stem cell therapy
- Biomaterials: The Holy Grail for Stem cell therapy in the Infarcted heart
- Epigenetic‐based therapy in allogenic hematopoietic Stem cell transplantation: Novel opportunities for personalized treatment
- Molecular Mechanisms of Mesenchymal Stem cell-Based therapy in Acute Kidney Injury
- Effect of umbilical cord blood Stem cell transplantation on restenosis after endovascular interventional therapy for diabetic hindlimb vascular disease
- Stem cell therapy for skin regeneration using mesenchymal Stem cells derived from the progeroid Werner syndrome-specific iPS cells
- Stem cell therapy and Diabetes
- Is autologous Stem cell transplantation a safe and effective alternative to whole brain radiation as consolidation therapy in patients with primary central nervous syStem …
- Characterization of Stem cells from human ovarian follicular fluid; a potential source of autologous Stem cell for cell-based therapy
- … Crest Stem cells to Combat Ischemic Stroke. Comment on Othman, FA; Tan, SC Preconditioning Strategies to Enhance Neural Stem cell-Based therapy for …
- In Vitro Models for Stem cell therapy: Methods and Protocols
- Stem cell therapy in patients with nonischemic heart failure
- A REVIEW ON Stem cell therapy IN TREATMENT OF DIFFERENT DISEASE
- Mesenchymal Stem cell-Based therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
- A Mutation-Agnostic Hematopoietic Stem cell Gene therapy for Metachromatic Leukodystrophy
- 094 Platelet-Rich Plasma and Stem cell therapy for Erectile Dysfunction: Characterization of Market Forces in a Major Metropolitan Area
- … Lymphoma (r/r B-NHL) Patients with TP53 Gene Disruption Treated with CD19/22 Cocktail CAR T-cell therapy Alone or Incorporated with Autologous Stem cell …
- Adipose-derived Mesenchymal Stem cell therapy for Reverse Bleomycin-induced Experimental Pulmonary Fibrosis
- Impact of pre-transplant induction therapy on outcomes of patients who undergo autologous Stem cell transplantation for mantle cell lymphoma in first …
- Mesenchymal Stem cell-Based therapy for Rheumatoid Arthritis
- Mesenchymal Stem cell-Derived Exosomes as an Emerging Paradigm for Regenerative therapy and Nano-Medicine: A Comprehensive Review
- Cytokine adsorption therapy in lymphoma-associated hemophagocytic lymphohistiocytosis and allogeneic Stem cell transplantation
- Stem cell therapy for the Treatment of Hip Osteonecrosis
- Case Report: Combination therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem cell Transplantation Resulted in …
- Stem cell therapy For The Treatment Of Crohn’s Disease; Current Obstacles And Future Hopes.(Mini-Review).
- … -Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem cell …
- Potential of Stem cell therapy to Combat Mastitis in Dairy Animals
- Angiogenesis in aging hearts—Cardiac Stem cell therapy
- Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous Stem cell transplantation
- Combining extracorporeal life support and cell therapy in critical illness: mesenchymal Stem cell therapy and extracorporeal membrane oxygenation in the …
- Effect of combination therapy with neural Stem cell transplantation and teramethylpyrazine in rats following acute spinal cord injury
- HISTOMORPHOMETRIC ASSESSMENT OF AUTOGENOUS Stem cell therapy IN HORIZONTAL ALVEOLAR RIDGE AUGMENTATION (EXPERIMENTAL …
- Stem cell transplantation therapy for diabetic foot ulcer: a narrative review
- Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous Stem cell transplantation: Czech Registry Data
- Specific Blood cells Derived from Pluripotent Stem cells: An Emerging Field with Great Potential in Clinical cell therapy
- Efficacy of Allogeneic Hematopoietic Stem cell Transplantation in Relapse/Refractory B-ALL Patients After Chimeric Antigen Receptor T cell therapy: A …
- Emerging value of Stem cell therapy in rheumatic diseases
- Application of Stem cell therapy during the treatment of HIV/AIDS and Duchenne Muscular Dystrophy.
- Development of a” Pro-Matrix” Advanced cell Scaffold Biomaterial to Support Mesenchymal Stem cell therapy
- Cardiac Stem cell therapy, Quo Vadis
- Developing Induced Neural Stem cell therapy to Treat Triple-Negative Breast Cancer and Brain Metastases
- Access to the Apical Cochlear Modiolus for Possible Stem cell-Based and Gene therapy of the Auditory Nerve
- Mesenchymal Stem cells: an overview of their potential in cell-based therapy for diabetic nephropathy
- Animal models in research examining Stem cell therapy for human lung disease: a support in the quest to develop therapies
- Rational Route of Delivery Mesenchymal Stem cell therapy for Acute Myocardial Infarction (AMI) and Chronic Ischemic Cardiomyopathy (ICM): a SyStematic …
- Mesenchymal Stem cell‐derived exosomes for organ development and cell‐free therapy
- Evaluation of Stem cell-derived cellular therapy products
- … cell Transplantation for Refractory/Relapsed T-cell Acute Lymphoblastic Leukemia/Lymphoma after Donor-Derived CD7-Chimeric Antigen Receptor T-cell therapy
- Mesenchymal Stem/Stromal cell therapy in Blood–Brain Barrier Preservation Following Ischemia: Molecular Mechanisms and Prospects
- Ruxolitinib combined with corticosteroids as first-line therapy for acute graft-versus-host disease in haploidentical peripheral blood Stem cell transplantation recipients
- Stem cell therapy in children with acute liver failure: The dream could come true
- Stem cell–secreted factor therapy regenerates the ovarian niche and rescues follicles
- Autism and Stem cell therapy
- … therapy preconditioning modifies nitric oxide pathway and oxidative stress in human-induced pluripotent Stem cell-derived ventricular cardiomyocytes treated with …
- Promise of Mesenchymal Stem cell Lysates in IBD therapy: Are the Parts Greater than the Whole?
- Stem cell therapy: A Whole World of New Era
- Early high dose corticosteroid therapy in hematopoietic Stem cell transplantation patients with acute respiratory distress syndrome: a propensity score matched study
- A Review of Neural Stem cell Transplant therapy for Traumatic Spinal Cord Injury
- Corrigendum: Stem cell therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury
- Hematopoietic Stem cell Transplantation Cures therapy-refractory Aspergillosis in Chronic Granulomatous Disease
- … Peripheral Blood Stem cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide therapy …
- Stem cell therapy IN BREAST CANCER
- The Future of Stem cell therapy Regulation Under the FDA’s Comprehensive Regenerative Medicine Policy Framework Through a Public Health Lens
- FLT3-ITDos and FLT3-ITDon’ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following Stem cell transplantation
- Stem cell therapy for erectile dysfunction: An update
- The Utilization of Mesenchymal Stem cell therapy in the treatment of human diseases
- Allogenic adipose mesenchymal Stem cell therapy in ischemic stroke with hypertension and hyperglycemia. Experimental animal models
- cell Cultured Procedure in Normal Human Lymphocytes for Stem cell therapy
- Survey On Knowledge, Awareness and Attitude Regarding Dental Stem cell therapy among Dental Students
- Salvage autologous hematopoietic Stem cell transplantation for multiple myeloma performed with Stem cells procured after previous high dose therapy–a multicenter …
- A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene therapy and One with HLA-Identical Hematopoietic Stem cell …
- Invited Discussion on:“Nanofat cell-Mediated Anti-Aging therapy: Evidence-Based Analysis of Efficacy and an Update of Stem cell Facelift” by Bishara Atiyeh, Fadi …
- Allogeneic hematopoietic Stem cell transplantation overcomes the poor prognosis in MLL-rearranged solid tumor therapy related-acute myeloid leukemia
- Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic Stem cell transplantation
- Efficacy and mechanism of action of intravenous allogenic umbilical cord blood-derived mesenchymal Stem cell therapy in patients with recessive dystrophic …
- … Hematopoietic Stem cell Transplant for Acute Myeloid Leukemia: a Retrospective Study From Francophone Society of Bone Marrow Transplantation and cell therapy …
- In Vivo Hematopoietic Stem cell Gene therapy Might Become a Reality
- … of Antioxidant Poly (Propylene Sulfide)-Microspheres for Pretreatment of Inflammatory Cytokine-Induced Chondrocytes to Facilitate Adipose-Drived Stem cell therapy
- Comparative Effectiveness of Arthroscopy and Non-arthroscopy Using Mesenchymal Stem cell therapy (MSCs) and Conditioned Medium for Osteoarthritis (OA)
- Case Report: Combination therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem cell Transplantation Resulted in …
- Comparative analysis of delivery methods for Stem cell therapy in liver diseases.
- Disparities in Utilization of Autologous Stem cell Transplantation as Consolidative therapy for Multiple Myeloma: A Single Institution Retrospective Review
- Recognition of Hematopoietic Stem cell Transplantation and cellular therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused …
- Stem cell therapy: A Potential Therapeutic Modality against COVID-19
- Engineering of human induced pluripotent Stem cells via human artificial chromosome vectors for cell therapy and disease modeling
- In Vitro Models for Stem cell therapy
- Human Pluripotent Stem cell-Derived Hepatocyte-Like cells and Organoids for Liver Disease and therapy
- Efficacy and Safety of mesenchymal Stem cell therapy in patients with acute myocardial infarction: a syStematic review and meta-analysis of randomized controlled …
- O11-Regulatory Challenges in Stem cell therapy
- Evaluation of Safety and Efficacy of cell therapy Based on Osteoblast Derived from Umbilical Cord Mesenchymal Stem cell for Osteonecrosis of the Femoral …
- PIWI proteins and piRNAs in cervical cancer: a propitious dart in cancer Stem cell-targeted therapy
- Mesenchymal Stem cell therapy for Acetaminophen-Related Liver Injury: A SyStematic Review and Meta-Analysis of Experimental Studies in Vivo.
- Allogeneic hematopoietic Stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy
- Application of marine collagen for Stem‑cell‑based therapy and tissue regeneration
- Research status and future of Stem cell therapy for spinal cord injury
- Nebulization therapy with umbilical cord mesenchymal Stem cell-derived exosomes for COVID-19 pneumonia
- Stem cell therapy: Health Care Providers’ Knowledge and Attitude
- CD133+ Stem cell therapy Effects on Myocardial Regeneration Through Increased Vascular Endothelial Growth Factor Correlate with Cardiac Magnetic Resonance …
- Mesenchymal Stem cell therapy for Knee Osteoarthritis: 5 years Follow-Up of Three Patients
- Engineered Stem cells combine Stem cell and gene therapy approaches to move intestine therapy from bench to bed
- Stem cells to the Rescue: Development and Application of cell-Based therapy for Microvascular Repair
- Intra-Articular Application of Mesenchymal Stem cell therapy for Osteoarthritis—The Next Step: Optimization of Therapeutic Capacity and Applicability
- P36-The Major Ethical Questions in Stem cell therapy
- Homology-directed gene-editing approaches for hematopoietic Stem and progenitor cell gene therapy
- Effect of Nicotine Exposure to Induced Pluripotent Stem cell Derived Endothelial cell therapy in a Murine Model of Peripheral Artery Disease
- cell therapy of COVID-19 patients using mesenchymal Stem cell; benefits and challenges
- O29-Stem cell therapy in Atherosclerosis
- P-MUC1C-ALLO1: A Fully Allogeneic Stem cell Memory T cell (TSCM) CAR-T therapy with Broad Potential in Solid Tumor
- The enzymatic disaggregation by trypsin does not alter cell quality and genomic stability of adipose-derived Stem cells cultivated for human cell therapy
- Stem cells and cell therapy: Sober view
- Stem cell therapy as a potential therapy for Duchenne muscular dystrophy.
- Ethical issues of using umbilical cord blood Stem cell therapy of John Stuart Mill perspective
- Outcomes with COVID-19 in patients with hematopoietic Stem cell transplant and cellular therapy: A syStemic review and meta-analysis.
- Canine dental pulp and umbilical cord-derived mesenchymal Stem cells as alternative sources for cell therapy in dogs
- Stem cell therapy: A Promising Treatment of Parkinson’s Diseases
- Correction to: Quality Management and Accreditation in Hematopoietic Stem cell Transplantation and cellular therapy
- Stem cell therapy for the Treatment of Musculoskeletal Diseases: Safe and Effective or Costly and Temporary?
- … following allogeneic hematopoietic Stem cell transplantation successfully rescued relapse of CD19-negative acute lymphoblastic leukemia after CAR-T cell therapy
- Should mesenchymal Stem cell therapy be used in adults with COVID-19?
- … after Allogeneic Stem cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second cellular therapy
- … : opportunities and challenges in cell-free therapy focus on mesenchymal Stem cell-derived exosomes: opportunities and challenges in cell-free therapy
- Effects of Aerobic and Resistance Exercise therapy with and without Weight Bearing on the Outcomes of Stem cell therapy for Knee Osteoarthritis: A Randomized …
- Research and Application of Stem cell-Based therapy in Idiopathic Pulmonary Fibrosis: A Review
- CD7-deleted hematopoietic Stem cells can restore immunity after CAR T cell therapy
- Mesenchymal Stem cell-Based therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials. cells 2021, 10, 588
- Protocol for human placental mesenchymal Stem cell therapy in a murine model of intra-abdominal infection of hypervirulent Klebsiella
- … of Bone Marrow Mesenchymal Stem cell-Mediated Synthetic Radiosensitive Promoter-Combined Sodium Iodide Symporter for Radiogenetic Ovarian Cancer therapy
- A Brief review on Safety of intra-articular cell–therapy with culture-expanded Stem cells
- Autologous peripheral blood Stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study
- Gene and Stem cell therapy in β-thalassemia
- Neural Stem cell-mediated brain tumor therapy
- Outcomes of high dose therapy and autologous haematopoietic Stem cell transplantation for non‐hodgkin lymphoma: A retrospective analysis in a resource‐limited …
- The Effect of Autologous Adipose Derived Mesenchymal Stem cell therapy in Chronic Patellar Tendinitis: A Case Study
- In Utero Fetal therapy: Stem cells, cell Transplantation, Gene therapy, and CRISPR-Cas9
- Effectiveness of structure teaching programme on knowledge regarding umbilical cord Stem cell therapy among staff nurses in Apollo hospital at Gandhinagar, Gujarat
- Brentuximab vedotin as consolidation therapy after autologous Stem cell transplantation in children and adolescents (< 18 y) with early relapse hodgkin lymphoma
- Setting up Stem cell therapy for human retina: from organotypic cultures to cell fusion understanding
- Translating a Stem cell-based therapy for epidermolysis bullosa into the clinic
- Discovery of TSC-101: A First-in-Class Natural HA-2-Specific TCR to Treat Leukemia Following Hematopoietic Stem cell Transplant therapy
- Combination of Mesenchymal Stem cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer therapy
- DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous Stem cell transplantation
- P-185: Impact of the changing landscape of induction therapy prior to autologous Stem cell transplantation in 540 myeloma patients: a retrospective real-world study
- Hematopoietic Stem cell Transplantation Is a Curative therapy for Transferrin Receptor 1 (TFRC) Deficiency
- … Hematopoietic Stem cell Transplant for Acute Myeloid Leukemia: a Retrospective Study From Francophone Society of Bone Marrow Transplantation and cell therapy …
- The Safety and Efficacy of Stem cell therapy as an Emerging therapy for ALS: A SyStematic Review of Controlled Clinical Trials
- OFR-9 An RCT of autologous Stem–cell transplantation in treatment refractory Crohn’s disease (low-intensity therapy evaluation): ASTIClite
- Preliminary study of early diagnosis by contrast-enhanced ultrasound combined with mesenchymal Stem cell therapy in improving prognosis of biliary ischemia after …
- Chidamide Maintenance therapy after Induction or Salvage Treatment in Patients with Peripheral T-cell Lymphoma Ineligible for Autologous Stem cell …
- Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
- Allogeneic Hematopoietic Stem cell Transplantation in therapy Related Acute Leukemia
- Journal: Quality Management and Accreditation in Hematopoietic Stem cell Transplantation and cellular therapy, 2021, p. 165-176
- Successful Salvage therapy by Second Haploidentical Allogeneic Hematopoietic Stem cell Transplantation in a Severe Aplastic Anemia Patient Presenting …
- The Comparative Effects of Mesenchymal Stem cell Transplantation therapy for Spinal Cord Injury in Humans and Animal Models: A SyStematic Review and Meta …
- Prolonged Lenalidomide therapy Does Not Impact Autologous Peripheral Blood Stem cell Mobilization and Collection in Multiple Myeloma Patients: A Single …
- In Utero Stem cell Transplantation, Enzyme Replacement, and Gene therapy
- Review on Therapeutic Efficacy of Mesenchymal Stem cell (MSC) therapy for Treating Different Disease
- Sequential therapy of Inotuzumab Ozogamicin and Blinatumomab as a Bridge-to Hematopoietic Stem cell Transplantation in a Pediatric Patient With Primary …
- Easix before Conditioning therapy Predicts Sepsis after Allogeneic Stem cell Transplantation
- Mesenchymal Stem cell therapy: Hope for Patients With SyStemic Lupus Erythematosus
- Mesenchymal Stem/stromal cell-based therapy: Mechanism, syStemic safety and biodistribution for precision clinical applications
- Autologous Hematopoietic Stem cell Transplantation for AL Amyloidosis Refractory to Induction therapy
- Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem cell Transplant (Allo-SCT) Following Pembrolizumab therapy
- Prospects of Mesenchymal Stem cell Secretome in Veterinary Regenerative therapy
- cell therapy for factor V deficiency: An approach based on human decidua mesenchymal Stem cells
- … and Refractory Peripheral T-cell Lymphoma (PTCL) with Intention for Curative therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem cell …
- … Single cell Transcriptomics in Paired Pediatric T-ALL Samples Collected at Diagnosis and Following End of Induction therapy Reveals an MRD-Associated Stem cell …
- Stem cell Based therapy-in COVID-19
- … and Young Adults Outcomes Differ from Those of Children? a Study on Behalf of the Francophone Society of Stem cell Transplantation and cellular therapy (SFGM …
- A Novel RPS19-Edited Hematopoietic Stem cell Model of Diamond-Blackfan Anemia for Development of Lentiviral Vector Gene therapy
- Co-Targeting E-Selectin/CXCR4 with GMI-1359 Facilitates AML Stem cell Mobilization and Protects BM Niches from Anti-Leukemia therapy
- Mesenchymal Stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
- The Role of Stem cell Transplant in the therapy of Acute Myeloid Leukemia (AML)
- Restored Hematopoietic Stem cell Transcriptional Program in Fanconi Anemia Patients Following Gene therapy
- Stem cell therapy for Neurodegenerative Diseases: Strategies for Regeneration against Degeneration
- Stem cell therapy for Neurodegenerative Diseases: Strategies for Regeneration against Degeneration
- Efficacy and safety of mesenchymal Stem/stromal cell therapy for inflammatory bowel diseases: an up-to-date syStematic review. Biomolecules. 2021; 11 (1): 82
- Isolation and Characterization of Swine MIAMI cells: A Valuable Animal Model for Adult Stem cell therapy
- Letermovir Prophylaxis Versus Pre-Emptive therapy for Cytomegalovirus after Hematopoietic Stem–cell Transplantation
- MP36-19 PLATELET-RICH PLASMA AND Stem cell therapy FOR ERECTILE DYSFUNCTION: CHARACTERIZATION OF MARKET FORCES IN MAJOR …
- Sustained Response to Selinexor-Based therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem cell Transplantation
- The use of gene-modified bone marrow mesenchymal Stem cells for cochlear cell therapy
- … Stem cell transplantation is a promising therapy for traumatic brain injury (TBI), but low efficiency of survival and differentiation of transplanted Stem cells limits its …
- Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance therapy after Allogeneic Hematopoietic Stem cell Transplantation: A Phase I Study
- MicroRNA-7 agomir is a potential bioactive material for breast cancer therapy by inhibiting breast cancer Stem cell tumorigenicity
- Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem cell Characteristics and therapy Resistance in Ovarian …
- High-dose Chemotherapy Combined with Autologous Hematopoietic Stem cell Transplantation as Frontline therapy for Intermediate/High-risk Diffuse Large B cell …
- … of Patellofemoral Bone Marrow Oedema and Subchondral Cysts on MRI Post a Single Autologous Fat-Derived Expanded Mesenchymal Stem cell therapy
- Regenerative therapy for Sensorineural Hearing Loss: Recent Progress and Future Directions. J Stem cell Res Dev Ther 7: 082
- Newer Horizon of Mesenchymal Stem cell–Based therapy in the Management of SARS-CoV-2–Associated Mucormycosis: A Safe Hope for Future Medicine
- … Alpha-Thalassemia to Study Abnormal Iron Metabolism and Erythropoiesis, Hematopoietic Stem cell Behavior and Development of a Gene therapy Approach for Its …
- … Study of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Starting Second-or Third-Line therapy and Not Receiving Autologous Stem cell …
- Advances in Adoptive cell therapy Using Induced Pluripotent Stem cell-Derived T cells
- Inhibition of DNA-Pkcs As Novel therapy for the Prevention of Acute Gvhd Following Hematopoietic Stem cell Transplantation
- Shaping the Microglia in Retinal Degenerative Diseases Using Stem cell therapy: Practice and Prospects
- Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lmphoblastic leukemia after allogeneic hematopoietic Stem cell transplantation
- I. Progress Towards a Stem cell Based therapy for Diabetes
- Effects of a structured exercise therapy on cancer-related fatigue during and after paediatric Stem cell transplantation: a randomized controlled trial
- Cancer Stem cell biomarkers: critical roles, challenges, clinical applications and perspectives in cancer therapy
- Outcomes with COVID-19 in hematopoietic Stem cell transplant and cellular therapy patients.
- cell therapy research for Diabetes: Pancreatic β cell differentiation from pluripotent Stem cells
- Hypoxia in Bone and Oxygen Releasing Biomaterials in Fracture Treatments Using Mesenchymal Stem cell therapy: A Review
- Complete Resolution of Extensive Labral tear and Para-labral Cysts on MRI Following 3D Collagen-Based Stem cell therapy in Dysplastic Hip: Case Report
- Enhancing Matured Stem-Cardiac cell Generation and Transplantation: A Novel Strategy for Heart Failure therapy
- Allogeneic Stem cell transplantation remains an effective therapeutic approach for patients with therapy-related acute myeloid leukemia
- HL-007: Brentuximab Vedotin Consolidation therapy after Autologous Stem–cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center …
- A Phase II Single Arm Study of Nivolumab As Maintenance therapy after Autologous Stem cell Transplantation in Patients with Hodgkin Lymphoma at Risk of …
- Derivation of Multipotent Neural Progenitors from Human Embryonic Stem cells for cell therapy and Biomedical Applications
- Brentuximab Vedotin As Consolidation therapy Following Autologous Stem cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin …
- … Candidacy in Pediatric Patients Treated With Hematopoietic Stem cell Transplant and Chimeric Antigen Receptor T-cell therapy: An International Survey
- Outcomes of Tyrosine Kinase Inhibitors Maintenance therapy with or without Allogeneic Hematopoietic Stem cell Transplantation in Philadelphia Positive Acute …
- … Consolidation with High-Dose therapy-Autologous Stem–cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-cell …
- Humanized Anti-CD19 CAR-T cell therapy and Sequential Allogeneic Hematopoietic Stem cell Transplantation Achieved Long-Term Survival in Refractory …
- Lysosomal Acid Lipase a (LIPA) Modulates Leukemia Stem cell (LSC) Response to Venetoclax/TKI Combination therapy in Blast Phase Chronic Myeloid Leukemia
- … Pomalidomide with Dexamethasone As Maintenance therapy after First Relapse Treatment with PCD Followed or Not By Autologous Stem cell Transplant in Multiple …
- Review on Therapeutic Efficacy of Mesenchymal Stem cell (MSC) therapy for Treating Different
- Sex Differences in Mesenchymal Stem cell therapy With Gelatin-Based Microribbon Hydrogels in a Murine Long Bone Critical-Size Defect Model
- Efficacy and Safety of Hematopoietic Stem cell Transplantation Vs. Immunosuppressive therapy in Patients with Hepatitis-Associated Aplastic Anemia: A Single …
- Stem cell epigenetics in medical therapy
- … Stem cell Institute’s Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental cell therapy to Patients With Rare Serious …
- … Stem cell Institute’s Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental cell therapy to Patients With Rare Serious …
- Single-cell Proteomic Profiling Identifies Nanoparticle Enhanced therapy for Triple Negative Breast Cancer Stem cells
- Auto Hematopoietic Stem cell Transplantation Combined with Another Target Humanized CAR-T cells for Refractory/Relapsed B-cell Non-Hodgkin Lymphoma after …
- Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of therapy Including Allogeneic Stem cell Transplantation Among Patients With …
- … II Trial of Eprenetapopt (APR-246) in Combination with Azacitidine (AZA) As Maintenance therapy for TP53 Mutated AML or MDS Following Allogeneic Stem cell …
- Mechanism of Action of Bone Marrow Mesenchymal Stem cell in Combination with miR-36b therapy in cellular Repair of Septic Lung Injury
- Fanconi Anemia: Hematopoietic Stem cell Transplant or Gene therapy?
- Evaluation of an In-Patient Exercise, Relaxation, and Music therapy Program for Allogeneic Hematopoietic Stem cell Transplant Patients
- Conditioned medium derived from bovine umbilical mesenchymal Stem cells as an alternative source of cell-free therapy
- Stem cell Transplantation therapy as a Treatment for Autism Spectrum Disorder
- CAR-T therapy: the role of the hematopoietic Stem cell processing laboratory
- Evaluation of an In-patient Exercise, Relaxation, and Music therapy Program for Allogeneic Hematopoietic Stem cell Transplant Patients
- Stem cell and Alopecia therapy
- … MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance therapy after Autologous Stem cell …
- MESENCHYMAL Stem cell-BASED therapy FOR CHRONIC KIDNEY FAILURE RELATING LUPUS ERYTHEMATOSUS-A CASE REPORT
- Transcriptional Regulation of the Colorectal Cancer Stem cell Markers, Nanog and Oct4, Induced by a Thermodynamic-Based therapy Approach
- Bladder cancer Stem cell markers and related signaling pathways: antibody targeted therapy
- Efficacy of Amniotic Membrane Stem cell Conditioned Medium (AMSC-CM) and Vitamin C following CO2 Fractional Laser for Photoaging therapy
- CART therapy followed by allo-HSCT for patients with B-cell acute lymphoblastic leukemia relapsing after the first hematopoietic Stem cell transplantation
- Foetal Stem cell conversion as a new mechanism of therapy resistance in intestinal cancer
- Antimicrobial photodynamic therapy as treatment of infected oral ulcers in patients undergoing hematopoietic Stem cell transplantation: Report of two cases.
- … Sclerosis before and after using High-dose Immunosuppressive therapy with Autologous Hematopoietic Stem cell Transplantation: Preliminary Results.
- Mesenchymal Stem cell Control of Metastatic Prostate Cancer cell Evolution and therapy Resistance in the Bone Microenvironment
- Hematopoietic Stem cell transplantation and gene therapy are the sole treatments for sickle cell disease and other hemoglobinopathies
- Human Umbilical Cord Mesenchymal Stem cell (HUCMSC)-derived Exosomes as a cell-Free therapy for Soluble Fms-like Tyrosine Kinase-1 (Sflt-1)-induced …
- Mesenchymal Stem cells in glioblastoma therapy and progression: How one cell does it all
- cell and gene therapy for anemia: hematopoietic Stem cells and gene editing
- Targeting glioma Stem cell metabolism to enhance therapy responses and minimize resistance
- … Trehalose Protects the Bone Marrow-Derived Mesenchymal Stem cells Under Oxidative Stress and Enhances the Stem cell-Based therapy for Cerebral Ischemic …
- … who subsequently received high dose chemotherapy (HDCT) with peripheral Stem cell transplant (PBSCT) following failure of initial therapy for metastatic disease …
- ALSTaR cells-Novel Stem–cell-based therapy for Amyotrophic Lateral Sclerosis: A Research Protocol
- Engineering cell adhesive properties on the hydrogel surface for Stem cell spheroid-based therapy
- Peripheral blood Stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series
- Measurable residual disease including AML leukemia Stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry
- Autologous Stem cell transplantation (ASCT) versus whole brain radiation (WBRT) as a consolidation therapy in primary CNS lymphoma (PCNSL): A nationwide …
- Extracorporeal shock wave therapy combined with engineered mesenchymal Stem cells expressing stromal cell-derived factor-1 can improve erectile …
- Performance features of hospital nurses in multidisciplinary rehabilitation team for the patients undergoing cytostatic therapy and hematopoietic Stem cell …
- Bioinformatics-Guided Design of Endogenously Regulated Lentiviral Vectors for Hematopoietic Stem cell Gene therapy
- Biological bone tissue engineering with adipose Stem cell combined gene therapy: A future prospect in treating o…
- Optimization of Preservation Solution and Temperature of Human Induced Pluripotent Stem cell-Derived Cardiomyocyte Patch for Regenerative therapy
- In prenatal Stem cell transplantation and in utero gene therapy, a wide spectrum of genetic diseases can be diagnosed and treated before birth
- … therapy for Patients With High Level of Anti-Human Leukocyte Antigen Donor-Specific Antibodies (Anti-HLA DSAs) Prior to Haploidentical Hematopoietic Stem cell …
- Mesenchymal Stem cells in the treatment of spinal cord injury: cell therapy and combination of new drugs and biomaterials
- Safety and efficacy of mesenchymal Stem cell (MSC) therapy in symptom management of multiple sclerosis as compared to the currently approved …
- Efficacy analysis of allogeneic hematopoietic Stem cell transplantation on therapy-related leukemia
- … therapy in patients (pts) with newly diagnosed multiple myeloma (NDMM) who are minimal residual disease (MRD) positive after frontline autologous Stem cell …
- Technological Advances of 3D Scaffold-Based Stem cell/Exosome therapy in Tissues and Organs
- Transplantation of human pluripotent Stem cell-derived cardiomyocytes for cardiac regenerative therapy
- Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of therapy Including Allogeneic Stem cell Transplantation Among Patients With …
- Preclinical Development of Autologous Hematopoietic Stem cell Based Gene therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side
- Potential cancer targeted therapy: role of microRNAs in breast cancer metastasis via epithelial-mesenchymal transition and cancer Stem cell regulation
- Long-term Outcomes of Brain-targeted Stem cell Gene therapy for Mucopolysaccharidosis Type II in a Pre-Clinical MPSII Mouse Model.
- Potential targeted therapy: The role of MicroRNAs in breast cancer metastasis via epithelial-mesenchymal transition and cancer Stem cell regulation
- Mesenchymal Stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy
- Emerging Antioxidant Paradigm of Mesenchymal Stem cell-Derived Exosome therapy
- Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem–cell-Driven therapy of Heart Failure in Mice
- Induced pluripotent Stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease
- Supplement to: Parotid Gland Stem cell Sparing Radiation therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial
- Mesenchymal Stem cell-Derived Exosome therapy of Microbial Diseases: From Bench to Bed
- … herpesvirus 6 re-activation after allogeneic Stem cell transplantation. Nakayama H, Yamazaki R, Kato J, et al. Transplantation and cellular therapy. 2021; 27: 174. e1 …
- The contributions of music therapy to the prevention and mitigation of the effects of toxic stress and trauma in pediatric patients undergoing Hematopoietic Stem cell …
- Profiling of gene and exosomal microRNA as therapy targets and biomarkers of cisplatin resistance in triple negative breast cancer Stem cell-like subpopulation
- The enzymatic disaggregation by trypsin does not alter cell quality and genomic stability of adipose-derived Stem cells cultivated for human cell therapy
- Mesenchymal Stem cells Derived Extracellular Vesicles as a New cell Free Biological Regenerative therapy
- Therapeutic Overcoming of Cancer Stem cell-Featured Chemo-Resistant Ovarian Cancer via Photodynamic therapy and Cascadic Chemotherapy Combined …
- Cytotoxic Engineered Induced Neural Stem cells as an Intravenous therapy for Primary Non–Small cell Lung Cancer and Triple-Negative Breast Cancer
- … Stem cell transplantation under venetoclax bridging myeloablative preconditioning regimen for an acute myeloid leukemia patient with primary induction therapy …
- … of Immunosuppressive therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem cell …
- Different Aspects of Head and Neck Squamous cell Carcinoma: Cancer Stem cells, their Niche and Targeted therapy
- Corona virus, origin and disease characteristics till cell therapy by mesenchymal Stem cells and exosomes: a gate for an effective therapeutic strategies
- … to allogeneic hematopoietic Stem cell transplantation followed by daratumumab and lenalidomide maintenance therapy for primary plasma cell leukemia: report of …
- … Followed by Sequential Autologous Hematopoietic Stem cell Transplantation and Lenalidomide-Based Maintenance therapy in Plasmablastic Lymphoma
- … Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem–cell …
- Epigenetic therapy Promotes the Ratio of Th1/Th17 Lineage to Reverse Immune Evasion and Treat Leukemia Relapse Post-allogeneic Stem cell …
- Mesenchymal Stem cells Lysate as a cell-Free therapy: A Review
- … of flavonoid compounds in walnut green skin on increasing cell therapy efficiency by differentiating adipose-derived mesenchymal Stem cells into insulin …
- Human Stem Leydig cells: A possible source for cell therapy in hypogonadism?
- Gene therapy with hematopoietic Stem and progenitor cell for monogenic disorders: a syStematic review and meta-analysis
- Engineering Human Stem cells for cell-Based therapy
- Immunosuppressed Miniswine as a Model for Testing cell therapy Success: Experience With Implants of Human Salivary Stem/Progenitor cell Constructs
- … Stem cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After therapy-Related Myelodysplastic Syndrome and CD8+ T-cell …
- Klotho and mesenchymal Stem cells: a review on cell and gene therapy for chronic kidney disease and acute kidney disease
- From Stem cells to functional lymphocytes: cell differentiation and gene therapy implementation for RAG-SCID
- Programmed cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem cells as Targeted therapy for Rheumatoid Arthritis
- Lentiviral Hematopoietic Stem and Progenitor cell Gene therapy for Metachromatic Leukodystrophy (MLD): Clinical Outcomes from 38 Patients
- Combined transcriptional, translational and cell surface targeted gene therapy of HER2-positive breast cancer Stem cells in three-dimentional cell culture
- Priming of mesenchymal Stem cells with a hydrosoluble form of curcumin allows keeping their mesenchymal properties for cell‐based therapy development
- … underlying highly-active or antiretroviral therapy-induced lipodystrophy: atazanavir, a protease inhibitor, compromises adipogenic conversion of adipose-derived Stem …
- cell‐Based therapy: Partial Coated Stem cells with Bioinspired Silica as New Generation of cellular Hybrid Materials (Adv. Funct. Mater. 29/2021)
- Effects of PARP Inhibitor therapy on p53-Deficient Hematopoietic Stem and Progenitor cell Fitness
- Long-Term Follow-up Study after Lentiviral Hematopoietic Stem/Progenitor cell Gene therapy for Wiskott-Aldrich Syndrome
- Advances in cell cryopreservation take a cue from nature: To minimize damage to frozen and thawed Stem cells used for therapy and research, new cryopreservation …
- Stem cell therapy: From idea to clinical practice
- Is hypoimmunogenic Stem cell therapy safe in times of pandemics?
- A Review of Recent Advances in Nanomaterial-based Stem cell therapy and the Corresponding Risks
- Innovations in Stem cell therapy for diabetic wound healing
- The synthetic artificial Stem cell (SASC): Shifting the paradigm of cell therapy in regenerative engineering
- Stem cell therapy Targets: Repêchage!
- Cardiac Stem cell therapy: Does a newborn infant’s heart have infinite potential for Stem cell therapy?
- Clinical translation of Stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1
- Dental Pulp Stem cell therapy in Ischemic Stroke: A Meta-Analysis of Preclinical Studies
- Exploring the role of Stem cell therapy in treating neurodegenerative diseases: Challenges and current perspectives
- Preclinical studies and clinical trials on mesenchymal Stem cell therapy for knee osteoarthritis: A syStematic review on models and cell doses
- Combination of Stem cell therapy and acupuncture to treat ischemic stroke: a prospective review
- Stem–cell therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
- Shining the light on clinical application of mesenchymal Stem cell therapy in autoimmune diseases
- Mesenchymal Stem cell therapy in Diabetic Cardiomyopathy
- Stem cell therapy applied for digestive anastomosis: Current state and future perspectives
- SUPT4H1-edited Stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington’s disease
- Adult Stem cell therapy for premature ovarian failure: from bench to bedside
- Evolution of Mesenchymal Stem cell therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
- Stem cell therapy for Neuroprotection in the Growth-Restricted Newborn
- … ‐CoV‐2 vaccination in hematopoietic Stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem cell Transplantation and cell therapy …
- Current status of clinical trials assessing mesenchymal Stem cell therapy for graft versus host disease: a syStematic review
- Targeted mesenchymal Stem cell therapy equipped with a cell-tissue nanomatchmaker attenuates osteoarthritis progression
- Neurofunctional and neuroimaging readouts for designing a preclinical Stem–cell therapy trial in experimental stroke
- Stem cell therapy for vocal fold regeneration after scarring: a review of experimental approaches
- Electroactive Scaffolds to Improve Neural Stem cell therapy for Spinal Cord Injury
- Application of some graphene derivatives to increase the efficiency of Stem cell therapy
- An Outstanding Role of Adipose Tissue in Canine Stem cell therapy
- … mitigate inflammasome signaling and cellular apoptosis is one of the neuroprotective effects of intra-arterial mesenchymal Stem cell therapy following ischemic stroke
- Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and Stem cell therapy
- Stem cell therapy for pulmonary arterial hypertension: An update
- Real-world evidence of mesenchymal Stem cell therapy in knee osteoarthritis: a large prospective two-year case series
- Safety study of allogeneic mesenchymal Stem cell therapy in animal model
- Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic Stem cell therapy
- Neural Stem cell therapy in conjunction with curcumin loaded in niosomal nanoparticles enhanced recovery from traumatic brain injury
- Efficacy of Stem cell therapy in Large Animal Models of Ischemic Cardiomyopathies: A SyStematic Review and Meta-Analysis
- Mesenchymal stromal (Stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
- Injectable Self-Crosslinkable Thiolated Hyaluronic Acid for Stem cell therapy of Atopic Dermatitis
- Efficacy and Safety of Stem cell therapy in Children With Autism Spectrum Disorders: A SyStematic Review and Meta-Analysis
- Advances in Stem cell therapy in Alzheimer’s disease: a comprehensive clinical trial review
- Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality
- Neurophysiological outcomes following mesenchymal Stem cell therapy in multiple sclerosis
- Mesenchymal Stem cell-based COVID-19 therapy: Bioengineering perspectives
- Normal ex vivo mesenchymal Stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic …
- Genetically Engineered Mesenchymal Stem cell therapy Against Murine Experimental Autoimmune Encephalomyelitis
- Stem cell therapy for COVID-19 pneumonia
- Mesenchymal stromal/Stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a syStematic review and meta …
- Applications of Stem cell therapy and Adipose-Derived Stem cells for Skin Repair
- Human corneal stromal Stem cells express anti-fibrotic microRNA-29a and 381-5p–a robust cell selection tool for Stem cell therapy of corneal scarring
- Polyphenols as potential enhancers of Stem cell therapy against neurodegeneration
- Save the day with a Stem cell Rescue’: Use of autologous hematopoietic Stem cell boost for hematopoietic recovery after CAR T cell therapy
- Stem cell therapy–When We Can Use Such Terminology?
- Current Status of Stem cell therapy in Heart Failure
- Mesenchymal Stem cell therapy for Focal Epilepsy: A SyStematic Review of Preclinical Models and Clinical Studies
- Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous Stem‐cell transplantation for high‐risk newly diagnosed …
- Novel vision restoration techniques: 3D bioprinting, gene and Stem cell therapy, optogenetics, and the bionic eye
- Recent Investigations on Neurotransmitters’ Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies—Glia Dynamics in Stem cell therapy
- Is there a role for Stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials
- Mesenchymal Stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial
- Mesenchymal Stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in …
- Autologous CD34+ Stem cell therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction
- Melatonin treatment improves human umbilical cord mesenchymal Stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling …
- Mesenchymal Stem cell therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn’s Disease: An International Survey Among …
- Immunological barriers to haematopoietic Stem cell gene therapy
- Autologous versus allogeneic mesenchymal Stem cell therapy: The pros and cons
- An Investigation of Google Searches for Knee Osteoarthritis and Stem cell therapy: What are Patients Searching Online?
- Effects of Stem cell therapy on Diabetic Mellitus Erectile Dysfunction: A SyStematic Review and Meta-analysis
- Regenerative Rehabilitation and Stem cell therapy Targeting Chronic Spinal Cord Injury: A Review of Preclinical Studies
- Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic Stem cell transplantation
- Mesenchymal Stem cell therapy for alleviating ocular surface inflammation in allergic conjunctivitis
- Low-dose mesenchymal Stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study
- Stem cell therapy for Parkinson’s disease
- Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent Stem cell therapy
- The Current Role of Stem cell therapy and iPS cells
- Metabolic Rewiring by Human Placenta-Derived Mesenchymal Stem cell therapy Promotes Rejuvenation in Aged Female Rats
- Strategies of pluripotent Stem cell-based therapy for retinal degeneration: update and challenges
- Current Status and Perspectives of Human Mesenchymal Stem cell therapy 2020
- Multimodality imaging in the assessment of bone marrow-derived mesenchymal Stem cell therapy for doxorubicin-induced cardiomyopathy
- Mesenchymal Stem cell therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a SyStematic Review and Meta-analysis
- Neuronal circuitry reconstruction after Stem cell therapy in damaged brain
- Development of an induced pluripotent Stem cell–specific microRNA assay for detection of residual undifferentiated cells in natural killer cell therapy products
- Stem cell therapy for Spinal Cord Injury: A Review of Recent Clinical Trials
- The Potential Therapeutic Effect of Orexin-Treated versus Orexin-Untreated Adipose Tissue-Derived Mesenchymal Stem cell therapy on Insulin Resistance …
- Mesenchymal Stem cell-Derived Nanovesicles as a Credible Agent for therapy of Pulmonary Hypertension
- Allogeneic double‐negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic Stem cell transplantation: A first‐in‐human …
- Mesenchymal Stem cell therapy for Chronic Wound Healing
- Mesenchymal Stem cell therapy for Osteoarthritis: Practice and Possible Promises
- Stem cell and Exosome therapy in Pulmonary Hypertension
- Mesenchymal Stem cell (MSCs) therapy for Ischemic Heart Disease: A Promising Frontier
- Stem cell therapy: From Idea to Clinical Practice.
- Cost utility of lifelong immunoglobulin replacement therapy vs hematopoietic Stem cell transplant to treat agammaglobulinemia
- Autologous NK cells as consolidation therapy following Stem cell transplantation in multiple myeloma
- Combination therapy of Stem cell-derived Exosomes and Biomaterials in the Wound Healing
- Stem cell Transplantation therapy and Neurological Disorders: Current Status and Future Perspectives
- Stem cell therapy for Learning Disability
- Mesenchymal Stem cell therapy for Inflammatory Bowel Disease
- Clinical Application of Stem cell therapy in Reconstructing Maxillary Cleft Alveolar Bone Defects: A SyStematic Review of Randomized Clinical Trials
- Evolution of Mesenchymal Stem cell therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective. Bioengineering 2022, 9, 111
- CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic Stem cell transplantation
- Autologous Stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
- Stem cell Educator therapy in type 1 diabetes: From the bench to clinical trials
- Mesenchymal Stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
- Longitudinal Patient Reported Outcomes with CAR-T cell therapy vs Autologous and Allogeneic Stem cell Transplant
- Cardiac cell therapy with Pluripotent Stem cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
- Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic Stem cell transplantation
- Meniscus repair: up-to-date advances in Stem cell-based therapy
- Stem cell therapy and Regenerative Medicine for ARDS: Can Stem cell therapy and Regenerative Medicine Contribute to the Protection or Recovery of the Injured …
- Therapeutic potential of mesenchymal Stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects
- A 3D Mathematical Model of Coupled Stem cell-Nutrient Dynamics in Myocardial Regeneration therapy
- Mesenchymal Stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy
- Potential of Stem cell-Based therapy to Restore Function in Aging SyStems: Are We There Yet?
- Online seminars as an information source for direct-to-consumer Stem cell therapy
- Nanoparticles functionalized with Stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy
- Tracking cell Viability for Adipose-Derived Mesenchymal Stem cell-Based therapy by Quantitative Fluorescence Imaging in the Second Near-Infrared Window
- Recent advances of 3D hydrogel culture syStems for mesenchymal Stem cell-based therapy and cell behavior regulation
- Current State of Stem cell therapy for Heart Diseases
- Multinuclear MRI reveals early efficacy of Stem cell therapy in stroke
- Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
- Breast Cancer Stem cell Membrane Biomarkers: therapy Targeting and Clinical Implications
- Stem cell therapy: Significance and Applications of Stem cell Products in Tissue Engineering and Regenerative Medicine
- Engineered mesenchymal Stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer
- Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases
- Inflammation, Stem cell therapy, and Cardiac Repair
- Induction therapy prior to autologous Stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
- Stem cell therapy for Myocardial Infarction: A Mini-Review
- Lentiviral haematopoietic Stem–cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase …
- Mesenchymal Stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
- Genetically-modified Stem cell in regenerative medicine and cancer therapy; a new era
- Niche-directed therapy in acute myeloid leukemia: optimization of Stem cell competition for niche occupancy
- Author Correction: SUPT4H1-edited Stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington’s disease
- Impact of induction therapy with VRD versus VCD on outcomes in patients with multiple myeloma in partial response or better undergoing upfront autologous Stem cell …
- Parotid gland Stem cell sparing radiation therapy for patients with head and neck cancer: A double-blind randomized controlled trial
- Iron Oxide Nanoparticles in Mesenchymal Stem cell Detection and therapy
- Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem cell-Derived Exosomes in cell-Free therapy
- Embryonic and fetal toxic lesions and Stem cell therapy
- Moral obligations in conducting Stem cell-based therapy trials for autism spectrum disorder
- … antigen receptor T‐cell therapy combined with autologous Stem cell transplantation improved progression‐free survival of relapsed or refractory diffuse large B‐cell …
- Allogeneic Stem cell therapy in Heart Failure
- Anti-Xa based dosing of enoxaparin in hematopoietic Stem cell transplant and adoptive cell therapy patients: A single center experience
- Rituximab as adjunctive therapy to BEAM conditioning for autologous Stem cell transplantation in Hodgkin lymphoma
- Mesenchymal Stem cell–Based therapy as a New Approach for the Treatment of SyStemic Sclerosis
- Neural Stem cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem cells in therapy of Spinal Bifida Aperta
- Targeting Oxidative Stress in Cancer: Opportunity for Natural and Synthetic Compounds, and Cancer Stem cell therapy
- Off-the-Shelf Third-Party Virus-Specific T cell therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem cell Transplantation Recipients
- The combined therapy of mesenchymal Stem cell transplantation and resveratrol for diabetes: Future applications and challenges
- Impact of maintenance therapy post autologous Stem cell transplantation for multiple myeloma in early and delayed transplant
- … therapy Stem cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo Stem cell gene therapy versus allogeneic hematopoietic Stem …
- Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous Stem cell transplantation
- Heterogeneity of mesenchymal Stem cells: characterization and application in cell therapy
- Stem cell therapy to Approach Refractory Asherman’s Syndrome
- Role of flow cytometry in evaluation of the cellular therapy products used in haematopoietic Stem cell transplantation
- Preemptive Interferon-α therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem cell …
- A review on the progress of Stem cell therapy as a treatment for Diabetes mellitus
- An organoid model of colorectal circulating tumor cells with Stem cell features, hybrid EMT state and distinctive therapy response profile
- Role of Stem cell therapy in neurosciences
- Suicide gene therapy by canine mesenchymal Stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and …
- Haematopoietic Stem cell gene therapy in inborn errors of metabolism
- Current status, challenges and reflections on Stem cell therapy for liver diseases
- Registered Trials on Stem cell therapy in Liver Diseases: a Cross-sectional Study on ClinicalTrials. gov
- … and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic Stem cell transplantation for relapsed Philadelphia chromosome-like B-cell …
- Mesenchymal Stem cell-Derived Extracellular Vesicles: Pleiotropic Impacts on Breast Cancer Occurrence, Development, and therapy
- Salvage high-dose melphalan with autologous Stem cell transplantation as bridge to consolidation therapy for chemoresistant aggressive B-cell lymphoma
- Advances, Opportunities, and Challenges in Stem cell-Based therapy
- Adoptive therapy with cytomegalovirus‐specific T cells for cytomegalovirus infection after haploidentical Stem cell transplantation and factors affecting efficacy
- A Compendium of Recent Research on Stem cell-Based therapy for Covid-19
- Stem cell therapy in the Treatment of Elbow Joint Osteoarthritis in Dogs
- Carbonic anhydrase IX-targeted chemodynamic & photodynamic cancer Stem cell therapy
- Preventive Effects of a Human Hematopoietic Mesenchymal Stem cell (hHMSC) therapy in Ovalbumin-Induced Food Allergy
- Autophagy Regulation on Cancer Stem cell Maintenance, Metastasis, and therapy Resistance
- Recognising inequalities in haematopoietic Stem–cell transplantation and cellular therapy training
- A New Target of Dental Pulp-Derived Stem cell-Based therapy on Recipient Bone Marrow Niche in SyStemic Lupus Erythematosus
- … Modulation of Inflammasome Signaling Confers Neuroprotection in Rodent Model of Ischemic Stroke Following Endovascular Mesenchymal Stem cell therapy (S33 …
- Rapid Stem cell Extraction and Culture Device for Regenerative therapy Using Biodegradable Nonwoven Fabrics with Strongly Oriented Fibers
- Ocular disorders and Stem cell therapy: A review
- Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous Stem cell transplantation
- Use of stromal vascular fraction Stem cell therapy for functional and cosmetic outcomes in a young female patient with deep dermal flame burns on the face
- Safety Assessment of Autologous Stem cell Combination therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study
- Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem cell Gene therapy the Solution for This Devastating Disorder?
- Commentary: Defining the role of Stem cell therapy in neonatal cardiac regeneration
- Patient-Derived Stem cell therapy for Diabetic Kidney Disease
- Isolation and Purification of Self-Renewable Human Neural Stem cells from iPSCs for cell therapy in Experimental Model of Ischemic Stroke
- … fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous Stem cell transplant between 2000 …
- Hematopoietic Stem cell transplantation and cellular therapy
- Stem cell therapy in Advanced Heart Failure
- Canine adipose tissue-derived mesenchymal Stem cell therapy in a dog with renal Fanconi syndrome
- Stem cell therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study
- Preclinical Research of Mesenchymal Stem cell-Based therapy for Ocular Diseases
- … of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic Stem cell …
- A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent Stem cells
- Stem cell-based therapy for myopic maculopathy: a new concept
- Real-World Use of Isavuconazole as Primary therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem cell Transplant
- Applications and Challenges of Neural Stem cell therapy
- Current Concepts of Neural Stem/Progenitor cell therapy for Chronic Spinal Cord Injury
- Gene-Directed Enzyme/Prodrug therapy of Rat Brain Tumor Mediated by Human Mesenchymal Stem cell Suicide Gene Extracellular Vesicles In Vitro and In Vivo
- Donor hematopoietic Stem cell/lymphocyte as maintenance treatment after CAR T-cell therapy in B-cell acute lymphoblastic leukemia relapsed after Stem cell …
- … cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin therapy
- A new step in understanding Stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy
- Mesenchymal Stem cell derived exosomes-based immunological signature in a rat model of corneal allograft rejection therapy
- Allogeneic hematopoietic Stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma
- First-line high-dose therapy and autologous blood Stem cell transplantation in patients with primary central nervous syStem non-Hodgkin lymphomas—a …
- Hematopoietic Stem cell Gene therapy Ameliorates CNS Involvement in Murine Model of GM1-gangliosidosis
- Blinatumomab as a Bridge therapy for Hematopoietic Stem cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia
- Chemotherapy or Allogeneic Stem cell Transplantation as Salvage therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis
- Mesenchymal Stem cell-Extracellular Vesicle therapy in Patients with Stroke
- Mesenchymal Stem cell therapy in COVID-19 pneumonia: a prospective, randomized clinical research
- Stem cell and Gene therapy for Inherited Retinal Diseases
- Mesenchymal Stem cell therapy for Patients with Post COVID ARDS on ECMO Referred for Lung Transplantation-Single Center Experience from India
- Quality Improvement in Hematopoietic Stem cell Transplant and cellular therapy: Using the Model for Improvement to impact Outcomes
- Disease modifying therapy management of multiple sclerosis after Stem cell therapies: A retrospective case series
- Nanotechnology in Stem cell Regenerative therapy and Its Applications
- Alzheimer’s disease: from pathogenesis to mesenchymal Stem cell therapy—bridging the missing link
- The Secret World of Stem cell therapy: What YOU Need to Know about the Health, Beauty, and Anti-Aging Breakthrough
- Heal thyself: The promise of autologous hematopoietic Stem cell gene therapy in neurometabolic disorders
- Stem cell therapy in Ischemic Non-treatable Cardiac Disease
- Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic Stem cell transplant recipients
- … Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem cell Transplant Followed by Melphalan therapy
- Mesenchymal Stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases
- Volumetric modulated arc therapy total body irradiation in pediatric and adolescent/young adult patients undergoing Stem cell transplantation: Early outcomes and …
- Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem cell therapy.
- Mesenchymal Stem cell as a Successful therapy for COVID-19 Patient: SyStematic Review
- … of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic Stem cell transplantatio: a multi …
- Research advances on Stem cell therapy for diabetic foot wounds
- Parotid Gland Stem cell Sparing Radiation therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial
- The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous Stem cell transplantation
- The Use of Mesenchymal Stem cell therapy in the Management of Spinal Cord Injuries
- Effect of Stem cell Infusion therapy on Sexual Function in Men and Women with Type 2 Diabetes and Metabolic Syndrome: Results from the ACESO & CERES …
- WBMT Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem cell Transplantation and cellular therapy
- Reply to” Prophylactic Allogeneic Hematopoietic Stem cell therapy for CSF1R-Related Leukoencephalopathy”
- The EHA Research Roadmap: Hematopoietic Stem cell Gene therapy
- Augmenting Mesenchymal Stem cell-Based therapy of the Infarcted Myocardium with Statins
- … )-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic Stem cell …
- Correction to Endovascular Stem cell therapy Post Stroke Rescues Neurons from Endoplasmic Reticulum Stress-Induced Apoptosis by Modulating Brain-Derived …
- … , ViaCyte Dose First Patient with cell therapy for Type 1 Diabetes: VCTX210 uses gene editing to engineer ViaCyte’s CyT49 pluripotent human Stem cell line, to avoid …
- Training the Graft: Enriched Environment and Exercise Enhance Stem cell therapy for Stroke, Parkinson’s Disease, and Huntington’s Disease
- Mesenchymal Stem cell therapy: challenges and future prospects
- Transformative Stem cell-Based therapy in Neurological Diseases and Beyond
- … with Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem cell …
- … Reconstitution following High-Dose Chemotherapy and Autologous Stem cell Transplantation with or without Pembrolizumab Maintenance therapy in Patients with …
- The Promise of CAR T-cell therapy for the treatment of cancer Stem cells: A Short Review.
- Short and Medium-term results of the autologous adult mucosa Stem cell therapy compared with mini-sling surgery in the treatment of women’s stress urinary …
- Impact of radiation therapy after high dose chemotherapy and autologous hematopoietic Stem cell transplantation in patients with relapsed/refractory lymphomas: A …
- Stem cell therapy for Treatment of Lower Back Pain Due to Degenerative Disk Disease: A SyStematic Review
- Stem cell therapy in Rats with Experimental Intrauterine Adhesions Induced by Trichloroacetic Acid
- … t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood Stem cell transplantation for hematologic …
- Stem cell Educator therapy in Diabetes
- Activation of the AKT/GSK-3β/β-catenin pathway via photobiomodulation therapy promotes neural Stem cell proliferation in neonatal rat models of hypoxic …
- Efficacy and Safety of Iron Chelation therapy After Allogeneic Hematopoietic Stem cell Transplantation in Pediatric Thalassemia Patients: A Retrospective …
- An innovative hematopoietic Stem cell gene therapy approach benefits CLN1 disease in the mouse model
- Antibiotic therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem cell Transplantation Population
- Mesenchymal Stem cell therapy for COVID-19-induced ARDS patients. A successful phase1, randomized, control-placebo group, clinical trial
- Radiation therapy for Young Children Treated with High-Dose Chemotherapy and Autologous Stem cell Transplantation for Primary Brain Tumors
- Donor hematopoietic Stem cell/lymphocyte as maintenance treatment after CAR T-cell therapy in B-cell acute lymphoblastic leukemia relapsed after Stem cell …
- Dose-dependent Improvement In Stroke Outcomes Following Intra-arterial Mesenchymal Stem cell therapy In A Canine Endovascular Stroke Model
- Breast Cancer Stem cell Membrane Biomarkers: therapy Targeting and Clinical Implications. cells 2022, 11, 934
- Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic Stem cell transplantation: A propensity …
- Remarkable pain control and functional improvement in clubfeet-related ankle osteoarthritis post autologous expanded mesenchymal Stem cell therapy
- … caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic Stem cell transplantation with colistin and amikacin inhalation therapy
- Expanded Mesenchymal Stem cell therapy for Symptomatic Knee Osteoarthritis
- Stem cell-Based therapy for Diabetic Foot Ulcers.
- Mesenchymal Stem cells: As a multi-target cell therapy for clearing β-amyloid deposition in Alzheimer’s disease
- Application of Stem cell and Exosome-Based therapy in COVID
- Cytokine storm and Stem cell activation in unveiling potential targets for diagnosis and therapy
- Integrin Receptor-Binding Nanofibrous Peptide Hydrogel for Combined Mesenchymal Stem cell therapy and Nitric Oxide Delivery in Renal Ischemia/Reperfusion …
- Immune restoration therapy for multidrug-resistant CMV disease in an allogenic Stem cell transplant recipient
- Preclinical Studies of Neural Stem/Progenitor cell therapy for Ischemic Stroke: A SyStematic Review.
- An Infodemic of Misinformation on Stem cell therapy Among the Population of Saudi Arabia: A Cross-Sectional Study
- … a Diagnosis of High-Risk Myeloma Refractory to Multiple Line of therapy and Treated with Selinexor, Bortezomib, and Dexamethasone Prior to Allogeneic Stem cell …
- Safety and efficacy of allogeneic hematopoietic Stem cell transplantation in R/R B-NHL patients with disease progression after CAR-T therapy
- Mesenchymal Stem cell-based therapy and female infertility: limitations and advances.
- Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem cell therapy
- Allogeneic Mesenchymal Human Stem cell Infusion therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO)
- A Pilot Study of the Therapeutic Potential of Stem cell Educator therapy in Type 1 Diabetes
- Sequential CAR T-cell therapy After Autologous Stem cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-cell Lymphoma With …
- Erratum to: Stem cell-derived extracellular vesicle therapy for acute brain insults and neurodegenerative diseases
- S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC Stem cell GENE therapy
- cell therapy Based on Gingiva-Derived Mesenchymal Stem cells Seeded in a Xenogeneic Collagen Matrix for Root Coverage of RT1 Gingival Lesions: An In Vivo …
- Will novel targeted drugs or immunocyte therapy replace hematopoietic Stem cell transplantation
- E-Selectin-Overexpressing Mesenchymal Stem cell therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia …
- The key factors influencing patients in selecting autologous hematopoietic Stem–cell transplantation as the main therapy for multiple myeloma: A population …
- Generation of thymic cells from pluripotent Stem cells for basic research and cell therapy
- Reversal of Type 1 Diabetes in Children by Stem cell Educator therapy
- … case report of haploidentical hematopoietic Stem cell trans-plantation for diffuse large B-cell lymphoma developing in the course of immunosuppressive therapy …
- Attenuation of the Stem cell properties and the oxidative phosphorylation by ampelopsin in therapy-resistant MDA-MB-231 breast cancer cells.
- Lenalidomide, Bortezomib, and Dexamethasone as Induction therapy Before Autologous Stem cell Transplant for Multiple Myeloma
- Effectiveness of combined therapy with midostaurin and standard chemotherapy and high-dose chemotherapy with allogeneic Stem cell transplantation in high-risk …
- Stem cell-Based therapy in Retinal Degeneration
- Acute radiation syndrome: On the issues of triage, Stem cell sources and immunosuppressive therapy
- Expression of RAD6, DDB2 and Cancer Stem cell / CSC Protein (CD44 +/CD24 -) on therapy Response to the Administration of Chemotherapy in Ovarian Cancer …
- Music therapy Effects after Autologous Stem cell Transplantation (ASCT)
- Adoptive therapy with CMV-specific T cells for CMV infection after haploidentical Stem cell transplantation and factors affecting efficacy.
- Low-Level Laser therapy: A Literature Review of the Prevention and Reduction of Oral Mucositis in Patients Undergoing Stem cell Transplantation
- Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood Stem cell transplantation: A retrospective comparative study
- Hematopoietic Stem cell-derived fibrocytes as targets and tools for cancer therapy: mechanisms and therapeutic implications
- hiPSC-neural Stem/progenitor cell transplantation therapy for spinal cord injury.
- Improving the Safety of Mesenchymal Stem cell-Based Ex Vivo therapy Using Herpes Simplex Virus Thymidine Kinase.
- … and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem cell Transplantation and cellular therapy
- Mesenchymal Stem cell-Derived Extracellular Vesicles in Liver Immunity and therapy
- Mesenchymal Stem cell-Based therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
- … T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic Stem cell transplantation or after gene therapy
- Limbal Mesenchymal Stem cell Secretome as Potential Adjuvant therapy for Ocular Alkali Injury
- Physiologic isolation and expansion of human mesenchymal Stem/stromal cells for manufacturing of cell‐based therapy products
- Preferential Expansion of Human CD34+CD133+CD90+ Hematopoietic Stem cells Enhances Gene-Modified cell Frequency for Gene therapy
- Stem cell-Derived Exosome therapy of Microbial Diseases: From Bench to Bed
- … ) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning therapy for Autologous Stem cell Transplantation in Patients …
- Mesenchymal Stem–cell Derived Exosome therapy as a Potential Future Approach for Treatment of Male Infertility Caused by Chlamydia Infection
- The CCR5 gene-edited CD34+ CD90+ Hematopoietic Stem cell population serves as an optimal graft source for HIV gene therapy
- Comparison of Hematopoietic Stem cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive therapy …
- Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer Stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell …
- Enzymatic self-assembly nanofibers anchoring mesenchymal Stem cells induce cell spheroids and amplify paracrine function for myocardial infarction therapy
- Intratumoural haematopoietic Stem and progenitor cell differentiation into M2 macrophages facilitates the regrowth of solid tumours after radiation therapy
- … Potential of Microvesicles in cell therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem cells-Derived Microvesicles …
- Long-term safety and efficacy of lentiviral hematopoietic Stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
- … Tissue-Mesenchymal Stem cells Caused to Change the Methylation Status of hTERT Gene Promoter CpG Islands of Molt-4 Leukemia cells as cell-based therapy
- Utilising S/MAR DNA vectors for the genetic modification of human induced pluripotent Stem cells for cell and gene therapy
- Melanocyte Stem cells in skin diseases and their potential in cell-based therapy.
- Mesenchymal Stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification.
- … syStem suicide gene therapy using Stem cells of human exfoliated deciduous teeth (SHED) expressing “Modified” HSV-TK against brain metastasis of non small cell …
